data_2mum_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2mum _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 3.2 tm? . . . . . 0 N--CA 1.471 0.597 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 224' ' ' TYR . . . . . 0.455 ' HE1' ' HE3' ' A' ' 244' ' ' LYS . 60.3 m-85 -148.32 125.42 11.41 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.657 1.183 . . . . 0.0 108.301 172.372 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 47.1 t 173.26 163.03 0.14 Allowed 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 124.7 1.2 . . . . 0.0 109.88 174.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -65.94 -33.97 77.03 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 122.41 0.284 . . . . 0.0 111.406 175.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 13.3 p -84.01 -5.86 59.31 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 122.152 0.181 . . . . 0.0 111.412 176.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 82.5 mm-40 48.67 85.95 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 125.467 1.507 . . . . 0.0 112.743 -175.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 22.9 tpp180 -153.92 148.54 26.32 Favored 'General case' 0 C--O 1.244 0.784 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 177.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 25.7 m -62.4 149.71 9.37 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 O-C-N 123.838 0.711 . . . . 0.0 110.73 178.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 17.5 p -87.01 69.52 10.24 Favored 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 123.382 0.673 . . . . 0.0 110.141 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 94.5 t80 -70.5 98.28 1.43 Allowed 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.164 0.986 . . . . 0.0 110.576 -176.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 78.5 -17.59 6.43 Favored Glycine 0 CA--C 1.536 1.404 0 CA-C-N 116.133 -0.485 . . . . 0.0 113.97 176.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -122.32 105.62 10.36 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.217 1.007 . . . . 0.0 108.424 178.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 235' ' ' MET . . . . . . . . . . . . . 21.3 ptt? -136.53 102.19 4.86 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 121.949 0.88 . . . . 0.0 111.143 178.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 5.0 p -101.48 123.72 54.77 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.785 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 172.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -92.67 147.82 22.57 Favored 'General case' 0 C--O 1.241 0.607 0 C-N-CA 123.168 0.587 . . . . 0.0 110.206 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 238' ' ' CYS . . . . . 0.499 ' HB3' ' HA ' ' A' ' 246' ' ' GLU . 35.4 t -106.41 154.52 20.7 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 124.034 0.934 . . . . 0.0 110.708 -179.228 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -111.15 96.23 6.01 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 170.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -140.67 119.93 1.65 Allowed Glycine 0 CA--C 1.527 0.802 0 CA-C-O 118.518 -1.156 . . . . 0.0 111.511 177.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -53.51 -39.07 83.68 Favored 'Trans proline' 0 C--N 1.382 2.323 0 C-N-CA 123.42 2.747 . . . . 0.0 113.276 174.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -114.76 101.73 9.34 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 171.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 12.8 t -173.07 102.82 0.13 Allowed 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 -173.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 244' ' ' LYS . . . . . 0.455 ' HE3' ' HE1' ' A' ' 224' ' ' TYR . 52.7 tptt -81.51 -31.34 32.87 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 123.252 0.621 . . . . 0.0 109.738 170.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -81.54 26.92 0.45 Allowed 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 124.938 1.295 . . . . 0.0 112.541 -179.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 246' ' ' GLU . . . . . 0.499 ' HA ' ' HB3' ' A' ' 238' ' ' CYS . 6.1 mm-40 -47.35 -45.77 25.0 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 123.883 0.873 . . . . 0.0 112.541 -178.099 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 247' ' ' TRP . . . . . 0.445 ' HB2' ' HB2' ' A' ' 224' ' ' TYR . 97.9 m95 -86.26 141.04 29.57 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.049 0.452 . . . . 0.0 111.035 178.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 32.9 m-85 -145.58 174.22 11.37 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.333 1.453 . . . . 0.0 109.231 176.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 249' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -113.47 141.11 47.5 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 168.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -54.95 -43.01 73.02 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.856 1.262 . . . . 0.0 112.673 -170.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -63.87 -34.47 78.02 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.389 0.676 . . . . 0.0 112.417 -175.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 252' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -65.55 -47.45 75.82 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-O 121.32 0.581 . . . . 0.0 110.246 179.12 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 30.6 m -88.04 5.46 4.02 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.897 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.747 -176.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 55.2 t30 58.73 70.91 0.62 Allowed 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.801 1.24 . . . . 0.0 110.785 178.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 76.6 mt -141.22 152.74 44.84 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.479 1.112 . . . . 0.0 109.121 177.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.8 -21.35 1.94 Allowed 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 123.864 0.866 . . . . 0.0 109.794 166.186 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -78.85 118.62 73.48 Favored Pre-proline 0 N--CA 1.478 0.97 0 C-N-CA 123.685 0.794 . . . . 0.0 109.49 176.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -57.34 121.36 9.91 Favored 'Trans proline' 0 C--N 1.372 1.799 0 C-N-CA 122.78 2.32 . . . . 0.0 111.129 165.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 259' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -52.92 132.79 48.83 Favored 'Trans proline' 0 C--N 1.378 2.12 0 C-N-CA 123.829 3.019 . . . . 0.0 113.738 -178.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 60.2 pttt -83.34 -2.55 55.99 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.313 1.045 . . . . 0.0 112.244 178.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -168.77 -155.63 9.83 Favored Glycine 0 C--N 1.344 0.984 0 CA-C-O 120.033 -0.315 . . . . 0.0 112.502 -179.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 25.8 p -62.19 106.81 0.78 Allowed 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.949 0.9 . . . . 0.0 111.447 -175.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 263' ' ' TRP . . . . . . . . . . . . . 63.1 t90 -92.49 113.98 26.41 Favored 'General case' 0 C--N 1.347 0.481 0 CA-C-N 115.771 -0.649 . . . . 0.0 109.435 -176.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 45.8 m-85 -93.68 118.6 31.61 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 175.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 265' ' ' CYS . . . . . 0.442 ' SG ' ' HB2' ' A' ' 267' ' ' GLU . 18.4 p -66.39 152.98 93.76 Favored Pre-proline 0 CA--C 1.545 0.774 0 CA-C-O 118.507 -0.759 . . . . 0.0 109.715 175.047 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_exo -47.85 -29.01 10.73 Favored 'Trans proline' 0 C--N 1.384 2.446 0 C-N-CA 123.728 2.952 . . . . 0.0 114.244 -178.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 267' ' ' GLU . . . . . 0.442 ' HB2' ' SG ' ' A' ' 265' ' ' CYS . 9.5 mp0 -64.74 -53.71 42.83 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 125.078 1.351 . . . . 0.0 109.814 178.352 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 268' ' ' CYS . . . . . . . . . . . . . 94.4 m -62.04 -34.91 77.12 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.29 0.636 . . . . 0.0 111.232 176.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -68.13 -23.99 64.95 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.291 0.636 . . . . 0.0 111.929 -179.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 2.8 pp -102.69 -4.68 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 N-CA-C 111.768 0.285 . . . . 0.0 111.768 175.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 . . . . . 0 N--CA 1.484 1.274 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 170.876 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 58.1 tp . . . . . 0 N--CA 1.472 0.666 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 224' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -136.72 128.89 29.72 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -173.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 42.2 t 172.75 166.9 0.12 Allowed 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 125.262 1.425 . . . . 0.0 108.838 171.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -68.34 -38.37 81.44 Favored 'General case' 0 N--CA 1.484 1.273 0 O-C-N 121.969 -0.457 . . . . 0.0 110.427 175.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 10.0 p -83.79 -9.8 58.54 Favored 'General case' 0 N--CA 1.484 1.257 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.909 176.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 22.2 mm-40 48.66 77.61 0.1 Allowed 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 124.742 1.217 . . . . 0.0 112.114 -173.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 229' ' ' ARG . . . . . 0.469 ' HE ' ' HE2' ' A' ' 232' ' ' PHE . 26.7 ttt85 -135.73 149.65 49.27 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.625 1.17 . . . . 0.0 108.273 -175.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 29.0 m -70.33 160.07 5.27 Favored 'Isoleucine or valine' 0 C--O 1.242 0.696 0 CA-C-O 121.255 0.55 . . . . 0.0 110.647 177.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 231' ' ' SER . . . . . 0.714 ' HB3' ' HB3' ' A' ' 235' ' ' MET . 48.2 m -113.88 118.18 33.47 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 176.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 232' ' ' PHE . . . . . 0.469 ' HE2' ' HE ' ' A' ' 229' ' ' ARG . 3.9 p90 -112.23 66.54 0.64 Allowed 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.318 1.047 . . . . 0.0 110.091 -167.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 86.58 -21.76 16.69 Favored Glycine 0 N--CA 1.472 1.086 0 CA-C-N 115.002 -0.999 . . . . 0.0 113.51 179.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 30.7 mm-40 -106.56 99.04 8.64 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 170.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 235' ' ' MET . . . . . 0.714 ' HB3' ' HB3' ' A' ' 231' ' ' SER . 25.7 ptt? -142.14 123.3 14.65 Favored 'General case' 0 C--O 1.241 0.647 0 CA-C-O 121.325 0.584 . . . . 0.0 110.836 178.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . 0.495 HG21 ' HG3' ' A' ' 259' ' ' PRO . 6.2 p -100.12 124.62 53.7 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 CA-C-N 115.332 -0.849 . . . . 0.0 108.912 172.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -91.2 148.19 22.53 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.31 -178.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 238' ' ' CYS . . . . . 0.57 ' HB3' ' HA ' ' A' ' 246' ' ' GLU . 36.7 t -108.09 153.15 23.55 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 123.531 0.732 . . . . 0.0 109.657 173.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -118.18 93.77 4.25 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.678 0.791 . . . . 0.0 109.176 174.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -143.88 126.39 2.73 Favored Glycine 0 CA--C 1.527 0.802 0 CA-C-O 118.21 -1.328 . . . . 0.0 110.632 172.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -58.51 -50.5 9.37 Favored 'Trans proline' 0 C--N 1.376 1.986 0 CA-C-N 120.342 2.071 . . . . 0.0 110.96 177.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 8.7 p-10 -94.1 89.91 6.19 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 114.61 -1.177 . . . . 0.0 109.058 171.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 42.8 t -173.23 110.9 0.2 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.293 1.037 . . . . 0.0 109.197 -176.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 244' ' ' LYS . . . . . 0.464 ' H ' ' HD2' ' A' ' 244' ' ' LYS . 0.0 OUTLIER -88.85 -24.91 22.42 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.32 0.648 . . . . 0.0 110.995 178.985 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 36.6 m-85 -90.85 27.48 1.79 Allowed 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.403 1.081 . . . . 0.0 111.667 -177.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 246' ' ' GLU . . . . . 0.57 ' HA ' ' HB3' ' A' ' 238' ' ' CYS . 6.9 mm-40 -46.66 -45.07 19.02 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 124.023 0.929 . . . . 0.0 112.307 -179.182 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 247' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -83.44 126.74 33.07 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 121.56 0.695 . . . . 0.0 111.039 178.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 48.0 m-85 -134.64 174.79 10.17 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.352 1.461 . . . . 0.0 108.411 170.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 249' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -127.32 148.53 50.24 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.725 0.81 . . . . 0.0 108.951 178.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -58.35 -32.7 68.78 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 124.358 1.063 . . . . 0.0 113.033 -172.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -65.86 -36.41 83.37 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.55 0.74 . . . . 0.0 112.067 179.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 252' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -70.82 -56.02 7.23 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.597 0.759 . . . . 0.0 110.295 -178.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . 0.493 HG21 HG11 ' A' ' 236' ' ' VAL . 34.2 m -79.86 -3.68 6.46 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 CA-C-N 114.775 -1.102 . . . . 0.0 111.839 -175.405 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 14.4 m120 65.59 27.28 11.52 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 125.012 1.325 . . . . 0.0 112.123 173.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 33.8 mt -79.01 112.7 16.48 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.589 0.756 . . . . 0.0 109.595 172.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -88.91 -2.85 58.79 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.82 0.848 . . . . 0.0 109.489 168.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -127.08 146.12 56.59 Favored Pre-proline 0 CA--C 1.547 0.851 0 C-N-CA 124.628 1.171 . . . . 0.0 109.564 -176.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -72.86 134.84 22.42 Favored 'Trans proline' 0 C--N 1.37 1.689 0 C-N-CA 122.47 2.113 . . . . 0.0 110.845 171.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 259' ' ' PRO . . . . . 0.495 ' HG3' HG21 ' A' ' 236' ' ' VAL . 39.6 Cg_endo -63.68 149.82 89.95 Favored 'Trans proline' 0 C--N 1.375 1.958 0 C-N-CA 122.362 2.041 . . . . 0.0 112.062 177.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -75.87 -18.87 59.26 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.058 0.943 . . . . 0.0 112.912 -168.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -170.66 -134.48 1.76 Allowed Glycine 0 C--N 1.343 0.935 0 N-CA-C 111.663 -0.575 . . . . 0.0 111.663 -178.102 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 42.1 p -69.57 106.34 2.99 Favored 'General case' 0 C--N 1.353 0.729 0 C-N-CA 122.865 0.466 . . . . 0.0 109.835 177.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 263' ' ' TRP . . . . . 0.474 ' O ' ' HA ' ' A' ' 238' ' ' CYS . 76.1 t90 -87.98 122.23 31.34 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.206 -176.544 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -101.17 118.12 36.36 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 176.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 265' ' ' CYS . . . . . 0.498 ' SG ' ' HG2' ' A' ' 267' ' ' GLU . 16.2 p -66.91 155.52 89.72 Favored Pre-proline 0 CA--C 1.551 0.988 0 C-N-CA 123.793 0.837 . . . . 0.0 110.946 -178.385 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -38.91 -50.47 2.57 Favored 'Trans proline' 0 C--N 1.388 2.647 0 C-N-CA 124.739 3.626 . . . . 0.0 115.314 -176.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 267' ' ' GLU . . . . . 0.498 ' HG2' ' SG ' ' A' ' 265' ' ' CYS . 2.5 pm0 -62.2 -39.34 92.4 Favored 'General case' 0 CA--C 1.549 0.933 0 CA-C-N 115.892 -0.594 . . . . 0.0 112.357 -178.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 268' ' ' CYS . . . . . . . . . . . . . 63.6 m -68.87 -44.1 74.01 Favored 'General case' 0 N--CA 1.495 1.821 0 C-N-CA 122.699 0.399 . . . . 0.0 111.223 176.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -66.78 -31.48 72.15 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.37 -169.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 1.8 mp -91.05 -46.82 14.58 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.078 0 C-N-CA 123.382 0.673 . . . . 0.0 109.666 176.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 . . . . . 0 CA--C 1.558 1.288 0 C-N-CA 123.309 0.644 . . . . 0.0 109.711 -175.555 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 5.8 tt . . . . . 0 N--CA 1.47 0.547 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 224' ' ' TYR . . . . . 0.439 ' HB3' ' HA ' ' A' ' 245' ' ' TYR . 63.7 m-85 -140.04 124.11 17.66 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 176.427 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 48.7 t 171.25 152.18 0.06 Allowed 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 125.52 1.528 . . . . 0.0 108.08 174.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 50.4 t80 -65.29 -38.74 91.19 Favored 'General case' 0 N--CA 1.486 1.351 0 CA-C-N 119.138 0.881 . . . . 0.0 110.965 -179.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 5.8 p -68.43 -14.23 62.86 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 123.034 0.208 . . . . 0.0 111.07 177.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 87.0 mm-40 57.12 85.82 0.08 Allowed 'General case' 0 C--N 1.364 1.238 0 C-N-CA 125.231 1.413 . . . . 0.0 111.845 179.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -160.17 149.12 17.29 Favored 'General case' 0 C--O 1.242 0.706 0 CA-C-N 114.745 -1.116 . . . . 0.0 108.713 178.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 31.0 m -71.51 149.97 9.35 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 122.78 0.432 . . . . 0.0 111.184 178.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 15.8 m -94.26 68.34 3.62 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-O 121.745 0.783 . . . . 0.0 109.23 177.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 47.6 t80 -83.04 91.42 7.18 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.463 -171.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 103.98 -19.79 42.74 Favored Glycine 0 N--CA 1.476 1.33 0 CA-C-N 116.066 -0.515 . . . . 0.0 113.694 175.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.1 64.67 1.59 Allowed 'General case' 0 N--CA 1.481 1.124 0 CA-C-O 122.392 1.091 . . . . 0.0 110.122 178.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 235' ' ' MET . . . . . . . . . . . . . 18.3 ptm -99.56 130.68 45.82 Favored 'General case' 0 N--CA 1.483 1.177 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.75 -176.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 7.0 p -124.95 126.88 71.96 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.939 0 C-N-CA 124.565 1.146 . . . . 0.0 108.964 177.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -91.86 154.22 19.02 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.873 0.869 . . . . 0.0 111.302 -178.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 238' ' ' CYS . . . . . 0.639 ' HB3' ' HA ' ' A' ' 246' ' ' GLU . 11.3 t -117.12 155.47 29.26 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.929 1.292 . . . . 0.0 109.565 175.523 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -117.9 105.34 11.82 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.757 0.823 . . . . 0.0 109.406 172.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -140.96 144.74 15.04 Favored Glycine 0 CA--C 1.528 0.874 0 CA-C-O 118.533 -1.148 . . . . 0.0 111.405 173.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -61.38 -47.88 10.89 Favored 'Trans proline' 0 C--N 1.378 2.112 0 C-N-CA 122.929 2.419 . . . . 0.0 112.028 -178.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 40.9 t30 -124.5 107.44 11.07 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 170.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 43.8 t -157.45 117.05 3.36 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 123.522 0.729 . . . . 0.0 109.376 -174.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -80.5 -44.62 18.84 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.441 0.697 . . . . 0.0 109.852 176.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 245' ' ' TYR . . . . . 0.439 ' HA ' ' HB3' ' A' ' 224' ' ' TYR . 45.6 m-85 -82.72 31.11 0.42 Allowed 'General case' 0 CA--C 1.553 1.089 0 C-N-CA 124.18 0.992 . . . . 0.0 112.393 -175.372 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 246' ' ' GLU . . . . . 0.639 ' HA ' ' HB3' ' A' ' 238' ' ' CYS . 6.9 mm-40 -47.34 -42.79 22.16 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.832 0.853 . . . . 0.0 111.537 173.446 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 247' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -90.34 139.05 31.04 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-O 121.052 0.453 . . . . 0.0 111.132 177.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -147.28 173.09 12.9 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.062 1.345 . . . . 0.0 109.401 174.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 249' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -117.63 140.4 49.7 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.427 0.691 . . . . 0.0 110.03 174.207 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -54.58 -28.09 43.64 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 125.301 1.44 . . . . 0.0 112.36 -179.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -60.61 -54.73 41.79 Favored 'General case' 0 CA--C 1.555 1.16 0 C-N-CA 123.407 0.683 . . . . 0.0 111.176 177.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 252' ' ' CYS . . . . . . . . . . . . . 1.1 m -66.21 -44.68 83.19 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.773 0.829 . . . . 0.0 111.594 -177.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 33.8 m -84.4 -0.71 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.619 -177.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 21.1 m120 60.66 19.18 9.18 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 125.038 1.335 . . . . 0.0 113.278 172.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 92.7 mt -84.64 120.94 26.95 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 177.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 31.9 mmtp -103.74 21.33 16.41 Favored 'General case' 0 N--CA 1.485 1.322 0 CA-C-O 121.319 0.58 . . . . 0.0 110.07 -177.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -157.89 139.56 9.93 Favored Pre-proline 0 C--O 1.245 0.832 0 C-N-CA 124.619 1.167 . . . . 0.0 109.069 -174.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_exo -67.99 115.19 3.67 Favored 'Trans proline' 0 C--N 1.373 1.842 0 C-N-CA 122.999 2.466 . . . . 0.0 111.668 176.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 259' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -68.48 121.1 8.02 Favored 'Trans proline' 0 C--N 1.376 2.026 0 C-N-CA 122.374 2.049 . . . . 0.0 111.252 178.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 260' ' ' LYS . . . . . 0.601 ' HZ1' ' HB2' ' A' ' 260' ' ' LYS . 10.3 mtmp? -72.48 124.31 24.93 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.12 0.568 . . . . 0.0 110.354 178.321 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 115.76 -159.74 13.67 Favored Glycine 0 C--N 1.337 0.627 0 N-CA-C 111.494 -0.642 . . . . 0.0 111.494 174.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 45.6 p -83.56 107.18 15.86 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 172.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 263' ' ' TRP . . . . . . . . . . . . . 40.2 t90 -77.04 147.23 36.86 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-O 121.119 0.485 . . . . 0.0 110.144 179.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -120.13 120.66 36.87 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 123.735 0.814 . . . . 0.0 108.972 178.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 17.3 p -67.71 161.09 69.23 Favored Pre-proline 0 CA--C 1.55 0.97 0 C-N-CA 123.537 0.735 . . . . 0.0 110.646 176.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -41.52 -29.91 0.84 Allowed 'Trans proline' 0 C--N 1.383 2.387 0 C-N-CA 124.002 3.134 . . . . 0.0 115.593 176.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -63.47 -66.78 0.49 Allowed 'General case' 0 N--CA 1.483 1.199 0 CA-C-O 121.605 0.717 . . . . 0.0 109.806 173.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 268' ' ' CYS . . . . . . . . . . . . . 58.6 m -71.26 -28.62 64.29 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 114.617 -1.174 . . . . 0.0 111.949 -167.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -80.04 -56.12 4.47 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.373 0.669 . . . . 0.0 110.504 -178.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 45.5 mm -82.21 -59.44 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 122.768 0.427 . . . . 0.0 111.714 -168.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 . . . . . 0 N--CA 1.481 1.083 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -168.769 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 5.4 tt . . . . . 0 N--CA 1.482 1.154 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 224' ' ' TYR . . . . . 0.61 ' HB3' ' HA ' ' A' ' 245' ' ' TYR . 88.0 m-85 -137.39 131.99 32.86 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.534 1.134 . . . . 0.0 108.251 177.283 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 34.8 t 172.48 160.07 0.11 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.028 1.331 . . . . 0.0 108.888 177.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -67.52 -29.09 68.4 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 122.543 0.337 . . . . 0.0 111.0 177.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 227' ' ' CYS . . . . . 0.428 ' SG ' ' HB2' ' A' ' 229' ' ' ARG . 12.2 p -84.86 -5.84 59.34 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-O 119.224 -0.417 . . . . 0.0 111.939 178.164 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 33.1 mm-40 54.88 78.94 0.16 Allowed 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 124.494 1.117 . . . . 0.0 111.269 -173.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 229' ' ' ARG . . . . . 0.428 ' HB2' ' SG ' ' A' ' 227' ' ' CYS . 3.1 tmm_? -154.23 150.21 27.82 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 -176.442 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 30.7 m -66.98 156.84 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 123.388 0.675 . . . . 0.0 112.56 178.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 22.5 m -109.67 89.53 3.04 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-N 115.251 -0.886 . . . . 0.0 108.655 175.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 88.2 t80 -114.45 124.68 52.53 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.513 0.725 . . . . 0.0 109.697 177.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 79.58 -16.68 10.02 Favored Glycine 0 C--N 1.347 1.173 0 CA-C-N 116.054 -0.521 . . . . 0.0 113.023 -179.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -140.62 98.1 3.34 Favored 'General case' 0 C--N 1.349 0.546 0 C-N-CA 124.844 1.257 . . . . 0.0 107.773 -176.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 235' ' ' MET . . . . . . . . . . . . . 3.5 mpp? -127.4 95.12 4.17 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 -178.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 4.1 p -103.13 126.28 57.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 171.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -95.86 156.99 16.1 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.293 0.568 . . . . 0.0 111.12 -177.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 238' ' ' CYS . . . . . 0.71 ' HB3' ' HA ' ' A' ' 246' ' ' GLU . 18.5 t -110.81 153.18 25.73 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 124.442 1.097 . . . . 0.0 109.409 174.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -108.65 92.58 4.11 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 174.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -143.9 114.34 0.81 Allowed Glycine 0 CA--C 1.529 0.912 0 CA-C-O 118.08 -1.4 . . . . 0.0 111.863 175.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -54.05 -39.75 84.19 Favored 'Trans proline' 0 C--N 1.377 2.039 0 C-N-CA 123.104 2.536 . . . . 0.0 112.907 178.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -111.3 91.23 3.58 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 171.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 51.5 t -171.98 116.74 0.37 Allowed 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.208 1.003 . . . . 0.0 108.745 -175.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 23.6 pttm -89.03 -33.38 17.17 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 122.701 0.401 . . . . 0.0 110.538 176.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 245' ' ' TYR . . . . . 0.61 ' HA ' ' HB3' ' A' ' 224' ' ' TYR . 22.0 m-30 -79.28 29.92 0.22 Allowed 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.741 1.216 . . . . 0.0 112.235 179.708 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 246' ' ' GLU . . . . . 0.71 ' HA ' ' HB3' ' A' ' 238' ' ' CYS . 6.9 mm-40 -47.44 -45.96 26.21 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.745 0.818 . . . . 0.0 111.086 170.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 247' ' ' TRP . . . . . 0.527 ' HB2' ' HB2' ' A' ' 224' ' ' TYR . 91.8 m95 -78.59 134.72 37.18 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 121.109 0.48 . . . . 0.0 110.76 177.211 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -144.08 170.88 15.11 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 125.163 1.385 . . . . 0.0 108.424 170.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 249' ' ' HIS . . . . . 0.408 ' HD2' ' HB2' ' A' ' 252' ' ' CYS . 0.0 OUTLIER -115.52 133.98 55.51 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 174.092 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -47.74 -57.5 5.49 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 125.354 1.462 . . . . 0.0 114.467 -168.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -69.18 -26.63 64.93 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 122.381 0.272 . . . . 0.0 111.246 -170.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 252' ' ' CYS . . . . . 0.408 ' HB2' ' HD2' ' A' ' 249' ' ' HIS . 36.1 t -68.32 -32.1 71.99 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 124.087 0.955 . . . . 0.0 111.013 177.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 17.5 m -105.24 16.84 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 C-N-CA 123.34 0.656 . . . . 0.0 110.879 175.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 17.2 m120 67.54 9.11 6.81 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 125.364 1.466 . . . . 0.0 114.13 172.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 87.0 mt -76.97 137.42 39.02 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 122.925 0.49 . . . . 0.0 109.909 173.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.74 -23.24 9.29 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.909 0.884 . . . . 0.0 109.747 176.232 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -126.44 148.83 65.65 Favored Pre-proline 0 CA--C 1.549 0.91 0 C-N-CA 124.061 0.944 . . . . 0.0 110.158 -179.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -65.59 139.52 58.75 Favored 'Trans proline' 0 C--N 1.38 2.224 0 C-N-CA 123.11 2.54 . . . . 0.0 112.404 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 259' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_exo -59.3 151.59 66.66 Favored 'Trans proline' 0 C--N 1.377 2.069 0 C-N-CA 122.705 2.27 . . . . 0.0 112.095 172.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -89.65 -21.0 22.99 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.846 0.858 . . . . 0.0 110.266 -176.07 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -147.87 -144.09 3.93 Favored Glycine 0 C--N 1.349 1.29 0 CA-C-O 119.821 -0.433 . . . . 0.0 112.332 -179.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 30.2 p -67.61 111.91 4.45 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 123.569 0.748 . . . . 0.0 111.105 -177.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 263' ' ' TRP . . . . . . . . . . . . . 32.1 t90 -93.41 116.8 29.35 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -100.51 107.01 18.61 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 123.421 0.689 . . . . 0.0 109.472 178.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 15.5 p -57.28 160.41 6.86 Favored Pre-proline 0 N--CA 1.487 1.384 0 C-N-CA 124.418 1.087 . . . . 0.0 111.046 177.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -33.83 -46.88 0.45 Allowed 'Trans proline' 0 C--N 1.396 3.05 0 C-N-CA 124.867 3.711 . . . . 0.0 114.834 -179.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -61.56 -50.41 72.76 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 124.823 1.249 . . . . 0.0 112.04 -177.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 268' ' ' CYS . . . . . . . . . . . . . 79.6 m -72.49 -29.11 63.35 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.851 0.86 . . . . 0.0 111.982 -175.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.02 -15.27 36.86 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 111.885 0.328 . . . . 0.0 111.885 -179.208 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 33.2 mm -88.09 -16.09 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 C-N-CA 123.337 0.655 . . . . 0.0 110.237 171.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 . . . . . 0 CA--C 1.559 1.313 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 172.52 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 66.6 tp . . . . . 0 N--CA 1.473 0.679 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 224' ' ' TYR . . . . . 0.661 ' HB3' ' HA ' ' A' ' 245' ' ' TYR . 19.2 m-85 -136.22 128.87 30.69 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.86 0.864 . . . . 0.0 109.31 -179.576 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 40.3 t 170.21 163.32 0.07 Allowed 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 125.64 1.576 . . . . 0.0 108.626 167.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -59.91 -44.93 94.01 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 122.475 0.31 . . . . 0.0 110.51 173.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 14.1 p -76.79 -12.17 59.94 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.106 0.563 . . . . 0.0 112.194 -176.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 82.3 mm-40 51.82 77.4 0.15 Allowed 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 124.519 1.128 . . . . 0.0 112.135 -172.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 72.5 ttt180 -147.56 149.52 32.73 Favored 'General case' 0 C--O 1.242 0.691 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 176.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 26.6 m -67.54 146.1 13.29 Favored 'Isoleucine or valine' 0 C--O 1.245 0.825 0 CA-C-O 121.14 0.495 . . . . 0.0 110.808 177.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 231' ' ' SER . . . . . 0.436 ' HB3' ' O ' ' A' ' 234' ' ' GLU . 50.9 m -79.43 87.14 5.07 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 172.43 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 83.1 t80 -86.25 107.87 18.13 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.453 0.701 . . . . 0.0 111.095 -173.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 73.53 -1.23 45.32 Favored Glycine 0 C--N 1.351 1.392 0 CA-C-N 115.741 -0.663 . . . . 0.0 114.191 175.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . 0.436 ' O ' ' HB3' ' A' ' 231' ' ' SER . 14.7 pt-20 -154.97 141.05 18.41 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 124.386 1.074 . . . . 0.0 108.908 -175.267 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 235' ' ' MET . . . . . 0.4 ' HB3' ' HB3' ' A' ' 231' ' ' SER . 0.0 OUTLIER -160.21 136.77 8.93 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 122.885 0.474 . . . . 0.0 110.534 174.857 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 4.2 p -117.7 124.22 72.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 173.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -87.96 127.61 35.37 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.048 0.539 . . . . 0.0 110.233 -177.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 238' ' ' CYS . . . . . . . . . . . . . 48.8 t -92.6 154.5 18.36 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.002 0.921 . . . . 0.0 110.691 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -116.59 109.74 17.63 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 169.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 240' ' ' GLY . . . . . 0.549 ' HA3' ' SG ' ' A' ' 268' ' ' CYS . . . -144.17 140.58 9.49 Favored Glycine 0 C--N 1.344 0.978 0 CA-C-O 118.786 -1.008 . . . . 0.0 113.215 172.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -57.54 -54.95 2.81 Favored 'Trans proline' 0 C--N 1.374 1.913 0 C-N-CA 122.856 2.37 . . . . 0.0 112.627 171.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -107.49 77.65 1.15 Allowed 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 176.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 34.5 t -150.85 106.25 3.36 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 -174.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 244' ' ' LYS . . . . . 0.446 ' HA ' ' HE3' ' A' ' 244' ' ' LYS . 0.4 OUTLIER -89.04 -29.36 19.5 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.307 0.643 . . . . 0.0 110.792 178.925 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 245' ' ' TYR . . . . . 0.661 ' HA ' ' HB3' ' A' ' 224' ' ' TYR . 23.5 m-85 -82.03 22.0 0.83 Allowed 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.632 0.773 . . . . 0.0 112.95 -174.329 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -46.75 -37.36 8.4 Favored 'General case' 0 N--CA 1.501 2.114 0 C-N-CA 124.72 1.208 . . . . 0.0 112.849 -171.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 247' ' ' TRP . . . . . . . . . . . . . 97.7 m95 -77.69 101.83 6.81 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.148 0.579 . . . . 0.0 109.771 175.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -113.98 176.37 5.07 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.357 1.063 . . . . 0.0 110.466 178.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 249' ' ' HIS . . . . . 0.518 ' CD2' ' HB2' ' A' ' 252' ' ' CYS . 0.9 OUTLIER -129.49 144.05 51.09 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.793 1.237 . . . . 0.0 109.166 174.724 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 250' ' ' TYR . . . . . 0.477 ' HB3' ' O ' ' A' ' 255' ' ' LEU . 65.8 m-85 -62.19 -38.8 90.51 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 124.494 1.118 . . . . 0.0 112.825 -169.219 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -60.72 -36.84 79.83 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 124.252 1.021 . . . . 0.0 111.452 -176.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 252' ' ' CYS . . . . . 0.518 ' HB2' ' CD2' ' A' ' 249' ' ' HIS . 0.5 OUTLIER -64.62 -42.27 95.61 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.346 1.058 . . . . 0.0 110.456 -177.037 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 34.0 m -100.07 5.89 9.78 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 CA-C-N 114.777 -1.101 . . . . 0.0 111.309 -173.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 17.3 m120 66.33 13.17 9.07 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 125.054 1.342 . . . . 0.0 113.288 172.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . 0.477 ' O ' ' HB3' ' A' ' 250' ' ' TYR . 92.3 mt -80.68 125.41 30.0 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 175.318 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -89.33 -23.5 22.23 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 172.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -134.08 150.97 75.73 Favored Pre-proline 0 CA--C 1.55 0.954 0 C-N-CA 124.589 1.156 . . . . 0.0 108.746 179.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -67.28 143.29 63.7 Favored 'Trans proline' 0 C--N 1.375 1.937 0 C-N-CA 122.318 2.012 . . . . 0.0 110.772 172.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 259' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_exo -60.65 163.89 14.68 Favored 'Trans proline' 0 C--N 1.374 1.899 0 C-N-CA 123.215 2.61 . . . . 0.0 113.849 -179.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -63.32 -34.66 78.18 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 114.943 -1.026 . . . . 0.0 112.095 -177.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -120.21 -164.44 12.53 Favored Glycine 0 CA--C 1.523 0.579 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.702 175.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 58.9 m -65.76 125.4 25.18 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.446 0.699 . . . . 0.0 110.0 -179.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 263' ' ' TRP . . . . . . . . . . . . . 39.5 t90 -84.5 129.42 34.86 Favored 'General case' 0 C--O 1.242 0.669 0 CA-C-O 121.719 0.771 . . . . 0.0 111.053 -175.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 264' ' ' TYR . . . . . 0.403 ' O ' ' HE3' ' A' ' 269' ' ' LYS . 75.6 m-85 -111.07 126.84 55.24 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.02 1.328 . . . . 0.0 107.587 172.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 265' ' ' CYS . . . . . 0.458 ' SG ' ' HB2' ' A' ' 267' ' ' GLU . 26.4 p -67.98 161.89 63.83 Favored Pre-proline 0 CA--C 1.554 1.121 0 CA-C-O 118.661 -0.685 . . . . 0.0 109.858 175.147 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_exo -46.84 -33.26 13.81 Favored 'Trans proline' 0 C--N 1.39 2.73 0 C-N-CA 123.414 2.743 . . . . 0.0 113.469 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 267' ' ' GLU . . . . . 0.458 ' HB2' ' SG ' ' A' ' 265' ' ' CYS . 26.6 mt-10 -59.9 -58.41 8.68 Favored 'General case' 0 C--O 1.213 -0.837 0 C-N-CA 124.651 1.181 . . . . 0.0 110.054 175.536 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 268' ' ' CYS . . . . . 0.549 ' SG ' ' HA3' ' A' ' 240' ' ' GLY . 99.0 m -63.86 -27.77 69.39 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.603 0.761 . . . . 0.0 113.049 -176.27 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . 0.403 ' HE3' ' O ' ' A' ' 264' ' ' TYR . 94.2 mttt -68.87 -37.32 78.98 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 122.579 0.352 . . . . 0.0 111.059 176.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 74.1 mt -95.66 -72.06 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.814 0 C-N-CA 122.947 0.499 . . . . 0.0 109.841 179.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 . . . . . 0 C--O 1.25 1.123 0 C-N-CA 124.798 1.239 . . . . 0.0 110.315 -179.714 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 34.4 tp . . . . . 0 N--CA 1.478 0.96 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 224' ' ' TYR . . . . . 0.453 ' HB3' ' HA ' ' A' ' 245' ' ' TYR . 48.0 m-85 -143.87 141.42 30.3 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.377 0.671 . . . . 0.0 110.29 -175.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 45.3 t 170.58 158.47 0.07 Allowed 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 125.367 1.467 . . . . 0.0 109.274 164.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 35.7 t80 -65.62 -37.99 88.14 Favored 'General case' 0 CA--C 1.551 0.991 0 CA-C-N 117.804 0.275 . . . . 0.0 110.985 177.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 4.6 p -80.45 -12.04 59.61 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 122.589 0.356 . . . . 0.0 111.129 176.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 84.2 mm-40 50.01 81.15 0.06 Allowed 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 124.745 1.218 . . . . 0.0 112.077 -173.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 229' ' ' ARG . . . . . 0.429 HH22 ' HB3' ' A' ' 251' ' ' ASP . 46.7 ttp180 -135.09 149.44 50.06 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 176.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 23.6 m -67.18 147.03 12.78 Favored 'Isoleucine or valine' 0 C--O 1.241 0.635 0 C-N-CA 122.63 0.372 . . . . 0.0 111.328 174.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 40.9 m -98.81 81.71 2.68 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 174.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -86.86 99.95 12.2 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.589 0.756 . . . . 0.0 109.768 -176.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 76.97 -0.09 67.67 Favored Glycine 0 N--CA 1.474 1.178 0 CA-C-N 116.232 -0.44 . . . . 0.0 113.823 178.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -135.35 72.71 1.45 Allowed 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.122 0.969 . . . . 0.0 109.571 -178.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 235' ' ' MET . . . . . . . . . . . . . 3.4 mpp? -105.76 108.46 19.99 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.285 -176.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 5.6 p -111.6 124.17 68.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 171.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -99.9 131.04 46.11 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 123.273 0.629 . . . . 0.0 109.732 -179.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 238' ' ' CYS . . . . . . . . . . . . . 18.1 t -81.66 143.25 32.04 Favored 'General case' 0 C--O 1.223 -0.3 0 C-N-CA 123.873 0.869 . . . . 0.0 110.58 179.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -97.39 93.79 6.68 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 166.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -142.56 112.92 0.76 Allowed Glycine 0 CA--C 1.521 0.442 0 CA-C-O 118.34 -1.255 . . . . 0.0 110.445 174.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -67.22 -24.43 44.08 Favored 'Trans proline' 0 C--N 1.366 1.492 0 CA-C-N 120.112 1.956 . . . . 0.0 111.38 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 15.3 p-10 -110.81 70.81 0.73 Allowed 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.408 1.483 . . . . 0.0 108.821 176.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 39.0 t -167.4 107.08 0.58 Allowed 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.308 -169.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? -77.1 -36.15 55.87 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.037 0.535 . . . . 0.0 109.808 171.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 245' ' ' TYR . . . . . 0.453 ' HA ' ' HB3' ' A' ' 224' ' ' TYR . 12.2 m-85 -79.62 24.77 0.36 Allowed 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 -171.272 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -45.98 -43.5 14.21 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 124.781 1.232 . . . . 0.0 114.122 -170.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 247' ' ' TRP . . . . . . . . . . . . . 70.5 m95 -76.92 129.53 36.3 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-O 121.155 0.502 . . . . 0.0 110.884 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -140.19 174.81 10.14 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.767 1.227 . . . . 0.0 109.193 179.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 249' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -125.1 141.03 52.37 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.062 0.945 . . . . 0.0 109.971 179.346 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 39.3 m-85 -56.16 -35.06 66.76 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 125.622 1.569 . . . . 0.0 112.852 -171.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 251' ' ' ASP . . . . . 0.429 ' HB3' HH22 ' A' ' 229' ' ' ARG . 11.6 t70 -57.97 -51.18 70.7 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 124.746 1.219 . . . . 0.0 111.504 177.575 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 252' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -62.26 -42.44 99.33 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.832 0.853 . . . . 0.0 110.946 -176.108 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 35.1 m -99.01 5.56 9.66 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.652 -172.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 34.6 m-80 62.95 17.93 10.46 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 125.075 1.35 . . . . 0.0 113.621 171.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 87.2 mt -79.62 126.01 30.35 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 177.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 83.3 mttt -99.18 -25.94 14.36 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.993 0.917 . . . . 0.0 109.399 178.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -119.82 156.41 54.08 Favored Pre-proline 0 CA--C 1.551 0.999 0 C-N-CA 125.013 1.325 . . . . 0.0 109.043 176.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -68.14 143.33 59.02 Favored 'Trans proline' 0 C--N 1.378 2.107 0 C-N-CA 122.409 2.073 . . . . 0.0 111.192 172.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 259' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -56.75 156.24 23.85 Favored 'Trans proline' 0 C--N 1.378 2.107 0 C-N-CA 123.163 2.576 . . . . 0.0 113.203 177.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -78.89 -7.53 58.02 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 122.889 0.476 . . . . 0.0 111.967 -179.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 178.93 -133.67 2.15 Favored Glycine 0 C--N 1.346 1.109 0 CA-C-O 119.949 -0.362 . . . . 0.0 112.565 177.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 37.1 p -63.71 106.54 1.0 Allowed 'General case' 0 C--N 1.351 0.651 0 C-N-CA 124.344 1.058 . . . . 0.0 110.356 -178.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 263' ' ' TRP . . . . . . . . . . . . . 54.7 t90 -98.48 109.4 22.16 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.493 0.717 . . . . 0.0 110.535 -174.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -94.65 106.23 18.2 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.312 0.645 . . . . 0.0 110.036 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 265' ' ' CYS . . . . . 0.425 ' SG ' ' OE2' ' A' ' 267' ' ' GLU . 13.5 p -64.36 157.9 68.83 Favored Pre-proline 0 CA--C 1.565 1.536 0 CA-C-O 118.05 -0.976 . . . . 0.0 109.783 176.453 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -23.67 -63.0 0.05 OUTLIER 'Trans proline' 0 C--N 1.392 2.824 1 C-N-CA 126.26 4.64 . . . . 0.0 117.981 -168.038 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 267' ' ' GLU . . . . . 0.425 ' OE2' ' SG ' ' A' ' 265' ' ' CYS . 0.0 OUTLIER -71.73 -28.11 63.46 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 122.027 -0.421 . . . . 0.0 111.731 -173.116 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 268' ' ' CYS . . . . . . . . . . . . . 91.1 m -68.21 -30.33 69.38 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 124.135 0.974 . . . . 0.0 112.315 179.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -92.75 -3.9 54.01 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 122.352 0.261 . . . . 0.0 111.595 -178.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 74.8 mt -106.51 -47.43 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 C-N-CA 124.032 0.933 . . . . 0.0 109.899 177.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 . . . . . 0 CA--C 1.563 1.448 0 C-N-CA 125.372 1.469 . . . . 0.0 108.997 -176.347 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 55.5 tp . . . . . 0 N--CA 1.479 1.003 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 224' ' ' TYR . . . . . 0.7 ' HB3' ' HA ' ' A' ' 245' ' ' TYR . 39.6 m-85 -137.63 126.1 23.48 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.768 0.827 . . . . 0.0 109.417 -178.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 39.0 t 172.47 162.86 0.12 Allowed 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 125.11 1.364 . . . . 0.0 109.294 169.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 56.1 t80 -69.01 -35.48 76.72 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 122.736 0.414 . . . . 0.0 111.383 177.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 13.5 p -82.79 -13.22 56.66 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 122.58 0.352 . . . . 0.0 111.434 178.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 83.8 mm-40 54.99 85.58 0.06 Allowed 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.501 1.12 . . . . 0.0 112.02 -172.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 42.0 ttp180 -150.77 150.64 31.26 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 115.064 -0.971 . . . . 0.0 108.439 174.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 32.9 m -76.17 152.98 5.99 Favored 'Isoleucine or valine' 0 C--O 1.242 0.665 0 CA-C-O 121.334 0.587 . . . . 0.0 110.974 178.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 231' ' ' SER . . . . . 0.45 ' HB2' ' HG2' ' A' ' 235' ' ' MET . 14.9 m -101.74 101.48 11.98 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.128 0.971 . . . . 0.0 108.445 175.099 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -72.48 81.05 1.06 Allowed 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.776 0.83 . . . . 0.0 109.661 -177.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 74.16 -18.39 2.07 Favored Glycine 0 CA--C 1.537 1.437 0 CA-C-N 115.193 -0.912 . . . . 0.0 114.366 -179.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -98.28 66.51 1.77 Allowed 'General case' 0 C--O 1.243 0.743 0 C-N-CA 123.75 0.82 . . . . 0.0 109.62 -176.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 235' ' ' MET . . . . . 0.45 ' HG2' ' HB2' ' A' ' 231' ' ' SER . 60.0 mtm -94.26 120.2 34.15 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 114.804 -1.089 . . . . 0.0 109.822 -178.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . 0.48 HG11 HG22 ' A' ' 253' ' ' VAL . 3.3 p -106.1 124.21 61.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 168.567 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -90.71 155.78 18.57 Favored 'General case' 0 C--O 1.242 0.706 0 C-N-CA 123.148 0.579 . . . . 0.0 110.077 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 238' ' ' CYS . . . . . 0.4 ' HB3' ' HA ' ' A' ' 246' ' ' GLU . 35.6 t -127.69 113.97 16.71 Favored 'General case' 0 C--O 1.243 0.735 0 C-N-CA 123.284 0.634 . . . . 0.0 110.069 -178.479 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -73.01 94.46 1.88 Allowed 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 173.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -143.68 133.05 5.2 Favored Glycine 0 C--N 1.346 1.11 0 CA-C-O 117.898 -1.501 . . . . 0.0 110.843 175.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -64.32 -46.04 8.45 Favored 'Trans proline' 0 C--N 1.377 2.051 0 C-N-CA 122.575 2.183 . . . . 0.0 111.352 -178.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 21.4 m120 -101.86 92.2 4.71 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 170.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 9.0 t -159.12 90.63 0.98 Allowed 'General case' 0 C--O 1.24 0.601 0 C-N-CA 122.984 0.514 . . . . 0.0 110.172 179.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 4.9 tppp? -65.87 -42.36 90.45 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-O 121.687 0.755 . . . . 0.0 109.95 173.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 245' ' ' TYR . . . . . 0.7 ' HA ' ' HB3' ' A' ' 224' ' ' TYR . 23.7 m-85 -84.09 24.6 0.91 Allowed 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 114.435 -1.257 . . . . 0.0 112.224 -177.646 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 246' ' ' GLU . . . . . 0.4 ' HA ' ' HB3' ' A' ' 238' ' ' CYS . 16.2 pt-20 -47.97 -33.75 8.26 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 124.537 1.135 . . . . 0.0 112.203 -179.562 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 247' ' ' TRP . . . . . . . . . . . . . 99.3 m95 -87.37 123.07 31.93 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.339 0.655 . . . . 0.0 110.016 172.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 49.8 m-85 -131.94 175.89 8.83 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.256 1.422 . . . . 0.0 109.23 176.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 249' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -110.94 144.5 39.91 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.093 0.957 . . . . 0.0 109.046 171.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 250' ' ' TYR . . . . . 0.468 ' HA ' HG21 ' A' ' 253' ' ' VAL . 74.8 m-85 -56.7 -27.06 58.29 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 124.652 1.181 . . . . 0.0 111.854 178.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -53.76 -59.37 4.7 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.861 1.264 . . . . 0.0 111.5 172.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 252' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -65.1 -35.11 80.08 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.789 0.836 . . . . 0.0 111.491 -175.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . 0.48 HG22 HG11 ' A' ' 236' ' ' VAL . 11.9 m -97.2 2.76 10.23 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.715 -172.232 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 64.7 t30 64.75 16.85 10.66 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 124.699 1.2 . . . . 0.0 112.455 168.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 88.6 mt -83.73 116.1 22.52 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 -177.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 46.4 mmtm -76.14 -8.41 56.95 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.719 0.808 . . . . 0.0 111.65 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -156.55 166.37 16.67 Favored Pre-proline 0 CA--C 1.556 1.176 0 C-N-CA 124.884 1.273 . . . . 0.0 108.983 -173.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -52.31 147.45 28.55 Favored 'Trans proline' 0 C--N 1.382 2.337 0 C-N-CA 122.717 2.278 . . . . 0.0 112.298 171.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 259' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -58.69 172.92 1.31 Allowed 'Trans proline' 0 C--N 1.381 2.253 0 C-N-CA 123.137 2.558 . . . . 0.0 113.991 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp -101.1 22.02 12.97 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.743 0.817 . . . . 0.0 111.506 -175.157 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 154.12 -156.29 26.73 Favored Glycine 0 C--N 1.349 1.276 0 N-CA-C 111.242 -0.743 . . . . 0.0 111.242 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 13.6 p -64.32 106.3 1.08 Allowed 'General case' 0 C--N 1.355 0.825 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 170.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 263' ' ' TRP . . . . . . . . . . . . . 80.4 t90 -85.94 126.48 34.13 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.012 -173.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 -106.32 128.24 53.85 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 173.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 23.4 p -75.09 152.4 86.32 Favored Pre-proline 0 N--CA 1.48 1.067 0 CA-C-O 117.832 -1.08 . . . . 0.0 108.443 173.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_exo -31.85 -63.38 0.12 Allowed 'Trans proline' 0 C--N 1.393 2.885 0 C-N-CA 125.238 3.959 . . . . 0.0 116.434 -169.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -57.68 -33.3 68.2 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 124.873 1.269 . . . . 0.0 113.603 -179.29 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 268' ' ' CYS . . . . . . . . . . . . . 89.5 m -70.07 -41.5 74.02 Favored 'General case' 0 N--CA 1.5 2.041 0 C-N-CA 122.807 0.443 . . . . 0.0 111.347 172.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -70.45 -32.92 70.68 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.578 -175.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 76.1 mt -81.35 -51.82 14.82 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 C-N-CA 123.635 0.774 . . . . 0.0 109.53 177.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 . . . . . 0 CA--C 1.554 1.121 0 C-N-CA 124.412 1.085 . . . . 0.0 108.896 -176.367 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 53.4 tp . . . . . 0 C--O 1.238 0.491 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 224' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -140.35 122.86 16.12 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 177.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 49.5 t 172.96 161.32 0.12 Allowed 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.652 1.181 . . . . 0.0 109.538 175.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -66.0 -37.96 87.25 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 122.71 0.404 . . . . 0.0 110.583 175.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 5.4 p -81.84 -4.24 56.0 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 111.634 0.235 . . . . 0.0 111.634 174.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 78.4 mm-40 52.37 81.71 0.08 Allowed 'General case' 0 C--N 1.36 1.041 0 C-N-CA 125.205 1.402 . . . . 0.0 112.549 -175.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 229' ' ' ARG . . . . . 0.431 ' HB2' ' CE1' ' A' ' 249' ' ' HIS . 33.1 mmt180 -138.17 155.71 48.44 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.161 0.984 . . . . 0.0 109.343 175.115 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 27.7 m -83.56 -178.59 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.644 177.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 231' ' ' SER . . . . . 0.452 ' HG ' ' HB3' ' A' ' 235' ' ' MET . 41.8 t -80.6 94.07 6.23 Favored 'General case' 0 CA--C 1.553 1.061 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.196 176.692 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -101.98 92.21 4.69 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.394 0.678 . . . . 0.0 109.479 179.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 73.88 -7.01 16.52 Favored Glycine 0 C--N 1.35 1.318 0 N-CA-C 114.44 0.536 . . . . 0.0 114.44 175.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -154.6 142.88 20.44 Favored 'General case' 0 C--O 1.242 0.674 0 C-N-CA 124.132 0.973 . . . . 0.0 109.456 -175.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 235' ' ' MET . . . . . 0.452 ' HB3' ' HG ' ' A' ' 231' ' ' SER . 25.4 ptt? -158.14 128.43 6.15 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.262 0.625 . . . . 0.0 110.204 175.604 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 3.3 p -115.11 124.34 71.64 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.767 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 173.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -89.8 156.54 18.44 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.361 0.664 . . . . 0.0 110.332 -179.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 238' ' ' CYS . . . . . 0.612 ' HB3' ' HA ' ' A' ' 246' ' ' GLU . 13.1 t -125.71 149.47 48.48 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.458 0.703 . . . . 0.0 111.543 -173.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -121.01 104.23 9.64 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.221 1.009 . . . . 0.0 109.043 176.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -141.99 162.57 27.11 Favored Glycine 0 C--O 1.244 0.719 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 174.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -61.69 -52.97 2.52 Favored 'Trans proline' 0 C--N 1.371 1.735 0 C-N-CA 122.033 1.822 . . . . 0.0 111.856 174.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 37.8 t30 -116.38 118.23 32.15 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 178.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 18.7 t -167.94 107.51 0.54 Allowed 'General case' 0 N--CA 1.47 0.556 0 O-C-N 123.167 0.292 . . . . 0.0 111.289 -175.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 14.9 ptpt -86.85 -26.99 23.74 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 165.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -83.17 28.95 0.5 Allowed 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.318 1.447 . . . . 0.0 112.683 179.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 246' ' ' GLU . . . . . 0.612 ' HA ' ' HB3' ' A' ' 238' ' ' CYS . 41.3 mt-10 -50.11 -37.3 33.46 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.675 0.79 . . . . 0.0 111.72 176.592 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 247' ' ' TRP . . . . . . . . . . . . . 84.7 m95 -96.85 134.13 40.57 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.566 -178.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -144.09 176.29 9.41 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.502 1.521 . . . . 0.0 108.939 175.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 249' ' ' HIS . . . . . 0.431 ' CE1' ' HB2' ' A' ' 229' ' ' ARG . 0.2 OUTLIER -119.56 147.44 44.48 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 171.357 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 250' ' ' TYR . . . . . 0.415 ' HB3' ' O ' ' A' ' 255' ' ' LEU . 20.1 m-85 -62.26 -33.93 75.57 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.026 1.33 . . . . 0.0 112.214 -168.494 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -59.85 -43.91 94.4 Favored 'General case' 0 N--CA 1.476 0.826 0 O-C-N 123.971 0.794 . . . . 0.0 111.31 179.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 252' ' ' CYS . . . . . . . . . . . . . 1.3 m -70.15 -38.34 75.45 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.577 -177.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 35.5 m -99.7 8.78 8.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 122.803 0.441 . . . . 0.0 111.794 -175.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 59.97 22.96 12.06 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 124.894 1.278 . . . . 0.0 113.234 170.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . 0.415 ' O ' ' HB3' ' A' ' 250' ' ' TYR . 93.1 mt -84.3 110.35 18.51 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 174.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -70.25 -33.2 71.34 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 121.44 0.638 . . . . 0.0 109.93 175.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -132.04 159.62 71.32 Favored Pre-proline 0 CA--C 1.555 1.169 0 C-N-CA 124.402 1.081 . . . . 0.0 109.39 -176.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -59.94 148.49 88.57 Favored 'Trans proline' 0 C--N 1.384 2.41 0 C-N-CA 122.813 2.342 . . . . 0.0 112.787 178.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 259' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_exo -58.79 167.83 4.93 Favored 'Trans proline' 0 C--N 1.385 2.5 0 C-N-CA 123.591 2.861 . . . . 0.0 113.727 -178.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -100.54 18.01 20.26 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.343 0.657 . . . . 0.0 111.34 -177.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 158.3 -143.9 9.86 Favored Glycine 0 C--N 1.348 1.232 0 N-CA-C 112.169 -0.373 . . . . 0.0 112.169 176.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 32.8 p -66.12 107.78 2.04 Favored 'General case' 0 C--N 1.35 0.596 0 C-N-CA 123.679 0.792 . . . . 0.0 110.018 178.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 263' ' ' TRP . . . . . . . . . . . . . 55.3 t90 -95.0 122.22 37.43 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.775 0.83 . . . . 0.0 110.676 -170.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -96.88 106.21 18.48 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.15 0.58 . . . . 0.0 109.747 177.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 265' ' ' CYS . . . . . 0.434 ' SG ' ' OE2' ' A' ' 267' ' ' GLU . 13.1 p -70.42 160.17 82.23 Favored Pre-proline 0 CA--C 1.553 1.059 0 CA-C-O 117.861 -1.066 . . . . 0.0 110.109 177.421 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -19.09 -70.11 0.02 OUTLIER 'Trans proline' 0 C--N 1.392 2.866 1 C-N-CA 126.388 4.725 . . . . 0.0 117.536 -174.224 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 267' ' ' GLU . . . . . 0.434 ' OE2' ' SG ' ' A' ' 265' ' ' CYS . 0.0 OUTLIER -68.06 -30.25 69.41 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -173.31 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 268' ' ' CYS . . . . . . . . . . . . . 75.0 m -70.54 -38.3 74.18 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.569 0.748 . . . . 0.0 111.071 175.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -71.95 -41.5 67.71 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.402 -175.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 23.6 pt -86.68 1.08 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.611 -177.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 . . . . . 0 C--O 1.249 1.043 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 174.287 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 31.5 tp . . . . . 0 CA--C 1.543 0.709 0 CA-C-O 120.727 0.298 . . . . 0.0 110.353 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 224' ' ' TYR . . . . . 0.421 ' HB3' ' HA ' ' A' ' 245' ' ' TYR . 75.0 m-85 -141.69 129.77 22.07 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 174.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 35.6 t 172.2 153.13 0.07 Allowed 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 125.029 1.332 . . . . 0.0 108.447 169.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 80.1 t80 -63.44 -35.11 79.36 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 122.826 0.45 . . . . 0.0 111.786 -178.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 13.7 p -79.18 -16.48 56.52 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 122.531 0.333 . . . . 0.0 111.283 179.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 85.0 mm-40 54.09 80.55 0.11 Allowed 'General case' 0 C--N 1.362 1.151 0 C-N-CA 124.701 1.2 . . . . 0.0 111.543 -171.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 229' ' ' ARG . . . . . 0.454 ' HD3' ' O ' ' A' ' 230' ' ' VAL . 4.5 tmt_? -150.02 148.76 29.42 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 -178.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . 0.454 ' O ' ' HD3' ' A' ' 229' ' ' ARG . 33.4 m -73.33 178.63 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 N-CA-C 112.759 0.652 . . . . 0.0 112.759 -172.009 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 19.6 m -139.22 49.11 1.85 Allowed 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 123.323 0.649 . . . . 0.0 109.54 -176.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 20.0 p90 -65.93 119.37 11.19 Favored 'General case' 0 CA--C 1.551 1.002 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.557 -173.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 77.18 -22.9 2.34 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 124.479 1.037 . . . . 0.0 115.327 178.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 61.7 mm-40 -143.62 99.78 3.48 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.047 0.939 . . . . 0.0 109.861 -178.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 235' ' ' MET . . . . . . . . . . . . . 18.5 ptp -122.91 132.27 54.1 Favored 'General case' 0 C--O 1.242 0.709 0 C-N-CA 124.457 1.103 . . . . 0.0 109.423 172.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 4.0 p -100.69 124.19 54.12 Favored 'Isoleucine or valine' 0 C--O 1.24 0.572 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 171.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -92.17 133.06 36.14 Favored 'General case' 0 C--O 1.242 0.663 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.048 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 238' ' ' CYS . . . . . 0.579 ' SG ' ' HA ' ' A' ' 264' ' ' TYR . 40.9 t -108.26 102.49 11.61 Favored 'General case' 0 C--O 1.243 0.719 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 176.438 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 239' ' ' ASP . . . . . 0.422 ' HB3' HG22 ' A' ' 262' ' ' THR . 30.2 t70 -82.37 94.32 7.36 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 240' ' ' GLY . . . . . 0.414 ' HA3' ' SG ' ' A' ' 268' ' ' CYS . . . -128.07 141.48 12.64 Favored Glycine 0 CA--C 1.527 0.811 0 CA-C-O 118.186 -1.341 . . . . 0.0 110.489 175.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -52.97 -42.74 62.23 Favored 'Trans proline' 0 C--N 1.379 2.145 0 C-N-CA 123.208 2.605 . . . . 0.0 112.166 -179.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -115.94 112.62 22.14 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.554 1.142 . . . . 0.0 108.02 171.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 243' ' ' CYS . . . . . 0.581 ' SG ' ' HA ' ' A' ' 246' ' ' GLU . 8.0 t -168.75 81.15 0.14 Allowed 'General case' 0 C--N 1.352 0.681 0 CA-C-O 121.496 0.665 . . . . 0.0 110.4 -175.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.5 -29.4 68.82 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 123.778 0.831 . . . . 0.0 112.574 178.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 245' ' ' TYR . . . . . 0.421 ' HA ' ' HB3' ' A' ' 224' ' ' TYR . 41.9 m-85 -101.75 24.59 9.65 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.86 0.864 . . . . 0.0 111.458 179.58 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 246' ' ' GLU . . . . . 0.581 ' HA ' ' SG ' ' A' ' 243' ' ' CYS . 14.8 pt-20 -47.21 -37.46 10.35 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 125.049 1.34 . . . . 0.0 114.235 -170.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 247' ' ' TRP . . . . . . . . . . . . . 99.0 m95 -80.01 122.17 26.4 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.102 0.561 . . . . 0.0 109.726 176.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -129.21 173.88 10.09 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.039 0.936 . . . . 0.0 109.713 178.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 249' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -124.04 152.52 42.53 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.395 1.078 . . . . 0.0 108.728 173.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -62.87 -27.15 69.15 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.687 1.195 . . . . 0.0 110.818 -173.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -61.2 -47.32 86.66 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.985 1.314 . . . . 0.0 110.947 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 252' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -71.27 -43.38 67.29 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 114.563 -1.199 . . . . 0.0 111.421 -176.106 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . 0.522 HG21 ' HG ' ' A' ' 255' ' ' LEU . 35.6 m -100.02 6.59 9.46 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.806 -172.32 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 12.0 m120 60.75 31.62 20.12 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 124.771 1.229 . . . . 0.0 113.102 171.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . 0.522 ' HG ' HG21 ' A' ' 253' ' ' VAL . 70.4 mt -79.22 116.21 19.34 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 176.56 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 50.9 tttp -70.59 -42.62 70.79 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.954 0.902 . . . . 0.0 109.591 174.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -126.7 157.16 72.12 Favored Pre-proline 0 C--O 1.248 0.998 0 CA-C-N 114.49 -1.232 . . . . 0.0 109.788 -176.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -56.93 146.09 81.4 Favored 'Trans proline' 0 C--N 1.378 2.104 0 C-N-CA 122.912 2.408 . . . . 0.0 112.712 171.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 259' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -67.08 148.65 81.66 Favored 'Trans proline' 0 C--N 1.372 1.787 0 C-N-CA 122.255 1.97 . . . . 0.0 111.442 172.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 85.4 mttt -87.86 -32.2 19.13 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.877 0.871 . . . . 0.0 110.299 -179.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -120.03 -171.21 14.56 Favored Glycine 0 C--N 1.345 1.055 0 CA-C-N 115.339 -0.846 . . . . 0.0 112.086 -178.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 262' ' ' THR . . . . . 0.422 HG22 ' HB3' ' A' ' 239' ' ' ASP . 76.9 m -62.95 109.81 1.58 Allowed 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.978 0.911 . . . . 0.0 109.92 179.043 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 263' ' ' TRP . . . . . . . . . . . . . 59.0 t90 -82.2 145.54 30.01 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.018 0.527 . . . . 0.0 110.005 -176.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 264' ' ' TYR . . . . . 0.579 ' HA ' ' SG ' ' A' ' 238' ' ' CYS . 98.6 m-85 -129.78 152.55 49.16 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.898 0.879 . . . . 0.0 110.339 -178.697 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 15.3 p -114.55 162.16 24.95 Favored Pre-proline 0 N--CA 1.482 1.136 0 CA-C-O 117.701 -1.142 . . . . 0.0 107.959 175.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -30.12 -65.44 0.08 OUTLIER 'Trans proline' 0 C--N 1.391 2.812 0 C-N-CA 125.151 3.901 . . . . 0.0 117.342 -175.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.2 -12.4 55.83 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 -172.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 268' ' ' CYS . . . . . 0.414 ' SG ' ' HA3' ' A' ' 240' ' ' GLY . 74.7 m -88.46 -42.2 12.29 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.669 0.788 . . . . 0.0 112.596 169.422 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . 0.546 ' HG3' HG21 ' A' ' 270' ' ' ILE . 14.7 ptmm? -97.67 -50.4 4.48 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 114.158 1.17 . . . . 0.0 114.158 -162.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 270' ' ' ILE . . . . . 0.546 HG21 ' HG3' ' A' ' 269' ' ' LYS . 19.2 pt -88.9 21.21 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -169.292 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 . . . . . 0 C--O 1.25 1.118 0 C-N-CA 123.805 0.842 . . . . 0.0 109.71 179.051 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 44.1 tp . . . . . 0 N--CA 1.475 0.821 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 224' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -142.13 142.95 32.8 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.012 0.925 . . . . 0.0 109.427 -175.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 45.5 t 171.8 163.84 0.1 Allowed 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 125.469 1.508 . . . . 0.0 108.352 173.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 41.4 t80 -66.78 -31.23 71.73 Favored 'General case' 0 CA--C 1.557 1.221 0 CA-C-N 118.668 0.667 . . . . 0.0 110.302 175.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 227' ' ' CYS . . . . . 0.521 ' SG ' ' HB2' ' A' ' 229' ' ' ARG . 4.6 p -89.49 -3.83 58.2 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 122.919 0.487 . . . . 0.0 111.444 174.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 81.4 mm-40 46.45 81.86 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 125.023 1.329 . . . . 0.0 111.817 -175.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 229' ' ' ARG . . . . . 0.521 ' HB2' ' SG ' ' A' ' 227' ' ' CYS . 1.0 OUTLIER -150.02 158.03 43.75 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 -171.504 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 27.2 m -71.83 150.53 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 O-C-N 123.524 0.515 . . . . 0.0 111.464 178.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 231' ' ' SER . . . . . 0.402 ' HA ' ' HB3' ' A' ' 249' ' ' HIS . 20.5 m -100.86 77.72 1.88 Allowed 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 175.512 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 82.5 t80 -71.67 101.11 2.46 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.423 0.689 . . . . 0.0 110.642 -174.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 80.66 -19.24 7.51 Favored Glycine 0 C--N 1.344 1.014 0 CA-C-N 115.513 -0.767 . . . . 0.0 114.247 175.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . 0.415 ' HB3' ' CD1' ' A' ' 250' ' ' TYR . 59.3 mm-40 -128.03 94.98 4.06 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.127 0.971 . . . . 0.0 109.351 -175.304 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 235' ' ' MET . . . . . 0.4 ' HG2' ' HB2' ' A' ' 231' ' ' SER . 44.7 mtt -118.2 97.76 5.95 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.357 0.663 . . . . 0.0 110.108 -174.537 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . 0.415 HG13 HG21 ' A' ' 253' ' ' VAL . 7.4 p -92.56 124.54 45.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 171.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -99.47 141.07 32.74 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 123.884 0.874 . . . . 0.0 109.853 179.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 238' ' ' CYS . . . . . 0.656 ' HB3' ' HA ' ' A' ' 246' ' ' GLU . 5.5 t -105.36 114.48 28.69 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 123.864 0.866 . . . . 0.0 109.785 179.571 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -72.6 95.63 1.86 Allowed 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.096 0.558 . . . . 0.0 109.516 176.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -139.06 116.48 1.25 Allowed Glycine 0 CA--C 1.53 0.988 0 CA-C-O 118.711 -1.049 . . . . 0.0 111.282 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -60.03 -29.08 88.45 Favored 'Trans proline' 0 C--N 1.377 2.055 0 C-N-CA 123.382 2.721 . . . . 0.0 112.621 178.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -120.35 88.71 2.99 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 171.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 42.1 t -172.17 112.15 0.28 Allowed 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.485 0.714 . . . . 0.0 110.456 -172.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 20.8 pttm -89.25 -25.01 21.95 Favored 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 167.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -79.33 27.47 0.26 Allowed 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 124.83 1.252 . . . . 0.0 112.527 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 246' ' ' GLU . . . . . 0.656 ' HA ' ' HB3' ' A' ' 238' ' ' CYS . 41.1 mt-10 -53.35 -46.55 69.57 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.163 0.585 . . . . 0.0 110.601 172.191 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 247' ' ' TRP . . . . . . . . . . . . . 97.8 m95 -72.42 122.18 20.8 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.366 179.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -142.38 171.32 14.21 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 125.206 1.402 . . . . 0.0 109.174 170.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 249' ' ' HIS . . . . . 0.402 ' HB3' ' HA ' ' A' ' 231' ' ' SER . 0.1 OUTLIER -123.12 142.42 50.91 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.249 1.019 . . . . 0.0 108.859 178.804 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 250' ' ' TYR . . . . . 0.415 ' CD1' ' HB3' ' A' ' 234' ' ' GLU . 8.8 m-85 -58.49 -26.69 63.72 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 124.98 1.312 . . . . 0.0 112.128 -174.087 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -59.46 -56.64 19.45 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.013 0.925 . . . . 0.0 110.833 174.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 252' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -61.39 -49.15 78.07 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.968 0.907 . . . . 0.0 111.595 -178.624 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . 0.454 HG22 ' HG ' ' A' ' 255' ' ' LEU . 26.8 m -88.64 5.32 4.41 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.909 -174.213 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 44.8 m-80 64.39 16.01 9.89 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 125.006 1.322 . . . . 0.0 113.415 169.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . 0.454 ' HG ' HG22 ' A' ' 253' ' ' VAL . 89.8 mt -74.24 108.02 6.77 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 122.891 0.476 . . . . 0.0 109.868 -176.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 62.1 mttm -72.15 -25.62 61.78 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.973 0.909 . . . . 0.0 110.326 176.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -131.59 159.69 70.71 Favored Pre-proline 0 CA--C 1.552 1.039 0 C-N-CA 124.619 1.167 . . . . 0.0 109.337 -177.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.31 140.64 44.88 Favored 'Trans proline' 0 C--N 1.369 1.625 0 C-N-CA 122.325 2.017 . . . . 0.0 111.78 169.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 259' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -61.66 158.49 36.96 Favored 'Trans proline' 0 C--N 1.38 2.211 0 C-N-CA 122.47 2.113 . . . . 0.0 111.542 169.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 31.6 mmmt -93.37 -2.15 55.08 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 112.724 0.638 . . . . 0.0 112.724 -175.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -164.53 -147.38 5.09 Favored Glycine 0 C--N 1.345 1.05 0 N-CA-C 112.213 -0.355 . . . . 0.0 112.213 -178.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 54.7 p -64.21 107.8 1.4 Allowed 'General case' 0 C--N 1.352 0.699 0 C-N-CA 123.401 0.681 . . . . 0.0 110.552 178.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 263' ' ' TRP . . . . . . . . . . . . . 63.3 t90 -87.45 144.78 26.57 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 176.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 264' ' ' TYR . . . . . 0.44 ' HA ' ' SG ' ' A' ' 238' ' ' CYS . 95.1 m-85 -126.14 129.39 48.97 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.433 0.693 . . . . 0.0 109.654 -178.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 265' ' ' CYS . . . . . 0.421 ' SG ' ' OE1' ' A' ' 267' ' ' GLU . 16.7 p -85.76 156.12 58.58 Favored Pre-proline 0 CA--C 1.555 1.163 0 CA-C-O 118.47 -0.776 . . . . 0.0 109.248 177.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 0.8 OUTLIER -23.7 -64.88 0.04 OUTLIER 'Trans proline' 0 C--N 1.392 2.845 1 C-N-CA 126.314 4.676 . . . . 0.0 118.098 -168.456 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 267' ' ' GLU . . . . . 0.421 ' OE1' ' SG ' ' A' ' 265' ' ' CYS . 0.0 OUTLIER -67.02 -32.18 73.23 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 122.574 0.35 . . . . 0.0 111.565 -171.619 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 268' ' ' CYS . . . . . . . . . . . . . 58.6 m -72.31 -38.59 68.68 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.763 0.825 . . . . 0.0 110.601 176.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 61.5 tttp -71.78 -34.31 69.32 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 115.042 -0.981 . . . . 0.0 111.294 -173.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 25.7 pt -90.0 -9.88 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 123.106 0.563 . . . . 0.0 111.408 -179.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 . . . . . 0 C--O 1.25 1.097 0 C-N-CA 123.739 0.815 . . . . 0.0 110.132 -177.586 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 51.3 tp . . . . . 0 N--CA 1.473 0.684 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 224' ' ' TYR . . . . . 0.428 ' HB3' ' HA ' ' A' ' 245' ' ' TYR . 47.4 m-85 -137.93 127.57 25.13 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.036 0.934 . . . . 0.0 109.2 178.714 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 14.0 t 174.08 158.08 0.15 Allowed 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.386 1.075 . . . . 0.0 109.953 172.174 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -64.23 -38.89 92.67 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 122.997 0.519 . . . . 0.0 111.412 175.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 9.8 p -77.54 -13.9 59.8 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.086 177.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 81.1 mm-40 52.65 66.82 1.11 Allowed 'General case' 0 C--N 1.368 1.394 0 C-N-CA 124.668 1.187 . . . . 0.0 111.688 -174.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 78.4 ttt180 -130.26 153.58 48.47 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.659 0.784 . . . . 0.0 109.41 -179.437 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 29.3 m -66.21 155.42 7.08 Favored 'Isoleucine or valine' 0 C--O 1.241 0.65 0 C-N-CA 123.38 0.672 . . . . 0.0 111.655 177.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 231' ' ' SER . . . . . 0.673 ' HB3' ' HB3' ' A' ' 235' ' ' MET . 46.2 m -105.66 69.18 0.82 Allowed 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.52 178.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 20.2 p90 -70.02 110.32 5.02 Favored 'General case' 0 CA--C 1.549 0.918 0 CA-C-N 114.353 -1.294 . . . . 0.0 111.237 -176.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 76.92 -20.69 2.86 Favored Glycine 0 N--CA 1.478 1.49 0 N-CA-C 115.204 0.842 . . . . 0.0 115.204 171.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . 0.415 ' HB3' ' HD2' ' A' ' 250' ' ' TYR . 49.3 mt-10 -142.75 127.45 18.1 Favored 'General case' 0 C--O 1.243 0.743 0 C-N-CA 124.251 1.02 . . . . 0.0 108.928 -178.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 235' ' ' MET . . . . . 0.673 ' HB3' ' HB3' ' A' ' 231' ' ' SER . 22.4 ptt? -151.91 129.57 11.54 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 123.313 0.645 . . . . 0.0 110.432 175.739 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 5.4 p -103.31 126.46 57.68 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 C-N-CA 123.866 0.867 . . . . 0.0 108.869 175.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -88.57 164.64 15.29 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.624 0.77 . . . . 0.0 110.281 179.1 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 238' ' ' CYS . . . . . 0.409 ' HB3' ' HA ' ' A' ' 246' ' ' GLU . 15.4 t -136.83 105.54 5.85 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.353 0.661 . . . . 0.0 109.349 179.322 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -79.99 94.96 6.0 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.791 -178.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -141.25 137.19 7.96 Favored Glycine 0 C--N 1.348 1.223 0 CA-C-O 118.678 -1.068 . . . . 0.0 111.456 178.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -60.03 -38.71 76.18 Favored 'Trans proline' 0 C--N 1.376 1.978 0 C-N-CA 123.232 2.622 . . . . 0.0 113.384 179.176 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -109.49 95.88 5.91 Favored 'General case' 0 C--O 1.243 0.739 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 175.109 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 243' ' ' CYS . . . . . 0.478 ' SG ' ' HA ' ' A' ' 246' ' ' GLU . 12.2 t -166.06 101.8 0.65 Allowed 'General case' 0 C--O 1.237 0.429 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.941 -171.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 21.7 pttm -86.16 -37.98 18.18 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 171.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 245' ' ' TYR . . . . . 0.428 ' HA ' ' HB3' ' A' ' 224' ' ' TYR . 53.9 m-85 -87.66 29.15 0.92 Allowed 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 124.29 1.036 . . . . 0.0 111.874 -179.106 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 246' ' ' GLU . . . . . 0.478 ' HA ' ' SG ' ' A' ' 243' ' ' CYS . 10.4 pt-20 -49.37 -36.57 22.03 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.087 0.955 . . . . 0.0 112.844 179.105 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 247' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -91.09 135.16 33.95 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.381 0.61 . . . . 0.0 111.043 178.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -142.8 174.09 10.96 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 125.665 1.586 . . . . 0.0 108.449 174.105 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 249' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -117.2 141.84 47.78 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.817 0.847 . . . . 0.0 108.832 174.563 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 250' ' ' TYR . . . . . 0.415 ' HD2' ' HB3' ' A' ' 234' ' ' GLU . 86.3 m-85 -57.2 -26.85 61.33 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 124.658 1.183 . . . . 0.0 112.074 -177.22 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -56.3 -58.4 8.15 Favored 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 123.861 0.864 . . . . 0.0 111.46 174.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 252' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -61.37 -41.94 97.91 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 124.203 1.001 . . . . 0.0 112.117 -173.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 35.8 m -92.23 -5.77 10.72 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.733 -175.161 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 10.8 t30 52.41 70.12 0.6 Allowed 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 124.611 1.164 . . . . 0.0 111.243 178.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 96.3 mt -129.92 122.87 29.42 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 178.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 64.2 tttp -90.64 -27.48 19.02 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 123.272 0.629 . . . . 0.0 110.166 178.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 16.9 mp0 -105.45 147.07 33.99 Favored Pre-proline 0 N--CA 1.477 0.903 0 C-N-CA 124.189 0.996 . . . . 0.0 109.336 178.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -74.63 117.62 5.02 Favored 'Trans proline' 0 C--N 1.373 1.831 0 C-N-CA 122.322 2.015 . . . . 0.0 110.548 170.022 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 259' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_exo -53.6 112.62 1.0 Allowed 'Trans proline' 0 C--N 1.378 2.119 0 C-N-CA 123.1 2.533 . . . . 0.0 113.397 -178.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -68.21 103.14 1.5 Allowed 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.869 0.868 . . . . 0.0 109.855 -179.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 118.3 -167.46 12.96 Favored Glycine 0 N--CA 1.472 1.034 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 -176.321 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 39.4 p -74.13 106.04 5.61 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 177.214 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 263' ' ' TRP . . . . . . . . . . . . . 52.1 t90 -73.79 134.21 43.36 Favored 'General case' 0 C--N 1.349 0.583 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 173.027 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -110.85 113.86 26.77 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 123.029 0.531 . . . . 0.0 109.777 179.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 17.4 p -64.75 160.78 51.17 Favored Pre-proline 0 CA--C 1.55 0.964 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.947 171.278 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -36.63 -38.8 0.37 Allowed 'Trans proline' 0 C--N 1.382 2.317 0 C-N-CA 124.329 3.352 . . . . 0.0 115.991 175.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -54.58 -61.73 2.12 Favored 'General case' 0 N--CA 1.485 1.32 0 CA-C-O 121.652 0.739 . . . . 0.0 110.807 176.098 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 268' ' ' CYS . . . . . . . . . . . . . 35.5 m -80.02 -30.85 39.59 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 114.493 -1.23 . . . . 0.0 111.853 -168.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -75.86 -53.08 8.99 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.7 0.8 . . . . 0.0 111.155 -173.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 270' ' ' ILE . . . . . 0.413 HG23 ' HG3' ' A' ' 271' ' ' GLU . 50.7 mm -72.16 -52.47 24.3 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.978 -176.468 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 271' ' ' GLU . . . . . 0.413 ' HG3' HG23 ' A' ' 270' ' ' ILE . 45.7 mt-10 . . . . . 0 CA--C 1.555 1.164 0 C-N-CA 123.207 0.603 . . . . 0.0 109.553 -178.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.477 0.889 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 224' ' ' TYR . . . . . 0.515 ' HB3' ' HA ' ' A' ' 245' ' ' TYR . 78.5 m-85 -133.76 130.43 38.03 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 123.855 0.862 . . . . 0.0 108.892 179.535 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 225' ' ' CYS . . . . . 0.412 ' HB2' ' O ' ' A' ' 224' ' ' TYR . 26.5 t 172.29 155.69 0.09 Allowed 'General case' 0 N--CA 1.474 0.761 0 O-C-N 124.794 1.309 . . . . 0.0 109.388 168.387 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 61.5 t80 -64.81 -27.67 69.04 Favored 'General case' 0 CA--C 1.556 1.193 0 C-N-CA 123.201 0.6 . . . . 0.0 111.214 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 13.2 p -90.57 -10.69 42.48 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 122.991 0.517 . . . . 0.0 111.442 177.078 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 83.4 mm-40 52.16 85.46 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 124.607 1.163 . . . . 0.0 111.437 -171.041 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 73.6 ttt180 -140.63 150.71 43.9 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.816 -176.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 34.3 m -69.18 170.38 1.14 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.61 0 C-N-CA 124.29 1.036 . . . . 0.0 112.754 -177.331 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 39.4 t -86.73 116.52 24.88 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 114.662 -1.154 . . . . 0.0 109.762 174.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 232' ' ' PHE . . . . . 0.592 ' HB3' ' HG2' ' A' ' 234' ' ' GLU . 91.8 t80 -75.63 -13.04 60.32 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 123.84 0.856 . . . . 0.0 109.728 166.786 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 109.78 -18.17 29.56 Favored Glycine 0 C--N 1.349 1.277 0 N-CA-C 111.521 -0.632 . . . . 0.0 111.521 -174.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . 0.592 ' HG2' ' HB3' ' A' ' 232' ' ' PHE . 8.5 pt-20 -77.65 64.55 2.96 Favored 'General case' 0 CA--C 1.555 1.163 0 C-N-CA 124.273 1.029 . . . . 0.0 110.129 174.683 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 235' ' ' MET . . . . . . . . . . . . . 73.2 mtm -91.61 100.96 13.6 Favored 'General case' 0 N--CA 1.475 0.801 0 O-C-N 121.823 -0.548 . . . . 0.0 110.682 -173.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 2.8 p -88.07 124.28 41.09 Favored 'Isoleucine or valine' 0 C--O 1.241 0.652 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 168.124 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -99.32 110.9 23.37 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 123.564 0.746 . . . . 0.0 110.074 -176.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 238' ' ' CYS . . . . . 0.442 ' HB3' ' HA ' ' A' ' 246' ' ' GLU . 42.3 t -71.64 153.75 41.88 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.242 169.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 239' ' ' ASP . . . . . 0.542 ' HB3' ' HB ' ' A' ' 262' ' ' THR . 23.5 t70 -134.23 95.61 3.44 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.606 0.762 . . . . 0.0 109.176 176.317 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 240' ' ' GLY . . . . . 0.544 ' HA3' ' SG ' ' A' ' 268' ' ' CYS . . . -142.05 140.71 10.26 Favored Glycine 0 CA--C 1.534 1.222 0 CA-C-O 118.442 -1.199 . . . . 0.0 111.917 175.192 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -59.44 -51.69 5.93 Favored 'Trans proline' 0 C--N 1.377 2.03 0 C-N-CA 122.746 2.297 . . . . 0.0 112.145 178.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -89.04 86.49 6.93 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 171.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 10.4 t -174.75 104.6 0.1 Allowed 'General case' 0 C--N 1.351 0.637 0 O-C-N 123.88 0.738 . . . . 0.0 109.688 -176.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -85.75 -31.93 22.13 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-O 121.842 0.83 . . . . 0.0 110.359 173.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 245' ' ' TYR . . . . . 0.515 ' HA ' ' HB3' ' A' ' 224' ' ' TYR . 59.7 m-85 -86.65 26.4 1.11 Allowed 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.053 1.341 . . . . 0.0 112.368 -171.126 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 246' ' ' GLU . . . . . 0.442 ' HA ' ' HB3' ' A' ' 238' ' ' CYS . 5.6 mm-40 -45.96 -42.34 12.85 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 125.105 1.362 . . . . 0.0 112.697 -174.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 247' ' ' TRP . . . . . 0.479 ' HB2' ' HB2' ' A' ' 224' ' ' TYR . 96.0 m95 -70.92 117.93 13.06 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.112 0.565 . . . . 0.0 110.262 175.331 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -131.23 173.49 10.99 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.349 1.06 . . . . 0.0 109.92 175.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 249' ' ' HIS . . . . . 0.575 ' HD2' ' HB2' ' A' ' 252' ' ' CYS . 0.2 OUTLIER -121.9 139.57 53.48 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.165 0.986 . . . . 0.0 109.031 175.639 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -54.63 -49.39 70.62 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 124.787 1.235 . . . . 0.0 113.063 -168.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -53.49 -40.83 65.66 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 124.127 0.971 . . . . 0.0 112.107 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 252' ' ' CYS . . . . . 0.575 ' HB2' ' HD2' ' A' ' 249' ' ' HIS . 2.8 t -66.17 -32.11 73.36 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 124.34 1.056 . . . . 0.0 111.582 -175.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 29.8 m -110.48 13.36 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 123.666 0.786 . . . . 0.0 111.362 -174.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 67.4 11.65 8.49 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 124.644 1.177 . . . . 0.0 112.398 173.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 95.0 mt -84.01 157.36 21.86 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-O 121.558 0.695 . . . . 0.0 109.337 174.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 27.0 tptp -145.86 -29.97 0.41 Allowed 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.199 0.999 . . . . 0.0 108.651 174.149 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -93.59 141.44 23.86 Favored Pre-proline 0 C--O 1.245 0.84 0 C-N-CA 124.09 0.956 . . . . 0.0 108.895 177.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -65.09 124.1 12.53 Favored 'Trans proline' 0 C--N 1.373 1.824 0 C-N-CA 122.4 2.066 . . . . 0.0 111.361 177.323 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 259' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -51.01 131.11 33.87 Favored 'Trans proline' 0 C--N 1.38 2.235 0 C-N-CA 123.455 2.77 . . . . 0.0 113.743 178.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.77 -4.79 39.69 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.023 0.929 . . . . 0.0 112.866 -175.002 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -153.25 -170.39 19.41 Favored Glycine 0 N--CA 1.471 0.989 0 N-CA-C 111.149 -0.78 . . . . 0.0 111.149 176.051 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 262' ' ' THR . . . . . 0.542 ' HB ' ' HB3' ' A' ' 239' ' ' ASP . 40.8 p -65.58 106.59 1.48 Allowed 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 175.414 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 263' ' ' TRP . . . . . . . . . . . . . 49.8 t90 -74.38 137.87 43.02 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.201 0.601 . . . . 0.0 111.238 -169.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 41.1 m-85 -114.85 109.27 17.89 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.815 0.846 . . . . 0.0 109.398 -176.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 265' ' ' CYS . . . . . 0.431 ' SG ' ' OE2' ' A' ' 267' ' ' GLU . 16.0 p -72.44 162.5 73.63 Favored Pre-proline 0 CA--C 1.559 1.302 0 C-N-CA 123.563 0.745 . . . . 0.0 110.183 176.505 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_exo -36.93 -51.83 1.37 Allowed 'Trans proline' 0 C--N 1.393 2.869 0 C-N-CA 124.511 3.474 . . . . 0.0 116.45 -178.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 267' ' ' GLU . . . . . 0.431 ' OE2' ' SG ' ' A' ' 265' ' ' CYS . 0.0 OUTLIER -72.11 -18.54 61.9 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -175.28 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 268' ' ' CYS . . . . . 0.544 ' SG ' ' HA3' ' A' ' 240' ' ' GLY . 59.2 m -82.36 -44.74 15.78 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.0 0.52 . . . . 0.0 111.542 171.291 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -82.38 -45.14 15.24 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.259 -166.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 50.9 mm -76.32 -40.18 35.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 123.604 0.761 . . . . 0.0 110.552 -176.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 23.9 mm-40 . . . . . 0 C--O 1.25 1.084 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 177.713 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 1.4 tm? . . . . . 0 N--CA 1.473 0.725 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 224' ' ' TYR . . . . . 0.471 ' HB2' ' HB2' ' A' ' 247' ' ' TRP . 68.1 m-85 -137.71 138.16 39.07 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 178.628 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 51.3 t 170.93 162.0 0.08 Allowed 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 125.662 1.585 . . . . 0.0 108.649 172.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -62.53 -40.01 95.41 Favored 'General case' 0 CA--C 1.552 1.036 0 CA-C-N 117.992 0.36 . . . . 0.0 110.808 176.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 9.2 p -81.49 -19.88 41.34 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 122.608 0.363 . . . . 0.0 111.195 176.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 24.2 mm-40 59.07 99.69 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 124.905 1.282 . . . . 0.0 112.288 -172.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 229' ' ' ARG . . . . . 0.446 ' HD3' ' N ' ' A' ' 230' ' ' VAL . 4.6 tmt_? -163.75 152.91 14.19 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 -173.224 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . 0.446 ' N ' ' HD3' ' A' ' 229' ' ' ARG . 30.7 m -64.52 165.84 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 C-N-CA 123.991 0.916 . . . . 0.0 112.645 -177.461 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 26.0 m -139.26 71.9 1.39 Allowed 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 123.275 0.63 . . . . 0.0 109.988 -177.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 53.2 m-85 -98.67 128.9 45.11 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.667 0.787 . . . . 0.0 110.406 178.173 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 84.25 -14.71 43.49 Favored Glycine 0 CA--C 1.535 1.321 0 O-C-N 123.212 0.32 . . . . 0.0 113.376 178.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -153.38 138.54 17.4 Favored 'General case' 0 C--N 1.351 0.645 0 C-N-CA 124.459 1.103 . . . . 0.0 108.83 179.124 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 235' ' ' MET . . . . . . . . . . . . . 21.1 ptp -163.11 133.13 4.37 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.232 0.613 . . . . 0.0 109.791 176.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . 0.44 HG11 ' HB2' ' A' ' 248' ' ' PHE . 2.4 p -119.0 122.96 70.63 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 171.395 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -90.61 130.48 36.63 Favored 'General case' 0 C--O 1.239 0.507 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 174.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 238' ' ' CYS . . . . . . . . . . . . . 18.9 t -105.89 122.59 46.43 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.88 0.872 . . . . 0.0 111.106 -172.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -71.7 113.47 8.77 Favored 'General case' 0 C--N 1.352 0.715 0 C-N-CA 123.457 0.703 . . . . 0.0 110.082 176.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -143.17 144.54 13.91 Favored Glycine 0 CA--C 1.525 0.7 0 CA-C-N 114.388 -1.278 . . . . 0.0 110.551 169.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -57.53 -44.39 42.48 Favored 'Trans proline' 0 C--N 1.37 1.673 0 C-N-CA 122.531 2.154 . . . . 0.0 111.034 165.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 36.2 t30 -127.69 115.17 18.32 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 171.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 243' ' ' CYS . . . . . 0.573 ' SG ' ' HA ' ' A' ' 246' ' ' GLU . 16.2 t -151.93 97.77 2.37 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 -179.292 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -74.66 -37.94 62.59 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-O 121.279 0.561 . . . . 0.0 110.106 -179.3 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -89.83 25.46 2.06 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.742 1.217 . . . . 0.0 110.743 179.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 246' ' ' GLU . . . . . 0.573 ' HA ' ' SG ' ' A' ' 243' ' ' CYS . 8.9 pt-20 -46.65 -37.66 8.6 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 125.165 1.386 . . . . 0.0 113.744 -173.423 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 247' ' ' TRP . . . . . 0.471 ' HB2' ' HB2' ' A' ' 224' ' ' TYR . 94.0 m95 -88.5 138.54 31.34 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 122.922 0.489 . . . . 0.0 109.887 175.658 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 248' ' ' PHE . . . . . 0.44 ' HB2' HG11 ' A' ' 236' ' ' VAL . 60.1 m-85 -140.36 171.81 13.63 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.387 1.075 . . . . 0.0 109.385 175.394 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 249' ' ' HIS . . . . . 0.479 ' CD2' ' HB2' ' A' ' 252' ' ' CYS . 0.1 OUTLIER -117.7 141.27 48.58 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 173.788 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -58.69 -34.73 71.62 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 124.449 1.099 . . . . 0.0 112.821 -169.237 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -63.43 -38.97 93.21 Favored 'General case' 0 N--CA 1.479 1.02 0 O-C-N 123.854 0.721 . . . . 0.0 111.22 -177.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 252' ' ' CYS . . . . . 0.479 ' HB2' ' CD2' ' A' ' 249' ' ' HIS . 0.2 OUTLIER -66.93 -49.16 66.37 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 124.643 1.177 . . . . 0.0 110.229 -174.747 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 26.9 m -92.0 2.99 7.88 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 CA-C-N 114.222 -1.354 . . . . 0.0 111.358 -174.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 16.2 m120 60.71 24.34 14.18 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 124.802 1.241 . . . . 0.0 112.781 172.393 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . 0.444 HD13 ' HD3' ' A' ' 259' ' ' PRO . 57.2 mt -71.95 94.83 1.5 Allowed 'General case' 0 C--N 1.35 0.59 0 C-N-CA 123.482 0.713 . . . . 0.0 109.458 176.321 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . 0.633 ' HZ2' ' HB2' ' A' ' 256' ' ' LYS . 8.7 mtmp? -77.29 -21.36 53.66 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.372 170.529 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 12.2 mp0 -111.58 125.85 29.65 Favored Pre-proline 0 C--O 1.244 0.801 0 C-N-CA 124.715 1.206 . . . . 0.0 107.921 178.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -65.71 121.39 8.75 Favored 'Trans proline' 0 C--N 1.372 1.785 0 C-N-CA 122.072 1.848 . . . . 0.0 110.356 172.152 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 259' ' ' PRO . . . . . 0.444 ' HD3' HD13 ' A' ' 255' ' ' LEU . 26.9 Cg_endo -58.28 116.91 3.58 Favored 'Trans proline' 0 C--N 1.378 2.118 0 C-N-CA 122.869 2.379 . . . . 0.0 112.413 -173.06 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 260' ' ' LYS . . . . . 0.473 ' HD3' ' H ' ' A' ' 260' ' ' LYS . 0.0 OUTLIER -56.31 -28.84 60.15 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.764 1.226 . . . . 0.0 113.026 -178.159 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -138.79 -147.49 5.14 Favored Glycine 0 C--N 1.348 1.211 0 CA-C-O 120.139 -0.256 . . . . 0.0 112.634 -178.241 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 46.6 p -72.12 106.1 4.21 Favored 'General case' 0 C--O 1.242 0.709 0 C-N-CA 123.515 0.726 . . . . 0.0 110.339 -178.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 263' ' ' TRP . . . . . . . . . . . . . 78.8 t90 -85.74 118.64 25.37 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.488 1.115 . . . . 0.0 109.543 178.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -102.31 115.79 31.3 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.231 1.012 . . . . 0.0 109.655 177.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 29.1 p -67.32 166.29 22.18 Favored Pre-proline 0 N--CA 1.487 1.417 0 C-N-CA 124.603 1.161 . . . . 0.0 110.634 176.16 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -40.01 -49.66 3.59 Favored 'Trans proline' 0 C--N 1.393 2.87 0 C-N-CA 123.917 3.078 . . . . 0.0 113.801 172.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -64.39 -26.8 68.62 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.379 0.672 . . . . 0.0 111.742 -174.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 268' ' ' CYS . . . . . . . . . . . . . 61.4 m -85.58 -41.48 15.22 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 123.215 0.606 . . . . 0.0 111.053 175.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 23.1 ttpp -77.37 -33.58 55.23 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.46 0.704 . . . . 0.0 111.634 -167.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 18.9 pt -130.08 50.74 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 124.3 1.04 . . . . 0.0 109.072 178.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 . . . . . 0 CA--C 1.559 1.313 0 CA-C-N 114.476 -1.238 . . . . 0.0 111.452 178.742 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 1.4 tm? . . . . . 0 N--CA 1.472 0.657 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 224' ' ' TYR . . . . . 0.572 ' HB2' ' HB2' ' A' ' 247' ' ' TRP . 62.8 m-85 -143.07 130.22 20.79 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 -179.433 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 49.2 t 172.78 158.1 0.11 Allowed 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.318 1.447 . . . . 0.0 108.669 171.001 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -58.22 -46.19 86.33 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 123.102 0.561 . . . . 0.0 110.807 177.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 227' ' ' CYS . . . . . 0.408 ' SG ' ' HB3' ' A' ' 229' ' ' ARG . 14.1 p -75.21 -15.1 60.57 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 122.782 0.433 . . . . 0.0 111.861 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 83.1 mm-40 57.81 90.18 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 124.409 1.084 . . . . 0.0 110.773 -172.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 229' ' ' ARG . . . . . 0.408 ' HB3' ' SG ' ' A' ' 227' ' ' CYS . 75.4 ttt180 -165.31 153.71 11.68 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.098 -171.374 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 35.4 m -73.51 171.85 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.927 0 C-N-CA 123.639 0.776 . . . . 0.0 111.648 175.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 43.4 m -112.5 126.24 55.11 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.943 0.897 . . . . 0.0 109.177 178.173 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 52.9 t80 -91.76 81.6 5.24 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 177.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 75.57 -20.31 2.25 Favored Glycine 0 N--CA 1.474 1.206 0 CA-C-N 115.44 -0.8 . . . . 0.0 114.554 179.046 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 31.9 mm-40 -108.79 99.2 8.58 Favored 'General case' 0 C--O 1.224 -0.25 0 C-N-CA 124.18 0.992 . . . . 0.0 109.781 -176.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 235' ' ' MET . . . . . . . . . . . . . 25.7 ptt? -125.32 129.56 50.2 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.008 0.523 . . . . 0.0 109.706 177.346 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 2.6 p -124.95 125.8 70.21 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 C-N-CA 123.893 0.877 . . . . 0.0 109.346 -178.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -86.37 150.07 24.58 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.333 177.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 238' ' ' CYS . . . . . 0.495 ' HB3' ' HA ' ' A' ' 246' ' ' GLU . 7.9 t -110.33 149.71 29.81 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 124.568 1.147 . . . . 0.0 109.184 -178.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -103.31 95.63 6.22 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 172.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -139.55 128.45 3.97 Favored Glycine 0 C--N 1.344 1.001 0 CA-C-O 118.937 -0.924 . . . . 0.0 111.745 177.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -66.19 -36.85 27.12 Favored 'Trans proline' 0 C--N 1.372 1.794 0 C-N-CA 122.647 2.231 . . . . 0.0 111.768 171.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 41.9 t30 -120.73 104.42 9.89 Favored 'General case' 0 C--O 1.242 0.669 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 174.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 46.6 t -173.12 114.34 0.25 Allowed 'General case' 0 N--CA 1.469 0.488 0 O-C-N 123.645 0.591 . . . . 0.0 109.811 -173.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 54.5 tptt -83.6 -28.05 28.77 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-O 121.369 0.604 . . . . 0.0 109.399 173.086 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 20.6 m-30 -90.99 28.74 1.5 Allowed 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.18 1.392 . . . . 0.0 111.957 -175.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 246' ' ' GLU . . . . . 0.495 ' HA ' ' HB3' ' A' ' 238' ' ' CYS . 6.4 mm-40 -48.28 -33.84 9.45 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 123.551 0.74 . . . . 0.0 112.829 177.554 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 247' ' ' TRP . . . . . 0.572 ' HB2' ' HB2' ' A' ' 224' ' ' TYR . 96.4 m95 -94.07 136.57 34.21 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 121.399 0.619 . . . . 0.0 110.68 173.532 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -140.36 176.37 8.83 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 125.845 1.658 . . . . 0.0 108.322 174.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 249' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -126.07 143.94 50.92 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 173.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 36.5 m-85 -58.02 -34.34 69.94 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.78 0.832 . . . . 0.0 112.49 -172.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -62.44 -36.12 81.41 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.043 0.537 . . . . 0.0 111.683 179.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 252' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -66.69 -42.56 86.28 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.97 0.908 . . . . 0.0 110.862 -177.303 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . 0.495 HG22 ' HB2' ' A' ' 255' ' ' LEU . 15.4 m -99.18 2.34 10.52 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.325 -176.109 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 4.6 t30 55.68 32.29 19.05 Favored 'General case' 0 N--CA 1.495 1.821 0 C-N-CA 124.513 1.125 . . . . 0.0 110.777 179.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . 0.495 ' HB2' HG22 ' A' ' 253' ' ' VAL . 15.7 tp -80.2 108.09 13.52 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 -178.597 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 58.5 tttm -82.77 -21.34 34.67 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.986 0.915 . . . . 0.0 111.34 -174.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -135.43 143.3 44.71 Favored Pre-proline 0 CA--C 1.542 0.641 0 C-N-CA 124.631 1.172 . . . . 0.0 109.235 -173.469 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -61.5 153.22 67.98 Favored 'Trans proline' 0 C--N 1.372 1.79 0 C-N-CA 122.648 2.232 . . . . 0.0 112.732 -177.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 259' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_exo -59.19 127.99 26.05 Favored 'Trans proline' 0 C--N 1.382 2.298 0 C-N-CA 122.794 2.329 . . . . 0.0 112.263 178.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -68.64 -37.06 79.38 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.365 0.666 . . . . 0.0 110.258 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -152.49 -126.49 1.2 Allowed Glycine 0 C--N 1.344 1.01 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.88 178.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 24.7 m -65.27 124.44 22.2 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.04 0.936 . . . . 0.0 110.457 177.467 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 263' ' ' TRP . . . . . . . . . . . . . 78.1 t90 -125.18 107.24 10.55 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.743 0.817 . . . . 0.0 109.432 -176.094 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -88.72 118.81 28.66 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.645 0.778 . . . . 0.0 109.534 174.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 12.7 p -69.47 156.56 91.43 Favored Pre-proline 0 CA--C 1.56 1.343 0 CA-C-O 117.951 -1.023 . . . . 0.0 109.301 174.376 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -19.6 -70.05 0.02 OUTLIER 'Trans proline' 0 C--N 1.394 2.931 1 C-N-CA 126.263 4.642 . . . . 0.0 117.523 -170.246 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.69 -27.28 65.81 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -172.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 268' ' ' CYS . . . . . . . . . . . . . 82.4 m -69.26 -30.89 69.11 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 123.476 0.71 . . . . 0.0 112.203 177.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -92.57 -46.27 7.7 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.296 0.639 . . . . 0.0 110.569 -177.115 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 85.5 mt -84.14 -48.08 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 123.74 0.816 . . . . 0.0 111.433 -171.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 . . . . . 0 C--O 1.255 1.378 0 CA-C-O 118.732 -0.651 . . . . 0.0 110.718 -171.684 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 5.9 tt . . . . . 0 N--CA 1.475 0.822 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 224' ' ' TYR . . . . . 0.494 ' HB2' ' HB2' ' A' ' 247' ' ' TRP . 67.5 m-85 -141.1 133.58 28.42 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 175.111 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 44.4 t 171.45 157.46 0.08 Allowed 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 124.752 1.221 . . . . 0.0 109.419 170.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -58.27 -44.41 88.41 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.86 0.864 . . . . 0.0 111.587 -179.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 16.2 p -73.33 -13.78 61.17 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 123.12 0.568 . . . . 0.0 111.401 -179.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 84.4 mm-40 55.84 73.69 0.42 Allowed 'General case' 0 C--N 1.366 1.297 0 C-N-CA 124.678 1.191 . . . . 0.0 111.327 -173.088 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 28.2 tpt180 -151.02 151.1 31.56 Favored 'General case' 0 C--O 1.244 0.772 0 CA-C-N 114.808 -1.087 . . . . 0.0 109.129 -178.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 21.0 m -66.93 160.77 3.97 Favored 'Isoleucine or valine' 0 C--O 1.243 0.755 0 C-N-CA 123.285 0.634 . . . . 0.0 111.301 173.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 231' ' ' SER . . . . . 0.403 ' HB3' ' O ' ' A' ' 234' ' ' GLU . 45.5 m -87.54 69.33 9.76 Favored 'General case' 0 CA--C 1.549 0.937 0 CA-C-N 115.373 -0.831 . . . . 0.0 109.961 179.566 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -68.97 111.91 5.28 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.223 0.609 . . . . 0.0 111.439 -177.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 79.88 -19.25 6.52 Favored Glycine 0 CA--C 1.538 1.494 0 CA-C-N 115.801 -0.636 . . . . 0.0 114.31 172.249 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . 0.403 ' O ' ' HB3' ' A' ' 231' ' ' SER . 30.0 mt-10 -132.01 148.71 52.52 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 125.235 1.414 . . . . 0.0 107.509 -175.025 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 235' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -154.71 135.21 13.4 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-O 121.593 0.711 . . . . 0.0 111.488 175.359 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . 0.512 HG11 ' HB2' ' A' ' 248' ' ' PHE . 1.1 p -145.09 123.08 4.98 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 170.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -96.47 140.26 31.38 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 173.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 238' ' ' CYS . . . . . . . . . . . . . 37.9 t -101.63 114.31 28.24 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 123.393 0.677 . . . . 0.0 109.984 -179.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -69.96 95.39 0.93 Allowed 'General case' 0 CA--C 1.543 0.693 0 O-C-N 123.93 0.769 . . . . 0.0 109.444 178.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -142.52 116.07 1.01 Allowed Glycine 0 C--N 1.342 0.911 0 CA-C-O 118.363 -1.243 . . . . 0.0 112.15 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_exo -58.24 -31.81 94.44 Favored 'Trans proline' 0 C--N 1.379 2.136 0 C-N-CA 122.787 2.325 . . . . 0.0 111.638 173.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -115.39 86.32 2.44 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 171.137 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 7.7 t -161.38 91.03 0.83 Allowed 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.497 0.719 . . . . 0.0 109.704 -178.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 244' ' ' LYS . . . . . 0.472 ' HZ1' ' HB2' ' A' ' 244' ' ' LYS . 0.0 OUTLIER -66.76 -44.93 80.11 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 122.975 0.51 . . . . 0.0 110.026 173.463 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 245' ' ' TYR . . . . . 0.487 ' HA ' ' HB3' ' A' ' 224' ' ' TYR . 96.5 m-85 -81.14 22.61 0.64 Allowed 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 124.669 1.187 . . . . 0.0 112.715 -176.388 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -52.36 -32.94 40.83 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 125.023 1.329 . . . . 0.0 114.202 -172.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 247' ' ' TRP . . . . . 0.494 ' HB2' ' HB2' ' A' ' 224' ' ' TYR . 39.3 m95 -75.08 130.36 39.15 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-O 121.331 0.586 . . . . 0.0 110.447 176.282 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 248' ' ' PHE . . . . . 0.512 ' HB2' HG11 ' A' ' 236' ' ' VAL . 98.5 m-85 -141.43 171.31 14.23 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.312 1.045 . . . . 0.0 109.746 177.844 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 249' ' ' HIS . . . . . 0.443 ' HD2' ' HB2' ' A' ' 252' ' ' CYS . 0.0 OUTLIER -134.68 145.64 48.72 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 176.745 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 250' ' ' TYR . . . . . 0.456 ' HB3' ' O ' ' A' ' 255' ' ' LEU . 21.1 m-30 -53.88 -55.98 21.83 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 124.213 1.005 . . . . 0.0 113.303 -166.325 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -60.86 -34.17 74.19 Favored 'General case' 0 N--CA 1.496 1.839 0 C-N-CA 123.311 0.644 . . . . 0.0 111.733 -174.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 252' ' ' CYS . . . . . 0.443 ' HB2' ' HD2' ' A' ' 249' ' ' HIS . 11.3 t -68.45 -32.25 72.14 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 124.162 0.985 . . . . 0.0 111.631 -175.425 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . 0.471 HG21 ' HG ' ' A' ' 255' ' ' LEU . 16.3 m -108.76 6.23 9.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 C-N-CA 124.04 0.936 . . . . 0.0 110.735 175.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 18.4 m120 64.32 24.84 13.37 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 125.574 1.549 . . . . 0.0 113.359 173.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . 0.471 ' HG ' HG21 ' A' ' 253' ' ' VAL . 96.5 mt -70.94 121.32 17.92 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 166.331 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 36.4 mtmm -96.55 15.73 20.77 Favored 'General case' 0 N--CA 1.485 1.276 0 CA-C-O 120.805 0.336 . . . . 0.0 110.661 175.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -164.3 163.41 15.07 Favored Pre-proline 0 CA--C 1.554 1.106 0 C-N-CA 124.131 0.972 . . . . 0.0 109.047 -172.432 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -69.41 160.14 50.96 Favored 'Trans proline' 0 C--N 1.374 1.879 0 C-N-CA 122.488 2.125 . . . . 0.0 112.607 175.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 259' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -59.61 156.88 34.7 Favored 'Trans proline' 0 C--N 1.377 2.063 0 C-N-CA 122.95 2.433 . . . . 0.0 112.783 171.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -103.73 31.07 4.65 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.703 0.801 . . . . 0.0 109.713 -179.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 136.81 -141.03 11.96 Favored Glycine 0 C--N 1.339 0.749 0 N-CA-C 110.313 -1.115 . . . . 0.0 110.313 -174.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 40.0 p -72.98 114.67 11.39 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 122.948 0.499 . . . . 0.0 109.821 178.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 263' ' ' TRP . . . . . . . . . . . . . 47.1 t90 -90.82 136.81 32.82 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.438 0.695 . . . . 0.0 109.856 -176.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -124.11 115.72 21.59 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.364 0.665 . . . . 0.0 110.688 -177.37 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 265' ' ' CYS . . . . . 0.51 ' SG ' ' HB2' ' A' ' 267' ' ' GLU . 19.1 p -70.75 160.08 83.13 Favored Pre-proline 0 N--CA 1.484 1.231 0 C-N-CA 124.308 1.043 . . . . 0.0 109.658 172.63 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 99.9 Cg_exo -47.29 -27.06 6.32 Favored 'Trans proline' 0 C--N 1.388 2.639 0 C-N-CA 123.825 3.017 . . . . 0.0 115.696 177.198 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 267' ' ' GLU . . . . . 0.51 ' HB2' ' SG ' ' A' ' 265' ' ' CYS . 39.6 mt-10 -59.4 -49.45 77.75 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 123.962 0.905 . . . . 0.0 110.581 174.296 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 268' ' ' CYS . . . . . . . . . . . . . 76.4 m -85.07 -30.86 23.74 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.268 1.027 . . . . 0.0 111.712 -177.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 65.2 tttm -85.49 -51.63 6.39 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.867 -168.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 45.2 mt -97.8 -52.07 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 C-N-CA 123.1 0.56 . . . . 0.0 110.952 -176.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 . . . . . 0 CA--C 1.554 1.106 0 C-N-CA 123.177 0.591 . . . . 0.0 110.595 -171.721 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 5.9 tt . . . . . 0 CA--C 1.539 0.546 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 224' ' ' TYR . . . . . 0.517 ' HB2' ' HB2' ' A' ' 247' ' ' TRP . 71.0 m-85 -135.28 133.21 38.67 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 176.69 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 36.9 t 175.13 166.67 0.3 Allowed 'General case' 0 N--CA 1.474 0.747 0 O-C-N 124.643 1.214 . . . . 0.0 109.562 175.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 32.9 t80 -73.05 -33.46 65.69 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 177.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 9.4 p -82.18 -11.39 58.74 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 122.84 0.456 . . . . 0.0 111.04 173.048 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 82.2 mm-40 56.46 89.38 0.04 OUTLIER 'General case' 0 C--N 1.361 1.08 0 C-N-CA 125.348 1.459 . . . . 0.0 111.249 -174.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 -153.41 149.04 27.37 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.87 -176.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 34.2 m -66.28 148.49 12.05 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.823 0 C-N-CA 123.7 0.8 . . . . 0.0 110.952 174.291 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 35.9 m -107.43 120.66 42.78 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 175.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 31.4 p90 -141.92 125.92 17.25 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.555 0.742 . . . . 0.0 109.822 -174.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 78.09 -14.69 10.32 Favored Glycine 0 C--N 1.354 1.533 0 CA-C-N 116.334 -0.394 . . . . 0.0 113.138 -174.088 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -154.88 101.33 2.27 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.543 1.137 . . . . 0.0 108.165 -176.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 235' ' ' MET . . . . . . . . . . . . . 54.1 mtp -128.25 113.33 15.53 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 -178.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 6.8 p -108.34 125.32 65.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 175.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -99.7 168.54 9.86 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.727 0.811 . . . . 0.0 110.519 179.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 238' ' ' CYS . . . . . . . . . . . . . 26.9 t -144.29 123.25 12.77 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 122.668 0.387 . . . . 0.0 111.51 -177.344 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -79.22 105.38 10.51 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.376 0.67 . . . . 0.0 109.981 174.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -142.16 141.22 10.65 Favored Glycine 0 C--N 1.341 0.813 0 CA-C-O 118.558 -1.134 . . . . 0.0 111.285 175.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -60.09 -52.9 3.58 Favored 'Trans proline' 0 C--N 1.379 2.183 0 C-N-CA 122.758 2.306 . . . . 0.0 110.757 176.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -106.55 129.04 54.56 Favored 'General case' 0 C--O 1.242 0.675 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 163.166 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 243' ' ' CYS . . . . . 0.452 ' SG ' ' HA ' ' A' ' 246' ' ' GLU . 26.5 t -173.13 89.42 0.08 Allowed 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 -174.382 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 244' ' ' LYS . . . . . 0.562 ' HZ2' ' HB2' ' A' ' 244' ' ' LYS . 0.1 OUTLIER -84.1 -24.29 30.4 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 122.893 0.477 . . . . 0.0 110.603 179.631 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 53.1 m-85 -101.32 26.88 6.69 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.321 1.049 . . . . 0.0 110.367 177.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 246' ' ' GLU . . . . . 0.452 ' HA ' ' SG ' ' A' ' 243' ' ' CYS . 8.5 pt-20 -48.66 -34.92 12.72 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 124.41 1.084 . . . . 0.0 112.579 176.653 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 247' ' ' TRP . . . . . 0.517 ' HB2' ' HB2' ' A' ' 224' ' ' TYR . 94.5 m95 -96.07 136.4 36.57 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 121.379 0.609 . . . . 0.0 111.133 176.609 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -144.71 173.44 11.83 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 125.196 1.398 . . . . 0.0 108.521 171.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 249' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -113.04 138.23 50.21 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 170.655 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -55.49 -32.86 63.19 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 124.181 0.992 . . . . 0.0 112.157 -173.385 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -56.47 -45.06 81.09 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 125.007 1.323 . . . . 0.0 112.455 178.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 252' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -68.04 -51.29 48.55 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.226 1.011 . . . . 0.0 110.984 -175.472 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 22.3 m -81.7 -9.95 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 CA-C-N 115.223 -0.898 . . . . 0.0 111.963 -178.242 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 17.5 m120 59.84 41.67 17.67 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.857 1.263 . . . . 0.0 110.795 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 34.7 tp -90.9 108.04 19.58 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 178.119 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -70.23 -44.81 67.81 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 122.986 0.515 . . . . 0.0 110.758 -178.205 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -133.53 130.97 21.14 Favored Pre-proline 0 C--O 1.24 0.567 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 -178.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -56.95 141.96 93.57 Favored 'Trans proline' 0 C--N 1.371 1.763 0 C-N-CA 122.257 1.972 . . . . 0.0 110.707 171.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 259' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -68.14 -178.94 1.94 Allowed 'Trans proline' 0 C--N 1.37 1.678 0 C-N-CA 123.06 2.507 . . . . 0.0 113.018 -169.02 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 27.7 mmmt -74.75 -3.6 32.55 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 116.068 -0.514 . . . . 0.0 112.383 -174.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -154.43 -143.92 3.79 Favored Glycine 0 C--N 1.338 0.689 0 N-CA-C 111.502 -0.639 . . . . 0.0 111.502 174.028 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 43.5 p -69.68 116.83 10.54 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 123.693 0.797 . . . . 0.0 110.607 -177.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 263' ' ' TRP . . . . . . . . . . . . . 37.9 t90 -66.41 135.69 54.66 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 122.965 0.506 . . . . 0.0 110.266 178.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 264' ' ' TYR . . . . . 0.413 ' HB3' ' HB3' ' A' ' 269' ' ' LYS . 39.6 m-85 -118.44 110.6 17.63 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.433 0.693 . . . . 0.0 109.768 -177.69 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 265' ' ' CYS . . . . . 0.412 ' SG ' ' HB2' ' A' ' 267' ' ' GLU . 14.8 p -67.25 162.77 52.16 Favored Pre-proline 0 CA--C 1.554 1.122 0 C-N-CA 124.128 0.971 . . . . 0.0 109.65 172.1 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -53.57 -24.51 29.31 Favored 'Trans proline' 0 C--N 1.385 2.452 0 C-N-CA 123.374 2.716 . . . . 0.0 114.594 -178.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 267' ' ' GLU . . . . . 0.412 ' HB2' ' SG ' ' A' ' 265' ' ' CYS . 33.7 mt-10 -57.38 -54.79 42.79 Favored 'General case' 0 N--CA 1.483 1.187 0 CA-C-O 121.488 0.661 . . . . 0.0 110.326 173.432 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 268' ' ' CYS . . . . . . . . . . . . . 57.9 m -86.75 -39.28 16.12 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 114.606 -1.179 . . . . 0.0 112.709 -168.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . 0.413 ' HB3' ' HB3' ' A' ' 264' ' ' TYR . 12.5 ptmm? -75.66 -28.87 58.88 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-O 120.654 0.264 . . . . 0.0 111.703 -169.612 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 61.8 mt -92.2 -50.7 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 177.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 . . . . . 0 CA--C 1.554 1.117 0 C-N-CA 123.456 0.703 . . . . 0.0 109.209 179.234 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 57.0 tp . . . . . 0 N--CA 1.473 0.699 0 CA-C-O 121.189 0.518 . . . . 0.0 109.929 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 224' ' ' TYR . . . . . 0.566 ' HB3' ' HA ' ' A' ' 245' ' ' TYR . 77.3 m-85 -135.49 134.33 39.43 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 172.551 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 49.3 t 172.84 161.62 0.12 Allowed 'General case' 0 N--CA 1.474 0.769 0 O-C-N 124.823 1.327 . . . . 0.0 108.284 171.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -67.09 -32.63 73.92 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 122.08 0.152 . . . . 0.0 110.965 177.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 13.1 p -85.52 -17.43 36.4 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 122.706 0.402 . . . . 0.0 111.288 177.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 20.4 mm-40 52.92 77.6 0.16 Allowed 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 124.645 1.178 . . . . 0.0 111.907 -172.233 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 4.6 tmt_? -151.32 154.57 36.99 Favored 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 -178.601 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 23.1 m -73.1 156.25 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 CA-C-O 121.394 0.616 . . . . 0.0 112.59 -173.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 17.3 m -95.91 104.48 16.41 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.864 0.866 . . . . 0.0 108.771 172.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -74.14 79.32 1.76 Allowed 'General case' 0 N--CA 1.479 1.009 0 CA-C-O 121.508 0.67 . . . . 0.0 110.24 -179.158 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 74.68 -18.17 2.42 Favored Glycine 0 CA--C 1.539 1.568 0 N-CA-C 115.331 0.893 . . . . 0.0 115.331 177.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -113.28 110.52 20.51 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.829 0.852 . . . . 0.0 109.335 -175.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 235' ' ' MET . . . . . . . . . . . . . 55.1 mtm -126.01 102.23 7.16 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.094 0.958 . . . . 0.0 109.679 -172.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 3.9 p -87.98 123.34 40.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 168.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -92.79 155.02 17.93 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 123.083 0.553 . . . . 0.0 109.92 -178.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 238' ' ' CYS . . . . . 0.616 ' HB3' ' HA ' ' A' ' 246' ' ' GLU . 42.1 t -116.23 152.12 34.4 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 115.126 -0.943 . . . . 0.0 108.87 176.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -119.92 99.22 6.49 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 171.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 240' ' ' GLY . . . . . 0.586 ' HA3' ' SG ' ' A' ' 268' ' ' CYS . . . -139.99 129.52 4.3 Favored Glycine 0 C--N 1.34 0.785 0 CA-C-O 118.124 -1.375 . . . . 0.0 111.004 176.763 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -48.89 -49.56 14.78 Favored 'Trans proline' 0 C--N 1.382 2.325 0 C-N-CA 123.666 2.91 . . . . 0.0 113.752 -177.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -111.19 101.87 10.34 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 171.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 43.9 t -172.86 106.62 0.16 Allowed 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 -173.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 9.3 ptpp? -86.78 -24.57 25.01 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 173.332 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 245' ' ' TYR . . . . . 0.566 ' HA ' ' HB3' ' A' ' 224' ' ' TYR . 22.7 m-85 -81.12 23.69 0.56 Allowed 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.403 1.081 . . . . 0.0 112.225 -177.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 246' ' ' GLU . . . . . 0.616 ' HA ' ' HB3' ' A' ' 238' ' ' CYS . 5.9 mm-40 -48.9 -37.51 19.96 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 123.641 0.776 . . . . 0.0 111.35 178.556 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 247' ' ' TRP . . . . . 0.486 ' HB2' ' HB2' ' A' ' 224' ' ' TYR . 98.4 m95 -76.45 115.85 16.58 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.505 174.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -130.18 173.35 10.85 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.652 1.181 . . . . 0.0 109.371 171.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 249' ' ' HIS . . . . . 0.553 ' HD2' ' HB2' ' A' ' 252' ' ' CYS . 0.1 OUTLIER -126.01 142.0 51.71 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.454 1.101 . . . . 0.0 108.508 178.232 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 -60.58 -34.83 74.77 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 124.489 1.116 . . . . 0.0 113.493 -168.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -67.52 -35.74 79.68 Favored 'General case' 0 N--CA 1.485 1.293 0 CA-C-O 121.537 0.684 . . . . 0.0 110.998 -178.147 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 252' ' ' CYS . . . . . 0.553 ' HB2' ' HD2' ' A' ' 249' ' ' HIS . 9.0 t -71.68 -41.06 69.14 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 125.024 1.33 . . . . 0.0 110.852 -175.454 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 27.9 m -93.16 -2.02 10.63 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.859 0 CA-C-N 114.481 -1.236 . . . . 0.0 110.957 179.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 33.5 m-80 62.69 24.89 14.81 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 124.803 1.241 . . . . 0.0 112.524 175.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 81.0 mt -80.58 119.64 23.49 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 173.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 14.3 tppt? -81.06 -25.34 37.17 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.425 0.69 . . . . 0.0 110.51 179.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -136.35 162.56 55.67 Favored Pre-proline 0 CA--C 1.55 0.949 0 C-N-CA 124.319 1.047 . . . . 0.0 109.552 -178.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -56.31 136.06 73.43 Favored 'Trans proline' 0 C--N 1.38 2.196 0 C-N-CA 122.435 2.09 . . . . 0.0 111.532 170.329 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 259' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -58.73 156.07 34.39 Favored 'Trans proline' 0 C--N 1.375 1.97 0 C-N-CA 123.289 2.659 . . . . 0.0 113.076 -176.528 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -66.38 -20.72 66.15 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.833 0.853 . . . . 0.0 112.764 -173.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -165.57 -141.94 3.28 Favored Glycine 0 C--N 1.347 1.145 0 CA-C-O 119.752 -0.471 . . . . 0.0 112.176 179.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 25.4 m -65.32 107.25 1.56 Allowed 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.638 0.775 . . . . 0.0 109.819 178.392 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 263' ' ' TRP . . . . . . . . . . . . . 53.8 t90 -88.58 114.12 24.87 Favored 'General case' 0 C--O 1.242 0.679 0 C-N-CA 123.285 0.634 . . . . 0.0 110.316 -175.613 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -96.64 118.84 33.97 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 123.93 0.892 . . . . 0.0 108.599 171.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 17.9 p -64.04 159.68 53.92 Favored Pre-proline 0 CA--C 1.555 1.164 0 C-N-CA 123.508 0.723 . . . . 0.0 110.122 172.162 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -50.91 -33.87 43.43 Favored 'Trans proline' 0 C--N 1.382 2.315 0 C-N-CA 123.202 2.601 . . . . 0.0 113.714 -178.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -59.18 -43.19 92.18 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-O 121.043 0.449 . . . . 0.0 111.242 177.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 268' ' ' CYS . . . . . 0.586 ' SG ' ' HA3' ' A' ' 240' ' ' GLY . 67.2 m -72.64 -27.92 62.43 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.087 0.955 . . . . 0.0 112.563 -177.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 49.1 mtmt -88.07 -41.56 12.98 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 122.84 0.456 . . . . 0.0 111.337 -175.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 16.8 mt -102.3 15.7 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 C-N-CA 123.283 0.633 . . . . 0.0 110.583 -168.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 . . . . . 0 CA--C 1.565 1.552 0 C-N-CA 122.651 0.38 . . . . 0.0 110.951 175.188 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 35.8 tp . . . . . 0 CA--C 1.541 0.602 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 224' ' ' TYR . . . . . 0.491 ' HB3' ' HA ' ' A' ' 245' ' ' TYR . 74.1 m-85 -138.09 125.95 22.52 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 175.591 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 34.4 t 174.54 161.85 0.2 Allowed 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.959 0.904 . . . . 0.0 109.203 173.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -69.24 -34.92 75.56 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 122.347 0.259 . . . . 0.0 110.458 175.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 3.9 p -83.47 -14.59 52.13 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.105 175.249 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 22.6 mm-40 53.87 101.09 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 125.601 1.56 . . . . 0.0 112.713 -172.233 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 22.8 tpp180 -162.97 157.97 21.68 Favored 'General case' 0 C--O 1.244 0.801 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 -178.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 19.5 m -71.4 154.21 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 CA-C-O 120.828 0.347 . . . . 0.0 111.173 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 17.1 m -116.86 60.57 0.74 Allowed 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 123.568 0.747 . . . . 0.0 109.422 -179.233 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 79.8 t80 -71.84 108.69 5.26 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.143 0.577 . . . . 0.0 111.769 -172.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 85.18 -18.22 29.03 Favored Glycine 0 N--CA 1.472 1.089 0 CA-C-N 115.6 -0.727 . . . . 0.0 114.156 174.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -131.51 94.57 3.56 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 124.257 1.023 . . . . 0.0 108.62 -177.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 235' ' ' MET . . . . . 0.409 ' HB3' ' CE3' ' A' ' 247' ' ' TRP . 63.3 mtm -122.03 100.75 7.14 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.8 0.84 . . . . 0.0 109.062 -179.366 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 4.8 p -87.8 124.83 41.26 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 170.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -88.65 130.53 35.27 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.539 0.736 . . . . 0.0 109.892 -178.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 238' ' ' CYS . . . . . 0.508 ' HB3' ' HA ' ' A' ' 246' ' ' GLU . 36.2 t -99.65 152.29 20.24 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.069 0.947 . . . . 0.0 109.398 175.239 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -127.23 108.23 10.7 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.933 0.893 . . . . 0.0 108.667 172.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -139.97 160.57 26.25 Favored Glycine 0 N--CA 1.473 1.144 0 CA-C-O 119.224 -0.765 . . . . 0.0 111.829 174.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -69.77 -35.31 12.85 Favored 'Trans proline' 0 C--N 1.375 1.973 0 C-N-CA 122.285 1.99 . . . . 0.0 112.156 174.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -128.48 110.19 12.08 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.896 0.879 . . . . 0.0 108.776 176.329 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 29.7 t -177.39 104.76 0.05 Allowed 'General case' 0 C--N 1.347 0.476 0 C-N-CA 123.56 0.744 . . . . 0.0 109.502 -175.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 16.8 tppt? -76.71 -30.6 56.73 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-O 121.548 0.69 . . . . 0.0 110.169 171.496 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 245' ' ' TYR . . . . . 0.491 ' HA ' ' HB3' ' A' ' 224' ' ' TYR . 15.5 m-85 -87.55 23.76 1.85 Allowed 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.42 1.088 . . . . 0.0 112.537 -168.347 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 246' ' ' GLU . . . . . 0.508 ' HA ' ' HB3' ' A' ' 238' ' ' CYS . 5.9 mm-40 -46.94 -45.07 20.49 Favored 'General case' 0 N--CA 1.499 2.001 0 C-N-CA 124.187 0.995 . . . . 0.0 112.481 -172.145 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 247' ' ' TRP . . . . . 0.409 ' CE3' ' HB3' ' A' ' 235' ' ' MET . 97.1 m95 -77.56 117.11 18.68 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 122.851 0.461 . . . . 0.0 110.056 173.665 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -122.18 159.26 27.61 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.93 0.892 . . . . 0.0 110.515 175.55 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 249' ' ' HIS . . . . . 0.498 ' CD2' ' HB2' ' A' ' 252' ' ' CYS . 0.7 OUTLIER -93.29 129.88 39.22 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 114.792 -1.094 . . . . 0.0 108.386 167.821 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 48.1 m-85 -52.91 -38.24 61.58 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 124.724 1.21 . . . . 0.0 112.272 -175.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -57.13 -34.79 68.75 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 124.79 1.236 . . . . 0.0 112.498 -177.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 252' ' ' CYS . . . . . 0.498 ' HB2' ' CD2' ' A' ' 249' ' ' HIS . 0.5 OUTLIER -65.63 -56.27 13.1 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 124.032 0.933 . . . . 0.0 110.585 -177.488 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . 0.486 HG23 ' HB2' ' A' ' 255' ' ' LEU . 20.7 m -82.85 -1.54 5.78 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.879 0 CA-C-N 114.595 -1.184 . . . . 0.0 111.314 -176.75 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 9.9 t30 61.13 31.37 19.67 Favored 'General case' 0 C--N 1.365 1.267 0 C-N-CA 124.662 1.185 . . . . 0.0 110.393 179.543 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . 0.516 HD23 ' HG3' ' A' ' 259' ' ' PRO . 16.4 tp -76.45 89.66 3.24 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 177.543 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -71.42 -20.32 62.13 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 115.114 -0.948 . . . . 0.0 111.893 -172.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -139.19 152.95 70.74 Favored Pre-proline 0 CA--C 1.552 1.021 0 C-N-CA 124.509 1.123 . . . . 0.0 109.581 -177.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -59.14 148.51 85.35 Favored 'Trans proline' 0 C--N 1.381 2.274 0 C-N-CA 123.249 2.633 . . . . 0.0 113.663 179.31 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 259' ' ' PRO . . . . . 0.516 ' HG3' HD23 ' A' ' 255' ' ' LEU . 14.3 Cg_exo -68.9 146.31 65.09 Favored 'Trans proline' 0 C--N 1.38 2.205 0 C-N-CA 122.963 2.442 . . . . 0.0 111.987 172.206 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 57.6 mttp -86.31 -28.01 23.97 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.661 0.784 . . . . 0.0 110.876 -178.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -137.1 -150.27 5.74 Favored Glycine 0 C--N 1.345 1.082 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.849 -179.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 25.8 m -71.04 116.87 11.83 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 123.447 0.699 . . . . 0.0 110.511 -177.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 263' ' ' TRP . . . . . . . . . . . . . 27.9 t90 -91.26 114.93 27.59 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.965 0.906 . . . . 0.0 110.207 -175.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -100.64 117.69 35.27 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 170.137 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 265' ' ' CYS . . . . . 0.41 ' SG ' ' OE2' ' A' ' 267' ' ' GLU . 14.4 p -70.92 161.82 75.67 Favored Pre-proline 0 CA--C 1.56 1.328 0 CA-C-O 117.77 -1.11 . . . . 0.0 109.773 176.35 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_exo -27.25 -69.62 0.04 OUTLIER 'Trans proline' 0 C--N 1.397 3.09 1 C-N-CA 125.402 4.068 . . . . 0.0 116.742 -173.673 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 267' ' ' GLU . . . . . 0.41 ' OE2' ' SG ' ' A' ' 265' ' ' CYS . 0.0 OUTLIER -63.81 -26.15 68.5 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -173.794 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 268' ' ' CYS . . . . . . . . . . . . . 97.3 m -72.17 -47.45 50.73 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 123.113 0.565 . . . . 0.0 112.013 176.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 12.2 ptmm? -77.05 -23.66 52.01 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.987 -173.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 86.1 mt -88.39 -43.35 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 123.761 0.824 . . . . 0.0 110.206 178.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 . . . . . 0 C--O 1.257 1.449 0 C-N-CA 123.596 0.759 . . . . 0.0 109.564 -174.874 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 53.7 tp . . . . . 0 N--CA 1.475 0.816 0 CA-C-O 120.871 0.367 . . . . 0.0 110.056 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 224' ' ' TYR . . . . . 0.428 ' HB3' ' HA ' ' A' ' 245' ' ' TYR . 66.5 m-85 -135.58 124.09 23.54 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.456 0.702 . . . . 0.0 109.279 172.747 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 36.8 t 172.01 158.69 0.1 Allowed 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 125.208 1.403 . . . . 0.0 109.349 172.033 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 77.5 t80 -66.99 -41.78 86.17 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 117.942 0.337 . . . . 0.0 110.919 177.049 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 6.3 p -72.48 -10.74 60.17 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 122.504 0.321 . . . . 0.0 110.43 176.319 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 82.4 mm-40 53.88 88.8 0.03 OUTLIER 'General case' 0 C--N 1.368 1.388 0 C-N-CA 124.823 1.249 . . . . 0.0 110.78 -173.073 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 2.4 tpm_? -153.32 146.11 24.35 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-N 114.721 -1.127 . . . . 0.0 108.389 -177.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 34.9 m -83.92 149.13 4.56 Favored 'Isoleucine or valine' 0 C--O 1.24 0.587 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 175.306 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 21.4 m -84.73 88.12 7.35 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.324 0.65 . . . . 0.0 110.104 -178.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -74.41 88.85 2.1 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.668 0.787 . . . . 0.0 110.625 -176.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 78.44 -19.39 4.81 Favored Glycine 0 CA--C 1.535 1.327 0 CA-C-N 115.112 -0.949 . . . . 0.0 114.614 177.087 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -116.26 94.39 4.62 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.035 0.934 . . . . 0.0 108.773 179.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 235' ' ' MET . . . . . . . . . . . . . 20.4 ptt? -120.03 108.98 14.95 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.957 0.903 . . . . 0.0 110.515 -176.186 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 7.5 p -100.22 125.72 53.91 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 169.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -101.4 138.16 38.78 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.553 0.741 . . . . 0.0 110.795 -172.131 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 238' ' ' CYS . . . . . 0.703 ' HB3' ' HA ' ' A' ' 246' ' ' GLU . 34.9 t -95.93 152.29 18.64 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 123.768 0.827 . . . . 0.0 109.055 173.606 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 239' ' ' ASP . . . . . 0.42 ' HB3' ' HB ' ' A' ' 262' ' ' THR . 31.3 t70 -125.96 104.85 8.51 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 175.442 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -138.43 147.94 19.58 Favored Glycine 0 C--N 1.337 0.607 0 CA-C-O 118.859 -0.967 . . . . 0.0 111.245 177.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -66.52 -34.28 34.03 Favored 'Trans proline' 0 C--N 1.372 1.788 0 C-N-CA 122.64 2.226 . . . . 0.0 112.368 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -135.98 94.91 3.12 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 176.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 45.1 t -163.93 110.88 1.11 Allowed 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.972 0.909 . . . . 0.0 109.003 -173.381 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 244' ' ' LYS . . . . . 0.462 ' H ' ' HD3' ' A' ' 244' ' ' LYS . 0.1 OUTLIER -82.92 -31.64 27.66 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.18 0.592 . . . . 0.0 110.876 175.991 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 245' ' ' TYR . . . . . 0.428 ' HA ' ' HB3' ' A' ' 224' ' ' TYR . 71.5 m-85 -79.54 28.68 0.25 Allowed 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 124.543 1.137 . . . . 0.0 113.208 -178.622 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 246' ' ' GLU . . . . . 0.703 ' HA ' ' HB3' ' A' ' 238' ' ' CYS . 5.7 mm-40 -48.91 -48.35 42.65 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.27 0.628 . . . . 0.0 112.276 178.007 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 247' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -78.69 130.83 36.27 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 121.186 0.517 . . . . 0.0 112.103 -176.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -143.73 172.43 12.84 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.192 1.397 . . . . 0.0 109.953 174.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 249' ' ' HIS . . . . . 0.436 ' HD2' ' HB2' ' A' ' 252' ' ' CYS . 0.0 OUTLIER -120.36 140.75 50.85 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.559 1.144 . . . . 0.0 108.499 179.329 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 250' ' ' TYR . . . . . 0.422 ' HB3' ' O ' ' A' ' 255' ' ' LEU . 49.0 m-85 -54.8 -54.38 42.89 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.855 1.262 . . . . 0.0 113.285 -167.292 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -59.8 -34.41 73.0 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 123.262 0.625 . . . . 0.0 112.174 -175.234 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 252' ' ' CYS . . . . . 0.436 ' HB2' ' HD2' ' A' ' 249' ' ' HIS . 7.3 t -67.0 -43.28 83.34 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.037 0.935 . . . . 0.0 111.195 -177.309 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 9.2 m -93.17 14.76 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.175 0 C-N-CA 123.788 0.835 . . . . 0.0 111.315 177.006 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 6.4 t30 67.48 7.87 5.9 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 125.103 1.361 . . . . 0.0 112.524 172.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . 0.422 ' O ' ' HB3' ' A' ' 250' ' ' TYR . 87.9 mt -74.43 104.15 5.05 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.048 0.539 . . . . 0.0 110.732 -179.004 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 52.3 tttm -63.73 -36.87 85.28 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.237 1.015 . . . . 0.0 110.303 169.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -142.96 149.61 49.98 Favored Pre-proline 0 CA--C 1.549 0.936 0 CA-C-N 114.676 -1.147 . . . . 0.0 109.777 -170.258 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 258' ' ' PRO . . . . . 0.451 ' HA ' ' HD3' ' A' ' 259' ' ' PRO . 33.6 Cg_endo -62.51 138.14 68.74 Favored 'Trans proline' 0 C--N 1.38 2.23 0 C-N-CA 122.864 2.376 . . . . 0.0 113.1 -175.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 259' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 258' ' ' PRO . 17.3 Cg_exo -69.6 137.81 36.82 Favored 'Trans proline' 0 C--N 1.372 1.779 0 C-N-CA 123.261 2.641 . . . . 0.0 111.917 177.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -73.21 96.99 2.33 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 123.505 0.722 . . . . 0.0 109.931 -175.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 117.65 -168.8 13.05 Favored Glycine 0 N--CA 1.472 1.063 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.83 178.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 262' ' ' THR . . . . . 0.42 ' HB ' ' HB3' ' A' ' 239' ' ' ASP . 32.5 p -66.34 107.01 1.86 Allowed 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.08 0.552 . . . . 0.0 109.879 173.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 263' ' ' TRP . . . . . . . . . . . . . 32.0 t90 -70.11 140.2 52.65 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 122.853 0.461 . . . . 0.0 110.139 -179.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -113.2 118.66 35.32 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 172.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 20.4 p -57.35 150.59 42.4 Favored Pre-proline 0 N--CA 1.478 0.952 0 CA-C-O 118.543 -0.741 . . . . 0.0 109.489 172.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_exo -45.57 -32.34 8.24 Favored 'Trans proline' 0 C--N 1.386 2.538 0 C-N-CA 123.407 2.738 . . . . 0.0 114.307 -173.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -65.39 -50.04 67.0 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 123.82 0.848 . . . . 0.0 110.822 -179.567 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 268' ' ' CYS . . . . . . . . . . . . . 43.9 m -59.83 -45.88 91.02 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 123.121 0.568 . . . . 0.0 112.306 -179.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . 0.567 ' HD3' HG13 ' A' ' 270' ' ' ILE . 0.1 OUTLIER -81.25 -14.53 57.34 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -171.825 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 270' ' ' ILE . . . . . 0.567 HG13 ' HD3' ' A' ' 269' ' ' LYS . 78.5 mt -92.84 -23.11 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 C-N-CA 123.211 0.604 . . . . 0.0 110.057 172.382 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 . . . . . 0 CA--C 1.559 1.322 0 CA-C-O 118.65 -0.69 . . . . 0.0 110.497 178.438 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 53.3 tp . . . . . 0 N--CA 1.472 0.649 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 224' ' ' TYR . . . . . 0.514 ' HB2' ' HB2' ' A' ' 247' ' ' TRP . 69.3 m-85 -133.34 125.46 29.24 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 177.259 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 40.8 t 171.3 154.19 0.07 Allowed 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 125.86 1.664 . . . . 0.0 107.734 173.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -61.62 -43.26 99.2 Favored 'General case' 0 CA--C 1.549 0.914 0 CA-C-N 117.872 0.305 . . . . 0.0 110.861 177.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 6.2 p -68.67 -17.07 64.02 Favored 'General case' 0 N--CA 1.483 1.177 0 O-C-N 123.321 0.388 . . . . 0.0 111.035 177.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 81.3 mm-40 58.81 83.89 0.12 Allowed 'General case' 0 C--N 1.365 1.262 0 C-N-CA 124.581 1.152 . . . . 0.0 110.753 -174.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 14.6 tpt180 -150.24 154.52 38.09 Favored 'General case' 0 C--O 1.243 0.727 0 C-N-CA 124.077 0.951 . . . . 0.0 108.532 179.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 27.0 m -81.78 177.37 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 CA-C-O 121.488 0.661 . . . . 0.0 110.78 172.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 22.2 p -96.64 153.22 17.98 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.897 171.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 40.8 t80 -84.83 1.53 46.54 Favored 'General case' 0 CA--C 1.56 1.334 0 C-N-CA 123.651 0.78 . . . . 0.0 110.002 168.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 135.6 -19.18 3.8 Favored Glycine 0 C--N 1.347 1.147 0 C-N-CA 124.006 0.812 . . . . 0.0 111.387 -179.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.41 123.14 35.51 Favored 'General case' 0 CA--C 1.555 1.136 0 C-N-CA 122.901 0.48 . . . . 0.0 110.017 -178.411 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 235' ' ' MET . . . . . . . . . . . . . 7.9 mmt -144.57 119.89 10.23 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.329 0.652 . . . . 0.0 110.391 -177.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 3.7 p -98.57 126.35 51.71 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 C-N-CA 124.423 1.089 . . . . 0.0 109.48 168.057 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -87.25 134.52 33.54 Favored 'General case' 0 C--O 1.242 0.679 0 C-N-CA 123.217 0.607 . . . . 0.0 110.014 177.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 238' ' ' CYS . . . . . 0.524 ' HB3' ' HA ' ' A' ' 246' ' ' GLU . 35.5 t -95.52 123.98 39.33 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 123.464 0.705 . . . . 0.0 111.117 -178.405 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -77.9 94.33 4.54 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 123.893 0.877 . . . . 0.0 109.195 177.19 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -142.04 125.03 2.58 Favored Glycine 0 CA--C 1.529 0.945 0 CA-C-O 118.761 -1.022 . . . . 0.0 111.917 -179.34 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -62.77 -33.79 75.13 Favored 'Trans proline' 0 C--N 1.379 2.132 0 C-N-CA 122.61 2.207 . . . . 0.0 111.422 171.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -118.32 100.02 7.22 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 169.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 12.1 t -165.54 109.29 0.83 Allowed 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 178.09 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 22.7 ttmm -82.99 -35.69 25.65 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-O 121.547 0.689 . . . . 0.0 109.25 170.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 245' ' ' TYR . . . . . 0.463 ' HA ' ' HB3' ' A' ' 224' ' ' TYR . 89.5 m-85 -83.26 24.12 0.83 Allowed 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 124.985 1.314 . . . . 0.0 113.069 -175.045 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 246' ' ' GLU . . . . . 0.524 ' HA ' ' HB3' ' A' ' 238' ' ' CYS . 42.9 mt-10 -47.85 -38.46 16.12 Favored 'General case' 0 N--CA 1.502 2.149 0 C-N-CA 124.33 1.052 . . . . 0.0 113.181 -174.077 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 247' ' ' TRP . . . . . 0.514 ' HB2' ' HB2' ' A' ' 224' ' ' TYR . 85.6 m95 -78.34 127.09 31.71 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.498 -179.343 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -143.93 130.35 19.93 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.052 0.941 . . . . 0.0 109.605 178.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 249' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -71.92 129.56 38.87 Favored 'General case' 0 CA--C 1.547 0.854 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 172.646 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 250' ' ' TYR . . . . . 0.425 ' HB3' ' O ' ' A' ' 255' ' ' LEU . 50.1 m-85 -52.31 -31.68 34.19 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 124.709 1.204 . . . . 0.0 112.321 -178.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -53.54 -48.01 69.48 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 124.116 0.966 . . . . 0.0 111.89 176.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 252' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -61.04 -41.42 96.54 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.86 0.864 . . . . 0.0 111.414 -176.168 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 31.9 m -97.23 0.24 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 CA-C-N 115.395 -0.821 . . . . 0.0 112.038 -175.055 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 20.2 m120 62.78 17.06 9.55 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 124.934 1.294 . . . . 0.0 113.294 175.008 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . 0.425 ' O ' ' HB3' ' A' ' 250' ' ' TYR . 92.6 mt -80.22 109.47 14.72 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 174.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -75.23 -34.98 61.49 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 121.205 0.526 . . . . 0.0 110.041 175.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -116.98 139.0 25.25 Favored Pre-proline 0 CA--C 1.55 0.966 0 C-N-CA 123.482 0.713 . . . . 0.0 109.566 -175.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -59.72 136.61 71.66 Favored 'Trans proline' 0 C--N 1.378 2.131 0 C-N-CA 123.66 2.907 . . . . 0.0 113.486 179.184 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 259' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -65.59 127.57 18.3 Favored 'Trans proline' 0 C--N 1.372 1.816 0 C-N-CA 122.641 2.227 . . . . 0.0 111.515 172.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 14.8 ptmm? -73.99 -16.08 61.08 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.419 0.688 . . . . 0.0 111.626 -179.101 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -118.31 176.9 16.31 Favored Glycine 0 C--N 1.345 1.043 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.893 179.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 36.6 p -57.13 123.05 13.89 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 124.131 0.972 . . . . 0.0 111.809 -177.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 263' ' ' TRP . . . . . . . . . . . . . 44.4 t90 -101.87 115.75 31.22 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.262 0.625 . . . . 0.0 109.36 -174.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -105.63 111.78 24.61 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.951 0.901 . . . . 0.0 109.253 177.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 16.6 p -64.35 149.11 95.29 Favored Pre-proline 0 CA--C 1.559 1.295 0 CA-C-O 118.326 -0.845 . . . . 0.0 109.4 174.223 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -27.44 -60.32 0.09 OUTLIER 'Trans proline' 0 C--N 1.384 2.411 1 C-N-CA 125.76 4.307 . . . . 0.0 118.026 -160.606 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.29 -39.89 86.03 Favored 'General case' 0 N--CA 1.485 1.281 0 CA-C-O 119.293 -0.384 . . . . 0.0 111.604 -175.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 268' ' ' CYS . . . . . . . . . . . . . 59.6 m -52.55 -30.94 33.27 Favored 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 -178.507 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 32.7 ttmt -78.35 -24.66 46.39 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.085 0.554 . . . . 0.0 111.516 -177.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 31.7 pt -112.76 2.51 8.49 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.258 0 C-N-CA 123.544 0.737 . . . . 0.0 112.034 179.08 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 . . . . . 0 C--O 1.256 1.396 0 C-N-CA 123.984 0.914 . . . . 0.0 109.544 -176.125 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 15.6 p . . . . . 0 N--CA 1.47 0.558 0 CA-C-O 120.807 0.337 . . . . 0.0 110.609 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -91.48 82.94 5.35 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.331 1.052 . . . . 0.0 108.212 176.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' TYR . . . . . 0.455 ' HE1' ' HE3' ' A' ' 244' ' ' LYS . 60.3 m-85 -148.32 125.42 11.41 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.657 1.183 . . . . 0.0 108.301 172.372 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 47.1 t 173.26 163.03 0.14 Allowed 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 124.7 1.2 . . . . 0.0 109.88 174.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -65.94 -33.97 77.03 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 122.41 0.284 . . . . 0.0 111.406 175.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 13.3 p -84.01 -5.86 59.31 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 122.152 0.181 . . . . 0.0 111.412 176.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 82.5 mm-40 48.67 85.95 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 125.467 1.507 . . . . 0.0 112.743 -175.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 22.9 tpp180 -153.92 148.54 26.32 Favored 'General case' 0 C--O 1.244 0.784 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 177.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 25.7 m -62.4 149.71 9.37 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 O-C-N 123.838 0.711 . . . . 0.0 110.73 178.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 17.5 p -87.01 69.52 10.24 Favored 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 123.382 0.673 . . . . 0.0 110.141 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 94.5 t80 -70.5 98.28 1.43 Allowed 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.164 0.986 . . . . 0.0 110.576 -176.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 78.5 -17.59 6.43 Favored Glycine 0 CA--C 1.536 1.404 0 CA-C-N 116.133 -0.485 . . . . 0.0 113.97 176.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -122.32 105.62 10.36 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.217 1.007 . . . . 0.0 108.424 178.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' MET . . . . . . . . . . . . . 21.3 ptt? -136.53 102.19 4.86 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 121.949 0.88 . . . . 0.0 111.143 178.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 5.0 p -101.48 123.72 54.77 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.785 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 172.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -92.67 147.82 22.57 Favored 'General case' 0 C--O 1.241 0.607 0 C-N-CA 123.168 0.587 . . . . 0.0 110.206 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' CYS . . . . . 0.499 ' HB3' ' HA ' ' A' ' 246' ' ' GLU . 35.4 t -106.41 154.52 20.7 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 124.034 0.934 . . . . 0.0 110.708 -179.228 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -111.15 96.23 6.01 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 170.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -140.67 119.93 1.65 Allowed Glycine 0 CA--C 1.527 0.802 0 CA-C-O 118.518 -1.156 . . . . 0.0 111.511 177.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -53.51 -39.07 83.68 Favored 'Trans proline' 0 C--N 1.382 2.323 0 C-N-CA 123.42 2.747 . . . . 0.0 113.276 174.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -114.76 101.73 9.34 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 171.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 12.8 t -173.07 102.82 0.13 Allowed 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 -173.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' LYS . . . . . 0.455 ' HE3' ' HE1' ' A' ' 224' ' ' TYR . 52.7 tptt -81.51 -31.34 32.87 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 123.252 0.621 . . . . 0.0 109.738 170.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -81.54 26.92 0.45 Allowed 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 124.938 1.295 . . . . 0.0 112.541 -179.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' GLU . . . . . 0.499 ' HA ' ' HB3' ' A' ' 238' ' ' CYS . 6.1 mm-40 -47.35 -45.77 25.0 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 123.883 0.873 . . . . 0.0 112.541 -178.099 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' TRP . . . . . 0.445 ' HB2' ' HB2' ' A' ' 224' ' ' TYR . 97.9 m95 -86.26 141.04 29.57 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.049 0.452 . . . . 0.0 111.035 178.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 32.9 m-85 -145.58 174.22 11.37 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.333 1.453 . . . . 0.0 109.231 176.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -113.47 141.11 47.5 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 168.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -54.95 -43.01 73.02 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.856 1.262 . . . . 0.0 112.673 -170.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -63.87 -34.47 78.02 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.389 0.676 . . . . 0.0 112.417 -175.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 252' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -65.55 -47.45 75.82 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-O 121.32 0.581 . . . . 0.0 110.246 179.12 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 30.6 m -88.04 5.46 4.02 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.897 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.747 -176.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 55.2 t30 58.73 70.91 0.62 Allowed 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.801 1.24 . . . . 0.0 110.785 178.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 76.6 mt -141.22 152.74 44.84 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.479 1.112 . . . . 0.0 109.121 177.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.8 -21.35 1.94 Allowed 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 123.864 0.866 . . . . 0.0 109.794 166.186 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -78.85 118.62 73.48 Favored Pre-proline 0 N--CA 1.478 0.97 0 C-N-CA 123.685 0.794 . . . . 0.0 109.49 176.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -57.34 121.36 9.91 Favored 'Trans proline' 0 C--N 1.372 1.799 0 C-N-CA 122.78 2.32 . . . . 0.0 111.129 165.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 259' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -52.92 132.79 48.83 Favored 'Trans proline' 0 C--N 1.378 2.12 0 C-N-CA 123.829 3.019 . . . . 0.0 113.738 -178.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 60.2 pttt -83.34 -2.55 55.99 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.313 1.045 . . . . 0.0 112.244 178.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -168.77 -155.63 9.83 Favored Glycine 0 C--N 1.344 0.984 0 CA-C-O 120.033 -0.315 . . . . 0.0 112.502 -179.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 25.8 p -62.19 106.81 0.78 Allowed 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.949 0.9 . . . . 0.0 111.447 -175.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 263' ' ' TRP . . . . . . . . . . . . . 63.1 t90 -92.49 113.98 26.41 Favored 'General case' 0 C--N 1.347 0.481 0 CA-C-N 115.771 -0.649 . . . . 0.0 109.435 -176.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 45.8 m-85 -93.68 118.6 31.61 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 175.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 265' ' ' CYS . . . . . 0.442 ' SG ' ' HB2' ' A' ' 267' ' ' GLU . 18.4 p -66.39 152.98 93.76 Favored Pre-proline 0 CA--C 1.545 0.774 0 CA-C-O 118.507 -0.759 . . . . 0.0 109.715 175.047 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_exo -47.85 -29.01 10.73 Favored 'Trans proline' 0 C--N 1.384 2.446 0 C-N-CA 123.728 2.952 . . . . 0.0 114.244 -178.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 267' ' ' GLU . . . . . 0.442 ' HB2' ' SG ' ' A' ' 265' ' ' CYS . 9.5 mp0 -64.74 -53.71 42.83 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 125.078 1.351 . . . . 0.0 109.814 178.352 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 268' ' ' CYS . . . . . . . . . . . . . 94.4 m -62.04 -34.91 77.12 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.29 0.636 . . . . 0.0 111.232 176.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -68.13 -23.99 64.95 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.291 0.636 . . . . 0.0 111.929 -179.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 2.8 pp -102.69 -4.68 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 N-CA-C 111.768 0.285 . . . . 0.0 111.768 175.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 . . . . . 0 N--CA 1.484 1.274 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 170.876 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 29.9 p . . . . . 0 N--CA 1.478 0.947 0 CA-C-O 121.526 0.679 . . . . 0.0 109.992 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 58.1 tp -110.63 98.76 7.86 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.026 0.931 . . . . 0.0 108.584 -178.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -136.72 128.89 29.72 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -173.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 42.2 t 172.75 166.9 0.12 Allowed 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 125.262 1.425 . . . . 0.0 108.838 171.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -68.34 -38.37 81.44 Favored 'General case' 0 N--CA 1.484 1.273 0 O-C-N 121.969 -0.457 . . . . 0.0 110.427 175.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 10.0 p -83.79 -9.8 58.54 Favored 'General case' 0 N--CA 1.484 1.257 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.909 176.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 22.2 mm-40 48.66 77.61 0.1 Allowed 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 124.742 1.217 . . . . 0.0 112.114 -173.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' ARG . . . . . 0.469 ' HE ' ' HE2' ' A' ' 232' ' ' PHE . 26.7 ttt85 -135.73 149.65 49.27 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.625 1.17 . . . . 0.0 108.273 -175.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 29.0 m -70.33 160.07 5.27 Favored 'Isoleucine or valine' 0 C--O 1.242 0.696 0 CA-C-O 121.255 0.55 . . . . 0.0 110.647 177.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' SER . . . . . 0.714 ' HB3' ' HB3' ' A' ' 235' ' ' MET . 48.2 m -113.88 118.18 33.47 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 176.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' PHE . . . . . 0.469 ' HE2' ' HE ' ' A' ' 229' ' ' ARG . 3.9 p90 -112.23 66.54 0.64 Allowed 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.318 1.047 . . . . 0.0 110.091 -167.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 86.58 -21.76 16.69 Favored Glycine 0 N--CA 1.472 1.086 0 CA-C-N 115.002 -0.999 . . . . 0.0 113.51 179.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 30.7 mm-40 -106.56 99.04 8.64 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 170.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 235' ' ' MET . . . . . 0.714 ' HB3' ' HB3' ' A' ' 231' ' ' SER . 25.7 ptt? -142.14 123.3 14.65 Favored 'General case' 0 C--O 1.241 0.647 0 CA-C-O 121.325 0.584 . . . . 0.0 110.836 178.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . 0.495 HG21 ' HG3' ' A' ' 259' ' ' PRO . 6.2 p -100.12 124.62 53.7 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 CA-C-N 115.332 -0.849 . . . . 0.0 108.912 172.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -91.2 148.19 22.53 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.31 -178.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 238' ' ' CYS . . . . . 0.57 ' HB3' ' HA ' ' A' ' 246' ' ' GLU . 36.7 t -108.09 153.15 23.55 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 123.531 0.732 . . . . 0.0 109.657 173.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -118.18 93.77 4.25 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.678 0.791 . . . . 0.0 109.176 174.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -143.88 126.39 2.73 Favored Glycine 0 CA--C 1.527 0.802 0 CA-C-O 118.21 -1.328 . . . . 0.0 110.632 172.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -58.51 -50.5 9.37 Favored 'Trans proline' 0 C--N 1.376 1.986 0 CA-C-N 120.342 2.071 . . . . 0.0 110.96 177.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 8.7 p-10 -94.1 89.91 6.19 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 114.61 -1.177 . . . . 0.0 109.058 171.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 42.8 t -173.23 110.9 0.2 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.293 1.037 . . . . 0.0 109.197 -176.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 244' ' ' LYS . . . . . 0.464 ' H ' ' HD2' ' A' ' 244' ' ' LYS . 0.0 OUTLIER -88.85 -24.91 22.42 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.32 0.648 . . . . 0.0 110.995 178.985 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 36.6 m-85 -90.85 27.48 1.79 Allowed 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.403 1.081 . . . . 0.0 111.667 -177.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 246' ' ' GLU . . . . . 0.57 ' HA ' ' HB3' ' A' ' 238' ' ' CYS . 6.9 mm-40 -46.66 -45.07 19.02 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 124.023 0.929 . . . . 0.0 112.307 -179.182 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 247' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -83.44 126.74 33.07 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 121.56 0.695 . . . . 0.0 111.039 178.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 48.0 m-85 -134.64 174.79 10.17 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.352 1.461 . . . . 0.0 108.411 170.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 249' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -127.32 148.53 50.24 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.725 0.81 . . . . 0.0 108.951 178.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -58.35 -32.7 68.78 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 124.358 1.063 . . . . 0.0 113.033 -172.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -65.86 -36.41 83.37 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.55 0.74 . . . . 0.0 112.067 179.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 252' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -70.82 -56.02 7.23 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.597 0.759 . . . . 0.0 110.295 -178.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . 0.493 HG21 HG11 ' A' ' 236' ' ' VAL . 34.2 m -79.86 -3.68 6.46 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 CA-C-N 114.775 -1.102 . . . . 0.0 111.839 -175.405 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 14.4 m120 65.59 27.28 11.52 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 125.012 1.325 . . . . 0.0 112.123 173.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 33.8 mt -79.01 112.7 16.48 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.589 0.756 . . . . 0.0 109.595 172.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -88.91 -2.85 58.79 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.82 0.848 . . . . 0.0 109.489 168.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -127.08 146.12 56.59 Favored Pre-proline 0 CA--C 1.547 0.851 0 C-N-CA 124.628 1.171 . . . . 0.0 109.564 -176.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -72.86 134.84 22.42 Favored 'Trans proline' 0 C--N 1.37 1.689 0 C-N-CA 122.47 2.113 . . . . 0.0 110.845 171.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 259' ' ' PRO . . . . . 0.495 ' HG3' HG21 ' A' ' 236' ' ' VAL . 39.6 Cg_endo -63.68 149.82 89.95 Favored 'Trans proline' 0 C--N 1.375 1.958 0 C-N-CA 122.362 2.041 . . . . 0.0 112.062 177.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -75.87 -18.87 59.26 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.058 0.943 . . . . 0.0 112.912 -168.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -170.66 -134.48 1.76 Allowed Glycine 0 C--N 1.343 0.935 0 N-CA-C 111.663 -0.575 . . . . 0.0 111.663 -178.102 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 42.1 p -69.57 106.34 2.99 Favored 'General case' 0 C--N 1.353 0.729 0 C-N-CA 122.865 0.466 . . . . 0.0 109.835 177.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 263' ' ' TRP . . . . . 0.474 ' O ' ' HA ' ' A' ' 238' ' ' CYS . 76.1 t90 -87.98 122.23 31.34 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.206 -176.544 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -101.17 118.12 36.36 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 176.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 265' ' ' CYS . . . . . 0.498 ' SG ' ' HG2' ' A' ' 267' ' ' GLU . 16.2 p -66.91 155.52 89.72 Favored Pre-proline 0 CA--C 1.551 0.988 0 C-N-CA 123.793 0.837 . . . . 0.0 110.946 -178.385 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -38.91 -50.47 2.57 Favored 'Trans proline' 0 C--N 1.388 2.647 0 C-N-CA 124.739 3.626 . . . . 0.0 115.314 -176.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 267' ' ' GLU . . . . . 0.498 ' HG2' ' SG ' ' A' ' 265' ' ' CYS . 2.5 pm0 -62.2 -39.34 92.4 Favored 'General case' 0 CA--C 1.549 0.933 0 CA-C-N 115.892 -0.594 . . . . 0.0 112.357 -178.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 268' ' ' CYS . . . . . . . . . . . . . 63.6 m -68.87 -44.1 74.01 Favored 'General case' 0 N--CA 1.495 1.821 0 C-N-CA 122.699 0.399 . . . . 0.0 111.223 176.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -66.78 -31.48 72.15 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.37 -169.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 1.8 mp -91.05 -46.82 14.58 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.078 0 C-N-CA 123.382 0.673 . . . . 0.0 109.666 176.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 . . . . . 0 CA--C 1.558 1.288 0 C-N-CA 123.309 0.644 . . . . 0.0 109.711 -175.555 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 9.1 p . . . . . 0 N--CA 1.476 0.844 0 CA-C-O 121.223 0.535 . . . . 0.0 111.027 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 5.8 tt -140.83 108.35 5.58 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 -174.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' TYR . . . . . 0.439 ' HB3' ' HA ' ' A' ' 245' ' ' TYR . 63.7 m-85 -140.04 124.11 17.66 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 176.427 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 48.7 t 171.25 152.18 0.06 Allowed 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 125.52 1.528 . . . . 0.0 108.08 174.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 50.4 t80 -65.29 -38.74 91.19 Favored 'General case' 0 N--CA 1.486 1.351 0 CA-C-N 119.138 0.881 . . . . 0.0 110.965 -179.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 5.8 p -68.43 -14.23 62.86 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 123.034 0.208 . . . . 0.0 111.07 177.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 87.0 mm-40 57.12 85.82 0.08 Allowed 'General case' 0 C--N 1.364 1.238 0 C-N-CA 125.231 1.413 . . . . 0.0 111.845 179.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -160.17 149.12 17.29 Favored 'General case' 0 C--O 1.242 0.706 0 CA-C-N 114.745 -1.116 . . . . 0.0 108.713 178.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 31.0 m -71.51 149.97 9.35 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 122.78 0.432 . . . . 0.0 111.184 178.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 15.8 m -94.26 68.34 3.62 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-O 121.745 0.783 . . . . 0.0 109.23 177.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 47.6 t80 -83.04 91.42 7.18 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.463 -171.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 103.98 -19.79 42.74 Favored Glycine 0 N--CA 1.476 1.33 0 CA-C-N 116.066 -0.515 . . . . 0.0 113.694 175.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.1 64.67 1.59 Allowed 'General case' 0 N--CA 1.481 1.124 0 CA-C-O 122.392 1.091 . . . . 0.0 110.122 178.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 235' ' ' MET . . . . . . . . . . . . . 18.3 ptm -99.56 130.68 45.82 Favored 'General case' 0 N--CA 1.483 1.177 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.75 -176.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 7.0 p -124.95 126.88 71.96 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.939 0 C-N-CA 124.565 1.146 . . . . 0.0 108.964 177.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -91.86 154.22 19.02 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.873 0.869 . . . . 0.0 111.302 -178.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 238' ' ' CYS . . . . . 0.639 ' HB3' ' HA ' ' A' ' 246' ' ' GLU . 11.3 t -117.12 155.47 29.26 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.929 1.292 . . . . 0.0 109.565 175.523 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -117.9 105.34 11.82 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.757 0.823 . . . . 0.0 109.406 172.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -140.96 144.74 15.04 Favored Glycine 0 CA--C 1.528 0.874 0 CA-C-O 118.533 -1.148 . . . . 0.0 111.405 173.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -61.38 -47.88 10.89 Favored 'Trans proline' 0 C--N 1.378 2.112 0 C-N-CA 122.929 2.419 . . . . 0.0 112.028 -178.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 40.9 t30 -124.5 107.44 11.07 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 170.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 43.8 t -157.45 117.05 3.36 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 123.522 0.729 . . . . 0.0 109.376 -174.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -80.5 -44.62 18.84 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.441 0.697 . . . . 0.0 109.852 176.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . 0.439 ' HA ' ' HB3' ' A' ' 224' ' ' TYR . 45.6 m-85 -82.72 31.11 0.42 Allowed 'General case' 0 CA--C 1.553 1.089 0 C-N-CA 124.18 0.992 . . . . 0.0 112.393 -175.372 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 246' ' ' GLU . . . . . 0.639 ' HA ' ' HB3' ' A' ' 238' ' ' CYS . 6.9 mm-40 -47.34 -42.79 22.16 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.832 0.853 . . . . 0.0 111.537 173.446 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 247' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -90.34 139.05 31.04 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-O 121.052 0.453 . . . . 0.0 111.132 177.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -147.28 173.09 12.9 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.062 1.345 . . . . 0.0 109.401 174.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 249' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -117.63 140.4 49.7 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.427 0.691 . . . . 0.0 110.03 174.207 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -54.58 -28.09 43.64 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 125.301 1.44 . . . . 0.0 112.36 -179.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -60.61 -54.73 41.79 Favored 'General case' 0 CA--C 1.555 1.16 0 C-N-CA 123.407 0.683 . . . . 0.0 111.176 177.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 252' ' ' CYS . . . . . . . . . . . . . 1.1 m -66.21 -44.68 83.19 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.773 0.829 . . . . 0.0 111.594 -177.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 33.8 m -84.4 -0.71 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.619 -177.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 21.1 m120 60.66 19.18 9.18 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 125.038 1.335 . . . . 0.0 113.278 172.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 92.7 mt -84.64 120.94 26.95 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 177.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 31.9 mmtp -103.74 21.33 16.41 Favored 'General case' 0 N--CA 1.485 1.322 0 CA-C-O 121.319 0.58 . . . . 0.0 110.07 -177.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -157.89 139.56 9.93 Favored Pre-proline 0 C--O 1.245 0.832 0 C-N-CA 124.619 1.167 . . . . 0.0 109.069 -174.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_exo -67.99 115.19 3.67 Favored 'Trans proline' 0 C--N 1.373 1.842 0 C-N-CA 122.999 2.466 . . . . 0.0 111.668 176.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 259' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -68.48 121.1 8.02 Favored 'Trans proline' 0 C--N 1.376 2.026 0 C-N-CA 122.374 2.049 . . . . 0.0 111.252 178.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 260' ' ' LYS . . . . . 0.601 ' HZ1' ' HB2' ' A' ' 260' ' ' LYS . 10.3 mtmp? -72.48 124.31 24.93 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.12 0.568 . . . . 0.0 110.354 178.321 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 115.76 -159.74 13.67 Favored Glycine 0 C--N 1.337 0.627 0 N-CA-C 111.494 -0.642 . . . . 0.0 111.494 174.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 45.6 p -83.56 107.18 15.86 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 172.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 263' ' ' TRP . . . . . . . . . . . . . 40.2 t90 -77.04 147.23 36.86 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-O 121.119 0.485 . . . . 0.0 110.144 179.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -120.13 120.66 36.87 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 123.735 0.814 . . . . 0.0 108.972 178.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 17.3 p -67.71 161.09 69.23 Favored Pre-proline 0 CA--C 1.55 0.97 0 C-N-CA 123.537 0.735 . . . . 0.0 110.646 176.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -41.52 -29.91 0.84 Allowed 'Trans proline' 0 C--N 1.383 2.387 0 C-N-CA 124.002 3.134 . . . . 0.0 115.593 176.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -63.47 -66.78 0.49 Allowed 'General case' 0 N--CA 1.483 1.199 0 CA-C-O 121.605 0.717 . . . . 0.0 109.806 173.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 268' ' ' CYS . . . . . . . . . . . . . 58.6 m -71.26 -28.62 64.29 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 114.617 -1.174 . . . . 0.0 111.949 -167.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -80.04 -56.12 4.47 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.373 0.669 . . . . 0.0 110.504 -178.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 45.5 mm -82.21 -59.44 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 122.768 0.427 . . . . 0.0 111.714 -168.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 . . . . . 0 N--CA 1.481 1.083 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -168.769 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 53.0 p . . . . . 0 CA--C 1.552 1.045 0 N-CA-C 111.558 0.207 . . . . 0.0 111.558 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 5.4 tt -70.53 86.03 0.63 Allowed 'General case' 0 C--N 1.363 1.158 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 176.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' TYR . . . . . 0.61 ' HB3' ' HA ' ' A' ' 245' ' ' TYR . 88.0 m-85 -137.39 131.99 32.86 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.534 1.134 . . . . 0.0 108.251 177.283 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 34.8 t 172.48 160.07 0.11 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.028 1.331 . . . . 0.0 108.888 177.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -67.52 -29.09 68.4 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 122.543 0.337 . . . . 0.0 111.0 177.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' CYS . . . . . 0.428 ' SG ' ' HB2' ' A' ' 229' ' ' ARG . 12.2 p -84.86 -5.84 59.34 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-O 119.224 -0.417 . . . . 0.0 111.939 178.164 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 33.1 mm-40 54.88 78.94 0.16 Allowed 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 124.494 1.117 . . . . 0.0 111.269 -173.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' ARG . . . . . 0.428 ' HB2' ' SG ' ' A' ' 227' ' ' CYS . 3.1 tmm_? -154.23 150.21 27.82 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 -176.442 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 30.7 m -66.98 156.84 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 123.388 0.675 . . . . 0.0 112.56 178.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 22.5 m -109.67 89.53 3.04 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-N 115.251 -0.886 . . . . 0.0 108.655 175.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 88.2 t80 -114.45 124.68 52.53 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.513 0.725 . . . . 0.0 109.697 177.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 79.58 -16.68 10.02 Favored Glycine 0 C--N 1.347 1.173 0 CA-C-N 116.054 -0.521 . . . . 0.0 113.023 -179.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -140.62 98.1 3.34 Favored 'General case' 0 C--N 1.349 0.546 0 C-N-CA 124.844 1.257 . . . . 0.0 107.773 -176.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 235' ' ' MET . . . . . . . . . . . . . 3.5 mpp? -127.4 95.12 4.17 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 -178.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 4.1 p -103.13 126.28 57.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 171.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -95.86 156.99 16.1 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.293 0.568 . . . . 0.0 111.12 -177.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 238' ' ' CYS . . . . . 0.71 ' HB3' ' HA ' ' A' ' 246' ' ' GLU . 18.5 t -110.81 153.18 25.73 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 124.442 1.097 . . . . 0.0 109.409 174.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -108.65 92.58 4.11 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 174.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -143.9 114.34 0.81 Allowed Glycine 0 CA--C 1.529 0.912 0 CA-C-O 118.08 -1.4 . . . . 0.0 111.863 175.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -54.05 -39.75 84.19 Favored 'Trans proline' 0 C--N 1.377 2.039 0 C-N-CA 123.104 2.536 . . . . 0.0 112.907 178.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -111.3 91.23 3.58 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 171.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 51.5 t -171.98 116.74 0.37 Allowed 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.208 1.003 . . . . 0.0 108.745 -175.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 23.6 pttm -89.03 -33.38 17.17 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 122.701 0.401 . . . . 0.0 110.538 176.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . 0.61 ' HA ' ' HB3' ' A' ' 224' ' ' TYR . 22.0 m-30 -79.28 29.92 0.22 Allowed 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.741 1.216 . . . . 0.0 112.235 179.708 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 246' ' ' GLU . . . . . 0.71 ' HA ' ' HB3' ' A' ' 238' ' ' CYS . 6.9 mm-40 -47.44 -45.96 26.21 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.745 0.818 . . . . 0.0 111.086 170.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 247' ' ' TRP . . . . . 0.527 ' HB2' ' HB2' ' A' ' 224' ' ' TYR . 91.8 m95 -78.59 134.72 37.18 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 121.109 0.48 . . . . 0.0 110.76 177.211 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -144.08 170.88 15.11 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 125.163 1.385 . . . . 0.0 108.424 170.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 249' ' ' HIS . . . . . 0.408 ' HD2' ' HB2' ' A' ' 252' ' ' CYS . 0.0 OUTLIER -115.52 133.98 55.51 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 174.092 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -47.74 -57.5 5.49 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 125.354 1.462 . . . . 0.0 114.467 -168.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -69.18 -26.63 64.93 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 122.381 0.272 . . . . 0.0 111.246 -170.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 252' ' ' CYS . . . . . 0.408 ' HB2' ' HD2' ' A' ' 249' ' ' HIS . 36.1 t -68.32 -32.1 71.99 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 124.087 0.955 . . . . 0.0 111.013 177.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 17.5 m -105.24 16.84 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 C-N-CA 123.34 0.656 . . . . 0.0 110.879 175.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 17.2 m120 67.54 9.11 6.81 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 125.364 1.466 . . . . 0.0 114.13 172.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 87.0 mt -76.97 137.42 39.02 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 122.925 0.49 . . . . 0.0 109.909 173.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.74 -23.24 9.29 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.909 0.884 . . . . 0.0 109.747 176.232 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -126.44 148.83 65.65 Favored Pre-proline 0 CA--C 1.549 0.91 0 C-N-CA 124.061 0.944 . . . . 0.0 110.158 -179.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -65.59 139.52 58.75 Favored 'Trans proline' 0 C--N 1.38 2.224 0 C-N-CA 123.11 2.54 . . . . 0.0 112.404 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 259' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_exo -59.3 151.59 66.66 Favored 'Trans proline' 0 C--N 1.377 2.069 0 C-N-CA 122.705 2.27 . . . . 0.0 112.095 172.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -89.65 -21.0 22.99 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.846 0.858 . . . . 0.0 110.266 -176.07 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -147.87 -144.09 3.93 Favored Glycine 0 C--N 1.349 1.29 0 CA-C-O 119.821 -0.433 . . . . 0.0 112.332 -179.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 30.2 p -67.61 111.91 4.45 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 123.569 0.748 . . . . 0.0 111.105 -177.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 263' ' ' TRP . . . . . . . . . . . . . 32.1 t90 -93.41 116.8 29.35 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -100.51 107.01 18.61 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 123.421 0.689 . . . . 0.0 109.472 178.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 15.5 p -57.28 160.41 6.86 Favored Pre-proline 0 N--CA 1.487 1.384 0 C-N-CA 124.418 1.087 . . . . 0.0 111.046 177.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -33.83 -46.88 0.45 Allowed 'Trans proline' 0 C--N 1.396 3.05 0 C-N-CA 124.867 3.711 . . . . 0.0 114.834 -179.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -61.56 -50.41 72.76 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 124.823 1.249 . . . . 0.0 112.04 -177.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 268' ' ' CYS . . . . . . . . . . . . . 79.6 m -72.49 -29.11 63.35 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.851 0.86 . . . . 0.0 111.982 -175.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.02 -15.27 36.86 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 111.885 0.328 . . . . 0.0 111.885 -179.208 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 33.2 mm -88.09 -16.09 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 C-N-CA 123.337 0.655 . . . . 0.0 110.237 171.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 . . . . . 0 CA--C 1.559 1.313 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 172.52 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 13.5 p . . . . . 0 N--CA 1.48 1.058 0 N-CA-C 110.382 -0.229 . . . . 0.0 110.382 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 66.6 tp -79.91 97.32 6.67 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.369 0.668 . . . . 0.0 109.491 178.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' TYR . . . . . 0.661 ' HB3' ' HA ' ' A' ' 245' ' ' TYR . 19.2 m-85 -136.22 128.87 30.69 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.86 0.864 . . . . 0.0 109.31 -179.576 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 40.3 t 170.21 163.32 0.07 Allowed 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 125.64 1.576 . . . . 0.0 108.626 167.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -59.91 -44.93 94.01 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 122.475 0.31 . . . . 0.0 110.51 173.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 14.1 p -76.79 -12.17 59.94 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.106 0.563 . . . . 0.0 112.194 -176.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 82.3 mm-40 51.82 77.4 0.15 Allowed 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 124.519 1.128 . . . . 0.0 112.135 -172.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 72.5 ttt180 -147.56 149.52 32.73 Favored 'General case' 0 C--O 1.242 0.691 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 176.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 26.6 m -67.54 146.1 13.29 Favored 'Isoleucine or valine' 0 C--O 1.245 0.825 0 CA-C-O 121.14 0.495 . . . . 0.0 110.808 177.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' SER . . . . . 0.436 ' HB3' ' O ' ' A' ' 234' ' ' GLU . 50.9 m -79.43 87.14 5.07 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 172.43 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 83.1 t80 -86.25 107.87 18.13 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.453 0.701 . . . . 0.0 111.095 -173.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 73.53 -1.23 45.32 Favored Glycine 0 C--N 1.351 1.392 0 CA-C-N 115.741 -0.663 . . . . 0.0 114.191 175.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . 0.436 ' O ' ' HB3' ' A' ' 231' ' ' SER . 14.7 pt-20 -154.97 141.05 18.41 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 124.386 1.074 . . . . 0.0 108.908 -175.267 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 235' ' ' MET . . . . . 0.4 ' HB3' ' HB3' ' A' ' 231' ' ' SER . 0.0 OUTLIER -160.21 136.77 8.93 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 122.885 0.474 . . . . 0.0 110.534 174.857 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 4.2 p -117.7 124.22 72.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 173.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -87.96 127.61 35.37 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.048 0.539 . . . . 0.0 110.233 -177.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 238' ' ' CYS . . . . . . . . . . . . . 48.8 t -92.6 154.5 18.36 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.002 0.921 . . . . 0.0 110.691 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -116.59 109.74 17.63 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 169.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . 0.549 ' HA3' ' SG ' ' A' ' 268' ' ' CYS . . . -144.17 140.58 9.49 Favored Glycine 0 C--N 1.344 0.978 0 CA-C-O 118.786 -1.008 . . . . 0.0 113.215 172.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -57.54 -54.95 2.81 Favored 'Trans proline' 0 C--N 1.374 1.913 0 C-N-CA 122.856 2.37 . . . . 0.0 112.627 171.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -107.49 77.65 1.15 Allowed 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 176.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 34.5 t -150.85 106.25 3.36 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 -174.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 244' ' ' LYS . . . . . 0.446 ' HA ' ' HE3' ' A' ' 244' ' ' LYS . 0.4 OUTLIER -89.04 -29.36 19.5 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.307 0.643 . . . . 0.0 110.792 178.925 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . 0.661 ' HA ' ' HB3' ' A' ' 224' ' ' TYR . 23.5 m-85 -82.03 22.0 0.83 Allowed 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.632 0.773 . . . . 0.0 112.95 -174.329 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -46.75 -37.36 8.4 Favored 'General case' 0 N--CA 1.501 2.114 0 C-N-CA 124.72 1.208 . . . . 0.0 112.849 -171.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 247' ' ' TRP . . . . . . . . . . . . . 97.7 m95 -77.69 101.83 6.81 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.148 0.579 . . . . 0.0 109.771 175.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -113.98 176.37 5.07 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.357 1.063 . . . . 0.0 110.466 178.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 249' ' ' HIS . . . . . 0.518 ' CD2' ' HB2' ' A' ' 252' ' ' CYS . 0.9 OUTLIER -129.49 144.05 51.09 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.793 1.237 . . . . 0.0 109.166 174.724 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . 0.477 ' HB3' ' O ' ' A' ' 255' ' ' LEU . 65.8 m-85 -62.19 -38.8 90.51 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 124.494 1.118 . . . . 0.0 112.825 -169.219 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -60.72 -36.84 79.83 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 124.252 1.021 . . . . 0.0 111.452 -176.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 252' ' ' CYS . . . . . 0.518 ' HB2' ' CD2' ' A' ' 249' ' ' HIS . 0.5 OUTLIER -64.62 -42.27 95.61 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.346 1.058 . . . . 0.0 110.456 -177.037 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 34.0 m -100.07 5.89 9.78 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 CA-C-N 114.777 -1.101 . . . . 0.0 111.309 -173.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 17.3 m120 66.33 13.17 9.07 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 125.054 1.342 . . . . 0.0 113.288 172.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . 0.477 ' O ' ' HB3' ' A' ' 250' ' ' TYR . 92.3 mt -80.68 125.41 30.0 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 175.318 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -89.33 -23.5 22.23 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 172.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -134.08 150.97 75.73 Favored Pre-proline 0 CA--C 1.55 0.954 0 C-N-CA 124.589 1.156 . . . . 0.0 108.746 179.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -67.28 143.29 63.7 Favored 'Trans proline' 0 C--N 1.375 1.937 0 C-N-CA 122.318 2.012 . . . . 0.0 110.772 172.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 259' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_exo -60.65 163.89 14.68 Favored 'Trans proline' 0 C--N 1.374 1.899 0 C-N-CA 123.215 2.61 . . . . 0.0 113.849 -179.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -63.32 -34.66 78.18 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 114.943 -1.026 . . . . 0.0 112.095 -177.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -120.21 -164.44 12.53 Favored Glycine 0 CA--C 1.523 0.579 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.702 175.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 58.9 m -65.76 125.4 25.18 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.446 0.699 . . . . 0.0 110.0 -179.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 263' ' ' TRP . . . . . . . . . . . . . 39.5 t90 -84.5 129.42 34.86 Favored 'General case' 0 C--O 1.242 0.669 0 CA-C-O 121.719 0.771 . . . . 0.0 111.053 -175.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 264' ' ' TYR . . . . . 0.403 ' O ' ' HE3' ' A' ' 269' ' ' LYS . 75.6 m-85 -111.07 126.84 55.24 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.02 1.328 . . . . 0.0 107.587 172.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 265' ' ' CYS . . . . . 0.458 ' SG ' ' HB2' ' A' ' 267' ' ' GLU . 26.4 p -67.98 161.89 63.83 Favored Pre-proline 0 CA--C 1.554 1.121 0 CA-C-O 118.661 -0.685 . . . . 0.0 109.858 175.147 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_exo -46.84 -33.26 13.81 Favored 'Trans proline' 0 C--N 1.39 2.73 0 C-N-CA 123.414 2.743 . . . . 0.0 113.469 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 267' ' ' GLU . . . . . 0.458 ' HB2' ' SG ' ' A' ' 265' ' ' CYS . 26.6 mt-10 -59.9 -58.41 8.68 Favored 'General case' 0 C--O 1.213 -0.837 0 C-N-CA 124.651 1.181 . . . . 0.0 110.054 175.536 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 268' ' ' CYS . . . . . 0.549 ' SG ' ' HA3' ' A' ' 240' ' ' GLY . 99.0 m -63.86 -27.77 69.39 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.603 0.761 . . . . 0.0 113.049 -176.27 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . 0.403 ' HE3' ' O ' ' A' ' 264' ' ' TYR . 94.2 mttt -68.87 -37.32 78.98 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 122.579 0.352 . . . . 0.0 111.059 176.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 74.1 mt -95.66 -72.06 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.814 0 C-N-CA 122.947 0.499 . . . . 0.0 109.841 179.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 . . . . . 0 C--O 1.25 1.123 0 C-N-CA 124.798 1.239 . . . . 0.0 110.315 -179.714 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 8.4 p . . . . . 0 N--CA 1.479 0.983 0 CA-C-O 120.866 0.365 . . . . 0.0 110.336 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 34.4 tp -97.25 119.3 35.52 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.481 0.712 . . . . 0.0 109.254 178.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' TYR . . . . . 0.453 ' HB3' ' HA ' ' A' ' 245' ' ' TYR . 48.0 m-85 -143.87 141.42 30.3 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.377 0.671 . . . . 0.0 110.29 -175.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 45.3 t 170.58 158.47 0.07 Allowed 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 125.367 1.467 . . . . 0.0 109.274 164.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 35.7 t80 -65.62 -37.99 88.14 Favored 'General case' 0 CA--C 1.551 0.991 0 CA-C-N 117.804 0.275 . . . . 0.0 110.985 177.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 4.6 p -80.45 -12.04 59.61 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 122.589 0.356 . . . . 0.0 111.129 176.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 84.2 mm-40 50.01 81.15 0.06 Allowed 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 124.745 1.218 . . . . 0.0 112.077 -173.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' ARG . . . . . 0.429 HH22 ' HB3' ' A' ' 251' ' ' ASP . 46.7 ttp180 -135.09 149.44 50.06 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 176.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 23.6 m -67.18 147.03 12.78 Favored 'Isoleucine or valine' 0 C--O 1.241 0.635 0 C-N-CA 122.63 0.372 . . . . 0.0 111.328 174.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 40.9 m -98.81 81.71 2.68 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 174.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -86.86 99.95 12.2 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.589 0.756 . . . . 0.0 109.768 -176.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 76.97 -0.09 67.67 Favored Glycine 0 N--CA 1.474 1.178 0 CA-C-N 116.232 -0.44 . . . . 0.0 113.823 178.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -135.35 72.71 1.45 Allowed 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.122 0.969 . . . . 0.0 109.571 -178.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 235' ' ' MET . . . . . . . . . . . . . 3.4 mpp? -105.76 108.46 19.99 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.285 -176.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 5.6 p -111.6 124.17 68.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 171.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -99.9 131.04 46.11 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 123.273 0.629 . . . . 0.0 109.732 -179.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 238' ' ' CYS . . . . . . . . . . . . . 18.1 t -81.66 143.25 32.04 Favored 'General case' 0 C--O 1.223 -0.3 0 C-N-CA 123.873 0.869 . . . . 0.0 110.58 179.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -97.39 93.79 6.68 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 166.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -142.56 112.92 0.76 Allowed Glycine 0 CA--C 1.521 0.442 0 CA-C-O 118.34 -1.255 . . . . 0.0 110.445 174.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -67.22 -24.43 44.08 Favored 'Trans proline' 0 C--N 1.366 1.492 0 CA-C-N 120.112 1.956 . . . . 0.0 111.38 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 15.3 p-10 -110.81 70.81 0.73 Allowed 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.408 1.483 . . . . 0.0 108.821 176.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 39.0 t -167.4 107.08 0.58 Allowed 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.308 -169.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? -77.1 -36.15 55.87 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.037 0.535 . . . . 0.0 109.808 171.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . 0.453 ' HA ' ' HB3' ' A' ' 224' ' ' TYR . 12.2 m-85 -79.62 24.77 0.36 Allowed 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 -171.272 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -45.98 -43.5 14.21 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 124.781 1.232 . . . . 0.0 114.122 -170.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 247' ' ' TRP . . . . . . . . . . . . . 70.5 m95 -76.92 129.53 36.3 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-O 121.155 0.502 . . . . 0.0 110.884 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -140.19 174.81 10.14 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.767 1.227 . . . . 0.0 109.193 179.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 249' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -125.1 141.03 52.37 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.062 0.945 . . . . 0.0 109.971 179.346 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 39.3 m-85 -56.16 -35.06 66.76 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 125.622 1.569 . . . . 0.0 112.852 -171.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 251' ' ' ASP . . . . . 0.429 ' HB3' HH22 ' A' ' 229' ' ' ARG . 11.6 t70 -57.97 -51.18 70.7 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 124.746 1.219 . . . . 0.0 111.504 177.575 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 252' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -62.26 -42.44 99.33 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.832 0.853 . . . . 0.0 110.946 -176.108 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 35.1 m -99.01 5.56 9.66 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.652 -172.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 34.6 m-80 62.95 17.93 10.46 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 125.075 1.35 . . . . 0.0 113.621 171.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 87.2 mt -79.62 126.01 30.35 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 177.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 83.3 mttt -99.18 -25.94 14.36 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.993 0.917 . . . . 0.0 109.399 178.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -119.82 156.41 54.08 Favored Pre-proline 0 CA--C 1.551 0.999 0 C-N-CA 125.013 1.325 . . . . 0.0 109.043 176.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -68.14 143.33 59.02 Favored 'Trans proline' 0 C--N 1.378 2.107 0 C-N-CA 122.409 2.073 . . . . 0.0 111.192 172.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 259' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -56.75 156.24 23.85 Favored 'Trans proline' 0 C--N 1.378 2.107 0 C-N-CA 123.163 2.576 . . . . 0.0 113.203 177.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -78.89 -7.53 58.02 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 122.889 0.476 . . . . 0.0 111.967 -179.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 178.93 -133.67 2.15 Favored Glycine 0 C--N 1.346 1.109 0 CA-C-O 119.949 -0.362 . . . . 0.0 112.565 177.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 37.1 p -63.71 106.54 1.0 Allowed 'General case' 0 C--N 1.351 0.651 0 C-N-CA 124.344 1.058 . . . . 0.0 110.356 -178.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 263' ' ' TRP . . . . . . . . . . . . . 54.7 t90 -98.48 109.4 22.16 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.493 0.717 . . . . 0.0 110.535 -174.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -94.65 106.23 18.2 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.312 0.645 . . . . 0.0 110.036 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 265' ' ' CYS . . . . . 0.425 ' SG ' ' OE2' ' A' ' 267' ' ' GLU . 13.5 p -64.36 157.9 68.83 Favored Pre-proline 0 CA--C 1.565 1.536 0 CA-C-O 118.05 -0.976 . . . . 0.0 109.783 176.453 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -23.67 -63.0 0.05 OUTLIER 'Trans proline' 0 C--N 1.392 2.824 1 C-N-CA 126.26 4.64 . . . . 0.0 117.981 -168.038 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 267' ' ' GLU . . . . . 0.425 ' OE2' ' SG ' ' A' ' 265' ' ' CYS . 0.0 OUTLIER -71.73 -28.11 63.46 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 122.027 -0.421 . . . . 0.0 111.731 -173.116 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 268' ' ' CYS . . . . . . . . . . . . . 91.1 m -68.21 -30.33 69.38 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 124.135 0.974 . . . . 0.0 112.315 179.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -92.75 -3.9 54.01 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 122.352 0.261 . . . . 0.0 111.595 -178.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 74.8 mt -106.51 -47.43 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 C-N-CA 124.032 0.933 . . . . 0.0 109.899 177.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 . . . . . 0 CA--C 1.563 1.448 0 C-N-CA 125.372 1.469 . . . . 0.0 108.997 -176.347 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 48.0 p . . . . . 0 N--CA 1.477 0.898 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 55.5 tp -96.53 94.04 7.14 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.265 0.626 . . . . 0.0 109.328 -179.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' TYR . . . . . 0.7 ' HB3' ' HA ' ' A' ' 245' ' ' TYR . 39.6 m-85 -137.63 126.1 23.48 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.768 0.827 . . . . 0.0 109.417 -178.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 39.0 t 172.47 162.86 0.12 Allowed 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 125.11 1.364 . . . . 0.0 109.294 169.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 56.1 t80 -69.01 -35.48 76.72 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 122.736 0.414 . . . . 0.0 111.383 177.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 13.5 p -82.79 -13.22 56.66 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 122.58 0.352 . . . . 0.0 111.434 178.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 83.8 mm-40 54.99 85.58 0.06 Allowed 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.501 1.12 . . . . 0.0 112.02 -172.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 42.0 ttp180 -150.77 150.64 31.26 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 115.064 -0.971 . . . . 0.0 108.439 174.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 32.9 m -76.17 152.98 5.99 Favored 'Isoleucine or valine' 0 C--O 1.242 0.665 0 CA-C-O 121.334 0.587 . . . . 0.0 110.974 178.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' SER . . . . . 0.45 ' HB2' ' HG2' ' A' ' 235' ' ' MET . 14.9 m -101.74 101.48 11.98 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.128 0.971 . . . . 0.0 108.445 175.099 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -72.48 81.05 1.06 Allowed 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.776 0.83 . . . . 0.0 109.661 -177.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 74.16 -18.39 2.07 Favored Glycine 0 CA--C 1.537 1.437 0 CA-C-N 115.193 -0.912 . . . . 0.0 114.366 -179.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -98.28 66.51 1.77 Allowed 'General case' 0 C--O 1.243 0.743 0 C-N-CA 123.75 0.82 . . . . 0.0 109.62 -176.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 235' ' ' MET . . . . . 0.45 ' HG2' ' HB2' ' A' ' 231' ' ' SER . 60.0 mtm -94.26 120.2 34.15 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 114.804 -1.089 . . . . 0.0 109.822 -178.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . 0.48 HG11 HG22 ' A' ' 253' ' ' VAL . 3.3 p -106.1 124.21 61.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 168.567 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -90.71 155.78 18.57 Favored 'General case' 0 C--O 1.242 0.706 0 C-N-CA 123.148 0.579 . . . . 0.0 110.077 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 238' ' ' CYS . . . . . 0.4 ' HB3' ' HA ' ' A' ' 246' ' ' GLU . 35.6 t -127.69 113.97 16.71 Favored 'General case' 0 C--O 1.243 0.735 0 C-N-CA 123.284 0.634 . . . . 0.0 110.069 -178.479 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -73.01 94.46 1.88 Allowed 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 173.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -143.68 133.05 5.2 Favored Glycine 0 C--N 1.346 1.11 0 CA-C-O 117.898 -1.501 . . . . 0.0 110.843 175.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -64.32 -46.04 8.45 Favored 'Trans proline' 0 C--N 1.377 2.051 0 C-N-CA 122.575 2.183 . . . . 0.0 111.352 -178.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 21.4 m120 -101.86 92.2 4.71 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 170.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 9.0 t -159.12 90.63 0.98 Allowed 'General case' 0 C--O 1.24 0.601 0 C-N-CA 122.984 0.514 . . . . 0.0 110.172 179.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 4.9 tppp? -65.87 -42.36 90.45 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-O 121.687 0.755 . . . . 0.0 109.95 173.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . 0.7 ' HA ' ' HB3' ' A' ' 224' ' ' TYR . 23.7 m-85 -84.09 24.6 0.91 Allowed 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 114.435 -1.257 . . . . 0.0 112.224 -177.646 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 246' ' ' GLU . . . . . 0.4 ' HA ' ' HB3' ' A' ' 238' ' ' CYS . 16.2 pt-20 -47.97 -33.75 8.26 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 124.537 1.135 . . . . 0.0 112.203 -179.562 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 247' ' ' TRP . . . . . . . . . . . . . 99.3 m95 -87.37 123.07 31.93 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.339 0.655 . . . . 0.0 110.016 172.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 49.8 m-85 -131.94 175.89 8.83 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.256 1.422 . . . . 0.0 109.23 176.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 249' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -110.94 144.5 39.91 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.093 0.957 . . . . 0.0 109.046 171.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . 0.468 ' HA ' HG21 ' A' ' 253' ' ' VAL . 74.8 m-85 -56.7 -27.06 58.29 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 124.652 1.181 . . . . 0.0 111.854 178.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -53.76 -59.37 4.7 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.861 1.264 . . . . 0.0 111.5 172.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 252' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -65.1 -35.11 80.08 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.789 0.836 . . . . 0.0 111.491 -175.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . 0.48 HG22 HG11 ' A' ' 236' ' ' VAL . 11.9 m -97.2 2.76 10.23 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.715 -172.232 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 64.7 t30 64.75 16.85 10.66 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 124.699 1.2 . . . . 0.0 112.455 168.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 88.6 mt -83.73 116.1 22.52 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 -177.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 46.4 mmtm -76.14 -8.41 56.95 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.719 0.808 . . . . 0.0 111.65 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -156.55 166.37 16.67 Favored Pre-proline 0 CA--C 1.556 1.176 0 C-N-CA 124.884 1.273 . . . . 0.0 108.983 -173.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -52.31 147.45 28.55 Favored 'Trans proline' 0 C--N 1.382 2.337 0 C-N-CA 122.717 2.278 . . . . 0.0 112.298 171.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 259' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -58.69 172.92 1.31 Allowed 'Trans proline' 0 C--N 1.381 2.253 0 C-N-CA 123.137 2.558 . . . . 0.0 113.991 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp -101.1 22.02 12.97 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.743 0.817 . . . . 0.0 111.506 -175.157 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 154.12 -156.29 26.73 Favored Glycine 0 C--N 1.349 1.276 0 N-CA-C 111.242 -0.743 . . . . 0.0 111.242 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 13.6 p -64.32 106.3 1.08 Allowed 'General case' 0 C--N 1.355 0.825 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 170.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 263' ' ' TRP . . . . . . . . . . . . . 80.4 t90 -85.94 126.48 34.13 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.012 -173.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 -106.32 128.24 53.85 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 173.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 23.4 p -75.09 152.4 86.32 Favored Pre-proline 0 N--CA 1.48 1.067 0 CA-C-O 117.832 -1.08 . . . . 0.0 108.443 173.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_exo -31.85 -63.38 0.12 Allowed 'Trans proline' 0 C--N 1.393 2.885 0 C-N-CA 125.238 3.959 . . . . 0.0 116.434 -169.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -57.68 -33.3 68.2 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 124.873 1.269 . . . . 0.0 113.603 -179.29 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 268' ' ' CYS . . . . . . . . . . . . . 89.5 m -70.07 -41.5 74.02 Favored 'General case' 0 N--CA 1.5 2.041 0 C-N-CA 122.807 0.443 . . . . 0.0 111.347 172.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -70.45 -32.92 70.68 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.578 -175.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 76.1 mt -81.35 -51.82 14.82 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 C-N-CA 123.635 0.774 . . . . 0.0 109.53 177.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 . . . . . 0 CA--C 1.554 1.121 0 C-N-CA 124.412 1.085 . . . . 0.0 108.896 -176.367 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 27.3 p . . . . . 0 N--CA 1.473 0.683 0 CA-C-O 120.877 0.37 . . . . 0.0 110.249 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 53.4 tp -83.46 80.04 9.23 Favored 'General case' 0 C--N 1.348 0.521 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 175.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -140.35 122.86 16.12 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 177.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 49.5 t 172.96 161.32 0.12 Allowed 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.652 1.181 . . . . 0.0 109.538 175.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -66.0 -37.96 87.25 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 122.71 0.404 . . . . 0.0 110.583 175.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 5.4 p -81.84 -4.24 56.0 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 111.634 0.235 . . . . 0.0 111.634 174.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 78.4 mm-40 52.37 81.71 0.08 Allowed 'General case' 0 C--N 1.36 1.041 0 C-N-CA 125.205 1.402 . . . . 0.0 112.549 -175.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' ARG . . . . . 0.431 ' HB2' ' CE1' ' A' ' 249' ' ' HIS . 33.1 mmt180 -138.17 155.71 48.44 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.161 0.984 . . . . 0.0 109.343 175.115 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 27.7 m -83.56 -178.59 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.644 177.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' SER . . . . . 0.452 ' HG ' ' HB3' ' A' ' 235' ' ' MET . 41.8 t -80.6 94.07 6.23 Favored 'General case' 0 CA--C 1.553 1.061 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.196 176.692 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -101.98 92.21 4.69 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.394 0.678 . . . . 0.0 109.479 179.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 73.88 -7.01 16.52 Favored Glycine 0 C--N 1.35 1.318 0 N-CA-C 114.44 0.536 . . . . 0.0 114.44 175.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -154.6 142.88 20.44 Favored 'General case' 0 C--O 1.242 0.674 0 C-N-CA 124.132 0.973 . . . . 0.0 109.456 -175.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 235' ' ' MET . . . . . 0.452 ' HB3' ' HG ' ' A' ' 231' ' ' SER . 25.4 ptt? -158.14 128.43 6.15 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.262 0.625 . . . . 0.0 110.204 175.604 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 3.3 p -115.11 124.34 71.64 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.767 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 173.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -89.8 156.54 18.44 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.361 0.664 . . . . 0.0 110.332 -179.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 238' ' ' CYS . . . . . 0.612 ' HB3' ' HA ' ' A' ' 246' ' ' GLU . 13.1 t -125.71 149.47 48.48 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.458 0.703 . . . . 0.0 111.543 -173.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -121.01 104.23 9.64 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.221 1.009 . . . . 0.0 109.043 176.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -141.99 162.57 27.11 Favored Glycine 0 C--O 1.244 0.719 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 174.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -61.69 -52.97 2.52 Favored 'Trans proline' 0 C--N 1.371 1.735 0 C-N-CA 122.033 1.822 . . . . 0.0 111.856 174.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 37.8 t30 -116.38 118.23 32.15 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 178.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 18.7 t -167.94 107.51 0.54 Allowed 'General case' 0 N--CA 1.47 0.556 0 O-C-N 123.167 0.292 . . . . 0.0 111.289 -175.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 14.9 ptpt -86.85 -26.99 23.74 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 165.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -83.17 28.95 0.5 Allowed 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.318 1.447 . . . . 0.0 112.683 179.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 246' ' ' GLU . . . . . 0.612 ' HA ' ' HB3' ' A' ' 238' ' ' CYS . 41.3 mt-10 -50.11 -37.3 33.46 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.675 0.79 . . . . 0.0 111.72 176.592 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 247' ' ' TRP . . . . . . . . . . . . . 84.7 m95 -96.85 134.13 40.57 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.566 -178.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -144.09 176.29 9.41 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.502 1.521 . . . . 0.0 108.939 175.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 249' ' ' HIS . . . . . 0.431 ' CE1' ' HB2' ' A' ' 229' ' ' ARG . 0.2 OUTLIER -119.56 147.44 44.48 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 171.357 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . 0.415 ' HB3' ' O ' ' A' ' 255' ' ' LEU . 20.1 m-85 -62.26 -33.93 75.57 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.026 1.33 . . . . 0.0 112.214 -168.494 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -59.85 -43.91 94.4 Favored 'General case' 0 N--CA 1.476 0.826 0 O-C-N 123.971 0.794 . . . . 0.0 111.31 179.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 252' ' ' CYS . . . . . . . . . . . . . 1.3 m -70.15 -38.34 75.45 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.577 -177.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 35.5 m -99.7 8.78 8.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 122.803 0.441 . . . . 0.0 111.794 -175.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 59.97 22.96 12.06 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 124.894 1.278 . . . . 0.0 113.234 170.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . 0.415 ' O ' ' HB3' ' A' ' 250' ' ' TYR . 93.1 mt -84.3 110.35 18.51 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 174.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -70.25 -33.2 71.34 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 121.44 0.638 . . . . 0.0 109.93 175.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -132.04 159.62 71.32 Favored Pre-proline 0 CA--C 1.555 1.169 0 C-N-CA 124.402 1.081 . . . . 0.0 109.39 -176.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -59.94 148.49 88.57 Favored 'Trans proline' 0 C--N 1.384 2.41 0 C-N-CA 122.813 2.342 . . . . 0.0 112.787 178.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 259' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_exo -58.79 167.83 4.93 Favored 'Trans proline' 0 C--N 1.385 2.5 0 C-N-CA 123.591 2.861 . . . . 0.0 113.727 -178.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -100.54 18.01 20.26 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.343 0.657 . . . . 0.0 111.34 -177.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 158.3 -143.9 9.86 Favored Glycine 0 C--N 1.348 1.232 0 N-CA-C 112.169 -0.373 . . . . 0.0 112.169 176.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 32.8 p -66.12 107.78 2.04 Favored 'General case' 0 C--N 1.35 0.596 0 C-N-CA 123.679 0.792 . . . . 0.0 110.018 178.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 263' ' ' TRP . . . . . . . . . . . . . 55.3 t90 -95.0 122.22 37.43 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.775 0.83 . . . . 0.0 110.676 -170.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -96.88 106.21 18.48 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.15 0.58 . . . . 0.0 109.747 177.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 265' ' ' CYS . . . . . 0.434 ' SG ' ' OE2' ' A' ' 267' ' ' GLU . 13.1 p -70.42 160.17 82.23 Favored Pre-proline 0 CA--C 1.553 1.059 0 CA-C-O 117.861 -1.066 . . . . 0.0 110.109 177.421 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -19.09 -70.11 0.02 OUTLIER 'Trans proline' 0 C--N 1.392 2.866 1 C-N-CA 126.388 4.725 . . . . 0.0 117.536 -174.224 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 267' ' ' GLU . . . . . 0.434 ' OE2' ' SG ' ' A' ' 265' ' ' CYS . 0.0 OUTLIER -68.06 -30.25 69.41 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -173.31 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 268' ' ' CYS . . . . . . . . . . . . . 75.0 m -70.54 -38.3 74.18 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.569 0.748 . . . . 0.0 111.071 175.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -71.95 -41.5 67.71 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.402 -175.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 23.6 pt -86.68 1.08 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.611 -177.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 . . . . . 0 C--O 1.249 1.043 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 174.287 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 25.2 p . . . . . 0 N--CA 1.475 0.819 0 CA-C-O 120.704 0.288 . . . . 0.0 110.479 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 31.5 tp -98.94 111.17 23.64 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.818 0.847 . . . . 0.0 110.353 -178.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' TYR . . . . . 0.421 ' HB3' ' HA ' ' A' ' 245' ' ' TYR . 75.0 m-85 -141.69 129.77 22.07 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 174.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 35.6 t 172.2 153.13 0.07 Allowed 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 125.029 1.332 . . . . 0.0 108.447 169.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 80.1 t80 -63.44 -35.11 79.36 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 122.826 0.45 . . . . 0.0 111.786 -178.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 13.7 p -79.18 -16.48 56.52 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 122.531 0.333 . . . . 0.0 111.283 179.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 85.0 mm-40 54.09 80.55 0.11 Allowed 'General case' 0 C--N 1.362 1.151 0 C-N-CA 124.701 1.2 . . . . 0.0 111.543 -171.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' ARG . . . . . 0.454 ' HD3' ' O ' ' A' ' 230' ' ' VAL . 4.5 tmt_? -150.02 148.76 29.42 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 -178.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . 0.454 ' O ' ' HD3' ' A' ' 229' ' ' ARG . 33.4 m -73.33 178.63 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 N-CA-C 112.759 0.652 . . . . 0.0 112.759 -172.009 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 19.6 m -139.22 49.11 1.85 Allowed 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 123.323 0.649 . . . . 0.0 109.54 -176.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 20.0 p90 -65.93 119.37 11.19 Favored 'General case' 0 CA--C 1.551 1.002 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.557 -173.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 77.18 -22.9 2.34 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 124.479 1.037 . . . . 0.0 115.327 178.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 61.7 mm-40 -143.62 99.78 3.48 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.047 0.939 . . . . 0.0 109.861 -178.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 235' ' ' MET . . . . . . . . . . . . . 18.5 ptp -122.91 132.27 54.1 Favored 'General case' 0 C--O 1.242 0.709 0 C-N-CA 124.457 1.103 . . . . 0.0 109.423 172.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 4.0 p -100.69 124.19 54.12 Favored 'Isoleucine or valine' 0 C--O 1.24 0.572 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 171.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -92.17 133.06 36.14 Favored 'General case' 0 C--O 1.242 0.663 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.048 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 238' ' ' CYS . . . . . 0.579 ' SG ' ' HA ' ' A' ' 264' ' ' TYR . 40.9 t -108.26 102.49 11.61 Favored 'General case' 0 C--O 1.243 0.719 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 176.438 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 239' ' ' ASP . . . . . 0.422 ' HB3' HG22 ' A' ' 262' ' ' THR . 30.2 t70 -82.37 94.32 7.36 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . 0.414 ' HA3' ' SG ' ' A' ' 268' ' ' CYS . . . -128.07 141.48 12.64 Favored Glycine 0 CA--C 1.527 0.811 0 CA-C-O 118.186 -1.341 . . . . 0.0 110.489 175.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -52.97 -42.74 62.23 Favored 'Trans proline' 0 C--N 1.379 2.145 0 C-N-CA 123.208 2.605 . . . . 0.0 112.166 -179.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -115.94 112.62 22.14 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.554 1.142 . . . . 0.0 108.02 171.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 243' ' ' CYS . . . . . 0.581 ' SG ' ' HA ' ' A' ' 246' ' ' GLU . 8.0 t -168.75 81.15 0.14 Allowed 'General case' 0 C--N 1.352 0.681 0 CA-C-O 121.496 0.665 . . . . 0.0 110.4 -175.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.5 -29.4 68.82 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 123.778 0.831 . . . . 0.0 112.574 178.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . 0.421 ' HA ' ' HB3' ' A' ' 224' ' ' TYR . 41.9 m-85 -101.75 24.59 9.65 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.86 0.864 . . . . 0.0 111.458 179.58 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 246' ' ' GLU . . . . . 0.581 ' HA ' ' SG ' ' A' ' 243' ' ' CYS . 14.8 pt-20 -47.21 -37.46 10.35 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 125.049 1.34 . . . . 0.0 114.235 -170.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 247' ' ' TRP . . . . . . . . . . . . . 99.0 m95 -80.01 122.17 26.4 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.102 0.561 . . . . 0.0 109.726 176.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -129.21 173.88 10.09 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.039 0.936 . . . . 0.0 109.713 178.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 249' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -124.04 152.52 42.53 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.395 1.078 . . . . 0.0 108.728 173.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -62.87 -27.15 69.15 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.687 1.195 . . . . 0.0 110.818 -173.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -61.2 -47.32 86.66 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.985 1.314 . . . . 0.0 110.947 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 252' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -71.27 -43.38 67.29 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 114.563 -1.199 . . . . 0.0 111.421 -176.106 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . 0.522 HG21 ' HG ' ' A' ' 255' ' ' LEU . 35.6 m -100.02 6.59 9.46 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.806 -172.32 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 12.0 m120 60.75 31.62 20.12 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 124.771 1.229 . . . . 0.0 113.102 171.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . 0.522 ' HG ' HG21 ' A' ' 253' ' ' VAL . 70.4 mt -79.22 116.21 19.34 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 176.56 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 50.9 tttp -70.59 -42.62 70.79 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.954 0.902 . . . . 0.0 109.591 174.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -126.7 157.16 72.12 Favored Pre-proline 0 C--O 1.248 0.998 0 CA-C-N 114.49 -1.232 . . . . 0.0 109.788 -176.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -56.93 146.09 81.4 Favored 'Trans proline' 0 C--N 1.378 2.104 0 C-N-CA 122.912 2.408 . . . . 0.0 112.712 171.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 259' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -67.08 148.65 81.66 Favored 'Trans proline' 0 C--N 1.372 1.787 0 C-N-CA 122.255 1.97 . . . . 0.0 111.442 172.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 85.4 mttt -87.86 -32.2 19.13 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.877 0.871 . . . . 0.0 110.299 -179.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -120.03 -171.21 14.56 Favored Glycine 0 C--N 1.345 1.055 0 CA-C-N 115.339 -0.846 . . . . 0.0 112.086 -178.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 262' ' ' THR . . . . . 0.422 HG22 ' HB3' ' A' ' 239' ' ' ASP . 76.9 m -62.95 109.81 1.58 Allowed 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.978 0.911 . . . . 0.0 109.92 179.043 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 263' ' ' TRP . . . . . . . . . . . . . 59.0 t90 -82.2 145.54 30.01 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.018 0.527 . . . . 0.0 110.005 -176.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 264' ' ' TYR . . . . . 0.579 ' HA ' ' SG ' ' A' ' 238' ' ' CYS . 98.6 m-85 -129.78 152.55 49.16 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.898 0.879 . . . . 0.0 110.339 -178.697 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 15.3 p -114.55 162.16 24.95 Favored Pre-proline 0 N--CA 1.482 1.136 0 CA-C-O 117.701 -1.142 . . . . 0.0 107.959 175.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -30.12 -65.44 0.08 OUTLIER 'Trans proline' 0 C--N 1.391 2.812 0 C-N-CA 125.151 3.901 . . . . 0.0 117.342 -175.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.2 -12.4 55.83 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 -172.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 268' ' ' CYS . . . . . 0.414 ' SG ' ' HA3' ' A' ' 240' ' ' GLY . 74.7 m -88.46 -42.2 12.29 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.669 0.788 . . . . 0.0 112.596 169.422 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . 0.546 ' HG3' HG21 ' A' ' 270' ' ' ILE . 14.7 ptmm? -97.67 -50.4 4.48 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 114.158 1.17 . . . . 0.0 114.158 -162.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 270' ' ' ILE . . . . . 0.546 HG21 ' HG3' ' A' ' 269' ' ' LYS . 19.2 pt -88.9 21.21 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -169.292 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 . . . . . 0 C--O 1.25 1.118 0 C-N-CA 123.805 0.842 . . . . 0.0 109.71 179.051 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 68.9 p . . . . . 0 N--CA 1.482 1.166 0 CA-C-O 121.526 0.679 . . . . 0.0 110.086 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 44.1 tp -135.75 91.42 2.7 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 -177.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -142.13 142.95 32.8 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.012 0.925 . . . . 0.0 109.427 -175.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 45.5 t 171.8 163.84 0.1 Allowed 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 125.469 1.508 . . . . 0.0 108.352 173.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 41.4 t80 -66.78 -31.23 71.73 Favored 'General case' 0 CA--C 1.557 1.221 0 CA-C-N 118.668 0.667 . . . . 0.0 110.302 175.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' CYS . . . . . 0.521 ' SG ' ' HB2' ' A' ' 229' ' ' ARG . 4.6 p -89.49 -3.83 58.2 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 122.919 0.487 . . . . 0.0 111.444 174.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 81.4 mm-40 46.45 81.86 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 125.023 1.329 . . . . 0.0 111.817 -175.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' ARG . . . . . 0.521 ' HB2' ' SG ' ' A' ' 227' ' ' CYS . 1.0 OUTLIER -150.02 158.03 43.75 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 -171.504 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 27.2 m -71.83 150.53 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 O-C-N 123.524 0.515 . . . . 0.0 111.464 178.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' SER . . . . . 0.402 ' HA ' ' HB3' ' A' ' 249' ' ' HIS . 20.5 m -100.86 77.72 1.88 Allowed 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 175.512 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 82.5 t80 -71.67 101.11 2.46 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.423 0.689 . . . . 0.0 110.642 -174.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 80.66 -19.24 7.51 Favored Glycine 0 C--N 1.344 1.014 0 CA-C-N 115.513 -0.767 . . . . 0.0 114.247 175.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . 0.415 ' HB3' ' CD1' ' A' ' 250' ' ' TYR . 59.3 mm-40 -128.03 94.98 4.06 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.127 0.971 . . . . 0.0 109.351 -175.304 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 235' ' ' MET . . . . . 0.4 ' HG2' ' HB2' ' A' ' 231' ' ' SER . 44.7 mtt -118.2 97.76 5.95 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.357 0.663 . . . . 0.0 110.108 -174.537 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . 0.415 HG13 HG21 ' A' ' 253' ' ' VAL . 7.4 p -92.56 124.54 45.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 171.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -99.47 141.07 32.74 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 123.884 0.874 . . . . 0.0 109.853 179.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 238' ' ' CYS . . . . . 0.656 ' HB3' ' HA ' ' A' ' 246' ' ' GLU . 5.5 t -105.36 114.48 28.69 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 123.864 0.866 . . . . 0.0 109.785 179.571 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -72.6 95.63 1.86 Allowed 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.096 0.558 . . . . 0.0 109.516 176.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -139.06 116.48 1.25 Allowed Glycine 0 CA--C 1.53 0.988 0 CA-C-O 118.711 -1.049 . . . . 0.0 111.282 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -60.03 -29.08 88.45 Favored 'Trans proline' 0 C--N 1.377 2.055 0 C-N-CA 123.382 2.721 . . . . 0.0 112.621 178.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -120.35 88.71 2.99 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 171.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 42.1 t -172.17 112.15 0.28 Allowed 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.485 0.714 . . . . 0.0 110.456 -172.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 20.8 pttm -89.25 -25.01 21.95 Favored 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 167.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -79.33 27.47 0.26 Allowed 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 124.83 1.252 . . . . 0.0 112.527 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 246' ' ' GLU . . . . . 0.656 ' HA ' ' HB3' ' A' ' 238' ' ' CYS . 41.1 mt-10 -53.35 -46.55 69.57 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.163 0.585 . . . . 0.0 110.601 172.191 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 247' ' ' TRP . . . . . . . . . . . . . 97.8 m95 -72.42 122.18 20.8 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.366 179.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -142.38 171.32 14.21 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 125.206 1.402 . . . . 0.0 109.174 170.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 249' ' ' HIS . . . . . 0.402 ' HB3' ' HA ' ' A' ' 231' ' ' SER . 0.1 OUTLIER -123.12 142.42 50.91 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.249 1.019 . . . . 0.0 108.859 178.804 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . 0.415 ' CD1' ' HB3' ' A' ' 234' ' ' GLU . 8.8 m-85 -58.49 -26.69 63.72 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 124.98 1.312 . . . . 0.0 112.128 -174.087 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -59.46 -56.64 19.45 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.013 0.925 . . . . 0.0 110.833 174.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 252' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -61.39 -49.15 78.07 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.968 0.907 . . . . 0.0 111.595 -178.624 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . 0.454 HG22 ' HG ' ' A' ' 255' ' ' LEU . 26.8 m -88.64 5.32 4.41 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.909 -174.213 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 44.8 m-80 64.39 16.01 9.89 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 125.006 1.322 . . . . 0.0 113.415 169.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . 0.454 ' HG ' HG22 ' A' ' 253' ' ' VAL . 89.8 mt -74.24 108.02 6.77 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 122.891 0.476 . . . . 0.0 109.868 -176.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 62.1 mttm -72.15 -25.62 61.78 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.973 0.909 . . . . 0.0 110.326 176.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -131.59 159.69 70.71 Favored Pre-proline 0 CA--C 1.552 1.039 0 C-N-CA 124.619 1.167 . . . . 0.0 109.337 -177.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.31 140.64 44.88 Favored 'Trans proline' 0 C--N 1.369 1.625 0 C-N-CA 122.325 2.017 . . . . 0.0 111.78 169.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 259' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -61.66 158.49 36.96 Favored 'Trans proline' 0 C--N 1.38 2.211 0 C-N-CA 122.47 2.113 . . . . 0.0 111.542 169.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 31.6 mmmt -93.37 -2.15 55.08 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 112.724 0.638 . . . . 0.0 112.724 -175.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -164.53 -147.38 5.09 Favored Glycine 0 C--N 1.345 1.05 0 N-CA-C 112.213 -0.355 . . . . 0.0 112.213 -178.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 54.7 p -64.21 107.8 1.4 Allowed 'General case' 0 C--N 1.352 0.699 0 C-N-CA 123.401 0.681 . . . . 0.0 110.552 178.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 263' ' ' TRP . . . . . . . . . . . . . 63.3 t90 -87.45 144.78 26.57 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 176.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 264' ' ' TYR . . . . . 0.44 ' HA ' ' SG ' ' A' ' 238' ' ' CYS . 95.1 m-85 -126.14 129.39 48.97 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.433 0.693 . . . . 0.0 109.654 -178.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 265' ' ' CYS . . . . . 0.421 ' SG ' ' OE1' ' A' ' 267' ' ' GLU . 16.7 p -85.76 156.12 58.58 Favored Pre-proline 0 CA--C 1.555 1.163 0 CA-C-O 118.47 -0.776 . . . . 0.0 109.248 177.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 0.8 OUTLIER -23.7 -64.88 0.04 OUTLIER 'Trans proline' 0 C--N 1.392 2.845 1 C-N-CA 126.314 4.676 . . . . 0.0 118.098 -168.456 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 267' ' ' GLU . . . . . 0.421 ' OE1' ' SG ' ' A' ' 265' ' ' CYS . 0.0 OUTLIER -67.02 -32.18 73.23 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 122.574 0.35 . . . . 0.0 111.565 -171.619 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 268' ' ' CYS . . . . . . . . . . . . . 58.6 m -72.31 -38.59 68.68 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.763 0.825 . . . . 0.0 110.601 176.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 61.5 tttp -71.78 -34.31 69.32 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 115.042 -0.981 . . . . 0.0 111.294 -173.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 25.7 pt -90.0 -9.88 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 123.106 0.563 . . . . 0.0 111.408 -179.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 . . . . . 0 C--O 1.25 1.097 0 C-N-CA 123.739 0.815 . . . . 0.0 110.132 -177.586 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 14.8 p . . . . . 0 N--CA 1.477 0.924 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 51.3 tp -116.64 95.97 5.28 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.227 1.011 . . . . 0.0 108.797 177.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 224' ' ' TYR . . . . . 0.428 ' HB3' ' HA ' ' A' ' 245' ' ' TYR . 47.4 m-85 -137.93 127.57 25.13 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.036 0.934 . . . . 0.0 109.2 178.714 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 14.0 t 174.08 158.08 0.15 Allowed 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.386 1.075 . . . . 0.0 109.953 172.174 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -64.23 -38.89 92.67 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 122.997 0.519 . . . . 0.0 111.412 175.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 9.8 p -77.54 -13.9 59.8 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.086 177.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 81.1 mm-40 52.65 66.82 1.11 Allowed 'General case' 0 C--N 1.368 1.394 0 C-N-CA 124.668 1.187 . . . . 0.0 111.688 -174.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 78.4 ttt180 -130.26 153.58 48.47 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.659 0.784 . . . . 0.0 109.41 -179.437 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 29.3 m -66.21 155.42 7.08 Favored 'Isoleucine or valine' 0 C--O 1.241 0.65 0 C-N-CA 123.38 0.672 . . . . 0.0 111.655 177.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 231' ' ' SER . . . . . 0.673 ' HB3' ' HB3' ' A' ' 235' ' ' MET . 46.2 m -105.66 69.18 0.82 Allowed 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.52 178.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 20.2 p90 -70.02 110.32 5.02 Favored 'General case' 0 CA--C 1.549 0.918 0 CA-C-N 114.353 -1.294 . . . . 0.0 111.237 -176.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 76.92 -20.69 2.86 Favored Glycine 0 N--CA 1.478 1.49 0 N-CA-C 115.204 0.842 . . . . 0.0 115.204 171.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . 0.415 ' HB3' ' HD2' ' A' ' 250' ' ' TYR . 49.3 mt-10 -142.75 127.45 18.1 Favored 'General case' 0 C--O 1.243 0.743 0 C-N-CA 124.251 1.02 . . . . 0.0 108.928 -178.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 235' ' ' MET . . . . . 0.673 ' HB3' ' HB3' ' A' ' 231' ' ' SER . 22.4 ptt? -151.91 129.57 11.54 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 123.313 0.645 . . . . 0.0 110.432 175.739 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 5.4 p -103.31 126.46 57.68 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 C-N-CA 123.866 0.867 . . . . 0.0 108.869 175.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -88.57 164.64 15.29 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.624 0.77 . . . . 0.0 110.281 179.1 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 238' ' ' CYS . . . . . 0.409 ' HB3' ' HA ' ' A' ' 246' ' ' GLU . 15.4 t -136.83 105.54 5.85 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.353 0.661 . . . . 0.0 109.349 179.322 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -79.99 94.96 6.0 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.791 -178.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -141.25 137.19 7.96 Favored Glycine 0 C--N 1.348 1.223 0 CA-C-O 118.678 -1.068 . . . . 0.0 111.456 178.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -60.03 -38.71 76.18 Favored 'Trans proline' 0 C--N 1.376 1.978 0 C-N-CA 123.232 2.622 . . . . 0.0 113.384 179.176 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -109.49 95.88 5.91 Favored 'General case' 0 C--O 1.243 0.739 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 175.109 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 243' ' ' CYS . . . . . 0.478 ' SG ' ' HA ' ' A' ' 246' ' ' GLU . 12.2 t -166.06 101.8 0.65 Allowed 'General case' 0 C--O 1.237 0.429 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.941 -171.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 21.7 pttm -86.16 -37.98 18.18 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 171.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . 0.428 ' HA ' ' HB3' ' A' ' 224' ' ' TYR . 53.9 m-85 -87.66 29.15 0.92 Allowed 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 124.29 1.036 . . . . 0.0 111.874 -179.106 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 246' ' ' GLU . . . . . 0.478 ' HA ' ' SG ' ' A' ' 243' ' ' CYS . 10.4 pt-20 -49.37 -36.57 22.03 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.087 0.955 . . . . 0.0 112.844 179.105 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 247' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -91.09 135.16 33.95 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.381 0.61 . . . . 0.0 111.043 178.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -142.8 174.09 10.96 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 125.665 1.586 . . . . 0.0 108.449 174.105 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 249' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -117.2 141.84 47.78 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.817 0.847 . . . . 0.0 108.832 174.563 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . 0.415 ' HD2' ' HB3' ' A' ' 234' ' ' GLU . 86.3 m-85 -57.2 -26.85 61.33 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 124.658 1.183 . . . . 0.0 112.074 -177.22 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -56.3 -58.4 8.15 Favored 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 123.861 0.864 . . . . 0.0 111.46 174.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 252' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -61.37 -41.94 97.91 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 124.203 1.001 . . . . 0.0 112.117 -173.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 35.8 m -92.23 -5.77 10.72 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.733 -175.161 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 10.8 t30 52.41 70.12 0.6 Allowed 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 124.611 1.164 . . . . 0.0 111.243 178.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 96.3 mt -129.92 122.87 29.42 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 178.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 64.2 tttp -90.64 -27.48 19.02 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 123.272 0.629 . . . . 0.0 110.166 178.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 16.9 mp0 -105.45 147.07 33.99 Favored Pre-proline 0 N--CA 1.477 0.903 0 C-N-CA 124.189 0.996 . . . . 0.0 109.336 178.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -74.63 117.62 5.02 Favored 'Trans proline' 0 C--N 1.373 1.831 0 C-N-CA 122.322 2.015 . . . . 0.0 110.548 170.022 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 259' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_exo -53.6 112.62 1.0 Allowed 'Trans proline' 0 C--N 1.378 2.119 0 C-N-CA 123.1 2.533 . . . . 0.0 113.397 -178.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -68.21 103.14 1.5 Allowed 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.869 0.868 . . . . 0.0 109.855 -179.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 118.3 -167.46 12.96 Favored Glycine 0 N--CA 1.472 1.034 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 -176.321 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 39.4 p -74.13 106.04 5.61 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 177.214 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 263' ' ' TRP . . . . . . . . . . . . . 52.1 t90 -73.79 134.21 43.36 Favored 'General case' 0 C--N 1.349 0.583 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 173.027 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -110.85 113.86 26.77 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 123.029 0.531 . . . . 0.0 109.777 179.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 17.4 p -64.75 160.78 51.17 Favored Pre-proline 0 CA--C 1.55 0.964 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.947 171.278 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -36.63 -38.8 0.37 Allowed 'Trans proline' 0 C--N 1.382 2.317 0 C-N-CA 124.329 3.352 . . . . 0.0 115.991 175.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -54.58 -61.73 2.12 Favored 'General case' 0 N--CA 1.485 1.32 0 CA-C-O 121.652 0.739 . . . . 0.0 110.807 176.098 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 268' ' ' CYS . . . . . . . . . . . . . 35.5 m -80.02 -30.85 39.59 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 114.493 -1.23 . . . . 0.0 111.853 -168.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -75.86 -53.08 8.99 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.7 0.8 . . . . 0.0 111.155 -173.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 270' ' ' ILE . . . . . 0.413 HG23 ' HG3' ' A' ' 271' ' ' GLU . 50.7 mm -72.16 -52.47 24.3 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.978 -176.468 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 271' ' ' GLU . . . . . 0.413 ' HG3' HG23 ' A' ' 270' ' ' ILE . 45.7 mt-10 . . . . . 0 CA--C 1.555 1.164 0 C-N-CA 123.207 0.603 . . . . 0.0 109.553 -178.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 32.6 p . . . . . 0 CA--C 1.544 0.713 0 CA-C-O 121.06 0.457 . . . . 0.0 110.068 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -111.26 90.28 3.29 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 175.222 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 224' ' ' TYR . . . . . 0.515 ' HB3' ' HA ' ' A' ' 245' ' ' TYR . 78.5 m-85 -133.76 130.43 38.03 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 123.855 0.862 . . . . 0.0 108.892 179.535 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 225' ' ' CYS . . . . . 0.412 ' HB2' ' O ' ' A' ' 224' ' ' TYR . 26.5 t 172.29 155.69 0.09 Allowed 'General case' 0 N--CA 1.474 0.761 0 O-C-N 124.794 1.309 . . . . 0.0 109.388 168.387 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 61.5 t80 -64.81 -27.67 69.04 Favored 'General case' 0 CA--C 1.556 1.193 0 C-N-CA 123.201 0.6 . . . . 0.0 111.214 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 13.2 p -90.57 -10.69 42.48 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 122.991 0.517 . . . . 0.0 111.442 177.078 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 83.4 mm-40 52.16 85.46 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 124.607 1.163 . . . . 0.0 111.437 -171.041 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 73.6 ttt180 -140.63 150.71 43.9 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.816 -176.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 34.3 m -69.18 170.38 1.14 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.61 0 C-N-CA 124.29 1.036 . . . . 0.0 112.754 -177.331 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 39.4 t -86.73 116.52 24.88 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 114.662 -1.154 . . . . 0.0 109.762 174.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 232' ' ' PHE . . . . . 0.592 ' HB3' ' HG2' ' A' ' 234' ' ' GLU . 91.8 t80 -75.63 -13.04 60.32 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 123.84 0.856 . . . . 0.0 109.728 166.786 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 109.78 -18.17 29.56 Favored Glycine 0 C--N 1.349 1.277 0 N-CA-C 111.521 -0.632 . . . . 0.0 111.521 -174.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . 0.592 ' HG2' ' HB3' ' A' ' 232' ' ' PHE . 8.5 pt-20 -77.65 64.55 2.96 Favored 'General case' 0 CA--C 1.555 1.163 0 C-N-CA 124.273 1.029 . . . . 0.0 110.129 174.683 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 235' ' ' MET . . . . . . . . . . . . . 73.2 mtm -91.61 100.96 13.6 Favored 'General case' 0 N--CA 1.475 0.801 0 O-C-N 121.823 -0.548 . . . . 0.0 110.682 -173.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 2.8 p -88.07 124.28 41.09 Favored 'Isoleucine or valine' 0 C--O 1.241 0.652 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 168.124 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -99.32 110.9 23.37 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 123.564 0.746 . . . . 0.0 110.074 -176.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 238' ' ' CYS . . . . . 0.442 ' HB3' ' HA ' ' A' ' 246' ' ' GLU . 42.3 t -71.64 153.75 41.88 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.242 169.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 239' ' ' ASP . . . . . 0.542 ' HB3' ' HB ' ' A' ' 262' ' ' THR . 23.5 t70 -134.23 95.61 3.44 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.606 0.762 . . . . 0.0 109.176 176.317 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . 0.544 ' HA3' ' SG ' ' A' ' 268' ' ' CYS . . . -142.05 140.71 10.26 Favored Glycine 0 CA--C 1.534 1.222 0 CA-C-O 118.442 -1.199 . . . . 0.0 111.917 175.192 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -59.44 -51.69 5.93 Favored 'Trans proline' 0 C--N 1.377 2.03 0 C-N-CA 122.746 2.297 . . . . 0.0 112.145 178.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -89.04 86.49 6.93 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 171.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 10.4 t -174.75 104.6 0.1 Allowed 'General case' 0 C--N 1.351 0.637 0 O-C-N 123.88 0.738 . . . . 0.0 109.688 -176.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -85.75 -31.93 22.13 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-O 121.842 0.83 . . . . 0.0 110.359 173.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . 0.515 ' HA ' ' HB3' ' A' ' 224' ' ' TYR . 59.7 m-85 -86.65 26.4 1.11 Allowed 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.053 1.341 . . . . 0.0 112.368 -171.126 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 246' ' ' GLU . . . . . 0.442 ' HA ' ' HB3' ' A' ' 238' ' ' CYS . 5.6 mm-40 -45.96 -42.34 12.85 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 125.105 1.362 . . . . 0.0 112.697 -174.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 247' ' ' TRP . . . . . 0.479 ' HB2' ' HB2' ' A' ' 224' ' ' TYR . 96.0 m95 -70.92 117.93 13.06 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.112 0.565 . . . . 0.0 110.262 175.331 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -131.23 173.49 10.99 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.349 1.06 . . . . 0.0 109.92 175.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 249' ' ' HIS . . . . . 0.575 ' HD2' ' HB2' ' A' ' 252' ' ' CYS . 0.2 OUTLIER -121.9 139.57 53.48 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.165 0.986 . . . . 0.0 109.031 175.639 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -54.63 -49.39 70.62 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 124.787 1.235 . . . . 0.0 113.063 -168.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -53.49 -40.83 65.66 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 124.127 0.971 . . . . 0.0 112.107 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 252' ' ' CYS . . . . . 0.575 ' HB2' ' HD2' ' A' ' 249' ' ' HIS . 2.8 t -66.17 -32.11 73.36 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 124.34 1.056 . . . . 0.0 111.582 -175.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 29.8 m -110.48 13.36 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 123.666 0.786 . . . . 0.0 111.362 -174.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 67.4 11.65 8.49 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 124.644 1.177 . . . . 0.0 112.398 173.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 95.0 mt -84.01 157.36 21.86 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-O 121.558 0.695 . . . . 0.0 109.337 174.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 27.0 tptp -145.86 -29.97 0.41 Allowed 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.199 0.999 . . . . 0.0 108.651 174.149 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -93.59 141.44 23.86 Favored Pre-proline 0 C--O 1.245 0.84 0 C-N-CA 124.09 0.956 . . . . 0.0 108.895 177.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -65.09 124.1 12.53 Favored 'Trans proline' 0 C--N 1.373 1.824 0 C-N-CA 122.4 2.066 . . . . 0.0 111.361 177.323 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 259' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -51.01 131.11 33.87 Favored 'Trans proline' 0 C--N 1.38 2.235 0 C-N-CA 123.455 2.77 . . . . 0.0 113.743 178.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.77 -4.79 39.69 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.023 0.929 . . . . 0.0 112.866 -175.002 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -153.25 -170.39 19.41 Favored Glycine 0 N--CA 1.471 0.989 0 N-CA-C 111.149 -0.78 . . . . 0.0 111.149 176.051 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 262' ' ' THR . . . . . 0.542 ' HB ' ' HB3' ' A' ' 239' ' ' ASP . 40.8 p -65.58 106.59 1.48 Allowed 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 175.414 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 263' ' ' TRP . . . . . . . . . . . . . 49.8 t90 -74.38 137.87 43.02 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.201 0.601 . . . . 0.0 111.238 -169.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 41.1 m-85 -114.85 109.27 17.89 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.815 0.846 . . . . 0.0 109.398 -176.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 265' ' ' CYS . . . . . 0.431 ' SG ' ' OE2' ' A' ' 267' ' ' GLU . 16.0 p -72.44 162.5 73.63 Favored Pre-proline 0 CA--C 1.559 1.302 0 C-N-CA 123.563 0.745 . . . . 0.0 110.183 176.505 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_exo -36.93 -51.83 1.37 Allowed 'Trans proline' 0 C--N 1.393 2.869 0 C-N-CA 124.511 3.474 . . . . 0.0 116.45 -178.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 267' ' ' GLU . . . . . 0.431 ' OE2' ' SG ' ' A' ' 265' ' ' CYS . 0.0 OUTLIER -72.11 -18.54 61.9 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -175.28 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 268' ' ' CYS . . . . . 0.544 ' SG ' ' HA3' ' A' ' 240' ' ' GLY . 59.2 m -82.36 -44.74 15.78 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.0 0.52 . . . . 0.0 111.542 171.291 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -82.38 -45.14 15.24 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.259 -166.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 50.9 mm -76.32 -40.18 35.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 123.604 0.761 . . . . 0.0 110.552 -176.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 23.9 mm-40 . . . . . 0 C--O 1.25 1.084 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 177.713 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 30.9 p . . . . . 0 N--CA 1.476 0.855 0 CA-C-O 121.49 0.662 . . . . 0.0 110.048 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -82.89 88.76 6.8 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 178.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 224' ' ' TYR . . . . . 0.471 ' HB2' ' HB2' ' A' ' 247' ' ' TRP . 68.1 m-85 -137.71 138.16 39.07 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 178.628 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 51.3 t 170.93 162.0 0.08 Allowed 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 125.662 1.585 . . . . 0.0 108.649 172.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -62.53 -40.01 95.41 Favored 'General case' 0 CA--C 1.552 1.036 0 CA-C-N 117.992 0.36 . . . . 0.0 110.808 176.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 9.2 p -81.49 -19.88 41.34 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 122.608 0.363 . . . . 0.0 111.195 176.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 24.2 mm-40 59.07 99.69 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 124.905 1.282 . . . . 0.0 112.288 -172.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 229' ' ' ARG . . . . . 0.446 ' HD3' ' N ' ' A' ' 230' ' ' VAL . 4.6 tmt_? -163.75 152.91 14.19 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 -173.224 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . 0.446 ' N ' ' HD3' ' A' ' 229' ' ' ARG . 30.7 m -64.52 165.84 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 C-N-CA 123.991 0.916 . . . . 0.0 112.645 -177.461 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 26.0 m -139.26 71.9 1.39 Allowed 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 123.275 0.63 . . . . 0.0 109.988 -177.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 53.2 m-85 -98.67 128.9 45.11 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.667 0.787 . . . . 0.0 110.406 178.173 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 84.25 -14.71 43.49 Favored Glycine 0 CA--C 1.535 1.321 0 O-C-N 123.212 0.32 . . . . 0.0 113.376 178.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -153.38 138.54 17.4 Favored 'General case' 0 C--N 1.351 0.645 0 C-N-CA 124.459 1.103 . . . . 0.0 108.83 179.124 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 235' ' ' MET . . . . . . . . . . . . . 21.1 ptp -163.11 133.13 4.37 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.232 0.613 . . . . 0.0 109.791 176.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . 0.44 HG11 ' HB2' ' A' ' 248' ' ' PHE . 2.4 p -119.0 122.96 70.63 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 171.395 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -90.61 130.48 36.63 Favored 'General case' 0 C--O 1.239 0.507 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 174.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 238' ' ' CYS . . . . . . . . . . . . . 18.9 t -105.89 122.59 46.43 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.88 0.872 . . . . 0.0 111.106 -172.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -71.7 113.47 8.77 Favored 'General case' 0 C--N 1.352 0.715 0 C-N-CA 123.457 0.703 . . . . 0.0 110.082 176.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -143.17 144.54 13.91 Favored Glycine 0 CA--C 1.525 0.7 0 CA-C-N 114.388 -1.278 . . . . 0.0 110.551 169.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -57.53 -44.39 42.48 Favored 'Trans proline' 0 C--N 1.37 1.673 0 C-N-CA 122.531 2.154 . . . . 0.0 111.034 165.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 36.2 t30 -127.69 115.17 18.32 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 171.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 243' ' ' CYS . . . . . 0.573 ' SG ' ' HA ' ' A' ' 246' ' ' GLU . 16.2 t -151.93 97.77 2.37 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 -179.292 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -74.66 -37.94 62.59 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-O 121.279 0.561 . . . . 0.0 110.106 -179.3 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -89.83 25.46 2.06 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.742 1.217 . . . . 0.0 110.743 179.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 246' ' ' GLU . . . . . 0.573 ' HA ' ' SG ' ' A' ' 243' ' ' CYS . 8.9 pt-20 -46.65 -37.66 8.6 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 125.165 1.386 . . . . 0.0 113.744 -173.423 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 247' ' ' TRP . . . . . 0.471 ' HB2' ' HB2' ' A' ' 224' ' ' TYR . 94.0 m95 -88.5 138.54 31.34 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 122.922 0.489 . . . . 0.0 109.887 175.658 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 248' ' ' PHE . . . . . 0.44 ' HB2' HG11 ' A' ' 236' ' ' VAL . 60.1 m-85 -140.36 171.81 13.63 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.387 1.075 . . . . 0.0 109.385 175.394 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 249' ' ' HIS . . . . . 0.479 ' CD2' ' HB2' ' A' ' 252' ' ' CYS . 0.1 OUTLIER -117.7 141.27 48.58 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 173.788 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -58.69 -34.73 71.62 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 124.449 1.099 . . . . 0.0 112.821 -169.237 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -63.43 -38.97 93.21 Favored 'General case' 0 N--CA 1.479 1.02 0 O-C-N 123.854 0.721 . . . . 0.0 111.22 -177.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 252' ' ' CYS . . . . . 0.479 ' HB2' ' CD2' ' A' ' 249' ' ' HIS . 0.2 OUTLIER -66.93 -49.16 66.37 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 124.643 1.177 . . . . 0.0 110.229 -174.747 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 26.9 m -92.0 2.99 7.88 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 CA-C-N 114.222 -1.354 . . . . 0.0 111.358 -174.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 16.2 m120 60.71 24.34 14.18 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 124.802 1.241 . . . . 0.0 112.781 172.393 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . 0.444 HD13 ' HD3' ' A' ' 259' ' ' PRO . 57.2 mt -71.95 94.83 1.5 Allowed 'General case' 0 C--N 1.35 0.59 0 C-N-CA 123.482 0.713 . . . . 0.0 109.458 176.321 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . 0.633 ' HZ2' ' HB2' ' A' ' 256' ' ' LYS . 8.7 mtmp? -77.29 -21.36 53.66 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.372 170.529 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 12.2 mp0 -111.58 125.85 29.65 Favored Pre-proline 0 C--O 1.244 0.801 0 C-N-CA 124.715 1.206 . . . . 0.0 107.921 178.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -65.71 121.39 8.75 Favored 'Trans proline' 0 C--N 1.372 1.785 0 C-N-CA 122.072 1.848 . . . . 0.0 110.356 172.152 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 259' ' ' PRO . . . . . 0.444 ' HD3' HD13 ' A' ' 255' ' ' LEU . 26.9 Cg_endo -58.28 116.91 3.58 Favored 'Trans proline' 0 C--N 1.378 2.118 0 C-N-CA 122.869 2.379 . . . . 0.0 112.413 -173.06 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 260' ' ' LYS . . . . . 0.473 ' HD3' ' H ' ' A' ' 260' ' ' LYS . 0.0 OUTLIER -56.31 -28.84 60.15 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.764 1.226 . . . . 0.0 113.026 -178.159 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -138.79 -147.49 5.14 Favored Glycine 0 C--N 1.348 1.211 0 CA-C-O 120.139 -0.256 . . . . 0.0 112.634 -178.241 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 46.6 p -72.12 106.1 4.21 Favored 'General case' 0 C--O 1.242 0.709 0 C-N-CA 123.515 0.726 . . . . 0.0 110.339 -178.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 263' ' ' TRP . . . . . . . . . . . . . 78.8 t90 -85.74 118.64 25.37 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.488 1.115 . . . . 0.0 109.543 178.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -102.31 115.79 31.3 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.231 1.012 . . . . 0.0 109.655 177.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 29.1 p -67.32 166.29 22.18 Favored Pre-proline 0 N--CA 1.487 1.417 0 C-N-CA 124.603 1.161 . . . . 0.0 110.634 176.16 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -40.01 -49.66 3.59 Favored 'Trans proline' 0 C--N 1.393 2.87 0 C-N-CA 123.917 3.078 . . . . 0.0 113.801 172.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -64.39 -26.8 68.62 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.379 0.672 . . . . 0.0 111.742 -174.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 268' ' ' CYS . . . . . . . . . . . . . 61.4 m -85.58 -41.48 15.22 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 123.215 0.606 . . . . 0.0 111.053 175.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 23.1 ttpp -77.37 -33.58 55.23 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.46 0.704 . . . . 0.0 111.634 -167.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 18.9 pt -130.08 50.74 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 124.3 1.04 . . . . 0.0 109.072 178.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 . . . . . 0 CA--C 1.559 1.313 0 CA-C-N 114.476 -1.238 . . . . 0.0 111.452 178.742 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 41.1 p . . . . . 0 N--CA 1.477 0.903 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -152.44 109.94 3.59 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 -176.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 224' ' ' TYR . . . . . 0.572 ' HB2' ' HB2' ' A' ' 247' ' ' TRP . 62.8 m-85 -143.07 130.22 20.79 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 -179.433 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 49.2 t 172.78 158.1 0.11 Allowed 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.318 1.447 . . . . 0.0 108.669 171.001 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -58.22 -46.19 86.33 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 123.102 0.561 . . . . 0.0 110.807 177.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 227' ' ' CYS . . . . . 0.408 ' SG ' ' HB3' ' A' ' 229' ' ' ARG . 14.1 p -75.21 -15.1 60.57 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 122.782 0.433 . . . . 0.0 111.861 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 83.1 mm-40 57.81 90.18 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 124.409 1.084 . . . . 0.0 110.773 -172.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 229' ' ' ARG . . . . . 0.408 ' HB3' ' SG ' ' A' ' 227' ' ' CYS . 75.4 ttt180 -165.31 153.71 11.68 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.098 -171.374 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 35.4 m -73.51 171.85 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.927 0 C-N-CA 123.639 0.776 . . . . 0.0 111.648 175.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 43.4 m -112.5 126.24 55.11 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.943 0.897 . . . . 0.0 109.177 178.173 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 52.9 t80 -91.76 81.6 5.24 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 177.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 75.57 -20.31 2.25 Favored Glycine 0 N--CA 1.474 1.206 0 CA-C-N 115.44 -0.8 . . . . 0.0 114.554 179.046 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 31.9 mm-40 -108.79 99.2 8.58 Favored 'General case' 0 C--O 1.224 -0.25 0 C-N-CA 124.18 0.992 . . . . 0.0 109.781 -176.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 235' ' ' MET . . . . . . . . . . . . . 25.7 ptt? -125.32 129.56 50.2 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.008 0.523 . . . . 0.0 109.706 177.346 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 2.6 p -124.95 125.8 70.21 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 C-N-CA 123.893 0.877 . . . . 0.0 109.346 -178.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -86.37 150.07 24.58 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.333 177.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 238' ' ' CYS . . . . . 0.495 ' HB3' ' HA ' ' A' ' 246' ' ' GLU . 7.9 t -110.33 149.71 29.81 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 124.568 1.147 . . . . 0.0 109.184 -178.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -103.31 95.63 6.22 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 172.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -139.55 128.45 3.97 Favored Glycine 0 C--N 1.344 1.001 0 CA-C-O 118.937 -0.924 . . . . 0.0 111.745 177.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -66.19 -36.85 27.12 Favored 'Trans proline' 0 C--N 1.372 1.794 0 C-N-CA 122.647 2.231 . . . . 0.0 111.768 171.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 41.9 t30 -120.73 104.42 9.89 Favored 'General case' 0 C--O 1.242 0.669 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 174.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 46.6 t -173.12 114.34 0.25 Allowed 'General case' 0 N--CA 1.469 0.488 0 O-C-N 123.645 0.591 . . . . 0.0 109.811 -173.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 54.5 tptt -83.6 -28.05 28.77 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-O 121.369 0.604 . . . . 0.0 109.399 173.086 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 20.6 m-30 -90.99 28.74 1.5 Allowed 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.18 1.392 . . . . 0.0 111.957 -175.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 246' ' ' GLU . . . . . 0.495 ' HA ' ' HB3' ' A' ' 238' ' ' CYS . 6.4 mm-40 -48.28 -33.84 9.45 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 123.551 0.74 . . . . 0.0 112.829 177.554 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 247' ' ' TRP . . . . . 0.572 ' HB2' ' HB2' ' A' ' 224' ' ' TYR . 96.4 m95 -94.07 136.57 34.21 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 121.399 0.619 . . . . 0.0 110.68 173.532 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -140.36 176.37 8.83 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 125.845 1.658 . . . . 0.0 108.322 174.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 249' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -126.07 143.94 50.92 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 173.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 36.5 m-85 -58.02 -34.34 69.94 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.78 0.832 . . . . 0.0 112.49 -172.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -62.44 -36.12 81.41 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.043 0.537 . . . . 0.0 111.683 179.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 252' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -66.69 -42.56 86.28 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.97 0.908 . . . . 0.0 110.862 -177.303 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . 0.495 HG22 ' HB2' ' A' ' 255' ' ' LEU . 15.4 m -99.18 2.34 10.52 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.325 -176.109 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 4.6 t30 55.68 32.29 19.05 Favored 'General case' 0 N--CA 1.495 1.821 0 C-N-CA 124.513 1.125 . . . . 0.0 110.777 179.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . 0.495 ' HB2' HG22 ' A' ' 253' ' ' VAL . 15.7 tp -80.2 108.09 13.52 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 -178.597 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 58.5 tttm -82.77 -21.34 34.67 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.986 0.915 . . . . 0.0 111.34 -174.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -135.43 143.3 44.71 Favored Pre-proline 0 CA--C 1.542 0.641 0 C-N-CA 124.631 1.172 . . . . 0.0 109.235 -173.469 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -61.5 153.22 67.98 Favored 'Trans proline' 0 C--N 1.372 1.79 0 C-N-CA 122.648 2.232 . . . . 0.0 112.732 -177.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 259' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_exo -59.19 127.99 26.05 Favored 'Trans proline' 0 C--N 1.382 2.298 0 C-N-CA 122.794 2.329 . . . . 0.0 112.263 178.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -68.64 -37.06 79.38 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.365 0.666 . . . . 0.0 110.258 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -152.49 -126.49 1.2 Allowed Glycine 0 C--N 1.344 1.01 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.88 178.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 24.7 m -65.27 124.44 22.2 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.04 0.936 . . . . 0.0 110.457 177.467 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 263' ' ' TRP . . . . . . . . . . . . . 78.1 t90 -125.18 107.24 10.55 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.743 0.817 . . . . 0.0 109.432 -176.094 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -88.72 118.81 28.66 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.645 0.778 . . . . 0.0 109.534 174.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 12.7 p -69.47 156.56 91.43 Favored Pre-proline 0 CA--C 1.56 1.343 0 CA-C-O 117.951 -1.023 . . . . 0.0 109.301 174.376 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -19.6 -70.05 0.02 OUTLIER 'Trans proline' 0 C--N 1.394 2.931 1 C-N-CA 126.263 4.642 . . . . 0.0 117.523 -170.246 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.69 -27.28 65.81 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -172.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 268' ' ' CYS . . . . . . . . . . . . . 82.4 m -69.26 -30.89 69.11 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 123.476 0.71 . . . . 0.0 112.203 177.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -92.57 -46.27 7.7 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.296 0.639 . . . . 0.0 110.569 -177.115 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 85.5 mt -84.14 -48.08 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 123.74 0.816 . . . . 0.0 111.433 -171.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 . . . . . 0 C--O 1.255 1.378 0 CA-C-O 118.732 -0.651 . . . . 0.0 110.718 -171.684 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 9.4 t . . . . . 0 CA--C 1.548 0.889 0 N-CA-C 110.291 -0.262 . . . . 0.0 110.291 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 5.9 tt -155.01 112.98 3.44 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 174.086 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 224' ' ' TYR . . . . . 0.494 ' HB2' ' HB2' ' A' ' 247' ' ' TRP . 67.5 m-85 -141.1 133.58 28.42 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 175.111 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 44.4 t 171.45 157.46 0.08 Allowed 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 124.752 1.221 . . . . 0.0 109.419 170.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -58.27 -44.41 88.41 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.86 0.864 . . . . 0.0 111.587 -179.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 16.2 p -73.33 -13.78 61.17 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 123.12 0.568 . . . . 0.0 111.401 -179.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 84.4 mm-40 55.84 73.69 0.42 Allowed 'General case' 0 C--N 1.366 1.297 0 C-N-CA 124.678 1.191 . . . . 0.0 111.327 -173.088 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 28.2 tpt180 -151.02 151.1 31.56 Favored 'General case' 0 C--O 1.244 0.772 0 CA-C-N 114.808 -1.087 . . . . 0.0 109.129 -178.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 21.0 m -66.93 160.77 3.97 Favored 'Isoleucine or valine' 0 C--O 1.243 0.755 0 C-N-CA 123.285 0.634 . . . . 0.0 111.301 173.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 231' ' ' SER . . . . . 0.403 ' HB3' ' O ' ' A' ' 234' ' ' GLU . 45.5 m -87.54 69.33 9.76 Favored 'General case' 0 CA--C 1.549 0.937 0 CA-C-N 115.373 -0.831 . . . . 0.0 109.961 179.566 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -68.97 111.91 5.28 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.223 0.609 . . . . 0.0 111.439 -177.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 79.88 -19.25 6.52 Favored Glycine 0 CA--C 1.538 1.494 0 CA-C-N 115.801 -0.636 . . . . 0.0 114.31 172.249 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . 0.403 ' O ' ' HB3' ' A' ' 231' ' ' SER . 30.0 mt-10 -132.01 148.71 52.52 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 125.235 1.414 . . . . 0.0 107.509 -175.025 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 235' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -154.71 135.21 13.4 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-O 121.593 0.711 . . . . 0.0 111.488 175.359 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . 0.512 HG11 ' HB2' ' A' ' 248' ' ' PHE . 1.1 p -145.09 123.08 4.98 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 170.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -96.47 140.26 31.38 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 173.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 238' ' ' CYS . . . . . . . . . . . . . 37.9 t -101.63 114.31 28.24 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 123.393 0.677 . . . . 0.0 109.984 -179.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -69.96 95.39 0.93 Allowed 'General case' 0 CA--C 1.543 0.693 0 O-C-N 123.93 0.769 . . . . 0.0 109.444 178.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -142.52 116.07 1.01 Allowed Glycine 0 C--N 1.342 0.911 0 CA-C-O 118.363 -1.243 . . . . 0.0 112.15 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_exo -58.24 -31.81 94.44 Favored 'Trans proline' 0 C--N 1.379 2.136 0 C-N-CA 122.787 2.325 . . . . 0.0 111.638 173.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -115.39 86.32 2.44 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 171.137 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 7.7 t -161.38 91.03 0.83 Allowed 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.497 0.719 . . . . 0.0 109.704 -178.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 244' ' ' LYS . . . . . 0.472 ' HZ1' ' HB2' ' A' ' 244' ' ' LYS . 0.0 OUTLIER -66.76 -44.93 80.11 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 122.975 0.51 . . . . 0.0 110.026 173.463 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . 0.487 ' HA ' ' HB3' ' A' ' 224' ' ' TYR . 96.5 m-85 -81.14 22.61 0.64 Allowed 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 124.669 1.187 . . . . 0.0 112.715 -176.388 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -52.36 -32.94 40.83 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 125.023 1.329 . . . . 0.0 114.202 -172.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 247' ' ' TRP . . . . . 0.494 ' HB2' ' HB2' ' A' ' 224' ' ' TYR . 39.3 m95 -75.08 130.36 39.15 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-O 121.331 0.586 . . . . 0.0 110.447 176.282 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 248' ' ' PHE . . . . . 0.512 ' HB2' HG11 ' A' ' 236' ' ' VAL . 98.5 m-85 -141.43 171.31 14.23 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.312 1.045 . . . . 0.0 109.746 177.844 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 249' ' ' HIS . . . . . 0.443 ' HD2' ' HB2' ' A' ' 252' ' ' CYS . 0.0 OUTLIER -134.68 145.64 48.72 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 176.745 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . 0.456 ' HB3' ' O ' ' A' ' 255' ' ' LEU . 21.1 m-30 -53.88 -55.98 21.83 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 124.213 1.005 . . . . 0.0 113.303 -166.325 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -60.86 -34.17 74.19 Favored 'General case' 0 N--CA 1.496 1.839 0 C-N-CA 123.311 0.644 . . . . 0.0 111.733 -174.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 252' ' ' CYS . . . . . 0.443 ' HB2' ' HD2' ' A' ' 249' ' ' HIS . 11.3 t -68.45 -32.25 72.14 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 124.162 0.985 . . . . 0.0 111.631 -175.425 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . 0.471 HG21 ' HG ' ' A' ' 255' ' ' LEU . 16.3 m -108.76 6.23 9.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 C-N-CA 124.04 0.936 . . . . 0.0 110.735 175.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 18.4 m120 64.32 24.84 13.37 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 125.574 1.549 . . . . 0.0 113.359 173.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . 0.471 ' HG ' HG21 ' A' ' 253' ' ' VAL . 96.5 mt -70.94 121.32 17.92 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 166.331 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 36.4 mtmm -96.55 15.73 20.77 Favored 'General case' 0 N--CA 1.485 1.276 0 CA-C-O 120.805 0.336 . . . . 0.0 110.661 175.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -164.3 163.41 15.07 Favored Pre-proline 0 CA--C 1.554 1.106 0 C-N-CA 124.131 0.972 . . . . 0.0 109.047 -172.432 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -69.41 160.14 50.96 Favored 'Trans proline' 0 C--N 1.374 1.879 0 C-N-CA 122.488 2.125 . . . . 0.0 112.607 175.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 259' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -59.61 156.88 34.7 Favored 'Trans proline' 0 C--N 1.377 2.063 0 C-N-CA 122.95 2.433 . . . . 0.0 112.783 171.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -103.73 31.07 4.65 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.703 0.801 . . . . 0.0 109.713 -179.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 136.81 -141.03 11.96 Favored Glycine 0 C--N 1.339 0.749 0 N-CA-C 110.313 -1.115 . . . . 0.0 110.313 -174.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 40.0 p -72.98 114.67 11.39 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 122.948 0.499 . . . . 0.0 109.821 178.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 263' ' ' TRP . . . . . . . . . . . . . 47.1 t90 -90.82 136.81 32.82 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.438 0.695 . . . . 0.0 109.856 -176.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -124.11 115.72 21.59 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.364 0.665 . . . . 0.0 110.688 -177.37 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 265' ' ' CYS . . . . . 0.51 ' SG ' ' HB2' ' A' ' 267' ' ' GLU . 19.1 p -70.75 160.08 83.13 Favored Pre-proline 0 N--CA 1.484 1.231 0 C-N-CA 124.308 1.043 . . . . 0.0 109.658 172.63 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 99.9 Cg_exo -47.29 -27.06 6.32 Favored 'Trans proline' 0 C--N 1.388 2.639 0 C-N-CA 123.825 3.017 . . . . 0.0 115.696 177.198 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 267' ' ' GLU . . . . . 0.51 ' HB2' ' SG ' ' A' ' 265' ' ' CYS . 39.6 mt-10 -59.4 -49.45 77.75 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 123.962 0.905 . . . . 0.0 110.581 174.296 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 268' ' ' CYS . . . . . . . . . . . . . 76.4 m -85.07 -30.86 23.74 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.268 1.027 . . . . 0.0 111.712 -177.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 65.2 tttm -85.49 -51.63 6.39 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.867 -168.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 45.2 mt -97.8 -52.07 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 C-N-CA 123.1 0.56 . . . . 0.0 110.952 -176.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 . . . . . 0 CA--C 1.554 1.106 0 C-N-CA 123.177 0.591 . . . . 0.0 110.595 -171.721 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 13.2 p . . . . . 0 N--CA 1.476 0.864 0 CA-C-O 120.748 0.308 . . . . 0.0 110.564 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 5.9 tt -99.59 90.53 4.52 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 178.135 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 224' ' ' TYR . . . . . 0.517 ' HB2' ' HB2' ' A' ' 247' ' ' TRP . 71.0 m-85 -135.28 133.21 38.67 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 176.69 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 36.9 t 175.13 166.67 0.3 Allowed 'General case' 0 N--CA 1.474 0.747 0 O-C-N 124.643 1.214 . . . . 0.0 109.562 175.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 32.9 t80 -73.05 -33.46 65.69 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 177.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 9.4 p -82.18 -11.39 58.74 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 122.84 0.456 . . . . 0.0 111.04 173.048 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 82.2 mm-40 56.46 89.38 0.04 OUTLIER 'General case' 0 C--N 1.361 1.08 0 C-N-CA 125.348 1.459 . . . . 0.0 111.249 -174.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 -153.41 149.04 27.37 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.87 -176.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 34.2 m -66.28 148.49 12.05 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.823 0 C-N-CA 123.7 0.8 . . . . 0.0 110.952 174.291 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 35.9 m -107.43 120.66 42.78 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 175.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 31.4 p90 -141.92 125.92 17.25 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.555 0.742 . . . . 0.0 109.822 -174.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 78.09 -14.69 10.32 Favored Glycine 0 C--N 1.354 1.533 0 CA-C-N 116.334 -0.394 . . . . 0.0 113.138 -174.088 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -154.88 101.33 2.27 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.543 1.137 . . . . 0.0 108.165 -176.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 235' ' ' MET . . . . . . . . . . . . . 54.1 mtp -128.25 113.33 15.53 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 -178.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 6.8 p -108.34 125.32 65.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 175.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -99.7 168.54 9.86 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.727 0.811 . . . . 0.0 110.519 179.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 238' ' ' CYS . . . . . . . . . . . . . 26.9 t -144.29 123.25 12.77 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 122.668 0.387 . . . . 0.0 111.51 -177.344 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -79.22 105.38 10.51 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.376 0.67 . . . . 0.0 109.981 174.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -142.16 141.22 10.65 Favored Glycine 0 C--N 1.341 0.813 0 CA-C-O 118.558 -1.134 . . . . 0.0 111.285 175.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -60.09 -52.9 3.58 Favored 'Trans proline' 0 C--N 1.379 2.183 0 C-N-CA 122.758 2.306 . . . . 0.0 110.757 176.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -106.55 129.04 54.56 Favored 'General case' 0 C--O 1.242 0.675 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 163.166 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 243' ' ' CYS . . . . . 0.452 ' SG ' ' HA ' ' A' ' 246' ' ' GLU . 26.5 t -173.13 89.42 0.08 Allowed 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 -174.382 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 244' ' ' LYS . . . . . 0.562 ' HZ2' ' HB2' ' A' ' 244' ' ' LYS . 0.1 OUTLIER -84.1 -24.29 30.4 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 122.893 0.477 . . . . 0.0 110.603 179.631 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 53.1 m-85 -101.32 26.88 6.69 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.321 1.049 . . . . 0.0 110.367 177.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 246' ' ' GLU . . . . . 0.452 ' HA ' ' SG ' ' A' ' 243' ' ' CYS . 8.5 pt-20 -48.66 -34.92 12.72 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 124.41 1.084 . . . . 0.0 112.579 176.653 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 247' ' ' TRP . . . . . 0.517 ' HB2' ' HB2' ' A' ' 224' ' ' TYR . 94.5 m95 -96.07 136.4 36.57 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 121.379 0.609 . . . . 0.0 111.133 176.609 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -144.71 173.44 11.83 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 125.196 1.398 . . . . 0.0 108.521 171.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 249' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -113.04 138.23 50.21 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 170.655 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -55.49 -32.86 63.19 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 124.181 0.992 . . . . 0.0 112.157 -173.385 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -56.47 -45.06 81.09 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 125.007 1.323 . . . . 0.0 112.455 178.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 252' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -68.04 -51.29 48.55 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.226 1.011 . . . . 0.0 110.984 -175.472 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 22.3 m -81.7 -9.95 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 CA-C-N 115.223 -0.898 . . . . 0.0 111.963 -178.242 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 17.5 m120 59.84 41.67 17.67 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.857 1.263 . . . . 0.0 110.795 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 34.7 tp -90.9 108.04 19.58 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 178.119 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -70.23 -44.81 67.81 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 122.986 0.515 . . . . 0.0 110.758 -178.205 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -133.53 130.97 21.14 Favored Pre-proline 0 C--O 1.24 0.567 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 -178.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -56.95 141.96 93.57 Favored 'Trans proline' 0 C--N 1.371 1.763 0 C-N-CA 122.257 1.972 . . . . 0.0 110.707 171.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 259' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -68.14 -178.94 1.94 Allowed 'Trans proline' 0 C--N 1.37 1.678 0 C-N-CA 123.06 2.507 . . . . 0.0 113.018 -169.02 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 27.7 mmmt -74.75 -3.6 32.55 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 116.068 -0.514 . . . . 0.0 112.383 -174.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -154.43 -143.92 3.79 Favored Glycine 0 C--N 1.338 0.689 0 N-CA-C 111.502 -0.639 . . . . 0.0 111.502 174.028 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 43.5 p -69.68 116.83 10.54 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 123.693 0.797 . . . . 0.0 110.607 -177.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 263' ' ' TRP . . . . . . . . . . . . . 37.9 t90 -66.41 135.69 54.66 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 122.965 0.506 . . . . 0.0 110.266 178.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 264' ' ' TYR . . . . . 0.413 ' HB3' ' HB3' ' A' ' 269' ' ' LYS . 39.6 m-85 -118.44 110.6 17.63 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.433 0.693 . . . . 0.0 109.768 -177.69 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 265' ' ' CYS . . . . . 0.412 ' SG ' ' HB2' ' A' ' 267' ' ' GLU . 14.8 p -67.25 162.77 52.16 Favored Pre-proline 0 CA--C 1.554 1.122 0 C-N-CA 124.128 0.971 . . . . 0.0 109.65 172.1 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -53.57 -24.51 29.31 Favored 'Trans proline' 0 C--N 1.385 2.452 0 C-N-CA 123.374 2.716 . . . . 0.0 114.594 -178.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 267' ' ' GLU . . . . . 0.412 ' HB2' ' SG ' ' A' ' 265' ' ' CYS . 33.7 mt-10 -57.38 -54.79 42.79 Favored 'General case' 0 N--CA 1.483 1.187 0 CA-C-O 121.488 0.661 . . . . 0.0 110.326 173.432 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 268' ' ' CYS . . . . . . . . . . . . . 57.9 m -86.75 -39.28 16.12 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 114.606 -1.179 . . . . 0.0 112.709 -168.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . 0.413 ' HB3' ' HB3' ' A' ' 264' ' ' TYR . 12.5 ptmm? -75.66 -28.87 58.88 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-O 120.654 0.264 . . . . 0.0 111.703 -169.612 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 61.8 mt -92.2 -50.7 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 177.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 . . . . . 0 CA--C 1.554 1.117 0 C-N-CA 123.456 0.703 . . . . 0.0 109.209 179.234 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 33.6 p . . . . . 0 C--O 1.244 0.812 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 57.0 tp -74.96 94.41 2.83 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.15 0.58 . . . . 0.0 109.929 -179.178 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 224' ' ' TYR . . . . . 0.566 ' HB3' ' HA ' ' A' ' 245' ' ' TYR . 77.3 m-85 -135.49 134.33 39.43 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 172.551 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 49.3 t 172.84 161.62 0.12 Allowed 'General case' 0 N--CA 1.474 0.769 0 O-C-N 124.823 1.327 . . . . 0.0 108.284 171.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -67.09 -32.63 73.92 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 122.08 0.152 . . . . 0.0 110.965 177.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 13.1 p -85.52 -17.43 36.4 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 122.706 0.402 . . . . 0.0 111.288 177.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 20.4 mm-40 52.92 77.6 0.16 Allowed 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 124.645 1.178 . . . . 0.0 111.907 -172.233 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 4.6 tmt_? -151.32 154.57 36.99 Favored 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 -178.601 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 23.1 m -73.1 156.25 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 CA-C-O 121.394 0.616 . . . . 0.0 112.59 -173.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 17.3 m -95.91 104.48 16.41 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.864 0.866 . . . . 0.0 108.771 172.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -74.14 79.32 1.76 Allowed 'General case' 0 N--CA 1.479 1.009 0 CA-C-O 121.508 0.67 . . . . 0.0 110.24 -179.158 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 74.68 -18.17 2.42 Favored Glycine 0 CA--C 1.539 1.568 0 N-CA-C 115.331 0.893 . . . . 0.0 115.331 177.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -113.28 110.52 20.51 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.829 0.852 . . . . 0.0 109.335 -175.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 235' ' ' MET . . . . . . . . . . . . . 55.1 mtm -126.01 102.23 7.16 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.094 0.958 . . . . 0.0 109.679 -172.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 3.9 p -87.98 123.34 40.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 168.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -92.79 155.02 17.93 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 123.083 0.553 . . . . 0.0 109.92 -178.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 238' ' ' CYS . . . . . 0.616 ' HB3' ' HA ' ' A' ' 246' ' ' GLU . 42.1 t -116.23 152.12 34.4 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 115.126 -0.943 . . . . 0.0 108.87 176.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -119.92 99.22 6.49 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 171.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . 0.586 ' HA3' ' SG ' ' A' ' 268' ' ' CYS . . . -139.99 129.52 4.3 Favored Glycine 0 C--N 1.34 0.785 0 CA-C-O 118.124 -1.375 . . . . 0.0 111.004 176.763 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -48.89 -49.56 14.78 Favored 'Trans proline' 0 C--N 1.382 2.325 0 C-N-CA 123.666 2.91 . . . . 0.0 113.752 -177.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -111.19 101.87 10.34 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 171.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 43.9 t -172.86 106.62 0.16 Allowed 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 -173.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 9.3 ptpp? -86.78 -24.57 25.01 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 173.332 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . 0.566 ' HA ' ' HB3' ' A' ' 224' ' ' TYR . 22.7 m-85 -81.12 23.69 0.56 Allowed 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.403 1.081 . . . . 0.0 112.225 -177.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 246' ' ' GLU . . . . . 0.616 ' HA ' ' HB3' ' A' ' 238' ' ' CYS . 5.9 mm-40 -48.9 -37.51 19.96 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 123.641 0.776 . . . . 0.0 111.35 178.556 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 247' ' ' TRP . . . . . 0.486 ' HB2' ' HB2' ' A' ' 224' ' ' TYR . 98.4 m95 -76.45 115.85 16.58 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.505 174.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -130.18 173.35 10.85 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.652 1.181 . . . . 0.0 109.371 171.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 249' ' ' HIS . . . . . 0.553 ' HD2' ' HB2' ' A' ' 252' ' ' CYS . 0.1 OUTLIER -126.01 142.0 51.71 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.454 1.101 . . . . 0.0 108.508 178.232 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 -60.58 -34.83 74.77 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 124.489 1.116 . . . . 0.0 113.493 -168.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -67.52 -35.74 79.68 Favored 'General case' 0 N--CA 1.485 1.293 0 CA-C-O 121.537 0.684 . . . . 0.0 110.998 -178.147 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 252' ' ' CYS . . . . . 0.553 ' HB2' ' HD2' ' A' ' 249' ' ' HIS . 9.0 t -71.68 -41.06 69.14 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 125.024 1.33 . . . . 0.0 110.852 -175.454 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 27.9 m -93.16 -2.02 10.63 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.859 0 CA-C-N 114.481 -1.236 . . . . 0.0 110.957 179.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 33.5 m-80 62.69 24.89 14.81 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 124.803 1.241 . . . . 0.0 112.524 175.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 81.0 mt -80.58 119.64 23.49 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 173.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 14.3 tppt? -81.06 -25.34 37.17 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.425 0.69 . . . . 0.0 110.51 179.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -136.35 162.56 55.67 Favored Pre-proline 0 CA--C 1.55 0.949 0 C-N-CA 124.319 1.047 . . . . 0.0 109.552 -178.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -56.31 136.06 73.43 Favored 'Trans proline' 0 C--N 1.38 2.196 0 C-N-CA 122.435 2.09 . . . . 0.0 111.532 170.329 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 259' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -58.73 156.07 34.39 Favored 'Trans proline' 0 C--N 1.375 1.97 0 C-N-CA 123.289 2.659 . . . . 0.0 113.076 -176.528 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -66.38 -20.72 66.15 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.833 0.853 . . . . 0.0 112.764 -173.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -165.57 -141.94 3.28 Favored Glycine 0 C--N 1.347 1.145 0 CA-C-O 119.752 -0.471 . . . . 0.0 112.176 179.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 25.4 m -65.32 107.25 1.56 Allowed 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.638 0.775 . . . . 0.0 109.819 178.392 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 263' ' ' TRP . . . . . . . . . . . . . 53.8 t90 -88.58 114.12 24.87 Favored 'General case' 0 C--O 1.242 0.679 0 C-N-CA 123.285 0.634 . . . . 0.0 110.316 -175.613 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -96.64 118.84 33.97 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 123.93 0.892 . . . . 0.0 108.599 171.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 17.9 p -64.04 159.68 53.92 Favored Pre-proline 0 CA--C 1.555 1.164 0 C-N-CA 123.508 0.723 . . . . 0.0 110.122 172.162 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -50.91 -33.87 43.43 Favored 'Trans proline' 0 C--N 1.382 2.315 0 C-N-CA 123.202 2.601 . . . . 0.0 113.714 -178.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -59.18 -43.19 92.18 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-O 121.043 0.449 . . . . 0.0 111.242 177.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 268' ' ' CYS . . . . . 0.586 ' SG ' ' HA3' ' A' ' 240' ' ' GLY . 67.2 m -72.64 -27.92 62.43 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.087 0.955 . . . . 0.0 112.563 -177.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 49.1 mtmt -88.07 -41.56 12.98 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 122.84 0.456 . . . . 0.0 111.337 -175.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 16.8 mt -102.3 15.7 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 C-N-CA 123.283 0.633 . . . . 0.0 110.583 -168.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 . . . . . 0 CA--C 1.565 1.552 0 C-N-CA 122.651 0.38 . . . . 0.0 110.951 175.188 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 23.0 p . . . . . 0 N--CA 1.478 0.95 0 CA-C-O 121.116 0.484 . . . . 0.0 109.81 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 35.8 tp -89.77 79.82 6.65 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 176.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 224' ' ' TYR . . . . . 0.491 ' HB3' ' HA ' ' A' ' 245' ' ' TYR . 74.1 m-85 -138.09 125.95 22.52 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 175.591 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 34.4 t 174.54 161.85 0.2 Allowed 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.959 0.904 . . . . 0.0 109.203 173.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -69.24 -34.92 75.56 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 122.347 0.259 . . . . 0.0 110.458 175.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 3.9 p -83.47 -14.59 52.13 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.105 175.249 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 22.6 mm-40 53.87 101.09 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 125.601 1.56 . . . . 0.0 112.713 -172.233 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 22.8 tpp180 -162.97 157.97 21.68 Favored 'General case' 0 C--O 1.244 0.801 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 -178.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 19.5 m -71.4 154.21 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 CA-C-O 120.828 0.347 . . . . 0.0 111.173 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 17.1 m -116.86 60.57 0.74 Allowed 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 123.568 0.747 . . . . 0.0 109.422 -179.233 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 79.8 t80 -71.84 108.69 5.26 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.143 0.577 . . . . 0.0 111.769 -172.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 85.18 -18.22 29.03 Favored Glycine 0 N--CA 1.472 1.089 0 CA-C-N 115.6 -0.727 . . . . 0.0 114.156 174.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -131.51 94.57 3.56 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 124.257 1.023 . . . . 0.0 108.62 -177.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 235' ' ' MET . . . . . 0.409 ' HB3' ' CE3' ' A' ' 247' ' ' TRP . 63.3 mtm -122.03 100.75 7.14 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.8 0.84 . . . . 0.0 109.062 -179.366 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 4.8 p -87.8 124.83 41.26 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 170.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -88.65 130.53 35.27 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.539 0.736 . . . . 0.0 109.892 -178.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 238' ' ' CYS . . . . . 0.508 ' HB3' ' HA ' ' A' ' 246' ' ' GLU . 36.2 t -99.65 152.29 20.24 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.069 0.947 . . . . 0.0 109.398 175.239 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -127.23 108.23 10.7 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.933 0.893 . . . . 0.0 108.667 172.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -139.97 160.57 26.25 Favored Glycine 0 N--CA 1.473 1.144 0 CA-C-O 119.224 -0.765 . . . . 0.0 111.829 174.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -69.77 -35.31 12.85 Favored 'Trans proline' 0 C--N 1.375 1.973 0 C-N-CA 122.285 1.99 . . . . 0.0 112.156 174.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -128.48 110.19 12.08 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.896 0.879 . . . . 0.0 108.776 176.329 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 29.7 t -177.39 104.76 0.05 Allowed 'General case' 0 C--N 1.347 0.476 0 C-N-CA 123.56 0.744 . . . . 0.0 109.502 -175.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 16.8 tppt? -76.71 -30.6 56.73 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-O 121.548 0.69 . . . . 0.0 110.169 171.496 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . 0.491 ' HA ' ' HB3' ' A' ' 224' ' ' TYR . 15.5 m-85 -87.55 23.76 1.85 Allowed 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.42 1.088 . . . . 0.0 112.537 -168.347 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 246' ' ' GLU . . . . . 0.508 ' HA ' ' HB3' ' A' ' 238' ' ' CYS . 5.9 mm-40 -46.94 -45.07 20.49 Favored 'General case' 0 N--CA 1.499 2.001 0 C-N-CA 124.187 0.995 . . . . 0.0 112.481 -172.145 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 247' ' ' TRP . . . . . 0.409 ' CE3' ' HB3' ' A' ' 235' ' ' MET . 97.1 m95 -77.56 117.11 18.68 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 122.851 0.461 . . . . 0.0 110.056 173.665 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -122.18 159.26 27.61 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.93 0.892 . . . . 0.0 110.515 175.55 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 249' ' ' HIS . . . . . 0.498 ' CD2' ' HB2' ' A' ' 252' ' ' CYS . 0.7 OUTLIER -93.29 129.88 39.22 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 114.792 -1.094 . . . . 0.0 108.386 167.821 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 48.1 m-85 -52.91 -38.24 61.58 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 124.724 1.21 . . . . 0.0 112.272 -175.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -57.13 -34.79 68.75 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 124.79 1.236 . . . . 0.0 112.498 -177.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 252' ' ' CYS . . . . . 0.498 ' HB2' ' CD2' ' A' ' 249' ' ' HIS . 0.5 OUTLIER -65.63 -56.27 13.1 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 124.032 0.933 . . . . 0.0 110.585 -177.488 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . 0.486 HG23 ' HB2' ' A' ' 255' ' ' LEU . 20.7 m -82.85 -1.54 5.78 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.879 0 CA-C-N 114.595 -1.184 . . . . 0.0 111.314 -176.75 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 9.9 t30 61.13 31.37 19.67 Favored 'General case' 0 C--N 1.365 1.267 0 C-N-CA 124.662 1.185 . . . . 0.0 110.393 179.543 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . 0.516 HD23 ' HG3' ' A' ' 259' ' ' PRO . 16.4 tp -76.45 89.66 3.24 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 177.543 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -71.42 -20.32 62.13 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 115.114 -0.948 . . . . 0.0 111.893 -172.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -139.19 152.95 70.74 Favored Pre-proline 0 CA--C 1.552 1.021 0 C-N-CA 124.509 1.123 . . . . 0.0 109.581 -177.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -59.14 148.51 85.35 Favored 'Trans proline' 0 C--N 1.381 2.274 0 C-N-CA 123.249 2.633 . . . . 0.0 113.663 179.31 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 259' ' ' PRO . . . . . 0.516 ' HG3' HD23 ' A' ' 255' ' ' LEU . 14.3 Cg_exo -68.9 146.31 65.09 Favored 'Trans proline' 0 C--N 1.38 2.205 0 C-N-CA 122.963 2.442 . . . . 0.0 111.987 172.206 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 57.6 mttp -86.31 -28.01 23.97 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.661 0.784 . . . . 0.0 110.876 -178.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -137.1 -150.27 5.74 Favored Glycine 0 C--N 1.345 1.082 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.849 -179.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 25.8 m -71.04 116.87 11.83 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 123.447 0.699 . . . . 0.0 110.511 -177.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 263' ' ' TRP . . . . . . . . . . . . . 27.9 t90 -91.26 114.93 27.59 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.965 0.906 . . . . 0.0 110.207 -175.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -100.64 117.69 35.27 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 170.137 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 265' ' ' CYS . . . . . 0.41 ' SG ' ' OE2' ' A' ' 267' ' ' GLU . 14.4 p -70.92 161.82 75.67 Favored Pre-proline 0 CA--C 1.56 1.328 0 CA-C-O 117.77 -1.11 . . . . 0.0 109.773 176.35 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_exo -27.25 -69.62 0.04 OUTLIER 'Trans proline' 0 C--N 1.397 3.09 1 C-N-CA 125.402 4.068 . . . . 0.0 116.742 -173.673 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 267' ' ' GLU . . . . . 0.41 ' OE2' ' SG ' ' A' ' 265' ' ' CYS . 0.0 OUTLIER -63.81 -26.15 68.5 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -173.794 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 268' ' ' CYS . . . . . . . . . . . . . 97.3 m -72.17 -47.45 50.73 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 123.113 0.565 . . . . 0.0 112.013 176.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 12.2 ptmm? -77.05 -23.66 52.01 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.987 -173.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 86.1 mt -88.39 -43.35 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 123.761 0.824 . . . . 0.0 110.206 178.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 . . . . . 0 C--O 1.257 1.449 0 C-N-CA 123.596 0.759 . . . . 0.0 109.564 -174.874 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 23.2 p . . . . . 0 N--CA 1.477 0.923 0 CA-C-O 120.774 0.321 . . . . 0.0 110.458 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 53.7 tp -94.86 93.81 7.67 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.003 0.921 . . . . 0.0 110.056 -177.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 224' ' ' TYR . . . . . 0.428 ' HB3' ' HA ' ' A' ' 245' ' ' TYR . 66.5 m-85 -135.58 124.09 23.54 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.456 0.702 . . . . 0.0 109.279 172.747 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 36.8 t 172.01 158.69 0.1 Allowed 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 125.208 1.403 . . . . 0.0 109.349 172.033 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 77.5 t80 -66.99 -41.78 86.17 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 117.942 0.337 . . . . 0.0 110.919 177.049 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 6.3 p -72.48 -10.74 60.17 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 122.504 0.321 . . . . 0.0 110.43 176.319 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 82.4 mm-40 53.88 88.8 0.03 OUTLIER 'General case' 0 C--N 1.368 1.388 0 C-N-CA 124.823 1.249 . . . . 0.0 110.78 -173.073 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 2.4 tpm_? -153.32 146.11 24.35 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-N 114.721 -1.127 . . . . 0.0 108.389 -177.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 34.9 m -83.92 149.13 4.56 Favored 'Isoleucine or valine' 0 C--O 1.24 0.587 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 175.306 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 21.4 m -84.73 88.12 7.35 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.324 0.65 . . . . 0.0 110.104 -178.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -74.41 88.85 2.1 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.668 0.787 . . . . 0.0 110.625 -176.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 78.44 -19.39 4.81 Favored Glycine 0 CA--C 1.535 1.327 0 CA-C-N 115.112 -0.949 . . . . 0.0 114.614 177.087 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -116.26 94.39 4.62 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.035 0.934 . . . . 0.0 108.773 179.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 235' ' ' MET . . . . . . . . . . . . . 20.4 ptt? -120.03 108.98 14.95 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.957 0.903 . . . . 0.0 110.515 -176.186 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 7.5 p -100.22 125.72 53.91 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 169.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -101.4 138.16 38.78 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.553 0.741 . . . . 0.0 110.795 -172.131 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 238' ' ' CYS . . . . . 0.703 ' HB3' ' HA ' ' A' ' 246' ' ' GLU . 34.9 t -95.93 152.29 18.64 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 123.768 0.827 . . . . 0.0 109.055 173.606 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 239' ' ' ASP . . . . . 0.42 ' HB3' ' HB ' ' A' ' 262' ' ' THR . 31.3 t70 -125.96 104.85 8.51 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 175.442 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -138.43 147.94 19.58 Favored Glycine 0 C--N 1.337 0.607 0 CA-C-O 118.859 -0.967 . . . . 0.0 111.245 177.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -66.52 -34.28 34.03 Favored 'Trans proline' 0 C--N 1.372 1.788 0 C-N-CA 122.64 2.226 . . . . 0.0 112.368 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -135.98 94.91 3.12 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 176.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 45.1 t -163.93 110.88 1.11 Allowed 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.972 0.909 . . . . 0.0 109.003 -173.381 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 244' ' ' LYS . . . . . 0.462 ' H ' ' HD3' ' A' ' 244' ' ' LYS . 0.1 OUTLIER -82.92 -31.64 27.66 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.18 0.592 . . . . 0.0 110.876 175.991 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . 0.428 ' HA ' ' HB3' ' A' ' 224' ' ' TYR . 71.5 m-85 -79.54 28.68 0.25 Allowed 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 124.543 1.137 . . . . 0.0 113.208 -178.622 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 246' ' ' GLU . . . . . 0.703 ' HA ' ' HB3' ' A' ' 238' ' ' CYS . 5.7 mm-40 -48.91 -48.35 42.65 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.27 0.628 . . . . 0.0 112.276 178.007 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 247' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -78.69 130.83 36.27 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 121.186 0.517 . . . . 0.0 112.103 -176.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -143.73 172.43 12.84 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.192 1.397 . . . . 0.0 109.953 174.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 249' ' ' HIS . . . . . 0.436 ' HD2' ' HB2' ' A' ' 252' ' ' CYS . 0.0 OUTLIER -120.36 140.75 50.85 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.559 1.144 . . . . 0.0 108.499 179.329 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . 0.422 ' HB3' ' O ' ' A' ' 255' ' ' LEU . 49.0 m-85 -54.8 -54.38 42.89 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.855 1.262 . . . . 0.0 113.285 -167.292 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -59.8 -34.41 73.0 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 123.262 0.625 . . . . 0.0 112.174 -175.234 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 252' ' ' CYS . . . . . 0.436 ' HB2' ' HD2' ' A' ' 249' ' ' HIS . 7.3 t -67.0 -43.28 83.34 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.037 0.935 . . . . 0.0 111.195 -177.309 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 9.2 m -93.17 14.76 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.175 0 C-N-CA 123.788 0.835 . . . . 0.0 111.315 177.006 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 6.4 t30 67.48 7.87 5.9 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 125.103 1.361 . . . . 0.0 112.524 172.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . 0.422 ' O ' ' HB3' ' A' ' 250' ' ' TYR . 87.9 mt -74.43 104.15 5.05 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.048 0.539 . . . . 0.0 110.732 -179.004 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 52.3 tttm -63.73 -36.87 85.28 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.237 1.015 . . . . 0.0 110.303 169.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -142.96 149.61 49.98 Favored Pre-proline 0 CA--C 1.549 0.936 0 CA-C-N 114.676 -1.147 . . . . 0.0 109.777 -170.258 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 258' ' ' PRO . . . . . 0.451 ' HA ' ' HD3' ' A' ' 259' ' ' PRO . 33.6 Cg_endo -62.51 138.14 68.74 Favored 'Trans proline' 0 C--N 1.38 2.23 0 C-N-CA 122.864 2.376 . . . . 0.0 113.1 -175.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 259' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 258' ' ' PRO . 17.3 Cg_exo -69.6 137.81 36.82 Favored 'Trans proline' 0 C--N 1.372 1.779 0 C-N-CA 123.261 2.641 . . . . 0.0 111.917 177.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -73.21 96.99 2.33 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 123.505 0.722 . . . . 0.0 109.931 -175.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 117.65 -168.8 13.05 Favored Glycine 0 N--CA 1.472 1.063 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.83 178.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 262' ' ' THR . . . . . 0.42 ' HB ' ' HB3' ' A' ' 239' ' ' ASP . 32.5 p -66.34 107.01 1.86 Allowed 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.08 0.552 . . . . 0.0 109.879 173.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 263' ' ' TRP . . . . . . . . . . . . . 32.0 t90 -70.11 140.2 52.65 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 122.853 0.461 . . . . 0.0 110.139 -179.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -113.2 118.66 35.32 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 172.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 20.4 p -57.35 150.59 42.4 Favored Pre-proline 0 N--CA 1.478 0.952 0 CA-C-O 118.543 -0.741 . . . . 0.0 109.489 172.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_exo -45.57 -32.34 8.24 Favored 'Trans proline' 0 C--N 1.386 2.538 0 C-N-CA 123.407 2.738 . . . . 0.0 114.307 -173.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -65.39 -50.04 67.0 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 123.82 0.848 . . . . 0.0 110.822 -179.567 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 268' ' ' CYS . . . . . . . . . . . . . 43.9 m -59.83 -45.88 91.02 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 123.121 0.568 . . . . 0.0 112.306 -179.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . 0.567 ' HD3' HG13 ' A' ' 270' ' ' ILE . 0.1 OUTLIER -81.25 -14.53 57.34 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -171.825 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 270' ' ' ILE . . . . . 0.567 HG13 ' HD3' ' A' ' 269' ' ' LYS . 78.5 mt -92.84 -23.11 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 C-N-CA 123.211 0.604 . . . . 0.0 110.057 172.382 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 . . . . . 0 CA--C 1.559 1.322 0 CA-C-O 118.65 -0.69 . . . . 0.0 110.497 178.438 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 15.3 p . . . . . 0 N--CA 1.474 0.759 0 CA-C-O 121.027 0.441 . . . . 0.0 110.37 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 53.3 tp -80.94 82.56 6.88 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 176.35 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 224' ' ' TYR . . . . . 0.514 ' HB2' ' HB2' ' A' ' 247' ' ' TRP . 69.3 m-85 -133.34 125.46 29.24 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 177.259 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 40.8 t 171.3 154.19 0.07 Allowed 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 125.86 1.664 . . . . 0.0 107.734 173.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -61.62 -43.26 99.2 Favored 'General case' 0 CA--C 1.549 0.914 0 CA-C-N 117.872 0.305 . . . . 0.0 110.861 177.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 6.2 p -68.67 -17.07 64.02 Favored 'General case' 0 N--CA 1.483 1.177 0 O-C-N 123.321 0.388 . . . . 0.0 111.035 177.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 81.3 mm-40 58.81 83.89 0.12 Allowed 'General case' 0 C--N 1.365 1.262 0 C-N-CA 124.581 1.152 . . . . 0.0 110.753 -174.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 14.6 tpt180 -150.24 154.52 38.09 Favored 'General case' 0 C--O 1.243 0.727 0 C-N-CA 124.077 0.951 . . . . 0.0 108.532 179.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 27.0 m -81.78 177.37 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 CA-C-O 121.488 0.661 . . . . 0.0 110.78 172.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 22.2 p -96.64 153.22 17.98 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.897 171.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 40.8 t80 -84.83 1.53 46.54 Favored 'General case' 0 CA--C 1.56 1.334 0 C-N-CA 123.651 0.78 . . . . 0.0 110.002 168.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 135.6 -19.18 3.8 Favored Glycine 0 C--N 1.347 1.147 0 C-N-CA 124.006 0.812 . . . . 0.0 111.387 -179.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.41 123.14 35.51 Favored 'General case' 0 CA--C 1.555 1.136 0 C-N-CA 122.901 0.48 . . . . 0.0 110.017 -178.411 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 235' ' ' MET . . . . . . . . . . . . . 7.9 mmt -144.57 119.89 10.23 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.329 0.652 . . . . 0.0 110.391 -177.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 3.7 p -98.57 126.35 51.71 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 C-N-CA 124.423 1.089 . . . . 0.0 109.48 168.057 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -87.25 134.52 33.54 Favored 'General case' 0 C--O 1.242 0.679 0 C-N-CA 123.217 0.607 . . . . 0.0 110.014 177.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 238' ' ' CYS . . . . . 0.524 ' HB3' ' HA ' ' A' ' 246' ' ' GLU . 35.5 t -95.52 123.98 39.33 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 123.464 0.705 . . . . 0.0 111.117 -178.405 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -77.9 94.33 4.54 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 123.893 0.877 . . . . 0.0 109.195 177.19 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -142.04 125.03 2.58 Favored Glycine 0 CA--C 1.529 0.945 0 CA-C-O 118.761 -1.022 . . . . 0.0 111.917 -179.34 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -62.77 -33.79 75.13 Favored 'Trans proline' 0 C--N 1.379 2.132 0 C-N-CA 122.61 2.207 . . . . 0.0 111.422 171.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -118.32 100.02 7.22 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 169.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 12.1 t -165.54 109.29 0.83 Allowed 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 178.09 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 22.7 ttmm -82.99 -35.69 25.65 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-O 121.547 0.689 . . . . 0.0 109.25 170.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . 0.463 ' HA ' ' HB3' ' A' ' 224' ' ' TYR . 89.5 m-85 -83.26 24.12 0.83 Allowed 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 124.985 1.314 . . . . 0.0 113.069 -175.045 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 246' ' ' GLU . . . . . 0.524 ' HA ' ' HB3' ' A' ' 238' ' ' CYS . 42.9 mt-10 -47.85 -38.46 16.12 Favored 'General case' 0 N--CA 1.502 2.149 0 C-N-CA 124.33 1.052 . . . . 0.0 113.181 -174.077 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 247' ' ' TRP . . . . . 0.514 ' HB2' ' HB2' ' A' ' 224' ' ' TYR . 85.6 m95 -78.34 127.09 31.71 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.498 -179.343 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -143.93 130.35 19.93 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.052 0.941 . . . . 0.0 109.605 178.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 249' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -71.92 129.56 38.87 Favored 'General case' 0 CA--C 1.547 0.854 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 172.646 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . 0.425 ' HB3' ' O ' ' A' ' 255' ' ' LEU . 50.1 m-85 -52.31 -31.68 34.19 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 124.709 1.204 . . . . 0.0 112.321 -178.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -53.54 -48.01 69.48 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 124.116 0.966 . . . . 0.0 111.89 176.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 252' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -61.04 -41.42 96.54 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.86 0.864 . . . . 0.0 111.414 -176.168 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 31.9 m -97.23 0.24 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 CA-C-N 115.395 -0.821 . . . . 0.0 112.038 -175.055 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 20.2 m120 62.78 17.06 9.55 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 124.934 1.294 . . . . 0.0 113.294 175.008 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . 0.425 ' O ' ' HB3' ' A' ' 250' ' ' TYR . 92.6 mt -80.22 109.47 14.72 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 174.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -75.23 -34.98 61.49 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 121.205 0.526 . . . . 0.0 110.041 175.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -116.98 139.0 25.25 Favored Pre-proline 0 CA--C 1.55 0.966 0 C-N-CA 123.482 0.713 . . . . 0.0 109.566 -175.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -59.72 136.61 71.66 Favored 'Trans proline' 0 C--N 1.378 2.131 0 C-N-CA 123.66 2.907 . . . . 0.0 113.486 179.184 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 259' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -65.59 127.57 18.3 Favored 'Trans proline' 0 C--N 1.372 1.816 0 C-N-CA 122.641 2.227 . . . . 0.0 111.515 172.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 14.8 ptmm? -73.99 -16.08 61.08 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.419 0.688 . . . . 0.0 111.626 -179.101 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -118.31 176.9 16.31 Favored Glycine 0 C--N 1.345 1.043 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.893 179.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 36.6 p -57.13 123.05 13.89 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 124.131 0.972 . . . . 0.0 111.809 -177.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 263' ' ' TRP . . . . . . . . . . . . . 44.4 t90 -101.87 115.75 31.22 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.262 0.625 . . . . 0.0 109.36 -174.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -105.63 111.78 24.61 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.951 0.901 . . . . 0.0 109.253 177.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 16.6 p -64.35 149.11 95.29 Favored Pre-proline 0 CA--C 1.559 1.295 0 CA-C-O 118.326 -0.845 . . . . 0.0 109.4 174.223 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -27.44 -60.32 0.09 OUTLIER 'Trans proline' 0 C--N 1.384 2.411 1 C-N-CA 125.76 4.307 . . . . 0.0 118.026 -160.606 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.29 -39.89 86.03 Favored 'General case' 0 N--CA 1.485 1.281 0 CA-C-O 119.293 -0.384 . . . . 0.0 111.604 -175.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 268' ' ' CYS . . . . . . . . . . . . . 59.6 m -52.55 -30.94 33.27 Favored 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 -178.507 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 32.7 ttmt -78.35 -24.66 46.39 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.085 0.554 . . . . 0.0 111.516 -177.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 31.7 pt -112.76 2.51 8.49 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.258 0 C-N-CA 123.544 0.737 . . . . 0.0 112.034 179.08 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 . . . . . 0 C--O 1.256 1.396 0 C-N-CA 123.984 0.914 . . . . 0.0 109.544 -176.125 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 3.2 tm? . . . . . 0 N--CA 1.471 0.597 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 224' ' ' TYR . . . . . 0.462 ' HE1' ' HE3' ' A' ' 244' ' ' LYS . 60.3 m-85 -148.32 125.42 11.41 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.657 1.183 . . . . 0.0 108.301 172.372 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 47.1 t 173.26 163.03 0.14 Allowed 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 124.7 1.2 . . . . 0.0 109.88 174.045 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -65.94 -33.97 77.03 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 122.41 0.284 . . . . 0.0 111.406 175.457 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 13.3 p -84.01 -5.86 59.31 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 122.152 0.181 . . . . 0.0 111.412 176.509 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 82.5 mm-40 48.67 85.95 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 125.467 1.507 . . . . 0.0 112.743 -175.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 22.9 tpp180 -153.92 148.54 26.32 Favored 'General case' 0 C--O 1.244 0.784 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 177.74 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 25.7 m -62.4 149.71 9.37 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 O-C-N 123.838 0.711 . . . . 0.0 110.73 178.85 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 17.5 p -87.01 69.52 10.24 Favored 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 123.382 0.673 . . . . 0.0 110.141 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 94.5 t80 -70.5 98.28 1.43 Allowed 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.164 0.986 . . . . 0.0 110.576 -176.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 78.5 -17.59 6.43 Favored Glycine 0 CA--C 1.536 1.404 0 CA-C-N 116.133 -0.485 . . . . 0.0 113.97 176.55 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -122.32 105.62 10.36 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.217 1.007 . . . . 0.0 108.424 178.324 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 235' ' ' MET . . . . . . . . . . . . . 21.3 ptt? -136.53 102.19 4.86 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 121.949 0.88 . . . . 0.0 111.143 178.405 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 5.0 p -101.48 123.72 54.77 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.785 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 172.561 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -92.67 147.82 22.57 Favored 'General case' 0 C--O 1.241 0.607 0 C-N-CA 123.168 0.587 . . . . 0.0 110.206 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 238' ' ' CYS . . . . . 0.51 ' HB3' ' HA ' ' A' ' 246' ' ' GLU . 35.4 t -106.41 154.52 20.7 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 124.034 0.934 . . . . 0.0 110.708 -179.228 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -111.15 96.23 6.01 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 170.543 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -140.67 119.93 1.65 Allowed Glycine 0 CA--C 1.527 0.802 0 CA-C-O 118.518 -1.156 . . . . 0.0 111.511 177.422 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -53.51 -39.07 83.68 Favored 'Trans proline' 0 C--N 1.382 2.323 0 C-N-CA 123.42 2.747 . . . . 0.0 113.276 174.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -114.76 101.73 9.34 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 171.281 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 12.8 t -173.07 102.82 0.13 Allowed 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 -173.202 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 244' ' ' LYS . . . . . 0.462 ' HE3' ' HE1' ' A' ' 224' ' ' TYR . 52.7 tptt -81.51 -31.34 32.87 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 123.252 0.621 . . . . 0.0 109.738 170.665 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -81.54 26.92 0.45 Allowed 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 124.938 1.295 . . . . 0.0 112.541 -179.095 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 246' ' ' GLU . . . . . 0.51 ' HA ' ' HB3' ' A' ' 238' ' ' CYS . 6.1 mm-40 -47.35 -45.77 25.0 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 123.883 0.873 . . . . 0.0 112.541 -178.099 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 247' ' ' TRP . . . . . 0.462 ' HB2' ' HB2' ' A' ' 224' ' ' TYR . 97.9 m95 -86.26 141.04 29.57 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.049 0.452 . . . . 0.0 111.035 178.824 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 32.9 m-85 -145.58 174.22 11.37 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.333 1.453 . . . . 0.0 109.231 176.43 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 249' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -113.47 141.11 47.5 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 168.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -54.95 -43.01 73.02 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.856 1.262 . . . . 0.0 112.673 -170.397 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -63.87 -34.47 78.02 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.389 0.676 . . . . 0.0 112.417 -175.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 252' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -65.55 -47.45 75.82 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-O 121.32 0.581 . . . . 0.0 110.246 179.12 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 30.6 m -88.04 5.46 4.02 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.897 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.747 -176.629 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 55.2 t30 58.73 70.91 0.62 Allowed 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.801 1.24 . . . . 0.0 110.785 178.81 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 76.6 mt -141.22 152.74 44.84 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.479 1.112 . . . . 0.0 109.121 177.136 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.8 -21.35 1.94 Allowed 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 123.864 0.866 . . . . 0.0 109.794 166.186 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -78.85 118.62 73.48 Favored Pre-proline 0 N--CA 1.478 0.97 0 C-N-CA 123.685 0.794 . . . . 0.0 109.49 176.319 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -57.34 121.36 9.91 Favored 'Trans proline' 0 C--N 1.372 1.799 0 C-N-CA 122.78 2.32 . . . . 0.0 111.129 165.46 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 259' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -52.92 132.79 48.83 Favored 'Trans proline' 0 C--N 1.378 2.12 0 C-N-CA 123.829 3.019 . . . . 0.0 113.738 -178.739 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 60.2 pttt -83.34 -2.55 55.99 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.313 1.045 . . . . 0.0 112.244 178.569 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -168.77 -155.63 9.83 Favored Glycine 0 C--N 1.344 0.984 0 CA-C-O 120.033 -0.315 . . . . 0.0 112.502 -179.054 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 25.8 p -62.19 106.81 0.78 Allowed 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.949 0.9 . . . . 0.0 111.447 -175.471 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 263' ' ' TRP . . . . . . . . . . . . . 63.1 t90 -92.49 113.98 26.41 Favored 'General case' 0 C--N 1.347 0.481 0 CA-C-N 115.771 -0.649 . . . . 0.0 109.435 -176.72 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 45.8 m-85 -93.68 118.6 31.61 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 175.255 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 265' ' ' CYS . . . . . 0.444 ' SG ' ' HB2' ' A' ' 267' ' ' GLU . 18.4 p -66.39 152.98 93.76 Favored Pre-proline 0 CA--C 1.545 0.774 0 CA-C-O 118.507 -0.759 . . . . 0.0 109.715 175.047 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_exo -47.85 -29.01 10.73 Favored 'Trans proline' 0 C--N 1.384 2.446 0 C-N-CA 123.728 2.952 . . . . 0.0 114.244 -178.329 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 267' ' ' GLU . . . . . 0.444 ' HB2' ' SG ' ' A' ' 265' ' ' CYS . 9.5 mp0 -64.74 -53.71 42.83 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 125.078 1.351 . . . . 0.0 109.814 178.352 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 268' ' ' CYS . . . . . . . . . . . . . 94.4 m -62.04 -34.91 77.12 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.29 0.636 . . . . 0.0 111.232 176.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -68.13 -23.99 64.95 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.291 0.636 . . . . 0.0 111.929 -179.362 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 2.8 pp -102.69 -4.68 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 N-CA-C 111.768 0.285 . . . . 0.0 111.768 175.29 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 . . . . . 0 N--CA 1.484 1.274 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 170.876 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 58.1 tp . . . . . 0 N--CA 1.472 0.666 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 224' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -136.72 128.89 29.72 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -173.851 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 225' ' ' CYS . . . . . 0.481 ' HG ' ' HD1' ' A' ' 248' ' ' PHE . 42.2 t 172.75 166.9 0.12 Allowed 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 125.262 1.425 . . . . 0.0 108.838 171.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -68.34 -38.37 81.44 Favored 'General case' 0 N--CA 1.484 1.273 0 O-C-N 121.969 -0.457 . . . . 0.0 110.427 175.861 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 10.0 p -83.79 -9.8 58.54 Favored 'General case' 0 N--CA 1.484 1.257 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.909 176.702 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 22.2 mm-40 48.66 77.61 0.1 Allowed 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 124.742 1.217 . . . . 0.0 112.114 -173.422 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 229' ' ' ARG . . . . . 0.516 ' HE ' ' HE2' ' A' ' 232' ' ' PHE . 26.7 ttt85 -135.73 149.65 49.27 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.625 1.17 . . . . 0.0 108.273 -175.779 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 29.0 m -70.33 160.07 5.27 Favored 'Isoleucine or valine' 0 C--O 1.242 0.696 0 CA-C-O 121.255 0.55 . . . . 0.0 110.647 177.284 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 231' ' ' SER . . . . . 0.736 ' HB3' ' HB3' ' A' ' 235' ' ' MET . 48.2 m -113.88 118.18 33.47 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 176.813 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 232' ' ' PHE . . . . . 0.516 ' HE2' ' HE ' ' A' ' 229' ' ' ARG . 3.9 p90 -112.23 66.54 0.64 Allowed 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.318 1.047 . . . . 0.0 110.091 -167.773 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 86.58 -21.76 16.69 Favored Glycine 0 N--CA 1.472 1.086 0 CA-C-N 115.002 -0.999 . . . . 0.0 113.51 179.224 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 30.7 mm-40 -106.56 99.04 8.64 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 170.778 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 235' ' ' MET . . . . . 0.736 ' HB3' ' HB3' ' A' ' 231' ' ' SER . 25.7 ptt? -142.14 123.3 14.65 Favored 'General case' 0 C--O 1.241 0.647 0 CA-C-O 121.325 0.584 . . . . 0.0 110.836 178.842 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 236' ' ' VAL . . . . . 0.529 HG23 ' HG3' ' A' ' 259' ' ' PRO . 6.2 p -100.12 124.62 53.7 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 CA-C-N 115.332 -0.849 . . . . 0.0 108.912 172.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -91.2 148.19 22.53 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.31 -178.838 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 238' ' ' CYS . . . . . 0.577 ' HB3' ' HA ' ' A' ' 246' ' ' GLU . 36.7 t -108.09 153.15 23.55 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 123.531 0.732 . . . . 0.0 109.657 173.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -118.18 93.77 4.25 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.678 0.791 . . . . 0.0 109.176 174.305 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -143.88 126.39 2.73 Favored Glycine 0 CA--C 1.527 0.802 0 CA-C-O 118.21 -1.328 . . . . 0.0 110.632 172.719 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -58.51 -50.5 9.37 Favored 'Trans proline' 0 C--N 1.376 1.986 0 CA-C-N 120.342 2.071 . . . . 0.0 110.96 177.632 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 8.7 p-10 -94.1 89.91 6.19 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 114.61 -1.177 . . . . 0.0 109.058 171.573 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 42.8 t -173.23 110.9 0.2 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.293 1.037 . . . . 0.0 109.197 -176.731 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 244' ' ' LYS . . . . . 0.549 ' H ' ' HD2' ' A' ' 244' ' ' LYS . 0.0 OUTLIER -88.85 -24.91 22.42 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.32 0.648 . . . . 0.0 110.995 178.985 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 36.6 m-85 -90.85 27.48 1.79 Allowed 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.403 1.081 . . . . 0.0 111.667 -177.784 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 246' ' ' GLU . . . . . 0.577 ' HA ' ' HB3' ' A' ' 238' ' ' CYS . 6.9 mm-40 -46.66 -45.07 19.02 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 124.023 0.929 . . . . 0.0 112.307 -179.182 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 247' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -83.44 126.74 33.07 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 121.56 0.695 . . . . 0.0 111.039 178.692 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 248' ' ' PHE . . . . . 0.481 ' HD1' ' HG ' ' A' ' 225' ' ' CYS . 48.0 m-85 -134.64 174.79 10.17 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.352 1.461 . . . . 0.0 108.411 170.456 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 249' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -127.32 148.53 50.24 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.725 0.81 . . . . 0.0 108.951 178.907 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -58.35 -32.7 68.78 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 124.358 1.063 . . . . 0.0 113.033 -172.157 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -65.86 -36.41 83.37 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.55 0.74 . . . . 0.0 112.067 179.222 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 252' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -70.82 -56.02 7.23 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.597 0.759 . . . . 0.0 110.295 -178.882 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 253' ' ' VAL . . . . . 0.523 HG21 HG11 ' A' ' 236' ' ' VAL . 34.2 m -79.86 -3.68 6.46 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 CA-C-N 114.775 -1.102 . . . . 0.0 111.839 -175.405 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 14.4 m120 65.59 27.28 11.52 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 125.012 1.325 . . . . 0.0 112.123 173.313 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 33.8 mt -79.01 112.7 16.48 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.589 0.756 . . . . 0.0 109.595 172.788 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -88.91 -2.85 58.79 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.82 0.848 . . . . 0.0 109.489 168.614 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -127.08 146.12 56.59 Favored Pre-proline 0 CA--C 1.547 0.851 0 C-N-CA 124.628 1.171 . . . . 0.0 109.564 -176.58 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -72.86 134.84 22.42 Favored 'Trans proline' 0 C--N 1.37 1.689 0 C-N-CA 122.47 2.113 . . . . 0.0 110.845 171.259 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 259' ' ' PRO . . . . . 0.529 ' HG3' HG23 ' A' ' 236' ' ' VAL . 39.6 Cg_endo -63.68 149.82 89.95 Favored 'Trans proline' 0 C--N 1.375 1.958 0 C-N-CA 122.362 2.041 . . . . 0.0 112.062 177.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -75.87 -18.87 59.26 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.058 0.943 . . . . 0.0 112.912 -168.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -170.66 -134.48 1.76 Allowed Glycine 0 C--N 1.343 0.935 0 N-CA-C 111.663 -0.575 . . . . 0.0 111.663 -178.102 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 42.1 p -69.57 106.34 2.99 Favored 'General case' 0 C--N 1.353 0.729 0 C-N-CA 122.865 0.466 . . . . 0.0 109.835 177.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 263' ' ' TRP . . . . . 0.466 ' O ' ' HA ' ' A' ' 238' ' ' CYS . 76.1 t90 -87.98 122.23 31.34 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.206 -176.544 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -101.17 118.12 36.36 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 176.812 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 265' ' ' CYS . . . . . 0.492 ' SG ' ' HG2' ' A' ' 267' ' ' GLU . 16.2 p -66.91 155.52 89.72 Favored Pre-proline 0 CA--C 1.551 0.988 0 C-N-CA 123.793 0.837 . . . . 0.0 110.946 -178.385 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -38.91 -50.47 2.57 Favored 'Trans proline' 0 C--N 1.388 2.647 0 C-N-CA 124.739 3.626 . . . . 0.0 115.314 -176.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 267' ' ' GLU . . . . . 0.492 ' HG2' ' SG ' ' A' ' 265' ' ' CYS . 2.5 pm0 -62.2 -39.34 92.4 Favored 'General case' 0 CA--C 1.549 0.933 0 CA-C-N 115.892 -0.594 . . . . 0.0 112.357 -178.837 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 268' ' ' CYS . . . . . . . . . . . . . 63.6 m -68.87 -44.1 74.01 Favored 'General case' 0 N--CA 1.495 1.821 0 C-N-CA 122.699 0.399 . . . . 0.0 111.223 176.675 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -66.78 -31.48 72.15 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.37 -169.554 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 1.8 mp -91.05 -46.82 14.58 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.078 0 C-N-CA 123.382 0.673 . . . . 0.0 109.666 176.158 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 . . . . . 0 CA--C 1.558 1.288 0 C-N-CA 123.309 0.644 . . . . 0.0 109.711 -175.555 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 5.8 tt . . . . . 0 N--CA 1.47 0.547 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 224' ' ' TYR . . . . . 0.44 ' HB3' ' HA ' ' A' ' 245' ' ' TYR . 63.7 m-85 -140.04 124.11 17.66 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 176.427 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 48.7 t 171.25 152.18 0.06 Allowed 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 125.52 1.528 . . . . 0.0 108.08 174.226 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 50.4 t80 -65.29 -38.74 91.19 Favored 'General case' 0 N--CA 1.486 1.351 0 CA-C-N 119.138 0.881 . . . . 0.0 110.965 -179.194 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 5.8 p -68.43 -14.23 62.86 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 123.034 0.208 . . . . 0.0 111.07 177.462 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 87.0 mm-40 57.12 85.82 0.08 Allowed 'General case' 0 C--N 1.364 1.238 0 C-N-CA 125.231 1.413 . . . . 0.0 111.845 179.075 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -160.17 149.12 17.29 Favored 'General case' 0 C--O 1.242 0.706 0 CA-C-N 114.745 -1.116 . . . . 0.0 108.713 178.876 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 31.0 m -71.51 149.97 9.35 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 122.78 0.432 . . . . 0.0 111.184 178.757 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 15.8 m -94.26 68.34 3.62 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-O 121.745 0.783 . . . . 0.0 109.23 177.614 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 47.6 t80 -83.04 91.42 7.18 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.463 -171.498 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 103.98 -19.79 42.74 Favored Glycine 0 N--CA 1.476 1.33 0 CA-C-N 116.066 -0.515 . . . . 0.0 113.694 175.114 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.1 64.67 1.59 Allowed 'General case' 0 N--CA 1.481 1.124 0 CA-C-O 122.392 1.091 . . . . 0.0 110.122 178.788 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 235' ' ' MET . . . . . . . . . . . . . 18.3 ptm -99.56 130.68 45.82 Favored 'General case' 0 N--CA 1.483 1.177 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.75 -176.215 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 7.0 p -124.95 126.88 71.96 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.939 0 C-N-CA 124.565 1.146 . . . . 0.0 108.964 177.628 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -91.86 154.22 19.02 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.873 0.869 . . . . 0.0 111.302 -178.518 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 238' ' ' CYS . . . . . 0.649 ' HB3' ' HA ' ' A' ' 246' ' ' GLU . 11.3 t -117.12 155.47 29.26 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.929 1.292 . . . . 0.0 109.565 175.523 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -117.9 105.34 11.82 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.757 0.823 . . . . 0.0 109.406 172.85 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -140.96 144.74 15.04 Favored Glycine 0 CA--C 1.528 0.874 0 CA-C-O 118.533 -1.148 . . . . 0.0 111.405 173.681 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -61.38 -47.88 10.89 Favored 'Trans proline' 0 C--N 1.378 2.112 0 C-N-CA 122.929 2.419 . . . . 0.0 112.028 -178.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 40.9 t30 -124.5 107.44 11.07 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 170.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 43.8 t -157.45 117.05 3.36 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 123.522 0.729 . . . . 0.0 109.376 -174.173 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -80.5 -44.62 18.84 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.441 0.697 . . . . 0.0 109.852 176.865 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 245' ' ' TYR . . . . . 0.44 ' HA ' ' HB3' ' A' ' 224' ' ' TYR . 45.6 m-85 -82.72 31.11 0.42 Allowed 'General case' 0 CA--C 1.553 1.089 0 C-N-CA 124.18 0.992 . . . . 0.0 112.393 -175.372 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 246' ' ' GLU . . . . . 0.649 ' HA ' ' HB3' ' A' ' 238' ' ' CYS . 6.9 mm-40 -47.34 -42.79 22.16 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.832 0.853 . . . . 0.0 111.537 173.446 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 247' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -90.34 139.05 31.04 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-O 121.052 0.453 . . . . 0.0 111.132 177.541 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -147.28 173.09 12.9 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.062 1.345 . . . . 0.0 109.401 174.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 249' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -117.63 140.4 49.7 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.427 0.691 . . . . 0.0 110.03 174.207 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -54.58 -28.09 43.64 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 125.301 1.44 . . . . 0.0 112.36 -179.578 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -60.61 -54.73 41.79 Favored 'General case' 0 CA--C 1.555 1.16 0 C-N-CA 123.407 0.683 . . . . 0.0 111.176 177.019 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 252' ' ' CYS . . . . . . . . . . . . . 1.1 m -66.21 -44.68 83.19 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.773 0.829 . . . . 0.0 111.594 -177.772 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 33.8 m -84.4 -0.71 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.619 -177.017 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 21.1 m120 60.66 19.18 9.18 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 125.038 1.335 . . . . 0.0 113.278 172.187 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 92.7 mt -84.64 120.94 26.95 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 177.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 31.9 mmtp -103.74 21.33 16.41 Favored 'General case' 0 N--CA 1.485 1.322 0 CA-C-O 121.319 0.58 . . . . 0.0 110.07 -177.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -157.89 139.56 9.93 Favored Pre-proline 0 C--O 1.245 0.832 0 C-N-CA 124.619 1.167 . . . . 0.0 109.069 -174.733 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_exo -67.99 115.19 3.67 Favored 'Trans proline' 0 C--N 1.373 1.842 0 C-N-CA 122.999 2.466 . . . . 0.0 111.668 176.535 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 259' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -68.48 121.1 8.02 Favored 'Trans proline' 0 C--N 1.376 2.026 0 C-N-CA 122.374 2.049 . . . . 0.0 111.252 178.378 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 10.3 mtmp? -72.48 124.31 24.93 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.12 0.568 . . . . 0.0 110.354 178.321 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 115.76 -159.74 13.67 Favored Glycine 0 C--N 1.337 0.627 0 N-CA-C 111.494 -0.642 . . . . 0.0 111.494 174.081 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 45.6 p -83.56 107.18 15.86 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 172.657 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 263' ' ' TRP . . . . . . . . . . . . . 40.2 t90 -77.04 147.23 36.86 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-O 121.119 0.485 . . . . 0.0 110.144 179.596 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -120.13 120.66 36.87 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 123.735 0.814 . . . . 0.0 108.972 178.531 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 17.3 p -67.71 161.09 69.23 Favored Pre-proline 0 CA--C 1.55 0.97 0 C-N-CA 123.537 0.735 . . . . 0.0 110.646 176.488 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -41.52 -29.91 0.84 Allowed 'Trans proline' 0 C--N 1.383 2.387 0 C-N-CA 124.002 3.134 . . . . 0.0 115.593 176.091 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -63.47 -66.78 0.49 Allowed 'General case' 0 N--CA 1.483 1.199 0 CA-C-O 121.605 0.717 . . . . 0.0 109.806 173.757 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 268' ' ' CYS . . . . . . . . . . . . . 58.6 m -71.26 -28.62 64.29 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 114.617 -1.174 . . . . 0.0 111.949 -167.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -80.04 -56.12 4.47 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.373 0.669 . . . . 0.0 110.504 -178.339 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 45.5 mm -82.21 -59.44 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 122.768 0.427 . . . . 0.0 111.714 -168.298 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 . . . . . 0 N--CA 1.481 1.083 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -168.769 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 5.4 tt . . . . . 0 N--CA 1.482 1.154 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 224' ' ' TYR . . . . . 0.618 ' HB3' ' HA ' ' A' ' 245' ' ' TYR . 88.0 m-85 -137.39 131.99 32.86 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.534 1.134 . . . . 0.0 108.251 177.283 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 34.8 t 172.48 160.07 0.11 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.028 1.331 . . . . 0.0 108.888 177.65 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -67.52 -29.09 68.4 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 122.543 0.337 . . . . 0.0 111.0 177.365 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 227' ' ' CYS . . . . . 0.453 ' SG ' ' HB2' ' A' ' 229' ' ' ARG . 12.2 p -84.86 -5.84 59.34 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-O 119.224 -0.417 . . . . 0.0 111.939 178.164 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 33.1 mm-40 54.88 78.94 0.16 Allowed 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 124.494 1.117 . . . . 0.0 111.269 -173.325 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 229' ' ' ARG . . . . . 0.453 ' HB2' ' SG ' ' A' ' 227' ' ' CYS . 3.1 tmm_? -154.23 150.21 27.82 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 -176.442 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 30.7 m -66.98 156.84 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 123.388 0.675 . . . . 0.0 112.56 178.461 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 22.5 m -109.67 89.53 3.04 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-N 115.251 -0.886 . . . . 0.0 108.655 175.318 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 88.2 t80 -114.45 124.68 52.53 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.513 0.725 . . . . 0.0 109.697 177.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 79.58 -16.68 10.02 Favored Glycine 0 C--N 1.347 1.173 0 CA-C-N 116.054 -0.521 . . . . 0.0 113.023 -179.04 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 234' ' ' GLU . . . . . 0.44 ' HB3' ' H ' ' A' ' 250' ' ' TYR . 41.5 mt-10 -140.62 98.1 3.34 Favored 'General case' 0 C--N 1.349 0.546 0 C-N-CA 124.844 1.257 . . . . 0.0 107.773 -176.668 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 235' ' ' MET . . . . . . . . . . . . . 3.5 mpp? -127.4 95.12 4.17 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 -178.224 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 4.1 p -103.13 126.28 57.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 171.264 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -95.86 156.99 16.1 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.293 0.568 . . . . 0.0 111.12 -177.71 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 238' ' ' CYS . . . . . 0.738 ' HB3' ' HA ' ' A' ' 246' ' ' GLU . 18.5 t -110.81 153.18 25.73 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 124.442 1.097 . . . . 0.0 109.409 174.885 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -108.65 92.58 4.11 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 174.071 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -143.9 114.34 0.81 Allowed Glycine 0 CA--C 1.529 0.912 0 CA-C-O 118.08 -1.4 . . . . 0.0 111.863 175.882 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -54.05 -39.75 84.19 Favored 'Trans proline' 0 C--N 1.377 2.039 0 C-N-CA 123.104 2.536 . . . . 0.0 112.907 178.369 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -111.3 91.23 3.58 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 171.633 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 51.5 t -171.98 116.74 0.37 Allowed 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.208 1.003 . . . . 0.0 108.745 -175.306 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 23.6 pttm -89.03 -33.38 17.17 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 122.701 0.401 . . . . 0.0 110.538 176.774 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 245' ' ' TYR . . . . . 0.618 ' HA ' ' HB3' ' A' ' 224' ' ' TYR . 22.0 m-30 -79.28 29.92 0.22 Allowed 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.741 1.216 . . . . 0.0 112.235 179.708 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 246' ' ' GLU . . . . . 0.738 ' HA ' ' HB3' ' A' ' 238' ' ' CYS . 6.9 mm-40 -47.44 -45.96 26.21 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.745 0.818 . . . . 0.0 111.086 170.93 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 247' ' ' TRP . . . . . 0.536 ' HB2' ' HB2' ' A' ' 224' ' ' TYR . 91.8 m95 -78.59 134.72 37.18 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 121.109 0.48 . . . . 0.0 110.76 177.211 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -144.08 170.88 15.11 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 125.163 1.385 . . . . 0.0 108.424 170.59 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 249' ' ' HIS . . . . . 0.422 ' HD2' ' HB2' ' A' ' 252' ' ' CYS . 0.0 OUTLIER -115.52 133.98 55.51 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 174.092 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 250' ' ' TYR . . . . . 0.44 ' H ' ' HB3' ' A' ' 234' ' ' GLU . 49.9 m-85 -47.74 -57.5 5.49 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 125.354 1.462 . . . . 0.0 114.467 -168.535 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -69.18 -26.63 64.93 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 122.381 0.272 . . . . 0.0 111.246 -170.748 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 252' ' ' CYS . . . . . 0.422 ' HB2' ' HD2' ' A' ' 249' ' ' HIS . 36.1 t -68.32 -32.1 71.99 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 124.087 0.955 . . . . 0.0 111.013 177.884 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 17.5 m -105.24 16.84 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 C-N-CA 123.34 0.656 . . . . 0.0 110.879 175.595 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 17.2 m120 67.54 9.11 6.81 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 125.364 1.466 . . . . 0.0 114.13 172.36 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 87.0 mt -76.97 137.42 39.02 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 122.925 0.49 . . . . 0.0 109.909 173.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.74 -23.24 9.29 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.909 0.884 . . . . 0.0 109.747 176.232 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -126.44 148.83 65.65 Favored Pre-proline 0 CA--C 1.549 0.91 0 C-N-CA 124.061 0.944 . . . . 0.0 110.158 -179.063 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -65.59 139.52 58.75 Favored 'Trans proline' 0 C--N 1.38 2.224 0 C-N-CA 123.11 2.54 . . . . 0.0 112.404 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 259' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_exo -59.3 151.59 66.66 Favored 'Trans proline' 0 C--N 1.377 2.069 0 C-N-CA 122.705 2.27 . . . . 0.0 112.095 172.44 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -89.65 -21.0 22.99 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.846 0.858 . . . . 0.0 110.266 -176.07 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -147.87 -144.09 3.93 Favored Glycine 0 C--N 1.349 1.29 0 CA-C-O 119.821 -0.433 . . . . 0.0 112.332 -179.292 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 30.2 p -67.61 111.91 4.45 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 123.569 0.748 . . . . 0.0 111.105 -177.395 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 263' ' ' TRP . . . . . . . . . . . . . 32.1 t90 -93.41 116.8 29.35 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -100.51 107.01 18.61 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 123.421 0.689 . . . . 0.0 109.472 178.148 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 15.5 p -57.28 160.41 6.86 Favored Pre-proline 0 N--CA 1.487 1.384 0 C-N-CA 124.418 1.087 . . . . 0.0 111.046 177.42 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -33.83 -46.88 0.45 Allowed 'Trans proline' 0 C--N 1.396 3.05 0 C-N-CA 124.867 3.711 . . . . 0.0 114.834 -179.044 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -61.56 -50.41 72.76 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 124.823 1.249 . . . . 0.0 112.04 -177.84 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 268' ' ' CYS . . . . . . . . . . . . . 79.6 m -72.49 -29.11 63.35 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.851 0.86 . . . . 0.0 111.982 -175.029 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.02 -15.27 36.86 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 111.885 0.328 . . . . 0.0 111.885 -179.208 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 33.2 mm -88.09 -16.09 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 C-N-CA 123.337 0.655 . . . . 0.0 110.237 171.369 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 . . . . . 0 CA--C 1.559 1.313 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 172.52 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 66.6 tp . . . . . 0 N--CA 1.473 0.679 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 224' ' ' TYR . . . . . 0.657 ' HB3' ' HA ' ' A' ' 245' ' ' TYR . 19.2 m-85 -136.22 128.87 30.69 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.86 0.864 . . . . 0.0 109.31 -179.576 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 225' ' ' CYS . . . . . 0.424 ' HB2' ' O ' ' A' ' 224' ' ' TYR . 40.3 t 170.21 163.32 0.07 Allowed 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 125.64 1.576 . . . . 0.0 108.626 167.029 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -59.91 -44.93 94.01 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 122.475 0.31 . . . . 0.0 110.51 173.591 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 14.1 p -76.79 -12.17 59.94 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.106 0.563 . . . . 0.0 112.194 -176.527 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 82.3 mm-40 51.82 77.4 0.15 Allowed 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 124.519 1.128 . . . . 0.0 112.135 -172.821 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 72.5 ttt180 -147.56 149.52 32.73 Favored 'General case' 0 C--O 1.242 0.691 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 176.469 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 26.6 m -67.54 146.1 13.29 Favored 'Isoleucine or valine' 0 C--O 1.245 0.825 0 CA-C-O 121.14 0.495 . . . . 0.0 110.808 177.771 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 231' ' ' SER . . . . . 0.448 ' HB3' ' O ' ' A' ' 234' ' ' GLU . 50.9 m -79.43 87.14 5.07 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 172.43 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 83.1 t80 -86.25 107.87 18.13 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.453 0.701 . . . . 0.0 111.095 -173.246 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 73.53 -1.23 45.32 Favored Glycine 0 C--N 1.351 1.392 0 CA-C-N 115.741 -0.663 . . . . 0.0 114.191 175.445 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 234' ' ' GLU . . . . . 0.448 ' O ' ' HB3' ' A' ' 231' ' ' SER . 14.7 pt-20 -154.97 141.05 18.41 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 124.386 1.074 . . . . 0.0 108.908 -175.267 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 235' ' ' MET . . . . . 0.419 ' HB3' ' HB3' ' A' ' 231' ' ' SER . 0.0 OUTLIER -160.21 136.77 8.93 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 122.885 0.474 . . . . 0.0 110.534 174.857 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 4.2 p -117.7 124.22 72.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 173.087 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -87.96 127.61 35.37 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.048 0.539 . . . . 0.0 110.233 -177.796 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 238' ' ' CYS . . . . . . . . . . . . . 48.8 t -92.6 154.5 18.36 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.002 0.921 . . . . 0.0 110.691 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -116.59 109.74 17.63 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 169.524 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 240' ' ' GLY . . . . . 0.577 ' HA3' ' SG ' ' A' ' 268' ' ' CYS . . . -144.17 140.58 9.49 Favored Glycine 0 C--N 1.344 0.978 0 CA-C-O 118.786 -1.008 . . . . 0.0 113.215 172.79 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -57.54 -54.95 2.81 Favored 'Trans proline' 0 C--N 1.374 1.913 0 C-N-CA 122.856 2.37 . . . . 0.0 112.627 171.801 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -107.49 77.65 1.15 Allowed 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 176.544 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 34.5 t -150.85 106.25 3.36 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 -174.708 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 244' ' ' LYS . . . . . 0.462 ' HA ' ' HE3' ' A' ' 244' ' ' LYS . 0.4 OUTLIER -89.04 -29.36 19.5 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.307 0.643 . . . . 0.0 110.792 178.925 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 245' ' ' TYR . . . . . 0.657 ' HA ' ' HB3' ' A' ' 224' ' ' TYR . 23.5 m-85 -82.03 22.0 0.83 Allowed 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.632 0.773 . . . . 0.0 112.95 -174.329 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -46.75 -37.36 8.4 Favored 'General case' 0 N--CA 1.501 2.114 0 C-N-CA 124.72 1.208 . . . . 0.0 112.849 -171.132 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 247' ' ' TRP . . . . . . . . . . . . . 97.7 m95 -77.69 101.83 6.81 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.148 0.579 . . . . 0.0 109.771 175.143 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -113.98 176.37 5.07 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.357 1.063 . . . . 0.0 110.466 178.247 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 249' ' ' HIS . . . . . 0.509 ' CD2' ' HB2' ' A' ' 252' ' ' CYS . 0.9 OUTLIER -129.49 144.05 51.09 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.793 1.237 . . . . 0.0 109.166 174.724 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 250' ' ' TYR . . . . . 0.484 ' HB3' ' O ' ' A' ' 255' ' ' LEU . 65.8 m-85 -62.19 -38.8 90.51 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 124.494 1.118 . . . . 0.0 112.825 -169.219 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -60.72 -36.84 79.83 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 124.252 1.021 . . . . 0.0 111.452 -176.445 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 252' ' ' CYS . . . . . 0.509 ' HB2' ' CD2' ' A' ' 249' ' ' HIS . 0.5 OUTLIER -64.62 -42.27 95.61 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.346 1.058 . . . . 0.0 110.456 -177.037 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 34.0 m -100.07 5.89 9.78 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 CA-C-N 114.777 -1.101 . . . . 0.0 111.309 -173.78 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 17.3 m120 66.33 13.17 9.07 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 125.054 1.342 . . . . 0.0 113.288 172.682 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.484 ' O ' ' HB3' ' A' ' 250' ' ' TYR . 92.3 mt -80.68 125.41 30.0 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 175.318 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -89.33 -23.5 22.23 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 172.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -134.08 150.97 75.73 Favored Pre-proline 0 CA--C 1.55 0.954 0 C-N-CA 124.589 1.156 . . . . 0.0 108.746 179.278 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 258' ' ' PRO . . . . . 0.429 ' HA ' ' HD3' ' A' ' 259' ' ' PRO . 45.6 Cg_endo -67.28 143.29 63.7 Favored 'Trans proline' 0 C--N 1.375 1.937 0 C-N-CA 122.318 2.012 . . . . 0.0 110.772 172.511 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 259' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 258' ' ' PRO . 40.6 Cg_exo -60.65 163.89 14.68 Favored 'Trans proline' 0 C--N 1.374 1.899 0 C-N-CA 123.215 2.61 . . . . 0.0 113.849 -179.194 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -63.32 -34.66 78.18 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 114.943 -1.026 . . . . 0.0 112.095 -177.021 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -120.21 -164.44 12.53 Favored Glycine 0 CA--C 1.523 0.579 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.702 175.64 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 58.9 m -65.76 125.4 25.18 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.446 0.699 . . . . 0.0 110.0 -179.157 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 263' ' ' TRP . . . . . . . . . . . . . 39.5 t90 -84.5 129.42 34.86 Favored 'General case' 0 C--O 1.242 0.669 0 CA-C-O 121.719 0.771 . . . . 0.0 111.053 -175.86 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 264' ' ' TYR . . . . . 0.419 ' O ' ' HE3' ' A' ' 269' ' ' LYS . 75.6 m-85 -111.07 126.84 55.24 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.02 1.328 . . . . 0.0 107.587 172.612 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 265' ' ' CYS . . . . . 0.448 ' SG ' ' HB2' ' A' ' 267' ' ' GLU . 26.4 p -67.98 161.89 63.83 Favored Pre-proline 0 CA--C 1.554 1.121 0 CA-C-O 118.661 -0.685 . . . . 0.0 109.858 175.147 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_exo -46.84 -33.26 13.81 Favored 'Trans proline' 0 C--N 1.39 2.73 0 C-N-CA 123.414 2.743 . . . . 0.0 113.469 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 267' ' ' GLU . . . . . 0.448 ' HB2' ' SG ' ' A' ' 265' ' ' CYS . 26.6 mt-10 -59.9 -58.41 8.68 Favored 'General case' 0 C--O 1.213 -0.837 0 C-N-CA 124.651 1.181 . . . . 0.0 110.054 175.536 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 268' ' ' CYS . . . . . 0.577 ' SG ' ' HA3' ' A' ' 240' ' ' GLY . 99.0 m -63.86 -27.77 69.39 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.603 0.761 . . . . 0.0 113.049 -176.27 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 269' ' ' LYS . . . . . 0.419 ' HE3' ' O ' ' A' ' 264' ' ' TYR . 94.2 mttt -68.87 -37.32 78.98 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 122.579 0.352 . . . . 0.0 111.059 176.816 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 74.1 mt -95.66 -72.06 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.814 0 C-N-CA 122.947 0.499 . . . . 0.0 109.841 179.423 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 . . . . . 0 C--O 1.25 1.123 0 C-N-CA 124.798 1.239 . . . . 0.0 110.315 -179.714 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 34.4 tp . . . . . 0 N--CA 1.478 0.96 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 224' ' ' TYR . . . . . 0.438 ' HB3' ' HA ' ' A' ' 245' ' ' TYR . 48.0 m-85 -143.87 141.42 30.3 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.377 0.671 . . . . 0.0 110.29 -175.935 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 45.3 t 170.58 158.47 0.07 Allowed 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 125.367 1.467 . . . . 0.0 109.274 164.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 35.7 t80 -65.62 -37.99 88.14 Favored 'General case' 0 CA--C 1.551 0.991 0 CA-C-N 117.804 0.275 . . . . 0.0 110.985 177.416 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 4.6 p -80.45 -12.04 59.61 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 122.589 0.356 . . . . 0.0 111.129 176.574 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 84.2 mm-40 50.01 81.15 0.06 Allowed 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 124.745 1.218 . . . . 0.0 112.077 -173.24 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 229' ' ' ARG . . . . . 0.464 HH22 ' HB3' ' A' ' 251' ' ' ASP . 46.7 ttp180 -135.09 149.44 50.06 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 176.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 23.6 m -67.18 147.03 12.78 Favored 'Isoleucine or valine' 0 C--O 1.241 0.635 0 C-N-CA 122.63 0.372 . . . . 0.0 111.328 174.409 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 40.9 m -98.81 81.71 2.68 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 174.491 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -86.86 99.95 12.2 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.589 0.756 . . . . 0.0 109.768 -176.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 76.97 -0.09 67.67 Favored Glycine 0 N--CA 1.474 1.178 0 CA-C-N 116.232 -0.44 . . . . 0.0 113.823 178.467 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -135.35 72.71 1.45 Allowed 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.122 0.969 . . . . 0.0 109.571 -178.342 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 235' ' ' MET . . . . . . . . . . . . . 3.4 mpp? -105.76 108.46 19.99 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.285 -176.213 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 5.6 p -111.6 124.17 68.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 171.07 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -99.9 131.04 46.11 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 123.273 0.629 . . . . 0.0 109.732 -179.169 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 238' ' ' CYS . . . . . . . . . . . . . 18.1 t -81.66 143.25 32.04 Favored 'General case' 0 C--O 1.223 -0.3 0 C-N-CA 123.873 0.869 . . . . 0.0 110.58 179.352 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -97.39 93.79 6.68 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 166.015 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -142.56 112.92 0.76 Allowed Glycine 0 CA--C 1.521 0.442 0 CA-C-O 118.34 -1.255 . . . . 0.0 110.445 174.324 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -67.22 -24.43 44.08 Favored 'Trans proline' 0 C--N 1.366 1.492 0 CA-C-N 120.112 1.956 . . . . 0.0 111.38 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 15.3 p-10 -110.81 70.81 0.73 Allowed 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.408 1.483 . . . . 0.0 108.821 176.859 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 39.0 t -167.4 107.08 0.58 Allowed 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.308 -169.199 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? -77.1 -36.15 55.87 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.037 0.535 . . . . 0.0 109.808 171.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 245' ' ' TYR . . . . . 0.438 ' HA ' ' HB3' ' A' ' 224' ' ' TYR . 12.2 m-85 -79.62 24.77 0.36 Allowed 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 -171.272 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -45.98 -43.5 14.21 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 124.781 1.232 . . . . 0.0 114.122 -170.038 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 247' ' ' TRP . . . . . . . . . . . . . 70.5 m95 -76.92 129.53 36.3 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-O 121.155 0.502 . . . . 0.0 110.884 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -140.19 174.81 10.14 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.767 1.227 . . . . 0.0 109.193 179.229 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 249' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -125.1 141.03 52.37 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.062 0.945 . . . . 0.0 109.971 179.346 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 39.3 m-85 -56.16 -35.06 66.76 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 125.622 1.569 . . . . 0.0 112.852 -171.289 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 251' ' ' ASP . . . . . 0.464 ' HB3' HH22 ' A' ' 229' ' ' ARG . 11.6 t70 -57.97 -51.18 70.7 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 124.746 1.219 . . . . 0.0 111.504 177.575 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 252' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -62.26 -42.44 99.33 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.832 0.853 . . . . 0.0 110.946 -176.108 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 253' ' ' VAL . . . . . 0.41 HG23 ' HG ' ' A' ' 255' ' ' LEU . 35.1 m -99.01 5.56 9.66 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.652 -172.871 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 34.6 m-80 62.95 17.93 10.46 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 125.075 1.35 . . . . 0.0 113.621 171.175 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.41 ' HG ' HG23 ' A' ' 253' ' ' VAL . 87.2 mt -79.62 126.01 30.35 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 177.505 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 83.3 mttt -99.18 -25.94 14.36 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.993 0.917 . . . . 0.0 109.399 178.382 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -119.82 156.41 54.08 Favored Pre-proline 0 CA--C 1.551 0.999 0 C-N-CA 125.013 1.325 . . . . 0.0 109.043 176.095 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -68.14 143.33 59.02 Favored 'Trans proline' 0 C--N 1.378 2.107 0 C-N-CA 122.409 2.073 . . . . 0.0 111.192 172.075 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 259' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -56.75 156.24 23.85 Favored 'Trans proline' 0 C--N 1.378 2.107 0 C-N-CA 123.163 2.576 . . . . 0.0 113.203 177.681 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -78.89 -7.53 58.02 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 122.889 0.476 . . . . 0.0 111.967 -179.234 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 178.93 -133.67 2.15 Favored Glycine 0 C--N 1.346 1.109 0 CA-C-O 119.949 -0.362 . . . . 0.0 112.565 177.875 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 37.1 p -63.71 106.54 1.0 Allowed 'General case' 0 C--N 1.351 0.651 0 C-N-CA 124.344 1.058 . . . . 0.0 110.356 -178.045 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 263' ' ' TRP . . . . . . . . . . . . . 54.7 t90 -98.48 109.4 22.16 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.493 0.717 . . . . 0.0 110.535 -174.169 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 264' ' ' TYR . . . . . 0.406 ' HD2' ' HB3' ' A' ' 268' ' ' CYS . 44.0 m-85 -94.65 106.23 18.2 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.312 0.645 . . . . 0.0 110.036 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 265' ' ' CYS . . . . . 0.425 ' SG ' ' OE2' ' A' ' 267' ' ' GLU . 13.5 p -64.36 157.9 68.83 Favored Pre-proline 0 CA--C 1.565 1.536 0 CA-C-O 118.05 -0.976 . . . . 0.0 109.783 176.453 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -23.67 -63.0 0.05 OUTLIER 'Trans proline' 0 C--N 1.392 2.824 1 C-N-CA 126.26 4.64 . . . . 0.0 117.981 -168.038 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 267' ' ' GLU . . . . . 0.425 ' OE2' ' SG ' ' A' ' 265' ' ' CYS . 0.0 OUTLIER -71.73 -28.11 63.46 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 122.027 -0.421 . . . . 0.0 111.731 -173.116 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 268' ' ' CYS . . . . . 0.406 ' HB3' ' HD2' ' A' ' 264' ' ' TYR . 91.1 m -68.21 -30.33 69.38 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 124.135 0.974 . . . . 0.0 112.315 179.482 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -92.75 -3.9 54.01 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 122.352 0.261 . . . . 0.0 111.595 -178.642 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 74.8 mt -106.51 -47.43 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 C-N-CA 124.032 0.933 . . . . 0.0 109.899 177.076 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 . . . . . 0 CA--C 1.563 1.448 0 C-N-CA 125.372 1.469 . . . . 0.0 108.997 -176.347 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 55.5 tp . . . . . 0 N--CA 1.479 1.003 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 224' ' ' TYR . . . . . 0.708 ' HB3' ' HA ' ' A' ' 245' ' ' TYR . 39.6 m-85 -137.63 126.1 23.48 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.768 0.827 . . . . 0.0 109.417 -178.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 225' ' ' CYS . . . . . 0.402 ' HB2' ' O ' ' A' ' 224' ' ' TYR . 39.0 t 172.47 162.86 0.12 Allowed 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 125.11 1.364 . . . . 0.0 109.294 169.294 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 56.1 t80 -69.01 -35.48 76.72 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 122.736 0.414 . . . . 0.0 111.383 177.442 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 13.5 p -82.79 -13.22 56.66 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 122.58 0.352 . . . . 0.0 111.434 178.304 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 83.8 mm-40 54.99 85.58 0.06 Allowed 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.501 1.12 . . . . 0.0 112.02 -172.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 42.0 ttp180 -150.77 150.64 31.26 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 115.064 -0.971 . . . . 0.0 108.439 174.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 32.9 m -76.17 152.98 5.99 Favored 'Isoleucine or valine' 0 C--O 1.242 0.665 0 CA-C-O 121.334 0.587 . . . . 0.0 110.974 178.2 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 231' ' ' SER . . . . . 0.489 ' HB2' ' HG2' ' A' ' 235' ' ' MET . 14.9 m -101.74 101.48 11.98 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.128 0.971 . . . . 0.0 108.445 175.099 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -72.48 81.05 1.06 Allowed 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.776 0.83 . . . . 0.0 109.661 -177.055 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 74.16 -18.39 2.07 Favored Glycine 0 CA--C 1.537 1.437 0 CA-C-N 115.193 -0.912 . . . . 0.0 114.366 -179.0 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -98.28 66.51 1.77 Allowed 'General case' 0 C--O 1.243 0.743 0 C-N-CA 123.75 0.82 . . . . 0.0 109.62 -176.6 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 235' ' ' MET . . . . . 0.489 ' HG2' ' HB2' ' A' ' 231' ' ' SER . 60.0 mtm -94.26 120.2 34.15 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 114.804 -1.089 . . . . 0.0 109.822 -178.89 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 236' ' ' VAL . . . . . 0.526 HG11 HG21 ' A' ' 253' ' ' VAL . 3.3 p -106.1 124.21 61.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 168.567 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -90.71 155.78 18.57 Favored 'General case' 0 C--O 1.242 0.706 0 C-N-CA 123.148 0.579 . . . . 0.0 110.077 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 238' ' ' CYS . . . . . 0.426 ' HB3' ' HA ' ' A' ' 246' ' ' GLU . 35.6 t -127.69 113.97 16.71 Favored 'General case' 0 C--O 1.243 0.735 0 C-N-CA 123.284 0.634 . . . . 0.0 110.069 -178.479 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -73.01 94.46 1.88 Allowed 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 173.645 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -143.68 133.05 5.2 Favored Glycine 0 C--N 1.346 1.11 0 CA-C-O 117.898 -1.501 . . . . 0.0 110.843 175.461 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -64.32 -46.04 8.45 Favored 'Trans proline' 0 C--N 1.377 2.051 0 C-N-CA 122.575 2.183 . . . . 0.0 111.352 -178.631 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 21.4 m120 -101.86 92.2 4.71 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 170.016 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 9.0 t -159.12 90.63 0.98 Allowed 'General case' 0 C--O 1.24 0.601 0 C-N-CA 122.984 0.514 . . . . 0.0 110.172 179.423 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 4.9 tppp? -65.87 -42.36 90.45 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-O 121.687 0.755 . . . . 0.0 109.95 173.643 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 245' ' ' TYR . . . . . 0.708 ' HA ' ' HB3' ' A' ' 224' ' ' TYR . 23.7 m-85 -84.09 24.6 0.91 Allowed 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 114.435 -1.257 . . . . 0.0 112.224 -177.646 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 246' ' ' GLU . . . . . 0.426 ' HA ' ' HB3' ' A' ' 238' ' ' CYS . 16.2 pt-20 -47.97 -33.75 8.26 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 124.537 1.135 . . . . 0.0 112.203 -179.562 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 247' ' ' TRP . . . . . . . . . . . . . 99.3 m95 -87.37 123.07 31.93 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.339 0.655 . . . . 0.0 110.016 172.381 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 49.8 m-85 -131.94 175.89 8.83 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.256 1.422 . . . . 0.0 109.23 176.463 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 249' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -110.94 144.5 39.91 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.093 0.957 . . . . 0.0 109.046 171.751 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 250' ' ' TYR . . . . . 0.481 ' HA ' HG22 ' A' ' 253' ' ' VAL . 74.8 m-85 -56.7 -27.06 58.29 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 124.652 1.181 . . . . 0.0 111.854 178.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -53.76 -59.37 4.7 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.861 1.264 . . . . 0.0 111.5 172.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 252' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -65.1 -35.11 80.08 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.789 0.836 . . . . 0.0 111.491 -175.682 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 253' ' ' VAL . . . . . 0.526 HG21 HG11 ' A' ' 236' ' ' VAL . 11.9 m -97.2 2.76 10.23 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.715 -172.232 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 64.7 t30 64.75 16.85 10.66 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 124.699 1.2 . . . . 0.0 112.455 168.682 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 88.6 mt -83.73 116.1 22.52 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 -177.447 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 46.4 mmtm -76.14 -8.41 56.95 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.719 0.808 . . . . 0.0 111.65 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -156.55 166.37 16.67 Favored Pre-proline 0 CA--C 1.556 1.176 0 C-N-CA 124.884 1.273 . . . . 0.0 108.983 -173.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -52.31 147.45 28.55 Favored 'Trans proline' 0 C--N 1.382 2.337 0 C-N-CA 122.717 2.278 . . . . 0.0 112.298 171.734 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 259' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -58.69 172.92 1.31 Allowed 'Trans proline' 0 C--N 1.381 2.253 0 C-N-CA 123.137 2.558 . . . . 0.0 113.991 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp -101.1 22.02 12.97 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.743 0.817 . . . . 0.0 111.506 -175.157 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 154.12 -156.29 26.73 Favored Glycine 0 C--N 1.349 1.276 0 N-CA-C 111.242 -0.743 . . . . 0.0 111.242 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 13.6 p -64.32 106.3 1.08 Allowed 'General case' 0 C--N 1.355 0.825 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 170.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 263' ' ' TRP . . . . . . . . . . . . . 80.4 t90 -85.94 126.48 34.13 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.012 -173.691 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 -106.32 128.24 53.85 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 173.589 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 23.4 p -75.09 152.4 86.32 Favored Pre-proline 0 N--CA 1.48 1.067 0 CA-C-O 117.832 -1.08 . . . . 0.0 108.443 173.754 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_exo -31.85 -63.38 0.12 Allowed 'Trans proline' 0 C--N 1.393 2.885 0 C-N-CA 125.238 3.959 . . . . 0.0 116.434 -169.48 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -57.68 -33.3 68.2 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 124.873 1.269 . . . . 0.0 113.603 -179.29 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 268' ' ' CYS . . . . . . . . . . . . . 89.5 m -70.07 -41.5 74.02 Favored 'General case' 0 N--CA 1.5 2.041 0 C-N-CA 122.807 0.443 . . . . 0.0 111.347 172.383 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -70.45 -32.92 70.68 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.578 -175.537 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 76.1 mt -81.35 -51.82 14.82 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 C-N-CA 123.635 0.774 . . . . 0.0 109.53 177.635 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 . . . . . 0 CA--C 1.554 1.121 0 C-N-CA 124.412 1.085 . . . . 0.0 108.896 -176.367 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 53.4 tp . . . . . 0 C--O 1.238 0.491 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 224' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -140.35 122.86 16.12 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 177.273 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 49.5 t 172.96 161.32 0.12 Allowed 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.652 1.181 . . . . 0.0 109.538 175.764 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -66.0 -37.96 87.25 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 122.71 0.404 . . . . 0.0 110.583 175.007 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 5.4 p -81.84 -4.24 56.0 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 111.634 0.235 . . . . 0.0 111.634 174.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 78.4 mm-40 52.37 81.71 0.08 Allowed 'General case' 0 C--N 1.36 1.041 0 C-N-CA 125.205 1.402 . . . . 0.0 112.549 -175.181 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 229' ' ' ARG . . . . . 0.446 ' HB2' ' CE1' ' A' ' 249' ' ' HIS . 33.1 mmt180 -138.17 155.71 48.44 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.161 0.984 . . . . 0.0 109.343 175.115 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 27.7 m -83.56 -178.59 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.644 177.665 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 41.8 t -80.6 94.07 6.23 Favored 'General case' 0 CA--C 1.553 1.061 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.196 176.692 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -101.98 92.21 4.69 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.394 0.678 . . . . 0.0 109.479 179.182 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 73.88 -7.01 16.52 Favored Glycine 0 C--N 1.35 1.318 0 N-CA-C 114.44 0.536 . . . . 0.0 114.44 175.488 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -154.6 142.88 20.44 Favored 'General case' 0 C--O 1.242 0.674 0 C-N-CA 124.132 0.973 . . . . 0.0 109.456 -175.116 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 235' ' ' MET . . . . . . . . . . . . . 25.4 ptt? -158.14 128.43 6.15 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.262 0.625 . . . . 0.0 110.204 175.604 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 3.3 p -115.11 124.34 71.64 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.767 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 173.783 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -89.8 156.54 18.44 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.361 0.664 . . . . 0.0 110.332 -179.457 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 238' ' ' CYS . . . . . 0.62 ' HB3' ' HA ' ' A' ' 246' ' ' GLU . 13.1 t -125.71 149.47 48.48 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.458 0.703 . . . . 0.0 111.543 -173.775 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -121.01 104.23 9.64 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.221 1.009 . . . . 0.0 109.043 176.537 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -141.99 162.57 27.11 Favored Glycine 0 C--O 1.244 0.719 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 174.802 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -61.69 -52.97 2.52 Favored 'Trans proline' 0 C--N 1.371 1.735 0 C-N-CA 122.033 1.822 . . . . 0.0 111.856 174.407 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 37.8 t30 -116.38 118.23 32.15 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 178.638 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 18.7 t -167.94 107.51 0.54 Allowed 'General case' 0 N--CA 1.47 0.556 0 O-C-N 123.167 0.292 . . . . 0.0 111.289 -175.267 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 14.9 ptpt -86.85 -26.99 23.74 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 165.021 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -83.17 28.95 0.5 Allowed 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.318 1.447 . . . . 0.0 112.683 179.033 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 246' ' ' GLU . . . . . 0.62 ' HA ' ' HB3' ' A' ' 238' ' ' CYS . 41.3 mt-10 -50.11 -37.3 33.46 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.675 0.79 . . . . 0.0 111.72 176.592 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 247' ' ' TRP . . . . . . . . . . . . . 84.7 m95 -96.85 134.13 40.57 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.566 -178.267 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -144.09 176.29 9.41 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.502 1.521 . . . . 0.0 108.939 175.718 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 249' ' ' HIS . . . . . 0.446 ' CE1' ' HB2' ' A' ' 229' ' ' ARG . 0.2 OUTLIER -119.56 147.44 44.48 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 171.357 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 250' ' ' TYR . . . . . 0.419 ' HB3' ' O ' ' A' ' 255' ' ' LEU . 20.1 m-85 -62.26 -33.93 75.57 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.026 1.33 . . . . 0.0 112.214 -168.494 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -59.85 -43.91 94.4 Favored 'General case' 0 N--CA 1.476 0.826 0 O-C-N 123.971 0.794 . . . . 0.0 111.31 179.53 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 252' ' ' CYS . . . . . . . . . . . . . 1.3 m -70.15 -38.34 75.45 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.577 -177.741 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 35.5 m -99.7 8.78 8.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 122.803 0.441 . . . . 0.0 111.794 -175.066 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 59.97 22.96 12.06 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 124.894 1.278 . . . . 0.0 113.234 170.236 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.419 ' O ' ' HB3' ' A' ' 250' ' ' TYR . 93.1 mt -84.3 110.35 18.51 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 174.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -70.25 -33.2 71.34 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 121.44 0.638 . . . . 0.0 109.93 175.223 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -132.04 159.62 71.32 Favored Pre-proline 0 CA--C 1.555 1.169 0 C-N-CA 124.402 1.081 . . . . 0.0 109.39 -176.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 258' ' ' PRO . . . . . 0.412 ' HA ' ' HD3' ' A' ' 259' ' ' PRO . 26.5 Cg_endo -59.94 148.49 88.57 Favored 'Trans proline' 0 C--N 1.384 2.41 0 C-N-CA 122.813 2.342 . . . . 0.0 112.787 178.617 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 259' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 258' ' ' PRO . 42.0 Cg_exo -58.79 167.83 4.93 Favored 'Trans proline' 0 C--N 1.385 2.5 0 C-N-CA 123.591 2.861 . . . . 0.0 113.727 -178.246 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -100.54 18.01 20.26 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.343 0.657 . . . . 0.0 111.34 -177.658 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 158.3 -143.9 9.86 Favored Glycine 0 C--N 1.348 1.232 0 N-CA-C 112.169 -0.373 . . . . 0.0 112.169 176.205 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 32.8 p -66.12 107.78 2.04 Favored 'General case' 0 C--N 1.35 0.596 0 C-N-CA 123.679 0.792 . . . . 0.0 110.018 178.162 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 263' ' ' TRP . . . . . . . . . . . . . 55.3 t90 -95.0 122.22 37.43 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.775 0.83 . . . . 0.0 110.676 -170.072 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -96.88 106.21 18.48 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.15 0.58 . . . . 0.0 109.747 177.36 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 265' ' ' CYS . . . . . 0.434 ' SG ' ' OE2' ' A' ' 267' ' ' GLU . 13.1 p -70.42 160.17 82.23 Favored Pre-proline 0 CA--C 1.553 1.059 0 CA-C-O 117.861 -1.066 . . . . 0.0 110.109 177.421 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 266' ' ' PRO . . . . . 0.404 ' HD2' ' HB2' ' A' ' 265' ' ' CYS . 6.1 Cg_exo -19.09 -70.11 0.02 OUTLIER 'Trans proline' 0 C--N 1.392 2.866 1 C-N-CA 126.388 4.725 . . . . 0.0 117.536 -174.224 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 267' ' ' GLU . . . . . 0.434 ' OE2' ' SG ' ' A' ' 265' ' ' CYS . 0.0 OUTLIER -68.06 -30.25 69.41 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -173.31 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 268' ' ' CYS . . . . . . . . . . . . . 75.0 m -70.54 -38.3 74.18 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.569 0.748 . . . . 0.0 111.071 175.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -71.95 -41.5 67.71 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.402 -175.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 23.6 pt -86.68 1.08 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.611 -177.897 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 . . . . . 0 C--O 1.249 1.043 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 174.287 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 31.5 tp . . . . . 0 CA--C 1.543 0.709 0 CA-C-O 120.727 0.298 . . . . 0.0 110.353 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 224' ' ' TYR . . . . . 0.422 ' HB3' ' HA ' ' A' ' 245' ' ' TYR . 75.0 m-85 -141.69 129.77 22.07 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 174.669 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 225' ' ' CYS . . . . . 0.402 ' HB2' ' O ' ' A' ' 224' ' ' TYR . 35.6 t 172.2 153.13 0.07 Allowed 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 125.029 1.332 . . . . 0.0 108.447 169.658 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 80.1 t80 -63.44 -35.11 79.36 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 122.826 0.45 . . . . 0.0 111.786 -178.743 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 13.7 p -79.18 -16.48 56.52 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 122.531 0.333 . . . . 0.0 111.283 179.128 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 85.0 mm-40 54.09 80.55 0.11 Allowed 'General case' 0 C--N 1.362 1.151 0 C-N-CA 124.701 1.2 . . . . 0.0 111.543 -171.511 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 229' ' ' ARG . . . . . 0.462 ' HD3' ' O ' ' A' ' 230' ' ' VAL . 4.5 tmt_? -150.02 148.76 29.42 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 -178.821 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 230' ' ' VAL . . . . . 0.462 ' O ' ' HD3' ' A' ' 229' ' ' ARG . 33.4 m -73.33 178.63 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 N-CA-C 112.759 0.652 . . . . 0.0 112.759 -172.009 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 19.6 m -139.22 49.11 1.85 Allowed 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 123.323 0.649 . . . . 0.0 109.54 -176.526 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 20.0 p90 -65.93 119.37 11.19 Favored 'General case' 0 CA--C 1.551 1.002 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.557 -173.643 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 77.18 -22.9 2.34 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 124.479 1.037 . . . . 0.0 115.327 178.209 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 61.7 mm-40 -143.62 99.78 3.48 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.047 0.939 . . . . 0.0 109.861 -178.075 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 235' ' ' MET . . . . . . . . . . . . . 18.5 ptp -122.91 132.27 54.1 Favored 'General case' 0 C--O 1.242 0.709 0 C-N-CA 124.457 1.103 . . . . 0.0 109.423 172.149 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 4.0 p -100.69 124.19 54.12 Favored 'Isoleucine or valine' 0 C--O 1.24 0.572 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 171.697 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -92.17 133.06 36.14 Favored 'General case' 0 C--O 1.242 0.663 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.048 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 238' ' ' CYS . . . . . 0.572 ' SG ' ' HA ' ' A' ' 264' ' ' TYR . 40.9 t -108.26 102.49 11.61 Favored 'General case' 0 C--O 1.243 0.719 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 176.438 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 239' ' ' ASP . . . . . 0.425 ' HB3' HG23 ' A' ' 262' ' ' THR . 30.2 t70 -82.37 94.32 7.36 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 240' ' ' GLY . . . . . 0.433 ' HA3' ' SG ' ' A' ' 268' ' ' CYS . . . -128.07 141.48 12.64 Favored Glycine 0 CA--C 1.527 0.811 0 CA-C-O 118.186 -1.341 . . . . 0.0 110.489 175.768 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -52.97 -42.74 62.23 Favored 'Trans proline' 0 C--N 1.379 2.145 0 C-N-CA 123.208 2.605 . . . . 0.0 112.166 -179.387 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -115.94 112.62 22.14 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.554 1.142 . . . . 0.0 108.02 171.32 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 243' ' ' CYS . . . . . 0.553 ' SG ' ' HA ' ' A' ' 246' ' ' GLU . 8.0 t -168.75 81.15 0.14 Allowed 'General case' 0 C--N 1.352 0.681 0 CA-C-O 121.496 0.665 . . . . 0.0 110.4 -175.693 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.5 -29.4 68.82 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 123.778 0.831 . . . . 0.0 112.574 178.884 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 245' ' ' TYR . . . . . 0.422 ' HA ' ' HB3' ' A' ' 224' ' ' TYR . 41.9 m-85 -101.75 24.59 9.65 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.86 0.864 . . . . 0.0 111.458 179.58 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 246' ' ' GLU . . . . . 0.553 ' HA ' ' SG ' ' A' ' 243' ' ' CYS . 14.8 pt-20 -47.21 -37.46 10.35 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 125.049 1.34 . . . . 0.0 114.235 -170.835 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 247' ' ' TRP . . . . . . . . . . . . . 99.0 m95 -80.01 122.17 26.4 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.102 0.561 . . . . 0.0 109.726 176.454 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -129.21 173.88 10.09 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.039 0.936 . . . . 0.0 109.713 178.105 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 249' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -124.04 152.52 42.53 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.395 1.078 . . . . 0.0 108.728 173.863 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -62.87 -27.15 69.15 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.687 1.195 . . . . 0.0 110.818 -173.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -61.2 -47.32 86.66 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.985 1.314 . . . . 0.0 110.947 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 252' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -71.27 -43.38 67.29 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 114.563 -1.199 . . . . 0.0 111.421 -176.106 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 253' ' ' VAL . . . . . 0.557 HG23 ' HG ' ' A' ' 255' ' ' LEU . 35.6 m -100.02 6.59 9.46 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.806 -172.32 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 12.0 m120 60.75 31.62 20.12 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 124.771 1.229 . . . . 0.0 113.102 171.1 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.557 ' HG ' HG23 ' A' ' 253' ' ' VAL . 70.4 mt -79.22 116.21 19.34 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 176.56 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 50.9 tttp -70.59 -42.62 70.79 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.954 0.902 . . . . 0.0 109.591 174.489 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -126.7 157.16 72.12 Favored Pre-proline 0 C--O 1.248 0.998 0 CA-C-N 114.49 -1.232 . . . . 0.0 109.788 -176.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -56.93 146.09 81.4 Favored 'Trans proline' 0 C--N 1.378 2.104 0 C-N-CA 122.912 2.408 . . . . 0.0 112.712 171.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 259' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -67.08 148.65 81.66 Favored 'Trans proline' 0 C--N 1.372 1.787 0 C-N-CA 122.255 1.97 . . . . 0.0 111.442 172.105 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 85.4 mttt -87.86 -32.2 19.13 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.877 0.871 . . . . 0.0 110.299 -179.542 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -120.03 -171.21 14.56 Favored Glycine 0 C--N 1.345 1.055 0 CA-C-N 115.339 -0.846 . . . . 0.0 112.086 -178.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 262' ' ' THR . . . . . 0.425 HG23 ' HB3' ' A' ' 239' ' ' ASP . 76.9 m -62.95 109.81 1.58 Allowed 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.978 0.911 . . . . 0.0 109.92 179.043 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 263' ' ' TRP . . . . . . . . . . . . . 59.0 t90 -82.2 145.54 30.01 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.018 0.527 . . . . 0.0 110.005 -176.068 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 264' ' ' TYR . . . . . 0.572 ' HA ' ' SG ' ' A' ' 238' ' ' CYS . 98.6 m-85 -129.78 152.55 49.16 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.898 0.879 . . . . 0.0 110.339 -178.697 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 15.3 p -114.55 162.16 24.95 Favored Pre-proline 0 N--CA 1.482 1.136 0 CA-C-O 117.701 -1.142 . . . . 0.0 107.959 175.537 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -30.12 -65.44 0.08 OUTLIER 'Trans proline' 0 C--N 1.391 2.812 0 C-N-CA 125.151 3.901 . . . . 0.0 117.342 -175.89 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 267' ' ' GLU . . . . . 0.4 ' H ' ' HG3' ' A' ' 267' ' ' GLU . 0.0 OUTLIER -66.2 -12.4 55.83 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 -172.773 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 268' ' ' CYS . . . . . 0.433 ' SG ' ' HA3' ' A' ' 240' ' ' GLY . 74.7 m -88.46 -42.2 12.29 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.669 0.788 . . . . 0.0 112.596 169.422 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 269' ' ' LYS . . . . . 0.564 ' HG3' HG23 ' A' ' 270' ' ' ILE . 14.7 ptmm? -97.67 -50.4 4.48 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 114.158 1.17 . . . . 0.0 114.158 -162.636 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 270' ' ' ILE . . . . . 0.564 HG23 ' HG3' ' A' ' 269' ' ' LYS . 19.2 pt -88.9 21.21 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -169.292 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 . . . . . 0 C--O 1.25 1.118 0 C-N-CA 123.805 0.842 . . . . 0.0 109.71 179.051 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 44.1 tp . . . . . 0 N--CA 1.475 0.821 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 224' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -142.13 142.95 32.8 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.012 0.925 . . . . 0.0 109.427 -175.078 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 45.5 t 171.8 163.84 0.1 Allowed 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 125.469 1.508 . . . . 0.0 108.352 173.577 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 41.4 t80 -66.78 -31.23 71.73 Favored 'General case' 0 CA--C 1.557 1.221 0 CA-C-N 118.668 0.667 . . . . 0.0 110.302 175.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 227' ' ' CYS . . . . . 0.543 ' SG ' ' HB2' ' A' ' 229' ' ' ARG . 4.6 p -89.49 -3.83 58.2 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 122.919 0.487 . . . . 0.0 111.444 174.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 81.4 mm-40 46.45 81.86 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 125.023 1.329 . . . . 0.0 111.817 -175.645 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 229' ' ' ARG . . . . . 0.543 ' HB2' ' SG ' ' A' ' 227' ' ' CYS . 1.0 OUTLIER -150.02 158.03 43.75 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 -171.504 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 27.2 m -71.83 150.53 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 O-C-N 123.524 0.515 . . . . 0.0 111.464 178.746 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 231' ' ' SER . . . . . 0.433 ' HB2' ' HG2' ' A' ' 235' ' ' MET . 20.5 m -100.86 77.72 1.88 Allowed 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 175.512 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 82.5 t80 -71.67 101.11 2.46 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.423 0.689 . . . . 0.0 110.642 -174.243 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 80.66 -19.24 7.51 Favored Glycine 0 C--N 1.344 1.014 0 CA-C-N 115.513 -0.767 . . . . 0.0 114.247 175.409 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 234' ' ' GLU . . . . . 0.419 ' HB3' ' CD1' ' A' ' 250' ' ' TYR . 59.3 mm-40 -128.03 94.98 4.06 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.127 0.971 . . . . 0.0 109.351 -175.304 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 235' ' ' MET . . . . . 0.433 ' HG2' ' HB2' ' A' ' 231' ' ' SER . 44.7 mtt -118.2 97.76 5.95 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.357 0.663 . . . . 0.0 110.108 -174.537 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 236' ' ' VAL . . . . . 0.421 HG11 HG21 ' A' ' 253' ' ' VAL . 7.4 p -92.56 124.54 45.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 171.83 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -99.47 141.07 32.74 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 123.884 0.874 . . . . 0.0 109.853 179.094 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 238' ' ' CYS . . . . . 0.663 ' HB3' ' HA ' ' A' ' 246' ' ' GLU . 5.5 t -105.36 114.48 28.69 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 123.864 0.866 . . . . 0.0 109.785 179.571 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -72.6 95.63 1.86 Allowed 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.096 0.558 . . . . 0.0 109.516 176.615 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -139.06 116.48 1.25 Allowed Glycine 0 CA--C 1.53 0.988 0 CA-C-O 118.711 -1.049 . . . . 0.0 111.282 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -60.03 -29.08 88.45 Favored 'Trans proline' 0 C--N 1.377 2.055 0 C-N-CA 123.382 2.721 . . . . 0.0 112.621 178.479 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -120.35 88.71 2.99 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 171.56 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 42.1 t -172.17 112.15 0.28 Allowed 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.485 0.714 . . . . 0.0 110.456 -172.464 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 20.8 pttm -89.25 -25.01 21.95 Favored 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 167.755 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -79.33 27.47 0.26 Allowed 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 124.83 1.252 . . . . 0.0 112.527 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 246' ' ' GLU . . . . . 0.663 ' HA ' ' HB3' ' A' ' 238' ' ' CYS . 41.1 mt-10 -53.35 -46.55 69.57 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.163 0.585 . . . . 0.0 110.601 172.191 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 247' ' ' TRP . . . . . . . . . . . . . 97.8 m95 -72.42 122.18 20.8 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.366 179.229 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -142.38 171.32 14.21 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 125.206 1.402 . . . . 0.0 109.174 170.305 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 249' ' ' HIS . . . . . 0.419 ' HB3' ' HA ' ' A' ' 231' ' ' SER . 0.1 OUTLIER -123.12 142.42 50.91 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.249 1.019 . . . . 0.0 108.859 178.804 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 250' ' ' TYR . . . . . 0.419 ' CD1' ' HB3' ' A' ' 234' ' ' GLU . 8.8 m-85 -58.49 -26.69 63.72 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 124.98 1.312 . . . . 0.0 112.128 -174.087 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -59.46 -56.64 19.45 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.013 0.925 . . . . 0.0 110.833 174.804 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 252' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -61.39 -49.15 78.07 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.968 0.907 . . . . 0.0 111.595 -178.624 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 253' ' ' VAL . . . . . 0.479 HG23 ' HG ' ' A' ' 255' ' ' LEU . 26.8 m -88.64 5.32 4.41 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.909 -174.213 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 44.8 m-80 64.39 16.01 9.89 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 125.006 1.322 . . . . 0.0 113.415 169.135 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.479 ' HG ' HG23 ' A' ' 253' ' ' VAL . 89.8 mt -74.24 108.02 6.77 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 122.891 0.476 . . . . 0.0 109.868 -176.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 62.1 mttm -72.15 -25.62 61.78 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.973 0.909 . . . . 0.0 110.326 176.889 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -131.59 159.69 70.71 Favored Pre-proline 0 CA--C 1.552 1.039 0 C-N-CA 124.619 1.167 . . . . 0.0 109.337 -177.225 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.31 140.64 44.88 Favored 'Trans proline' 0 C--N 1.369 1.625 0 C-N-CA 122.325 2.017 . . . . 0.0 111.78 169.783 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 259' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -61.66 158.49 36.96 Favored 'Trans proline' 0 C--N 1.38 2.211 0 C-N-CA 122.47 2.113 . . . . 0.0 111.542 169.657 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 31.6 mmmt -93.37 -2.15 55.08 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 112.724 0.638 . . . . 0.0 112.724 -175.794 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -164.53 -147.38 5.09 Favored Glycine 0 C--N 1.345 1.05 0 N-CA-C 112.213 -0.355 . . . . 0.0 112.213 -178.662 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 54.7 p -64.21 107.8 1.4 Allowed 'General case' 0 C--N 1.352 0.699 0 C-N-CA 123.401 0.681 . . . . 0.0 110.552 178.875 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 263' ' ' TRP . . . . . . . . . . . . . 63.3 t90 -87.45 144.78 26.57 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 176.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 264' ' ' TYR . . . . . 0.438 ' HA ' ' SG ' ' A' ' 238' ' ' CYS . 95.1 m-85 -126.14 129.39 48.97 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.433 0.693 . . . . 0.0 109.654 -178.772 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 16.7 p -85.76 156.12 58.58 Favored Pre-proline 0 CA--C 1.555 1.163 0 CA-C-O 118.47 -0.776 . . . . 0.0 109.248 177.813 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 0.8 OUTLIER -23.7 -64.88 0.04 OUTLIER 'Trans proline' 0 C--N 1.392 2.845 1 C-N-CA 126.314 4.676 . . . . 0.0 118.098 -168.456 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.02 -32.18 73.23 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 122.574 0.35 . . . . 0.0 111.565 -171.619 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 268' ' ' CYS . . . . . . . . . . . . . 58.6 m -72.31 -38.59 68.68 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.763 0.825 . . . . 0.0 110.601 176.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 61.5 tttp -71.78 -34.31 69.32 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 115.042 -0.981 . . . . 0.0 111.294 -173.114 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 25.7 pt -90.0 -9.88 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 123.106 0.563 . . . . 0.0 111.408 -179.092 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 . . . . . 0 C--O 1.25 1.097 0 C-N-CA 123.739 0.815 . . . . 0.0 110.132 -177.586 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 51.3 tp . . . . . 0 N--CA 1.473 0.684 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 224' ' ' TYR . . . . . 0.426 ' HB3' ' HA ' ' A' ' 245' ' ' TYR . 47.4 m-85 -137.93 127.57 25.13 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.036 0.934 . . . . 0.0 109.2 178.714 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 225' ' ' CYS . . . . . 0.416 ' HB2' ' O ' ' A' ' 224' ' ' TYR . 14.0 t 174.08 158.08 0.15 Allowed 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.386 1.075 . . . . 0.0 109.953 172.174 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -64.23 -38.89 92.67 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 122.997 0.519 . . . . 0.0 111.412 175.626 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 9.8 p -77.54 -13.9 59.8 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.086 177.309 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 10.9 mm100 52.65 66.82 1.11 Allowed 'General case' 0 C--N 1.368 1.394 0 C-N-CA 124.668 1.187 . . . . 0.0 111.688 -174.776 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 78.4 ttt180 -130.26 153.58 48.47 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.659 0.784 . . . . 0.0 109.41 -179.437 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 29.3 m -66.21 155.42 7.08 Favored 'Isoleucine or valine' 0 C--O 1.241 0.65 0 C-N-CA 123.38 0.672 . . . . 0.0 111.655 177.592 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 231' ' ' SER . . . . . 0.71 ' HB3' ' HB3' ' A' ' 235' ' ' MET . 46.2 m -105.66 69.18 0.82 Allowed 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.52 178.971 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 20.2 p90 -70.02 110.32 5.02 Favored 'General case' 0 CA--C 1.549 0.918 0 CA-C-N 114.353 -1.294 . . . . 0.0 111.237 -176.49 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 76.92 -20.69 2.86 Favored Glycine 0 N--CA 1.478 1.49 0 N-CA-C 115.204 0.842 . . . . 0.0 115.204 171.764 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 234' ' ' GLU . . . . . 0.416 ' HB3' ' HD2' ' A' ' 250' ' ' TYR . 49.3 mt-10 -142.75 127.45 18.1 Favored 'General case' 0 C--O 1.243 0.743 0 C-N-CA 124.251 1.02 . . . . 0.0 108.928 -178.834 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 235' ' ' MET . . . . . 0.71 ' HB3' ' HB3' ' A' ' 231' ' ' SER . 22.4 ptt? -151.91 129.57 11.54 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 123.313 0.645 . . . . 0.0 110.432 175.739 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 5.4 p -103.31 126.46 57.68 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 C-N-CA 123.866 0.867 . . . . 0.0 108.869 175.502 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -88.57 164.64 15.29 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.624 0.77 . . . . 0.0 110.281 179.1 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 238' ' ' CYS . . . . . 0.428 ' HB3' ' HA ' ' A' ' 246' ' ' GLU . 15.4 t -136.83 105.54 5.85 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.353 0.661 . . . . 0.0 109.349 179.322 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -79.99 94.96 6.0 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.791 -178.67 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -141.25 137.19 7.96 Favored Glycine 0 C--N 1.348 1.223 0 CA-C-O 118.678 -1.068 . . . . 0.0 111.456 178.169 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -60.03 -38.71 76.18 Favored 'Trans proline' 0 C--N 1.376 1.978 0 C-N-CA 123.232 2.622 . . . . 0.0 113.384 179.176 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -109.49 95.88 5.91 Favored 'General case' 0 C--O 1.243 0.739 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 175.109 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 243' ' ' CYS . . . . . 0.456 ' SG ' ' HA ' ' A' ' 246' ' ' GLU . 12.2 t -166.06 101.8 0.65 Allowed 'General case' 0 C--O 1.237 0.429 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.941 -171.0 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 21.7 pttm -86.16 -37.98 18.18 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 171.884 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 245' ' ' TYR . . . . . 0.426 ' HA ' ' HB3' ' A' ' 224' ' ' TYR . 53.9 m-85 -87.66 29.15 0.92 Allowed 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 124.29 1.036 . . . . 0.0 111.874 -179.106 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 246' ' ' GLU . . . . . 0.456 ' HA ' ' SG ' ' A' ' 243' ' ' CYS . 10.4 pt-20 -49.37 -36.57 22.03 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.087 0.955 . . . . 0.0 112.844 179.105 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 247' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -91.09 135.16 33.95 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.381 0.61 . . . . 0.0 111.043 178.244 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -142.8 174.09 10.96 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 125.665 1.586 . . . . 0.0 108.449 174.105 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 249' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -117.2 141.84 47.78 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.817 0.847 . . . . 0.0 108.832 174.563 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 250' ' ' TYR . . . . . 0.416 ' HD2' ' HB3' ' A' ' 234' ' ' GLU . 86.3 m-85 -57.2 -26.85 61.33 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 124.658 1.183 . . . . 0.0 112.074 -177.22 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -56.3 -58.4 8.15 Favored 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 123.861 0.864 . . . . 0.0 111.46 174.408 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 252' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -61.37 -41.94 97.91 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 124.203 1.001 . . . . 0.0 112.117 -173.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 35.8 m -92.23 -5.77 10.72 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.733 -175.161 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 10.8 t30 52.41 70.12 0.6 Allowed 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 124.611 1.164 . . . . 0.0 111.243 178.659 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 96.3 mt -129.92 122.87 29.42 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 178.128 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 64.2 tttp -90.64 -27.48 19.02 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 123.272 0.629 . . . . 0.0 110.166 178.377 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 16.9 mp0 -105.45 147.07 33.99 Favored Pre-proline 0 N--CA 1.477 0.903 0 C-N-CA 124.189 0.996 . . . . 0.0 109.336 178.537 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -74.63 117.62 5.02 Favored 'Trans proline' 0 C--N 1.373 1.831 0 C-N-CA 122.322 2.015 . . . . 0.0 110.548 170.022 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 259' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_exo -53.6 112.62 1.0 Allowed 'Trans proline' 0 C--N 1.378 2.119 0 C-N-CA 123.1 2.533 . . . . 0.0 113.397 -178.438 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -68.21 103.14 1.5 Allowed 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.869 0.868 . . . . 0.0 109.855 -179.402 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 118.3 -167.46 12.96 Favored Glycine 0 N--CA 1.472 1.034 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 -176.321 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 39.4 p -74.13 106.04 5.61 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 177.214 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 263' ' ' TRP . . . . . . . . . . . . . 52.1 t90 -73.79 134.21 43.36 Favored 'General case' 0 C--N 1.349 0.583 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 173.027 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -110.85 113.86 26.77 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 123.029 0.531 . . . . 0.0 109.777 179.412 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 17.4 p -64.75 160.78 51.17 Favored Pre-proline 0 CA--C 1.55 0.964 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.947 171.278 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -36.63 -38.8 0.37 Allowed 'Trans proline' 0 C--N 1.382 2.317 0 C-N-CA 124.329 3.352 . . . . 0.0 115.991 175.963 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -54.58 -61.73 2.12 Favored 'General case' 0 N--CA 1.485 1.32 0 CA-C-O 121.652 0.739 . . . . 0.0 110.807 176.098 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 268' ' ' CYS . . . . . . . . . . . . . 35.5 m -80.02 -30.85 39.59 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 114.493 -1.23 . . . . 0.0 111.853 -168.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -75.86 -53.08 8.99 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.7 0.8 . . . . 0.0 111.155 -173.364 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 270' ' ' ILE . . . . . 0.434 HG22 ' HG3' ' A' ' 271' ' ' GLU . 50.7 mm -72.16 -52.47 24.3 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.978 -176.468 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 271' ' ' GLU . . . . . 0.434 ' HG3' HG22 ' A' ' 270' ' ' ILE . 45.7 mt-10 . . . . . 0 CA--C 1.555 1.164 0 C-N-CA 123.207 0.603 . . . . 0.0 109.553 -178.518 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.477 0.889 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 224' ' ' TYR . . . . . 0.524 ' HB3' ' HA ' ' A' ' 245' ' ' TYR . 78.5 m-85 -133.76 130.43 38.03 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 123.855 0.862 . . . . 0.0 108.892 179.535 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 225' ' ' CYS . . . . . 0.43 ' HB2' ' O ' ' A' ' 224' ' ' TYR . 26.5 t 172.29 155.69 0.09 Allowed 'General case' 0 N--CA 1.474 0.761 0 O-C-N 124.794 1.309 . . . . 0.0 109.388 168.387 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 61.5 t80 -64.81 -27.67 69.04 Favored 'General case' 0 CA--C 1.556 1.193 0 C-N-CA 123.201 0.6 . . . . 0.0 111.214 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 13.2 p -90.57 -10.69 42.48 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 122.991 0.517 . . . . 0.0 111.442 177.078 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 83.4 mm-40 52.16 85.46 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 124.607 1.163 . . . . 0.0 111.437 -171.041 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 73.6 ttt180 -140.63 150.71 43.9 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.816 -176.607 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 34.3 m -69.18 170.38 1.14 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.61 0 C-N-CA 124.29 1.036 . . . . 0.0 112.754 -177.331 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 39.4 t -86.73 116.52 24.88 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 114.662 -1.154 . . . . 0.0 109.762 174.951 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 232' ' ' PHE . . . . . 0.603 ' HB3' ' HG2' ' A' ' 234' ' ' GLU . 91.8 t80 -75.63 -13.04 60.32 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 123.84 0.856 . . . . 0.0 109.728 166.786 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 109.78 -18.17 29.56 Favored Glycine 0 C--N 1.349 1.277 0 N-CA-C 111.521 -0.632 . . . . 0.0 111.521 -174.416 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 234' ' ' GLU . . . . . 0.603 ' HG2' ' HB3' ' A' ' 232' ' ' PHE . 8.5 pt-20 -77.65 64.55 2.96 Favored 'General case' 0 CA--C 1.555 1.163 0 C-N-CA 124.273 1.029 . . . . 0.0 110.129 174.683 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 235' ' ' MET . . . . . . . . . . . . . 73.2 mtm -91.61 100.96 13.6 Favored 'General case' 0 N--CA 1.475 0.801 0 O-C-N 121.823 -0.548 . . . . 0.0 110.682 -173.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 2.8 p -88.07 124.28 41.09 Favored 'Isoleucine or valine' 0 C--O 1.241 0.652 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 168.124 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -99.32 110.9 23.37 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 123.564 0.746 . . . . 0.0 110.074 -176.288 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 238' ' ' CYS . . . . . 0.461 ' HB3' ' HA ' ' A' ' 246' ' ' GLU . 42.3 t -71.64 153.75 41.88 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.242 169.857 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 239' ' ' ASP . . . . . 0.557 ' HB3' ' HB ' ' A' ' 262' ' ' THR . 23.5 t70 -134.23 95.61 3.44 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.606 0.762 . . . . 0.0 109.176 176.317 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 240' ' ' GLY . . . . . 0.556 ' HA3' ' SG ' ' A' ' 268' ' ' CYS . . . -142.05 140.71 10.26 Favored Glycine 0 CA--C 1.534 1.222 0 CA-C-O 118.442 -1.199 . . . . 0.0 111.917 175.192 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -59.44 -51.69 5.93 Favored 'Trans proline' 0 C--N 1.377 2.03 0 C-N-CA 122.746 2.297 . . . . 0.0 112.145 178.637 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -89.04 86.49 6.93 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 171.663 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 10.4 t -174.75 104.6 0.1 Allowed 'General case' 0 C--N 1.351 0.637 0 O-C-N 123.88 0.738 . . . . 0.0 109.688 -176.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -85.75 -31.93 22.13 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-O 121.842 0.83 . . . . 0.0 110.359 173.421 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 245' ' ' TYR . . . . . 0.524 ' HA ' ' HB3' ' A' ' 224' ' ' TYR . 59.7 m-85 -86.65 26.4 1.11 Allowed 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.053 1.341 . . . . 0.0 112.368 -171.126 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 246' ' ' GLU . . . . . 0.461 ' HA ' ' HB3' ' A' ' 238' ' ' CYS . 5.6 mm-40 -45.96 -42.34 12.85 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 125.105 1.362 . . . . 0.0 112.697 -174.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 247' ' ' TRP . . . . . 0.497 ' HB2' ' HB2' ' A' ' 224' ' ' TYR . 96.0 m95 -70.92 117.93 13.06 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.112 0.565 . . . . 0.0 110.262 175.331 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -131.23 173.49 10.99 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.349 1.06 . . . . 0.0 109.92 175.37 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 249' ' ' HIS . . . . . 0.438 ' HA ' ' O ' ' A' ' 234' ' ' GLU . 0.1 OUTLIER -121.9 139.57 53.48 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.165 0.986 . . . . 0.0 109.031 175.639 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -54.63 -49.39 70.62 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 124.787 1.235 . . . . 0.0 113.063 -168.867 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -53.49 -40.83 65.66 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 124.127 0.971 . . . . 0.0 112.107 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 252' ' ' CYS . . . . . . . . . . . . . 2.8 t -66.17 -32.11 73.36 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 124.34 1.056 . . . . 0.0 111.582 -175.818 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 29.8 m -110.48 13.36 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 123.666 0.786 . . . . 0.0 111.362 -174.618 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 67.4 11.65 8.49 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 124.644 1.177 . . . . 0.0 112.398 173.748 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 95.0 mt -84.01 157.36 21.86 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-O 121.558 0.695 . . . . 0.0 109.337 174.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 27.0 tptp -145.86 -29.97 0.41 Allowed 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.199 0.999 . . . . 0.0 108.651 174.149 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -93.59 141.44 23.86 Favored Pre-proline 0 C--O 1.245 0.84 0 C-N-CA 124.09 0.956 . . . . 0.0 108.895 177.721 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -65.09 124.1 12.53 Favored 'Trans proline' 0 C--N 1.373 1.824 0 C-N-CA 122.4 2.066 . . . . 0.0 111.361 177.323 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 259' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -51.01 131.11 33.87 Favored 'Trans proline' 0 C--N 1.38 2.235 0 C-N-CA 123.455 2.77 . . . . 0.0 113.743 178.918 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.77 -4.79 39.69 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.023 0.929 . . . . 0.0 112.866 -175.002 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -153.25 -170.39 19.41 Favored Glycine 0 N--CA 1.471 0.989 0 N-CA-C 111.149 -0.78 . . . . 0.0 111.149 176.051 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 262' ' ' THR . . . . . 0.557 ' HB ' ' HB3' ' A' ' 239' ' ' ASP . 40.8 p -65.58 106.59 1.48 Allowed 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 175.414 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 263' ' ' TRP . . . . . . . . . . . . . 49.8 t90 -74.38 137.87 43.02 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.201 0.601 . . . . 0.0 111.238 -169.833 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 41.1 m-85 -114.85 109.27 17.89 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.815 0.846 . . . . 0.0 109.398 -176.73 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 265' ' ' CYS . . . . . 0.431 ' SG ' ' OE2' ' A' ' 267' ' ' GLU . 16.0 p -72.44 162.5 73.63 Favored Pre-proline 0 CA--C 1.559 1.302 0 C-N-CA 123.563 0.745 . . . . 0.0 110.183 176.505 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_exo -36.93 -51.83 1.37 Allowed 'Trans proline' 0 C--N 1.393 2.869 0 C-N-CA 124.511 3.474 . . . . 0.0 116.45 -178.615 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 267' ' ' GLU . . . . . 0.431 ' OE2' ' SG ' ' A' ' 265' ' ' CYS . 0.0 OUTLIER -72.11 -18.54 61.9 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -175.28 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 268' ' ' CYS . . . . . 0.556 ' SG ' ' HA3' ' A' ' 240' ' ' GLY . 59.2 m -82.36 -44.74 15.78 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.0 0.52 . . . . 0.0 111.542 171.291 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -82.38 -45.14 15.24 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.259 -166.377 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 50.9 mm -76.32 -40.18 35.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 123.604 0.761 . . . . 0.0 110.552 -176.827 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 23.9 mm-40 . . . . . 0 C--O 1.25 1.084 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 177.713 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 1.4 tm? . . . . . 0 N--CA 1.473 0.725 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 224' ' ' TYR . . . . . 0.477 ' HB2' ' HB2' ' A' ' 247' ' ' TRP . 68.1 m-85 -137.71 138.16 39.07 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 178.628 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 51.3 t 170.93 162.0 0.08 Allowed 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 125.662 1.585 . . . . 0.0 108.649 172.603 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -62.53 -40.01 95.41 Favored 'General case' 0 CA--C 1.552 1.036 0 CA-C-N 117.992 0.36 . . . . 0.0 110.808 176.406 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 9.2 p -81.49 -19.88 41.34 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 122.608 0.363 . . . . 0.0 111.195 176.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 24.2 mm-40 59.07 99.69 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 124.905 1.282 . . . . 0.0 112.288 -172.836 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 229' ' ' ARG . . . . . 0.446 ' HD3' ' N ' ' A' ' 230' ' ' VAL . 4.6 tmt_? -163.75 152.91 14.19 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 -173.224 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 230' ' ' VAL . . . . . 0.446 ' N ' ' HD3' ' A' ' 229' ' ' ARG . 30.7 m -64.52 165.84 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 C-N-CA 123.991 0.916 . . . . 0.0 112.645 -177.461 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 26.0 m -139.26 71.9 1.39 Allowed 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 123.275 0.63 . . . . 0.0 109.988 -177.801 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 53.2 m-85 -98.67 128.9 45.11 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.667 0.787 . . . . 0.0 110.406 178.173 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 84.25 -14.71 43.49 Favored Glycine 0 CA--C 1.535 1.321 0 O-C-N 123.212 0.32 . . . . 0.0 113.376 178.7 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -153.38 138.54 17.4 Favored 'General case' 0 C--N 1.351 0.645 0 C-N-CA 124.459 1.103 . . . . 0.0 108.83 179.124 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 235' ' ' MET . . . . . . . . . . . . . 21.1 ptp -163.11 133.13 4.37 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.232 0.613 . . . . 0.0 109.791 176.856 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 236' ' ' VAL . . . . . 0.459 HG13 ' HB2' ' A' ' 248' ' ' PHE . 2.4 p -119.0 122.96 70.63 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 171.395 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -90.61 130.48 36.63 Favored 'General case' 0 C--O 1.239 0.507 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 174.353 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 238' ' ' CYS . . . . . . . . . . . . . 18.9 t -105.89 122.59 46.43 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.88 0.872 . . . . 0.0 111.106 -172.955 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -71.7 113.47 8.77 Favored 'General case' 0 C--N 1.352 0.715 0 C-N-CA 123.457 0.703 . . . . 0.0 110.082 176.223 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -143.17 144.54 13.91 Favored Glycine 0 CA--C 1.525 0.7 0 CA-C-N 114.388 -1.278 . . . . 0.0 110.551 169.742 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -57.53 -44.39 42.48 Favored 'Trans proline' 0 C--N 1.37 1.673 0 C-N-CA 122.531 2.154 . . . . 0.0 111.034 165.019 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 36.2 t30 -127.69 115.17 18.32 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 171.131 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 243' ' ' CYS . . . . . 0.543 ' SG ' ' HA ' ' A' ' 246' ' ' GLU . 16.2 t -151.93 97.77 2.37 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 -179.292 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -74.66 -37.94 62.59 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-O 121.279 0.561 . . . . 0.0 110.106 -179.3 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -89.83 25.46 2.06 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.742 1.217 . . . . 0.0 110.743 179.21 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 246' ' ' GLU . . . . . 0.543 ' HA ' ' SG ' ' A' ' 243' ' ' CYS . 8.9 pt-20 -46.65 -37.66 8.6 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 125.165 1.386 . . . . 0.0 113.744 -173.423 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 247' ' ' TRP . . . . . 0.477 ' HB2' ' HB2' ' A' ' 224' ' ' TYR . 94.0 m95 -88.5 138.54 31.34 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 122.922 0.489 . . . . 0.0 109.887 175.658 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 248' ' ' PHE . . . . . 0.459 ' HB2' HG13 ' A' ' 236' ' ' VAL . 60.1 m-85 -140.36 171.81 13.63 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.387 1.075 . . . . 0.0 109.385 175.394 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 249' ' ' HIS . . . . . 0.473 ' CD2' ' HB2' ' A' ' 252' ' ' CYS . 0.1 OUTLIER -117.7 141.27 48.58 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 173.788 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -58.69 -34.73 71.62 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 124.449 1.099 . . . . 0.0 112.821 -169.237 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -63.43 -38.97 93.21 Favored 'General case' 0 N--CA 1.479 1.02 0 O-C-N 123.854 0.721 . . . . 0.0 111.22 -177.853 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 252' ' ' CYS . . . . . 0.473 ' HB2' ' CD2' ' A' ' 249' ' ' HIS . 0.2 OUTLIER -66.93 -49.16 66.37 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 124.643 1.177 . . . . 0.0 110.229 -174.747 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 26.9 m -92.0 2.99 7.88 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 CA-C-N 114.222 -1.354 . . . . 0.0 111.358 -174.927 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 16.2 m120 60.71 24.34 14.18 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 124.802 1.241 . . . . 0.0 112.781 172.393 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.463 HD13 ' HD3' ' A' ' 259' ' ' PRO . 57.2 mt -71.95 94.83 1.5 Allowed 'General case' 0 C--N 1.35 0.59 0 C-N-CA 123.482 0.713 . . . . 0.0 109.458 176.321 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 8.7 mtmp? -77.29 -21.36 53.66 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.372 170.529 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 12.2 mp0 -111.58 125.85 29.65 Favored Pre-proline 0 C--O 1.244 0.801 0 C-N-CA 124.715 1.206 . . . . 0.0 107.921 178.714 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -65.71 121.39 8.75 Favored 'Trans proline' 0 C--N 1.372 1.785 0 C-N-CA 122.072 1.848 . . . . 0.0 110.356 172.152 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 259' ' ' PRO . . . . . 0.463 ' HD3' HD13 ' A' ' 255' ' ' LEU . 26.9 Cg_endo -58.28 116.91 3.58 Favored 'Trans proline' 0 C--N 1.378 2.118 0 C-N-CA 122.869 2.379 . . . . 0.0 112.413 -173.06 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 260' ' ' LYS . . . . . 0.558 ' HD3' ' H ' ' A' ' 260' ' ' LYS . 0.0 OUTLIER -56.31 -28.84 60.15 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.764 1.226 . . . . 0.0 113.026 -178.159 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -138.79 -147.49 5.14 Favored Glycine 0 C--N 1.348 1.211 0 CA-C-O 120.139 -0.256 . . . . 0.0 112.634 -178.241 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 46.6 p -72.12 106.1 4.21 Favored 'General case' 0 C--O 1.242 0.709 0 C-N-CA 123.515 0.726 . . . . 0.0 110.339 -178.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 263' ' ' TRP . . . . . . . . . . . . . 78.8 t90 -85.74 118.64 25.37 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.488 1.115 . . . . 0.0 109.543 178.349 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 264' ' ' TYR . . . . . 0.4 ' HD2' ' HB3' ' A' ' 268' ' ' CYS . 21.1 m-85 -102.31 115.79 31.3 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.231 1.012 . . . . 0.0 109.655 177.35 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 29.1 p -67.32 166.29 22.18 Favored Pre-proline 0 N--CA 1.487 1.417 0 C-N-CA 124.603 1.161 . . . . 0.0 110.634 176.16 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -40.01 -49.66 3.59 Favored 'Trans proline' 0 C--N 1.393 2.87 0 C-N-CA 123.917 3.078 . . . . 0.0 113.801 172.032 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -64.39 -26.8 68.62 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.379 0.672 . . . . 0.0 111.742 -174.841 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 268' ' ' CYS . . . . . 0.4 ' HB3' ' HD2' ' A' ' 264' ' ' TYR . 61.4 m -85.58 -41.48 15.22 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 123.215 0.606 . . . . 0.0 111.053 175.843 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 23.1 ttpp -77.37 -33.58 55.23 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.46 0.704 . . . . 0.0 111.634 -167.041 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 18.9 pt -130.08 50.74 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 124.3 1.04 . . . . 0.0 109.072 178.683 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 . . . . . 0 CA--C 1.559 1.313 0 CA-C-N 114.476 -1.238 . . . . 0.0 111.452 178.742 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 1.4 tm? . . . . . 0 N--CA 1.472 0.657 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 224' ' ' TYR . . . . . 0.587 ' HB2' ' HB2' ' A' ' 247' ' ' TRP . 62.8 m-85 -143.07 130.22 20.79 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 -179.433 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 49.2 t 172.78 158.1 0.11 Allowed 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.318 1.447 . . . . 0.0 108.669 171.001 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -58.22 -46.19 86.33 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 123.102 0.561 . . . . 0.0 110.807 177.77 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 227' ' ' CYS . . . . . 0.41 ' SG ' ' HB3' ' A' ' 229' ' ' ARG . 14.1 p -75.21 -15.1 60.57 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 122.782 0.433 . . . . 0.0 111.861 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 83.1 mm-40 57.81 90.18 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 124.409 1.084 . . . . 0.0 110.773 -172.317 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 229' ' ' ARG . . . . . 0.41 ' HB3' ' SG ' ' A' ' 227' ' ' CYS . 75.4 ttt180 -165.31 153.71 11.68 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.098 -171.374 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 35.4 m -73.51 171.85 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.927 0 C-N-CA 123.639 0.776 . . . . 0.0 111.648 175.01 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 43.4 m -112.5 126.24 55.11 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.943 0.897 . . . . 0.0 109.177 178.173 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 52.9 t80 -91.76 81.6 5.24 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 177.63 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 75.57 -20.31 2.25 Favored Glycine 0 N--CA 1.474 1.206 0 CA-C-N 115.44 -0.8 . . . . 0.0 114.554 179.046 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 31.9 mm-40 -108.79 99.2 8.58 Favored 'General case' 0 C--O 1.224 -0.25 0 C-N-CA 124.18 0.992 . . . . 0.0 109.781 -176.612 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 235' ' ' MET . . . . . . . . . . . . . 25.7 ptt? -125.32 129.56 50.2 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.008 0.523 . . . . 0.0 109.706 177.346 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 2.6 p -124.95 125.8 70.21 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 C-N-CA 123.893 0.877 . . . . 0.0 109.346 -178.288 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -86.37 150.07 24.58 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.333 177.705 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 238' ' ' CYS . . . . . 0.503 ' HB3' ' HA ' ' A' ' 246' ' ' GLU . 7.9 t -110.33 149.71 29.81 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 124.568 1.147 . . . . 0.0 109.184 -178.969 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -103.31 95.63 6.22 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 172.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -139.55 128.45 3.97 Favored Glycine 0 C--N 1.344 1.001 0 CA-C-O 118.937 -0.924 . . . . 0.0 111.745 177.501 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -66.19 -36.85 27.12 Favored 'Trans proline' 0 C--N 1.372 1.794 0 C-N-CA 122.647 2.231 . . . . 0.0 111.768 171.407 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 41.9 t30 -120.73 104.42 9.89 Favored 'General case' 0 C--O 1.242 0.669 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 174.564 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 46.6 t -173.12 114.34 0.25 Allowed 'General case' 0 N--CA 1.469 0.488 0 O-C-N 123.645 0.591 . . . . 0.0 109.811 -173.478 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 54.5 tptt -83.6 -28.05 28.77 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-O 121.369 0.604 . . . . 0.0 109.399 173.086 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 20.6 m-30 -90.99 28.74 1.5 Allowed 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.18 1.392 . . . . 0.0 111.957 -175.667 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 246' ' ' GLU . . . . . 0.503 ' HA ' ' HB3' ' A' ' 238' ' ' CYS . 6.4 mm-40 -48.28 -33.84 9.45 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 123.551 0.74 . . . . 0.0 112.829 177.554 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 247' ' ' TRP . . . . . 0.587 ' HB2' ' HB2' ' A' ' 224' ' ' TYR . 96.4 m95 -94.07 136.57 34.21 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 121.399 0.619 . . . . 0.0 110.68 173.532 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -140.36 176.37 8.83 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 125.845 1.658 . . . . 0.0 108.322 174.718 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 249' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -126.07 143.94 50.92 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 173.783 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 36.5 m-85 -58.02 -34.34 69.94 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.78 0.832 . . . . 0.0 112.49 -172.74 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -62.44 -36.12 81.41 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.043 0.537 . . . . 0.0 111.683 179.734 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 252' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -66.69 -42.56 86.28 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.97 0.908 . . . . 0.0 110.862 -177.303 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 253' ' ' VAL . . . . . 0.54 HG23 ' HB2' ' A' ' 255' ' ' LEU . 15.4 m -99.18 2.34 10.52 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.325 -176.109 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 4.6 t30 55.68 32.29 19.05 Favored 'General case' 0 N--CA 1.495 1.821 0 C-N-CA 124.513 1.125 . . . . 0.0 110.777 179.051 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.54 ' HB2' HG23 ' A' ' 253' ' ' VAL . 15.7 tp -80.2 108.09 13.52 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 -178.597 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 58.5 tttm -82.77 -21.34 34.67 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.986 0.915 . . . . 0.0 111.34 -174.579 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -135.43 143.3 44.71 Favored Pre-proline 0 CA--C 1.542 0.641 0 C-N-CA 124.631 1.172 . . . . 0.0 109.235 -173.469 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -61.5 153.22 67.98 Favored 'Trans proline' 0 C--N 1.372 1.79 0 C-N-CA 122.648 2.232 . . . . 0.0 112.732 -177.216 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 259' ' ' PRO . . . . . 0.411 ' HB3' ' HB2' ' A' ' 263' ' ' TRP . 43.6 Cg_exo -59.19 127.99 26.05 Favored 'Trans proline' 0 C--N 1.382 2.298 0 C-N-CA 122.794 2.329 . . . . 0.0 112.263 178.503 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -68.64 -37.06 79.38 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.365 0.666 . . . . 0.0 110.258 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -152.49 -126.49 1.2 Allowed Glycine 0 C--N 1.344 1.01 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.88 178.692 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 24.7 m -65.27 124.44 22.2 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.04 0.936 . . . . 0.0 110.457 177.467 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 263' ' ' TRP . . . . . 0.411 ' HB2' ' HB3' ' A' ' 259' ' ' PRO . 78.1 t90 -125.18 107.24 10.55 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.743 0.817 . . . . 0.0 109.432 -176.094 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -88.72 118.81 28.66 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.645 0.778 . . . . 0.0 109.534 174.38 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 12.7 p -69.47 156.56 91.43 Favored Pre-proline 0 CA--C 1.56 1.343 0 CA-C-O 117.951 -1.023 . . . . 0.0 109.301 174.376 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -19.6 -70.05 0.02 OUTLIER 'Trans proline' 0 C--N 1.394 2.931 1 C-N-CA 126.263 4.642 . . . . 0.0 117.523 -170.246 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.69 -27.28 65.81 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -172.876 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 268' ' ' CYS . . . . . . . . . . . . . 82.4 m -69.26 -30.89 69.11 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 123.476 0.71 . . . . 0.0 112.203 177.455 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -92.57 -46.27 7.7 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.296 0.639 . . . . 0.0 110.569 -177.115 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 85.5 mt -84.14 -48.08 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 123.74 0.816 . . . . 0.0 111.433 -171.303 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 . . . . . 0 C--O 1.255 1.378 0 CA-C-O 118.732 -0.651 . . . . 0.0 110.718 -171.684 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 5.9 tt . . . . . 0 N--CA 1.475 0.822 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 224' ' ' TYR . . . . . 0.522 ' HB3' ' HA ' ' A' ' 245' ' ' TYR . 67.5 m-85 -141.1 133.58 28.42 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 175.111 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 44.4 t 171.45 157.46 0.08 Allowed 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 124.752 1.221 . . . . 0.0 109.419 170.437 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -58.27 -44.41 88.41 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.86 0.864 . . . . 0.0 111.587 -179.781 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 16.2 p -73.33 -13.78 61.17 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 123.12 0.568 . . . . 0.0 111.401 -179.549 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 84.4 mm-40 55.84 73.69 0.42 Allowed 'General case' 0 C--N 1.366 1.297 0 C-N-CA 124.678 1.191 . . . . 0.0 111.327 -173.088 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 28.2 tpt180 -151.02 151.1 31.56 Favored 'General case' 0 C--O 1.244 0.772 0 CA-C-N 114.808 -1.087 . . . . 0.0 109.129 -178.836 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 21.0 m -66.93 160.77 3.97 Favored 'Isoleucine or valine' 0 C--O 1.243 0.755 0 C-N-CA 123.285 0.634 . . . . 0.0 111.301 173.627 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 231' ' ' SER . . . . . 0.423 ' HB3' ' O ' ' A' ' 234' ' ' GLU . 45.5 m -87.54 69.33 9.76 Favored 'General case' 0 CA--C 1.549 0.937 0 CA-C-N 115.373 -0.831 . . . . 0.0 109.961 179.566 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -68.97 111.91 5.28 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.223 0.609 . . . . 0.0 111.439 -177.495 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 79.88 -19.25 6.52 Favored Glycine 0 CA--C 1.538 1.494 0 CA-C-N 115.801 -0.636 . . . . 0.0 114.31 172.249 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 234' ' ' GLU . . . . . 0.423 ' O ' ' HB3' ' A' ' 231' ' ' SER . 30.0 mt-10 -132.01 148.71 52.52 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 125.235 1.414 . . . . 0.0 107.509 -175.025 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 235' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -154.71 135.21 13.4 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-O 121.593 0.711 . . . . 0.0 111.488 175.359 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 236' ' ' VAL . . . . . 0.528 HG13 ' HB2' ' A' ' 248' ' ' PHE . 1.1 p -145.09 123.08 4.98 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 170.93 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -96.47 140.26 31.38 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 173.731 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 238' ' ' CYS . . . . . . . . . . . . . 37.9 t -101.63 114.31 28.24 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 123.393 0.677 . . . . 0.0 109.984 -179.518 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -69.96 95.39 0.93 Allowed 'General case' 0 CA--C 1.543 0.693 0 O-C-N 123.93 0.769 . . . . 0.0 109.444 178.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -142.52 116.07 1.01 Allowed Glycine 0 C--N 1.342 0.911 0 CA-C-O 118.363 -1.243 . . . . 0.0 112.15 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_exo -58.24 -31.81 94.44 Favored 'Trans proline' 0 C--N 1.379 2.136 0 C-N-CA 122.787 2.325 . . . . 0.0 111.638 173.385 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -115.39 86.32 2.44 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 171.137 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 7.7 t -161.38 91.03 0.83 Allowed 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.497 0.719 . . . . 0.0 109.704 -178.746 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.76 -44.93 80.11 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 122.975 0.51 . . . . 0.0 110.026 173.463 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 245' ' ' TYR . . . . . 0.522 ' HA ' ' HB3' ' A' ' 224' ' ' TYR . 96.5 m-85 -81.14 22.61 0.64 Allowed 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 124.669 1.187 . . . . 0.0 112.715 -176.388 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -52.36 -32.94 40.83 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 125.023 1.329 . . . . 0.0 114.202 -172.41 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 247' ' ' TRP . . . . . 0.507 ' HB2' ' HB2' ' A' ' 224' ' ' TYR . 39.3 m95 -75.08 130.36 39.15 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-O 121.331 0.586 . . . . 0.0 110.447 176.282 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 248' ' ' PHE . . . . . 0.528 ' HB2' HG13 ' A' ' 236' ' ' VAL . 98.5 m-85 -141.43 171.31 14.23 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.312 1.045 . . . . 0.0 109.746 177.844 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 249' ' ' HIS . . . . . 0.449 ' HD2' ' HB2' ' A' ' 252' ' ' CYS . 0.0 OUTLIER -134.68 145.64 48.72 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 176.745 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 250' ' ' TYR . . . . . 0.464 ' HB3' ' O ' ' A' ' 255' ' ' LEU . 21.1 m-30 -53.88 -55.98 21.83 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 124.213 1.005 . . . . 0.0 113.303 -166.325 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -60.86 -34.17 74.19 Favored 'General case' 0 N--CA 1.496 1.839 0 C-N-CA 123.311 0.644 . . . . 0.0 111.733 -174.889 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 252' ' ' CYS . . . . . 0.449 ' HB2' ' HD2' ' A' ' 249' ' ' HIS . 11.3 t -68.45 -32.25 72.14 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 124.162 0.985 . . . . 0.0 111.631 -175.425 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 253' ' ' VAL . . . . . 0.493 HG23 ' HG ' ' A' ' 255' ' ' LEU . 16.3 m -108.76 6.23 9.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 C-N-CA 124.04 0.936 . . . . 0.0 110.735 175.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 18.4 m120 64.32 24.84 13.37 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 125.574 1.549 . . . . 0.0 113.359 173.425 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.493 ' HG ' HG23 ' A' ' 253' ' ' VAL . 96.5 mt -70.94 121.32 17.92 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 166.331 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 36.4 mtmm -96.55 15.73 20.77 Favored 'General case' 0 N--CA 1.485 1.276 0 CA-C-O 120.805 0.336 . . . . 0.0 110.661 175.589 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -164.3 163.41 15.07 Favored Pre-proline 0 CA--C 1.554 1.106 0 C-N-CA 124.131 0.972 . . . . 0.0 109.047 -172.432 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -69.41 160.14 50.96 Favored 'Trans proline' 0 C--N 1.374 1.879 0 C-N-CA 122.488 2.125 . . . . 0.0 112.607 175.571 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 259' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -59.61 156.88 34.7 Favored 'Trans proline' 0 C--N 1.377 2.063 0 C-N-CA 122.95 2.433 . . . . 0.0 112.783 171.361 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -103.73 31.07 4.65 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.703 0.801 . . . . 0.0 109.713 -179.601 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 136.81 -141.03 11.96 Favored Glycine 0 C--N 1.339 0.749 0 N-CA-C 110.313 -1.115 . . . . 0.0 110.313 -174.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 40.0 p -72.98 114.67 11.39 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 122.948 0.499 . . . . 0.0 109.821 178.598 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 263' ' ' TRP . . . . . . . . . . . . . 47.1 t90 -90.82 136.81 32.82 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.438 0.695 . . . . 0.0 109.856 -176.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -124.11 115.72 21.59 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.364 0.665 . . . . 0.0 110.688 -177.37 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 265' ' ' CYS . . . . . 0.494 ' SG ' ' HB2' ' A' ' 267' ' ' GLU . 19.1 p -70.75 160.08 83.13 Favored Pre-proline 0 N--CA 1.484 1.231 0 C-N-CA 124.308 1.043 . . . . 0.0 109.658 172.63 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 99.9 Cg_exo -47.29 -27.06 6.32 Favored 'Trans proline' 0 C--N 1.388 2.639 0 C-N-CA 123.825 3.017 . . . . 0.0 115.696 177.198 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 267' ' ' GLU . . . . . 0.494 ' HB2' ' SG ' ' A' ' 265' ' ' CYS . 39.6 mt-10 -59.4 -49.45 77.75 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 123.962 0.905 . . . . 0.0 110.581 174.296 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 268' ' ' CYS . . . . . . . . . . . . . 76.4 m -85.07 -30.86 23.74 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.268 1.027 . . . . 0.0 111.712 -177.263 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 65.2 tttm -85.49 -51.63 6.39 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.867 -168.391 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 45.2 mt -97.8 -52.07 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 C-N-CA 123.1 0.56 . . . . 0.0 110.952 -176.752 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 . . . . . 0 CA--C 1.554 1.106 0 C-N-CA 123.177 0.591 . . . . 0.0 110.595 -171.721 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 5.9 tt . . . . . 0 CA--C 1.539 0.546 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 224' ' ' TYR . . . . . 0.528 ' HB2' ' HB2' ' A' ' 247' ' ' TRP . 71.0 m-85 -135.28 133.21 38.67 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 176.69 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 36.9 t 175.13 166.67 0.3 Allowed 'General case' 0 N--CA 1.474 0.747 0 O-C-N 124.643 1.214 . . . . 0.0 109.562 175.285 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 32.9 t80 -73.05 -33.46 65.69 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 177.452 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 9.4 p -82.18 -11.39 58.74 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 122.84 0.456 . . . . 0.0 111.04 173.048 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 82.2 mm-40 56.46 89.38 0.04 OUTLIER 'General case' 0 C--N 1.361 1.08 0 C-N-CA 125.348 1.459 . . . . 0.0 111.249 -174.724 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 -153.41 149.04 27.37 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.87 -176.801 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 34.2 m -66.28 148.49 12.05 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.823 0 C-N-CA 123.7 0.8 . . . . 0.0 110.952 174.291 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 35.9 m -107.43 120.66 42.78 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 175.759 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 31.4 p90 -141.92 125.92 17.25 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.555 0.742 . . . . 0.0 109.822 -174.785 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 78.09 -14.69 10.32 Favored Glycine 0 C--N 1.354 1.533 0 CA-C-N 116.334 -0.394 . . . . 0.0 113.138 -174.088 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -154.88 101.33 2.27 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.543 1.137 . . . . 0.0 108.165 -176.552 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 235' ' ' MET . . . . . . . . . . . . . 54.1 mtp -128.25 113.33 15.53 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 -178.912 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 6.8 p -108.34 125.32 65.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 175.558 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -99.7 168.54 9.86 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.727 0.811 . . . . 0.0 110.519 179.723 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 238' ' ' CYS . . . . . . . . . . . . . 26.9 t -144.29 123.25 12.77 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 122.668 0.387 . . . . 0.0 111.51 -177.344 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -79.22 105.38 10.51 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.376 0.67 . . . . 0.0 109.981 174.701 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -142.16 141.22 10.65 Favored Glycine 0 C--N 1.341 0.813 0 CA-C-O 118.558 -1.134 . . . . 0.0 111.285 175.926 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -60.09 -52.9 3.58 Favored 'Trans proline' 0 C--N 1.379 2.183 0 C-N-CA 122.758 2.306 . . . . 0.0 110.757 176.356 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -106.55 129.04 54.56 Favored 'General case' 0 C--O 1.242 0.675 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 163.166 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 243' ' ' CYS . . . . . 0.437 ' SG ' ' HA ' ' A' ' 246' ' ' GLU . 26.5 t -173.13 89.42 0.08 Allowed 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 -174.382 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.1 -24.29 30.4 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 122.893 0.477 . . . . 0.0 110.603 179.631 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 53.1 m-85 -101.32 26.88 6.69 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.321 1.049 . . . . 0.0 110.367 177.446 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 246' ' ' GLU . . . . . 0.437 ' HA ' ' SG ' ' A' ' 243' ' ' CYS . 8.5 pt-20 -48.66 -34.92 12.72 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 124.41 1.084 . . . . 0.0 112.579 176.653 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 247' ' ' TRP . . . . . 0.528 ' HB2' ' HB2' ' A' ' 224' ' ' TYR . 94.5 m95 -96.07 136.4 36.57 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 121.379 0.609 . . . . 0.0 111.133 176.609 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -144.71 173.44 11.83 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 125.196 1.398 . . . . 0.0 108.521 171.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 249' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -113.04 138.23 50.21 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 170.655 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -55.49 -32.86 63.19 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 124.181 0.992 . . . . 0.0 112.157 -173.385 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -56.47 -45.06 81.09 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 125.007 1.323 . . . . 0.0 112.455 178.36 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 252' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -68.04 -51.29 48.55 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.226 1.011 . . . . 0.0 110.984 -175.472 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 22.3 m -81.7 -9.95 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 CA-C-N 115.223 -0.898 . . . . 0.0 111.963 -178.242 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 17.5 m120 59.84 41.67 17.67 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.857 1.263 . . . . 0.0 110.795 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 34.7 tp -90.9 108.04 19.58 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 178.119 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -70.23 -44.81 67.81 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 122.986 0.515 . . . . 0.0 110.758 -178.205 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -133.53 130.97 21.14 Favored Pre-proline 0 C--O 1.24 0.567 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 -178.63 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -56.95 141.96 93.57 Favored 'Trans proline' 0 C--N 1.371 1.763 0 C-N-CA 122.257 1.972 . . . . 0.0 110.707 171.608 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 259' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -68.14 -178.94 1.94 Allowed 'Trans proline' 0 C--N 1.37 1.678 0 C-N-CA 123.06 2.507 . . . . 0.0 113.018 -169.02 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 27.7 mmmt -74.75 -3.6 32.55 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 116.068 -0.514 . . . . 0.0 112.383 -174.747 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -154.43 -143.92 3.79 Favored Glycine 0 C--N 1.338 0.689 0 N-CA-C 111.502 -0.639 . . . . 0.0 111.502 174.028 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 43.5 p -69.68 116.83 10.54 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 123.693 0.797 . . . . 0.0 110.607 -177.784 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 263' ' ' TRP . . . . . . . . . . . . . 37.9 t90 -66.41 135.69 54.66 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 122.965 0.506 . . . . 0.0 110.266 178.839 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 264' ' ' TYR . . . . . 0.445 ' HB3' ' HB3' ' A' ' 269' ' ' LYS . 39.6 m-85 -118.44 110.6 17.63 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.433 0.693 . . . . 0.0 109.768 -177.69 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 265' ' ' CYS . . . . . 0.4 ' SG ' ' HB2' ' A' ' 267' ' ' GLU . 14.8 p -67.25 162.77 52.16 Favored Pre-proline 0 CA--C 1.554 1.122 0 C-N-CA 124.128 0.971 . . . . 0.0 109.65 172.1 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -53.57 -24.51 29.31 Favored 'Trans proline' 0 C--N 1.385 2.452 0 C-N-CA 123.374 2.716 . . . . 0.0 114.594 -178.728 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 267' ' ' GLU . . . . . 0.4 ' HB2' ' SG ' ' A' ' 265' ' ' CYS . 33.7 mt-10 -57.38 -54.79 42.79 Favored 'General case' 0 N--CA 1.483 1.187 0 CA-C-O 121.488 0.661 . . . . 0.0 110.326 173.432 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 268' ' ' CYS . . . . . . . . . . . . . 57.9 m -86.75 -39.28 16.12 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 114.606 -1.179 . . . . 0.0 112.709 -168.775 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 269' ' ' LYS . . . . . 0.445 ' HB3' ' HB3' ' A' ' 264' ' ' TYR . 12.5 ptmm? -75.66 -28.87 58.88 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-O 120.654 0.264 . . . . 0.0 111.703 -169.612 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 61.8 mt -92.2 -50.7 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 177.492 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 . . . . . 0 CA--C 1.554 1.117 0 C-N-CA 123.456 0.703 . . . . 0.0 109.209 179.234 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 57.0 tp . . . . . 0 N--CA 1.473 0.699 0 CA-C-O 121.189 0.518 . . . . 0.0 109.929 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 224' ' ' TYR . . . . . 0.588 ' HB3' ' HA ' ' A' ' 245' ' ' TYR . 77.3 m-85 -135.49 134.33 39.43 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 172.551 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 49.3 t 172.84 161.62 0.12 Allowed 'General case' 0 N--CA 1.474 0.769 0 O-C-N 124.823 1.327 . . . . 0.0 108.284 171.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -67.09 -32.63 73.92 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 122.08 0.152 . . . . 0.0 110.965 177.894 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 13.1 p -85.52 -17.43 36.4 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 122.706 0.402 . . . . 0.0 111.288 177.711 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 20.4 mm-40 52.92 77.6 0.16 Allowed 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 124.645 1.178 . . . . 0.0 111.907 -172.233 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 4.6 tmt_? -151.32 154.57 36.99 Favored 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 -178.601 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 23.1 m -73.1 156.25 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 CA-C-O 121.394 0.616 . . . . 0.0 112.59 -173.669 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 17.3 m -95.91 104.48 16.41 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.864 0.866 . . . . 0.0 108.771 172.838 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -74.14 79.32 1.76 Allowed 'General case' 0 N--CA 1.479 1.009 0 CA-C-O 121.508 0.67 . . . . 0.0 110.24 -179.158 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 74.68 -18.17 2.42 Favored Glycine 0 CA--C 1.539 1.568 0 N-CA-C 115.331 0.893 . . . . 0.0 115.331 177.59 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 234' ' ' GLU . . . . . 0.403 ' HB3' ' HD1' ' A' ' 250' ' ' TYR . 20.5 mm-40 -113.28 110.52 20.51 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.829 0.852 . . . . 0.0 109.335 -175.371 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 235' ' ' MET . . . . . . . . . . . . . 55.1 mtm -126.01 102.23 7.16 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.094 0.958 . . . . 0.0 109.679 -172.86 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 236' ' ' VAL . . . . . 0.4 HG11 HG21 ' A' ' 253' ' ' VAL . 3.9 p -87.98 123.34 40.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 168.817 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -92.79 155.02 17.93 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 123.083 0.553 . . . . 0.0 109.92 -178.829 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 238' ' ' CYS . . . . . 0.633 ' HB3' ' HA ' ' A' ' 246' ' ' GLU . 42.1 t -116.23 152.12 34.4 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 115.126 -0.943 . . . . 0.0 108.87 176.965 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -119.92 99.22 6.49 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 171.848 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 240' ' ' GLY . . . . . 0.61 ' HA3' ' SG ' ' A' ' 268' ' ' CYS . . . -139.99 129.52 4.3 Favored Glycine 0 C--N 1.34 0.785 0 CA-C-O 118.124 -1.375 . . . . 0.0 111.004 176.763 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -48.89 -49.56 14.78 Favored 'Trans proline' 0 C--N 1.382 2.325 0 C-N-CA 123.666 2.91 . . . . 0.0 113.752 -177.656 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -111.19 101.87 10.34 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 171.722 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 43.9 t -172.86 106.62 0.16 Allowed 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 -173.561 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 9.3 ptpp? -86.78 -24.57 25.01 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 173.332 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 245' ' ' TYR . . . . . 0.588 ' HA ' ' HB3' ' A' ' 224' ' ' TYR . 22.7 m-85 -81.12 23.69 0.56 Allowed 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.403 1.081 . . . . 0.0 112.225 -177.942 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 246' ' ' GLU . . . . . 0.633 ' HA ' ' HB3' ' A' ' 238' ' ' CYS . 5.9 mm-40 -48.9 -37.51 19.96 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 123.641 0.776 . . . . 0.0 111.35 178.556 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 247' ' ' TRP . . . . . 0.502 ' HB2' ' HB2' ' A' ' 224' ' ' TYR . 98.4 m95 -76.45 115.85 16.58 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.505 174.961 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -130.18 173.35 10.85 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.652 1.181 . . . . 0.0 109.371 171.266 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 249' ' ' HIS . . . . . 0.569 ' HD2' ' HB2' ' A' ' 252' ' ' CYS . 0.1 OUTLIER -126.01 142.0 51.71 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.454 1.101 . . . . 0.0 108.508 178.232 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 250' ' ' TYR . . . . . 0.403 ' HD1' ' HB3' ' A' ' 234' ' ' GLU . 70.3 m-85 -60.58 -34.83 74.77 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 124.489 1.116 . . . . 0.0 113.493 -168.867 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -67.52 -35.74 79.68 Favored 'General case' 0 N--CA 1.485 1.293 0 CA-C-O 121.537 0.684 . . . . 0.0 110.998 -178.147 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 252' ' ' CYS . . . . . 0.569 ' HB2' ' HD2' ' A' ' 249' ' ' HIS . 9.0 t -71.68 -41.06 69.14 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 125.024 1.33 . . . . 0.0 110.852 -175.454 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 253' ' ' VAL . . . . . 0.4 HG21 HG11 ' A' ' 236' ' ' VAL . 27.9 m -93.16 -2.02 10.63 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.859 0 CA-C-N 114.481 -1.236 . . . . 0.0 110.957 179.685 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 33.5 m-80 62.69 24.89 14.81 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 124.803 1.241 . . . . 0.0 112.524 175.617 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 81.0 mt -80.58 119.64 23.49 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 173.161 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 14.3 tppt? -81.06 -25.34 37.17 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.425 0.69 . . . . 0.0 110.51 179.86 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -136.35 162.56 55.67 Favored Pre-proline 0 CA--C 1.55 0.949 0 C-N-CA 124.319 1.047 . . . . 0.0 109.552 -178.711 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -56.31 136.06 73.43 Favored 'Trans proline' 0 C--N 1.38 2.196 0 C-N-CA 122.435 2.09 . . . . 0.0 111.532 170.329 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 259' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -58.73 156.07 34.39 Favored 'Trans proline' 0 C--N 1.375 1.97 0 C-N-CA 123.289 2.659 . . . . 0.0 113.076 -176.528 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -66.38 -20.72 66.15 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.833 0.853 . . . . 0.0 112.764 -173.313 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -165.57 -141.94 3.28 Favored Glycine 0 C--N 1.347 1.145 0 CA-C-O 119.752 -0.471 . . . . 0.0 112.176 179.232 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 25.4 m -65.32 107.25 1.56 Allowed 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.638 0.775 . . . . 0.0 109.819 178.392 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 263' ' ' TRP . . . . . . . . . . . . . 53.8 t90 -88.58 114.12 24.87 Favored 'General case' 0 C--O 1.242 0.679 0 C-N-CA 123.285 0.634 . . . . 0.0 110.316 -175.613 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -96.64 118.84 33.97 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 123.93 0.892 . . . . 0.0 108.599 171.855 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 17.9 p -64.04 159.68 53.92 Favored Pre-proline 0 CA--C 1.555 1.164 0 C-N-CA 123.508 0.723 . . . . 0.0 110.122 172.162 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -50.91 -33.87 43.43 Favored 'Trans proline' 0 C--N 1.382 2.315 0 C-N-CA 123.202 2.601 . . . . 0.0 113.714 -178.983 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -59.18 -43.19 92.18 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-O 121.043 0.449 . . . . 0.0 111.242 177.92 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 268' ' ' CYS . . . . . 0.61 ' SG ' ' HA3' ' A' ' 240' ' ' GLY . 67.2 m -72.64 -27.92 62.43 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.087 0.955 . . . . 0.0 112.563 -177.864 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 49.1 mtmt -88.07 -41.56 12.98 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 122.84 0.456 . . . . 0.0 111.337 -175.698 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 16.8 mt -102.3 15.7 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 C-N-CA 123.283 0.633 . . . . 0.0 110.583 -168.673 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 . . . . . 0 CA--C 1.565 1.552 0 C-N-CA 122.651 0.38 . . . . 0.0 110.951 175.188 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 35.8 tp . . . . . 0 CA--C 1.541 0.602 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 224' ' ' TYR . . . . . 0.524 ' HB3' ' HA ' ' A' ' 245' ' ' TYR . 74.1 m-85 -138.09 125.95 22.52 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 175.591 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 225' ' ' CYS . . . . . 0.403 ' HB2' ' O ' ' A' ' 224' ' ' TYR . 34.4 t 174.54 161.85 0.2 Allowed 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.959 0.904 . . . . 0.0 109.203 173.586 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -69.24 -34.92 75.56 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 122.347 0.259 . . . . 0.0 110.458 175.306 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 3.9 p -83.47 -14.59 52.13 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.105 175.249 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 22.6 mm-40 53.87 101.09 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 125.601 1.56 . . . . 0.0 112.713 -172.233 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 22.8 tpp180 -162.97 157.97 21.68 Favored 'General case' 0 C--O 1.244 0.801 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 -178.735 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 19.5 m -71.4 154.21 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 CA-C-O 120.828 0.347 . . . . 0.0 111.173 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 17.1 m -116.86 60.57 0.74 Allowed 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 123.568 0.747 . . . . 0.0 109.422 -179.233 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 79.8 t80 -71.84 108.69 5.26 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.143 0.577 . . . . 0.0 111.769 -172.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 85.18 -18.22 29.03 Favored Glycine 0 N--CA 1.472 1.089 0 CA-C-N 115.6 -0.727 . . . . 0.0 114.156 174.52 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -131.51 94.57 3.56 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 124.257 1.023 . . . . 0.0 108.62 -177.269 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 235' ' ' MET . . . . . 0.418 ' HB3' ' CE3' ' A' ' 247' ' ' TRP . 63.3 mtm -122.03 100.75 7.14 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.8 0.84 . . . . 0.0 109.062 -179.366 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 4.8 p -87.8 124.83 41.26 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 170.927 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -88.65 130.53 35.27 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.539 0.736 . . . . 0.0 109.892 -178.634 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 238' ' ' CYS . . . . . 0.519 ' HB3' ' HA ' ' A' ' 246' ' ' GLU . 36.2 t -99.65 152.29 20.24 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.069 0.947 . . . . 0.0 109.398 175.239 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -127.23 108.23 10.7 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.933 0.893 . . . . 0.0 108.667 172.878 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -139.97 160.57 26.25 Favored Glycine 0 N--CA 1.473 1.144 0 CA-C-O 119.224 -0.765 . . . . 0.0 111.829 174.528 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -69.77 -35.31 12.85 Favored 'Trans proline' 0 C--N 1.375 1.973 0 C-N-CA 122.285 1.99 . . . . 0.0 112.156 174.311 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -128.48 110.19 12.08 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.896 0.879 . . . . 0.0 108.776 176.329 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 29.7 t -177.39 104.76 0.05 Allowed 'General case' 0 C--N 1.347 0.476 0 C-N-CA 123.56 0.744 . . . . 0.0 109.502 -175.502 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 16.8 tppt? -76.71 -30.6 56.73 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-O 121.548 0.69 . . . . 0.0 110.169 171.496 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 245' ' ' TYR . . . . . 0.524 ' HA ' ' HB3' ' A' ' 224' ' ' TYR . 15.5 m-85 -87.55 23.76 1.85 Allowed 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.42 1.088 . . . . 0.0 112.537 -168.347 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 246' ' ' GLU . . . . . 0.519 ' HA ' ' HB3' ' A' ' 238' ' ' CYS . 5.9 mm-40 -46.94 -45.07 20.49 Favored 'General case' 0 N--CA 1.499 2.001 0 C-N-CA 124.187 0.995 . . . . 0.0 112.481 -172.145 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 247' ' ' TRP . . . . . 0.418 ' CE3' ' HB3' ' A' ' 235' ' ' MET . 97.1 m95 -77.56 117.11 18.68 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 122.851 0.461 . . . . 0.0 110.056 173.665 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -122.18 159.26 27.61 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.93 0.892 . . . . 0.0 110.515 175.55 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 249' ' ' HIS . . . . . 0.49 ' CD2' ' HB2' ' A' ' 252' ' ' CYS . 0.7 OUTLIER -93.29 129.88 39.22 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 114.792 -1.094 . . . . 0.0 108.386 167.821 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 48.1 m-85 -52.91 -38.24 61.58 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 124.724 1.21 . . . . 0.0 112.272 -175.627 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -57.13 -34.79 68.75 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 124.79 1.236 . . . . 0.0 112.498 -177.943 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 252' ' ' CYS . . . . . 0.49 ' HB2' ' CD2' ' A' ' 249' ' ' HIS . 0.5 OUTLIER -65.63 -56.27 13.1 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 124.032 0.933 . . . . 0.0 110.585 -177.488 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 253' ' ' VAL . . . . . 0.512 HG23 ' HB2' ' A' ' 255' ' ' LEU . 20.7 m -82.85 -1.54 5.78 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.879 0 CA-C-N 114.595 -1.184 . . . . 0.0 111.314 -176.75 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 9.9 t30 61.13 31.37 19.67 Favored 'General case' 0 C--N 1.365 1.267 0 C-N-CA 124.662 1.185 . . . . 0.0 110.393 179.543 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.529 HD21 ' HG3' ' A' ' 259' ' ' PRO . 16.4 tp -76.45 89.66 3.24 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 177.543 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -71.42 -20.32 62.13 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 115.114 -0.948 . . . . 0.0 111.893 -172.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -139.19 152.95 70.74 Favored Pre-proline 0 CA--C 1.552 1.021 0 C-N-CA 124.509 1.123 . . . . 0.0 109.581 -177.567 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -59.14 148.51 85.35 Favored 'Trans proline' 0 C--N 1.381 2.274 0 C-N-CA 123.249 2.633 . . . . 0.0 113.663 179.31 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 259' ' ' PRO . . . . . 0.529 ' HG3' HD21 ' A' ' 255' ' ' LEU . 14.3 Cg_exo -68.9 146.31 65.09 Favored 'Trans proline' 0 C--N 1.38 2.205 0 C-N-CA 122.963 2.442 . . . . 0.0 111.987 172.206 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 57.6 mttp -86.31 -28.01 23.97 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.661 0.784 . . . . 0.0 110.876 -178.627 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -137.1 -150.27 5.74 Favored Glycine 0 C--N 1.345 1.082 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.849 -179.294 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 25.8 m -71.04 116.87 11.83 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 123.447 0.699 . . . . 0.0 110.511 -177.744 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 263' ' ' TRP . . . . . . . . . . . . . 27.9 t90 -91.26 114.93 27.59 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.965 0.906 . . . . 0.0 110.207 -175.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -100.64 117.69 35.27 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 170.137 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 265' ' ' CYS . . . . . 0.41 ' SG ' ' OE2' ' A' ' 267' ' ' GLU . 14.4 p -70.92 161.82 75.67 Favored Pre-proline 0 CA--C 1.56 1.328 0 CA-C-O 117.77 -1.11 . . . . 0.0 109.773 176.35 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_exo -27.25 -69.62 0.04 OUTLIER 'Trans proline' 0 C--N 1.397 3.09 1 C-N-CA 125.402 4.068 . . . . 0.0 116.742 -173.673 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 267' ' ' GLU . . . . . 0.41 ' OE2' ' SG ' ' A' ' 265' ' ' CYS . 0.0 OUTLIER -63.81 -26.15 68.5 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -173.794 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 268' ' ' CYS . . . . . . . . . . . . . 97.3 m -72.17 -47.45 50.73 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 123.113 0.565 . . . . 0.0 112.013 176.94 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 12.2 ptmm? -77.05 -23.66 52.01 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.987 -173.818 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 86.1 mt -88.39 -43.35 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 123.761 0.824 . . . . 0.0 110.206 178.462 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 . . . . . 0 C--O 1.257 1.449 0 C-N-CA 123.596 0.759 . . . . 0.0 109.564 -174.874 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 53.7 tp . . . . . 0 N--CA 1.475 0.816 0 CA-C-O 120.871 0.367 . . . . 0.0 110.056 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 224' ' ' TYR . . . . . 0.428 ' HB3' ' HA ' ' A' ' 245' ' ' TYR . 66.5 m-85 -135.58 124.09 23.54 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.456 0.702 . . . . 0.0 109.279 172.747 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 36.8 t 172.01 158.69 0.1 Allowed 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 125.208 1.403 . . . . 0.0 109.349 172.033 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 77.5 t80 -66.99 -41.78 86.17 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 117.942 0.337 . . . . 0.0 110.919 177.049 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 6.3 p -72.48 -10.74 60.17 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 122.504 0.321 . . . . 0.0 110.43 176.319 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 82.4 mm-40 53.88 88.8 0.03 OUTLIER 'General case' 0 C--N 1.368 1.388 0 C-N-CA 124.823 1.249 . . . . 0.0 110.78 -173.073 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 2.4 tpm_? -153.32 146.11 24.35 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-N 114.721 -1.127 . . . . 0.0 108.389 -177.924 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 34.9 m -83.92 149.13 4.56 Favored 'Isoleucine or valine' 0 C--O 1.24 0.587 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 175.306 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 21.4 m -84.73 88.12 7.35 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.324 0.65 . . . . 0.0 110.104 -178.647 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -74.41 88.85 2.1 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.668 0.787 . . . . 0.0 110.625 -176.504 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 78.44 -19.39 4.81 Favored Glycine 0 CA--C 1.535 1.327 0 CA-C-N 115.112 -0.949 . . . . 0.0 114.614 177.087 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -116.26 94.39 4.62 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.035 0.934 . . . . 0.0 108.773 179.341 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 235' ' ' MET . . . . . . . . . . . . . 20.4 ptt? -120.03 108.98 14.95 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.957 0.903 . . . . 0.0 110.515 -176.186 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 7.5 p -100.22 125.72 53.91 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 169.794 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -101.4 138.16 38.78 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.553 0.741 . . . . 0.0 110.795 -172.131 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 238' ' ' CYS . . . . . 0.722 ' HB3' ' HA ' ' A' ' 246' ' ' GLU . 34.9 t -95.93 152.29 18.64 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 123.768 0.827 . . . . 0.0 109.055 173.606 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 239' ' ' ASP . . . . . 0.435 ' HB3' ' HB ' ' A' ' 262' ' ' THR . 31.3 t70 -125.96 104.85 8.51 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 175.442 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -138.43 147.94 19.58 Favored Glycine 0 C--N 1.337 0.607 0 CA-C-O 118.859 -0.967 . . . . 0.0 111.245 177.422 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -66.52 -34.28 34.03 Favored 'Trans proline' 0 C--N 1.372 1.788 0 C-N-CA 122.64 2.226 . . . . 0.0 112.368 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -135.98 94.91 3.12 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 176.728 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 45.1 t -163.93 110.88 1.11 Allowed 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.972 0.909 . . . . 0.0 109.003 -173.381 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 244' ' ' LYS . . . . . 0.56 ' H ' ' HD3' ' A' ' 244' ' ' LYS . 0.1 OUTLIER -82.92 -31.64 27.66 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.18 0.592 . . . . 0.0 110.876 175.991 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 245' ' ' TYR . . . . . 0.428 ' HA ' ' HB3' ' A' ' 224' ' ' TYR . 71.5 m-85 -79.54 28.68 0.25 Allowed 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 124.543 1.137 . . . . 0.0 113.208 -178.622 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 246' ' ' GLU . . . . . 0.722 ' HA ' ' HB3' ' A' ' 238' ' ' CYS . 5.7 mm-40 -48.91 -48.35 42.65 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.27 0.628 . . . . 0.0 112.276 178.007 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 247' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -78.69 130.83 36.27 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 121.186 0.517 . . . . 0.0 112.103 -176.886 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -143.73 172.43 12.84 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.192 1.397 . . . . 0.0 109.953 174.539 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 249' ' ' HIS . . . . . 0.439 ' HD2' ' HB2' ' A' ' 252' ' ' CYS . 0.0 OUTLIER -120.36 140.75 50.85 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.559 1.144 . . . . 0.0 108.499 179.329 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 250' ' ' TYR . . . . . 0.425 ' HB3' ' O ' ' A' ' 255' ' ' LEU . 49.0 m-85 -54.8 -54.38 42.89 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.855 1.262 . . . . 0.0 113.285 -167.292 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -59.8 -34.41 73.0 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 123.262 0.625 . . . . 0.0 112.174 -175.234 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 252' ' ' CYS . . . . . 0.439 ' HB2' ' HD2' ' A' ' 249' ' ' HIS . 7.3 t -67.0 -43.28 83.34 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.037 0.935 . . . . 0.0 111.195 -177.309 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 9.2 m -93.17 14.76 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.175 0 C-N-CA 123.788 0.835 . . . . 0.0 111.315 177.006 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 6.4 t30 67.48 7.87 5.9 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 125.103 1.361 . . . . 0.0 112.524 172.607 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.425 ' O ' ' HB3' ' A' ' 250' ' ' TYR . 87.9 mt -74.43 104.15 5.05 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.048 0.539 . . . . 0.0 110.732 -179.004 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 52.3 tttm -63.73 -36.87 85.28 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.237 1.015 . . . . 0.0 110.303 169.603 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -142.96 149.61 49.98 Favored Pre-proline 0 CA--C 1.549 0.936 0 CA-C-N 114.676 -1.147 . . . . 0.0 109.777 -170.258 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 258' ' ' PRO . . . . . 0.504 ' HA ' ' HD3' ' A' ' 259' ' ' PRO . 33.6 Cg_endo -62.51 138.14 68.74 Favored 'Trans proline' 0 C--N 1.38 2.23 0 C-N-CA 122.864 2.376 . . . . 0.0 113.1 -175.9 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 259' ' ' PRO . . . . . 0.504 ' HD3' ' HA ' ' A' ' 258' ' ' PRO . 17.3 Cg_exo -69.6 137.81 36.82 Favored 'Trans proline' 0 C--N 1.372 1.779 0 C-N-CA 123.261 2.641 . . . . 0.0 111.917 177.96 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -73.21 96.99 2.33 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 123.505 0.722 . . . . 0.0 109.931 -175.739 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 117.65 -168.8 13.05 Favored Glycine 0 N--CA 1.472 1.063 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.83 178.31 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 262' ' ' THR . . . . . 0.435 ' HB ' ' HB3' ' A' ' 239' ' ' ASP . 32.5 p -66.34 107.01 1.86 Allowed 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.08 0.552 . . . . 0.0 109.879 173.972 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 263' ' ' TRP . . . . . . . . . . . . . 32.0 t90 -70.11 140.2 52.65 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 122.853 0.461 . . . . 0.0 110.139 -179.435 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -113.2 118.66 35.32 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 172.703 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 20.4 p -57.35 150.59 42.4 Favored Pre-proline 0 N--CA 1.478 0.952 0 CA-C-O 118.543 -0.741 . . . . 0.0 109.489 172.694 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_exo -45.57 -32.34 8.24 Favored 'Trans proline' 0 C--N 1.386 2.538 0 C-N-CA 123.407 2.738 . . . . 0.0 114.307 -173.713 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -65.39 -50.04 67.0 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 123.82 0.848 . . . . 0.0 110.822 -179.567 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 268' ' ' CYS . . . . . . . . . . . . . 43.9 m -59.83 -45.88 91.02 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 123.121 0.568 . . . . 0.0 112.306 -179.377 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 269' ' ' LYS . . . . . 0.595 ' HD3' HG13 ' A' ' 270' ' ' ILE . 0.1 OUTLIER -81.25 -14.53 57.34 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -171.825 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 270' ' ' ILE . . . . . 0.595 HG13 ' HD3' ' A' ' 269' ' ' LYS . 78.5 mt -92.84 -23.11 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 C-N-CA 123.211 0.604 . . . . 0.0 110.057 172.382 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 . . . . . 0 CA--C 1.559 1.322 0 CA-C-O 118.65 -0.69 . . . . 0.0 110.497 178.438 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 53.3 tp . . . . . 0 N--CA 1.472 0.649 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 224' ' ' TYR . . . . . 0.532 ' HB2' ' HB2' ' A' ' 247' ' ' TRP . 69.3 m-85 -133.34 125.46 29.24 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 177.259 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 40.8 t 171.3 154.19 0.07 Allowed 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 125.86 1.664 . . . . 0.0 107.734 173.351 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -61.62 -43.26 99.2 Favored 'General case' 0 CA--C 1.549 0.914 0 CA-C-N 117.872 0.305 . . . . 0.0 110.861 177.93 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 6.2 p -68.67 -17.07 64.02 Favored 'General case' 0 N--CA 1.483 1.177 0 O-C-N 123.321 0.388 . . . . 0.0 111.035 177.838 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 81.3 mm-40 58.81 83.89 0.12 Allowed 'General case' 0 C--N 1.365 1.262 0 C-N-CA 124.581 1.152 . . . . 0.0 110.753 -174.118 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 14.6 tpt180 -150.24 154.52 38.09 Favored 'General case' 0 C--O 1.243 0.727 0 C-N-CA 124.077 0.951 . . . . 0.0 108.532 179.372 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 27.0 m -81.78 177.37 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 CA-C-O 121.488 0.661 . . . . 0.0 110.78 172.711 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 22.2 p -96.64 153.22 17.98 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.897 171.976 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 40.8 t80 -84.83 1.53 46.54 Favored 'General case' 0 CA--C 1.56 1.334 0 C-N-CA 123.651 0.78 . . . . 0.0 110.002 168.111 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 135.6 -19.18 3.8 Favored Glycine 0 C--N 1.347 1.147 0 C-N-CA 124.006 0.812 . . . . 0.0 111.387 -179.022 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.41 123.14 35.51 Favored 'General case' 0 CA--C 1.555 1.136 0 C-N-CA 122.901 0.48 . . . . 0.0 110.017 -178.411 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 235' ' ' MET . . . . . . . . . . . . . 7.9 mmt -144.57 119.89 10.23 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.329 0.652 . . . . 0.0 110.391 -177.726 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 3.7 p -98.57 126.35 51.71 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 C-N-CA 124.423 1.089 . . . . 0.0 109.48 168.057 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -87.25 134.52 33.54 Favored 'General case' 0 C--O 1.242 0.679 0 C-N-CA 123.217 0.607 . . . . 0.0 110.014 177.589 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 238' ' ' CYS . . . . . 0.542 ' HB3' ' HA ' ' A' ' 246' ' ' GLU . 35.5 t -95.52 123.98 39.33 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 123.464 0.705 . . . . 0.0 111.117 -178.405 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -77.9 94.33 4.54 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 123.893 0.877 . . . . 0.0 109.195 177.19 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -142.04 125.03 2.58 Favored Glycine 0 CA--C 1.529 0.945 0 CA-C-O 118.761 -1.022 . . . . 0.0 111.917 -179.34 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -62.77 -33.79 75.13 Favored 'Trans proline' 0 C--N 1.379 2.132 0 C-N-CA 122.61 2.207 . . . . 0.0 111.422 171.853 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -118.32 100.02 7.22 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 169.894 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 12.1 t -165.54 109.29 0.83 Allowed 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 178.09 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 22.7 ttmm -82.99 -35.69 25.65 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-O 121.547 0.689 . . . . 0.0 109.25 170.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 245' ' ' TYR . . . . . 0.463 ' HA ' ' HB3' ' A' ' 224' ' ' TYR . 89.5 m-85 -83.26 24.12 0.83 Allowed 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 124.985 1.314 . . . . 0.0 113.069 -175.045 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 246' ' ' GLU . . . . . 0.542 ' HA ' ' HB3' ' A' ' 238' ' ' CYS . 42.9 mt-10 -47.85 -38.46 16.12 Favored 'General case' 0 N--CA 1.502 2.149 0 C-N-CA 124.33 1.052 . . . . 0.0 113.181 -174.077 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 247' ' ' TRP . . . . . 0.532 ' HB2' ' HB2' ' A' ' 224' ' ' TYR . 85.6 m95 -78.34 127.09 31.71 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.498 -179.343 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -143.93 130.35 19.93 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.052 0.941 . . . . 0.0 109.605 178.551 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 249' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -71.92 129.56 38.87 Favored 'General case' 0 CA--C 1.547 0.854 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 172.646 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 250' ' ' TYR . . . . . 0.42 ' HB3' ' O ' ' A' ' 255' ' ' LEU . 50.1 m-85 -52.31 -31.68 34.19 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 124.709 1.204 . . . . 0.0 112.321 -178.965 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -53.54 -48.01 69.48 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 124.116 0.966 . . . . 0.0 111.89 176.439 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 252' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -61.04 -41.42 96.54 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.86 0.864 . . . . 0.0 111.414 -176.168 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 31.9 m -97.23 0.24 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 CA-C-N 115.395 -0.821 . . . . 0.0 112.038 -175.055 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 20.2 m120 62.78 17.06 9.55 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 124.934 1.294 . . . . 0.0 113.294 175.008 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.42 ' O ' ' HB3' ' A' ' 250' ' ' TYR . 92.6 mt -80.22 109.47 14.72 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 174.904 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -75.23 -34.98 61.49 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 121.205 0.526 . . . . 0.0 110.041 175.878 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -116.98 139.0 25.25 Favored Pre-proline 0 CA--C 1.55 0.966 0 C-N-CA 123.482 0.713 . . . . 0.0 109.566 -175.83 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -59.72 136.61 71.66 Favored 'Trans proline' 0 C--N 1.378 2.131 0 C-N-CA 123.66 2.907 . . . . 0.0 113.486 179.184 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 259' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -65.59 127.57 18.3 Favored 'Trans proline' 0 C--N 1.372 1.816 0 C-N-CA 122.641 2.227 . . . . 0.0 111.515 172.919 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 14.8 ptmm? -73.99 -16.08 61.08 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.419 0.688 . . . . 0.0 111.626 -179.101 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -118.31 176.9 16.31 Favored Glycine 0 C--N 1.345 1.043 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.893 179.434 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 36.6 p -57.13 123.05 13.89 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 124.131 0.972 . . . . 0.0 111.809 -177.881 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 263' ' ' TRP . . . . . . . . . . . . . 44.4 t90 -101.87 115.75 31.22 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.262 0.625 . . . . 0.0 109.36 -174.964 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -105.63 111.78 24.61 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.951 0.901 . . . . 0.0 109.253 177.701 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 16.6 p -64.35 149.11 95.29 Favored Pre-proline 0 CA--C 1.559 1.295 0 CA-C-O 118.326 -0.845 . . . . 0.0 109.4 174.223 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -27.44 -60.32 0.09 OUTLIER 'Trans proline' 0 C--N 1.384 2.411 1 C-N-CA 125.76 4.307 . . . . 0.0 118.026 -160.606 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.29 -39.89 86.03 Favored 'General case' 0 N--CA 1.485 1.281 0 CA-C-O 119.293 -0.384 . . . . 0.0 111.604 -175.949 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 268' ' ' CYS . . . . . . . . . . . . . 59.6 m -52.55 -30.94 33.27 Favored 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 -178.507 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 32.7 ttmt -78.35 -24.66 46.39 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.085 0.554 . . . . 0.0 111.516 -177.77 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 31.7 pt -112.76 2.51 8.49 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.258 0 C-N-CA 123.544 0.737 . . . . 0.0 112.034 179.08 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 . . . . . 0 C--O 1.256 1.396 0 C-N-CA 123.984 0.914 . . . . 0.0 109.544 -176.125 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 15.6 p . . . . . 0 N--CA 1.47 0.558 0 CA-C-O 120.807 0.337 . . . . 0.0 110.609 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -91.48 82.94 5.35 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.331 1.052 . . . . 0.0 108.212 176.657 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 224' ' ' TYR . . . . . 0.462 ' HE1' ' HE3' ' A' ' 244' ' ' LYS . 60.3 m-85 -148.32 125.42 11.41 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.657 1.183 . . . . 0.0 108.301 172.372 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 47.1 t 173.26 163.03 0.14 Allowed 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 124.7 1.2 . . . . 0.0 109.88 174.045 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -65.94 -33.97 77.03 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 122.41 0.284 . . . . 0.0 111.406 175.457 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 13.3 p -84.01 -5.86 59.31 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 122.152 0.181 . . . . 0.0 111.412 176.509 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 82.5 mm-40 48.67 85.95 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 125.467 1.507 . . . . 0.0 112.743 -175.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 22.9 tpp180 -153.92 148.54 26.32 Favored 'General case' 0 C--O 1.244 0.784 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 177.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 25.7 m -62.4 149.71 9.37 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 O-C-N 123.838 0.711 . . . . 0.0 110.73 178.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 17.5 p -87.01 69.52 10.24 Favored 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 123.382 0.673 . . . . 0.0 110.141 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 94.5 t80 -70.5 98.28 1.43 Allowed 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.164 0.986 . . . . 0.0 110.576 -176.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 78.5 -17.59 6.43 Favored Glycine 0 CA--C 1.536 1.404 0 CA-C-N 116.133 -0.485 . . . . 0.0 113.97 176.55 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -122.32 105.62 10.36 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.217 1.007 . . . . 0.0 108.424 178.324 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 235' ' ' MET . . . . . . . . . . . . . 21.3 ptt? -136.53 102.19 4.86 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 121.949 0.88 . . . . 0.0 111.143 178.405 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 5.0 p -101.48 123.72 54.77 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.785 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 172.561 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -92.67 147.82 22.57 Favored 'General case' 0 C--O 1.241 0.607 0 C-N-CA 123.168 0.587 . . . . 0.0 110.206 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 238' ' ' CYS . . . . . 0.51 ' HB3' ' HA ' ' A' ' 246' ' ' GLU . 35.4 t -106.41 154.52 20.7 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 124.034 0.934 . . . . 0.0 110.708 -179.228 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -111.15 96.23 6.01 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 170.543 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -140.67 119.93 1.65 Allowed Glycine 0 CA--C 1.527 0.802 0 CA-C-O 118.518 -1.156 . . . . 0.0 111.511 177.422 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -53.51 -39.07 83.68 Favored 'Trans proline' 0 C--N 1.382 2.323 0 C-N-CA 123.42 2.747 . . . . 0.0 113.276 174.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -114.76 101.73 9.34 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 171.281 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 12.8 t -173.07 102.82 0.13 Allowed 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 -173.202 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 244' ' ' LYS . . . . . 0.462 ' HE3' ' HE1' ' A' ' 224' ' ' TYR . 52.7 tptt -81.51 -31.34 32.87 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 123.252 0.621 . . . . 0.0 109.738 170.665 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -81.54 26.92 0.45 Allowed 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 124.938 1.295 . . . . 0.0 112.541 -179.095 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 246' ' ' GLU . . . . . 0.51 ' HA ' ' HB3' ' A' ' 238' ' ' CYS . 6.1 mm-40 -47.35 -45.77 25.0 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 123.883 0.873 . . . . 0.0 112.541 -178.099 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 247' ' ' TRP . . . . . 0.462 ' HB2' ' HB2' ' A' ' 224' ' ' TYR . 97.9 m95 -86.26 141.04 29.57 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.049 0.452 . . . . 0.0 111.035 178.824 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 32.9 m-85 -145.58 174.22 11.37 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.333 1.453 . . . . 0.0 109.231 176.43 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 249' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -113.47 141.11 47.5 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 168.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -54.95 -43.01 73.02 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.856 1.262 . . . . 0.0 112.673 -170.397 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -63.87 -34.47 78.02 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.389 0.676 . . . . 0.0 112.417 -175.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 252' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -65.55 -47.45 75.82 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-O 121.32 0.581 . . . . 0.0 110.246 179.12 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 30.6 m -88.04 5.46 4.02 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.897 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.747 -176.629 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 55.2 t30 58.73 70.91 0.62 Allowed 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.801 1.24 . . . . 0.0 110.785 178.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 76.6 mt -141.22 152.74 44.84 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.479 1.112 . . . . 0.0 109.121 177.136 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.8 -21.35 1.94 Allowed 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 123.864 0.866 . . . . 0.0 109.794 166.186 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -78.85 118.62 73.48 Favored Pre-proline 0 N--CA 1.478 0.97 0 C-N-CA 123.685 0.794 . . . . 0.0 109.49 176.319 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -57.34 121.36 9.91 Favored 'Trans proline' 0 C--N 1.372 1.799 0 C-N-CA 122.78 2.32 . . . . 0.0 111.129 165.46 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 259' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -52.92 132.79 48.83 Favored 'Trans proline' 0 C--N 1.378 2.12 0 C-N-CA 123.829 3.019 . . . . 0.0 113.738 -178.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 60.2 pttt -83.34 -2.55 55.99 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.313 1.045 . . . . 0.0 112.244 178.569 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -168.77 -155.63 9.83 Favored Glycine 0 C--N 1.344 0.984 0 CA-C-O 120.033 -0.315 . . . . 0.0 112.502 -179.054 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 25.8 p -62.19 106.81 0.78 Allowed 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.949 0.9 . . . . 0.0 111.447 -175.471 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 263' ' ' TRP . . . . . . . . . . . . . 63.1 t90 -92.49 113.98 26.41 Favored 'General case' 0 C--N 1.347 0.481 0 CA-C-N 115.771 -0.649 . . . . 0.0 109.435 -176.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 45.8 m-85 -93.68 118.6 31.61 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 175.255 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 265' ' ' CYS . . . . . 0.444 ' SG ' ' HB2' ' A' ' 267' ' ' GLU . 18.4 p -66.39 152.98 93.76 Favored Pre-proline 0 CA--C 1.545 0.774 0 CA-C-O 118.507 -0.759 . . . . 0.0 109.715 175.047 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_exo -47.85 -29.01 10.73 Favored 'Trans proline' 0 C--N 1.384 2.446 0 C-N-CA 123.728 2.952 . . . . 0.0 114.244 -178.329 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 267' ' ' GLU . . . . . 0.444 ' HB2' ' SG ' ' A' ' 265' ' ' CYS . 9.5 mp0 -64.74 -53.71 42.83 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 125.078 1.351 . . . . 0.0 109.814 178.352 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 268' ' ' CYS . . . . . . . . . . . . . 94.4 m -62.04 -34.91 77.12 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.29 0.636 . . . . 0.0 111.232 176.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -68.13 -23.99 64.95 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.291 0.636 . . . . 0.0 111.929 -179.362 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 2.8 pp -102.69 -4.68 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 N-CA-C 111.768 0.285 . . . . 0.0 111.768 175.29 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 . . . . . 0 N--CA 1.484 1.274 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 170.876 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 29.9 p . . . . . 0 N--CA 1.478 0.947 0 CA-C-O 121.526 0.679 . . . . 0.0 109.992 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 58.1 tp -110.63 98.76 7.86 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.026 0.931 . . . . 0.0 108.584 -178.06 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 224' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -136.72 128.89 29.72 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -173.851 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 42.2 t 172.75 166.9 0.12 Allowed 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 125.262 1.425 . . . . 0.0 108.838 171.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -68.34 -38.37 81.44 Favored 'General case' 0 N--CA 1.484 1.273 0 O-C-N 121.969 -0.457 . . . . 0.0 110.427 175.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 10.0 p -83.79 -9.8 58.54 Favored 'General case' 0 N--CA 1.484 1.257 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.909 176.702 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 22.2 mm-40 48.66 77.61 0.1 Allowed 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 124.742 1.217 . . . . 0.0 112.114 -173.422 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 229' ' ' ARG . . . . . 0.516 ' HE ' ' HE2' ' A' ' 232' ' ' PHE . 26.7 ttt85 -135.73 149.65 49.27 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.625 1.17 . . . . 0.0 108.273 -175.779 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 29.0 m -70.33 160.07 5.27 Favored 'Isoleucine or valine' 0 C--O 1.242 0.696 0 CA-C-O 121.255 0.55 . . . . 0.0 110.647 177.284 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 231' ' ' SER . . . . . 0.736 ' HB3' ' HB3' ' A' ' 235' ' ' MET . 48.2 m -113.88 118.18 33.47 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 176.813 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 232' ' ' PHE . . . . . 0.516 ' HE2' ' HE ' ' A' ' 229' ' ' ARG . 3.9 p90 -112.23 66.54 0.64 Allowed 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.318 1.047 . . . . 0.0 110.091 -167.773 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 86.58 -21.76 16.69 Favored Glycine 0 N--CA 1.472 1.086 0 CA-C-N 115.002 -0.999 . . . . 0.0 113.51 179.224 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 30.7 mm-40 -106.56 99.04 8.64 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 170.778 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 235' ' ' MET . . . . . 0.736 ' HB3' ' HB3' ' A' ' 231' ' ' SER . 25.7 ptt? -142.14 123.3 14.65 Favored 'General case' 0 C--O 1.241 0.647 0 CA-C-O 121.325 0.584 . . . . 0.0 110.836 178.842 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 0.529 HG23 ' HG3' ' A' ' 259' ' ' PRO . 6.2 p -100.12 124.62 53.7 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 CA-C-N 115.332 -0.849 . . . . 0.0 108.912 172.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -91.2 148.19 22.53 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.31 -178.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 238' ' ' CYS . . . . . 0.577 ' HB3' ' HA ' ' A' ' 246' ' ' GLU . 36.7 t -108.09 153.15 23.55 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 123.531 0.732 . . . . 0.0 109.657 173.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -118.18 93.77 4.25 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.678 0.791 . . . . 0.0 109.176 174.305 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -143.88 126.39 2.73 Favored Glycine 0 CA--C 1.527 0.802 0 CA-C-O 118.21 -1.328 . . . . 0.0 110.632 172.719 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -58.51 -50.5 9.37 Favored 'Trans proline' 0 C--N 1.376 1.986 0 CA-C-N 120.342 2.071 . . . . 0.0 110.96 177.632 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 8.7 p-10 -94.1 89.91 6.19 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 114.61 -1.177 . . . . 0.0 109.058 171.573 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 42.8 t -173.23 110.9 0.2 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.293 1.037 . . . . 0.0 109.197 -176.731 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 244' ' ' LYS . . . . . 0.549 ' H ' ' HD2' ' A' ' 244' ' ' LYS . 0.0 OUTLIER -88.85 -24.91 22.42 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.32 0.648 . . . . 0.0 110.995 178.985 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 36.6 m-85 -90.85 27.48 1.79 Allowed 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.403 1.081 . . . . 0.0 111.667 -177.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 246' ' ' GLU . . . . . 0.577 ' HA ' ' HB3' ' A' ' 238' ' ' CYS . 6.9 mm-40 -46.66 -45.07 19.02 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 124.023 0.929 . . . . 0.0 112.307 -179.182 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 247' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -83.44 126.74 33.07 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 121.56 0.695 . . . . 0.0 111.039 178.692 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 48.0 m-85 -134.64 174.79 10.17 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.352 1.461 . . . . 0.0 108.411 170.456 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 249' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -127.32 148.53 50.24 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.725 0.81 . . . . 0.0 108.951 178.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -58.35 -32.7 68.78 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 124.358 1.063 . . . . 0.0 113.033 -172.157 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -65.86 -36.41 83.37 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.55 0.74 . . . . 0.0 112.067 179.222 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 252' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -70.82 -56.02 7.23 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.597 0.759 . . . . 0.0 110.295 -178.882 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 253' ' ' VAL . . . . . 0.523 HG21 HG11 ' A' ' 236' ' ' VAL . 34.2 m -79.86 -3.68 6.46 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 CA-C-N 114.775 -1.102 . . . . 0.0 111.839 -175.405 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 14.4 m120 65.59 27.28 11.52 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 125.012 1.325 . . . . 0.0 112.123 173.313 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 33.8 mt -79.01 112.7 16.48 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.589 0.756 . . . . 0.0 109.595 172.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -88.91 -2.85 58.79 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.82 0.848 . . . . 0.0 109.489 168.614 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -127.08 146.12 56.59 Favored Pre-proline 0 CA--C 1.547 0.851 0 C-N-CA 124.628 1.171 . . . . 0.0 109.564 -176.58 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -72.86 134.84 22.42 Favored 'Trans proline' 0 C--N 1.37 1.689 0 C-N-CA 122.47 2.113 . . . . 0.0 110.845 171.259 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 259' ' ' PRO . . . . . 0.529 ' HG3' HG23 ' A' ' 236' ' ' VAL . 39.6 Cg_endo -63.68 149.82 89.95 Favored 'Trans proline' 0 C--N 1.375 1.958 0 C-N-CA 122.362 2.041 . . . . 0.0 112.062 177.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -75.87 -18.87 59.26 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.058 0.943 . . . . 0.0 112.912 -168.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -170.66 -134.48 1.76 Allowed Glycine 0 C--N 1.343 0.935 0 N-CA-C 111.663 -0.575 . . . . 0.0 111.663 -178.102 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 42.1 p -69.57 106.34 2.99 Favored 'General case' 0 C--N 1.353 0.729 0 C-N-CA 122.865 0.466 . . . . 0.0 109.835 177.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 263' ' ' TRP . . . . . 0.466 ' O ' ' HA ' ' A' ' 238' ' ' CYS . 76.1 t90 -87.98 122.23 31.34 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.206 -176.544 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -101.17 118.12 36.36 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 176.812 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 265' ' ' CYS . . . . . 0.492 ' SG ' ' HG2' ' A' ' 267' ' ' GLU . 16.2 p -66.91 155.52 89.72 Favored Pre-proline 0 CA--C 1.551 0.988 0 C-N-CA 123.793 0.837 . . . . 0.0 110.946 -178.385 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -38.91 -50.47 2.57 Favored 'Trans proline' 0 C--N 1.388 2.647 0 C-N-CA 124.739 3.626 . . . . 0.0 115.314 -176.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 267' ' ' GLU . . . . . 0.492 ' HG2' ' SG ' ' A' ' 265' ' ' CYS . 2.5 pm0 -62.2 -39.34 92.4 Favored 'General case' 0 CA--C 1.549 0.933 0 CA-C-N 115.892 -0.594 . . . . 0.0 112.357 -178.837 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 268' ' ' CYS . . . . . . . . . . . . . 63.6 m -68.87 -44.1 74.01 Favored 'General case' 0 N--CA 1.495 1.821 0 C-N-CA 122.699 0.399 . . . . 0.0 111.223 176.675 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -66.78 -31.48 72.15 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.37 -169.554 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 1.8 mp -91.05 -46.82 14.58 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.078 0 C-N-CA 123.382 0.673 . . . . 0.0 109.666 176.158 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 . . . . . 0 CA--C 1.558 1.288 0 C-N-CA 123.309 0.644 . . . . 0.0 109.711 -175.555 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 9.1 p . . . . . 0 N--CA 1.476 0.844 0 CA-C-O 121.223 0.535 . . . . 0.0 111.027 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 5.8 tt -140.83 108.35 5.58 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 -174.54 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 224' ' ' TYR . . . . . 0.44 ' HB3' ' HA ' ' A' ' 245' ' ' TYR . 63.7 m-85 -140.04 124.11 17.66 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 176.427 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 48.7 t 171.25 152.18 0.06 Allowed 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 125.52 1.528 . . . . 0.0 108.08 174.226 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 50.4 t80 -65.29 -38.74 91.19 Favored 'General case' 0 N--CA 1.486 1.351 0 CA-C-N 119.138 0.881 . . . . 0.0 110.965 -179.194 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 5.8 p -68.43 -14.23 62.86 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 123.034 0.208 . . . . 0.0 111.07 177.462 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 87.0 mm-40 57.12 85.82 0.08 Allowed 'General case' 0 C--N 1.364 1.238 0 C-N-CA 125.231 1.413 . . . . 0.0 111.845 179.075 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -160.17 149.12 17.29 Favored 'General case' 0 C--O 1.242 0.706 0 CA-C-N 114.745 -1.116 . . . . 0.0 108.713 178.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 31.0 m -71.51 149.97 9.35 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 122.78 0.432 . . . . 0.0 111.184 178.757 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 15.8 m -94.26 68.34 3.62 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-O 121.745 0.783 . . . . 0.0 109.23 177.614 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 47.6 t80 -83.04 91.42 7.18 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.463 -171.498 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 103.98 -19.79 42.74 Favored Glycine 0 N--CA 1.476 1.33 0 CA-C-N 116.066 -0.515 . . . . 0.0 113.694 175.114 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.1 64.67 1.59 Allowed 'General case' 0 N--CA 1.481 1.124 0 CA-C-O 122.392 1.091 . . . . 0.0 110.122 178.788 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 235' ' ' MET . . . . . . . . . . . . . 18.3 ptm -99.56 130.68 45.82 Favored 'General case' 0 N--CA 1.483 1.177 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.75 -176.215 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 7.0 p -124.95 126.88 71.96 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.939 0 C-N-CA 124.565 1.146 . . . . 0.0 108.964 177.628 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -91.86 154.22 19.02 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.873 0.869 . . . . 0.0 111.302 -178.518 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 238' ' ' CYS . . . . . 0.649 ' HB3' ' HA ' ' A' ' 246' ' ' GLU . 11.3 t -117.12 155.47 29.26 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.929 1.292 . . . . 0.0 109.565 175.523 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -117.9 105.34 11.82 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.757 0.823 . . . . 0.0 109.406 172.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -140.96 144.74 15.04 Favored Glycine 0 CA--C 1.528 0.874 0 CA-C-O 118.533 -1.148 . . . . 0.0 111.405 173.681 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -61.38 -47.88 10.89 Favored 'Trans proline' 0 C--N 1.378 2.112 0 C-N-CA 122.929 2.419 . . . . 0.0 112.028 -178.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 40.9 t30 -124.5 107.44 11.07 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 170.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 43.8 t -157.45 117.05 3.36 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 123.522 0.729 . . . . 0.0 109.376 -174.173 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -80.5 -44.62 18.84 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.441 0.697 . . . . 0.0 109.852 176.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 245' ' ' TYR . . . . . 0.44 ' HA ' ' HB3' ' A' ' 224' ' ' TYR . 45.6 m-85 -82.72 31.11 0.42 Allowed 'General case' 0 CA--C 1.553 1.089 0 C-N-CA 124.18 0.992 . . . . 0.0 112.393 -175.372 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 246' ' ' GLU . . . . . 0.649 ' HA ' ' HB3' ' A' ' 238' ' ' CYS . 6.9 mm-40 -47.34 -42.79 22.16 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.832 0.853 . . . . 0.0 111.537 173.446 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 247' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -90.34 139.05 31.04 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-O 121.052 0.453 . . . . 0.0 111.132 177.541 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -147.28 173.09 12.9 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.062 1.345 . . . . 0.0 109.401 174.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 249' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -117.63 140.4 49.7 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.427 0.691 . . . . 0.0 110.03 174.207 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -54.58 -28.09 43.64 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 125.301 1.44 . . . . 0.0 112.36 -179.578 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -60.61 -54.73 41.79 Favored 'General case' 0 CA--C 1.555 1.16 0 C-N-CA 123.407 0.683 . . . . 0.0 111.176 177.019 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 252' ' ' CYS . . . . . . . . . . . . . 1.1 m -66.21 -44.68 83.19 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.773 0.829 . . . . 0.0 111.594 -177.772 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 33.8 m -84.4 -0.71 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.619 -177.017 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 21.1 m120 60.66 19.18 9.18 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 125.038 1.335 . . . . 0.0 113.278 172.187 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 92.7 mt -84.64 120.94 26.95 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 177.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 31.9 mmtp -103.74 21.33 16.41 Favored 'General case' 0 N--CA 1.485 1.322 0 CA-C-O 121.319 0.58 . . . . 0.0 110.07 -177.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -157.89 139.56 9.93 Favored Pre-proline 0 C--O 1.245 0.832 0 C-N-CA 124.619 1.167 . . . . 0.0 109.069 -174.733 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_exo -67.99 115.19 3.67 Favored 'Trans proline' 0 C--N 1.373 1.842 0 C-N-CA 122.999 2.466 . . . . 0.0 111.668 176.535 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 259' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -68.48 121.1 8.02 Favored 'Trans proline' 0 C--N 1.376 2.026 0 C-N-CA 122.374 2.049 . . . . 0.0 111.252 178.378 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 10.3 mtmp? -72.48 124.31 24.93 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.12 0.568 . . . . 0.0 110.354 178.321 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 115.76 -159.74 13.67 Favored Glycine 0 C--N 1.337 0.627 0 N-CA-C 111.494 -0.642 . . . . 0.0 111.494 174.081 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 45.6 p -83.56 107.18 15.86 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 172.657 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 263' ' ' TRP . . . . . . . . . . . . . 40.2 t90 -77.04 147.23 36.86 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-O 121.119 0.485 . . . . 0.0 110.144 179.596 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -120.13 120.66 36.87 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 123.735 0.814 . . . . 0.0 108.972 178.531 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 17.3 p -67.71 161.09 69.23 Favored Pre-proline 0 CA--C 1.55 0.97 0 C-N-CA 123.537 0.735 . . . . 0.0 110.646 176.488 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -41.52 -29.91 0.84 Allowed 'Trans proline' 0 C--N 1.383 2.387 0 C-N-CA 124.002 3.134 . . . . 0.0 115.593 176.091 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -63.47 -66.78 0.49 Allowed 'General case' 0 N--CA 1.483 1.199 0 CA-C-O 121.605 0.717 . . . . 0.0 109.806 173.757 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 268' ' ' CYS . . . . . . . . . . . . . 58.6 m -71.26 -28.62 64.29 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 114.617 -1.174 . . . . 0.0 111.949 -167.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -80.04 -56.12 4.47 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.373 0.669 . . . . 0.0 110.504 -178.339 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 45.5 mm -82.21 -59.44 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 122.768 0.427 . . . . 0.0 111.714 -168.298 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 . . . . . 0 N--CA 1.481 1.083 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -168.769 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 53.0 p . . . . . 0 CA--C 1.552 1.045 0 N-CA-C 111.558 0.207 . . . . 0.0 111.558 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 5.4 tt -70.53 86.03 0.63 Allowed 'General case' 0 C--N 1.363 1.158 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 176.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 224' ' ' TYR . . . . . 0.618 ' HB3' ' HA ' ' A' ' 245' ' ' TYR . 88.0 m-85 -137.39 131.99 32.86 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.534 1.134 . . . . 0.0 108.251 177.283 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 34.8 t 172.48 160.07 0.11 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.028 1.331 . . . . 0.0 108.888 177.65 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -67.52 -29.09 68.4 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 122.543 0.337 . . . . 0.0 111.0 177.365 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 227' ' ' CYS . . . . . 0.453 ' SG ' ' HB2' ' A' ' 229' ' ' ARG . 12.2 p -84.86 -5.84 59.34 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-O 119.224 -0.417 . . . . 0.0 111.939 178.164 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 33.1 mm-40 54.88 78.94 0.16 Allowed 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 124.494 1.117 . . . . 0.0 111.269 -173.325 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 229' ' ' ARG . . . . . 0.453 ' HB2' ' SG ' ' A' ' 227' ' ' CYS . 3.1 tmm_? -154.23 150.21 27.82 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 -176.442 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 30.7 m -66.98 156.84 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 123.388 0.675 . . . . 0.0 112.56 178.461 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 22.5 m -109.67 89.53 3.04 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-N 115.251 -0.886 . . . . 0.0 108.655 175.318 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 88.2 t80 -114.45 124.68 52.53 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.513 0.725 . . . . 0.0 109.697 177.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 79.58 -16.68 10.02 Favored Glycine 0 C--N 1.347 1.173 0 CA-C-N 116.054 -0.521 . . . . 0.0 113.023 -179.04 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 234' ' ' GLU . . . . . 0.44 ' HB3' ' H ' ' A' ' 250' ' ' TYR . 41.5 mt-10 -140.62 98.1 3.34 Favored 'General case' 0 C--N 1.349 0.546 0 C-N-CA 124.844 1.257 . . . . 0.0 107.773 -176.668 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 235' ' ' MET . . . . . . . . . . . . . 3.5 mpp? -127.4 95.12 4.17 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 -178.224 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 4.1 p -103.13 126.28 57.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 171.264 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -95.86 156.99 16.1 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.293 0.568 . . . . 0.0 111.12 -177.71 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 238' ' ' CYS . . . . . 0.738 ' HB3' ' HA ' ' A' ' 246' ' ' GLU . 18.5 t -110.81 153.18 25.73 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 124.442 1.097 . . . . 0.0 109.409 174.885 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -108.65 92.58 4.11 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 174.071 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -143.9 114.34 0.81 Allowed Glycine 0 CA--C 1.529 0.912 0 CA-C-O 118.08 -1.4 . . . . 0.0 111.863 175.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -54.05 -39.75 84.19 Favored 'Trans proline' 0 C--N 1.377 2.039 0 C-N-CA 123.104 2.536 . . . . 0.0 112.907 178.369 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -111.3 91.23 3.58 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 171.633 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 51.5 t -171.98 116.74 0.37 Allowed 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.208 1.003 . . . . 0.0 108.745 -175.306 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 23.6 pttm -89.03 -33.38 17.17 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 122.701 0.401 . . . . 0.0 110.538 176.774 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 245' ' ' TYR . . . . . 0.618 ' HA ' ' HB3' ' A' ' 224' ' ' TYR . 22.0 m-30 -79.28 29.92 0.22 Allowed 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.741 1.216 . . . . 0.0 112.235 179.708 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 246' ' ' GLU . . . . . 0.738 ' HA ' ' HB3' ' A' ' 238' ' ' CYS . 6.9 mm-40 -47.44 -45.96 26.21 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.745 0.818 . . . . 0.0 111.086 170.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 247' ' ' TRP . . . . . 0.536 ' HB2' ' HB2' ' A' ' 224' ' ' TYR . 91.8 m95 -78.59 134.72 37.18 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 121.109 0.48 . . . . 0.0 110.76 177.211 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -144.08 170.88 15.11 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 125.163 1.385 . . . . 0.0 108.424 170.59 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 249' ' ' HIS . . . . . 0.422 ' HD2' ' HB2' ' A' ' 252' ' ' CYS . 0.0 OUTLIER -115.52 133.98 55.51 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 174.092 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 250' ' ' TYR . . . . . 0.44 ' H ' ' HB3' ' A' ' 234' ' ' GLU . 49.9 m-85 -47.74 -57.5 5.49 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 125.354 1.462 . . . . 0.0 114.467 -168.535 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -69.18 -26.63 64.93 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 122.381 0.272 . . . . 0.0 111.246 -170.748 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 252' ' ' CYS . . . . . 0.422 ' HB2' ' HD2' ' A' ' 249' ' ' HIS . 36.1 t -68.32 -32.1 71.99 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 124.087 0.955 . . . . 0.0 111.013 177.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 17.5 m -105.24 16.84 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 C-N-CA 123.34 0.656 . . . . 0.0 110.879 175.595 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 17.2 m120 67.54 9.11 6.81 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 125.364 1.466 . . . . 0.0 114.13 172.36 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 87.0 mt -76.97 137.42 39.02 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 122.925 0.49 . . . . 0.0 109.909 173.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.74 -23.24 9.29 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.909 0.884 . . . . 0.0 109.747 176.232 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -126.44 148.83 65.65 Favored Pre-proline 0 CA--C 1.549 0.91 0 C-N-CA 124.061 0.944 . . . . 0.0 110.158 -179.063 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -65.59 139.52 58.75 Favored 'Trans proline' 0 C--N 1.38 2.224 0 C-N-CA 123.11 2.54 . . . . 0.0 112.404 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 259' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_exo -59.3 151.59 66.66 Favored 'Trans proline' 0 C--N 1.377 2.069 0 C-N-CA 122.705 2.27 . . . . 0.0 112.095 172.44 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -89.65 -21.0 22.99 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.846 0.858 . . . . 0.0 110.266 -176.07 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -147.87 -144.09 3.93 Favored Glycine 0 C--N 1.349 1.29 0 CA-C-O 119.821 -0.433 . . . . 0.0 112.332 -179.292 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 30.2 p -67.61 111.91 4.45 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 123.569 0.748 . . . . 0.0 111.105 -177.395 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 263' ' ' TRP . . . . . . . . . . . . . 32.1 t90 -93.41 116.8 29.35 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -100.51 107.01 18.61 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 123.421 0.689 . . . . 0.0 109.472 178.148 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 15.5 p -57.28 160.41 6.86 Favored Pre-proline 0 N--CA 1.487 1.384 0 C-N-CA 124.418 1.087 . . . . 0.0 111.046 177.42 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -33.83 -46.88 0.45 Allowed 'Trans proline' 0 C--N 1.396 3.05 0 C-N-CA 124.867 3.711 . . . . 0.0 114.834 -179.044 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -61.56 -50.41 72.76 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 124.823 1.249 . . . . 0.0 112.04 -177.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 268' ' ' CYS . . . . . . . . . . . . . 79.6 m -72.49 -29.11 63.35 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.851 0.86 . . . . 0.0 111.982 -175.029 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.02 -15.27 36.86 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 111.885 0.328 . . . . 0.0 111.885 -179.208 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 33.2 mm -88.09 -16.09 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 C-N-CA 123.337 0.655 . . . . 0.0 110.237 171.369 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 . . . . . 0 CA--C 1.559 1.313 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 172.52 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 13.5 p . . . . . 0 N--CA 1.48 1.058 0 N-CA-C 110.382 -0.229 . . . . 0.0 110.382 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 66.6 tp -79.91 97.32 6.67 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.369 0.668 . . . . 0.0 109.491 178.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 224' ' ' TYR . . . . . 0.657 ' HB3' ' HA ' ' A' ' 245' ' ' TYR . 19.2 m-85 -136.22 128.87 30.69 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.86 0.864 . . . . 0.0 109.31 -179.576 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 225' ' ' CYS . . . . . 0.424 ' HB2' ' O ' ' A' ' 224' ' ' TYR . 40.3 t 170.21 163.32 0.07 Allowed 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 125.64 1.576 . . . . 0.0 108.626 167.029 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -59.91 -44.93 94.01 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 122.475 0.31 . . . . 0.0 110.51 173.591 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 14.1 p -76.79 -12.17 59.94 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.106 0.563 . . . . 0.0 112.194 -176.527 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 82.3 mm-40 51.82 77.4 0.15 Allowed 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 124.519 1.128 . . . . 0.0 112.135 -172.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 72.5 ttt180 -147.56 149.52 32.73 Favored 'General case' 0 C--O 1.242 0.691 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 176.469 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 26.6 m -67.54 146.1 13.29 Favored 'Isoleucine or valine' 0 C--O 1.245 0.825 0 CA-C-O 121.14 0.495 . . . . 0.0 110.808 177.771 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 231' ' ' SER . . . . . 0.448 ' HB3' ' O ' ' A' ' 234' ' ' GLU . 50.9 m -79.43 87.14 5.07 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 172.43 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 83.1 t80 -86.25 107.87 18.13 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.453 0.701 . . . . 0.0 111.095 -173.246 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 73.53 -1.23 45.32 Favored Glycine 0 C--N 1.351 1.392 0 CA-C-N 115.741 -0.663 . . . . 0.0 114.191 175.445 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 234' ' ' GLU . . . . . 0.448 ' O ' ' HB3' ' A' ' 231' ' ' SER . 14.7 pt-20 -154.97 141.05 18.41 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 124.386 1.074 . . . . 0.0 108.908 -175.267 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 235' ' ' MET . . . . . 0.419 ' HB3' ' HB3' ' A' ' 231' ' ' SER . 0.0 OUTLIER -160.21 136.77 8.93 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 122.885 0.474 . . . . 0.0 110.534 174.857 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 4.2 p -117.7 124.22 72.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 173.087 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -87.96 127.61 35.37 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.048 0.539 . . . . 0.0 110.233 -177.796 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 238' ' ' CYS . . . . . . . . . . . . . 48.8 t -92.6 154.5 18.36 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.002 0.921 . . . . 0.0 110.691 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -116.59 109.74 17.63 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 169.524 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 240' ' ' GLY . . . . . 0.577 ' HA3' ' SG ' ' A' ' 268' ' ' CYS . . . -144.17 140.58 9.49 Favored Glycine 0 C--N 1.344 0.978 0 CA-C-O 118.786 -1.008 . . . . 0.0 113.215 172.79 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -57.54 -54.95 2.81 Favored 'Trans proline' 0 C--N 1.374 1.913 0 C-N-CA 122.856 2.37 . . . . 0.0 112.627 171.801 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -107.49 77.65 1.15 Allowed 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 176.544 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 34.5 t -150.85 106.25 3.36 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 -174.708 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 244' ' ' LYS . . . . . 0.462 ' HA ' ' HE3' ' A' ' 244' ' ' LYS . 0.4 OUTLIER -89.04 -29.36 19.5 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.307 0.643 . . . . 0.0 110.792 178.925 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 245' ' ' TYR . . . . . 0.657 ' HA ' ' HB3' ' A' ' 224' ' ' TYR . 23.5 m-85 -82.03 22.0 0.83 Allowed 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.632 0.773 . . . . 0.0 112.95 -174.329 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -46.75 -37.36 8.4 Favored 'General case' 0 N--CA 1.501 2.114 0 C-N-CA 124.72 1.208 . . . . 0.0 112.849 -171.132 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 247' ' ' TRP . . . . . . . . . . . . . 97.7 m95 -77.69 101.83 6.81 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.148 0.579 . . . . 0.0 109.771 175.143 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -113.98 176.37 5.07 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.357 1.063 . . . . 0.0 110.466 178.247 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 249' ' ' HIS . . . . . 0.509 ' CD2' ' HB2' ' A' ' 252' ' ' CYS . 0.9 OUTLIER -129.49 144.05 51.09 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.793 1.237 . . . . 0.0 109.166 174.724 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 250' ' ' TYR . . . . . 0.484 ' HB3' ' O ' ' A' ' 255' ' ' LEU . 65.8 m-85 -62.19 -38.8 90.51 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 124.494 1.118 . . . . 0.0 112.825 -169.219 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -60.72 -36.84 79.83 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 124.252 1.021 . . . . 0.0 111.452 -176.445 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 252' ' ' CYS . . . . . 0.509 ' HB2' ' CD2' ' A' ' 249' ' ' HIS . 0.5 OUTLIER -64.62 -42.27 95.61 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.346 1.058 . . . . 0.0 110.456 -177.037 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 34.0 m -100.07 5.89 9.78 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 CA-C-N 114.777 -1.101 . . . . 0.0 111.309 -173.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 17.3 m120 66.33 13.17 9.07 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 125.054 1.342 . . . . 0.0 113.288 172.682 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.484 ' O ' ' HB3' ' A' ' 250' ' ' TYR . 92.3 mt -80.68 125.41 30.0 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 175.318 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -89.33 -23.5 22.23 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 172.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -134.08 150.97 75.73 Favored Pre-proline 0 CA--C 1.55 0.954 0 C-N-CA 124.589 1.156 . . . . 0.0 108.746 179.278 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 258' ' ' PRO . . . . . 0.429 ' HA ' ' HD3' ' A' ' 259' ' ' PRO . 45.6 Cg_endo -67.28 143.29 63.7 Favored 'Trans proline' 0 C--N 1.375 1.937 0 C-N-CA 122.318 2.012 . . . . 0.0 110.772 172.511 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 259' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 258' ' ' PRO . 40.6 Cg_exo -60.65 163.89 14.68 Favored 'Trans proline' 0 C--N 1.374 1.899 0 C-N-CA 123.215 2.61 . . . . 0.0 113.849 -179.194 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -63.32 -34.66 78.18 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 114.943 -1.026 . . . . 0.0 112.095 -177.021 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -120.21 -164.44 12.53 Favored Glycine 0 CA--C 1.523 0.579 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.702 175.64 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 58.9 m -65.76 125.4 25.18 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.446 0.699 . . . . 0.0 110.0 -179.157 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 263' ' ' TRP . . . . . . . . . . . . . 39.5 t90 -84.5 129.42 34.86 Favored 'General case' 0 C--O 1.242 0.669 0 CA-C-O 121.719 0.771 . . . . 0.0 111.053 -175.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 264' ' ' TYR . . . . . 0.419 ' O ' ' HE3' ' A' ' 269' ' ' LYS . 75.6 m-85 -111.07 126.84 55.24 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.02 1.328 . . . . 0.0 107.587 172.612 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 265' ' ' CYS . . . . . 0.448 ' SG ' ' HB2' ' A' ' 267' ' ' GLU . 26.4 p -67.98 161.89 63.83 Favored Pre-proline 0 CA--C 1.554 1.121 0 CA-C-O 118.661 -0.685 . . . . 0.0 109.858 175.147 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_exo -46.84 -33.26 13.81 Favored 'Trans proline' 0 C--N 1.39 2.73 0 C-N-CA 123.414 2.743 . . . . 0.0 113.469 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 267' ' ' GLU . . . . . 0.448 ' HB2' ' SG ' ' A' ' 265' ' ' CYS . 26.6 mt-10 -59.9 -58.41 8.68 Favored 'General case' 0 C--O 1.213 -0.837 0 C-N-CA 124.651 1.181 . . . . 0.0 110.054 175.536 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 268' ' ' CYS . . . . . 0.577 ' SG ' ' HA3' ' A' ' 240' ' ' GLY . 99.0 m -63.86 -27.77 69.39 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.603 0.761 . . . . 0.0 113.049 -176.27 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 269' ' ' LYS . . . . . 0.419 ' HE3' ' O ' ' A' ' 264' ' ' TYR . 94.2 mttt -68.87 -37.32 78.98 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 122.579 0.352 . . . . 0.0 111.059 176.816 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 74.1 mt -95.66 -72.06 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.814 0 C-N-CA 122.947 0.499 . . . . 0.0 109.841 179.423 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 . . . . . 0 C--O 1.25 1.123 0 C-N-CA 124.798 1.239 . . . . 0.0 110.315 -179.714 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 8.4 p . . . . . 0 N--CA 1.479 0.983 0 CA-C-O 120.866 0.365 . . . . 0.0 110.336 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 34.4 tp -97.25 119.3 35.52 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.481 0.712 . . . . 0.0 109.254 178.214 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 224' ' ' TYR . . . . . 0.438 ' HB3' ' HA ' ' A' ' 245' ' ' TYR . 48.0 m-85 -143.87 141.42 30.3 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.377 0.671 . . . . 0.0 110.29 -175.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 45.3 t 170.58 158.47 0.07 Allowed 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 125.367 1.467 . . . . 0.0 109.274 164.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 35.7 t80 -65.62 -37.99 88.14 Favored 'General case' 0 CA--C 1.551 0.991 0 CA-C-N 117.804 0.275 . . . . 0.0 110.985 177.416 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 4.6 p -80.45 -12.04 59.61 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 122.589 0.356 . . . . 0.0 111.129 176.574 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 84.2 mm-40 50.01 81.15 0.06 Allowed 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 124.745 1.218 . . . . 0.0 112.077 -173.24 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 229' ' ' ARG . . . . . 0.464 HH22 ' HB3' ' A' ' 251' ' ' ASP . 46.7 ttp180 -135.09 149.44 50.06 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 176.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 23.6 m -67.18 147.03 12.78 Favored 'Isoleucine or valine' 0 C--O 1.241 0.635 0 C-N-CA 122.63 0.372 . . . . 0.0 111.328 174.409 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 40.9 m -98.81 81.71 2.68 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 174.491 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -86.86 99.95 12.2 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.589 0.756 . . . . 0.0 109.768 -176.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 76.97 -0.09 67.67 Favored Glycine 0 N--CA 1.474 1.178 0 CA-C-N 116.232 -0.44 . . . . 0.0 113.823 178.467 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -135.35 72.71 1.45 Allowed 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.122 0.969 . . . . 0.0 109.571 -178.342 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 235' ' ' MET . . . . . . . . . . . . . 3.4 mpp? -105.76 108.46 19.99 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.285 -176.213 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 5.6 p -111.6 124.17 68.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 171.07 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -99.9 131.04 46.11 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 123.273 0.629 . . . . 0.0 109.732 -179.169 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 238' ' ' CYS . . . . . . . . . . . . . 18.1 t -81.66 143.25 32.04 Favored 'General case' 0 C--O 1.223 -0.3 0 C-N-CA 123.873 0.869 . . . . 0.0 110.58 179.352 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -97.39 93.79 6.68 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 166.015 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -142.56 112.92 0.76 Allowed Glycine 0 CA--C 1.521 0.442 0 CA-C-O 118.34 -1.255 . . . . 0.0 110.445 174.324 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -67.22 -24.43 44.08 Favored 'Trans proline' 0 C--N 1.366 1.492 0 CA-C-N 120.112 1.956 . . . . 0.0 111.38 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 15.3 p-10 -110.81 70.81 0.73 Allowed 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.408 1.483 . . . . 0.0 108.821 176.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 39.0 t -167.4 107.08 0.58 Allowed 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.308 -169.199 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? -77.1 -36.15 55.87 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.037 0.535 . . . . 0.0 109.808 171.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 245' ' ' TYR . . . . . 0.438 ' HA ' ' HB3' ' A' ' 224' ' ' TYR . 12.2 m-85 -79.62 24.77 0.36 Allowed 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 -171.272 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -45.98 -43.5 14.21 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 124.781 1.232 . . . . 0.0 114.122 -170.038 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 247' ' ' TRP . . . . . . . . . . . . . 70.5 m95 -76.92 129.53 36.3 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-O 121.155 0.502 . . . . 0.0 110.884 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -140.19 174.81 10.14 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.767 1.227 . . . . 0.0 109.193 179.229 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 249' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -125.1 141.03 52.37 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.062 0.945 . . . . 0.0 109.971 179.346 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 39.3 m-85 -56.16 -35.06 66.76 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 125.622 1.569 . . . . 0.0 112.852 -171.289 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 251' ' ' ASP . . . . . 0.464 ' HB3' HH22 ' A' ' 229' ' ' ARG . 11.6 t70 -57.97 -51.18 70.7 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 124.746 1.219 . . . . 0.0 111.504 177.575 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 252' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -62.26 -42.44 99.33 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.832 0.853 . . . . 0.0 110.946 -176.108 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 253' ' ' VAL . . . . . 0.41 HG23 ' HG ' ' A' ' 255' ' ' LEU . 35.1 m -99.01 5.56 9.66 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.652 -172.871 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 34.6 m-80 62.95 17.93 10.46 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 125.075 1.35 . . . . 0.0 113.621 171.175 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.41 ' HG ' HG23 ' A' ' 253' ' ' VAL . 87.2 mt -79.62 126.01 30.35 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 177.505 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 83.3 mttt -99.18 -25.94 14.36 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.993 0.917 . . . . 0.0 109.399 178.382 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -119.82 156.41 54.08 Favored Pre-proline 0 CA--C 1.551 0.999 0 C-N-CA 125.013 1.325 . . . . 0.0 109.043 176.095 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -68.14 143.33 59.02 Favored 'Trans proline' 0 C--N 1.378 2.107 0 C-N-CA 122.409 2.073 . . . . 0.0 111.192 172.075 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 259' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -56.75 156.24 23.85 Favored 'Trans proline' 0 C--N 1.378 2.107 0 C-N-CA 123.163 2.576 . . . . 0.0 113.203 177.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -78.89 -7.53 58.02 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 122.889 0.476 . . . . 0.0 111.967 -179.234 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 178.93 -133.67 2.15 Favored Glycine 0 C--N 1.346 1.109 0 CA-C-O 119.949 -0.362 . . . . 0.0 112.565 177.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 37.1 p -63.71 106.54 1.0 Allowed 'General case' 0 C--N 1.351 0.651 0 C-N-CA 124.344 1.058 . . . . 0.0 110.356 -178.045 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 263' ' ' TRP . . . . . . . . . . . . . 54.7 t90 -98.48 109.4 22.16 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.493 0.717 . . . . 0.0 110.535 -174.169 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 264' ' ' TYR . . . . . 0.406 ' HD2' ' HB3' ' A' ' 268' ' ' CYS . 44.0 m-85 -94.65 106.23 18.2 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.312 0.645 . . . . 0.0 110.036 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 265' ' ' CYS . . . . . 0.425 ' SG ' ' OE2' ' A' ' 267' ' ' GLU . 13.5 p -64.36 157.9 68.83 Favored Pre-proline 0 CA--C 1.565 1.536 0 CA-C-O 118.05 -0.976 . . . . 0.0 109.783 176.453 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -23.67 -63.0 0.05 OUTLIER 'Trans proline' 0 C--N 1.392 2.824 1 C-N-CA 126.26 4.64 . . . . 0.0 117.981 -168.038 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 267' ' ' GLU . . . . . 0.425 ' OE2' ' SG ' ' A' ' 265' ' ' CYS . 0.0 OUTLIER -71.73 -28.11 63.46 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 122.027 -0.421 . . . . 0.0 111.731 -173.116 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 268' ' ' CYS . . . . . 0.406 ' HB3' ' HD2' ' A' ' 264' ' ' TYR . 91.1 m -68.21 -30.33 69.38 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 124.135 0.974 . . . . 0.0 112.315 179.482 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -92.75 -3.9 54.01 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 122.352 0.261 . . . . 0.0 111.595 -178.642 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 74.8 mt -106.51 -47.43 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 C-N-CA 124.032 0.933 . . . . 0.0 109.899 177.076 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 . . . . . 0 CA--C 1.563 1.448 0 C-N-CA 125.372 1.469 . . . . 0.0 108.997 -176.347 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 48.0 p . . . . . 0 N--CA 1.477 0.898 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 55.5 tp -96.53 94.04 7.14 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.265 0.626 . . . . 0.0 109.328 -179.385 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 224' ' ' TYR . . . . . 0.708 ' HB3' ' HA ' ' A' ' 245' ' ' TYR . 39.6 m-85 -137.63 126.1 23.48 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.768 0.827 . . . . 0.0 109.417 -178.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 225' ' ' CYS . . . . . 0.402 ' HB2' ' O ' ' A' ' 224' ' ' TYR . 39.0 t 172.47 162.86 0.12 Allowed 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 125.11 1.364 . . . . 0.0 109.294 169.294 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 56.1 t80 -69.01 -35.48 76.72 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 122.736 0.414 . . . . 0.0 111.383 177.442 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 13.5 p -82.79 -13.22 56.66 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 122.58 0.352 . . . . 0.0 111.434 178.304 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 83.8 mm-40 54.99 85.58 0.06 Allowed 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.501 1.12 . . . . 0.0 112.02 -172.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 42.0 ttp180 -150.77 150.64 31.26 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 115.064 -0.971 . . . . 0.0 108.439 174.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 32.9 m -76.17 152.98 5.99 Favored 'Isoleucine or valine' 0 C--O 1.242 0.665 0 CA-C-O 121.334 0.587 . . . . 0.0 110.974 178.2 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 231' ' ' SER . . . . . 0.489 ' HB2' ' HG2' ' A' ' 235' ' ' MET . 14.9 m -101.74 101.48 11.98 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.128 0.971 . . . . 0.0 108.445 175.099 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -72.48 81.05 1.06 Allowed 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.776 0.83 . . . . 0.0 109.661 -177.055 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 74.16 -18.39 2.07 Favored Glycine 0 CA--C 1.537 1.437 0 CA-C-N 115.193 -0.912 . . . . 0.0 114.366 -179.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -98.28 66.51 1.77 Allowed 'General case' 0 C--O 1.243 0.743 0 C-N-CA 123.75 0.82 . . . . 0.0 109.62 -176.6 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 235' ' ' MET . . . . . 0.489 ' HG2' ' HB2' ' A' ' 231' ' ' SER . 60.0 mtm -94.26 120.2 34.15 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 114.804 -1.089 . . . . 0.0 109.822 -178.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 0.526 HG11 HG21 ' A' ' 253' ' ' VAL . 3.3 p -106.1 124.21 61.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 168.567 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -90.71 155.78 18.57 Favored 'General case' 0 C--O 1.242 0.706 0 C-N-CA 123.148 0.579 . . . . 0.0 110.077 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 238' ' ' CYS . . . . . 0.426 ' HB3' ' HA ' ' A' ' 246' ' ' GLU . 35.6 t -127.69 113.97 16.71 Favored 'General case' 0 C--O 1.243 0.735 0 C-N-CA 123.284 0.634 . . . . 0.0 110.069 -178.479 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -73.01 94.46 1.88 Allowed 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 173.645 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -143.68 133.05 5.2 Favored Glycine 0 C--N 1.346 1.11 0 CA-C-O 117.898 -1.501 . . . . 0.0 110.843 175.461 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -64.32 -46.04 8.45 Favored 'Trans proline' 0 C--N 1.377 2.051 0 C-N-CA 122.575 2.183 . . . . 0.0 111.352 -178.631 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 21.4 m120 -101.86 92.2 4.71 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 170.016 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 9.0 t -159.12 90.63 0.98 Allowed 'General case' 0 C--O 1.24 0.601 0 C-N-CA 122.984 0.514 . . . . 0.0 110.172 179.423 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 4.9 tppp? -65.87 -42.36 90.45 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-O 121.687 0.755 . . . . 0.0 109.95 173.643 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 245' ' ' TYR . . . . . 0.708 ' HA ' ' HB3' ' A' ' 224' ' ' TYR . 23.7 m-85 -84.09 24.6 0.91 Allowed 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 114.435 -1.257 . . . . 0.0 112.224 -177.646 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 246' ' ' GLU . . . . . 0.426 ' HA ' ' HB3' ' A' ' 238' ' ' CYS . 16.2 pt-20 -47.97 -33.75 8.26 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 124.537 1.135 . . . . 0.0 112.203 -179.562 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 247' ' ' TRP . . . . . . . . . . . . . 99.3 m95 -87.37 123.07 31.93 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.339 0.655 . . . . 0.0 110.016 172.381 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 49.8 m-85 -131.94 175.89 8.83 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.256 1.422 . . . . 0.0 109.23 176.463 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 249' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -110.94 144.5 39.91 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.093 0.957 . . . . 0.0 109.046 171.751 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 250' ' ' TYR . . . . . 0.481 ' HA ' HG22 ' A' ' 253' ' ' VAL . 74.8 m-85 -56.7 -27.06 58.29 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 124.652 1.181 . . . . 0.0 111.854 178.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -53.76 -59.37 4.7 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.861 1.264 . . . . 0.0 111.5 172.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 252' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -65.1 -35.11 80.08 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.789 0.836 . . . . 0.0 111.491 -175.682 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 253' ' ' VAL . . . . . 0.526 HG21 HG11 ' A' ' 236' ' ' VAL . 11.9 m -97.2 2.76 10.23 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.715 -172.232 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 64.7 t30 64.75 16.85 10.66 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 124.699 1.2 . . . . 0.0 112.455 168.682 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 88.6 mt -83.73 116.1 22.52 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 -177.447 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 46.4 mmtm -76.14 -8.41 56.95 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.719 0.808 . . . . 0.0 111.65 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -156.55 166.37 16.67 Favored Pre-proline 0 CA--C 1.556 1.176 0 C-N-CA 124.884 1.273 . . . . 0.0 108.983 -173.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -52.31 147.45 28.55 Favored 'Trans proline' 0 C--N 1.382 2.337 0 C-N-CA 122.717 2.278 . . . . 0.0 112.298 171.734 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 259' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -58.69 172.92 1.31 Allowed 'Trans proline' 0 C--N 1.381 2.253 0 C-N-CA 123.137 2.558 . . . . 0.0 113.991 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp -101.1 22.02 12.97 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.743 0.817 . . . . 0.0 111.506 -175.157 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 154.12 -156.29 26.73 Favored Glycine 0 C--N 1.349 1.276 0 N-CA-C 111.242 -0.743 . . . . 0.0 111.242 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 13.6 p -64.32 106.3 1.08 Allowed 'General case' 0 C--N 1.355 0.825 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 170.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 263' ' ' TRP . . . . . . . . . . . . . 80.4 t90 -85.94 126.48 34.13 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.012 -173.691 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 -106.32 128.24 53.85 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 173.589 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 23.4 p -75.09 152.4 86.32 Favored Pre-proline 0 N--CA 1.48 1.067 0 CA-C-O 117.832 -1.08 . . . . 0.0 108.443 173.754 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_exo -31.85 -63.38 0.12 Allowed 'Trans proline' 0 C--N 1.393 2.885 0 C-N-CA 125.238 3.959 . . . . 0.0 116.434 -169.48 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -57.68 -33.3 68.2 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 124.873 1.269 . . . . 0.0 113.603 -179.29 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 268' ' ' CYS . . . . . . . . . . . . . 89.5 m -70.07 -41.5 74.02 Favored 'General case' 0 N--CA 1.5 2.041 0 C-N-CA 122.807 0.443 . . . . 0.0 111.347 172.383 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -70.45 -32.92 70.68 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.578 -175.537 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 76.1 mt -81.35 -51.82 14.82 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 C-N-CA 123.635 0.774 . . . . 0.0 109.53 177.635 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 . . . . . 0 CA--C 1.554 1.121 0 C-N-CA 124.412 1.085 . . . . 0.0 108.896 -176.367 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 27.3 p . . . . . 0 N--CA 1.473 0.683 0 CA-C-O 120.877 0.37 . . . . 0.0 110.249 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 53.4 tp -83.46 80.04 9.23 Favored 'General case' 0 C--N 1.348 0.521 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 175.627 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 224' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -140.35 122.86 16.12 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 177.273 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 49.5 t 172.96 161.32 0.12 Allowed 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.652 1.181 . . . . 0.0 109.538 175.764 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -66.0 -37.96 87.25 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 122.71 0.404 . . . . 0.0 110.583 175.007 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 5.4 p -81.84 -4.24 56.0 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 111.634 0.235 . . . . 0.0 111.634 174.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 78.4 mm-40 52.37 81.71 0.08 Allowed 'General case' 0 C--N 1.36 1.041 0 C-N-CA 125.205 1.402 . . . . 0.0 112.549 -175.181 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 229' ' ' ARG . . . . . 0.446 ' HB2' ' CE1' ' A' ' 249' ' ' HIS . 33.1 mmt180 -138.17 155.71 48.44 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.161 0.984 . . . . 0.0 109.343 175.115 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 27.7 m -83.56 -178.59 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.644 177.665 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 41.8 t -80.6 94.07 6.23 Favored 'General case' 0 CA--C 1.553 1.061 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.196 176.692 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -101.98 92.21 4.69 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.394 0.678 . . . . 0.0 109.479 179.182 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 73.88 -7.01 16.52 Favored Glycine 0 C--N 1.35 1.318 0 N-CA-C 114.44 0.536 . . . . 0.0 114.44 175.488 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -154.6 142.88 20.44 Favored 'General case' 0 C--O 1.242 0.674 0 C-N-CA 124.132 0.973 . . . . 0.0 109.456 -175.116 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 235' ' ' MET . . . . . . . . . . . . . 25.4 ptt? -158.14 128.43 6.15 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.262 0.625 . . . . 0.0 110.204 175.604 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 3.3 p -115.11 124.34 71.64 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.767 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 173.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -89.8 156.54 18.44 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.361 0.664 . . . . 0.0 110.332 -179.457 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 238' ' ' CYS . . . . . 0.62 ' HB3' ' HA ' ' A' ' 246' ' ' GLU . 13.1 t -125.71 149.47 48.48 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.458 0.703 . . . . 0.0 111.543 -173.775 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -121.01 104.23 9.64 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.221 1.009 . . . . 0.0 109.043 176.537 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -141.99 162.57 27.11 Favored Glycine 0 C--O 1.244 0.719 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 174.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -61.69 -52.97 2.52 Favored 'Trans proline' 0 C--N 1.371 1.735 0 C-N-CA 122.033 1.822 . . . . 0.0 111.856 174.407 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 37.8 t30 -116.38 118.23 32.15 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 178.638 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 18.7 t -167.94 107.51 0.54 Allowed 'General case' 0 N--CA 1.47 0.556 0 O-C-N 123.167 0.292 . . . . 0.0 111.289 -175.267 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 14.9 ptpt -86.85 -26.99 23.74 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 165.021 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -83.17 28.95 0.5 Allowed 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.318 1.447 . . . . 0.0 112.683 179.033 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 246' ' ' GLU . . . . . 0.62 ' HA ' ' HB3' ' A' ' 238' ' ' CYS . 41.3 mt-10 -50.11 -37.3 33.46 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.675 0.79 . . . . 0.0 111.72 176.592 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 247' ' ' TRP . . . . . . . . . . . . . 84.7 m95 -96.85 134.13 40.57 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.566 -178.267 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -144.09 176.29 9.41 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.502 1.521 . . . . 0.0 108.939 175.718 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 249' ' ' HIS . . . . . 0.446 ' CE1' ' HB2' ' A' ' 229' ' ' ARG . 0.2 OUTLIER -119.56 147.44 44.48 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 171.357 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 250' ' ' TYR . . . . . 0.419 ' HB3' ' O ' ' A' ' 255' ' ' LEU . 20.1 m-85 -62.26 -33.93 75.57 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.026 1.33 . . . . 0.0 112.214 -168.494 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -59.85 -43.91 94.4 Favored 'General case' 0 N--CA 1.476 0.826 0 O-C-N 123.971 0.794 . . . . 0.0 111.31 179.53 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 252' ' ' CYS . . . . . . . . . . . . . 1.3 m -70.15 -38.34 75.45 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.577 -177.741 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 35.5 m -99.7 8.78 8.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 122.803 0.441 . . . . 0.0 111.794 -175.066 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 59.97 22.96 12.06 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 124.894 1.278 . . . . 0.0 113.234 170.236 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.419 ' O ' ' HB3' ' A' ' 250' ' ' TYR . 93.1 mt -84.3 110.35 18.51 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 174.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -70.25 -33.2 71.34 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 121.44 0.638 . . . . 0.0 109.93 175.223 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -132.04 159.62 71.32 Favored Pre-proline 0 CA--C 1.555 1.169 0 C-N-CA 124.402 1.081 . . . . 0.0 109.39 -176.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 258' ' ' PRO . . . . . 0.412 ' HA ' ' HD3' ' A' ' 259' ' ' PRO . 26.5 Cg_endo -59.94 148.49 88.57 Favored 'Trans proline' 0 C--N 1.384 2.41 0 C-N-CA 122.813 2.342 . . . . 0.0 112.787 178.617 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 259' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 258' ' ' PRO . 42.0 Cg_exo -58.79 167.83 4.93 Favored 'Trans proline' 0 C--N 1.385 2.5 0 C-N-CA 123.591 2.861 . . . . 0.0 113.727 -178.246 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -100.54 18.01 20.26 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.343 0.657 . . . . 0.0 111.34 -177.658 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 158.3 -143.9 9.86 Favored Glycine 0 C--N 1.348 1.232 0 N-CA-C 112.169 -0.373 . . . . 0.0 112.169 176.205 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 32.8 p -66.12 107.78 2.04 Favored 'General case' 0 C--N 1.35 0.596 0 C-N-CA 123.679 0.792 . . . . 0.0 110.018 178.162 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 263' ' ' TRP . . . . . . . . . . . . . 55.3 t90 -95.0 122.22 37.43 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.775 0.83 . . . . 0.0 110.676 -170.072 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -96.88 106.21 18.48 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.15 0.58 . . . . 0.0 109.747 177.36 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 265' ' ' CYS . . . . . 0.434 ' SG ' ' OE2' ' A' ' 267' ' ' GLU . 13.1 p -70.42 160.17 82.23 Favored Pre-proline 0 CA--C 1.553 1.059 0 CA-C-O 117.861 -1.066 . . . . 0.0 110.109 177.421 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 266' ' ' PRO . . . . . 0.404 ' HD2' ' HB2' ' A' ' 265' ' ' CYS . 6.1 Cg_exo -19.09 -70.11 0.02 OUTLIER 'Trans proline' 0 C--N 1.392 2.866 1 C-N-CA 126.388 4.725 . . . . 0.0 117.536 -174.224 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 267' ' ' GLU . . . . . 0.434 ' OE2' ' SG ' ' A' ' 265' ' ' CYS . 0.0 OUTLIER -68.06 -30.25 69.41 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -173.31 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 268' ' ' CYS . . . . . . . . . . . . . 75.0 m -70.54 -38.3 74.18 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.569 0.748 . . . . 0.0 111.071 175.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -71.95 -41.5 67.71 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.402 -175.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 23.6 pt -86.68 1.08 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.611 -177.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 . . . . . 0 C--O 1.249 1.043 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 174.287 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 25.2 p . . . . . 0 N--CA 1.475 0.819 0 CA-C-O 120.704 0.288 . . . . 0.0 110.479 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 31.5 tp -98.94 111.17 23.64 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.818 0.847 . . . . 0.0 110.353 -178.751 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 224' ' ' TYR . . . . . 0.422 ' HB3' ' HA ' ' A' ' 245' ' ' TYR . 75.0 m-85 -141.69 129.77 22.07 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 174.669 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 225' ' ' CYS . . . . . 0.402 ' HB2' ' O ' ' A' ' 224' ' ' TYR . 35.6 t 172.2 153.13 0.07 Allowed 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 125.029 1.332 . . . . 0.0 108.447 169.658 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 80.1 t80 -63.44 -35.11 79.36 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 122.826 0.45 . . . . 0.0 111.786 -178.743 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 13.7 p -79.18 -16.48 56.52 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 122.531 0.333 . . . . 0.0 111.283 179.128 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 85.0 mm-40 54.09 80.55 0.11 Allowed 'General case' 0 C--N 1.362 1.151 0 C-N-CA 124.701 1.2 . . . . 0.0 111.543 -171.511 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 229' ' ' ARG . . . . . 0.462 ' HD3' ' O ' ' A' ' 230' ' ' VAL . 4.5 tmt_? -150.02 148.76 29.42 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 -178.821 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.462 ' O ' ' HD3' ' A' ' 229' ' ' ARG . 33.4 m -73.33 178.63 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 N-CA-C 112.759 0.652 . . . . 0.0 112.759 -172.009 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 19.6 m -139.22 49.11 1.85 Allowed 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 123.323 0.649 . . . . 0.0 109.54 -176.526 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 20.0 p90 -65.93 119.37 11.19 Favored 'General case' 0 CA--C 1.551 1.002 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.557 -173.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 77.18 -22.9 2.34 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 124.479 1.037 . . . . 0.0 115.327 178.209 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 61.7 mm-40 -143.62 99.78 3.48 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.047 0.939 . . . . 0.0 109.861 -178.075 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 235' ' ' MET . . . . . . . . . . . . . 18.5 ptp -122.91 132.27 54.1 Favored 'General case' 0 C--O 1.242 0.709 0 C-N-CA 124.457 1.103 . . . . 0.0 109.423 172.149 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 4.0 p -100.69 124.19 54.12 Favored 'Isoleucine or valine' 0 C--O 1.24 0.572 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 171.697 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -92.17 133.06 36.14 Favored 'General case' 0 C--O 1.242 0.663 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.048 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 238' ' ' CYS . . . . . 0.572 ' SG ' ' HA ' ' A' ' 264' ' ' TYR . 40.9 t -108.26 102.49 11.61 Favored 'General case' 0 C--O 1.243 0.719 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 176.438 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 239' ' ' ASP . . . . . 0.425 ' HB3' HG23 ' A' ' 262' ' ' THR . 30.2 t70 -82.37 94.32 7.36 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 240' ' ' GLY . . . . . 0.433 ' HA3' ' SG ' ' A' ' 268' ' ' CYS . . . -128.07 141.48 12.64 Favored Glycine 0 CA--C 1.527 0.811 0 CA-C-O 118.186 -1.341 . . . . 0.0 110.489 175.768 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -52.97 -42.74 62.23 Favored 'Trans proline' 0 C--N 1.379 2.145 0 C-N-CA 123.208 2.605 . . . . 0.0 112.166 -179.387 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -115.94 112.62 22.14 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.554 1.142 . . . . 0.0 108.02 171.32 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 243' ' ' CYS . . . . . 0.553 ' SG ' ' HA ' ' A' ' 246' ' ' GLU . 8.0 t -168.75 81.15 0.14 Allowed 'General case' 0 C--N 1.352 0.681 0 CA-C-O 121.496 0.665 . . . . 0.0 110.4 -175.693 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.5 -29.4 68.82 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 123.778 0.831 . . . . 0.0 112.574 178.884 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 245' ' ' TYR . . . . . 0.422 ' HA ' ' HB3' ' A' ' 224' ' ' TYR . 41.9 m-85 -101.75 24.59 9.65 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.86 0.864 . . . . 0.0 111.458 179.58 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 246' ' ' GLU . . . . . 0.553 ' HA ' ' SG ' ' A' ' 243' ' ' CYS . 14.8 pt-20 -47.21 -37.46 10.35 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 125.049 1.34 . . . . 0.0 114.235 -170.835 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 247' ' ' TRP . . . . . . . . . . . . . 99.0 m95 -80.01 122.17 26.4 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.102 0.561 . . . . 0.0 109.726 176.454 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -129.21 173.88 10.09 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.039 0.936 . . . . 0.0 109.713 178.105 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 249' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -124.04 152.52 42.53 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.395 1.078 . . . . 0.0 108.728 173.863 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -62.87 -27.15 69.15 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.687 1.195 . . . . 0.0 110.818 -173.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -61.2 -47.32 86.66 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.985 1.314 . . . . 0.0 110.947 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 252' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -71.27 -43.38 67.29 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 114.563 -1.199 . . . . 0.0 111.421 -176.106 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 253' ' ' VAL . . . . . 0.557 HG23 ' HG ' ' A' ' 255' ' ' LEU . 35.6 m -100.02 6.59 9.46 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.806 -172.32 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 12.0 m120 60.75 31.62 20.12 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 124.771 1.229 . . . . 0.0 113.102 171.1 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.557 ' HG ' HG23 ' A' ' 253' ' ' VAL . 70.4 mt -79.22 116.21 19.34 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 176.56 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 50.9 tttp -70.59 -42.62 70.79 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.954 0.902 . . . . 0.0 109.591 174.489 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -126.7 157.16 72.12 Favored Pre-proline 0 C--O 1.248 0.998 0 CA-C-N 114.49 -1.232 . . . . 0.0 109.788 -176.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -56.93 146.09 81.4 Favored 'Trans proline' 0 C--N 1.378 2.104 0 C-N-CA 122.912 2.408 . . . . 0.0 112.712 171.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 259' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -67.08 148.65 81.66 Favored 'Trans proline' 0 C--N 1.372 1.787 0 C-N-CA 122.255 1.97 . . . . 0.0 111.442 172.105 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 85.4 mttt -87.86 -32.2 19.13 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.877 0.871 . . . . 0.0 110.299 -179.542 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -120.03 -171.21 14.56 Favored Glycine 0 C--N 1.345 1.055 0 CA-C-N 115.339 -0.846 . . . . 0.0 112.086 -178.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 262' ' ' THR . . . . . 0.425 HG23 ' HB3' ' A' ' 239' ' ' ASP . 76.9 m -62.95 109.81 1.58 Allowed 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.978 0.911 . . . . 0.0 109.92 179.043 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 263' ' ' TRP . . . . . . . . . . . . . 59.0 t90 -82.2 145.54 30.01 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.018 0.527 . . . . 0.0 110.005 -176.068 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 264' ' ' TYR . . . . . 0.572 ' HA ' ' SG ' ' A' ' 238' ' ' CYS . 98.6 m-85 -129.78 152.55 49.16 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.898 0.879 . . . . 0.0 110.339 -178.697 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 15.3 p -114.55 162.16 24.95 Favored Pre-proline 0 N--CA 1.482 1.136 0 CA-C-O 117.701 -1.142 . . . . 0.0 107.959 175.537 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -30.12 -65.44 0.08 OUTLIER 'Trans proline' 0 C--N 1.391 2.812 0 C-N-CA 125.151 3.901 . . . . 0.0 117.342 -175.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 267' ' ' GLU . . . . . 0.4 ' H ' ' HG3' ' A' ' 267' ' ' GLU . 0.0 OUTLIER -66.2 -12.4 55.83 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 -172.773 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 268' ' ' CYS . . . . . 0.433 ' SG ' ' HA3' ' A' ' 240' ' ' GLY . 74.7 m -88.46 -42.2 12.29 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.669 0.788 . . . . 0.0 112.596 169.422 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 269' ' ' LYS . . . . . 0.564 ' HG3' HG23 ' A' ' 270' ' ' ILE . 14.7 ptmm? -97.67 -50.4 4.48 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 114.158 1.17 . . . . 0.0 114.158 -162.636 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 270' ' ' ILE . . . . . 0.564 HG23 ' HG3' ' A' ' 269' ' ' LYS . 19.2 pt -88.9 21.21 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -169.292 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 . . . . . 0 C--O 1.25 1.118 0 C-N-CA 123.805 0.842 . . . . 0.0 109.71 179.051 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 68.9 p . . . . . 0 N--CA 1.482 1.166 0 CA-C-O 121.526 0.679 . . . . 0.0 110.086 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 44.1 tp -135.75 91.42 2.7 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 -177.259 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 224' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -142.13 142.95 32.8 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.012 0.925 . . . . 0.0 109.427 -175.078 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 45.5 t 171.8 163.84 0.1 Allowed 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 125.469 1.508 . . . . 0.0 108.352 173.577 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 41.4 t80 -66.78 -31.23 71.73 Favored 'General case' 0 CA--C 1.557 1.221 0 CA-C-N 118.668 0.667 . . . . 0.0 110.302 175.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 227' ' ' CYS . . . . . 0.543 ' SG ' ' HB2' ' A' ' 229' ' ' ARG . 4.6 p -89.49 -3.83 58.2 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 122.919 0.487 . . . . 0.0 111.444 174.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 81.4 mm-40 46.45 81.86 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 125.023 1.329 . . . . 0.0 111.817 -175.645 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 229' ' ' ARG . . . . . 0.543 ' HB2' ' SG ' ' A' ' 227' ' ' CYS . 1.0 OUTLIER -150.02 158.03 43.75 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 -171.504 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 27.2 m -71.83 150.53 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 O-C-N 123.524 0.515 . . . . 0.0 111.464 178.746 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 231' ' ' SER . . . . . 0.433 ' HB2' ' HG2' ' A' ' 235' ' ' MET . 20.5 m -100.86 77.72 1.88 Allowed 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 175.512 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 82.5 t80 -71.67 101.11 2.46 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.423 0.689 . . . . 0.0 110.642 -174.243 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 80.66 -19.24 7.51 Favored Glycine 0 C--N 1.344 1.014 0 CA-C-N 115.513 -0.767 . . . . 0.0 114.247 175.409 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 234' ' ' GLU . . . . . 0.419 ' HB3' ' CD1' ' A' ' 250' ' ' TYR . 59.3 mm-40 -128.03 94.98 4.06 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.127 0.971 . . . . 0.0 109.351 -175.304 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 235' ' ' MET . . . . . 0.433 ' HG2' ' HB2' ' A' ' 231' ' ' SER . 44.7 mtt -118.2 97.76 5.95 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.357 0.663 . . . . 0.0 110.108 -174.537 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 0.421 HG11 HG21 ' A' ' 253' ' ' VAL . 7.4 p -92.56 124.54 45.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 171.83 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -99.47 141.07 32.74 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 123.884 0.874 . . . . 0.0 109.853 179.094 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 238' ' ' CYS . . . . . 0.663 ' HB3' ' HA ' ' A' ' 246' ' ' GLU . 5.5 t -105.36 114.48 28.69 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 123.864 0.866 . . . . 0.0 109.785 179.571 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -72.6 95.63 1.86 Allowed 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.096 0.558 . . . . 0.0 109.516 176.615 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -139.06 116.48 1.25 Allowed Glycine 0 CA--C 1.53 0.988 0 CA-C-O 118.711 -1.049 . . . . 0.0 111.282 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -60.03 -29.08 88.45 Favored 'Trans proline' 0 C--N 1.377 2.055 0 C-N-CA 123.382 2.721 . . . . 0.0 112.621 178.479 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -120.35 88.71 2.99 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 171.56 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 42.1 t -172.17 112.15 0.28 Allowed 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.485 0.714 . . . . 0.0 110.456 -172.464 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 20.8 pttm -89.25 -25.01 21.95 Favored 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 167.755 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -79.33 27.47 0.26 Allowed 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 124.83 1.252 . . . . 0.0 112.527 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 246' ' ' GLU . . . . . 0.663 ' HA ' ' HB3' ' A' ' 238' ' ' CYS . 41.1 mt-10 -53.35 -46.55 69.57 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.163 0.585 . . . . 0.0 110.601 172.191 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 247' ' ' TRP . . . . . . . . . . . . . 97.8 m95 -72.42 122.18 20.8 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.366 179.229 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -142.38 171.32 14.21 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 125.206 1.402 . . . . 0.0 109.174 170.305 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 249' ' ' HIS . . . . . 0.419 ' HB3' ' HA ' ' A' ' 231' ' ' SER . 0.1 OUTLIER -123.12 142.42 50.91 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.249 1.019 . . . . 0.0 108.859 178.804 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 250' ' ' TYR . . . . . 0.419 ' CD1' ' HB3' ' A' ' 234' ' ' GLU . 8.8 m-85 -58.49 -26.69 63.72 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 124.98 1.312 . . . . 0.0 112.128 -174.087 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -59.46 -56.64 19.45 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.013 0.925 . . . . 0.0 110.833 174.804 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 252' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -61.39 -49.15 78.07 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.968 0.907 . . . . 0.0 111.595 -178.624 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 253' ' ' VAL . . . . . 0.479 HG23 ' HG ' ' A' ' 255' ' ' LEU . 26.8 m -88.64 5.32 4.41 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.909 -174.213 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 44.8 m-80 64.39 16.01 9.89 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 125.006 1.322 . . . . 0.0 113.415 169.135 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.479 ' HG ' HG23 ' A' ' 253' ' ' VAL . 89.8 mt -74.24 108.02 6.77 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 122.891 0.476 . . . . 0.0 109.868 -176.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 62.1 mttm -72.15 -25.62 61.78 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.973 0.909 . . . . 0.0 110.326 176.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -131.59 159.69 70.71 Favored Pre-proline 0 CA--C 1.552 1.039 0 C-N-CA 124.619 1.167 . . . . 0.0 109.337 -177.225 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.31 140.64 44.88 Favored 'Trans proline' 0 C--N 1.369 1.625 0 C-N-CA 122.325 2.017 . . . . 0.0 111.78 169.783 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 259' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -61.66 158.49 36.96 Favored 'Trans proline' 0 C--N 1.38 2.211 0 C-N-CA 122.47 2.113 . . . . 0.0 111.542 169.657 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 31.6 mmmt -93.37 -2.15 55.08 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 112.724 0.638 . . . . 0.0 112.724 -175.794 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -164.53 -147.38 5.09 Favored Glycine 0 C--N 1.345 1.05 0 N-CA-C 112.213 -0.355 . . . . 0.0 112.213 -178.662 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 54.7 p -64.21 107.8 1.4 Allowed 'General case' 0 C--N 1.352 0.699 0 C-N-CA 123.401 0.681 . . . . 0.0 110.552 178.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 263' ' ' TRP . . . . . . . . . . . . . 63.3 t90 -87.45 144.78 26.57 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 176.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 264' ' ' TYR . . . . . 0.438 ' HA ' ' SG ' ' A' ' 238' ' ' CYS . 95.1 m-85 -126.14 129.39 48.97 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.433 0.693 . . . . 0.0 109.654 -178.772 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 265' ' ' CYS . . . . . 0.421 ' SG ' ' OE1' ' A' ' 267' ' ' GLU . 16.7 p -85.76 156.12 58.58 Favored Pre-proline 0 CA--C 1.555 1.163 0 CA-C-O 118.47 -0.776 . . . . 0.0 109.248 177.813 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 0.8 OUTLIER -23.7 -64.88 0.04 OUTLIER 'Trans proline' 0 C--N 1.392 2.845 1 C-N-CA 126.314 4.676 . . . . 0.0 118.098 -168.456 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 267' ' ' GLU . . . . . 0.421 ' OE1' ' SG ' ' A' ' 265' ' ' CYS . 0.0 OUTLIER -67.02 -32.18 73.23 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 122.574 0.35 . . . . 0.0 111.565 -171.619 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 268' ' ' CYS . . . . . . . . . . . . . 58.6 m -72.31 -38.59 68.68 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.763 0.825 . . . . 0.0 110.601 176.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 61.5 tttp -71.78 -34.31 69.32 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 115.042 -0.981 . . . . 0.0 111.294 -173.114 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 25.7 pt -90.0 -9.88 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 123.106 0.563 . . . . 0.0 111.408 -179.092 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 . . . . . 0 C--O 1.25 1.097 0 C-N-CA 123.739 0.815 . . . . 0.0 110.132 -177.586 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 14.8 p . . . . . 0 N--CA 1.477 0.924 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 51.3 tp -116.64 95.97 5.28 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.227 1.011 . . . . 0.0 108.797 177.513 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 224' ' ' TYR . . . . . 0.426 ' HB3' ' HA ' ' A' ' 245' ' ' TYR . 47.4 m-85 -137.93 127.57 25.13 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.036 0.934 . . . . 0.0 109.2 178.714 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 225' ' ' CYS . . . . . 0.416 ' HB2' ' O ' ' A' ' 224' ' ' TYR . 14.0 t 174.08 158.08 0.15 Allowed 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.386 1.075 . . . . 0.0 109.953 172.174 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -64.23 -38.89 92.67 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 122.997 0.519 . . . . 0.0 111.412 175.626 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 9.8 p -77.54 -13.9 59.8 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.086 177.309 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 10.9 mm100 52.65 66.82 1.11 Allowed 'General case' 0 C--N 1.368 1.394 0 C-N-CA 124.668 1.187 . . . . 0.0 111.688 -174.776 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 78.4 ttt180 -130.26 153.58 48.47 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.659 0.784 . . . . 0.0 109.41 -179.437 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 29.3 m -66.21 155.42 7.08 Favored 'Isoleucine or valine' 0 C--O 1.241 0.65 0 C-N-CA 123.38 0.672 . . . . 0.0 111.655 177.592 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 231' ' ' SER . . . . . 0.71 ' HB3' ' HB3' ' A' ' 235' ' ' MET . 46.2 m -105.66 69.18 0.82 Allowed 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.52 178.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 20.2 p90 -70.02 110.32 5.02 Favored 'General case' 0 CA--C 1.549 0.918 0 CA-C-N 114.353 -1.294 . . . . 0.0 111.237 -176.49 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 76.92 -20.69 2.86 Favored Glycine 0 N--CA 1.478 1.49 0 N-CA-C 115.204 0.842 . . . . 0.0 115.204 171.764 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 234' ' ' GLU . . . . . 0.416 ' HB3' ' HD2' ' A' ' 250' ' ' TYR . 49.3 mt-10 -142.75 127.45 18.1 Favored 'General case' 0 C--O 1.243 0.743 0 C-N-CA 124.251 1.02 . . . . 0.0 108.928 -178.834 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 235' ' ' MET . . . . . 0.71 ' HB3' ' HB3' ' A' ' 231' ' ' SER . 22.4 ptt? -151.91 129.57 11.54 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 123.313 0.645 . . . . 0.0 110.432 175.739 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 5.4 p -103.31 126.46 57.68 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 C-N-CA 123.866 0.867 . . . . 0.0 108.869 175.502 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -88.57 164.64 15.29 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.624 0.77 . . . . 0.0 110.281 179.1 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 238' ' ' CYS . . . . . 0.428 ' HB3' ' HA ' ' A' ' 246' ' ' GLU . 15.4 t -136.83 105.54 5.85 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.353 0.661 . . . . 0.0 109.349 179.322 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -79.99 94.96 6.0 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.791 -178.67 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -141.25 137.19 7.96 Favored Glycine 0 C--N 1.348 1.223 0 CA-C-O 118.678 -1.068 . . . . 0.0 111.456 178.169 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -60.03 -38.71 76.18 Favored 'Trans proline' 0 C--N 1.376 1.978 0 C-N-CA 123.232 2.622 . . . . 0.0 113.384 179.176 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -109.49 95.88 5.91 Favored 'General case' 0 C--O 1.243 0.739 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 175.109 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 243' ' ' CYS . . . . . 0.456 ' SG ' ' HA ' ' A' ' 246' ' ' GLU . 12.2 t -166.06 101.8 0.65 Allowed 'General case' 0 C--O 1.237 0.429 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.941 -171.0 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 21.7 pttm -86.16 -37.98 18.18 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 171.884 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 245' ' ' TYR . . . . . 0.426 ' HA ' ' HB3' ' A' ' 224' ' ' TYR . 53.9 m-85 -87.66 29.15 0.92 Allowed 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 124.29 1.036 . . . . 0.0 111.874 -179.106 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 246' ' ' GLU . . . . . 0.456 ' HA ' ' SG ' ' A' ' 243' ' ' CYS . 10.4 pt-20 -49.37 -36.57 22.03 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.087 0.955 . . . . 0.0 112.844 179.105 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 247' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -91.09 135.16 33.95 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.381 0.61 . . . . 0.0 111.043 178.244 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -142.8 174.09 10.96 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 125.665 1.586 . . . . 0.0 108.449 174.105 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 249' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -117.2 141.84 47.78 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.817 0.847 . . . . 0.0 108.832 174.563 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 250' ' ' TYR . . . . . 0.416 ' HD2' ' HB3' ' A' ' 234' ' ' GLU . 86.3 m-85 -57.2 -26.85 61.33 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 124.658 1.183 . . . . 0.0 112.074 -177.22 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -56.3 -58.4 8.15 Favored 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 123.861 0.864 . . . . 0.0 111.46 174.408 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 252' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -61.37 -41.94 97.91 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 124.203 1.001 . . . . 0.0 112.117 -173.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 35.8 m -92.23 -5.77 10.72 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.733 -175.161 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 10.8 t30 52.41 70.12 0.6 Allowed 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 124.611 1.164 . . . . 0.0 111.243 178.659 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 96.3 mt -129.92 122.87 29.42 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 178.128 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 64.2 tttp -90.64 -27.48 19.02 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 123.272 0.629 . . . . 0.0 110.166 178.377 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 16.9 mp0 -105.45 147.07 33.99 Favored Pre-proline 0 N--CA 1.477 0.903 0 C-N-CA 124.189 0.996 . . . . 0.0 109.336 178.537 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -74.63 117.62 5.02 Favored 'Trans proline' 0 C--N 1.373 1.831 0 C-N-CA 122.322 2.015 . . . . 0.0 110.548 170.022 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 259' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_exo -53.6 112.62 1.0 Allowed 'Trans proline' 0 C--N 1.378 2.119 0 C-N-CA 123.1 2.533 . . . . 0.0 113.397 -178.438 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -68.21 103.14 1.5 Allowed 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.869 0.868 . . . . 0.0 109.855 -179.402 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 118.3 -167.46 12.96 Favored Glycine 0 N--CA 1.472 1.034 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 -176.321 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 39.4 p -74.13 106.04 5.61 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 177.214 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 263' ' ' TRP . . . . . . . . . . . . . 52.1 t90 -73.79 134.21 43.36 Favored 'General case' 0 C--N 1.349 0.583 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 173.027 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -110.85 113.86 26.77 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 123.029 0.531 . . . . 0.0 109.777 179.412 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 17.4 p -64.75 160.78 51.17 Favored Pre-proline 0 CA--C 1.55 0.964 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.947 171.278 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -36.63 -38.8 0.37 Allowed 'Trans proline' 0 C--N 1.382 2.317 0 C-N-CA 124.329 3.352 . . . . 0.0 115.991 175.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -54.58 -61.73 2.12 Favored 'General case' 0 N--CA 1.485 1.32 0 CA-C-O 121.652 0.739 . . . . 0.0 110.807 176.098 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 268' ' ' CYS . . . . . . . . . . . . . 35.5 m -80.02 -30.85 39.59 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 114.493 -1.23 . . . . 0.0 111.853 -168.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -75.86 -53.08 8.99 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.7 0.8 . . . . 0.0 111.155 -173.364 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 270' ' ' ILE . . . . . 0.434 HG22 ' HG3' ' A' ' 271' ' ' GLU . 50.7 mm -72.16 -52.47 24.3 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.978 -176.468 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 271' ' ' GLU . . . . . 0.434 ' HG3' HG22 ' A' ' 270' ' ' ILE . 45.7 mt-10 . . . . . 0 CA--C 1.555 1.164 0 C-N-CA 123.207 0.603 . . . . 0.0 109.553 -178.518 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 32.6 p . . . . . 0 CA--C 1.544 0.713 0 CA-C-O 121.06 0.457 . . . . 0.0 110.068 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -111.26 90.28 3.29 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 175.222 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 224' ' ' TYR . . . . . 0.524 ' HB3' ' HA ' ' A' ' 245' ' ' TYR . 78.5 m-85 -133.76 130.43 38.03 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 123.855 0.862 . . . . 0.0 108.892 179.535 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 225' ' ' CYS . . . . . 0.43 ' HB2' ' O ' ' A' ' 224' ' ' TYR . 26.5 t 172.29 155.69 0.09 Allowed 'General case' 0 N--CA 1.474 0.761 0 O-C-N 124.794 1.309 . . . . 0.0 109.388 168.387 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 61.5 t80 -64.81 -27.67 69.04 Favored 'General case' 0 CA--C 1.556 1.193 0 C-N-CA 123.201 0.6 . . . . 0.0 111.214 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 13.2 p -90.57 -10.69 42.48 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 122.991 0.517 . . . . 0.0 111.442 177.078 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 83.4 mm-40 52.16 85.46 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 124.607 1.163 . . . . 0.0 111.437 -171.041 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 73.6 ttt180 -140.63 150.71 43.9 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.816 -176.607 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 34.3 m -69.18 170.38 1.14 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.61 0 C-N-CA 124.29 1.036 . . . . 0.0 112.754 -177.331 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 39.4 t -86.73 116.52 24.88 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 114.662 -1.154 . . . . 0.0 109.762 174.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 232' ' ' PHE . . . . . 0.603 ' HB3' ' HG2' ' A' ' 234' ' ' GLU . 91.8 t80 -75.63 -13.04 60.32 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 123.84 0.856 . . . . 0.0 109.728 166.786 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 109.78 -18.17 29.56 Favored Glycine 0 C--N 1.349 1.277 0 N-CA-C 111.521 -0.632 . . . . 0.0 111.521 -174.416 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 234' ' ' GLU . . . . . 0.603 ' HG2' ' HB3' ' A' ' 232' ' ' PHE . 8.5 pt-20 -77.65 64.55 2.96 Favored 'General case' 0 CA--C 1.555 1.163 0 C-N-CA 124.273 1.029 . . . . 0.0 110.129 174.683 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 235' ' ' MET . . . . . . . . . . . . . 73.2 mtm -91.61 100.96 13.6 Favored 'General case' 0 N--CA 1.475 0.801 0 O-C-N 121.823 -0.548 . . . . 0.0 110.682 -173.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 2.8 p -88.07 124.28 41.09 Favored 'Isoleucine or valine' 0 C--O 1.241 0.652 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 168.124 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -99.32 110.9 23.37 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 123.564 0.746 . . . . 0.0 110.074 -176.288 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 238' ' ' CYS . . . . . 0.461 ' HB3' ' HA ' ' A' ' 246' ' ' GLU . 42.3 t -71.64 153.75 41.88 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.242 169.857 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 239' ' ' ASP . . . . . 0.557 ' HB3' ' HB ' ' A' ' 262' ' ' THR . 23.5 t70 -134.23 95.61 3.44 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.606 0.762 . . . . 0.0 109.176 176.317 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 240' ' ' GLY . . . . . 0.556 ' HA3' ' SG ' ' A' ' 268' ' ' CYS . . . -142.05 140.71 10.26 Favored Glycine 0 CA--C 1.534 1.222 0 CA-C-O 118.442 -1.199 . . . . 0.0 111.917 175.192 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -59.44 -51.69 5.93 Favored 'Trans proline' 0 C--N 1.377 2.03 0 C-N-CA 122.746 2.297 . . . . 0.0 112.145 178.637 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -89.04 86.49 6.93 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 171.663 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 10.4 t -174.75 104.6 0.1 Allowed 'General case' 0 C--N 1.351 0.637 0 O-C-N 123.88 0.738 . . . . 0.0 109.688 -176.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -85.75 -31.93 22.13 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-O 121.842 0.83 . . . . 0.0 110.359 173.421 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 245' ' ' TYR . . . . . 0.524 ' HA ' ' HB3' ' A' ' 224' ' ' TYR . 59.7 m-85 -86.65 26.4 1.11 Allowed 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.053 1.341 . . . . 0.0 112.368 -171.126 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 246' ' ' GLU . . . . . 0.461 ' HA ' ' HB3' ' A' ' 238' ' ' CYS . 5.6 mm-40 -45.96 -42.34 12.85 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 125.105 1.362 . . . . 0.0 112.697 -174.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 247' ' ' TRP . . . . . 0.497 ' HB2' ' HB2' ' A' ' 224' ' ' TYR . 96.0 m95 -70.92 117.93 13.06 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.112 0.565 . . . . 0.0 110.262 175.331 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -131.23 173.49 10.99 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.349 1.06 . . . . 0.0 109.92 175.37 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 249' ' ' HIS . . . . . 0.582 ' HD2' ' HB2' ' A' ' 252' ' ' CYS . 0.2 OUTLIER -121.9 139.57 53.48 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.165 0.986 . . . . 0.0 109.031 175.639 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -54.63 -49.39 70.62 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 124.787 1.235 . . . . 0.0 113.063 -168.867 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -53.49 -40.83 65.66 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 124.127 0.971 . . . . 0.0 112.107 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 252' ' ' CYS . . . . . 0.582 ' HB2' ' HD2' ' A' ' 249' ' ' HIS . 2.8 t -66.17 -32.11 73.36 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 124.34 1.056 . . . . 0.0 111.582 -175.818 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 29.8 m -110.48 13.36 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 123.666 0.786 . . . . 0.0 111.362 -174.618 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 67.4 11.65 8.49 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 124.644 1.177 . . . . 0.0 112.398 173.748 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 95.0 mt -84.01 157.36 21.86 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-O 121.558 0.695 . . . . 0.0 109.337 174.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 27.0 tptp -145.86 -29.97 0.41 Allowed 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.199 0.999 . . . . 0.0 108.651 174.149 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -93.59 141.44 23.86 Favored Pre-proline 0 C--O 1.245 0.84 0 C-N-CA 124.09 0.956 . . . . 0.0 108.895 177.721 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -65.09 124.1 12.53 Favored 'Trans proline' 0 C--N 1.373 1.824 0 C-N-CA 122.4 2.066 . . . . 0.0 111.361 177.323 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 259' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -51.01 131.11 33.87 Favored 'Trans proline' 0 C--N 1.38 2.235 0 C-N-CA 123.455 2.77 . . . . 0.0 113.743 178.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.77 -4.79 39.69 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.023 0.929 . . . . 0.0 112.866 -175.002 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -153.25 -170.39 19.41 Favored Glycine 0 N--CA 1.471 0.989 0 N-CA-C 111.149 -0.78 . . . . 0.0 111.149 176.051 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 262' ' ' THR . . . . . 0.557 ' HB ' ' HB3' ' A' ' 239' ' ' ASP . 40.8 p -65.58 106.59 1.48 Allowed 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 175.414 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 263' ' ' TRP . . . . . . . . . . . . . 49.8 t90 -74.38 137.87 43.02 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.201 0.601 . . . . 0.0 111.238 -169.833 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 41.1 m-85 -114.85 109.27 17.89 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.815 0.846 . . . . 0.0 109.398 -176.73 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 265' ' ' CYS . . . . . 0.431 ' SG ' ' OE2' ' A' ' 267' ' ' GLU . 16.0 p -72.44 162.5 73.63 Favored Pre-proline 0 CA--C 1.559 1.302 0 C-N-CA 123.563 0.745 . . . . 0.0 110.183 176.505 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_exo -36.93 -51.83 1.37 Allowed 'Trans proline' 0 C--N 1.393 2.869 0 C-N-CA 124.511 3.474 . . . . 0.0 116.45 -178.615 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 267' ' ' GLU . . . . . 0.431 ' OE2' ' SG ' ' A' ' 265' ' ' CYS . 0.0 OUTLIER -72.11 -18.54 61.9 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -175.28 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 268' ' ' CYS . . . . . 0.556 ' SG ' ' HA3' ' A' ' 240' ' ' GLY . 59.2 m -82.36 -44.74 15.78 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.0 0.52 . . . . 0.0 111.542 171.291 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -82.38 -45.14 15.24 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.259 -166.377 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 50.9 mm -76.32 -40.18 35.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 123.604 0.761 . . . . 0.0 110.552 -176.827 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 23.9 mm-40 . . . . . 0 C--O 1.25 1.084 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 177.713 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 30.9 p . . . . . 0 N--CA 1.476 0.855 0 CA-C-O 121.49 0.662 . . . . 0.0 110.048 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -82.89 88.76 6.8 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 178.626 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 224' ' ' TYR . . . . . 0.477 ' HB2' ' HB2' ' A' ' 247' ' ' TRP . 68.1 m-85 -137.71 138.16 39.07 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 178.628 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 51.3 t 170.93 162.0 0.08 Allowed 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 125.662 1.585 . . . . 0.0 108.649 172.603 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -62.53 -40.01 95.41 Favored 'General case' 0 CA--C 1.552 1.036 0 CA-C-N 117.992 0.36 . . . . 0.0 110.808 176.406 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 9.2 p -81.49 -19.88 41.34 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 122.608 0.363 . . . . 0.0 111.195 176.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 24.2 mm-40 59.07 99.69 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 124.905 1.282 . . . . 0.0 112.288 -172.836 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 229' ' ' ARG . . . . . 0.446 ' HD3' ' N ' ' A' ' 230' ' ' VAL . 4.6 tmt_? -163.75 152.91 14.19 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 -173.224 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.446 ' N ' ' HD3' ' A' ' 229' ' ' ARG . 30.7 m -64.52 165.84 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 C-N-CA 123.991 0.916 . . . . 0.0 112.645 -177.461 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 26.0 m -139.26 71.9 1.39 Allowed 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 123.275 0.63 . . . . 0.0 109.988 -177.801 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 53.2 m-85 -98.67 128.9 45.11 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.667 0.787 . . . . 0.0 110.406 178.173 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 84.25 -14.71 43.49 Favored Glycine 0 CA--C 1.535 1.321 0 O-C-N 123.212 0.32 . . . . 0.0 113.376 178.7 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -153.38 138.54 17.4 Favored 'General case' 0 C--N 1.351 0.645 0 C-N-CA 124.459 1.103 . . . . 0.0 108.83 179.124 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 235' ' ' MET . . . . . . . . . . . . . 21.1 ptp -163.11 133.13 4.37 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.232 0.613 . . . . 0.0 109.791 176.856 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 0.459 HG13 ' HB2' ' A' ' 248' ' ' PHE . 2.4 p -119.0 122.96 70.63 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 171.395 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -90.61 130.48 36.63 Favored 'General case' 0 C--O 1.239 0.507 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 174.353 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 238' ' ' CYS . . . . . . . . . . . . . 18.9 t -105.89 122.59 46.43 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.88 0.872 . . . . 0.0 111.106 -172.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -71.7 113.47 8.77 Favored 'General case' 0 C--N 1.352 0.715 0 C-N-CA 123.457 0.703 . . . . 0.0 110.082 176.223 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -143.17 144.54 13.91 Favored Glycine 0 CA--C 1.525 0.7 0 CA-C-N 114.388 -1.278 . . . . 0.0 110.551 169.742 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -57.53 -44.39 42.48 Favored 'Trans proline' 0 C--N 1.37 1.673 0 C-N-CA 122.531 2.154 . . . . 0.0 111.034 165.019 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 36.2 t30 -127.69 115.17 18.32 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 171.131 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 243' ' ' CYS . . . . . 0.543 ' SG ' ' HA ' ' A' ' 246' ' ' GLU . 16.2 t -151.93 97.77 2.37 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 -179.292 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -74.66 -37.94 62.59 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-O 121.279 0.561 . . . . 0.0 110.106 -179.3 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -89.83 25.46 2.06 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.742 1.217 . . . . 0.0 110.743 179.21 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 246' ' ' GLU . . . . . 0.543 ' HA ' ' SG ' ' A' ' 243' ' ' CYS . 8.9 pt-20 -46.65 -37.66 8.6 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 125.165 1.386 . . . . 0.0 113.744 -173.423 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 247' ' ' TRP . . . . . 0.477 ' HB2' ' HB2' ' A' ' 224' ' ' TYR . 94.0 m95 -88.5 138.54 31.34 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 122.922 0.489 . . . . 0.0 109.887 175.658 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 248' ' ' PHE . . . . . 0.459 ' HB2' HG13 ' A' ' 236' ' ' VAL . 60.1 m-85 -140.36 171.81 13.63 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.387 1.075 . . . . 0.0 109.385 175.394 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 249' ' ' HIS . . . . . 0.473 ' CD2' ' HB2' ' A' ' 252' ' ' CYS . 0.1 OUTLIER -117.7 141.27 48.58 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 173.788 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -58.69 -34.73 71.62 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 124.449 1.099 . . . . 0.0 112.821 -169.237 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -63.43 -38.97 93.21 Favored 'General case' 0 N--CA 1.479 1.02 0 O-C-N 123.854 0.721 . . . . 0.0 111.22 -177.853 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 252' ' ' CYS . . . . . 0.473 ' HB2' ' CD2' ' A' ' 249' ' ' HIS . 0.2 OUTLIER -66.93 -49.16 66.37 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 124.643 1.177 . . . . 0.0 110.229 -174.747 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 26.9 m -92.0 2.99 7.88 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 CA-C-N 114.222 -1.354 . . . . 0.0 111.358 -174.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 16.2 m120 60.71 24.34 14.18 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 124.802 1.241 . . . . 0.0 112.781 172.393 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.463 HD13 ' HD3' ' A' ' 259' ' ' PRO . 57.2 mt -71.95 94.83 1.5 Allowed 'General case' 0 C--N 1.35 0.59 0 C-N-CA 123.482 0.713 . . . . 0.0 109.458 176.321 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 8.7 mtmp? -77.29 -21.36 53.66 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.372 170.529 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 12.2 mp0 -111.58 125.85 29.65 Favored Pre-proline 0 C--O 1.244 0.801 0 C-N-CA 124.715 1.206 . . . . 0.0 107.921 178.714 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -65.71 121.39 8.75 Favored 'Trans proline' 0 C--N 1.372 1.785 0 C-N-CA 122.072 1.848 . . . . 0.0 110.356 172.152 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 259' ' ' PRO . . . . . 0.463 ' HD3' HD13 ' A' ' 255' ' ' LEU . 26.9 Cg_endo -58.28 116.91 3.58 Favored 'Trans proline' 0 C--N 1.378 2.118 0 C-N-CA 122.869 2.379 . . . . 0.0 112.413 -173.06 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 260' ' ' LYS . . . . . 0.558 ' HD3' ' H ' ' A' ' 260' ' ' LYS . 0.0 OUTLIER -56.31 -28.84 60.15 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.764 1.226 . . . . 0.0 113.026 -178.159 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -138.79 -147.49 5.14 Favored Glycine 0 C--N 1.348 1.211 0 CA-C-O 120.139 -0.256 . . . . 0.0 112.634 -178.241 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 46.6 p -72.12 106.1 4.21 Favored 'General case' 0 C--O 1.242 0.709 0 C-N-CA 123.515 0.726 . . . . 0.0 110.339 -178.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 263' ' ' TRP . . . . . . . . . . . . . 78.8 t90 -85.74 118.64 25.37 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.488 1.115 . . . . 0.0 109.543 178.349 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 264' ' ' TYR . . . . . 0.4 ' HD2' ' HB3' ' A' ' 268' ' ' CYS . 21.1 m-85 -102.31 115.79 31.3 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.231 1.012 . . . . 0.0 109.655 177.35 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 29.1 p -67.32 166.29 22.18 Favored Pre-proline 0 N--CA 1.487 1.417 0 C-N-CA 124.603 1.161 . . . . 0.0 110.634 176.16 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -40.01 -49.66 3.59 Favored 'Trans proline' 0 C--N 1.393 2.87 0 C-N-CA 123.917 3.078 . . . . 0.0 113.801 172.032 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -64.39 -26.8 68.62 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.379 0.672 . . . . 0.0 111.742 -174.841 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 268' ' ' CYS . . . . . 0.4 ' HB3' ' HD2' ' A' ' 264' ' ' TYR . 61.4 m -85.58 -41.48 15.22 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 123.215 0.606 . . . . 0.0 111.053 175.843 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 23.1 ttpp -77.37 -33.58 55.23 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.46 0.704 . . . . 0.0 111.634 -167.041 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 18.9 pt -130.08 50.74 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 124.3 1.04 . . . . 0.0 109.072 178.683 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 . . . . . 0 CA--C 1.559 1.313 0 CA-C-N 114.476 -1.238 . . . . 0.0 111.452 178.742 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 41.1 p . . . . . 0 N--CA 1.477 0.903 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -152.44 109.94 3.59 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 -176.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 224' ' ' TYR . . . . . 0.587 ' HB2' ' HB2' ' A' ' 247' ' ' TRP . 62.8 m-85 -143.07 130.22 20.79 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 -179.433 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 49.2 t 172.78 158.1 0.11 Allowed 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.318 1.447 . . . . 0.0 108.669 171.001 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -58.22 -46.19 86.33 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 123.102 0.561 . . . . 0.0 110.807 177.77 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 227' ' ' CYS . . . . . 0.41 ' SG ' ' HB3' ' A' ' 229' ' ' ARG . 14.1 p -75.21 -15.1 60.57 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 122.782 0.433 . . . . 0.0 111.861 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 83.1 mm-40 57.81 90.18 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 124.409 1.084 . . . . 0.0 110.773 -172.317 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 229' ' ' ARG . . . . . 0.41 ' HB3' ' SG ' ' A' ' 227' ' ' CYS . 75.4 ttt180 -165.31 153.71 11.68 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.098 -171.374 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 35.4 m -73.51 171.85 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.927 0 C-N-CA 123.639 0.776 . . . . 0.0 111.648 175.01 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 43.4 m -112.5 126.24 55.11 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.943 0.897 . . . . 0.0 109.177 178.173 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 52.9 t80 -91.76 81.6 5.24 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 177.63 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 75.57 -20.31 2.25 Favored Glycine 0 N--CA 1.474 1.206 0 CA-C-N 115.44 -0.8 . . . . 0.0 114.554 179.046 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 31.9 mm-40 -108.79 99.2 8.58 Favored 'General case' 0 C--O 1.224 -0.25 0 C-N-CA 124.18 0.992 . . . . 0.0 109.781 -176.612 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 235' ' ' MET . . . . . . . . . . . . . 25.7 ptt? -125.32 129.56 50.2 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.008 0.523 . . . . 0.0 109.706 177.346 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 2.6 p -124.95 125.8 70.21 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 C-N-CA 123.893 0.877 . . . . 0.0 109.346 -178.288 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -86.37 150.07 24.58 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.333 177.705 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 238' ' ' CYS . . . . . 0.503 ' HB3' ' HA ' ' A' ' 246' ' ' GLU . 7.9 t -110.33 149.71 29.81 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 124.568 1.147 . . . . 0.0 109.184 -178.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -103.31 95.63 6.22 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 172.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -139.55 128.45 3.97 Favored Glycine 0 C--N 1.344 1.001 0 CA-C-O 118.937 -0.924 . . . . 0.0 111.745 177.501 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -66.19 -36.85 27.12 Favored 'Trans proline' 0 C--N 1.372 1.794 0 C-N-CA 122.647 2.231 . . . . 0.0 111.768 171.407 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 41.9 t30 -120.73 104.42 9.89 Favored 'General case' 0 C--O 1.242 0.669 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 174.564 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 46.6 t -173.12 114.34 0.25 Allowed 'General case' 0 N--CA 1.469 0.488 0 O-C-N 123.645 0.591 . . . . 0.0 109.811 -173.478 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 54.5 tptt -83.6 -28.05 28.77 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-O 121.369 0.604 . . . . 0.0 109.399 173.086 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 20.6 m-30 -90.99 28.74 1.5 Allowed 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.18 1.392 . . . . 0.0 111.957 -175.667 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 246' ' ' GLU . . . . . 0.503 ' HA ' ' HB3' ' A' ' 238' ' ' CYS . 6.4 mm-40 -48.28 -33.84 9.45 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 123.551 0.74 . . . . 0.0 112.829 177.554 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 247' ' ' TRP . . . . . 0.587 ' HB2' ' HB2' ' A' ' 224' ' ' TYR . 96.4 m95 -94.07 136.57 34.21 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 121.399 0.619 . . . . 0.0 110.68 173.532 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -140.36 176.37 8.83 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 125.845 1.658 . . . . 0.0 108.322 174.718 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 249' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -126.07 143.94 50.92 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 173.783 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 36.5 m-85 -58.02 -34.34 69.94 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.78 0.832 . . . . 0.0 112.49 -172.74 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -62.44 -36.12 81.41 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.043 0.537 . . . . 0.0 111.683 179.734 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 252' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -66.69 -42.56 86.28 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.97 0.908 . . . . 0.0 110.862 -177.303 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 253' ' ' VAL . . . . . 0.54 HG23 ' HB2' ' A' ' 255' ' ' LEU . 15.4 m -99.18 2.34 10.52 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.325 -176.109 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 4.6 t30 55.68 32.29 19.05 Favored 'General case' 0 N--CA 1.495 1.821 0 C-N-CA 124.513 1.125 . . . . 0.0 110.777 179.051 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.54 ' HB2' HG23 ' A' ' 253' ' ' VAL . 15.7 tp -80.2 108.09 13.52 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 -178.597 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 58.5 tttm -82.77 -21.34 34.67 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.986 0.915 . . . . 0.0 111.34 -174.579 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -135.43 143.3 44.71 Favored Pre-proline 0 CA--C 1.542 0.641 0 C-N-CA 124.631 1.172 . . . . 0.0 109.235 -173.469 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -61.5 153.22 67.98 Favored 'Trans proline' 0 C--N 1.372 1.79 0 C-N-CA 122.648 2.232 . . . . 0.0 112.732 -177.216 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 259' ' ' PRO . . . . . 0.411 ' HB3' ' HB2' ' A' ' 263' ' ' TRP . 43.6 Cg_exo -59.19 127.99 26.05 Favored 'Trans proline' 0 C--N 1.382 2.298 0 C-N-CA 122.794 2.329 . . . . 0.0 112.263 178.503 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -68.64 -37.06 79.38 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.365 0.666 . . . . 0.0 110.258 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -152.49 -126.49 1.2 Allowed Glycine 0 C--N 1.344 1.01 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.88 178.692 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 24.7 m -65.27 124.44 22.2 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.04 0.936 . . . . 0.0 110.457 177.467 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 263' ' ' TRP . . . . . 0.411 ' HB2' ' HB3' ' A' ' 259' ' ' PRO . 78.1 t90 -125.18 107.24 10.55 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.743 0.817 . . . . 0.0 109.432 -176.094 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -88.72 118.81 28.66 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.645 0.778 . . . . 0.0 109.534 174.38 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 12.7 p -69.47 156.56 91.43 Favored Pre-proline 0 CA--C 1.56 1.343 0 CA-C-O 117.951 -1.023 . . . . 0.0 109.301 174.376 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -19.6 -70.05 0.02 OUTLIER 'Trans proline' 0 C--N 1.394 2.931 1 C-N-CA 126.263 4.642 . . . . 0.0 117.523 -170.246 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.69 -27.28 65.81 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -172.876 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 268' ' ' CYS . . . . . . . . . . . . . 82.4 m -69.26 -30.89 69.11 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 123.476 0.71 . . . . 0.0 112.203 177.455 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -92.57 -46.27 7.7 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.296 0.639 . . . . 0.0 110.569 -177.115 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 85.5 mt -84.14 -48.08 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 123.74 0.816 . . . . 0.0 111.433 -171.303 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 . . . . . 0 C--O 1.255 1.378 0 CA-C-O 118.732 -0.651 . . . . 0.0 110.718 -171.684 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 9.4 t . . . . . 0 CA--C 1.548 0.889 0 N-CA-C 110.291 -0.262 . . . . 0.0 110.291 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 5.9 tt -155.01 112.98 3.44 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 174.086 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 224' ' ' TYR . . . . . 0.522 ' HB3' ' HA ' ' A' ' 245' ' ' TYR . 67.5 m-85 -141.1 133.58 28.42 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 175.111 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 44.4 t 171.45 157.46 0.08 Allowed 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 124.752 1.221 . . . . 0.0 109.419 170.437 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -58.27 -44.41 88.41 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.86 0.864 . . . . 0.0 111.587 -179.781 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 16.2 p -73.33 -13.78 61.17 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 123.12 0.568 . . . . 0.0 111.401 -179.549 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 84.4 mm-40 55.84 73.69 0.42 Allowed 'General case' 0 C--N 1.366 1.297 0 C-N-CA 124.678 1.191 . . . . 0.0 111.327 -173.088 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 28.2 tpt180 -151.02 151.1 31.56 Favored 'General case' 0 C--O 1.244 0.772 0 CA-C-N 114.808 -1.087 . . . . 0.0 109.129 -178.836 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 21.0 m -66.93 160.77 3.97 Favored 'Isoleucine or valine' 0 C--O 1.243 0.755 0 C-N-CA 123.285 0.634 . . . . 0.0 111.301 173.627 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 231' ' ' SER . . . . . 0.423 ' HB3' ' O ' ' A' ' 234' ' ' GLU . 45.5 m -87.54 69.33 9.76 Favored 'General case' 0 CA--C 1.549 0.937 0 CA-C-N 115.373 -0.831 . . . . 0.0 109.961 179.566 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -68.97 111.91 5.28 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.223 0.609 . . . . 0.0 111.439 -177.495 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 79.88 -19.25 6.52 Favored Glycine 0 CA--C 1.538 1.494 0 CA-C-N 115.801 -0.636 . . . . 0.0 114.31 172.249 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 234' ' ' GLU . . . . . 0.423 ' O ' ' HB3' ' A' ' 231' ' ' SER . 30.0 mt-10 -132.01 148.71 52.52 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 125.235 1.414 . . . . 0.0 107.509 -175.025 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 235' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -154.71 135.21 13.4 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-O 121.593 0.711 . . . . 0.0 111.488 175.359 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 0.528 HG13 ' HB2' ' A' ' 248' ' ' PHE . 1.1 p -145.09 123.08 4.98 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 170.93 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -96.47 140.26 31.38 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 173.731 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 238' ' ' CYS . . . . . . . . . . . . . 37.9 t -101.63 114.31 28.24 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 123.393 0.677 . . . . 0.0 109.984 -179.518 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -69.96 95.39 0.93 Allowed 'General case' 0 CA--C 1.543 0.693 0 O-C-N 123.93 0.769 . . . . 0.0 109.444 178.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -142.52 116.07 1.01 Allowed Glycine 0 C--N 1.342 0.911 0 CA-C-O 118.363 -1.243 . . . . 0.0 112.15 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_exo -58.24 -31.81 94.44 Favored 'Trans proline' 0 C--N 1.379 2.136 0 C-N-CA 122.787 2.325 . . . . 0.0 111.638 173.385 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -115.39 86.32 2.44 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 171.137 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 7.7 t -161.38 91.03 0.83 Allowed 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.497 0.719 . . . . 0.0 109.704 -178.746 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.76 -44.93 80.11 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 122.975 0.51 . . . . 0.0 110.026 173.463 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 245' ' ' TYR . . . . . 0.522 ' HA ' ' HB3' ' A' ' 224' ' ' TYR . 96.5 m-85 -81.14 22.61 0.64 Allowed 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 124.669 1.187 . . . . 0.0 112.715 -176.388 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -52.36 -32.94 40.83 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 125.023 1.329 . . . . 0.0 114.202 -172.41 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 247' ' ' TRP . . . . . 0.507 ' HB2' ' HB2' ' A' ' 224' ' ' TYR . 39.3 m95 -75.08 130.36 39.15 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-O 121.331 0.586 . . . . 0.0 110.447 176.282 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 248' ' ' PHE . . . . . 0.528 ' HB2' HG13 ' A' ' 236' ' ' VAL . 98.5 m-85 -141.43 171.31 14.23 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.312 1.045 . . . . 0.0 109.746 177.844 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 249' ' ' HIS . . . . . 0.449 ' HD2' ' HB2' ' A' ' 252' ' ' CYS . 0.0 OUTLIER -134.68 145.64 48.72 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 176.745 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 250' ' ' TYR . . . . . 0.464 ' HB3' ' O ' ' A' ' 255' ' ' LEU . 21.1 m-30 -53.88 -55.98 21.83 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 124.213 1.005 . . . . 0.0 113.303 -166.325 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -60.86 -34.17 74.19 Favored 'General case' 0 N--CA 1.496 1.839 0 C-N-CA 123.311 0.644 . . . . 0.0 111.733 -174.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 252' ' ' CYS . . . . . 0.449 ' HB2' ' HD2' ' A' ' 249' ' ' HIS . 11.3 t -68.45 -32.25 72.14 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 124.162 0.985 . . . . 0.0 111.631 -175.425 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 253' ' ' VAL . . . . . 0.493 HG23 ' HG ' ' A' ' 255' ' ' LEU . 16.3 m -108.76 6.23 9.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 C-N-CA 124.04 0.936 . . . . 0.0 110.735 175.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 18.4 m120 64.32 24.84 13.37 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 125.574 1.549 . . . . 0.0 113.359 173.425 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.493 ' HG ' HG23 ' A' ' 253' ' ' VAL . 96.5 mt -70.94 121.32 17.92 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 166.331 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 36.4 mtmm -96.55 15.73 20.77 Favored 'General case' 0 N--CA 1.485 1.276 0 CA-C-O 120.805 0.336 . . . . 0.0 110.661 175.589 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -164.3 163.41 15.07 Favored Pre-proline 0 CA--C 1.554 1.106 0 C-N-CA 124.131 0.972 . . . . 0.0 109.047 -172.432 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -69.41 160.14 50.96 Favored 'Trans proline' 0 C--N 1.374 1.879 0 C-N-CA 122.488 2.125 . . . . 0.0 112.607 175.571 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 259' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -59.61 156.88 34.7 Favored 'Trans proline' 0 C--N 1.377 2.063 0 C-N-CA 122.95 2.433 . . . . 0.0 112.783 171.361 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -103.73 31.07 4.65 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.703 0.801 . . . . 0.0 109.713 -179.601 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 136.81 -141.03 11.96 Favored Glycine 0 C--N 1.339 0.749 0 N-CA-C 110.313 -1.115 . . . . 0.0 110.313 -174.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 40.0 p -72.98 114.67 11.39 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 122.948 0.499 . . . . 0.0 109.821 178.598 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 263' ' ' TRP . . . . . . . . . . . . . 47.1 t90 -90.82 136.81 32.82 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.438 0.695 . . . . 0.0 109.856 -176.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -124.11 115.72 21.59 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.364 0.665 . . . . 0.0 110.688 -177.37 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 265' ' ' CYS . . . . . 0.494 ' SG ' ' HB2' ' A' ' 267' ' ' GLU . 19.1 p -70.75 160.08 83.13 Favored Pre-proline 0 N--CA 1.484 1.231 0 C-N-CA 124.308 1.043 . . . . 0.0 109.658 172.63 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 99.9 Cg_exo -47.29 -27.06 6.32 Favored 'Trans proline' 0 C--N 1.388 2.639 0 C-N-CA 123.825 3.017 . . . . 0.0 115.696 177.198 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 267' ' ' GLU . . . . . 0.494 ' HB2' ' SG ' ' A' ' 265' ' ' CYS . 39.6 mt-10 -59.4 -49.45 77.75 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 123.962 0.905 . . . . 0.0 110.581 174.296 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 268' ' ' CYS . . . . . . . . . . . . . 76.4 m -85.07 -30.86 23.74 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.268 1.027 . . . . 0.0 111.712 -177.263 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 65.2 tttm -85.49 -51.63 6.39 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.867 -168.391 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 45.2 mt -97.8 -52.07 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 C-N-CA 123.1 0.56 . . . . 0.0 110.952 -176.752 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 . . . . . 0 CA--C 1.554 1.106 0 C-N-CA 123.177 0.591 . . . . 0.0 110.595 -171.721 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 13.2 p . . . . . 0 N--CA 1.476 0.864 0 CA-C-O 120.748 0.308 . . . . 0.0 110.564 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 5.9 tt -99.59 90.53 4.52 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 178.135 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 224' ' ' TYR . . . . . 0.528 ' HB2' ' HB2' ' A' ' 247' ' ' TRP . 71.0 m-85 -135.28 133.21 38.67 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 176.69 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 36.9 t 175.13 166.67 0.3 Allowed 'General case' 0 N--CA 1.474 0.747 0 O-C-N 124.643 1.214 . . . . 0.0 109.562 175.285 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 32.9 t80 -73.05 -33.46 65.69 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 177.452 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 9.4 p -82.18 -11.39 58.74 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 122.84 0.456 . . . . 0.0 111.04 173.048 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 82.2 mm-40 56.46 89.38 0.04 OUTLIER 'General case' 0 C--N 1.361 1.08 0 C-N-CA 125.348 1.459 . . . . 0.0 111.249 -174.724 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 -153.41 149.04 27.37 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.87 -176.801 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 34.2 m -66.28 148.49 12.05 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.823 0 C-N-CA 123.7 0.8 . . . . 0.0 110.952 174.291 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 35.9 m -107.43 120.66 42.78 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 175.759 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 31.4 p90 -141.92 125.92 17.25 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.555 0.742 . . . . 0.0 109.822 -174.785 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 78.09 -14.69 10.32 Favored Glycine 0 C--N 1.354 1.533 0 CA-C-N 116.334 -0.394 . . . . 0.0 113.138 -174.088 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -154.88 101.33 2.27 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.543 1.137 . . . . 0.0 108.165 -176.552 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 235' ' ' MET . . . . . . . . . . . . . 54.1 mtp -128.25 113.33 15.53 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 -178.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 6.8 p -108.34 125.32 65.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 175.558 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -99.7 168.54 9.86 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.727 0.811 . . . . 0.0 110.519 179.723 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 238' ' ' CYS . . . . . . . . . . . . . 26.9 t -144.29 123.25 12.77 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 122.668 0.387 . . . . 0.0 111.51 -177.344 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -79.22 105.38 10.51 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.376 0.67 . . . . 0.0 109.981 174.701 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -142.16 141.22 10.65 Favored Glycine 0 C--N 1.341 0.813 0 CA-C-O 118.558 -1.134 . . . . 0.0 111.285 175.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -60.09 -52.9 3.58 Favored 'Trans proline' 0 C--N 1.379 2.183 0 C-N-CA 122.758 2.306 . . . . 0.0 110.757 176.356 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -106.55 129.04 54.56 Favored 'General case' 0 C--O 1.242 0.675 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 163.166 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 243' ' ' CYS . . . . . 0.437 ' SG ' ' HA ' ' A' ' 246' ' ' GLU . 26.5 t -173.13 89.42 0.08 Allowed 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 -174.382 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.1 -24.29 30.4 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 122.893 0.477 . . . . 0.0 110.603 179.631 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 53.1 m-85 -101.32 26.88 6.69 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.321 1.049 . . . . 0.0 110.367 177.446 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 246' ' ' GLU . . . . . 0.437 ' HA ' ' SG ' ' A' ' 243' ' ' CYS . 8.5 pt-20 -48.66 -34.92 12.72 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 124.41 1.084 . . . . 0.0 112.579 176.653 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 247' ' ' TRP . . . . . 0.528 ' HB2' ' HB2' ' A' ' 224' ' ' TYR . 94.5 m95 -96.07 136.4 36.57 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 121.379 0.609 . . . . 0.0 111.133 176.609 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -144.71 173.44 11.83 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 125.196 1.398 . . . . 0.0 108.521 171.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 249' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -113.04 138.23 50.21 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 170.655 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -55.49 -32.86 63.19 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 124.181 0.992 . . . . 0.0 112.157 -173.385 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -56.47 -45.06 81.09 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 125.007 1.323 . . . . 0.0 112.455 178.36 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 252' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -68.04 -51.29 48.55 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.226 1.011 . . . . 0.0 110.984 -175.472 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 22.3 m -81.7 -9.95 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 CA-C-N 115.223 -0.898 . . . . 0.0 111.963 -178.242 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 17.5 m120 59.84 41.67 17.67 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.857 1.263 . . . . 0.0 110.795 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 34.7 tp -90.9 108.04 19.58 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 178.119 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -70.23 -44.81 67.81 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 122.986 0.515 . . . . 0.0 110.758 -178.205 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -133.53 130.97 21.14 Favored Pre-proline 0 C--O 1.24 0.567 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 -178.63 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -56.95 141.96 93.57 Favored 'Trans proline' 0 C--N 1.371 1.763 0 C-N-CA 122.257 1.972 . . . . 0.0 110.707 171.608 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 259' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -68.14 -178.94 1.94 Allowed 'Trans proline' 0 C--N 1.37 1.678 0 C-N-CA 123.06 2.507 . . . . 0.0 113.018 -169.02 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 27.7 mmmt -74.75 -3.6 32.55 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 116.068 -0.514 . . . . 0.0 112.383 -174.747 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -154.43 -143.92 3.79 Favored Glycine 0 C--N 1.338 0.689 0 N-CA-C 111.502 -0.639 . . . . 0.0 111.502 174.028 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 43.5 p -69.68 116.83 10.54 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 123.693 0.797 . . . . 0.0 110.607 -177.784 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 263' ' ' TRP . . . . . . . . . . . . . 37.9 t90 -66.41 135.69 54.66 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 122.965 0.506 . . . . 0.0 110.266 178.839 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 264' ' ' TYR . . . . . 0.445 ' HB3' ' HB3' ' A' ' 269' ' ' LYS . 39.6 m-85 -118.44 110.6 17.63 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.433 0.693 . . . . 0.0 109.768 -177.69 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 265' ' ' CYS . . . . . 0.4 ' SG ' ' HB2' ' A' ' 267' ' ' GLU . 14.8 p -67.25 162.77 52.16 Favored Pre-proline 0 CA--C 1.554 1.122 0 C-N-CA 124.128 0.971 . . . . 0.0 109.65 172.1 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -53.57 -24.51 29.31 Favored 'Trans proline' 0 C--N 1.385 2.452 0 C-N-CA 123.374 2.716 . . . . 0.0 114.594 -178.728 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 267' ' ' GLU . . . . . 0.4 ' HB2' ' SG ' ' A' ' 265' ' ' CYS . 33.7 mt-10 -57.38 -54.79 42.79 Favored 'General case' 0 N--CA 1.483 1.187 0 CA-C-O 121.488 0.661 . . . . 0.0 110.326 173.432 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 268' ' ' CYS . . . . . . . . . . . . . 57.9 m -86.75 -39.28 16.12 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 114.606 -1.179 . . . . 0.0 112.709 -168.775 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 269' ' ' LYS . . . . . 0.445 ' HB3' ' HB3' ' A' ' 264' ' ' TYR . 12.5 ptmm? -75.66 -28.87 58.88 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-O 120.654 0.264 . . . . 0.0 111.703 -169.612 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 61.8 mt -92.2 -50.7 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 177.492 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 . . . . . 0 CA--C 1.554 1.117 0 C-N-CA 123.456 0.703 . . . . 0.0 109.209 179.234 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 33.6 p . . . . . 0 C--O 1.244 0.812 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 57.0 tp -74.96 94.41 2.83 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.15 0.58 . . . . 0.0 109.929 -179.178 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 224' ' ' TYR . . . . . 0.588 ' HB3' ' HA ' ' A' ' 245' ' ' TYR . 77.3 m-85 -135.49 134.33 39.43 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 172.551 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 49.3 t 172.84 161.62 0.12 Allowed 'General case' 0 N--CA 1.474 0.769 0 O-C-N 124.823 1.327 . . . . 0.0 108.284 171.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -67.09 -32.63 73.92 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 122.08 0.152 . . . . 0.0 110.965 177.894 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 13.1 p -85.52 -17.43 36.4 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 122.706 0.402 . . . . 0.0 111.288 177.711 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 20.4 mm-40 52.92 77.6 0.16 Allowed 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 124.645 1.178 . . . . 0.0 111.907 -172.233 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 4.6 tmt_? -151.32 154.57 36.99 Favored 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 -178.601 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 23.1 m -73.1 156.25 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 CA-C-O 121.394 0.616 . . . . 0.0 112.59 -173.669 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 17.3 m -95.91 104.48 16.41 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.864 0.866 . . . . 0.0 108.771 172.838 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -74.14 79.32 1.76 Allowed 'General case' 0 N--CA 1.479 1.009 0 CA-C-O 121.508 0.67 . . . . 0.0 110.24 -179.158 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 74.68 -18.17 2.42 Favored Glycine 0 CA--C 1.539 1.568 0 N-CA-C 115.331 0.893 . . . . 0.0 115.331 177.59 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 234' ' ' GLU . . . . . 0.403 ' HB3' ' HD1' ' A' ' 250' ' ' TYR . 20.5 mm-40 -113.28 110.52 20.51 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.829 0.852 . . . . 0.0 109.335 -175.371 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 235' ' ' MET . . . . . . . . . . . . . 55.1 mtm -126.01 102.23 7.16 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.094 0.958 . . . . 0.0 109.679 -172.86 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 0.4 HG11 HG21 ' A' ' 253' ' ' VAL . 3.9 p -87.98 123.34 40.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 168.817 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -92.79 155.02 17.93 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 123.083 0.553 . . . . 0.0 109.92 -178.829 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 238' ' ' CYS . . . . . 0.633 ' HB3' ' HA ' ' A' ' 246' ' ' GLU . 42.1 t -116.23 152.12 34.4 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 115.126 -0.943 . . . . 0.0 108.87 176.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -119.92 99.22 6.49 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 171.848 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 240' ' ' GLY . . . . . 0.61 ' HA3' ' SG ' ' A' ' 268' ' ' CYS . . . -139.99 129.52 4.3 Favored Glycine 0 C--N 1.34 0.785 0 CA-C-O 118.124 -1.375 . . . . 0.0 111.004 176.763 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -48.89 -49.56 14.78 Favored 'Trans proline' 0 C--N 1.382 2.325 0 C-N-CA 123.666 2.91 . . . . 0.0 113.752 -177.656 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -111.19 101.87 10.34 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 171.722 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 43.9 t -172.86 106.62 0.16 Allowed 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 -173.561 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 9.3 ptpp? -86.78 -24.57 25.01 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 173.332 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 245' ' ' TYR . . . . . 0.588 ' HA ' ' HB3' ' A' ' 224' ' ' TYR . 22.7 m-85 -81.12 23.69 0.56 Allowed 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.403 1.081 . . . . 0.0 112.225 -177.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 246' ' ' GLU . . . . . 0.633 ' HA ' ' HB3' ' A' ' 238' ' ' CYS . 5.9 mm-40 -48.9 -37.51 19.96 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 123.641 0.776 . . . . 0.0 111.35 178.556 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 247' ' ' TRP . . . . . 0.502 ' HB2' ' HB2' ' A' ' 224' ' ' TYR . 98.4 m95 -76.45 115.85 16.58 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.505 174.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -130.18 173.35 10.85 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.652 1.181 . . . . 0.0 109.371 171.266 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 249' ' ' HIS . . . . . 0.569 ' HD2' ' HB2' ' A' ' 252' ' ' CYS . 0.1 OUTLIER -126.01 142.0 51.71 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.454 1.101 . . . . 0.0 108.508 178.232 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 250' ' ' TYR . . . . . 0.403 ' HD1' ' HB3' ' A' ' 234' ' ' GLU . 70.3 m-85 -60.58 -34.83 74.77 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 124.489 1.116 . . . . 0.0 113.493 -168.867 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -67.52 -35.74 79.68 Favored 'General case' 0 N--CA 1.485 1.293 0 CA-C-O 121.537 0.684 . . . . 0.0 110.998 -178.147 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 252' ' ' CYS . . . . . 0.569 ' HB2' ' HD2' ' A' ' 249' ' ' HIS . 9.0 t -71.68 -41.06 69.14 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 125.024 1.33 . . . . 0.0 110.852 -175.454 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 253' ' ' VAL . . . . . 0.4 HG21 HG11 ' A' ' 236' ' ' VAL . 27.9 m -93.16 -2.02 10.63 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.859 0 CA-C-N 114.481 -1.236 . . . . 0.0 110.957 179.685 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 33.5 m-80 62.69 24.89 14.81 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 124.803 1.241 . . . . 0.0 112.524 175.617 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 81.0 mt -80.58 119.64 23.49 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 173.161 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 14.3 tppt? -81.06 -25.34 37.17 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.425 0.69 . . . . 0.0 110.51 179.86 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -136.35 162.56 55.67 Favored Pre-proline 0 CA--C 1.55 0.949 0 C-N-CA 124.319 1.047 . . . . 0.0 109.552 -178.711 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -56.31 136.06 73.43 Favored 'Trans proline' 0 C--N 1.38 2.196 0 C-N-CA 122.435 2.09 . . . . 0.0 111.532 170.329 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 259' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -58.73 156.07 34.39 Favored 'Trans proline' 0 C--N 1.375 1.97 0 C-N-CA 123.289 2.659 . . . . 0.0 113.076 -176.528 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -66.38 -20.72 66.15 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.833 0.853 . . . . 0.0 112.764 -173.313 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -165.57 -141.94 3.28 Favored Glycine 0 C--N 1.347 1.145 0 CA-C-O 119.752 -0.471 . . . . 0.0 112.176 179.232 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 25.4 m -65.32 107.25 1.56 Allowed 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.638 0.775 . . . . 0.0 109.819 178.392 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 263' ' ' TRP . . . . . . . . . . . . . 53.8 t90 -88.58 114.12 24.87 Favored 'General case' 0 C--O 1.242 0.679 0 C-N-CA 123.285 0.634 . . . . 0.0 110.316 -175.613 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -96.64 118.84 33.97 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 123.93 0.892 . . . . 0.0 108.599 171.855 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 17.9 p -64.04 159.68 53.92 Favored Pre-proline 0 CA--C 1.555 1.164 0 C-N-CA 123.508 0.723 . . . . 0.0 110.122 172.162 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -50.91 -33.87 43.43 Favored 'Trans proline' 0 C--N 1.382 2.315 0 C-N-CA 123.202 2.601 . . . . 0.0 113.714 -178.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -59.18 -43.19 92.18 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-O 121.043 0.449 . . . . 0.0 111.242 177.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 268' ' ' CYS . . . . . 0.61 ' SG ' ' HA3' ' A' ' 240' ' ' GLY . 67.2 m -72.64 -27.92 62.43 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.087 0.955 . . . . 0.0 112.563 -177.864 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 49.1 mtmt -88.07 -41.56 12.98 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 122.84 0.456 . . . . 0.0 111.337 -175.698 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 16.8 mt -102.3 15.7 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 C-N-CA 123.283 0.633 . . . . 0.0 110.583 -168.673 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 . . . . . 0 CA--C 1.565 1.552 0 C-N-CA 122.651 0.38 . . . . 0.0 110.951 175.188 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 23.0 p . . . . . 0 N--CA 1.478 0.95 0 CA-C-O 121.116 0.484 . . . . 0.0 109.81 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 35.8 tp -89.77 79.82 6.65 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 176.874 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 224' ' ' TYR . . . . . 0.524 ' HB3' ' HA ' ' A' ' 245' ' ' TYR . 74.1 m-85 -138.09 125.95 22.52 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 175.591 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 225' ' ' CYS . . . . . 0.403 ' HB2' ' O ' ' A' ' 224' ' ' TYR . 34.4 t 174.54 161.85 0.2 Allowed 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.959 0.904 . . . . 0.0 109.203 173.586 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -69.24 -34.92 75.56 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 122.347 0.259 . . . . 0.0 110.458 175.306 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 3.9 p -83.47 -14.59 52.13 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.105 175.249 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 22.6 mm-40 53.87 101.09 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 125.601 1.56 . . . . 0.0 112.713 -172.233 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 22.8 tpp180 -162.97 157.97 21.68 Favored 'General case' 0 C--O 1.244 0.801 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 -178.735 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 19.5 m -71.4 154.21 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 CA-C-O 120.828 0.347 . . . . 0.0 111.173 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 17.1 m -116.86 60.57 0.74 Allowed 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 123.568 0.747 . . . . 0.0 109.422 -179.233 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 79.8 t80 -71.84 108.69 5.26 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.143 0.577 . . . . 0.0 111.769 -172.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 85.18 -18.22 29.03 Favored Glycine 0 N--CA 1.472 1.089 0 CA-C-N 115.6 -0.727 . . . . 0.0 114.156 174.52 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -131.51 94.57 3.56 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 124.257 1.023 . . . . 0.0 108.62 -177.269 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 235' ' ' MET . . . . . 0.418 ' HB3' ' CE3' ' A' ' 247' ' ' TRP . 63.3 mtm -122.03 100.75 7.14 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.8 0.84 . . . . 0.0 109.062 -179.366 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 4.8 p -87.8 124.83 41.26 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 170.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -88.65 130.53 35.27 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.539 0.736 . . . . 0.0 109.892 -178.634 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 238' ' ' CYS . . . . . 0.519 ' HB3' ' HA ' ' A' ' 246' ' ' GLU . 36.2 t -99.65 152.29 20.24 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.069 0.947 . . . . 0.0 109.398 175.239 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -127.23 108.23 10.7 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.933 0.893 . . . . 0.0 108.667 172.878 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -139.97 160.57 26.25 Favored Glycine 0 N--CA 1.473 1.144 0 CA-C-O 119.224 -0.765 . . . . 0.0 111.829 174.528 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -69.77 -35.31 12.85 Favored 'Trans proline' 0 C--N 1.375 1.973 0 C-N-CA 122.285 1.99 . . . . 0.0 112.156 174.311 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -128.48 110.19 12.08 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.896 0.879 . . . . 0.0 108.776 176.329 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 29.7 t -177.39 104.76 0.05 Allowed 'General case' 0 C--N 1.347 0.476 0 C-N-CA 123.56 0.744 . . . . 0.0 109.502 -175.502 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 16.8 tppt? -76.71 -30.6 56.73 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-O 121.548 0.69 . . . . 0.0 110.169 171.496 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 245' ' ' TYR . . . . . 0.524 ' HA ' ' HB3' ' A' ' 224' ' ' TYR . 15.5 m-85 -87.55 23.76 1.85 Allowed 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.42 1.088 . . . . 0.0 112.537 -168.347 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 246' ' ' GLU . . . . . 0.519 ' HA ' ' HB3' ' A' ' 238' ' ' CYS . 5.9 mm-40 -46.94 -45.07 20.49 Favored 'General case' 0 N--CA 1.499 2.001 0 C-N-CA 124.187 0.995 . . . . 0.0 112.481 -172.145 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 247' ' ' TRP . . . . . 0.418 ' CE3' ' HB3' ' A' ' 235' ' ' MET . 97.1 m95 -77.56 117.11 18.68 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 122.851 0.461 . . . . 0.0 110.056 173.665 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -122.18 159.26 27.61 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.93 0.892 . . . . 0.0 110.515 175.55 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 249' ' ' HIS . . . . . 0.49 ' CD2' ' HB2' ' A' ' 252' ' ' CYS . 0.7 OUTLIER -93.29 129.88 39.22 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 114.792 -1.094 . . . . 0.0 108.386 167.821 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 48.1 m-85 -52.91 -38.24 61.58 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 124.724 1.21 . . . . 0.0 112.272 -175.627 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -57.13 -34.79 68.75 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 124.79 1.236 . . . . 0.0 112.498 -177.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 252' ' ' CYS . . . . . 0.49 ' HB2' ' CD2' ' A' ' 249' ' ' HIS . 0.5 OUTLIER -65.63 -56.27 13.1 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 124.032 0.933 . . . . 0.0 110.585 -177.488 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 253' ' ' VAL . . . . . 0.512 HG23 ' HB2' ' A' ' 255' ' ' LEU . 20.7 m -82.85 -1.54 5.78 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.879 0 CA-C-N 114.595 -1.184 . . . . 0.0 111.314 -176.75 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 9.9 t30 61.13 31.37 19.67 Favored 'General case' 0 C--N 1.365 1.267 0 C-N-CA 124.662 1.185 . . . . 0.0 110.393 179.543 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.529 HD21 ' HG3' ' A' ' 259' ' ' PRO . 16.4 tp -76.45 89.66 3.24 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 177.543 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -71.42 -20.32 62.13 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 115.114 -0.948 . . . . 0.0 111.893 -172.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -139.19 152.95 70.74 Favored Pre-proline 0 CA--C 1.552 1.021 0 C-N-CA 124.509 1.123 . . . . 0.0 109.581 -177.567 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -59.14 148.51 85.35 Favored 'Trans proline' 0 C--N 1.381 2.274 0 C-N-CA 123.249 2.633 . . . . 0.0 113.663 179.31 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 259' ' ' PRO . . . . . 0.529 ' HG3' HD21 ' A' ' 255' ' ' LEU . 14.3 Cg_exo -68.9 146.31 65.09 Favored 'Trans proline' 0 C--N 1.38 2.205 0 C-N-CA 122.963 2.442 . . . . 0.0 111.987 172.206 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 57.6 mttp -86.31 -28.01 23.97 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.661 0.784 . . . . 0.0 110.876 -178.627 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -137.1 -150.27 5.74 Favored Glycine 0 C--N 1.345 1.082 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.849 -179.294 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 25.8 m -71.04 116.87 11.83 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 123.447 0.699 . . . . 0.0 110.511 -177.744 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 263' ' ' TRP . . . . . . . . . . . . . 27.9 t90 -91.26 114.93 27.59 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.965 0.906 . . . . 0.0 110.207 -175.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -100.64 117.69 35.27 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 170.137 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 265' ' ' CYS . . . . . 0.41 ' SG ' ' OE2' ' A' ' 267' ' ' GLU . 14.4 p -70.92 161.82 75.67 Favored Pre-proline 0 CA--C 1.56 1.328 0 CA-C-O 117.77 -1.11 . . . . 0.0 109.773 176.35 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_exo -27.25 -69.62 0.04 OUTLIER 'Trans proline' 0 C--N 1.397 3.09 1 C-N-CA 125.402 4.068 . . . . 0.0 116.742 -173.673 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 267' ' ' GLU . . . . . 0.41 ' OE2' ' SG ' ' A' ' 265' ' ' CYS . 0.0 OUTLIER -63.81 -26.15 68.5 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -173.794 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 268' ' ' CYS . . . . . . . . . . . . . 97.3 m -72.17 -47.45 50.73 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 123.113 0.565 . . . . 0.0 112.013 176.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 12.2 ptmm? -77.05 -23.66 52.01 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.987 -173.818 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 86.1 mt -88.39 -43.35 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 123.761 0.824 . . . . 0.0 110.206 178.462 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 . . . . . 0 C--O 1.257 1.449 0 C-N-CA 123.596 0.759 . . . . 0.0 109.564 -174.874 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 23.2 p . . . . . 0 N--CA 1.477 0.923 0 CA-C-O 120.774 0.321 . . . . 0.0 110.458 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 53.7 tp -94.86 93.81 7.67 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.003 0.921 . . . . 0.0 110.056 -177.841 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 224' ' ' TYR . . . . . 0.428 ' HB3' ' HA ' ' A' ' 245' ' ' TYR . 66.5 m-85 -135.58 124.09 23.54 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.456 0.702 . . . . 0.0 109.279 172.747 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 36.8 t 172.01 158.69 0.1 Allowed 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 125.208 1.403 . . . . 0.0 109.349 172.033 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 77.5 t80 -66.99 -41.78 86.17 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 117.942 0.337 . . . . 0.0 110.919 177.049 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 6.3 p -72.48 -10.74 60.17 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 122.504 0.321 . . . . 0.0 110.43 176.319 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 82.4 mm-40 53.88 88.8 0.03 OUTLIER 'General case' 0 C--N 1.368 1.388 0 C-N-CA 124.823 1.249 . . . . 0.0 110.78 -173.073 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 2.4 tpm_? -153.32 146.11 24.35 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-N 114.721 -1.127 . . . . 0.0 108.389 -177.924 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 34.9 m -83.92 149.13 4.56 Favored 'Isoleucine or valine' 0 C--O 1.24 0.587 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 175.306 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 21.4 m -84.73 88.12 7.35 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.324 0.65 . . . . 0.0 110.104 -178.647 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -74.41 88.85 2.1 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.668 0.787 . . . . 0.0 110.625 -176.504 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 78.44 -19.39 4.81 Favored Glycine 0 CA--C 1.535 1.327 0 CA-C-N 115.112 -0.949 . . . . 0.0 114.614 177.087 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -116.26 94.39 4.62 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.035 0.934 . . . . 0.0 108.773 179.341 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 235' ' ' MET . . . . . . . . . . . . . 20.4 ptt? -120.03 108.98 14.95 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.957 0.903 . . . . 0.0 110.515 -176.186 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 7.5 p -100.22 125.72 53.91 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 169.794 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -101.4 138.16 38.78 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.553 0.741 . . . . 0.0 110.795 -172.131 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 238' ' ' CYS . . . . . 0.722 ' HB3' ' HA ' ' A' ' 246' ' ' GLU . 34.9 t -95.93 152.29 18.64 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 123.768 0.827 . . . . 0.0 109.055 173.606 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 239' ' ' ASP . . . . . 0.435 ' HB3' ' HB ' ' A' ' 262' ' ' THR . 31.3 t70 -125.96 104.85 8.51 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 175.442 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -138.43 147.94 19.58 Favored Glycine 0 C--N 1.337 0.607 0 CA-C-O 118.859 -0.967 . . . . 0.0 111.245 177.422 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -66.52 -34.28 34.03 Favored 'Trans proline' 0 C--N 1.372 1.788 0 C-N-CA 122.64 2.226 . . . . 0.0 112.368 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -135.98 94.91 3.12 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 176.728 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 45.1 t -163.93 110.88 1.11 Allowed 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.972 0.909 . . . . 0.0 109.003 -173.381 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 244' ' ' LYS . . . . . 0.56 ' H ' ' HD3' ' A' ' 244' ' ' LYS . 0.1 OUTLIER -82.92 -31.64 27.66 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.18 0.592 . . . . 0.0 110.876 175.991 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 245' ' ' TYR . . . . . 0.428 ' HA ' ' HB3' ' A' ' 224' ' ' TYR . 71.5 m-85 -79.54 28.68 0.25 Allowed 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 124.543 1.137 . . . . 0.0 113.208 -178.622 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 246' ' ' GLU . . . . . 0.722 ' HA ' ' HB3' ' A' ' 238' ' ' CYS . 5.7 mm-40 -48.91 -48.35 42.65 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.27 0.628 . . . . 0.0 112.276 178.007 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 247' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -78.69 130.83 36.27 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 121.186 0.517 . . . . 0.0 112.103 -176.886 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -143.73 172.43 12.84 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.192 1.397 . . . . 0.0 109.953 174.539 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 249' ' ' HIS . . . . . 0.439 ' HD2' ' HB2' ' A' ' 252' ' ' CYS . 0.0 OUTLIER -120.36 140.75 50.85 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.559 1.144 . . . . 0.0 108.499 179.329 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 250' ' ' TYR . . . . . 0.425 ' HB3' ' O ' ' A' ' 255' ' ' LEU . 49.0 m-85 -54.8 -54.38 42.89 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.855 1.262 . . . . 0.0 113.285 -167.292 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -59.8 -34.41 73.0 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 123.262 0.625 . . . . 0.0 112.174 -175.234 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 252' ' ' CYS . . . . . 0.439 ' HB2' ' HD2' ' A' ' 249' ' ' HIS . 7.3 t -67.0 -43.28 83.34 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.037 0.935 . . . . 0.0 111.195 -177.309 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 9.2 m -93.17 14.76 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.175 0 C-N-CA 123.788 0.835 . . . . 0.0 111.315 177.006 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 6.4 t30 67.48 7.87 5.9 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 125.103 1.361 . . . . 0.0 112.524 172.607 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.425 ' O ' ' HB3' ' A' ' 250' ' ' TYR . 87.9 mt -74.43 104.15 5.05 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.048 0.539 . . . . 0.0 110.732 -179.004 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 52.3 tttm -63.73 -36.87 85.28 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.237 1.015 . . . . 0.0 110.303 169.603 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -142.96 149.61 49.98 Favored Pre-proline 0 CA--C 1.549 0.936 0 CA-C-N 114.676 -1.147 . . . . 0.0 109.777 -170.258 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 258' ' ' PRO . . . . . 0.504 ' HA ' ' HD3' ' A' ' 259' ' ' PRO . 33.6 Cg_endo -62.51 138.14 68.74 Favored 'Trans proline' 0 C--N 1.38 2.23 0 C-N-CA 122.864 2.376 . . . . 0.0 113.1 -175.9 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 259' ' ' PRO . . . . . 0.504 ' HD3' ' HA ' ' A' ' 258' ' ' PRO . 17.3 Cg_exo -69.6 137.81 36.82 Favored 'Trans proline' 0 C--N 1.372 1.779 0 C-N-CA 123.261 2.641 . . . . 0.0 111.917 177.96 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -73.21 96.99 2.33 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 123.505 0.722 . . . . 0.0 109.931 -175.739 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 117.65 -168.8 13.05 Favored Glycine 0 N--CA 1.472 1.063 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.83 178.31 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 262' ' ' THR . . . . . 0.435 ' HB ' ' HB3' ' A' ' 239' ' ' ASP . 32.5 p -66.34 107.01 1.86 Allowed 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.08 0.552 . . . . 0.0 109.879 173.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 263' ' ' TRP . . . . . . . . . . . . . 32.0 t90 -70.11 140.2 52.65 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 122.853 0.461 . . . . 0.0 110.139 -179.435 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -113.2 118.66 35.32 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 172.703 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 20.4 p -57.35 150.59 42.4 Favored Pre-proline 0 N--CA 1.478 0.952 0 CA-C-O 118.543 -0.741 . . . . 0.0 109.489 172.694 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_exo -45.57 -32.34 8.24 Favored 'Trans proline' 0 C--N 1.386 2.538 0 C-N-CA 123.407 2.738 . . . . 0.0 114.307 -173.713 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -65.39 -50.04 67.0 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 123.82 0.848 . . . . 0.0 110.822 -179.567 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 268' ' ' CYS . . . . . . . . . . . . . 43.9 m -59.83 -45.88 91.02 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 123.121 0.568 . . . . 0.0 112.306 -179.377 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 269' ' ' LYS . . . . . 0.595 ' HD3' HG13 ' A' ' 270' ' ' ILE . 0.1 OUTLIER -81.25 -14.53 57.34 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -171.825 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 270' ' ' ILE . . . . . 0.595 HG13 ' HD3' ' A' ' 269' ' ' LYS . 78.5 mt -92.84 -23.11 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 C-N-CA 123.211 0.604 . . . . 0.0 110.057 172.382 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 . . . . . 0 CA--C 1.559 1.322 0 CA-C-O 118.65 -0.69 . . . . 0.0 110.497 178.438 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 15.3 p . . . . . 0 N--CA 1.474 0.759 0 CA-C-O 121.027 0.441 . . . . 0.0 110.37 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 53.3 tp -80.94 82.56 6.88 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 176.35 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 224' ' ' TYR . . . . . 0.532 ' HB2' ' HB2' ' A' ' 247' ' ' TRP . 69.3 m-85 -133.34 125.46 29.24 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 177.259 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 40.8 t 171.3 154.19 0.07 Allowed 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 125.86 1.664 . . . . 0.0 107.734 173.351 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -61.62 -43.26 99.2 Favored 'General case' 0 CA--C 1.549 0.914 0 CA-C-N 117.872 0.305 . . . . 0.0 110.861 177.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 6.2 p -68.67 -17.07 64.02 Favored 'General case' 0 N--CA 1.483 1.177 0 O-C-N 123.321 0.388 . . . . 0.0 111.035 177.838 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 81.3 mm-40 58.81 83.89 0.12 Allowed 'General case' 0 C--N 1.365 1.262 0 C-N-CA 124.581 1.152 . . . . 0.0 110.753 -174.118 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 14.6 tpt180 -150.24 154.52 38.09 Favored 'General case' 0 C--O 1.243 0.727 0 C-N-CA 124.077 0.951 . . . . 0.0 108.532 179.372 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 27.0 m -81.78 177.37 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 CA-C-O 121.488 0.661 . . . . 0.0 110.78 172.711 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 22.2 p -96.64 153.22 17.98 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.897 171.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 40.8 t80 -84.83 1.53 46.54 Favored 'General case' 0 CA--C 1.56 1.334 0 C-N-CA 123.651 0.78 . . . . 0.0 110.002 168.111 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 135.6 -19.18 3.8 Favored Glycine 0 C--N 1.347 1.147 0 C-N-CA 124.006 0.812 . . . . 0.0 111.387 -179.022 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.41 123.14 35.51 Favored 'General case' 0 CA--C 1.555 1.136 0 C-N-CA 122.901 0.48 . . . . 0.0 110.017 -178.411 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 235' ' ' MET . . . . . . . . . . . . . 7.9 mmt -144.57 119.89 10.23 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.329 0.652 . . . . 0.0 110.391 -177.726 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 3.7 p -98.57 126.35 51.71 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 C-N-CA 124.423 1.089 . . . . 0.0 109.48 168.057 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -87.25 134.52 33.54 Favored 'General case' 0 C--O 1.242 0.679 0 C-N-CA 123.217 0.607 . . . . 0.0 110.014 177.589 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 238' ' ' CYS . . . . . 0.542 ' HB3' ' HA ' ' A' ' 246' ' ' GLU . 35.5 t -95.52 123.98 39.33 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 123.464 0.705 . . . . 0.0 111.117 -178.405 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -77.9 94.33 4.54 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 123.893 0.877 . . . . 0.0 109.195 177.19 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -142.04 125.03 2.58 Favored Glycine 0 CA--C 1.529 0.945 0 CA-C-O 118.761 -1.022 . . . . 0.0 111.917 -179.34 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -62.77 -33.79 75.13 Favored 'Trans proline' 0 C--N 1.379 2.132 0 C-N-CA 122.61 2.207 . . . . 0.0 111.422 171.853 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -118.32 100.02 7.22 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 169.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 12.1 t -165.54 109.29 0.83 Allowed 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 178.09 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 22.7 ttmm -82.99 -35.69 25.65 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-O 121.547 0.689 . . . . 0.0 109.25 170.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 245' ' ' TYR . . . . . 0.463 ' HA ' ' HB3' ' A' ' 224' ' ' TYR . 89.5 m-85 -83.26 24.12 0.83 Allowed 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 124.985 1.314 . . . . 0.0 113.069 -175.045 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 246' ' ' GLU . . . . . 0.542 ' HA ' ' HB3' ' A' ' 238' ' ' CYS . 42.9 mt-10 -47.85 -38.46 16.12 Favored 'General case' 0 N--CA 1.502 2.149 0 C-N-CA 124.33 1.052 . . . . 0.0 113.181 -174.077 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 247' ' ' TRP . . . . . 0.532 ' HB2' ' HB2' ' A' ' 224' ' ' TYR . 85.6 m95 -78.34 127.09 31.71 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.498 -179.343 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -143.93 130.35 19.93 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.052 0.941 . . . . 0.0 109.605 178.551 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 249' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -71.92 129.56 38.87 Favored 'General case' 0 CA--C 1.547 0.854 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 172.646 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 250' ' ' TYR . . . . . 0.42 ' HB3' ' O ' ' A' ' 255' ' ' LEU . 50.1 m-85 -52.31 -31.68 34.19 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 124.709 1.204 . . . . 0.0 112.321 -178.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -53.54 -48.01 69.48 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 124.116 0.966 . . . . 0.0 111.89 176.439 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 252' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -61.04 -41.42 96.54 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.86 0.864 . . . . 0.0 111.414 -176.168 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 31.9 m -97.23 0.24 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 CA-C-N 115.395 -0.821 . . . . 0.0 112.038 -175.055 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 20.2 m120 62.78 17.06 9.55 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 124.934 1.294 . . . . 0.0 113.294 175.008 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.42 ' O ' ' HB3' ' A' ' 250' ' ' TYR . 92.6 mt -80.22 109.47 14.72 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 174.904 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -75.23 -34.98 61.49 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 121.205 0.526 . . . . 0.0 110.041 175.878 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -116.98 139.0 25.25 Favored Pre-proline 0 CA--C 1.55 0.966 0 C-N-CA 123.482 0.713 . . . . 0.0 109.566 -175.83 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -59.72 136.61 71.66 Favored 'Trans proline' 0 C--N 1.378 2.131 0 C-N-CA 123.66 2.907 . . . . 0.0 113.486 179.184 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 259' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -65.59 127.57 18.3 Favored 'Trans proline' 0 C--N 1.372 1.816 0 C-N-CA 122.641 2.227 . . . . 0.0 111.515 172.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 14.8 ptmm? -73.99 -16.08 61.08 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.419 0.688 . . . . 0.0 111.626 -179.101 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -118.31 176.9 16.31 Favored Glycine 0 C--N 1.345 1.043 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.893 179.434 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 36.6 p -57.13 123.05 13.89 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 124.131 0.972 . . . . 0.0 111.809 -177.881 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 263' ' ' TRP . . . . . . . . . . . . . 44.4 t90 -101.87 115.75 31.22 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.262 0.625 . . . . 0.0 109.36 -174.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -105.63 111.78 24.61 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.951 0.901 . . . . 0.0 109.253 177.701 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 16.6 p -64.35 149.11 95.29 Favored Pre-proline 0 CA--C 1.559 1.295 0 CA-C-O 118.326 -0.845 . . . . 0.0 109.4 174.223 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -27.44 -60.32 0.09 OUTLIER 'Trans proline' 0 C--N 1.384 2.411 1 C-N-CA 125.76 4.307 . . . . 0.0 118.026 -160.606 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.29 -39.89 86.03 Favored 'General case' 0 N--CA 1.485 1.281 0 CA-C-O 119.293 -0.384 . . . . 0.0 111.604 -175.949 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 268' ' ' CYS . . . . . . . . . . . . . 59.6 m -52.55 -30.94 33.27 Favored 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 -178.507 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 32.7 ttmt -78.35 -24.66 46.39 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.085 0.554 . . . . 0.0 111.516 -177.77 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 31.7 pt -112.76 2.51 8.49 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.258 0 C-N-CA 123.544 0.737 . . . . 0.0 112.034 179.08 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 . . . . . 0 C--O 1.256 1.396 0 C-N-CA 123.984 0.914 . . . . 0.0 109.544 -176.125 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 3.2 tm? . . . . . 0 N--CA 1.471 0.597 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 224' ' ' TYR . . . . . 0.462 ' HE1' ' HE3' ' A' ' 244' ' ' LYS . 60.3 m-85 -148.32 125.42 11.41 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.657 1.183 . . . . 0.0 108.301 172.372 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 47.1 t 173.26 163.03 0.14 Allowed 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 124.7 1.2 . . . . 0.0 109.88 174.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -65.94 -33.97 77.03 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 122.41 0.284 . . . . 0.0 111.406 175.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 13.3 p -84.01 -5.86 59.31 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 122.152 0.181 . . . . 0.0 111.412 176.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 82.5 mm-40 48.67 85.95 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 125.467 1.507 . . . . 0.0 112.743 -175.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 22.9 tpp180 -153.92 148.54 26.32 Favored 'General case' 0 C--O 1.244 0.784 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 177.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 25.7 m -62.4 149.71 9.37 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 O-C-N 123.838 0.711 . . . . 0.0 110.73 178.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 17.5 p -87.01 69.52 10.24 Favored 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 123.382 0.673 . . . . 0.0 110.141 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 94.5 t80 -70.5 98.28 1.43 Allowed 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.164 0.986 . . . . 0.0 110.576 -176.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 78.5 -17.59 6.43 Favored Glycine 0 CA--C 1.536 1.404 0 CA-C-N 116.133 -0.485 . . . . 0.0 113.97 176.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -122.32 105.62 10.36 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.217 1.007 . . . . 0.0 108.424 178.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 235' ' ' MET . . . . . . . . . . . . . 21.3 ptt? -136.53 102.19 4.86 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 121.949 0.88 . . . . 0.0 111.143 178.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 5.0 p -101.48 123.72 54.77 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.785 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 172.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -92.67 147.82 22.57 Favored 'General case' 0 C--O 1.241 0.607 0 C-N-CA 123.168 0.587 . . . . 0.0 110.206 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 238' ' ' CYS . . . . . 0.51 ' HB3' ' HA ' ' A' ' 246' ' ' GLU . 35.4 t -106.41 154.52 20.7 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 124.034 0.934 . . . . 0.0 110.708 -179.228 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -111.15 96.23 6.01 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 170.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -140.67 119.93 1.65 Allowed Glycine 0 CA--C 1.527 0.802 0 CA-C-O 118.518 -1.156 . . . . 0.0 111.511 177.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -53.51 -39.07 83.68 Favored 'Trans proline' 0 C--N 1.382 2.323 0 C-N-CA 123.42 2.747 . . . . 0.0 113.276 174.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -114.76 101.73 9.34 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 171.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 12.8 t -173.07 102.82 0.13 Allowed 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 -173.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 244' ' ' LYS . . . . . 0.462 ' HE3' ' HE1' ' A' ' 224' ' ' TYR . 52.7 tptt -81.51 -31.34 32.87 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 123.252 0.621 . . . . 0.0 109.738 170.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -81.54 26.92 0.45 Allowed 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 124.938 1.295 . . . . 0.0 112.541 -179.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 246' ' ' GLU . . . . . 0.51 ' HA ' ' HB3' ' A' ' 238' ' ' CYS . 6.1 mm-40 -47.35 -45.77 25.0 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 123.883 0.873 . . . . 0.0 112.541 -178.099 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 247' ' ' TRP . . . . . 0.462 ' HB2' ' HB2' ' A' ' 224' ' ' TYR . 97.9 m95 -86.26 141.04 29.57 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.049 0.452 . . . . 0.0 111.035 178.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 32.9 m-85 -145.58 174.22 11.37 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.333 1.453 . . . . 0.0 109.231 176.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 249' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -113.47 141.11 47.5 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 168.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -54.95 -43.01 73.02 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.856 1.262 . . . . 0.0 112.673 -170.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -63.87 -34.47 78.02 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.389 0.676 . . . . 0.0 112.417 -175.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 252' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -65.55 -47.45 75.82 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-O 121.32 0.581 . . . . 0.0 110.246 179.12 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 30.6 m -88.04 5.46 4.02 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.897 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.747 -176.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 55.2 t30 58.73 70.91 0.62 Allowed 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.801 1.24 . . . . 0.0 110.785 178.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 76.6 mt -141.22 152.74 44.84 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.479 1.112 . . . . 0.0 109.121 177.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.8 -21.35 1.94 Allowed 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 123.864 0.866 . . . . 0.0 109.794 166.186 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -78.85 118.62 73.48 Favored Pre-proline 0 N--CA 1.478 0.97 0 C-N-CA 123.685 0.794 . . . . 0.0 109.49 176.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -57.34 121.36 9.91 Favored 'Trans proline' 0 C--N 1.372 1.799 0 C-N-CA 122.78 2.32 . . . . 0.0 111.129 165.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 259' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -52.92 132.79 48.83 Favored 'Trans proline' 0 C--N 1.378 2.12 0 C-N-CA 123.829 3.019 . . . . 0.0 113.738 -178.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 60.2 pttt -83.34 -2.55 55.99 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.313 1.045 . . . . 0.0 112.244 178.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -168.77 -155.63 9.83 Favored Glycine 0 C--N 1.344 0.984 0 CA-C-O 120.033 -0.315 . . . . 0.0 112.502 -179.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 25.8 p -62.19 106.81 0.78 Allowed 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.949 0.9 . . . . 0.0 111.447 -175.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 263' ' ' TRP . . . . . . . . . . . . . 63.1 t90 -92.49 113.98 26.41 Favored 'General case' 0 C--N 1.347 0.481 0 CA-C-N 115.771 -0.649 . . . . 0.0 109.435 -176.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 45.8 m-85 -93.68 118.6 31.61 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 175.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 265' ' ' CYS . . . . . 0.444 ' SG ' ' HB2' ' A' ' 267' ' ' GLU . 18.4 p -66.39 152.98 93.76 Favored Pre-proline 0 CA--C 1.545 0.774 0 CA-C-O 118.507 -0.759 . . . . 0.0 109.715 175.047 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_exo -47.85 -29.01 10.73 Favored 'Trans proline' 0 C--N 1.384 2.446 0 C-N-CA 123.728 2.952 . . . . 0.0 114.244 -178.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 267' ' ' GLU . . . . . 0.444 ' HB2' ' SG ' ' A' ' 265' ' ' CYS . 9.5 mp0 -64.74 -53.71 42.83 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 125.078 1.351 . . . . 0.0 109.814 178.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 268' ' ' CYS . . . . . . . . . . . . . 94.4 m -62.04 -34.91 77.12 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.29 0.636 . . . . 0.0 111.232 176.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -68.13 -23.99 64.95 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.291 0.636 . . . . 0.0 111.929 -179.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 2.8 pp -102.69 -4.68 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 N-CA-C 111.768 0.285 . . . . 0.0 111.768 175.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 . . . . . 0 N--CA 1.484 1.274 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 170.876 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 58.1 tp . . . . . 0 N--CA 1.472 0.666 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 224' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -136.72 128.89 29.72 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -173.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 225' ' ' CYS . . . . . 0.481 ' HG ' ' HD1' ' A' ' 248' ' ' PHE . 42.2 t 172.75 166.9 0.12 Allowed 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 125.262 1.425 . . . . 0.0 108.838 171.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -68.34 -38.37 81.44 Favored 'General case' 0 N--CA 1.484 1.273 0 O-C-N 121.969 -0.457 . . . . 0.0 110.427 175.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 10.0 p -83.79 -9.8 58.54 Favored 'General case' 0 N--CA 1.484 1.257 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.909 176.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 22.2 mm-40 48.66 77.61 0.1 Allowed 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 124.742 1.217 . . . . 0.0 112.114 -173.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 229' ' ' ARG . . . . . 0.516 ' HE ' ' HE2' ' A' ' 232' ' ' PHE . 26.7 ttt85 -135.73 149.65 49.27 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.625 1.17 . . . . 0.0 108.273 -175.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 29.0 m -70.33 160.07 5.27 Favored 'Isoleucine or valine' 0 C--O 1.242 0.696 0 CA-C-O 121.255 0.55 . . . . 0.0 110.647 177.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 231' ' ' SER . . . . . 0.736 ' HB3' ' HB3' ' A' ' 235' ' ' MET . 48.2 m -113.88 118.18 33.47 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 176.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 232' ' ' PHE . . . . . 0.516 ' HE2' ' HE ' ' A' ' 229' ' ' ARG . 3.9 p90 -112.23 66.54 0.64 Allowed 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.318 1.047 . . . . 0.0 110.091 -167.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 86.58 -21.76 16.69 Favored Glycine 0 N--CA 1.472 1.086 0 CA-C-N 115.002 -0.999 . . . . 0.0 113.51 179.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 30.7 mm-40 -106.56 99.04 8.64 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 170.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 235' ' ' MET . . . . . 0.736 ' HB3' ' HB3' ' A' ' 231' ' ' SER . 25.7 ptt? -142.14 123.3 14.65 Favored 'General case' 0 C--O 1.241 0.647 0 CA-C-O 121.325 0.584 . . . . 0.0 110.836 178.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . 0.529 HG23 ' HG3' ' A' ' 259' ' ' PRO . 6.2 p -100.12 124.62 53.7 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 CA-C-N 115.332 -0.849 . . . . 0.0 108.912 172.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -91.2 148.19 22.53 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.31 -178.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 238' ' ' CYS . . . . . 0.577 ' HB3' ' HA ' ' A' ' 246' ' ' GLU . 36.7 t -108.09 153.15 23.55 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 123.531 0.732 . . . . 0.0 109.657 173.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -118.18 93.77 4.25 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.678 0.791 . . . . 0.0 109.176 174.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -143.88 126.39 2.73 Favored Glycine 0 CA--C 1.527 0.802 0 CA-C-O 118.21 -1.328 . . . . 0.0 110.632 172.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -58.51 -50.5 9.37 Favored 'Trans proline' 0 C--N 1.376 1.986 0 CA-C-N 120.342 2.071 . . . . 0.0 110.96 177.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 8.7 p-10 -94.1 89.91 6.19 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 114.61 -1.177 . . . . 0.0 109.058 171.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 42.8 t -173.23 110.9 0.2 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.293 1.037 . . . . 0.0 109.197 -176.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 244' ' ' LYS . . . . . 0.549 ' H ' ' HD2' ' A' ' 244' ' ' LYS . 0.0 OUTLIER -88.85 -24.91 22.42 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.32 0.648 . . . . 0.0 110.995 178.985 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 36.6 m-85 -90.85 27.48 1.79 Allowed 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.403 1.081 . . . . 0.0 111.667 -177.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 246' ' ' GLU . . . . . 0.577 ' HA ' ' HB3' ' A' ' 238' ' ' CYS . 6.9 mm-40 -46.66 -45.07 19.02 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 124.023 0.929 . . . . 0.0 112.307 -179.182 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 247' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -83.44 126.74 33.07 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 121.56 0.695 . . . . 0.0 111.039 178.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 248' ' ' PHE . . . . . 0.481 ' HD1' ' HG ' ' A' ' 225' ' ' CYS . 48.0 m-85 -134.64 174.79 10.17 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.352 1.461 . . . . 0.0 108.411 170.456 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 249' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -127.32 148.53 50.24 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.725 0.81 . . . . 0.0 108.951 178.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -58.35 -32.7 68.78 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 124.358 1.063 . . . . 0.0 113.033 -172.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -65.86 -36.41 83.37 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.55 0.74 . . . . 0.0 112.067 179.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 252' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -70.82 -56.02 7.23 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.597 0.759 . . . . 0.0 110.295 -178.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . 0.523 HG21 HG11 ' A' ' 236' ' ' VAL . 34.2 m -79.86 -3.68 6.46 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 CA-C-N 114.775 -1.102 . . . . 0.0 111.839 -175.405 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 14.4 m120 65.59 27.28 11.52 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 125.012 1.325 . . . . 0.0 112.123 173.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 33.8 mt -79.01 112.7 16.48 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.589 0.756 . . . . 0.0 109.595 172.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -88.91 -2.85 58.79 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.82 0.848 . . . . 0.0 109.489 168.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -127.08 146.12 56.59 Favored Pre-proline 0 CA--C 1.547 0.851 0 C-N-CA 124.628 1.171 . . . . 0.0 109.564 -176.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -72.86 134.84 22.42 Favored 'Trans proline' 0 C--N 1.37 1.689 0 C-N-CA 122.47 2.113 . . . . 0.0 110.845 171.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 259' ' ' PRO . . . . . 0.529 ' HG3' HG23 ' A' ' 236' ' ' VAL . 39.6 Cg_endo -63.68 149.82 89.95 Favored 'Trans proline' 0 C--N 1.375 1.958 0 C-N-CA 122.362 2.041 . . . . 0.0 112.062 177.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -75.87 -18.87 59.26 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.058 0.943 . . . . 0.0 112.912 -168.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -170.66 -134.48 1.76 Allowed Glycine 0 C--N 1.343 0.935 0 N-CA-C 111.663 -0.575 . . . . 0.0 111.663 -178.102 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 42.1 p -69.57 106.34 2.99 Favored 'General case' 0 C--N 1.353 0.729 0 C-N-CA 122.865 0.466 . . . . 0.0 109.835 177.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 263' ' ' TRP . . . . . 0.466 ' O ' ' HA ' ' A' ' 238' ' ' CYS . 76.1 t90 -87.98 122.23 31.34 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.206 -176.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -101.17 118.12 36.36 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 176.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 265' ' ' CYS . . . . . 0.492 ' SG ' ' HG2' ' A' ' 267' ' ' GLU . 16.2 p -66.91 155.52 89.72 Favored Pre-proline 0 CA--C 1.551 0.988 0 C-N-CA 123.793 0.837 . . . . 0.0 110.946 -178.385 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -38.91 -50.47 2.57 Favored 'Trans proline' 0 C--N 1.388 2.647 0 C-N-CA 124.739 3.626 . . . . 0.0 115.314 -176.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 267' ' ' GLU . . . . . 0.492 ' HG2' ' SG ' ' A' ' 265' ' ' CYS . 2.5 pm0 -62.2 -39.34 92.4 Favored 'General case' 0 CA--C 1.549 0.933 0 CA-C-N 115.892 -0.594 . . . . 0.0 112.357 -178.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 268' ' ' CYS . . . . . . . . . . . . . 63.6 m -68.87 -44.1 74.01 Favored 'General case' 0 N--CA 1.495 1.821 0 C-N-CA 122.699 0.399 . . . . 0.0 111.223 176.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -66.78 -31.48 72.15 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.37 -169.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 1.8 mp -91.05 -46.82 14.58 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.078 0 C-N-CA 123.382 0.673 . . . . 0.0 109.666 176.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 . . . . . 0 CA--C 1.558 1.288 0 C-N-CA 123.309 0.644 . . . . 0.0 109.711 -175.555 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 5.8 tt . . . . . 0 N--CA 1.47 0.547 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 224' ' ' TYR . . . . . 0.44 ' HB3' ' HA ' ' A' ' 245' ' ' TYR . 63.7 m-85 -140.04 124.11 17.66 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 176.427 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 48.7 t 171.25 152.18 0.06 Allowed 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 125.52 1.528 . . . . 0.0 108.08 174.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 50.4 t80 -65.29 -38.74 91.19 Favored 'General case' 0 N--CA 1.486 1.351 0 CA-C-N 119.138 0.881 . . . . 0.0 110.965 -179.194 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 5.8 p -68.43 -14.23 62.86 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 123.034 0.208 . . . . 0.0 111.07 177.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 87.0 mm-40 57.12 85.82 0.08 Allowed 'General case' 0 C--N 1.364 1.238 0 C-N-CA 125.231 1.413 . . . . 0.0 111.845 179.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -160.17 149.12 17.29 Favored 'General case' 0 C--O 1.242 0.706 0 CA-C-N 114.745 -1.116 . . . . 0.0 108.713 178.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 31.0 m -71.51 149.97 9.35 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 122.78 0.432 . . . . 0.0 111.184 178.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 15.8 m -94.26 68.34 3.62 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-O 121.745 0.783 . . . . 0.0 109.23 177.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 47.6 t80 -83.04 91.42 7.18 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.463 -171.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 103.98 -19.79 42.74 Favored Glycine 0 N--CA 1.476 1.33 0 CA-C-N 116.066 -0.515 . . . . 0.0 113.694 175.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.1 64.67 1.59 Allowed 'General case' 0 N--CA 1.481 1.124 0 CA-C-O 122.392 1.091 . . . . 0.0 110.122 178.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 235' ' ' MET . . . . . . . . . . . . . 18.3 ptm -99.56 130.68 45.82 Favored 'General case' 0 N--CA 1.483 1.177 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.75 -176.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 7.0 p -124.95 126.88 71.96 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.939 0 C-N-CA 124.565 1.146 . . . . 0.0 108.964 177.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -91.86 154.22 19.02 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.873 0.869 . . . . 0.0 111.302 -178.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 238' ' ' CYS . . . . . 0.649 ' HB3' ' HA ' ' A' ' 246' ' ' GLU . 11.3 t -117.12 155.47 29.26 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.929 1.292 . . . . 0.0 109.565 175.523 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -117.9 105.34 11.82 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.757 0.823 . . . . 0.0 109.406 172.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -140.96 144.74 15.04 Favored Glycine 0 CA--C 1.528 0.874 0 CA-C-O 118.533 -1.148 . . . . 0.0 111.405 173.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -61.38 -47.88 10.89 Favored 'Trans proline' 0 C--N 1.378 2.112 0 C-N-CA 122.929 2.419 . . . . 0.0 112.028 -178.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 40.9 t30 -124.5 107.44 11.07 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 170.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 43.8 t -157.45 117.05 3.36 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 123.522 0.729 . . . . 0.0 109.376 -174.173 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -80.5 -44.62 18.84 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.441 0.697 . . . . 0.0 109.852 176.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 245' ' ' TYR . . . . . 0.44 ' HA ' ' HB3' ' A' ' 224' ' ' TYR . 45.6 m-85 -82.72 31.11 0.42 Allowed 'General case' 0 CA--C 1.553 1.089 0 C-N-CA 124.18 0.992 . . . . 0.0 112.393 -175.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 246' ' ' GLU . . . . . 0.649 ' HA ' ' HB3' ' A' ' 238' ' ' CYS . 6.9 mm-40 -47.34 -42.79 22.16 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.832 0.853 . . . . 0.0 111.537 173.446 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 247' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -90.34 139.05 31.04 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-O 121.052 0.453 . . . . 0.0 111.132 177.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -147.28 173.09 12.9 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.062 1.345 . . . . 0.0 109.401 174.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 249' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -117.63 140.4 49.7 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.427 0.691 . . . . 0.0 110.03 174.207 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -54.58 -28.09 43.64 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 125.301 1.44 . . . . 0.0 112.36 -179.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -60.61 -54.73 41.79 Favored 'General case' 0 CA--C 1.555 1.16 0 C-N-CA 123.407 0.683 . . . . 0.0 111.176 177.019 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 252' ' ' CYS . . . . . . . . . . . . . 1.1 m -66.21 -44.68 83.19 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.773 0.829 . . . . 0.0 111.594 -177.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 33.8 m -84.4 -0.71 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.619 -177.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 21.1 m120 60.66 19.18 9.18 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 125.038 1.335 . . . . 0.0 113.278 172.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 92.7 mt -84.64 120.94 26.95 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 177.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 31.9 mmtp -103.74 21.33 16.41 Favored 'General case' 0 N--CA 1.485 1.322 0 CA-C-O 121.319 0.58 . . . . 0.0 110.07 -177.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -157.89 139.56 9.93 Favored Pre-proline 0 C--O 1.245 0.832 0 C-N-CA 124.619 1.167 . . . . 0.0 109.069 -174.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_exo -67.99 115.19 3.67 Favored 'Trans proline' 0 C--N 1.373 1.842 0 C-N-CA 122.999 2.466 . . . . 0.0 111.668 176.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 259' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -68.48 121.1 8.02 Favored 'Trans proline' 0 C--N 1.376 2.026 0 C-N-CA 122.374 2.049 . . . . 0.0 111.252 178.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 10.3 mtmp? -72.48 124.31 24.93 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.12 0.568 . . . . 0.0 110.354 178.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 115.76 -159.74 13.67 Favored Glycine 0 C--N 1.337 0.627 0 N-CA-C 111.494 -0.642 . . . . 0.0 111.494 174.081 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 45.6 p -83.56 107.18 15.86 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 172.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 263' ' ' TRP . . . . . . . . . . . . . 40.2 t90 -77.04 147.23 36.86 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-O 121.119 0.485 . . . . 0.0 110.144 179.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -120.13 120.66 36.87 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 123.735 0.814 . . . . 0.0 108.972 178.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 17.3 p -67.71 161.09 69.23 Favored Pre-proline 0 CA--C 1.55 0.97 0 C-N-CA 123.537 0.735 . . . . 0.0 110.646 176.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -41.52 -29.91 0.84 Allowed 'Trans proline' 0 C--N 1.383 2.387 0 C-N-CA 124.002 3.134 . . . . 0.0 115.593 176.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -63.47 -66.78 0.49 Allowed 'General case' 0 N--CA 1.483 1.199 0 CA-C-O 121.605 0.717 . . . . 0.0 109.806 173.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 268' ' ' CYS . . . . . . . . . . . . . 58.6 m -71.26 -28.62 64.29 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 114.617 -1.174 . . . . 0.0 111.949 -167.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -80.04 -56.12 4.47 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.373 0.669 . . . . 0.0 110.504 -178.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 45.5 mm -82.21 -59.44 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 122.768 0.427 . . . . 0.0 111.714 -168.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 . . . . . 0 N--CA 1.481 1.083 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -168.769 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 5.4 tt . . . . . 0 N--CA 1.482 1.154 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 224' ' ' TYR . . . . . 0.618 ' HB3' ' HA ' ' A' ' 245' ' ' TYR . 88.0 m-85 -137.39 131.99 32.86 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.534 1.134 . . . . 0.0 108.251 177.283 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 34.8 t 172.48 160.07 0.11 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.028 1.331 . . . . 0.0 108.888 177.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -67.52 -29.09 68.4 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 122.543 0.337 . . . . 0.0 111.0 177.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 227' ' ' CYS . . . . . 0.453 ' SG ' ' HB2' ' A' ' 229' ' ' ARG . 12.2 p -84.86 -5.84 59.34 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-O 119.224 -0.417 . . . . 0.0 111.939 178.164 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 33.1 mm-40 54.88 78.94 0.16 Allowed 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 124.494 1.117 . . . . 0.0 111.269 -173.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 229' ' ' ARG . . . . . 0.453 ' HB2' ' SG ' ' A' ' 227' ' ' CYS . 3.1 tmm_? -154.23 150.21 27.82 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 -176.442 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 30.7 m -66.98 156.84 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 123.388 0.675 . . . . 0.0 112.56 178.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 22.5 m -109.67 89.53 3.04 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-N 115.251 -0.886 . . . . 0.0 108.655 175.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 88.2 t80 -114.45 124.68 52.53 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.513 0.725 . . . . 0.0 109.697 177.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 79.58 -16.68 10.02 Favored Glycine 0 C--N 1.347 1.173 0 CA-C-N 116.054 -0.521 . . . . 0.0 113.023 -179.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . 0.44 ' HB3' ' H ' ' A' ' 250' ' ' TYR . 41.5 mt-10 -140.62 98.1 3.34 Favored 'General case' 0 C--N 1.349 0.546 0 C-N-CA 124.844 1.257 . . . . 0.0 107.773 -176.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 235' ' ' MET . . . . . . . . . . . . . 3.5 mpp? -127.4 95.12 4.17 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 -178.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 4.1 p -103.13 126.28 57.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 171.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -95.86 156.99 16.1 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.293 0.568 . . . . 0.0 111.12 -177.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 238' ' ' CYS . . . . . 0.738 ' HB3' ' HA ' ' A' ' 246' ' ' GLU . 18.5 t -110.81 153.18 25.73 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 124.442 1.097 . . . . 0.0 109.409 174.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -108.65 92.58 4.11 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 174.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -143.9 114.34 0.81 Allowed Glycine 0 CA--C 1.529 0.912 0 CA-C-O 118.08 -1.4 . . . . 0.0 111.863 175.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -54.05 -39.75 84.19 Favored 'Trans proline' 0 C--N 1.377 2.039 0 C-N-CA 123.104 2.536 . . . . 0.0 112.907 178.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -111.3 91.23 3.58 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 171.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 51.5 t -171.98 116.74 0.37 Allowed 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.208 1.003 . . . . 0.0 108.745 -175.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 23.6 pttm -89.03 -33.38 17.17 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 122.701 0.401 . . . . 0.0 110.538 176.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 245' ' ' TYR . . . . . 0.618 ' HA ' ' HB3' ' A' ' 224' ' ' TYR . 22.0 m-30 -79.28 29.92 0.22 Allowed 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.741 1.216 . . . . 0.0 112.235 179.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 246' ' ' GLU . . . . . 0.738 ' HA ' ' HB3' ' A' ' 238' ' ' CYS . 6.9 mm-40 -47.44 -45.96 26.21 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.745 0.818 . . . . 0.0 111.086 170.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 247' ' ' TRP . . . . . 0.536 ' HB2' ' HB2' ' A' ' 224' ' ' TYR . 91.8 m95 -78.59 134.72 37.18 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 121.109 0.48 . . . . 0.0 110.76 177.211 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -144.08 170.88 15.11 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 125.163 1.385 . . . . 0.0 108.424 170.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 249' ' ' HIS . . . . . 0.422 ' HD2' ' HB2' ' A' ' 252' ' ' CYS . 0.0 OUTLIER -115.52 133.98 55.51 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 174.092 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 250' ' ' TYR . . . . . 0.44 ' H ' ' HB3' ' A' ' 234' ' ' GLU . 49.9 m-85 -47.74 -57.5 5.49 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 125.354 1.462 . . . . 0.0 114.467 -168.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -69.18 -26.63 64.93 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 122.381 0.272 . . . . 0.0 111.246 -170.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 252' ' ' CYS . . . . . 0.422 ' HB2' ' HD2' ' A' ' 249' ' ' HIS . 36.1 t -68.32 -32.1 71.99 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 124.087 0.955 . . . . 0.0 111.013 177.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 17.5 m -105.24 16.84 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 C-N-CA 123.34 0.656 . . . . 0.0 110.879 175.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 17.2 m120 67.54 9.11 6.81 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 125.364 1.466 . . . . 0.0 114.13 172.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 87.0 mt -76.97 137.42 39.02 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 122.925 0.49 . . . . 0.0 109.909 173.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.74 -23.24 9.29 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.909 0.884 . . . . 0.0 109.747 176.232 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -126.44 148.83 65.65 Favored Pre-proline 0 CA--C 1.549 0.91 0 C-N-CA 124.061 0.944 . . . . 0.0 110.158 -179.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -65.59 139.52 58.75 Favored 'Trans proline' 0 C--N 1.38 2.224 0 C-N-CA 123.11 2.54 . . . . 0.0 112.404 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 259' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_exo -59.3 151.59 66.66 Favored 'Trans proline' 0 C--N 1.377 2.069 0 C-N-CA 122.705 2.27 . . . . 0.0 112.095 172.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -89.65 -21.0 22.99 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.846 0.858 . . . . 0.0 110.266 -176.07 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -147.87 -144.09 3.93 Favored Glycine 0 C--N 1.349 1.29 0 CA-C-O 119.821 -0.433 . . . . 0.0 112.332 -179.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 30.2 p -67.61 111.91 4.45 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 123.569 0.748 . . . . 0.0 111.105 -177.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 263' ' ' TRP . . . . . . . . . . . . . 32.1 t90 -93.41 116.8 29.35 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -100.51 107.01 18.61 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 123.421 0.689 . . . . 0.0 109.472 178.148 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 15.5 p -57.28 160.41 6.86 Favored Pre-proline 0 N--CA 1.487 1.384 0 C-N-CA 124.418 1.087 . . . . 0.0 111.046 177.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -33.83 -46.88 0.45 Allowed 'Trans proline' 0 C--N 1.396 3.05 0 C-N-CA 124.867 3.711 . . . . 0.0 114.834 -179.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -61.56 -50.41 72.76 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 124.823 1.249 . . . . 0.0 112.04 -177.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 268' ' ' CYS . . . . . . . . . . . . . 79.6 m -72.49 -29.11 63.35 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.851 0.86 . . . . 0.0 111.982 -175.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.02 -15.27 36.86 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 111.885 0.328 . . . . 0.0 111.885 -179.208 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 33.2 mm -88.09 -16.09 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 C-N-CA 123.337 0.655 . . . . 0.0 110.237 171.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 . . . . . 0 CA--C 1.559 1.313 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 172.52 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 66.6 tp . . . . . 0 N--CA 1.473 0.679 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 224' ' ' TYR . . . . . 0.657 ' HB3' ' HA ' ' A' ' 245' ' ' TYR . 19.2 m-85 -136.22 128.87 30.69 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.86 0.864 . . . . 0.0 109.31 -179.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 225' ' ' CYS . . . . . 0.424 ' HB2' ' O ' ' A' ' 224' ' ' TYR . 40.3 t 170.21 163.32 0.07 Allowed 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 125.64 1.576 . . . . 0.0 108.626 167.029 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -59.91 -44.93 94.01 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 122.475 0.31 . . . . 0.0 110.51 173.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 14.1 p -76.79 -12.17 59.94 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.106 0.563 . . . . 0.0 112.194 -176.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 82.3 mm-40 51.82 77.4 0.15 Allowed 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 124.519 1.128 . . . . 0.0 112.135 -172.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 72.5 ttt180 -147.56 149.52 32.73 Favored 'General case' 0 C--O 1.242 0.691 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 176.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 26.6 m -67.54 146.1 13.29 Favored 'Isoleucine or valine' 0 C--O 1.245 0.825 0 CA-C-O 121.14 0.495 . . . . 0.0 110.808 177.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 231' ' ' SER . . . . . 0.448 ' HB3' ' O ' ' A' ' 234' ' ' GLU . 50.9 m -79.43 87.14 5.07 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 172.43 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 83.1 t80 -86.25 107.87 18.13 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.453 0.701 . . . . 0.0 111.095 -173.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 73.53 -1.23 45.32 Favored Glycine 0 C--N 1.351 1.392 0 CA-C-N 115.741 -0.663 . . . . 0.0 114.191 175.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . 0.448 ' O ' ' HB3' ' A' ' 231' ' ' SER . 14.7 pt-20 -154.97 141.05 18.41 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 124.386 1.074 . . . . 0.0 108.908 -175.267 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 235' ' ' MET . . . . . 0.419 ' HB3' ' HB3' ' A' ' 231' ' ' SER . 0.0 OUTLIER -160.21 136.77 8.93 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 122.885 0.474 . . . . 0.0 110.534 174.857 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 4.2 p -117.7 124.22 72.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 173.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -87.96 127.61 35.37 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.048 0.539 . . . . 0.0 110.233 -177.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 238' ' ' CYS . . . . . . . . . . . . . 48.8 t -92.6 154.5 18.36 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.002 0.921 . . . . 0.0 110.691 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -116.59 109.74 17.63 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 169.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 240' ' ' GLY . . . . . 0.577 ' HA3' ' SG ' ' A' ' 268' ' ' CYS . . . -144.17 140.58 9.49 Favored Glycine 0 C--N 1.344 0.978 0 CA-C-O 118.786 -1.008 . . . . 0.0 113.215 172.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -57.54 -54.95 2.81 Favored 'Trans proline' 0 C--N 1.374 1.913 0 C-N-CA 122.856 2.37 . . . . 0.0 112.627 171.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -107.49 77.65 1.15 Allowed 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 176.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 34.5 t -150.85 106.25 3.36 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 -174.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 244' ' ' LYS . . . . . 0.462 ' HA ' ' HE3' ' A' ' 244' ' ' LYS . 0.4 OUTLIER -89.04 -29.36 19.5 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.307 0.643 . . . . 0.0 110.792 178.925 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 245' ' ' TYR . . . . . 0.657 ' HA ' ' HB3' ' A' ' 224' ' ' TYR . 23.5 m-85 -82.03 22.0 0.83 Allowed 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.632 0.773 . . . . 0.0 112.95 -174.329 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -46.75 -37.36 8.4 Favored 'General case' 0 N--CA 1.501 2.114 0 C-N-CA 124.72 1.208 . . . . 0.0 112.849 -171.132 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 247' ' ' TRP . . . . . . . . . . . . . 97.7 m95 -77.69 101.83 6.81 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.148 0.579 . . . . 0.0 109.771 175.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -113.98 176.37 5.07 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.357 1.063 . . . . 0.0 110.466 178.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 249' ' ' HIS . . . . . 0.509 ' CD2' ' HB2' ' A' ' 252' ' ' CYS . 0.9 OUTLIER -129.49 144.05 51.09 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.793 1.237 . . . . 0.0 109.166 174.724 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 250' ' ' TYR . . . . . 0.484 ' HB3' ' O ' ' A' ' 255' ' ' LEU . 65.8 m-85 -62.19 -38.8 90.51 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 124.494 1.118 . . . . 0.0 112.825 -169.219 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -60.72 -36.84 79.83 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 124.252 1.021 . . . . 0.0 111.452 -176.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 252' ' ' CYS . . . . . 0.509 ' HB2' ' CD2' ' A' ' 249' ' ' HIS . 0.5 OUTLIER -64.62 -42.27 95.61 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.346 1.058 . . . . 0.0 110.456 -177.037 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 34.0 m -100.07 5.89 9.78 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 CA-C-N 114.777 -1.101 . . . . 0.0 111.309 -173.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 17.3 m120 66.33 13.17 9.07 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 125.054 1.342 . . . . 0.0 113.288 172.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.484 ' O ' ' HB3' ' A' ' 250' ' ' TYR . 92.3 mt -80.68 125.41 30.0 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 175.318 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -89.33 -23.5 22.23 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 172.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -134.08 150.97 75.73 Favored Pre-proline 0 CA--C 1.55 0.954 0 C-N-CA 124.589 1.156 . . . . 0.0 108.746 179.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 258' ' ' PRO . . . . . 0.429 ' HA ' ' HD3' ' A' ' 259' ' ' PRO . 45.6 Cg_endo -67.28 143.29 63.7 Favored 'Trans proline' 0 C--N 1.375 1.937 0 C-N-CA 122.318 2.012 . . . . 0.0 110.772 172.511 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 259' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 258' ' ' PRO . 40.6 Cg_exo -60.65 163.89 14.68 Favored 'Trans proline' 0 C--N 1.374 1.899 0 C-N-CA 123.215 2.61 . . . . 0.0 113.849 -179.194 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -63.32 -34.66 78.18 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 114.943 -1.026 . . . . 0.0 112.095 -177.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -120.21 -164.44 12.53 Favored Glycine 0 CA--C 1.523 0.579 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.702 175.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 58.9 m -65.76 125.4 25.18 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.446 0.699 . . . . 0.0 110.0 -179.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 263' ' ' TRP . . . . . . . . . . . . . 39.5 t90 -84.5 129.42 34.86 Favored 'General case' 0 C--O 1.242 0.669 0 CA-C-O 121.719 0.771 . . . . 0.0 111.053 -175.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 264' ' ' TYR . . . . . 0.419 ' O ' ' HE3' ' A' ' 269' ' ' LYS . 75.6 m-85 -111.07 126.84 55.24 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.02 1.328 . . . . 0.0 107.587 172.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 265' ' ' CYS . . . . . 0.448 ' SG ' ' HB2' ' A' ' 267' ' ' GLU . 26.4 p -67.98 161.89 63.83 Favored Pre-proline 0 CA--C 1.554 1.121 0 CA-C-O 118.661 -0.685 . . . . 0.0 109.858 175.147 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_exo -46.84 -33.26 13.81 Favored 'Trans proline' 0 C--N 1.39 2.73 0 C-N-CA 123.414 2.743 . . . . 0.0 113.469 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 267' ' ' GLU . . . . . 0.448 ' HB2' ' SG ' ' A' ' 265' ' ' CYS . 26.6 mt-10 -59.9 -58.41 8.68 Favored 'General case' 0 C--O 1.213 -0.837 0 C-N-CA 124.651 1.181 . . . . 0.0 110.054 175.536 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 268' ' ' CYS . . . . . 0.577 ' SG ' ' HA3' ' A' ' 240' ' ' GLY . 99.0 m -63.86 -27.77 69.39 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.603 0.761 . . . . 0.0 113.049 -176.27 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . 0.419 ' HE3' ' O ' ' A' ' 264' ' ' TYR . 94.2 mttt -68.87 -37.32 78.98 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 122.579 0.352 . . . . 0.0 111.059 176.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 74.1 mt -95.66 -72.06 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.814 0 C-N-CA 122.947 0.499 . . . . 0.0 109.841 179.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 . . . . . 0 C--O 1.25 1.123 0 C-N-CA 124.798 1.239 . . . . 0.0 110.315 -179.714 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 34.4 tp . . . . . 0 N--CA 1.478 0.96 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 224' ' ' TYR . . . . . 0.438 ' HB3' ' HA ' ' A' ' 245' ' ' TYR . 48.0 m-85 -143.87 141.42 30.3 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.377 0.671 . . . . 0.0 110.29 -175.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 45.3 t 170.58 158.47 0.07 Allowed 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 125.367 1.467 . . . . 0.0 109.274 164.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 35.7 t80 -65.62 -37.99 88.14 Favored 'General case' 0 CA--C 1.551 0.991 0 CA-C-N 117.804 0.275 . . . . 0.0 110.985 177.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 4.6 p -80.45 -12.04 59.61 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 122.589 0.356 . . . . 0.0 111.129 176.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 84.2 mm-40 50.01 81.15 0.06 Allowed 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 124.745 1.218 . . . . 0.0 112.077 -173.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 229' ' ' ARG . . . . . 0.464 HH22 ' HB3' ' A' ' 251' ' ' ASP . 46.7 ttp180 -135.09 149.44 50.06 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 176.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 23.6 m -67.18 147.03 12.78 Favored 'Isoleucine or valine' 0 C--O 1.241 0.635 0 C-N-CA 122.63 0.372 . . . . 0.0 111.328 174.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 40.9 m -98.81 81.71 2.68 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 174.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -86.86 99.95 12.2 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.589 0.756 . . . . 0.0 109.768 -176.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 76.97 -0.09 67.67 Favored Glycine 0 N--CA 1.474 1.178 0 CA-C-N 116.232 -0.44 . . . . 0.0 113.823 178.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -135.35 72.71 1.45 Allowed 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.122 0.969 . . . . 0.0 109.571 -178.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 235' ' ' MET . . . . . . . . . . . . . 3.4 mpp? -105.76 108.46 19.99 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.285 -176.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 5.6 p -111.6 124.17 68.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 171.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -99.9 131.04 46.11 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 123.273 0.629 . . . . 0.0 109.732 -179.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 238' ' ' CYS . . . . . . . . . . . . . 18.1 t -81.66 143.25 32.04 Favored 'General case' 0 C--O 1.223 -0.3 0 C-N-CA 123.873 0.869 . . . . 0.0 110.58 179.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -97.39 93.79 6.68 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 166.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -142.56 112.92 0.76 Allowed Glycine 0 CA--C 1.521 0.442 0 CA-C-O 118.34 -1.255 . . . . 0.0 110.445 174.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -67.22 -24.43 44.08 Favored 'Trans proline' 0 C--N 1.366 1.492 0 CA-C-N 120.112 1.956 . . . . 0.0 111.38 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 15.3 p-10 -110.81 70.81 0.73 Allowed 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.408 1.483 . . . . 0.0 108.821 176.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 39.0 t -167.4 107.08 0.58 Allowed 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.308 -169.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? -77.1 -36.15 55.87 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.037 0.535 . . . . 0.0 109.808 171.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 245' ' ' TYR . . . . . 0.438 ' HA ' ' HB3' ' A' ' 224' ' ' TYR . 12.2 m-85 -79.62 24.77 0.36 Allowed 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 -171.272 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -45.98 -43.5 14.21 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 124.781 1.232 . . . . 0.0 114.122 -170.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 247' ' ' TRP . . . . . . . . . . . . . 70.5 m95 -76.92 129.53 36.3 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-O 121.155 0.502 . . . . 0.0 110.884 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -140.19 174.81 10.14 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.767 1.227 . . . . 0.0 109.193 179.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 249' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -125.1 141.03 52.37 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.062 0.945 . . . . 0.0 109.971 179.346 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 39.3 m-85 -56.16 -35.06 66.76 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 125.622 1.569 . . . . 0.0 112.852 -171.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 251' ' ' ASP . . . . . 0.464 ' HB3' HH22 ' A' ' 229' ' ' ARG . 11.6 t70 -57.97 -51.18 70.7 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 124.746 1.219 . . . . 0.0 111.504 177.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 252' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -62.26 -42.44 99.33 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.832 0.853 . . . . 0.0 110.946 -176.108 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . 0.41 HG23 ' HG ' ' A' ' 255' ' ' LEU . 35.1 m -99.01 5.56 9.66 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.652 -172.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 34.6 m-80 62.95 17.93 10.46 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 125.075 1.35 . . . . 0.0 113.621 171.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.41 ' HG ' HG23 ' A' ' 253' ' ' VAL . 87.2 mt -79.62 126.01 30.35 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 177.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 83.3 mttt -99.18 -25.94 14.36 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.993 0.917 . . . . 0.0 109.399 178.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -119.82 156.41 54.08 Favored Pre-proline 0 CA--C 1.551 0.999 0 C-N-CA 125.013 1.325 . . . . 0.0 109.043 176.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -68.14 143.33 59.02 Favored 'Trans proline' 0 C--N 1.378 2.107 0 C-N-CA 122.409 2.073 . . . . 0.0 111.192 172.075 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 259' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -56.75 156.24 23.85 Favored 'Trans proline' 0 C--N 1.378 2.107 0 C-N-CA 123.163 2.576 . . . . 0.0 113.203 177.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -78.89 -7.53 58.02 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 122.889 0.476 . . . . 0.0 111.967 -179.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 178.93 -133.67 2.15 Favored Glycine 0 C--N 1.346 1.109 0 CA-C-O 119.949 -0.362 . . . . 0.0 112.565 177.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 37.1 p -63.71 106.54 1.0 Allowed 'General case' 0 C--N 1.351 0.651 0 C-N-CA 124.344 1.058 . . . . 0.0 110.356 -178.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 263' ' ' TRP . . . . . . . . . . . . . 54.7 t90 -98.48 109.4 22.16 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.493 0.717 . . . . 0.0 110.535 -174.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 264' ' ' TYR . . . . . 0.406 ' HD2' ' HB3' ' A' ' 268' ' ' CYS . 44.0 m-85 -94.65 106.23 18.2 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.312 0.645 . . . . 0.0 110.036 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 265' ' ' CYS . . . . . 0.425 ' SG ' ' OE2' ' A' ' 267' ' ' GLU . 13.5 p -64.36 157.9 68.83 Favored Pre-proline 0 CA--C 1.565 1.536 0 CA-C-O 118.05 -0.976 . . . . 0.0 109.783 176.453 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -23.67 -63.0 0.05 OUTLIER 'Trans proline' 0 C--N 1.392 2.824 1 C-N-CA 126.26 4.64 . . . . 0.0 117.981 -168.038 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 267' ' ' GLU . . . . . 0.425 ' OE2' ' SG ' ' A' ' 265' ' ' CYS . 0.0 OUTLIER -71.73 -28.11 63.46 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 122.027 -0.421 . . . . 0.0 111.731 -173.116 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 268' ' ' CYS . . . . . 0.406 ' HB3' ' HD2' ' A' ' 264' ' ' TYR . 91.1 m -68.21 -30.33 69.38 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 124.135 0.974 . . . . 0.0 112.315 179.482 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -92.75 -3.9 54.01 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 122.352 0.261 . . . . 0.0 111.595 -178.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 74.8 mt -106.51 -47.43 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 C-N-CA 124.032 0.933 . . . . 0.0 109.899 177.076 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 . . . . . 0 CA--C 1.563 1.448 0 C-N-CA 125.372 1.469 . . . . 0.0 108.997 -176.347 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 55.5 tp . . . . . 0 N--CA 1.479 1.003 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 224' ' ' TYR . . . . . 0.708 ' HB3' ' HA ' ' A' ' 245' ' ' TYR . 39.6 m-85 -137.63 126.1 23.48 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.768 0.827 . . . . 0.0 109.417 -178.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 225' ' ' CYS . . . . . 0.402 ' HB2' ' O ' ' A' ' 224' ' ' TYR . 39.0 t 172.47 162.86 0.12 Allowed 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 125.11 1.364 . . . . 0.0 109.294 169.294 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 56.1 t80 -69.01 -35.48 76.72 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 122.736 0.414 . . . . 0.0 111.383 177.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 13.5 p -82.79 -13.22 56.66 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 122.58 0.352 . . . . 0.0 111.434 178.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 83.8 mm-40 54.99 85.58 0.06 Allowed 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.501 1.12 . . . . 0.0 112.02 -172.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 42.0 ttp180 -150.77 150.64 31.26 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 115.064 -0.971 . . . . 0.0 108.439 174.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 32.9 m -76.17 152.98 5.99 Favored 'Isoleucine or valine' 0 C--O 1.242 0.665 0 CA-C-O 121.334 0.587 . . . . 0.0 110.974 178.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 231' ' ' SER . . . . . 0.489 ' HB2' ' HG2' ' A' ' 235' ' ' MET . 14.9 m -101.74 101.48 11.98 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.128 0.971 . . . . 0.0 108.445 175.099 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -72.48 81.05 1.06 Allowed 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.776 0.83 . . . . 0.0 109.661 -177.055 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 74.16 -18.39 2.07 Favored Glycine 0 CA--C 1.537 1.437 0 CA-C-N 115.193 -0.912 . . . . 0.0 114.366 -179.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -98.28 66.51 1.77 Allowed 'General case' 0 C--O 1.243 0.743 0 C-N-CA 123.75 0.82 . . . . 0.0 109.62 -176.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 235' ' ' MET . . . . . 0.489 ' HG2' ' HB2' ' A' ' 231' ' ' SER . 60.0 mtm -94.26 120.2 34.15 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 114.804 -1.089 . . . . 0.0 109.822 -178.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . 0.526 HG11 HG21 ' A' ' 253' ' ' VAL . 3.3 p -106.1 124.21 61.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 168.567 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -90.71 155.78 18.57 Favored 'General case' 0 C--O 1.242 0.706 0 C-N-CA 123.148 0.579 . . . . 0.0 110.077 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 238' ' ' CYS . . . . . 0.426 ' HB3' ' HA ' ' A' ' 246' ' ' GLU . 35.6 t -127.69 113.97 16.71 Favored 'General case' 0 C--O 1.243 0.735 0 C-N-CA 123.284 0.634 . . . . 0.0 110.069 -178.479 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -73.01 94.46 1.88 Allowed 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 173.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -143.68 133.05 5.2 Favored Glycine 0 C--N 1.346 1.11 0 CA-C-O 117.898 -1.501 . . . . 0.0 110.843 175.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -64.32 -46.04 8.45 Favored 'Trans proline' 0 C--N 1.377 2.051 0 C-N-CA 122.575 2.183 . . . . 0.0 111.352 -178.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 21.4 m120 -101.86 92.2 4.71 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 170.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 9.0 t -159.12 90.63 0.98 Allowed 'General case' 0 C--O 1.24 0.601 0 C-N-CA 122.984 0.514 . . . . 0.0 110.172 179.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 4.9 tppp? -65.87 -42.36 90.45 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-O 121.687 0.755 . . . . 0.0 109.95 173.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 245' ' ' TYR . . . . . 0.708 ' HA ' ' HB3' ' A' ' 224' ' ' TYR . 23.7 m-85 -84.09 24.6 0.91 Allowed 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 114.435 -1.257 . . . . 0.0 112.224 -177.646 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 246' ' ' GLU . . . . . 0.426 ' HA ' ' HB3' ' A' ' 238' ' ' CYS . 16.2 pt-20 -47.97 -33.75 8.26 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 124.537 1.135 . . . . 0.0 112.203 -179.562 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 247' ' ' TRP . . . . . . . . . . . . . 99.3 m95 -87.37 123.07 31.93 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.339 0.655 . . . . 0.0 110.016 172.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 49.8 m-85 -131.94 175.89 8.83 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.256 1.422 . . . . 0.0 109.23 176.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 249' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -110.94 144.5 39.91 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.093 0.957 . . . . 0.0 109.046 171.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 250' ' ' TYR . . . . . 0.481 ' HA ' HG22 ' A' ' 253' ' ' VAL . 74.8 m-85 -56.7 -27.06 58.29 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 124.652 1.181 . . . . 0.0 111.854 178.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -53.76 -59.37 4.7 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.861 1.264 . . . . 0.0 111.5 172.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 252' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -65.1 -35.11 80.08 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.789 0.836 . . . . 0.0 111.491 -175.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . 0.526 HG21 HG11 ' A' ' 236' ' ' VAL . 11.9 m -97.2 2.76 10.23 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.715 -172.232 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 64.7 t30 64.75 16.85 10.66 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 124.699 1.2 . . . . 0.0 112.455 168.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 88.6 mt -83.73 116.1 22.52 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 -177.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 46.4 mmtm -76.14 -8.41 56.95 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.719 0.808 . . . . 0.0 111.65 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -156.55 166.37 16.67 Favored Pre-proline 0 CA--C 1.556 1.176 0 C-N-CA 124.884 1.273 . . . . 0.0 108.983 -173.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -52.31 147.45 28.55 Favored 'Trans proline' 0 C--N 1.382 2.337 0 C-N-CA 122.717 2.278 . . . . 0.0 112.298 171.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 259' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -58.69 172.92 1.31 Allowed 'Trans proline' 0 C--N 1.381 2.253 0 C-N-CA 123.137 2.558 . . . . 0.0 113.991 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp -101.1 22.02 12.97 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.743 0.817 . . . . 0.0 111.506 -175.157 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 154.12 -156.29 26.73 Favored Glycine 0 C--N 1.349 1.276 0 N-CA-C 111.242 -0.743 . . . . 0.0 111.242 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 13.6 p -64.32 106.3 1.08 Allowed 'General case' 0 C--N 1.355 0.825 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 170.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 263' ' ' TRP . . . . . . . . . . . . . 80.4 t90 -85.94 126.48 34.13 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.012 -173.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 -106.32 128.24 53.85 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 173.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 23.4 p -75.09 152.4 86.32 Favored Pre-proline 0 N--CA 1.48 1.067 0 CA-C-O 117.832 -1.08 . . . . 0.0 108.443 173.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_exo -31.85 -63.38 0.12 Allowed 'Trans proline' 0 C--N 1.393 2.885 0 C-N-CA 125.238 3.959 . . . . 0.0 116.434 -169.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -57.68 -33.3 68.2 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 124.873 1.269 . . . . 0.0 113.603 -179.29 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 268' ' ' CYS . . . . . . . . . . . . . 89.5 m -70.07 -41.5 74.02 Favored 'General case' 0 N--CA 1.5 2.041 0 C-N-CA 122.807 0.443 . . . . 0.0 111.347 172.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -70.45 -32.92 70.68 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.578 -175.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 76.1 mt -81.35 -51.82 14.82 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 C-N-CA 123.635 0.774 . . . . 0.0 109.53 177.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 . . . . . 0 CA--C 1.554 1.121 0 C-N-CA 124.412 1.085 . . . . 0.0 108.896 -176.367 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 53.4 tp . . . . . 0 C--O 1.238 0.491 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 224' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -140.35 122.86 16.12 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 177.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 49.5 t 172.96 161.32 0.12 Allowed 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.652 1.181 . . . . 0.0 109.538 175.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -66.0 -37.96 87.25 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 122.71 0.404 . . . . 0.0 110.583 175.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 5.4 p -81.84 -4.24 56.0 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 111.634 0.235 . . . . 0.0 111.634 174.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 78.4 mm-40 52.37 81.71 0.08 Allowed 'General case' 0 C--N 1.36 1.041 0 C-N-CA 125.205 1.402 . . . . 0.0 112.549 -175.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 229' ' ' ARG . . . . . 0.446 ' HB2' ' CE1' ' A' ' 249' ' ' HIS . 33.1 mmt180 -138.17 155.71 48.44 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.161 0.984 . . . . 0.0 109.343 175.115 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 27.7 m -83.56 -178.59 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.644 177.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 41.8 t -80.6 94.07 6.23 Favored 'General case' 0 CA--C 1.553 1.061 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.196 176.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -101.98 92.21 4.69 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.394 0.678 . . . . 0.0 109.479 179.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 73.88 -7.01 16.52 Favored Glycine 0 C--N 1.35 1.318 0 N-CA-C 114.44 0.536 . . . . 0.0 114.44 175.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -154.6 142.88 20.44 Favored 'General case' 0 C--O 1.242 0.674 0 C-N-CA 124.132 0.973 . . . . 0.0 109.456 -175.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 235' ' ' MET . . . . . . . . . . . . . 25.4 ptt? -158.14 128.43 6.15 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.262 0.625 . . . . 0.0 110.204 175.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 3.3 p -115.11 124.34 71.64 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.767 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 173.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -89.8 156.54 18.44 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.361 0.664 . . . . 0.0 110.332 -179.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 238' ' ' CYS . . . . . 0.62 ' HB3' ' HA ' ' A' ' 246' ' ' GLU . 13.1 t -125.71 149.47 48.48 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.458 0.703 . . . . 0.0 111.543 -173.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -121.01 104.23 9.64 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.221 1.009 . . . . 0.0 109.043 176.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -141.99 162.57 27.11 Favored Glycine 0 C--O 1.244 0.719 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 174.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -61.69 -52.97 2.52 Favored 'Trans proline' 0 C--N 1.371 1.735 0 C-N-CA 122.033 1.822 . . . . 0.0 111.856 174.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 37.8 t30 -116.38 118.23 32.15 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 178.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 18.7 t -167.94 107.51 0.54 Allowed 'General case' 0 N--CA 1.47 0.556 0 O-C-N 123.167 0.292 . . . . 0.0 111.289 -175.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 14.9 ptpt -86.85 -26.99 23.74 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 165.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -83.17 28.95 0.5 Allowed 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.318 1.447 . . . . 0.0 112.683 179.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 246' ' ' GLU . . . . . 0.62 ' HA ' ' HB3' ' A' ' 238' ' ' CYS . 41.3 mt-10 -50.11 -37.3 33.46 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.675 0.79 . . . . 0.0 111.72 176.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 247' ' ' TRP . . . . . . . . . . . . . 84.7 m95 -96.85 134.13 40.57 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.566 -178.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -144.09 176.29 9.41 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.502 1.521 . . . . 0.0 108.939 175.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 249' ' ' HIS . . . . . 0.446 ' CE1' ' HB2' ' A' ' 229' ' ' ARG . 0.2 OUTLIER -119.56 147.44 44.48 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 171.357 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 250' ' ' TYR . . . . . 0.419 ' HB3' ' O ' ' A' ' 255' ' ' LEU . 20.1 m-85 -62.26 -33.93 75.57 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.026 1.33 . . . . 0.0 112.214 -168.494 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -59.85 -43.91 94.4 Favored 'General case' 0 N--CA 1.476 0.826 0 O-C-N 123.971 0.794 . . . . 0.0 111.31 179.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 252' ' ' CYS . . . . . . . . . . . . . 1.3 m -70.15 -38.34 75.45 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.577 -177.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 35.5 m -99.7 8.78 8.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 122.803 0.441 . . . . 0.0 111.794 -175.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 59.97 22.96 12.06 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 124.894 1.278 . . . . 0.0 113.234 170.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.419 ' O ' ' HB3' ' A' ' 250' ' ' TYR . 93.1 mt -84.3 110.35 18.51 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 174.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -70.25 -33.2 71.34 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 121.44 0.638 . . . . 0.0 109.93 175.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -132.04 159.62 71.32 Favored Pre-proline 0 CA--C 1.555 1.169 0 C-N-CA 124.402 1.081 . . . . 0.0 109.39 -176.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 258' ' ' PRO . . . . . 0.412 ' HA ' ' HD3' ' A' ' 259' ' ' PRO . 26.5 Cg_endo -59.94 148.49 88.57 Favored 'Trans proline' 0 C--N 1.384 2.41 0 C-N-CA 122.813 2.342 . . . . 0.0 112.787 178.617 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 259' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 258' ' ' PRO . 42.0 Cg_exo -58.79 167.83 4.93 Favored 'Trans proline' 0 C--N 1.385 2.5 0 C-N-CA 123.591 2.861 . . . . 0.0 113.727 -178.246 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -100.54 18.01 20.26 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.343 0.657 . . . . 0.0 111.34 -177.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 158.3 -143.9 9.86 Favored Glycine 0 C--N 1.348 1.232 0 N-CA-C 112.169 -0.373 . . . . 0.0 112.169 176.205 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 32.8 p -66.12 107.78 2.04 Favored 'General case' 0 C--N 1.35 0.596 0 C-N-CA 123.679 0.792 . . . . 0.0 110.018 178.162 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 263' ' ' TRP . . . . . . . . . . . . . 55.3 t90 -95.0 122.22 37.43 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.775 0.83 . . . . 0.0 110.676 -170.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -96.88 106.21 18.48 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.15 0.58 . . . . 0.0 109.747 177.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 265' ' ' CYS . . . . . 0.434 ' SG ' ' OE2' ' A' ' 267' ' ' GLU . 13.1 p -70.42 160.17 82.23 Favored Pre-proline 0 CA--C 1.553 1.059 0 CA-C-O 117.861 -1.066 . . . . 0.0 110.109 177.421 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 266' ' ' PRO . . . . . 0.404 ' HD2' ' HB2' ' A' ' 265' ' ' CYS . 6.1 Cg_exo -19.09 -70.11 0.02 OUTLIER 'Trans proline' 0 C--N 1.392 2.866 1 C-N-CA 126.388 4.725 . . . . 0.0 117.536 -174.224 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 267' ' ' GLU . . . . . 0.434 ' OE2' ' SG ' ' A' ' 265' ' ' CYS . 0.0 OUTLIER -68.06 -30.25 69.41 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -173.31 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 268' ' ' CYS . . . . . . . . . . . . . 75.0 m -70.54 -38.3 74.18 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.569 0.748 . . . . 0.0 111.071 175.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -71.95 -41.5 67.71 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.402 -175.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 23.6 pt -86.68 1.08 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.611 -177.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 . . . . . 0 C--O 1.249 1.043 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 174.287 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 31.5 tp . . . . . 0 CA--C 1.543 0.709 0 CA-C-O 120.727 0.298 . . . . 0.0 110.353 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 224' ' ' TYR . . . . . 0.422 ' HB3' ' HA ' ' A' ' 245' ' ' TYR . 75.0 m-85 -141.69 129.77 22.07 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 174.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 225' ' ' CYS . . . . . 0.402 ' HB2' ' O ' ' A' ' 224' ' ' TYR . 35.6 t 172.2 153.13 0.07 Allowed 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 125.029 1.332 . . . . 0.0 108.447 169.658 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 80.1 t80 -63.44 -35.11 79.36 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 122.826 0.45 . . . . 0.0 111.786 -178.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 13.7 p -79.18 -16.48 56.52 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 122.531 0.333 . . . . 0.0 111.283 179.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 85.0 mm-40 54.09 80.55 0.11 Allowed 'General case' 0 C--N 1.362 1.151 0 C-N-CA 124.701 1.2 . . . . 0.0 111.543 -171.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 229' ' ' ARG . . . . . 0.462 ' HD3' ' O ' ' A' ' 230' ' ' VAL . 4.5 tmt_? -150.02 148.76 29.42 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 -178.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . 0.462 ' O ' ' HD3' ' A' ' 229' ' ' ARG . 33.4 m -73.33 178.63 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 N-CA-C 112.759 0.652 . . . . 0.0 112.759 -172.009 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 19.6 m -139.22 49.11 1.85 Allowed 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 123.323 0.649 . . . . 0.0 109.54 -176.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 20.0 p90 -65.93 119.37 11.19 Favored 'General case' 0 CA--C 1.551 1.002 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.557 -173.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 77.18 -22.9 2.34 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 124.479 1.037 . . . . 0.0 115.327 178.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 61.7 mm-40 -143.62 99.78 3.48 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.047 0.939 . . . . 0.0 109.861 -178.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 235' ' ' MET . . . . . . . . . . . . . 18.5 ptp -122.91 132.27 54.1 Favored 'General case' 0 C--O 1.242 0.709 0 C-N-CA 124.457 1.103 . . . . 0.0 109.423 172.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 4.0 p -100.69 124.19 54.12 Favored 'Isoleucine or valine' 0 C--O 1.24 0.572 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 171.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -92.17 133.06 36.14 Favored 'General case' 0 C--O 1.242 0.663 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.048 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 238' ' ' CYS . . . . . 0.572 ' SG ' ' HA ' ' A' ' 264' ' ' TYR . 40.9 t -108.26 102.49 11.61 Favored 'General case' 0 C--O 1.243 0.719 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 176.438 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 239' ' ' ASP . . . . . 0.425 ' HB3' HG23 ' A' ' 262' ' ' THR . 30.2 t70 -82.37 94.32 7.36 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 240' ' ' GLY . . . . . 0.433 ' HA3' ' SG ' ' A' ' 268' ' ' CYS . . . -128.07 141.48 12.64 Favored Glycine 0 CA--C 1.527 0.811 0 CA-C-O 118.186 -1.341 . . . . 0.0 110.489 175.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -52.97 -42.74 62.23 Favored 'Trans proline' 0 C--N 1.379 2.145 0 C-N-CA 123.208 2.605 . . . . 0.0 112.166 -179.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -115.94 112.62 22.14 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.554 1.142 . . . . 0.0 108.02 171.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 243' ' ' CYS . . . . . 0.553 ' SG ' ' HA ' ' A' ' 246' ' ' GLU . 8.0 t -168.75 81.15 0.14 Allowed 'General case' 0 C--N 1.352 0.681 0 CA-C-O 121.496 0.665 . . . . 0.0 110.4 -175.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.5 -29.4 68.82 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 123.778 0.831 . . . . 0.0 112.574 178.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 245' ' ' TYR . . . . . 0.422 ' HA ' ' HB3' ' A' ' 224' ' ' TYR . 41.9 m-85 -101.75 24.59 9.65 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.86 0.864 . . . . 0.0 111.458 179.58 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 246' ' ' GLU . . . . . 0.553 ' HA ' ' SG ' ' A' ' 243' ' ' CYS . 14.8 pt-20 -47.21 -37.46 10.35 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 125.049 1.34 . . . . 0.0 114.235 -170.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 247' ' ' TRP . . . . . . . . . . . . . 99.0 m95 -80.01 122.17 26.4 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.102 0.561 . . . . 0.0 109.726 176.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -129.21 173.88 10.09 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.039 0.936 . . . . 0.0 109.713 178.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 249' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -124.04 152.52 42.53 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.395 1.078 . . . . 0.0 108.728 173.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -62.87 -27.15 69.15 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.687 1.195 . . . . 0.0 110.818 -173.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -61.2 -47.32 86.66 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.985 1.314 . . . . 0.0 110.947 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 252' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -71.27 -43.38 67.29 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 114.563 -1.199 . . . . 0.0 111.421 -176.106 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . 0.557 HG23 ' HG ' ' A' ' 255' ' ' LEU . 35.6 m -100.02 6.59 9.46 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.806 -172.32 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 12.0 m120 60.75 31.62 20.12 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 124.771 1.229 . . . . 0.0 113.102 171.1 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.557 ' HG ' HG23 ' A' ' 253' ' ' VAL . 70.4 mt -79.22 116.21 19.34 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 176.56 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 50.9 tttp -70.59 -42.62 70.79 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.954 0.902 . . . . 0.0 109.591 174.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -126.7 157.16 72.12 Favored Pre-proline 0 C--O 1.248 0.998 0 CA-C-N 114.49 -1.232 . . . . 0.0 109.788 -176.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -56.93 146.09 81.4 Favored 'Trans proline' 0 C--N 1.378 2.104 0 C-N-CA 122.912 2.408 . . . . 0.0 112.712 171.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 259' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -67.08 148.65 81.66 Favored 'Trans proline' 0 C--N 1.372 1.787 0 C-N-CA 122.255 1.97 . . . . 0.0 111.442 172.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 85.4 mttt -87.86 -32.2 19.13 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.877 0.871 . . . . 0.0 110.299 -179.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -120.03 -171.21 14.56 Favored Glycine 0 C--N 1.345 1.055 0 CA-C-N 115.339 -0.846 . . . . 0.0 112.086 -178.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 262' ' ' THR . . . . . 0.425 HG23 ' HB3' ' A' ' 239' ' ' ASP . 76.9 m -62.95 109.81 1.58 Allowed 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.978 0.911 . . . . 0.0 109.92 179.043 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 263' ' ' TRP . . . . . . . . . . . . . 59.0 t90 -82.2 145.54 30.01 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.018 0.527 . . . . 0.0 110.005 -176.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 264' ' ' TYR . . . . . 0.572 ' HA ' ' SG ' ' A' ' 238' ' ' CYS . 98.6 m-85 -129.78 152.55 49.16 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.898 0.879 . . . . 0.0 110.339 -178.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 15.3 p -114.55 162.16 24.95 Favored Pre-proline 0 N--CA 1.482 1.136 0 CA-C-O 117.701 -1.142 . . . . 0.0 107.959 175.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -30.12 -65.44 0.08 OUTLIER 'Trans proline' 0 C--N 1.391 2.812 0 C-N-CA 125.151 3.901 . . . . 0.0 117.342 -175.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 267' ' ' GLU . . . . . 0.4 ' H ' ' HG3' ' A' ' 267' ' ' GLU . 0.0 OUTLIER -66.2 -12.4 55.83 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 -172.773 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 268' ' ' CYS . . . . . 0.433 ' SG ' ' HA3' ' A' ' 240' ' ' GLY . 74.7 m -88.46 -42.2 12.29 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.669 0.788 . . . . 0.0 112.596 169.422 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . 0.564 ' HG3' HG23 ' A' ' 270' ' ' ILE . 14.7 ptmm? -97.67 -50.4 4.48 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 114.158 1.17 . . . . 0.0 114.158 -162.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 270' ' ' ILE . . . . . 0.564 HG23 ' HG3' ' A' ' 269' ' ' LYS . 19.2 pt -88.9 21.21 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -169.292 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 . . . . . 0 C--O 1.25 1.118 0 C-N-CA 123.805 0.842 . . . . 0.0 109.71 179.051 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 44.1 tp . . . . . 0 N--CA 1.475 0.821 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 224' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -142.13 142.95 32.8 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.012 0.925 . . . . 0.0 109.427 -175.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 45.5 t 171.8 163.84 0.1 Allowed 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 125.469 1.508 . . . . 0.0 108.352 173.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 41.4 t80 -66.78 -31.23 71.73 Favored 'General case' 0 CA--C 1.557 1.221 0 CA-C-N 118.668 0.667 . . . . 0.0 110.302 175.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 227' ' ' CYS . . . . . 0.543 ' SG ' ' HB2' ' A' ' 229' ' ' ARG . 4.6 p -89.49 -3.83 58.2 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 122.919 0.487 . . . . 0.0 111.444 174.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 81.4 mm-40 46.45 81.86 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 125.023 1.329 . . . . 0.0 111.817 -175.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 229' ' ' ARG . . . . . 0.543 ' HB2' ' SG ' ' A' ' 227' ' ' CYS . 1.0 OUTLIER -150.02 158.03 43.75 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 -171.504 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 27.2 m -71.83 150.53 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 O-C-N 123.524 0.515 . . . . 0.0 111.464 178.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 231' ' ' SER . . . . . 0.433 ' HB2' ' HG2' ' A' ' 235' ' ' MET . 20.5 m -100.86 77.72 1.88 Allowed 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 175.512 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 82.5 t80 -71.67 101.11 2.46 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.423 0.689 . . . . 0.0 110.642 -174.243 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 80.66 -19.24 7.51 Favored Glycine 0 C--N 1.344 1.014 0 CA-C-N 115.513 -0.767 . . . . 0.0 114.247 175.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . 0.419 ' HB3' ' CD1' ' A' ' 250' ' ' TYR . 59.3 mm-40 -128.03 94.98 4.06 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.127 0.971 . . . . 0.0 109.351 -175.304 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 235' ' ' MET . . . . . 0.433 ' HG2' ' HB2' ' A' ' 231' ' ' SER . 44.7 mtt -118.2 97.76 5.95 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.357 0.663 . . . . 0.0 110.108 -174.537 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . 0.421 HG11 HG21 ' A' ' 253' ' ' VAL . 7.4 p -92.56 124.54 45.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 171.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -99.47 141.07 32.74 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 123.884 0.874 . . . . 0.0 109.853 179.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 238' ' ' CYS . . . . . 0.663 ' HB3' ' HA ' ' A' ' 246' ' ' GLU . 5.5 t -105.36 114.48 28.69 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 123.864 0.866 . . . . 0.0 109.785 179.571 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -72.6 95.63 1.86 Allowed 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.096 0.558 . . . . 0.0 109.516 176.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -139.06 116.48 1.25 Allowed Glycine 0 CA--C 1.53 0.988 0 CA-C-O 118.711 -1.049 . . . . 0.0 111.282 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -60.03 -29.08 88.45 Favored 'Trans proline' 0 C--N 1.377 2.055 0 C-N-CA 123.382 2.721 . . . . 0.0 112.621 178.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -120.35 88.71 2.99 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 171.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 42.1 t -172.17 112.15 0.28 Allowed 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.485 0.714 . . . . 0.0 110.456 -172.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 20.8 pttm -89.25 -25.01 21.95 Favored 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 167.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -79.33 27.47 0.26 Allowed 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 124.83 1.252 . . . . 0.0 112.527 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 246' ' ' GLU . . . . . 0.663 ' HA ' ' HB3' ' A' ' 238' ' ' CYS . 41.1 mt-10 -53.35 -46.55 69.57 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.163 0.585 . . . . 0.0 110.601 172.191 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 247' ' ' TRP . . . . . . . . . . . . . 97.8 m95 -72.42 122.18 20.8 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.366 179.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -142.38 171.32 14.21 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 125.206 1.402 . . . . 0.0 109.174 170.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 249' ' ' HIS . . . . . 0.419 ' HB3' ' HA ' ' A' ' 231' ' ' SER . 0.1 OUTLIER -123.12 142.42 50.91 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.249 1.019 . . . . 0.0 108.859 178.804 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 250' ' ' TYR . . . . . 0.419 ' CD1' ' HB3' ' A' ' 234' ' ' GLU . 8.8 m-85 -58.49 -26.69 63.72 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 124.98 1.312 . . . . 0.0 112.128 -174.087 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -59.46 -56.64 19.45 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.013 0.925 . . . . 0.0 110.833 174.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 252' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -61.39 -49.15 78.07 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.968 0.907 . . . . 0.0 111.595 -178.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . 0.479 HG23 ' HG ' ' A' ' 255' ' ' LEU . 26.8 m -88.64 5.32 4.41 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.909 -174.213 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 44.8 m-80 64.39 16.01 9.89 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 125.006 1.322 . . . . 0.0 113.415 169.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.479 ' HG ' HG23 ' A' ' 253' ' ' VAL . 89.8 mt -74.24 108.02 6.77 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 122.891 0.476 . . . . 0.0 109.868 -176.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 62.1 mttm -72.15 -25.62 61.78 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.973 0.909 . . . . 0.0 110.326 176.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -131.59 159.69 70.71 Favored Pre-proline 0 CA--C 1.552 1.039 0 C-N-CA 124.619 1.167 . . . . 0.0 109.337 -177.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.31 140.64 44.88 Favored 'Trans proline' 0 C--N 1.369 1.625 0 C-N-CA 122.325 2.017 . . . . 0.0 111.78 169.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 259' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -61.66 158.49 36.96 Favored 'Trans proline' 0 C--N 1.38 2.211 0 C-N-CA 122.47 2.113 . . . . 0.0 111.542 169.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 31.6 mmmt -93.37 -2.15 55.08 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 112.724 0.638 . . . . 0.0 112.724 -175.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -164.53 -147.38 5.09 Favored Glycine 0 C--N 1.345 1.05 0 N-CA-C 112.213 -0.355 . . . . 0.0 112.213 -178.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 54.7 p -64.21 107.8 1.4 Allowed 'General case' 0 C--N 1.352 0.699 0 C-N-CA 123.401 0.681 . . . . 0.0 110.552 178.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 263' ' ' TRP . . . . . . . . . . . . . 63.3 t90 -87.45 144.78 26.57 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 176.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 264' ' ' TYR . . . . . 0.438 ' HA ' ' SG ' ' A' ' 238' ' ' CYS . 95.1 m-85 -126.14 129.39 48.97 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.433 0.693 . . . . 0.0 109.654 -178.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 16.7 p -85.76 156.12 58.58 Favored Pre-proline 0 CA--C 1.555 1.163 0 CA-C-O 118.47 -0.776 . . . . 0.0 109.248 177.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 0.8 OUTLIER -23.7 -64.88 0.04 OUTLIER 'Trans proline' 0 C--N 1.392 2.845 1 C-N-CA 126.314 4.676 . . . . 0.0 118.098 -168.456 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.02 -32.18 73.23 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 122.574 0.35 . . . . 0.0 111.565 -171.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 268' ' ' CYS . . . . . . . . . . . . . 58.6 m -72.31 -38.59 68.68 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.763 0.825 . . . . 0.0 110.601 176.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 61.5 tttp -71.78 -34.31 69.32 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 115.042 -0.981 . . . . 0.0 111.294 -173.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 25.7 pt -90.0 -9.88 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 123.106 0.563 . . . . 0.0 111.408 -179.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 . . . . . 0 C--O 1.25 1.097 0 C-N-CA 123.739 0.815 . . . . 0.0 110.132 -177.586 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 51.3 tp . . . . . 0 N--CA 1.473 0.684 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 224' ' ' TYR . . . . . 0.426 ' HB3' ' HA ' ' A' ' 245' ' ' TYR . 47.4 m-85 -137.93 127.57 25.13 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.036 0.934 . . . . 0.0 109.2 178.714 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 225' ' ' CYS . . . . . 0.416 ' HB2' ' O ' ' A' ' 224' ' ' TYR . 14.0 t 174.08 158.08 0.15 Allowed 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.386 1.075 . . . . 0.0 109.953 172.174 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -64.23 -38.89 92.67 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 122.997 0.519 . . . . 0.0 111.412 175.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 9.8 p -77.54 -13.9 59.8 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.086 177.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 81.1 mm-40 52.65 66.82 1.11 Allowed 'General case' 0 C--N 1.368 1.394 0 C-N-CA 124.668 1.187 . . . . 0.0 111.688 -174.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 78.4 ttt180 -130.26 153.58 48.47 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.659 0.784 . . . . 0.0 109.41 -179.437 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 29.3 m -66.21 155.42 7.08 Favored 'Isoleucine or valine' 0 C--O 1.241 0.65 0 C-N-CA 123.38 0.672 . . . . 0.0 111.655 177.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 231' ' ' SER . . . . . 0.71 ' HB3' ' HB3' ' A' ' 235' ' ' MET . 46.2 m -105.66 69.18 0.82 Allowed 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.52 178.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 20.2 p90 -70.02 110.32 5.02 Favored 'General case' 0 CA--C 1.549 0.918 0 CA-C-N 114.353 -1.294 . . . . 0.0 111.237 -176.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 76.92 -20.69 2.86 Favored Glycine 0 N--CA 1.478 1.49 0 N-CA-C 115.204 0.842 . . . . 0.0 115.204 171.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . 0.416 ' HB3' ' HD2' ' A' ' 250' ' ' TYR . 49.3 mt-10 -142.75 127.45 18.1 Favored 'General case' 0 C--O 1.243 0.743 0 C-N-CA 124.251 1.02 . . . . 0.0 108.928 -178.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 235' ' ' MET . . . . . 0.71 ' HB3' ' HB3' ' A' ' 231' ' ' SER . 22.4 ptt? -151.91 129.57 11.54 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 123.313 0.645 . . . . 0.0 110.432 175.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 5.4 p -103.31 126.46 57.68 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 C-N-CA 123.866 0.867 . . . . 0.0 108.869 175.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -88.57 164.64 15.29 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.624 0.77 . . . . 0.0 110.281 179.1 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 238' ' ' CYS . . . . . 0.428 ' HB3' ' HA ' ' A' ' 246' ' ' GLU . 15.4 t -136.83 105.54 5.85 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.353 0.661 . . . . 0.0 109.349 179.322 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -79.99 94.96 6.0 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.791 -178.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -141.25 137.19 7.96 Favored Glycine 0 C--N 1.348 1.223 0 CA-C-O 118.678 -1.068 . . . . 0.0 111.456 178.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -60.03 -38.71 76.18 Favored 'Trans proline' 0 C--N 1.376 1.978 0 C-N-CA 123.232 2.622 . . . . 0.0 113.384 179.176 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -109.49 95.88 5.91 Favored 'General case' 0 C--O 1.243 0.739 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 175.109 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 243' ' ' CYS . . . . . 0.456 ' SG ' ' HA ' ' A' ' 246' ' ' GLU . 12.2 t -166.06 101.8 0.65 Allowed 'General case' 0 C--O 1.237 0.429 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.941 -171.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 21.7 pttm -86.16 -37.98 18.18 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 171.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 245' ' ' TYR . . . . . 0.426 ' HA ' ' HB3' ' A' ' 224' ' ' TYR . 53.9 m-85 -87.66 29.15 0.92 Allowed 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 124.29 1.036 . . . . 0.0 111.874 -179.106 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 246' ' ' GLU . . . . . 0.456 ' HA ' ' SG ' ' A' ' 243' ' ' CYS . 10.4 pt-20 -49.37 -36.57 22.03 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.087 0.955 . . . . 0.0 112.844 179.105 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 247' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -91.09 135.16 33.95 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.381 0.61 . . . . 0.0 111.043 178.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -142.8 174.09 10.96 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 125.665 1.586 . . . . 0.0 108.449 174.105 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 249' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -117.2 141.84 47.78 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.817 0.847 . . . . 0.0 108.832 174.563 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 250' ' ' TYR . . . . . 0.416 ' HD2' ' HB3' ' A' ' 234' ' ' GLU . 86.3 m-85 -57.2 -26.85 61.33 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 124.658 1.183 . . . . 0.0 112.074 -177.22 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -56.3 -58.4 8.15 Favored 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 123.861 0.864 . . . . 0.0 111.46 174.408 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 252' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -61.37 -41.94 97.91 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 124.203 1.001 . . . . 0.0 112.117 -173.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 35.8 m -92.23 -5.77 10.72 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.733 -175.161 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 10.8 t30 52.41 70.12 0.6 Allowed 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 124.611 1.164 . . . . 0.0 111.243 178.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 96.3 mt -129.92 122.87 29.42 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 178.128 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 64.2 tttp -90.64 -27.48 19.02 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 123.272 0.629 . . . . 0.0 110.166 178.377 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 16.9 mp0 -105.45 147.07 33.99 Favored Pre-proline 0 N--CA 1.477 0.903 0 C-N-CA 124.189 0.996 . . . . 0.0 109.336 178.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -74.63 117.62 5.02 Favored 'Trans proline' 0 C--N 1.373 1.831 0 C-N-CA 122.322 2.015 . . . . 0.0 110.548 170.022 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 259' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_exo -53.6 112.62 1.0 Allowed 'Trans proline' 0 C--N 1.378 2.119 0 C-N-CA 123.1 2.533 . . . . 0.0 113.397 -178.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -68.21 103.14 1.5 Allowed 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.869 0.868 . . . . 0.0 109.855 -179.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 118.3 -167.46 12.96 Favored Glycine 0 N--CA 1.472 1.034 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 -176.321 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 39.4 p -74.13 106.04 5.61 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 177.214 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 263' ' ' TRP . . . . . . . . . . . . . 52.1 t90 -73.79 134.21 43.36 Favored 'General case' 0 C--N 1.349 0.583 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 173.027 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -110.85 113.86 26.77 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 123.029 0.531 . . . . 0.0 109.777 179.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 17.4 p -64.75 160.78 51.17 Favored Pre-proline 0 CA--C 1.55 0.964 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.947 171.278 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -36.63 -38.8 0.37 Allowed 'Trans proline' 0 C--N 1.382 2.317 0 C-N-CA 124.329 3.352 . . . . 0.0 115.991 175.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -54.58 -61.73 2.12 Favored 'General case' 0 N--CA 1.485 1.32 0 CA-C-O 121.652 0.739 . . . . 0.0 110.807 176.098 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 268' ' ' CYS . . . . . . . . . . . . . 35.5 m -80.02 -30.85 39.59 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 114.493 -1.23 . . . . 0.0 111.853 -168.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -75.86 -53.08 8.99 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.7 0.8 . . . . 0.0 111.155 -173.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 270' ' ' ILE . . . . . 0.434 HG22 ' HG3' ' A' ' 271' ' ' GLU . 50.7 mm -72.16 -52.47 24.3 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.978 -176.468 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 271' ' ' GLU . . . . . 0.434 ' HG3' HG22 ' A' ' 270' ' ' ILE . 45.7 mt-10 . . . . . 0 CA--C 1.555 1.164 0 C-N-CA 123.207 0.603 . . . . 0.0 109.553 -178.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.477 0.889 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 224' ' ' TYR . . . . . 0.524 ' HB3' ' HA ' ' A' ' 245' ' ' TYR . 78.5 m-85 -133.76 130.43 38.03 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 123.855 0.862 . . . . 0.0 108.892 179.535 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 225' ' ' CYS . . . . . 0.43 ' HB2' ' O ' ' A' ' 224' ' ' TYR . 26.5 t 172.29 155.69 0.09 Allowed 'General case' 0 N--CA 1.474 0.761 0 O-C-N 124.794 1.309 . . . . 0.0 109.388 168.387 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 61.5 t80 -64.81 -27.67 69.04 Favored 'General case' 0 CA--C 1.556 1.193 0 C-N-CA 123.201 0.6 . . . . 0.0 111.214 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 13.2 p -90.57 -10.69 42.48 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 122.991 0.517 . . . . 0.0 111.442 177.078 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 83.4 mm-40 52.16 85.46 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 124.607 1.163 . . . . 0.0 111.437 -171.041 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 73.6 ttt180 -140.63 150.71 43.9 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.816 -176.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 34.3 m -69.18 170.38 1.14 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.61 0 C-N-CA 124.29 1.036 . . . . 0.0 112.754 -177.331 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 39.4 t -86.73 116.52 24.88 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 114.662 -1.154 . . . . 0.0 109.762 174.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 232' ' ' PHE . . . . . 0.603 ' HB3' ' HG2' ' A' ' 234' ' ' GLU . 91.8 t80 -75.63 -13.04 60.32 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 123.84 0.856 . . . . 0.0 109.728 166.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 109.78 -18.17 29.56 Favored Glycine 0 C--N 1.349 1.277 0 N-CA-C 111.521 -0.632 . . . . 0.0 111.521 -174.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . 0.603 ' HG2' ' HB3' ' A' ' 232' ' ' PHE . 8.5 pt-20 -77.65 64.55 2.96 Favored 'General case' 0 CA--C 1.555 1.163 0 C-N-CA 124.273 1.029 . . . . 0.0 110.129 174.683 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 235' ' ' MET . . . . . . . . . . . . . 73.2 mtm -91.61 100.96 13.6 Favored 'General case' 0 N--CA 1.475 0.801 0 O-C-N 121.823 -0.548 . . . . 0.0 110.682 -173.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 2.8 p -88.07 124.28 41.09 Favored 'Isoleucine or valine' 0 C--O 1.241 0.652 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 168.124 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -99.32 110.9 23.37 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 123.564 0.746 . . . . 0.0 110.074 -176.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 238' ' ' CYS . . . . . 0.461 ' HB3' ' HA ' ' A' ' 246' ' ' GLU . 42.3 t -71.64 153.75 41.88 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.242 169.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 239' ' ' ASP . . . . . 0.557 ' HB3' ' HB ' ' A' ' 262' ' ' THR . 23.5 t70 -134.23 95.61 3.44 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.606 0.762 . . . . 0.0 109.176 176.317 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 240' ' ' GLY . . . . . 0.556 ' HA3' ' SG ' ' A' ' 268' ' ' CYS . . . -142.05 140.71 10.26 Favored Glycine 0 CA--C 1.534 1.222 0 CA-C-O 118.442 -1.199 . . . . 0.0 111.917 175.192 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -59.44 -51.69 5.93 Favored 'Trans proline' 0 C--N 1.377 2.03 0 C-N-CA 122.746 2.297 . . . . 0.0 112.145 178.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -89.04 86.49 6.93 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 171.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 10.4 t -174.75 104.6 0.1 Allowed 'General case' 0 C--N 1.351 0.637 0 O-C-N 123.88 0.738 . . . . 0.0 109.688 -176.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -85.75 -31.93 22.13 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-O 121.842 0.83 . . . . 0.0 110.359 173.421 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 245' ' ' TYR . . . . . 0.524 ' HA ' ' HB3' ' A' ' 224' ' ' TYR . 59.7 m-85 -86.65 26.4 1.11 Allowed 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.053 1.341 . . . . 0.0 112.368 -171.126 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 246' ' ' GLU . . . . . 0.461 ' HA ' ' HB3' ' A' ' 238' ' ' CYS . 5.6 mm-40 -45.96 -42.34 12.85 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 125.105 1.362 . . . . 0.0 112.697 -174.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 247' ' ' TRP . . . . . 0.497 ' HB2' ' HB2' ' A' ' 224' ' ' TYR . 96.0 m95 -70.92 117.93 13.06 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.112 0.565 . . . . 0.0 110.262 175.331 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -131.23 173.49 10.99 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.349 1.06 . . . . 0.0 109.92 175.37 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 249' ' ' HIS . . . . . 0.582 ' HD2' ' HB2' ' A' ' 252' ' ' CYS . 0.2 OUTLIER -121.9 139.57 53.48 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.165 0.986 . . . . 0.0 109.031 175.639 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -54.63 -49.39 70.62 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 124.787 1.235 . . . . 0.0 113.063 -168.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -53.49 -40.83 65.66 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 124.127 0.971 . . . . 0.0 112.107 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 252' ' ' CYS . . . . . 0.582 ' HB2' ' HD2' ' A' ' 249' ' ' HIS . 2.8 t -66.17 -32.11 73.36 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 124.34 1.056 . . . . 0.0 111.582 -175.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 29.8 m -110.48 13.36 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 123.666 0.786 . . . . 0.0 111.362 -174.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 67.4 11.65 8.49 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 124.644 1.177 . . . . 0.0 112.398 173.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 95.0 mt -84.01 157.36 21.86 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-O 121.558 0.695 . . . . 0.0 109.337 174.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 27.0 tptp -145.86 -29.97 0.41 Allowed 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.199 0.999 . . . . 0.0 108.651 174.149 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -93.59 141.44 23.86 Favored Pre-proline 0 C--O 1.245 0.84 0 C-N-CA 124.09 0.956 . . . . 0.0 108.895 177.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -65.09 124.1 12.53 Favored 'Trans proline' 0 C--N 1.373 1.824 0 C-N-CA 122.4 2.066 . . . . 0.0 111.361 177.323 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 259' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -51.01 131.11 33.87 Favored 'Trans proline' 0 C--N 1.38 2.235 0 C-N-CA 123.455 2.77 . . . . 0.0 113.743 178.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.77 -4.79 39.69 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.023 0.929 . . . . 0.0 112.866 -175.002 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -153.25 -170.39 19.41 Favored Glycine 0 N--CA 1.471 0.989 0 N-CA-C 111.149 -0.78 . . . . 0.0 111.149 176.051 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 262' ' ' THR . . . . . 0.557 ' HB ' ' HB3' ' A' ' 239' ' ' ASP . 40.8 p -65.58 106.59 1.48 Allowed 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 175.414 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 263' ' ' TRP . . . . . . . . . . . . . 49.8 t90 -74.38 137.87 43.02 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.201 0.601 . . . . 0.0 111.238 -169.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 41.1 m-85 -114.85 109.27 17.89 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.815 0.846 . . . . 0.0 109.398 -176.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 265' ' ' CYS . . . . . 0.431 ' SG ' ' OE2' ' A' ' 267' ' ' GLU . 16.0 p -72.44 162.5 73.63 Favored Pre-proline 0 CA--C 1.559 1.302 0 C-N-CA 123.563 0.745 . . . . 0.0 110.183 176.505 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_exo -36.93 -51.83 1.37 Allowed 'Trans proline' 0 C--N 1.393 2.869 0 C-N-CA 124.511 3.474 . . . . 0.0 116.45 -178.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 267' ' ' GLU . . . . . 0.431 ' OE2' ' SG ' ' A' ' 265' ' ' CYS . 0.0 OUTLIER -72.11 -18.54 61.9 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -175.28 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 268' ' ' CYS . . . . . 0.556 ' SG ' ' HA3' ' A' ' 240' ' ' GLY . 59.2 m -82.36 -44.74 15.78 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.0 0.52 . . . . 0.0 111.542 171.291 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -82.38 -45.14 15.24 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.259 -166.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 50.9 mm -76.32 -40.18 35.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 123.604 0.761 . . . . 0.0 110.552 -176.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 23.9 mm-40 . . . . . 0 C--O 1.25 1.084 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 177.713 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 1.4 tm? . . . . . 0 N--CA 1.473 0.725 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 224' ' ' TYR . . . . . 0.477 ' HB2' ' HB2' ' A' ' 247' ' ' TRP . 68.1 m-85 -137.71 138.16 39.07 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 178.628 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 51.3 t 170.93 162.0 0.08 Allowed 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 125.662 1.585 . . . . 0.0 108.649 172.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -62.53 -40.01 95.41 Favored 'General case' 0 CA--C 1.552 1.036 0 CA-C-N 117.992 0.36 . . . . 0.0 110.808 176.406 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 9.2 p -81.49 -19.88 41.34 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 122.608 0.363 . . . . 0.0 111.195 176.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 24.2 mm-40 59.07 99.69 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 124.905 1.282 . . . . 0.0 112.288 -172.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 229' ' ' ARG . . . . . 0.446 ' HD3' ' N ' ' A' ' 230' ' ' VAL . 4.6 tmt_? -163.75 152.91 14.19 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 -173.224 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . 0.446 ' N ' ' HD3' ' A' ' 229' ' ' ARG . 30.7 m -64.52 165.84 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 C-N-CA 123.991 0.916 . . . . 0.0 112.645 -177.461 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 26.0 m -139.26 71.9 1.39 Allowed 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 123.275 0.63 . . . . 0.0 109.988 -177.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 53.2 m-85 -98.67 128.9 45.11 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.667 0.787 . . . . 0.0 110.406 178.173 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 84.25 -14.71 43.49 Favored Glycine 0 CA--C 1.535 1.321 0 O-C-N 123.212 0.32 . . . . 0.0 113.376 178.7 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -153.38 138.54 17.4 Favored 'General case' 0 C--N 1.351 0.645 0 C-N-CA 124.459 1.103 . . . . 0.0 108.83 179.124 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 235' ' ' MET . . . . . . . . . . . . . 21.1 ptp -163.11 133.13 4.37 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.232 0.613 . . . . 0.0 109.791 176.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . 0.459 HG13 ' HB2' ' A' ' 248' ' ' PHE . 2.4 p -119.0 122.96 70.63 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 171.395 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -90.61 130.48 36.63 Favored 'General case' 0 C--O 1.239 0.507 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 174.353 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 238' ' ' CYS . . . . . . . . . . . . . 18.9 t -105.89 122.59 46.43 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.88 0.872 . . . . 0.0 111.106 -172.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -71.7 113.47 8.77 Favored 'General case' 0 C--N 1.352 0.715 0 C-N-CA 123.457 0.703 . . . . 0.0 110.082 176.223 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -143.17 144.54 13.91 Favored Glycine 0 CA--C 1.525 0.7 0 CA-C-N 114.388 -1.278 . . . . 0.0 110.551 169.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -57.53 -44.39 42.48 Favored 'Trans proline' 0 C--N 1.37 1.673 0 C-N-CA 122.531 2.154 . . . . 0.0 111.034 165.019 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 36.2 t30 -127.69 115.17 18.32 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 171.131 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 243' ' ' CYS . . . . . 0.543 ' SG ' ' HA ' ' A' ' 246' ' ' GLU . 16.2 t -151.93 97.77 2.37 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 -179.292 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -74.66 -37.94 62.59 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-O 121.279 0.561 . . . . 0.0 110.106 -179.3 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -89.83 25.46 2.06 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.742 1.217 . . . . 0.0 110.743 179.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 246' ' ' GLU . . . . . 0.543 ' HA ' ' SG ' ' A' ' 243' ' ' CYS . 8.9 pt-20 -46.65 -37.66 8.6 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 125.165 1.386 . . . . 0.0 113.744 -173.423 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 247' ' ' TRP . . . . . 0.477 ' HB2' ' HB2' ' A' ' 224' ' ' TYR . 94.0 m95 -88.5 138.54 31.34 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 122.922 0.489 . . . . 0.0 109.887 175.658 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 248' ' ' PHE . . . . . 0.459 ' HB2' HG13 ' A' ' 236' ' ' VAL . 60.1 m-85 -140.36 171.81 13.63 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.387 1.075 . . . . 0.0 109.385 175.394 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 249' ' ' HIS . . . . . 0.473 ' CD2' ' HB2' ' A' ' 252' ' ' CYS . 0.1 OUTLIER -117.7 141.27 48.58 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 173.788 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -58.69 -34.73 71.62 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 124.449 1.099 . . . . 0.0 112.821 -169.237 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -63.43 -38.97 93.21 Favored 'General case' 0 N--CA 1.479 1.02 0 O-C-N 123.854 0.721 . . . . 0.0 111.22 -177.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 252' ' ' CYS . . . . . 0.473 ' HB2' ' CD2' ' A' ' 249' ' ' HIS . 0.2 OUTLIER -66.93 -49.16 66.37 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 124.643 1.177 . . . . 0.0 110.229 -174.747 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 26.9 m -92.0 2.99 7.88 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 CA-C-N 114.222 -1.354 . . . . 0.0 111.358 -174.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 16.2 m120 60.71 24.34 14.18 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 124.802 1.241 . . . . 0.0 112.781 172.393 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.463 HD13 ' HD3' ' A' ' 259' ' ' PRO . 57.2 mt -71.95 94.83 1.5 Allowed 'General case' 0 C--N 1.35 0.59 0 C-N-CA 123.482 0.713 . . . . 0.0 109.458 176.321 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 8.7 mtmp? -77.29 -21.36 53.66 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.372 170.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 12.2 mp0 -111.58 125.85 29.65 Favored Pre-proline 0 C--O 1.244 0.801 0 C-N-CA 124.715 1.206 . . . . 0.0 107.921 178.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -65.71 121.39 8.75 Favored 'Trans proline' 0 C--N 1.372 1.785 0 C-N-CA 122.072 1.848 . . . . 0.0 110.356 172.152 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 259' ' ' PRO . . . . . 0.463 ' HD3' HD13 ' A' ' 255' ' ' LEU . 26.9 Cg_endo -58.28 116.91 3.58 Favored 'Trans proline' 0 C--N 1.378 2.118 0 C-N-CA 122.869 2.379 . . . . 0.0 112.413 -173.06 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 260' ' ' LYS . . . . . 0.558 ' HD3' ' H ' ' A' ' 260' ' ' LYS . 0.0 OUTLIER -56.31 -28.84 60.15 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.764 1.226 . . . . 0.0 113.026 -178.159 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -138.79 -147.49 5.14 Favored Glycine 0 C--N 1.348 1.211 0 CA-C-O 120.139 -0.256 . . . . 0.0 112.634 -178.241 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 46.6 p -72.12 106.1 4.21 Favored 'General case' 0 C--O 1.242 0.709 0 C-N-CA 123.515 0.726 . . . . 0.0 110.339 -178.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 263' ' ' TRP . . . . . . . . . . . . . 78.8 t90 -85.74 118.64 25.37 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.488 1.115 . . . . 0.0 109.543 178.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 264' ' ' TYR . . . . . 0.4 ' HD2' ' HB3' ' A' ' 268' ' ' CYS . 21.1 m-85 -102.31 115.79 31.3 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.231 1.012 . . . . 0.0 109.655 177.35 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 29.1 p -67.32 166.29 22.18 Favored Pre-proline 0 N--CA 1.487 1.417 0 C-N-CA 124.603 1.161 . . . . 0.0 110.634 176.16 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -40.01 -49.66 3.59 Favored 'Trans proline' 0 C--N 1.393 2.87 0 C-N-CA 123.917 3.078 . . . . 0.0 113.801 172.032 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -64.39 -26.8 68.62 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.379 0.672 . . . . 0.0 111.742 -174.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 268' ' ' CYS . . . . . 0.4 ' HB3' ' HD2' ' A' ' 264' ' ' TYR . 61.4 m -85.58 -41.48 15.22 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 123.215 0.606 . . . . 0.0 111.053 175.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 23.1 ttpp -77.37 -33.58 55.23 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.46 0.704 . . . . 0.0 111.634 -167.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 18.9 pt -130.08 50.74 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 124.3 1.04 . . . . 0.0 109.072 178.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 . . . . . 0 CA--C 1.559 1.313 0 CA-C-N 114.476 -1.238 . . . . 0.0 111.452 178.742 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 1.4 tm? . . . . . 0 N--CA 1.472 0.657 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 224' ' ' TYR . . . . . 0.587 ' HB2' ' HB2' ' A' ' 247' ' ' TRP . 62.8 m-85 -143.07 130.22 20.79 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 -179.433 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 49.2 t 172.78 158.1 0.11 Allowed 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.318 1.447 . . . . 0.0 108.669 171.001 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -58.22 -46.19 86.33 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 123.102 0.561 . . . . 0.0 110.807 177.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 227' ' ' CYS . . . . . 0.41 ' SG ' ' HB3' ' A' ' 229' ' ' ARG . 14.1 p -75.21 -15.1 60.57 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 122.782 0.433 . . . . 0.0 111.861 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 83.1 mm-40 57.81 90.18 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 124.409 1.084 . . . . 0.0 110.773 -172.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 229' ' ' ARG . . . . . 0.41 ' HB3' ' SG ' ' A' ' 227' ' ' CYS . 75.4 ttt180 -165.31 153.71 11.68 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.098 -171.374 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 35.4 m -73.51 171.85 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.927 0 C-N-CA 123.639 0.776 . . . . 0.0 111.648 175.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 43.4 m -112.5 126.24 55.11 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.943 0.897 . . . . 0.0 109.177 178.173 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 52.9 t80 -91.76 81.6 5.24 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 177.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 75.57 -20.31 2.25 Favored Glycine 0 N--CA 1.474 1.206 0 CA-C-N 115.44 -0.8 . . . . 0.0 114.554 179.046 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 31.9 mm-40 -108.79 99.2 8.58 Favored 'General case' 0 C--O 1.224 -0.25 0 C-N-CA 124.18 0.992 . . . . 0.0 109.781 -176.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 235' ' ' MET . . . . . . . . . . . . . 25.7 ptt? -125.32 129.56 50.2 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.008 0.523 . . . . 0.0 109.706 177.346 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 2.6 p -124.95 125.8 70.21 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 C-N-CA 123.893 0.877 . . . . 0.0 109.346 -178.288 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -86.37 150.07 24.58 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.333 177.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 238' ' ' CYS . . . . . 0.503 ' HB3' ' HA ' ' A' ' 246' ' ' GLU . 7.9 t -110.33 149.71 29.81 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 124.568 1.147 . . . . 0.0 109.184 -178.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -103.31 95.63 6.22 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 172.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -139.55 128.45 3.97 Favored Glycine 0 C--N 1.344 1.001 0 CA-C-O 118.937 -0.924 . . . . 0.0 111.745 177.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -66.19 -36.85 27.12 Favored 'Trans proline' 0 C--N 1.372 1.794 0 C-N-CA 122.647 2.231 . . . . 0.0 111.768 171.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 41.9 t30 -120.73 104.42 9.89 Favored 'General case' 0 C--O 1.242 0.669 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 174.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 46.6 t -173.12 114.34 0.25 Allowed 'General case' 0 N--CA 1.469 0.488 0 O-C-N 123.645 0.591 . . . . 0.0 109.811 -173.478 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 54.5 tptt -83.6 -28.05 28.77 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-O 121.369 0.604 . . . . 0.0 109.399 173.086 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 20.6 m-30 -90.99 28.74 1.5 Allowed 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.18 1.392 . . . . 0.0 111.957 -175.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 246' ' ' GLU . . . . . 0.503 ' HA ' ' HB3' ' A' ' 238' ' ' CYS . 6.4 mm-40 -48.28 -33.84 9.45 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 123.551 0.74 . . . . 0.0 112.829 177.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 247' ' ' TRP . . . . . 0.587 ' HB2' ' HB2' ' A' ' 224' ' ' TYR . 96.4 m95 -94.07 136.57 34.21 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 121.399 0.619 . . . . 0.0 110.68 173.532 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -140.36 176.37 8.83 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 125.845 1.658 . . . . 0.0 108.322 174.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 249' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -126.07 143.94 50.92 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 173.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 36.5 m-85 -58.02 -34.34 69.94 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.78 0.832 . . . . 0.0 112.49 -172.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -62.44 -36.12 81.41 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.043 0.537 . . . . 0.0 111.683 179.734 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 252' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -66.69 -42.56 86.28 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.97 0.908 . . . . 0.0 110.862 -177.303 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . 0.54 HG23 ' HB2' ' A' ' 255' ' ' LEU . 15.4 m -99.18 2.34 10.52 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.325 -176.109 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 4.6 t30 55.68 32.29 19.05 Favored 'General case' 0 N--CA 1.495 1.821 0 C-N-CA 124.513 1.125 . . . . 0.0 110.777 179.051 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.54 ' HB2' HG23 ' A' ' 253' ' ' VAL . 15.7 tp -80.2 108.09 13.52 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 -178.597 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 58.5 tttm -82.77 -21.34 34.67 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.986 0.915 . . . . 0.0 111.34 -174.579 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -135.43 143.3 44.71 Favored Pre-proline 0 CA--C 1.542 0.641 0 C-N-CA 124.631 1.172 . . . . 0.0 109.235 -173.469 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -61.5 153.22 67.98 Favored 'Trans proline' 0 C--N 1.372 1.79 0 C-N-CA 122.648 2.232 . . . . 0.0 112.732 -177.216 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 259' ' ' PRO . . . . . 0.411 ' HB3' ' HB2' ' A' ' 263' ' ' TRP . 43.6 Cg_exo -59.19 127.99 26.05 Favored 'Trans proline' 0 C--N 1.382 2.298 0 C-N-CA 122.794 2.329 . . . . 0.0 112.263 178.503 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -68.64 -37.06 79.38 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.365 0.666 . . . . 0.0 110.258 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -152.49 -126.49 1.2 Allowed Glycine 0 C--N 1.344 1.01 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.88 178.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 24.7 m -65.27 124.44 22.2 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.04 0.936 . . . . 0.0 110.457 177.467 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 263' ' ' TRP . . . . . 0.411 ' HB2' ' HB3' ' A' ' 259' ' ' PRO . 78.1 t90 -125.18 107.24 10.55 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.743 0.817 . . . . 0.0 109.432 -176.094 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -88.72 118.81 28.66 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.645 0.778 . . . . 0.0 109.534 174.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 12.7 p -69.47 156.56 91.43 Favored Pre-proline 0 CA--C 1.56 1.343 0 CA-C-O 117.951 -1.023 . . . . 0.0 109.301 174.376 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -19.6 -70.05 0.02 OUTLIER 'Trans proline' 0 C--N 1.394 2.931 1 C-N-CA 126.263 4.642 . . . . 0.0 117.523 -170.246 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.69 -27.28 65.81 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -172.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 268' ' ' CYS . . . . . . . . . . . . . 82.4 m -69.26 -30.89 69.11 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 123.476 0.71 . . . . 0.0 112.203 177.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -92.57 -46.27 7.7 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.296 0.639 . . . . 0.0 110.569 -177.115 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 85.5 mt -84.14 -48.08 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 123.74 0.816 . . . . 0.0 111.433 -171.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 . . . . . 0 C--O 1.255 1.378 0 CA-C-O 118.732 -0.651 . . . . 0.0 110.718 -171.684 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 5.9 tt . . . . . 0 N--CA 1.475 0.822 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 224' ' ' TYR . . . . . 0.522 ' HB3' ' HA ' ' A' ' 245' ' ' TYR . 67.5 m-85 -141.1 133.58 28.42 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 175.111 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 44.4 t 171.45 157.46 0.08 Allowed 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 124.752 1.221 . . . . 0.0 109.419 170.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -58.27 -44.41 88.41 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.86 0.864 . . . . 0.0 111.587 -179.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 16.2 p -73.33 -13.78 61.17 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 123.12 0.568 . . . . 0.0 111.401 -179.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 84.4 mm-40 55.84 73.69 0.42 Allowed 'General case' 0 C--N 1.366 1.297 0 C-N-CA 124.678 1.191 . . . . 0.0 111.327 -173.088 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 28.2 tpt180 -151.02 151.1 31.56 Favored 'General case' 0 C--O 1.244 0.772 0 CA-C-N 114.808 -1.087 . . . . 0.0 109.129 -178.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 21.0 m -66.93 160.77 3.97 Favored 'Isoleucine or valine' 0 C--O 1.243 0.755 0 C-N-CA 123.285 0.634 . . . . 0.0 111.301 173.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 231' ' ' SER . . . . . 0.423 ' HB3' ' O ' ' A' ' 234' ' ' GLU . 45.5 m -87.54 69.33 9.76 Favored 'General case' 0 CA--C 1.549 0.937 0 CA-C-N 115.373 -0.831 . . . . 0.0 109.961 179.566 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -68.97 111.91 5.28 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.223 0.609 . . . . 0.0 111.439 -177.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 79.88 -19.25 6.52 Favored Glycine 0 CA--C 1.538 1.494 0 CA-C-N 115.801 -0.636 . . . . 0.0 114.31 172.249 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . 0.423 ' O ' ' HB3' ' A' ' 231' ' ' SER . 30.0 mt-10 -132.01 148.71 52.52 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 125.235 1.414 . . . . 0.0 107.509 -175.025 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 235' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -154.71 135.21 13.4 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-O 121.593 0.711 . . . . 0.0 111.488 175.359 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . 0.528 HG13 ' HB2' ' A' ' 248' ' ' PHE . 1.1 p -145.09 123.08 4.98 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 170.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -96.47 140.26 31.38 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 173.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 238' ' ' CYS . . . . . . . . . . . . . 37.9 t -101.63 114.31 28.24 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 123.393 0.677 . . . . 0.0 109.984 -179.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -69.96 95.39 0.93 Allowed 'General case' 0 CA--C 1.543 0.693 0 O-C-N 123.93 0.769 . . . . 0.0 109.444 178.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -142.52 116.07 1.01 Allowed Glycine 0 C--N 1.342 0.911 0 CA-C-O 118.363 -1.243 . . . . 0.0 112.15 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_exo -58.24 -31.81 94.44 Favored 'Trans proline' 0 C--N 1.379 2.136 0 C-N-CA 122.787 2.325 . . . . 0.0 111.638 173.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -115.39 86.32 2.44 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 171.137 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 7.7 t -161.38 91.03 0.83 Allowed 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.497 0.719 . . . . 0.0 109.704 -178.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.76 -44.93 80.11 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 122.975 0.51 . . . . 0.0 110.026 173.463 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 245' ' ' TYR . . . . . 0.522 ' HA ' ' HB3' ' A' ' 224' ' ' TYR . 96.5 m-85 -81.14 22.61 0.64 Allowed 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 124.669 1.187 . . . . 0.0 112.715 -176.388 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -52.36 -32.94 40.83 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 125.023 1.329 . . . . 0.0 114.202 -172.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 247' ' ' TRP . . . . . 0.507 ' HB2' ' HB2' ' A' ' 224' ' ' TYR . 39.3 m95 -75.08 130.36 39.15 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-O 121.331 0.586 . . . . 0.0 110.447 176.282 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 248' ' ' PHE . . . . . 0.528 ' HB2' HG13 ' A' ' 236' ' ' VAL . 98.5 m-85 -141.43 171.31 14.23 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.312 1.045 . . . . 0.0 109.746 177.844 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 249' ' ' HIS . . . . . 0.449 ' HD2' ' HB2' ' A' ' 252' ' ' CYS . 0.0 OUTLIER -134.68 145.64 48.72 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 176.745 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 250' ' ' TYR . . . . . 0.464 ' HB3' ' O ' ' A' ' 255' ' ' LEU . 21.1 m-30 -53.88 -55.98 21.83 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 124.213 1.005 . . . . 0.0 113.303 -166.325 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -60.86 -34.17 74.19 Favored 'General case' 0 N--CA 1.496 1.839 0 C-N-CA 123.311 0.644 . . . . 0.0 111.733 -174.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 252' ' ' CYS . . . . . 0.449 ' HB2' ' HD2' ' A' ' 249' ' ' HIS . 11.3 t -68.45 -32.25 72.14 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 124.162 0.985 . . . . 0.0 111.631 -175.425 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . 0.493 HG23 ' HG ' ' A' ' 255' ' ' LEU . 16.3 m -108.76 6.23 9.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 C-N-CA 124.04 0.936 . . . . 0.0 110.735 175.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 18.4 m120 64.32 24.84 13.37 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 125.574 1.549 . . . . 0.0 113.359 173.425 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.493 ' HG ' HG23 ' A' ' 253' ' ' VAL . 96.5 mt -70.94 121.32 17.92 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 166.331 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 36.4 mtmm -96.55 15.73 20.77 Favored 'General case' 0 N--CA 1.485 1.276 0 CA-C-O 120.805 0.336 . . . . 0.0 110.661 175.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -164.3 163.41 15.07 Favored Pre-proline 0 CA--C 1.554 1.106 0 C-N-CA 124.131 0.972 . . . . 0.0 109.047 -172.432 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -69.41 160.14 50.96 Favored 'Trans proline' 0 C--N 1.374 1.879 0 C-N-CA 122.488 2.125 . . . . 0.0 112.607 175.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 259' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -59.61 156.88 34.7 Favored 'Trans proline' 0 C--N 1.377 2.063 0 C-N-CA 122.95 2.433 . . . . 0.0 112.783 171.361 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -103.73 31.07 4.65 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.703 0.801 . . . . 0.0 109.713 -179.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 136.81 -141.03 11.96 Favored Glycine 0 C--N 1.339 0.749 0 N-CA-C 110.313 -1.115 . . . . 0.0 110.313 -174.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 40.0 p -72.98 114.67 11.39 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 122.948 0.499 . . . . 0.0 109.821 178.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 263' ' ' TRP . . . . . . . . . . . . . 47.1 t90 -90.82 136.81 32.82 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.438 0.695 . . . . 0.0 109.856 -176.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -124.11 115.72 21.59 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.364 0.665 . . . . 0.0 110.688 -177.37 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 265' ' ' CYS . . . . . 0.494 ' SG ' ' HB2' ' A' ' 267' ' ' GLU . 19.1 p -70.75 160.08 83.13 Favored Pre-proline 0 N--CA 1.484 1.231 0 C-N-CA 124.308 1.043 . . . . 0.0 109.658 172.63 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 99.9 Cg_exo -47.29 -27.06 6.32 Favored 'Trans proline' 0 C--N 1.388 2.639 0 C-N-CA 123.825 3.017 . . . . 0.0 115.696 177.198 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 267' ' ' GLU . . . . . 0.494 ' HB2' ' SG ' ' A' ' 265' ' ' CYS . 39.6 mt-10 -59.4 -49.45 77.75 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 123.962 0.905 . . . . 0.0 110.581 174.296 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 268' ' ' CYS . . . . . . . . . . . . . 76.4 m -85.07 -30.86 23.74 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.268 1.027 . . . . 0.0 111.712 -177.263 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 65.2 tttm -85.49 -51.63 6.39 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.867 -168.391 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 45.2 mt -97.8 -52.07 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 C-N-CA 123.1 0.56 . . . . 0.0 110.952 -176.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 . . . . . 0 CA--C 1.554 1.106 0 C-N-CA 123.177 0.591 . . . . 0.0 110.595 -171.721 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 5.9 tt . . . . . 0 CA--C 1.539 0.546 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 224' ' ' TYR . . . . . 0.528 ' HB2' ' HB2' ' A' ' 247' ' ' TRP . 71.0 m-85 -135.28 133.21 38.67 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 176.69 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 36.9 t 175.13 166.67 0.3 Allowed 'General case' 0 N--CA 1.474 0.747 0 O-C-N 124.643 1.214 . . . . 0.0 109.562 175.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 32.9 t80 -73.05 -33.46 65.69 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 177.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 9.4 p -82.18 -11.39 58.74 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 122.84 0.456 . . . . 0.0 111.04 173.048 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 82.2 mm-40 56.46 89.38 0.04 OUTLIER 'General case' 0 C--N 1.361 1.08 0 C-N-CA 125.348 1.459 . . . . 0.0 111.249 -174.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 -153.41 149.04 27.37 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.87 -176.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 34.2 m -66.28 148.49 12.05 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.823 0 C-N-CA 123.7 0.8 . . . . 0.0 110.952 174.291 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 35.9 m -107.43 120.66 42.78 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 175.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 31.4 p90 -141.92 125.92 17.25 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.555 0.742 . . . . 0.0 109.822 -174.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 78.09 -14.69 10.32 Favored Glycine 0 C--N 1.354 1.533 0 CA-C-N 116.334 -0.394 . . . . 0.0 113.138 -174.088 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -154.88 101.33 2.27 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.543 1.137 . . . . 0.0 108.165 -176.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 235' ' ' MET . . . . . . . . . . . . . 54.1 mtp -128.25 113.33 15.53 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 -178.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 6.8 p -108.34 125.32 65.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 175.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -99.7 168.54 9.86 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.727 0.811 . . . . 0.0 110.519 179.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 238' ' ' CYS . . . . . . . . . . . . . 26.9 t -144.29 123.25 12.77 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 122.668 0.387 . . . . 0.0 111.51 -177.344 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -79.22 105.38 10.51 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.376 0.67 . . . . 0.0 109.981 174.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -142.16 141.22 10.65 Favored Glycine 0 C--N 1.341 0.813 0 CA-C-O 118.558 -1.134 . . . . 0.0 111.285 175.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -60.09 -52.9 3.58 Favored 'Trans proline' 0 C--N 1.379 2.183 0 C-N-CA 122.758 2.306 . . . . 0.0 110.757 176.356 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -106.55 129.04 54.56 Favored 'General case' 0 C--O 1.242 0.675 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 163.166 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 243' ' ' CYS . . . . . 0.437 ' SG ' ' HA ' ' A' ' 246' ' ' GLU . 26.5 t -173.13 89.42 0.08 Allowed 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 -174.382 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.1 -24.29 30.4 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 122.893 0.477 . . . . 0.0 110.603 179.631 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 53.1 m-85 -101.32 26.88 6.69 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.321 1.049 . . . . 0.0 110.367 177.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 246' ' ' GLU . . . . . 0.437 ' HA ' ' SG ' ' A' ' 243' ' ' CYS . 8.5 pt-20 -48.66 -34.92 12.72 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 124.41 1.084 . . . . 0.0 112.579 176.653 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 247' ' ' TRP . . . . . 0.528 ' HB2' ' HB2' ' A' ' 224' ' ' TYR . 94.5 m95 -96.07 136.4 36.57 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 121.379 0.609 . . . . 0.0 111.133 176.609 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -144.71 173.44 11.83 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 125.196 1.398 . . . . 0.0 108.521 171.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 249' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -113.04 138.23 50.21 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 170.655 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -55.49 -32.86 63.19 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 124.181 0.992 . . . . 0.0 112.157 -173.385 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -56.47 -45.06 81.09 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 125.007 1.323 . . . . 0.0 112.455 178.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 252' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -68.04 -51.29 48.55 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.226 1.011 . . . . 0.0 110.984 -175.472 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 22.3 m -81.7 -9.95 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 CA-C-N 115.223 -0.898 . . . . 0.0 111.963 -178.242 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 17.5 m120 59.84 41.67 17.67 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.857 1.263 . . . . 0.0 110.795 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 34.7 tp -90.9 108.04 19.58 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 178.119 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -70.23 -44.81 67.81 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 122.986 0.515 . . . . 0.0 110.758 -178.205 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -133.53 130.97 21.14 Favored Pre-proline 0 C--O 1.24 0.567 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 -178.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -56.95 141.96 93.57 Favored 'Trans proline' 0 C--N 1.371 1.763 0 C-N-CA 122.257 1.972 . . . . 0.0 110.707 171.608 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 259' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -68.14 -178.94 1.94 Allowed 'Trans proline' 0 C--N 1.37 1.678 0 C-N-CA 123.06 2.507 . . . . 0.0 113.018 -169.02 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 27.7 mmmt -74.75 -3.6 32.55 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 116.068 -0.514 . . . . 0.0 112.383 -174.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -154.43 -143.92 3.79 Favored Glycine 0 C--N 1.338 0.689 0 N-CA-C 111.502 -0.639 . . . . 0.0 111.502 174.028 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 43.5 p -69.68 116.83 10.54 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 123.693 0.797 . . . . 0.0 110.607 -177.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 263' ' ' TRP . . . . . . . . . . . . . 37.9 t90 -66.41 135.69 54.66 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 122.965 0.506 . . . . 0.0 110.266 178.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 264' ' ' TYR . . . . . 0.445 ' HB3' ' HB3' ' A' ' 269' ' ' LYS . 39.6 m-85 -118.44 110.6 17.63 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.433 0.693 . . . . 0.0 109.768 -177.69 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 265' ' ' CYS . . . . . 0.4 ' SG ' ' HB2' ' A' ' 267' ' ' GLU . 14.8 p -67.25 162.77 52.16 Favored Pre-proline 0 CA--C 1.554 1.122 0 C-N-CA 124.128 0.971 . . . . 0.0 109.65 172.1 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -53.57 -24.51 29.31 Favored 'Trans proline' 0 C--N 1.385 2.452 0 C-N-CA 123.374 2.716 . . . . 0.0 114.594 -178.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 267' ' ' GLU . . . . . 0.4 ' HB2' ' SG ' ' A' ' 265' ' ' CYS . 33.7 mt-10 -57.38 -54.79 42.79 Favored 'General case' 0 N--CA 1.483 1.187 0 CA-C-O 121.488 0.661 . . . . 0.0 110.326 173.432 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 268' ' ' CYS . . . . . . . . . . . . . 57.9 m -86.75 -39.28 16.12 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 114.606 -1.179 . . . . 0.0 112.709 -168.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . 0.445 ' HB3' ' HB3' ' A' ' 264' ' ' TYR . 12.5 ptmm? -75.66 -28.87 58.88 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-O 120.654 0.264 . . . . 0.0 111.703 -169.612 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 61.8 mt -92.2 -50.7 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 177.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 . . . . . 0 CA--C 1.554 1.117 0 C-N-CA 123.456 0.703 . . . . 0.0 109.209 179.234 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 57.0 tp . . . . . 0 N--CA 1.473 0.699 0 CA-C-O 121.189 0.518 . . . . 0.0 109.929 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 224' ' ' TYR . . . . . 0.588 ' HB3' ' HA ' ' A' ' 245' ' ' TYR . 77.3 m-85 -135.49 134.33 39.43 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 172.551 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 49.3 t 172.84 161.62 0.12 Allowed 'General case' 0 N--CA 1.474 0.769 0 O-C-N 124.823 1.327 . . . . 0.0 108.284 171.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -67.09 -32.63 73.92 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 122.08 0.152 . . . . 0.0 110.965 177.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 13.1 p -85.52 -17.43 36.4 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 122.706 0.402 . . . . 0.0 111.288 177.711 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 20.4 mm-40 52.92 77.6 0.16 Allowed 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 124.645 1.178 . . . . 0.0 111.907 -172.233 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 4.6 tmt_? -151.32 154.57 36.99 Favored 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 -178.601 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 23.1 m -73.1 156.25 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 CA-C-O 121.394 0.616 . . . . 0.0 112.59 -173.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 17.3 m -95.91 104.48 16.41 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.864 0.866 . . . . 0.0 108.771 172.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -74.14 79.32 1.76 Allowed 'General case' 0 N--CA 1.479 1.009 0 CA-C-O 121.508 0.67 . . . . 0.0 110.24 -179.158 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 74.68 -18.17 2.42 Favored Glycine 0 CA--C 1.539 1.568 0 N-CA-C 115.331 0.893 . . . . 0.0 115.331 177.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . 0.403 ' HB3' ' HD1' ' A' ' 250' ' ' TYR . 20.5 mm-40 -113.28 110.52 20.51 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.829 0.852 . . . . 0.0 109.335 -175.371 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 235' ' ' MET . . . . . . . . . . . . . 55.1 mtm -126.01 102.23 7.16 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.094 0.958 . . . . 0.0 109.679 -172.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . 0.4 HG11 HG21 ' A' ' 253' ' ' VAL . 3.9 p -87.98 123.34 40.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 168.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -92.79 155.02 17.93 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 123.083 0.553 . . . . 0.0 109.92 -178.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 238' ' ' CYS . . . . . 0.633 ' HB3' ' HA ' ' A' ' 246' ' ' GLU . 42.1 t -116.23 152.12 34.4 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 115.126 -0.943 . . . . 0.0 108.87 176.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -119.92 99.22 6.49 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 171.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 240' ' ' GLY . . . . . 0.61 ' HA3' ' SG ' ' A' ' 268' ' ' CYS . . . -139.99 129.52 4.3 Favored Glycine 0 C--N 1.34 0.785 0 CA-C-O 118.124 -1.375 . . . . 0.0 111.004 176.763 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -48.89 -49.56 14.78 Favored 'Trans proline' 0 C--N 1.382 2.325 0 C-N-CA 123.666 2.91 . . . . 0.0 113.752 -177.656 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -111.19 101.87 10.34 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 171.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 43.9 t -172.86 106.62 0.16 Allowed 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 -173.561 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 9.3 ptpp? -86.78 -24.57 25.01 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 173.332 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 245' ' ' TYR . . . . . 0.588 ' HA ' ' HB3' ' A' ' 224' ' ' TYR . 22.7 m-85 -81.12 23.69 0.56 Allowed 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.403 1.081 . . . . 0.0 112.225 -177.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 246' ' ' GLU . . . . . 0.633 ' HA ' ' HB3' ' A' ' 238' ' ' CYS . 5.9 mm-40 -48.9 -37.51 19.96 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 123.641 0.776 . . . . 0.0 111.35 178.556 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 247' ' ' TRP . . . . . 0.502 ' HB2' ' HB2' ' A' ' 224' ' ' TYR . 98.4 m95 -76.45 115.85 16.58 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.505 174.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -130.18 173.35 10.85 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.652 1.181 . . . . 0.0 109.371 171.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 249' ' ' HIS . . . . . 0.569 ' HD2' ' HB2' ' A' ' 252' ' ' CYS . 0.1 OUTLIER -126.01 142.0 51.71 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.454 1.101 . . . . 0.0 108.508 178.232 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 250' ' ' TYR . . . . . 0.403 ' HD1' ' HB3' ' A' ' 234' ' ' GLU . 70.3 m-85 -60.58 -34.83 74.77 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 124.489 1.116 . . . . 0.0 113.493 -168.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -67.52 -35.74 79.68 Favored 'General case' 0 N--CA 1.485 1.293 0 CA-C-O 121.537 0.684 . . . . 0.0 110.998 -178.147 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 252' ' ' CYS . . . . . 0.569 ' HB2' ' HD2' ' A' ' 249' ' ' HIS . 9.0 t -71.68 -41.06 69.14 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 125.024 1.33 . . . . 0.0 110.852 -175.454 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . 0.4 HG21 HG11 ' A' ' 236' ' ' VAL . 27.9 m -93.16 -2.02 10.63 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.859 0 CA-C-N 114.481 -1.236 . . . . 0.0 110.957 179.685 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 33.5 m-80 62.69 24.89 14.81 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 124.803 1.241 . . . . 0.0 112.524 175.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 81.0 mt -80.58 119.64 23.49 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 173.161 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 14.3 tppt? -81.06 -25.34 37.17 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.425 0.69 . . . . 0.0 110.51 179.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -136.35 162.56 55.67 Favored Pre-proline 0 CA--C 1.55 0.949 0 C-N-CA 124.319 1.047 . . . . 0.0 109.552 -178.711 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -56.31 136.06 73.43 Favored 'Trans proline' 0 C--N 1.38 2.196 0 C-N-CA 122.435 2.09 . . . . 0.0 111.532 170.329 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 259' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -58.73 156.07 34.39 Favored 'Trans proline' 0 C--N 1.375 1.97 0 C-N-CA 123.289 2.659 . . . . 0.0 113.076 -176.528 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -66.38 -20.72 66.15 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.833 0.853 . . . . 0.0 112.764 -173.313 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -165.57 -141.94 3.28 Favored Glycine 0 C--N 1.347 1.145 0 CA-C-O 119.752 -0.471 . . . . 0.0 112.176 179.232 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 25.4 m -65.32 107.25 1.56 Allowed 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.638 0.775 . . . . 0.0 109.819 178.392 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 263' ' ' TRP . . . . . . . . . . . . . 53.8 t90 -88.58 114.12 24.87 Favored 'General case' 0 C--O 1.242 0.679 0 C-N-CA 123.285 0.634 . . . . 0.0 110.316 -175.613 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -96.64 118.84 33.97 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 123.93 0.892 . . . . 0.0 108.599 171.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 17.9 p -64.04 159.68 53.92 Favored Pre-proline 0 CA--C 1.555 1.164 0 C-N-CA 123.508 0.723 . . . . 0.0 110.122 172.162 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -50.91 -33.87 43.43 Favored 'Trans proline' 0 C--N 1.382 2.315 0 C-N-CA 123.202 2.601 . . . . 0.0 113.714 -178.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -59.18 -43.19 92.18 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-O 121.043 0.449 . . . . 0.0 111.242 177.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 268' ' ' CYS . . . . . 0.61 ' SG ' ' HA3' ' A' ' 240' ' ' GLY . 67.2 m -72.64 -27.92 62.43 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.087 0.955 . . . . 0.0 112.563 -177.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 49.1 mtmt -88.07 -41.56 12.98 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 122.84 0.456 . . . . 0.0 111.337 -175.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 16.8 mt -102.3 15.7 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 C-N-CA 123.283 0.633 . . . . 0.0 110.583 -168.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 . . . . . 0 CA--C 1.565 1.552 0 C-N-CA 122.651 0.38 . . . . 0.0 110.951 175.188 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 35.8 tp . . . . . 0 CA--C 1.541 0.602 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 224' ' ' TYR . . . . . 0.524 ' HB3' ' HA ' ' A' ' 245' ' ' TYR . 74.1 m-85 -138.09 125.95 22.52 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 175.591 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 225' ' ' CYS . . . . . 0.403 ' HB2' ' O ' ' A' ' 224' ' ' TYR . 34.4 t 174.54 161.85 0.2 Allowed 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.959 0.904 . . . . 0.0 109.203 173.586 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -69.24 -34.92 75.56 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 122.347 0.259 . . . . 0.0 110.458 175.306 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 3.9 p -83.47 -14.59 52.13 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.105 175.249 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 22.6 mm-40 53.87 101.09 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 125.601 1.56 . . . . 0.0 112.713 -172.233 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 22.8 tpp180 -162.97 157.97 21.68 Favored 'General case' 0 C--O 1.244 0.801 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 -178.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 19.5 m -71.4 154.21 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 CA-C-O 120.828 0.347 . . . . 0.0 111.173 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 17.1 m -116.86 60.57 0.74 Allowed 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 123.568 0.747 . . . . 0.0 109.422 -179.233 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 79.8 t80 -71.84 108.69 5.26 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.143 0.577 . . . . 0.0 111.769 -172.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 85.18 -18.22 29.03 Favored Glycine 0 N--CA 1.472 1.089 0 CA-C-N 115.6 -0.727 . . . . 0.0 114.156 174.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -131.51 94.57 3.56 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 124.257 1.023 . . . . 0.0 108.62 -177.269 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 235' ' ' MET . . . . . 0.418 ' HB3' ' CE3' ' A' ' 247' ' ' TRP . 63.3 mtm -122.03 100.75 7.14 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.8 0.84 . . . . 0.0 109.062 -179.366 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 4.8 p -87.8 124.83 41.26 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 170.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -88.65 130.53 35.27 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.539 0.736 . . . . 0.0 109.892 -178.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 238' ' ' CYS . . . . . 0.519 ' HB3' ' HA ' ' A' ' 246' ' ' GLU . 36.2 t -99.65 152.29 20.24 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.069 0.947 . . . . 0.0 109.398 175.239 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -127.23 108.23 10.7 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.933 0.893 . . . . 0.0 108.667 172.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -139.97 160.57 26.25 Favored Glycine 0 N--CA 1.473 1.144 0 CA-C-O 119.224 -0.765 . . . . 0.0 111.829 174.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -69.77 -35.31 12.85 Favored 'Trans proline' 0 C--N 1.375 1.973 0 C-N-CA 122.285 1.99 . . . . 0.0 112.156 174.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -128.48 110.19 12.08 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.896 0.879 . . . . 0.0 108.776 176.329 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 29.7 t -177.39 104.76 0.05 Allowed 'General case' 0 C--N 1.347 0.476 0 C-N-CA 123.56 0.744 . . . . 0.0 109.502 -175.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 16.8 tppt? -76.71 -30.6 56.73 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-O 121.548 0.69 . . . . 0.0 110.169 171.496 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 245' ' ' TYR . . . . . 0.524 ' HA ' ' HB3' ' A' ' 224' ' ' TYR . 15.5 m-85 -87.55 23.76 1.85 Allowed 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.42 1.088 . . . . 0.0 112.537 -168.347 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 246' ' ' GLU . . . . . 0.519 ' HA ' ' HB3' ' A' ' 238' ' ' CYS . 5.9 mm-40 -46.94 -45.07 20.49 Favored 'General case' 0 N--CA 1.499 2.001 0 C-N-CA 124.187 0.995 . . . . 0.0 112.481 -172.145 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 247' ' ' TRP . . . . . 0.418 ' CE3' ' HB3' ' A' ' 235' ' ' MET . 97.1 m95 -77.56 117.11 18.68 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 122.851 0.461 . . . . 0.0 110.056 173.665 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -122.18 159.26 27.61 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.93 0.892 . . . . 0.0 110.515 175.55 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 249' ' ' HIS . . . . . 0.49 ' CD2' ' HB2' ' A' ' 252' ' ' CYS . 0.7 OUTLIER -93.29 129.88 39.22 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 114.792 -1.094 . . . . 0.0 108.386 167.821 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 48.1 m-85 -52.91 -38.24 61.58 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 124.724 1.21 . . . . 0.0 112.272 -175.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -57.13 -34.79 68.75 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 124.79 1.236 . . . . 0.0 112.498 -177.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 252' ' ' CYS . . . . . 0.49 ' HB2' ' CD2' ' A' ' 249' ' ' HIS . 0.5 OUTLIER -65.63 -56.27 13.1 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 124.032 0.933 . . . . 0.0 110.585 -177.488 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . 0.512 HG23 ' HB2' ' A' ' 255' ' ' LEU . 20.7 m -82.85 -1.54 5.78 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.879 0 CA-C-N 114.595 -1.184 . . . . 0.0 111.314 -176.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 9.9 t30 61.13 31.37 19.67 Favored 'General case' 0 C--N 1.365 1.267 0 C-N-CA 124.662 1.185 . . . . 0.0 110.393 179.543 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.529 HD21 ' HG3' ' A' ' 259' ' ' PRO . 16.4 tp -76.45 89.66 3.24 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 177.543 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -71.42 -20.32 62.13 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 115.114 -0.948 . . . . 0.0 111.893 -172.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -139.19 152.95 70.74 Favored Pre-proline 0 CA--C 1.552 1.021 0 C-N-CA 124.509 1.123 . . . . 0.0 109.581 -177.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -59.14 148.51 85.35 Favored 'Trans proline' 0 C--N 1.381 2.274 0 C-N-CA 123.249 2.633 . . . . 0.0 113.663 179.31 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 259' ' ' PRO . . . . . 0.529 ' HG3' HD21 ' A' ' 255' ' ' LEU . 14.3 Cg_exo -68.9 146.31 65.09 Favored 'Trans proline' 0 C--N 1.38 2.205 0 C-N-CA 122.963 2.442 . . . . 0.0 111.987 172.206 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 57.6 mttp -86.31 -28.01 23.97 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.661 0.784 . . . . 0.0 110.876 -178.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -137.1 -150.27 5.74 Favored Glycine 0 C--N 1.345 1.082 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.849 -179.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 25.8 m -71.04 116.87 11.83 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 123.447 0.699 . . . . 0.0 110.511 -177.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 263' ' ' TRP . . . . . . . . . . . . . 27.9 t90 -91.26 114.93 27.59 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.965 0.906 . . . . 0.0 110.207 -175.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -100.64 117.69 35.27 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 170.137 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 265' ' ' CYS . . . . . 0.41 ' SG ' ' OE2' ' A' ' 267' ' ' GLU . 14.4 p -70.92 161.82 75.67 Favored Pre-proline 0 CA--C 1.56 1.328 0 CA-C-O 117.77 -1.11 . . . . 0.0 109.773 176.35 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_exo -27.25 -69.62 0.04 OUTLIER 'Trans proline' 0 C--N 1.397 3.09 1 C-N-CA 125.402 4.068 . . . . 0.0 116.742 -173.673 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 267' ' ' GLU . . . . . 0.41 ' OE2' ' SG ' ' A' ' 265' ' ' CYS . 0.0 OUTLIER -63.81 -26.15 68.5 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -173.794 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 268' ' ' CYS . . . . . . . . . . . . . 97.3 m -72.17 -47.45 50.73 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 123.113 0.565 . . . . 0.0 112.013 176.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 12.2 ptmm? -77.05 -23.66 52.01 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.987 -173.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 86.1 mt -88.39 -43.35 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 123.761 0.824 . . . . 0.0 110.206 178.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 . . . . . 0 C--O 1.257 1.449 0 C-N-CA 123.596 0.759 . . . . 0.0 109.564 -174.874 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 53.7 tp . . . . . 0 N--CA 1.475 0.816 0 CA-C-O 120.871 0.367 . . . . 0.0 110.056 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 224' ' ' TYR . . . . . 0.428 ' HB3' ' HA ' ' A' ' 245' ' ' TYR . 66.5 m-85 -135.58 124.09 23.54 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.456 0.702 . . . . 0.0 109.279 172.747 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 36.8 t 172.01 158.69 0.1 Allowed 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 125.208 1.403 . . . . 0.0 109.349 172.033 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 77.5 t80 -66.99 -41.78 86.17 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 117.942 0.337 . . . . 0.0 110.919 177.049 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 6.3 p -72.48 -10.74 60.17 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 122.504 0.321 . . . . 0.0 110.43 176.319 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 82.4 mm-40 53.88 88.8 0.03 OUTLIER 'General case' 0 C--N 1.368 1.388 0 C-N-CA 124.823 1.249 . . . . 0.0 110.78 -173.073 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 2.4 tpm_? -153.32 146.11 24.35 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-N 114.721 -1.127 . . . . 0.0 108.389 -177.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 34.9 m -83.92 149.13 4.56 Favored 'Isoleucine or valine' 0 C--O 1.24 0.587 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 175.306 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 21.4 m -84.73 88.12 7.35 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.324 0.65 . . . . 0.0 110.104 -178.647 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -74.41 88.85 2.1 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.668 0.787 . . . . 0.0 110.625 -176.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 78.44 -19.39 4.81 Favored Glycine 0 CA--C 1.535 1.327 0 CA-C-N 115.112 -0.949 . . . . 0.0 114.614 177.087 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -116.26 94.39 4.62 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.035 0.934 . . . . 0.0 108.773 179.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 235' ' ' MET . . . . . . . . . . . . . 20.4 ptt? -120.03 108.98 14.95 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.957 0.903 . . . . 0.0 110.515 -176.186 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 7.5 p -100.22 125.72 53.91 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 169.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -101.4 138.16 38.78 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.553 0.741 . . . . 0.0 110.795 -172.131 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 238' ' ' CYS . . . . . 0.722 ' HB3' ' HA ' ' A' ' 246' ' ' GLU . 34.9 t -95.93 152.29 18.64 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 123.768 0.827 . . . . 0.0 109.055 173.606 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 239' ' ' ASP . . . . . 0.435 ' HB3' ' HB ' ' A' ' 262' ' ' THR . 31.3 t70 -125.96 104.85 8.51 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 175.442 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -138.43 147.94 19.58 Favored Glycine 0 C--N 1.337 0.607 0 CA-C-O 118.859 -0.967 . . . . 0.0 111.245 177.422 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -66.52 -34.28 34.03 Favored 'Trans proline' 0 C--N 1.372 1.788 0 C-N-CA 122.64 2.226 . . . . 0.0 112.368 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -135.98 94.91 3.12 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 176.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 45.1 t -163.93 110.88 1.11 Allowed 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.972 0.909 . . . . 0.0 109.003 -173.381 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 244' ' ' LYS . . . . . 0.56 ' H ' ' HD3' ' A' ' 244' ' ' LYS . 0.1 OUTLIER -82.92 -31.64 27.66 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.18 0.592 . . . . 0.0 110.876 175.991 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 245' ' ' TYR . . . . . 0.428 ' HA ' ' HB3' ' A' ' 224' ' ' TYR . 71.5 m-85 -79.54 28.68 0.25 Allowed 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 124.543 1.137 . . . . 0.0 113.208 -178.622 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 246' ' ' GLU . . . . . 0.722 ' HA ' ' HB3' ' A' ' 238' ' ' CYS . 5.7 mm-40 -48.91 -48.35 42.65 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.27 0.628 . . . . 0.0 112.276 178.007 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 247' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -78.69 130.83 36.27 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 121.186 0.517 . . . . 0.0 112.103 -176.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -143.73 172.43 12.84 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.192 1.397 . . . . 0.0 109.953 174.539 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 249' ' ' HIS . . . . . 0.439 ' HD2' ' HB2' ' A' ' 252' ' ' CYS . 0.0 OUTLIER -120.36 140.75 50.85 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.559 1.144 . . . . 0.0 108.499 179.329 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 250' ' ' TYR . . . . . 0.425 ' HB3' ' O ' ' A' ' 255' ' ' LEU . 49.0 m-85 -54.8 -54.38 42.89 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.855 1.262 . . . . 0.0 113.285 -167.292 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -59.8 -34.41 73.0 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 123.262 0.625 . . . . 0.0 112.174 -175.234 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 252' ' ' CYS . . . . . 0.439 ' HB2' ' HD2' ' A' ' 249' ' ' HIS . 7.3 t -67.0 -43.28 83.34 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.037 0.935 . . . . 0.0 111.195 -177.309 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 9.2 m -93.17 14.76 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.175 0 C-N-CA 123.788 0.835 . . . . 0.0 111.315 177.006 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 6.4 t30 67.48 7.87 5.9 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 125.103 1.361 . . . . 0.0 112.524 172.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.425 ' O ' ' HB3' ' A' ' 250' ' ' TYR . 87.9 mt -74.43 104.15 5.05 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.048 0.539 . . . . 0.0 110.732 -179.004 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 52.3 tttm -63.73 -36.87 85.28 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.237 1.015 . . . . 0.0 110.303 169.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -142.96 149.61 49.98 Favored Pre-proline 0 CA--C 1.549 0.936 0 CA-C-N 114.676 -1.147 . . . . 0.0 109.777 -170.258 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 258' ' ' PRO . . . . . 0.504 ' HA ' ' HD3' ' A' ' 259' ' ' PRO . 33.6 Cg_endo -62.51 138.14 68.74 Favored 'Trans proline' 0 C--N 1.38 2.23 0 C-N-CA 122.864 2.376 . . . . 0.0 113.1 -175.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 259' ' ' PRO . . . . . 0.504 ' HD3' ' HA ' ' A' ' 258' ' ' PRO . 17.3 Cg_exo -69.6 137.81 36.82 Favored 'Trans proline' 0 C--N 1.372 1.779 0 C-N-CA 123.261 2.641 . . . . 0.0 111.917 177.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -73.21 96.99 2.33 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 123.505 0.722 . . . . 0.0 109.931 -175.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 117.65 -168.8 13.05 Favored Glycine 0 N--CA 1.472 1.063 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.83 178.31 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 262' ' ' THR . . . . . 0.435 ' HB ' ' HB3' ' A' ' 239' ' ' ASP . 32.5 p -66.34 107.01 1.86 Allowed 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.08 0.552 . . . . 0.0 109.879 173.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 263' ' ' TRP . . . . . . . . . . . . . 32.0 t90 -70.11 140.2 52.65 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 122.853 0.461 . . . . 0.0 110.139 -179.435 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -113.2 118.66 35.32 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 172.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 20.4 p -57.35 150.59 42.4 Favored Pre-proline 0 N--CA 1.478 0.952 0 CA-C-O 118.543 -0.741 . . . . 0.0 109.489 172.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_exo -45.57 -32.34 8.24 Favored 'Trans proline' 0 C--N 1.386 2.538 0 C-N-CA 123.407 2.738 . . . . 0.0 114.307 -173.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -65.39 -50.04 67.0 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 123.82 0.848 . . . . 0.0 110.822 -179.567 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 268' ' ' CYS . . . . . . . . . . . . . 43.9 m -59.83 -45.88 91.02 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 123.121 0.568 . . . . 0.0 112.306 -179.377 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . 0.595 ' HD3' HG13 ' A' ' 270' ' ' ILE . 0.1 OUTLIER -81.25 -14.53 57.34 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -171.825 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 270' ' ' ILE . . . . . 0.595 HG13 ' HD3' ' A' ' 269' ' ' LYS . 78.5 mt -92.84 -23.11 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 C-N-CA 123.211 0.604 . . . . 0.0 110.057 172.382 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 . . . . . 0 CA--C 1.559 1.322 0 CA-C-O 118.65 -0.69 . . . . 0.0 110.497 178.438 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 53.3 tp . . . . . 0 N--CA 1.472 0.649 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 224' ' ' TYR . . . . . 0.532 ' HB2' ' HB2' ' A' ' 247' ' ' TRP . 69.3 m-85 -133.34 125.46 29.24 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 177.259 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 40.8 t 171.3 154.19 0.07 Allowed 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 125.86 1.664 . . . . 0.0 107.734 173.351 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -61.62 -43.26 99.2 Favored 'General case' 0 CA--C 1.549 0.914 0 CA-C-N 117.872 0.305 . . . . 0.0 110.861 177.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 6.2 p -68.67 -17.07 64.02 Favored 'General case' 0 N--CA 1.483 1.177 0 O-C-N 123.321 0.388 . . . . 0.0 111.035 177.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 81.3 mm-40 58.81 83.89 0.12 Allowed 'General case' 0 C--N 1.365 1.262 0 C-N-CA 124.581 1.152 . . . . 0.0 110.753 -174.118 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 14.6 tpt180 -150.24 154.52 38.09 Favored 'General case' 0 C--O 1.243 0.727 0 C-N-CA 124.077 0.951 . . . . 0.0 108.532 179.372 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 27.0 m -81.78 177.37 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 CA-C-O 121.488 0.661 . . . . 0.0 110.78 172.711 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 22.2 p -96.64 153.22 17.98 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.897 171.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 40.8 t80 -84.83 1.53 46.54 Favored 'General case' 0 CA--C 1.56 1.334 0 C-N-CA 123.651 0.78 . . . . 0.0 110.002 168.111 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 135.6 -19.18 3.8 Favored Glycine 0 C--N 1.347 1.147 0 C-N-CA 124.006 0.812 . . . . 0.0 111.387 -179.022 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.41 123.14 35.51 Favored 'General case' 0 CA--C 1.555 1.136 0 C-N-CA 122.901 0.48 . . . . 0.0 110.017 -178.411 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 235' ' ' MET . . . . . . . . . . . . . 7.9 mmt -144.57 119.89 10.23 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.329 0.652 . . . . 0.0 110.391 -177.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 3.7 p -98.57 126.35 51.71 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 C-N-CA 124.423 1.089 . . . . 0.0 109.48 168.057 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -87.25 134.52 33.54 Favored 'General case' 0 C--O 1.242 0.679 0 C-N-CA 123.217 0.607 . . . . 0.0 110.014 177.589 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 238' ' ' CYS . . . . . 0.542 ' HB3' ' HA ' ' A' ' 246' ' ' GLU . 35.5 t -95.52 123.98 39.33 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 123.464 0.705 . . . . 0.0 111.117 -178.405 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -77.9 94.33 4.54 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 123.893 0.877 . . . . 0.0 109.195 177.19 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -142.04 125.03 2.58 Favored Glycine 0 CA--C 1.529 0.945 0 CA-C-O 118.761 -1.022 . . . . 0.0 111.917 -179.34 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -62.77 -33.79 75.13 Favored 'Trans proline' 0 C--N 1.379 2.132 0 C-N-CA 122.61 2.207 . . . . 0.0 111.422 171.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -118.32 100.02 7.22 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 169.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 12.1 t -165.54 109.29 0.83 Allowed 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 178.09 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 22.7 ttmm -82.99 -35.69 25.65 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-O 121.547 0.689 . . . . 0.0 109.25 170.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 245' ' ' TYR . . . . . 0.463 ' HA ' ' HB3' ' A' ' 224' ' ' TYR . 89.5 m-85 -83.26 24.12 0.83 Allowed 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 124.985 1.314 . . . . 0.0 113.069 -175.045 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 246' ' ' GLU . . . . . 0.542 ' HA ' ' HB3' ' A' ' 238' ' ' CYS . 42.9 mt-10 -47.85 -38.46 16.12 Favored 'General case' 0 N--CA 1.502 2.149 0 C-N-CA 124.33 1.052 . . . . 0.0 113.181 -174.077 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 247' ' ' TRP . . . . . 0.532 ' HB2' ' HB2' ' A' ' 224' ' ' TYR . 85.6 m95 -78.34 127.09 31.71 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.498 -179.343 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -143.93 130.35 19.93 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.052 0.941 . . . . 0.0 109.605 178.551 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 249' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -71.92 129.56 38.87 Favored 'General case' 0 CA--C 1.547 0.854 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 172.646 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 250' ' ' TYR . . . . . 0.42 ' HB3' ' O ' ' A' ' 255' ' ' LEU . 50.1 m-85 -52.31 -31.68 34.19 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 124.709 1.204 . . . . 0.0 112.321 -178.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -53.54 -48.01 69.48 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 124.116 0.966 . . . . 0.0 111.89 176.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 252' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -61.04 -41.42 96.54 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.86 0.864 . . . . 0.0 111.414 -176.168 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 31.9 m -97.23 0.24 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 CA-C-N 115.395 -0.821 . . . . 0.0 112.038 -175.055 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 20.2 m120 62.78 17.06 9.55 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 124.934 1.294 . . . . 0.0 113.294 175.008 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.42 ' O ' ' HB3' ' A' ' 250' ' ' TYR . 92.6 mt -80.22 109.47 14.72 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 174.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -75.23 -34.98 61.49 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 121.205 0.526 . . . . 0.0 110.041 175.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -116.98 139.0 25.25 Favored Pre-proline 0 CA--C 1.55 0.966 0 C-N-CA 123.482 0.713 . . . . 0.0 109.566 -175.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -59.72 136.61 71.66 Favored 'Trans proline' 0 C--N 1.378 2.131 0 C-N-CA 123.66 2.907 . . . . 0.0 113.486 179.184 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 259' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -65.59 127.57 18.3 Favored 'Trans proline' 0 C--N 1.372 1.816 0 C-N-CA 122.641 2.227 . . . . 0.0 111.515 172.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 14.8 ptmm? -73.99 -16.08 61.08 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.419 0.688 . . . . 0.0 111.626 -179.101 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -118.31 176.9 16.31 Favored Glycine 0 C--N 1.345 1.043 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.893 179.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 36.6 p -57.13 123.05 13.89 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 124.131 0.972 . . . . 0.0 111.809 -177.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 263' ' ' TRP . . . . . . . . . . . . . 44.4 t90 -101.87 115.75 31.22 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.262 0.625 . . . . 0.0 109.36 -174.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -105.63 111.78 24.61 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.951 0.901 . . . . 0.0 109.253 177.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 16.6 p -64.35 149.11 95.29 Favored Pre-proline 0 CA--C 1.559 1.295 0 CA-C-O 118.326 -0.845 . . . . 0.0 109.4 174.223 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -27.44 -60.32 0.09 OUTLIER 'Trans proline' 0 C--N 1.384 2.411 1 C-N-CA 125.76 4.307 . . . . 0.0 118.026 -160.606 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.29 -39.89 86.03 Favored 'General case' 0 N--CA 1.485 1.281 0 CA-C-O 119.293 -0.384 . . . . 0.0 111.604 -175.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 268' ' ' CYS . . . . . . . . . . . . . 59.6 m -52.55 -30.94 33.27 Favored 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 -178.507 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 32.7 ttmt -78.35 -24.66 46.39 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.085 0.554 . . . . 0.0 111.516 -177.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 31.7 pt -112.76 2.51 8.49 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.258 0 C-N-CA 123.544 0.737 . . . . 0.0 112.034 179.08 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 . . . . . 0 C--O 1.256 1.396 0 C-N-CA 123.984 0.914 . . . . 0.0 109.544 -176.125 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 15.6 p . . . . . 0 N--CA 1.47 0.558 0 CA-C-O 120.807 0.337 . . . . 0.0 110.609 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -91.48 82.94 5.35 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.331 1.052 . . . . 0.0 108.212 176.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' TYR . . . . . 0.462 ' HE1' ' HE3' ' A' ' 244' ' ' LYS . 60.3 m-85 -148.32 125.42 11.41 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.657 1.183 . . . . 0.0 108.301 172.372 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 47.1 t 173.26 163.03 0.14 Allowed 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 124.7 1.2 . . . . 0.0 109.88 174.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -65.94 -33.97 77.03 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 122.41 0.284 . . . . 0.0 111.406 175.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 13.3 p -84.01 -5.86 59.31 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 122.152 0.181 . . . . 0.0 111.412 176.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 82.5 mm-40 48.67 85.95 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 125.467 1.507 . . . . 0.0 112.743 -175.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 22.9 tpp180 -153.92 148.54 26.32 Favored 'General case' 0 C--O 1.244 0.784 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 177.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 25.7 m -62.4 149.71 9.37 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 O-C-N 123.838 0.711 . . . . 0.0 110.73 178.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 17.5 p -87.01 69.52 10.24 Favored 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 123.382 0.673 . . . . 0.0 110.141 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 94.5 t80 -70.5 98.28 1.43 Allowed 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.164 0.986 . . . . 0.0 110.576 -176.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 78.5 -17.59 6.43 Favored Glycine 0 CA--C 1.536 1.404 0 CA-C-N 116.133 -0.485 . . . . 0.0 113.97 176.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -122.32 105.62 10.36 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.217 1.007 . . . . 0.0 108.424 178.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' MET . . . . . . . . . . . . . 21.3 ptt? -136.53 102.19 4.86 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 121.949 0.88 . . . . 0.0 111.143 178.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 5.0 p -101.48 123.72 54.77 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.785 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 172.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -92.67 147.82 22.57 Favored 'General case' 0 C--O 1.241 0.607 0 C-N-CA 123.168 0.587 . . . . 0.0 110.206 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' CYS . . . . . 0.51 ' HB3' ' HA ' ' A' ' 246' ' ' GLU . 35.4 t -106.41 154.52 20.7 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 124.034 0.934 . . . . 0.0 110.708 -179.228 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -111.15 96.23 6.01 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 170.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -140.67 119.93 1.65 Allowed Glycine 0 CA--C 1.527 0.802 0 CA-C-O 118.518 -1.156 . . . . 0.0 111.511 177.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -53.51 -39.07 83.68 Favored 'Trans proline' 0 C--N 1.382 2.323 0 C-N-CA 123.42 2.747 . . . . 0.0 113.276 174.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -114.76 101.73 9.34 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 171.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 12.8 t -173.07 102.82 0.13 Allowed 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 -173.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' LYS . . . . . 0.462 ' HE3' ' HE1' ' A' ' 224' ' ' TYR . 52.7 tptt -81.51 -31.34 32.87 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 123.252 0.621 . . . . 0.0 109.738 170.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -81.54 26.92 0.45 Allowed 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 124.938 1.295 . . . . 0.0 112.541 -179.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' GLU . . . . . 0.51 ' HA ' ' HB3' ' A' ' 238' ' ' CYS . 6.1 mm-40 -47.35 -45.77 25.0 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 123.883 0.873 . . . . 0.0 112.541 -178.099 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' TRP . . . . . 0.462 ' HB2' ' HB2' ' A' ' 224' ' ' TYR . 97.9 m95 -86.26 141.04 29.57 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.049 0.452 . . . . 0.0 111.035 178.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 32.9 m-85 -145.58 174.22 11.37 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.333 1.453 . . . . 0.0 109.231 176.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -113.47 141.11 47.5 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 168.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -54.95 -43.01 73.02 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.856 1.262 . . . . 0.0 112.673 -170.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -63.87 -34.47 78.02 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.389 0.676 . . . . 0.0 112.417 -175.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 252' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -65.55 -47.45 75.82 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-O 121.32 0.581 . . . . 0.0 110.246 179.12 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 30.6 m -88.04 5.46 4.02 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.897 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.747 -176.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 55.2 t30 58.73 70.91 0.62 Allowed 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.801 1.24 . . . . 0.0 110.785 178.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 76.6 mt -141.22 152.74 44.84 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.479 1.112 . . . . 0.0 109.121 177.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.8 -21.35 1.94 Allowed 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 123.864 0.866 . . . . 0.0 109.794 166.186 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -78.85 118.62 73.48 Favored Pre-proline 0 N--CA 1.478 0.97 0 C-N-CA 123.685 0.794 . . . . 0.0 109.49 176.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -57.34 121.36 9.91 Favored 'Trans proline' 0 C--N 1.372 1.799 0 C-N-CA 122.78 2.32 . . . . 0.0 111.129 165.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 259' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -52.92 132.79 48.83 Favored 'Trans proline' 0 C--N 1.378 2.12 0 C-N-CA 123.829 3.019 . . . . 0.0 113.738 -178.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 60.2 pttt -83.34 -2.55 55.99 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.313 1.045 . . . . 0.0 112.244 178.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -168.77 -155.63 9.83 Favored Glycine 0 C--N 1.344 0.984 0 CA-C-O 120.033 -0.315 . . . . 0.0 112.502 -179.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 25.8 p -62.19 106.81 0.78 Allowed 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.949 0.9 . . . . 0.0 111.447 -175.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 263' ' ' TRP . . . . . . . . . . . . . 63.1 t90 -92.49 113.98 26.41 Favored 'General case' 0 C--N 1.347 0.481 0 CA-C-N 115.771 -0.649 . . . . 0.0 109.435 -176.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 45.8 m-85 -93.68 118.6 31.61 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 175.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 265' ' ' CYS . . . . . 0.444 ' SG ' ' HB2' ' A' ' 267' ' ' GLU . 18.4 p -66.39 152.98 93.76 Favored Pre-proline 0 CA--C 1.545 0.774 0 CA-C-O 118.507 -0.759 . . . . 0.0 109.715 175.047 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_exo -47.85 -29.01 10.73 Favored 'Trans proline' 0 C--N 1.384 2.446 0 C-N-CA 123.728 2.952 . . . . 0.0 114.244 -178.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 267' ' ' GLU . . . . . 0.444 ' HB2' ' SG ' ' A' ' 265' ' ' CYS . 9.5 mp0 -64.74 -53.71 42.83 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 125.078 1.351 . . . . 0.0 109.814 178.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 268' ' ' CYS . . . . . . . . . . . . . 94.4 m -62.04 -34.91 77.12 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.29 0.636 . . . . 0.0 111.232 176.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -68.13 -23.99 64.95 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.291 0.636 . . . . 0.0 111.929 -179.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 2.8 pp -102.69 -4.68 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 N-CA-C 111.768 0.285 . . . . 0.0 111.768 175.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 . . . . . 0 N--CA 1.484 1.274 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 170.876 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 29.9 p . . . . . 0 N--CA 1.478 0.947 0 CA-C-O 121.526 0.679 . . . . 0.0 109.992 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 58.1 tp -110.63 98.76 7.86 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.026 0.931 . . . . 0.0 108.584 -178.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -136.72 128.89 29.72 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -173.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 42.2 t 172.75 166.9 0.12 Allowed 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 125.262 1.425 . . . . 0.0 108.838 171.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -68.34 -38.37 81.44 Favored 'General case' 0 N--CA 1.484 1.273 0 O-C-N 121.969 -0.457 . . . . 0.0 110.427 175.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 10.0 p -83.79 -9.8 58.54 Favored 'General case' 0 N--CA 1.484 1.257 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.909 176.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 22.2 mm-40 48.66 77.61 0.1 Allowed 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 124.742 1.217 . . . . 0.0 112.114 -173.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' ARG . . . . . 0.516 ' HE ' ' HE2' ' A' ' 232' ' ' PHE . 26.7 ttt85 -135.73 149.65 49.27 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.625 1.17 . . . . 0.0 108.273 -175.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 29.0 m -70.33 160.07 5.27 Favored 'Isoleucine or valine' 0 C--O 1.242 0.696 0 CA-C-O 121.255 0.55 . . . . 0.0 110.647 177.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . 0.736 ' HB3' ' HB3' ' A' ' 235' ' ' MET . 48.2 m -113.88 118.18 33.47 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 176.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' PHE . . . . . 0.516 ' HE2' ' HE ' ' A' ' 229' ' ' ARG . 3.9 p90 -112.23 66.54 0.64 Allowed 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.318 1.047 . . . . 0.0 110.091 -167.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 86.58 -21.76 16.69 Favored Glycine 0 N--CA 1.472 1.086 0 CA-C-N 115.002 -0.999 . . . . 0.0 113.51 179.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 30.7 mm-40 -106.56 99.04 8.64 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 170.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 235' ' ' MET . . . . . 0.736 ' HB3' ' HB3' ' A' ' 231' ' ' SER . 25.7 ptt? -142.14 123.3 14.65 Favored 'General case' 0 C--O 1.241 0.647 0 CA-C-O 121.325 0.584 . . . . 0.0 110.836 178.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 0.529 HG23 ' HG3' ' A' ' 259' ' ' PRO . 6.2 p -100.12 124.62 53.7 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 CA-C-N 115.332 -0.849 . . . . 0.0 108.912 172.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -91.2 148.19 22.53 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.31 -178.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 238' ' ' CYS . . . . . 0.577 ' HB3' ' HA ' ' A' ' 246' ' ' GLU . 36.7 t -108.09 153.15 23.55 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 123.531 0.732 . . . . 0.0 109.657 173.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -118.18 93.77 4.25 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.678 0.791 . . . . 0.0 109.176 174.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -143.88 126.39 2.73 Favored Glycine 0 CA--C 1.527 0.802 0 CA-C-O 118.21 -1.328 . . . . 0.0 110.632 172.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -58.51 -50.5 9.37 Favored 'Trans proline' 0 C--N 1.376 1.986 0 CA-C-N 120.342 2.071 . . . . 0.0 110.96 177.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 8.7 p-10 -94.1 89.91 6.19 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 114.61 -1.177 . . . . 0.0 109.058 171.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 42.8 t -173.23 110.9 0.2 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.293 1.037 . . . . 0.0 109.197 -176.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 244' ' ' LYS . . . . . 0.549 ' H ' ' HD2' ' A' ' 244' ' ' LYS . 0.0 OUTLIER -88.85 -24.91 22.42 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.32 0.648 . . . . 0.0 110.995 178.985 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 36.6 m-85 -90.85 27.48 1.79 Allowed 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.403 1.081 . . . . 0.0 111.667 -177.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 246' ' ' GLU . . . . . 0.577 ' HA ' ' HB3' ' A' ' 238' ' ' CYS . 6.9 mm-40 -46.66 -45.07 19.02 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 124.023 0.929 . . . . 0.0 112.307 -179.182 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 247' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -83.44 126.74 33.07 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 121.56 0.695 . . . . 0.0 111.039 178.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 48.0 m-85 -134.64 174.79 10.17 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.352 1.461 . . . . 0.0 108.411 170.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 249' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -127.32 148.53 50.24 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.725 0.81 . . . . 0.0 108.951 178.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -58.35 -32.7 68.78 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 124.358 1.063 . . . . 0.0 113.033 -172.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -65.86 -36.41 83.37 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.55 0.74 . . . . 0.0 112.067 179.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 252' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -70.82 -56.02 7.23 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.597 0.759 . . . . 0.0 110.295 -178.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . 0.523 HG21 HG11 ' A' ' 236' ' ' VAL . 34.2 m -79.86 -3.68 6.46 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 CA-C-N 114.775 -1.102 . . . . 0.0 111.839 -175.405 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 14.4 m120 65.59 27.28 11.52 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 125.012 1.325 . . . . 0.0 112.123 173.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 33.8 mt -79.01 112.7 16.48 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.589 0.756 . . . . 0.0 109.595 172.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -88.91 -2.85 58.79 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.82 0.848 . . . . 0.0 109.489 168.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -127.08 146.12 56.59 Favored Pre-proline 0 CA--C 1.547 0.851 0 C-N-CA 124.628 1.171 . . . . 0.0 109.564 -176.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -72.86 134.84 22.42 Favored 'Trans proline' 0 C--N 1.37 1.689 0 C-N-CA 122.47 2.113 . . . . 0.0 110.845 171.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 259' ' ' PRO . . . . . 0.529 ' HG3' HG23 ' A' ' 236' ' ' VAL . 39.6 Cg_endo -63.68 149.82 89.95 Favored 'Trans proline' 0 C--N 1.375 1.958 0 C-N-CA 122.362 2.041 . . . . 0.0 112.062 177.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -75.87 -18.87 59.26 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.058 0.943 . . . . 0.0 112.912 -168.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -170.66 -134.48 1.76 Allowed Glycine 0 C--N 1.343 0.935 0 N-CA-C 111.663 -0.575 . . . . 0.0 111.663 -178.102 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 42.1 p -69.57 106.34 2.99 Favored 'General case' 0 C--N 1.353 0.729 0 C-N-CA 122.865 0.466 . . . . 0.0 109.835 177.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 263' ' ' TRP . . . . . 0.466 ' O ' ' HA ' ' A' ' 238' ' ' CYS . 76.1 t90 -87.98 122.23 31.34 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.206 -176.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -101.17 118.12 36.36 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 176.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 265' ' ' CYS . . . . . 0.492 ' SG ' ' HG2' ' A' ' 267' ' ' GLU . 16.2 p -66.91 155.52 89.72 Favored Pre-proline 0 CA--C 1.551 0.988 0 C-N-CA 123.793 0.837 . . . . 0.0 110.946 -178.385 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -38.91 -50.47 2.57 Favored 'Trans proline' 0 C--N 1.388 2.647 0 C-N-CA 124.739 3.626 . . . . 0.0 115.314 -176.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 267' ' ' GLU . . . . . 0.492 ' HG2' ' SG ' ' A' ' 265' ' ' CYS . 2.5 pm0 -62.2 -39.34 92.4 Favored 'General case' 0 CA--C 1.549 0.933 0 CA-C-N 115.892 -0.594 . . . . 0.0 112.357 -178.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 268' ' ' CYS . . . . . . . . . . . . . 63.6 m -68.87 -44.1 74.01 Favored 'General case' 0 N--CA 1.495 1.821 0 C-N-CA 122.699 0.399 . . . . 0.0 111.223 176.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -66.78 -31.48 72.15 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.37 -169.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 1.8 mp -91.05 -46.82 14.58 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.078 0 C-N-CA 123.382 0.673 . . . . 0.0 109.666 176.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 . . . . . 0 CA--C 1.558 1.288 0 C-N-CA 123.309 0.644 . . . . 0.0 109.711 -175.555 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 9.1 p . . . . . 0 N--CA 1.476 0.844 0 CA-C-O 121.223 0.535 . . . . 0.0 111.027 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 5.8 tt -140.83 108.35 5.58 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 -174.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' TYR . . . . . 0.44 ' HB3' ' HA ' ' A' ' 245' ' ' TYR . 63.7 m-85 -140.04 124.11 17.66 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 176.427 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 48.7 t 171.25 152.18 0.06 Allowed 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 125.52 1.528 . . . . 0.0 108.08 174.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 50.4 t80 -65.29 -38.74 91.19 Favored 'General case' 0 N--CA 1.486 1.351 0 CA-C-N 119.138 0.881 . . . . 0.0 110.965 -179.194 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 5.8 p -68.43 -14.23 62.86 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 123.034 0.208 . . . . 0.0 111.07 177.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 87.0 mm-40 57.12 85.82 0.08 Allowed 'General case' 0 C--N 1.364 1.238 0 C-N-CA 125.231 1.413 . . . . 0.0 111.845 179.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -160.17 149.12 17.29 Favored 'General case' 0 C--O 1.242 0.706 0 CA-C-N 114.745 -1.116 . . . . 0.0 108.713 178.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 31.0 m -71.51 149.97 9.35 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 122.78 0.432 . . . . 0.0 111.184 178.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 15.8 m -94.26 68.34 3.62 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-O 121.745 0.783 . . . . 0.0 109.23 177.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 47.6 t80 -83.04 91.42 7.18 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.463 -171.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 103.98 -19.79 42.74 Favored Glycine 0 N--CA 1.476 1.33 0 CA-C-N 116.066 -0.515 . . . . 0.0 113.694 175.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.1 64.67 1.59 Allowed 'General case' 0 N--CA 1.481 1.124 0 CA-C-O 122.392 1.091 . . . . 0.0 110.122 178.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 235' ' ' MET . . . . . . . . . . . . . 18.3 ptm -99.56 130.68 45.82 Favored 'General case' 0 N--CA 1.483 1.177 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.75 -176.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 7.0 p -124.95 126.88 71.96 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.939 0 C-N-CA 124.565 1.146 . . . . 0.0 108.964 177.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -91.86 154.22 19.02 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.873 0.869 . . . . 0.0 111.302 -178.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 238' ' ' CYS . . . . . 0.649 ' HB3' ' HA ' ' A' ' 246' ' ' GLU . 11.3 t -117.12 155.47 29.26 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.929 1.292 . . . . 0.0 109.565 175.523 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -117.9 105.34 11.82 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.757 0.823 . . . . 0.0 109.406 172.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -140.96 144.74 15.04 Favored Glycine 0 CA--C 1.528 0.874 0 CA-C-O 118.533 -1.148 . . . . 0.0 111.405 173.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -61.38 -47.88 10.89 Favored 'Trans proline' 0 C--N 1.378 2.112 0 C-N-CA 122.929 2.419 . . . . 0.0 112.028 -178.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 40.9 t30 -124.5 107.44 11.07 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 170.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 43.8 t -157.45 117.05 3.36 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 123.522 0.729 . . . . 0.0 109.376 -174.173 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -80.5 -44.62 18.84 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.441 0.697 . . . . 0.0 109.852 176.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . 0.44 ' HA ' ' HB3' ' A' ' 224' ' ' TYR . 45.6 m-85 -82.72 31.11 0.42 Allowed 'General case' 0 CA--C 1.553 1.089 0 C-N-CA 124.18 0.992 . . . . 0.0 112.393 -175.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 246' ' ' GLU . . . . . 0.649 ' HA ' ' HB3' ' A' ' 238' ' ' CYS . 6.9 mm-40 -47.34 -42.79 22.16 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.832 0.853 . . . . 0.0 111.537 173.446 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 247' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -90.34 139.05 31.04 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-O 121.052 0.453 . . . . 0.0 111.132 177.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -147.28 173.09 12.9 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.062 1.345 . . . . 0.0 109.401 174.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 249' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -117.63 140.4 49.7 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.427 0.691 . . . . 0.0 110.03 174.207 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -54.58 -28.09 43.64 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 125.301 1.44 . . . . 0.0 112.36 -179.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -60.61 -54.73 41.79 Favored 'General case' 0 CA--C 1.555 1.16 0 C-N-CA 123.407 0.683 . . . . 0.0 111.176 177.019 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 252' ' ' CYS . . . . . . . . . . . . . 1.1 m -66.21 -44.68 83.19 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.773 0.829 . . . . 0.0 111.594 -177.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 33.8 m -84.4 -0.71 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.619 -177.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 21.1 m120 60.66 19.18 9.18 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 125.038 1.335 . . . . 0.0 113.278 172.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 92.7 mt -84.64 120.94 26.95 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 177.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 31.9 mmtp -103.74 21.33 16.41 Favored 'General case' 0 N--CA 1.485 1.322 0 CA-C-O 121.319 0.58 . . . . 0.0 110.07 -177.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -157.89 139.56 9.93 Favored Pre-proline 0 C--O 1.245 0.832 0 C-N-CA 124.619 1.167 . . . . 0.0 109.069 -174.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_exo -67.99 115.19 3.67 Favored 'Trans proline' 0 C--N 1.373 1.842 0 C-N-CA 122.999 2.466 . . . . 0.0 111.668 176.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 259' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -68.48 121.1 8.02 Favored 'Trans proline' 0 C--N 1.376 2.026 0 C-N-CA 122.374 2.049 . . . . 0.0 111.252 178.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 10.3 mtmp? -72.48 124.31 24.93 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.12 0.568 . . . . 0.0 110.354 178.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 115.76 -159.74 13.67 Favored Glycine 0 C--N 1.337 0.627 0 N-CA-C 111.494 -0.642 . . . . 0.0 111.494 174.081 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 45.6 p -83.56 107.18 15.86 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 172.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 263' ' ' TRP . . . . . . . . . . . . . 40.2 t90 -77.04 147.23 36.86 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-O 121.119 0.485 . . . . 0.0 110.144 179.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -120.13 120.66 36.87 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 123.735 0.814 . . . . 0.0 108.972 178.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 17.3 p -67.71 161.09 69.23 Favored Pre-proline 0 CA--C 1.55 0.97 0 C-N-CA 123.537 0.735 . . . . 0.0 110.646 176.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -41.52 -29.91 0.84 Allowed 'Trans proline' 0 C--N 1.383 2.387 0 C-N-CA 124.002 3.134 . . . . 0.0 115.593 176.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -63.47 -66.78 0.49 Allowed 'General case' 0 N--CA 1.483 1.199 0 CA-C-O 121.605 0.717 . . . . 0.0 109.806 173.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 268' ' ' CYS . . . . . . . . . . . . . 58.6 m -71.26 -28.62 64.29 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 114.617 -1.174 . . . . 0.0 111.949 -167.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -80.04 -56.12 4.47 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.373 0.669 . . . . 0.0 110.504 -178.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 45.5 mm -82.21 -59.44 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 122.768 0.427 . . . . 0.0 111.714 -168.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 . . . . . 0 N--CA 1.481 1.083 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -168.769 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 53.0 p . . . . . 0 CA--C 1.552 1.045 0 N-CA-C 111.558 0.207 . . . . 0.0 111.558 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 5.4 tt -70.53 86.03 0.63 Allowed 'General case' 0 C--N 1.363 1.158 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 176.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' TYR . . . . . 0.618 ' HB3' ' HA ' ' A' ' 245' ' ' TYR . 88.0 m-85 -137.39 131.99 32.86 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.534 1.134 . . . . 0.0 108.251 177.283 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 34.8 t 172.48 160.07 0.11 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.028 1.331 . . . . 0.0 108.888 177.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -67.52 -29.09 68.4 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 122.543 0.337 . . . . 0.0 111.0 177.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' CYS . . . . . 0.453 ' SG ' ' HB2' ' A' ' 229' ' ' ARG . 12.2 p -84.86 -5.84 59.34 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-O 119.224 -0.417 . . . . 0.0 111.939 178.164 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 33.1 mm-40 54.88 78.94 0.16 Allowed 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 124.494 1.117 . . . . 0.0 111.269 -173.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' ARG . . . . . 0.453 ' HB2' ' SG ' ' A' ' 227' ' ' CYS . 3.1 tmm_? -154.23 150.21 27.82 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 -176.442 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 30.7 m -66.98 156.84 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 123.388 0.675 . . . . 0.0 112.56 178.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 22.5 m -109.67 89.53 3.04 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-N 115.251 -0.886 . . . . 0.0 108.655 175.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 88.2 t80 -114.45 124.68 52.53 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.513 0.725 . . . . 0.0 109.697 177.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 79.58 -16.68 10.02 Favored Glycine 0 C--N 1.347 1.173 0 CA-C-N 116.054 -0.521 . . . . 0.0 113.023 -179.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . 0.44 ' HB3' ' H ' ' A' ' 250' ' ' TYR . 41.5 mt-10 -140.62 98.1 3.34 Favored 'General case' 0 C--N 1.349 0.546 0 C-N-CA 124.844 1.257 . . . . 0.0 107.773 -176.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 235' ' ' MET . . . . . . . . . . . . . 3.5 mpp? -127.4 95.12 4.17 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 -178.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 4.1 p -103.13 126.28 57.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 171.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -95.86 156.99 16.1 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.293 0.568 . . . . 0.0 111.12 -177.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 238' ' ' CYS . . . . . 0.738 ' HB3' ' HA ' ' A' ' 246' ' ' GLU . 18.5 t -110.81 153.18 25.73 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 124.442 1.097 . . . . 0.0 109.409 174.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -108.65 92.58 4.11 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 174.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -143.9 114.34 0.81 Allowed Glycine 0 CA--C 1.529 0.912 0 CA-C-O 118.08 -1.4 . . . . 0.0 111.863 175.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -54.05 -39.75 84.19 Favored 'Trans proline' 0 C--N 1.377 2.039 0 C-N-CA 123.104 2.536 . . . . 0.0 112.907 178.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -111.3 91.23 3.58 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 171.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 51.5 t -171.98 116.74 0.37 Allowed 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.208 1.003 . . . . 0.0 108.745 -175.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 23.6 pttm -89.03 -33.38 17.17 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 122.701 0.401 . . . . 0.0 110.538 176.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . 0.618 ' HA ' ' HB3' ' A' ' 224' ' ' TYR . 22.0 m-30 -79.28 29.92 0.22 Allowed 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.741 1.216 . . . . 0.0 112.235 179.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 246' ' ' GLU . . . . . 0.738 ' HA ' ' HB3' ' A' ' 238' ' ' CYS . 6.9 mm-40 -47.44 -45.96 26.21 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.745 0.818 . . . . 0.0 111.086 170.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 247' ' ' TRP . . . . . 0.536 ' HB2' ' HB2' ' A' ' 224' ' ' TYR . 91.8 m95 -78.59 134.72 37.18 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 121.109 0.48 . . . . 0.0 110.76 177.211 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -144.08 170.88 15.11 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 125.163 1.385 . . . . 0.0 108.424 170.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 249' ' ' HIS . . . . . 0.422 ' HD2' ' HB2' ' A' ' 252' ' ' CYS . 0.0 OUTLIER -115.52 133.98 55.51 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 174.092 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . 0.44 ' H ' ' HB3' ' A' ' 234' ' ' GLU . 49.9 m-85 -47.74 -57.5 5.49 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 125.354 1.462 . . . . 0.0 114.467 -168.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -69.18 -26.63 64.93 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 122.381 0.272 . . . . 0.0 111.246 -170.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 252' ' ' CYS . . . . . 0.422 ' HB2' ' HD2' ' A' ' 249' ' ' HIS . 36.1 t -68.32 -32.1 71.99 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 124.087 0.955 . . . . 0.0 111.013 177.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 17.5 m -105.24 16.84 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 C-N-CA 123.34 0.656 . . . . 0.0 110.879 175.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 17.2 m120 67.54 9.11 6.81 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 125.364 1.466 . . . . 0.0 114.13 172.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 87.0 mt -76.97 137.42 39.02 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 122.925 0.49 . . . . 0.0 109.909 173.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.74 -23.24 9.29 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.909 0.884 . . . . 0.0 109.747 176.232 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -126.44 148.83 65.65 Favored Pre-proline 0 CA--C 1.549 0.91 0 C-N-CA 124.061 0.944 . . . . 0.0 110.158 -179.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -65.59 139.52 58.75 Favored 'Trans proline' 0 C--N 1.38 2.224 0 C-N-CA 123.11 2.54 . . . . 0.0 112.404 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 259' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_exo -59.3 151.59 66.66 Favored 'Trans proline' 0 C--N 1.377 2.069 0 C-N-CA 122.705 2.27 . . . . 0.0 112.095 172.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -89.65 -21.0 22.99 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.846 0.858 . . . . 0.0 110.266 -176.07 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -147.87 -144.09 3.93 Favored Glycine 0 C--N 1.349 1.29 0 CA-C-O 119.821 -0.433 . . . . 0.0 112.332 -179.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 30.2 p -67.61 111.91 4.45 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 123.569 0.748 . . . . 0.0 111.105 -177.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 263' ' ' TRP . . . . . . . . . . . . . 32.1 t90 -93.41 116.8 29.35 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -100.51 107.01 18.61 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 123.421 0.689 . . . . 0.0 109.472 178.148 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 15.5 p -57.28 160.41 6.86 Favored Pre-proline 0 N--CA 1.487 1.384 0 C-N-CA 124.418 1.087 . . . . 0.0 111.046 177.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -33.83 -46.88 0.45 Allowed 'Trans proline' 0 C--N 1.396 3.05 0 C-N-CA 124.867 3.711 . . . . 0.0 114.834 -179.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -61.56 -50.41 72.76 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 124.823 1.249 . . . . 0.0 112.04 -177.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 268' ' ' CYS . . . . . . . . . . . . . 79.6 m -72.49 -29.11 63.35 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.851 0.86 . . . . 0.0 111.982 -175.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.02 -15.27 36.86 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 111.885 0.328 . . . . 0.0 111.885 -179.208 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 33.2 mm -88.09 -16.09 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 C-N-CA 123.337 0.655 . . . . 0.0 110.237 171.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 . . . . . 0 CA--C 1.559 1.313 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 172.52 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 13.5 p . . . . . 0 N--CA 1.48 1.058 0 N-CA-C 110.382 -0.229 . . . . 0.0 110.382 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 66.6 tp -79.91 97.32 6.67 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.369 0.668 . . . . 0.0 109.491 178.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' TYR . . . . . 0.657 ' HB3' ' HA ' ' A' ' 245' ' ' TYR . 19.2 m-85 -136.22 128.87 30.69 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.86 0.864 . . . . 0.0 109.31 -179.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' CYS . . . . . 0.424 ' HB2' ' O ' ' A' ' 224' ' ' TYR . 40.3 t 170.21 163.32 0.07 Allowed 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 125.64 1.576 . . . . 0.0 108.626 167.029 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -59.91 -44.93 94.01 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 122.475 0.31 . . . . 0.0 110.51 173.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 14.1 p -76.79 -12.17 59.94 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.106 0.563 . . . . 0.0 112.194 -176.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 82.3 mm-40 51.82 77.4 0.15 Allowed 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 124.519 1.128 . . . . 0.0 112.135 -172.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 72.5 ttt180 -147.56 149.52 32.73 Favored 'General case' 0 C--O 1.242 0.691 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 176.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 26.6 m -67.54 146.1 13.29 Favored 'Isoleucine or valine' 0 C--O 1.245 0.825 0 CA-C-O 121.14 0.495 . . . . 0.0 110.808 177.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . 0.448 ' HB3' ' O ' ' A' ' 234' ' ' GLU . 50.9 m -79.43 87.14 5.07 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 172.43 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 83.1 t80 -86.25 107.87 18.13 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.453 0.701 . . . . 0.0 111.095 -173.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 73.53 -1.23 45.32 Favored Glycine 0 C--N 1.351 1.392 0 CA-C-N 115.741 -0.663 . . . . 0.0 114.191 175.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . 0.448 ' O ' ' HB3' ' A' ' 231' ' ' SER . 14.7 pt-20 -154.97 141.05 18.41 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 124.386 1.074 . . . . 0.0 108.908 -175.267 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 235' ' ' MET . . . . . 0.419 ' HB3' ' HB3' ' A' ' 231' ' ' SER . 0.0 OUTLIER -160.21 136.77 8.93 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 122.885 0.474 . . . . 0.0 110.534 174.857 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 4.2 p -117.7 124.22 72.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 173.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -87.96 127.61 35.37 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.048 0.539 . . . . 0.0 110.233 -177.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 238' ' ' CYS . . . . . . . . . . . . . 48.8 t -92.6 154.5 18.36 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.002 0.921 . . . . 0.0 110.691 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -116.59 109.74 17.63 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 169.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . 0.577 ' HA3' ' SG ' ' A' ' 268' ' ' CYS . . . -144.17 140.58 9.49 Favored Glycine 0 C--N 1.344 0.978 0 CA-C-O 118.786 -1.008 . . . . 0.0 113.215 172.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -57.54 -54.95 2.81 Favored 'Trans proline' 0 C--N 1.374 1.913 0 C-N-CA 122.856 2.37 . . . . 0.0 112.627 171.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -107.49 77.65 1.15 Allowed 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 176.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 34.5 t -150.85 106.25 3.36 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 -174.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 244' ' ' LYS . . . . . 0.462 ' HA ' ' HE3' ' A' ' 244' ' ' LYS . 0.4 OUTLIER -89.04 -29.36 19.5 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.307 0.643 . . . . 0.0 110.792 178.925 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . 0.657 ' HA ' ' HB3' ' A' ' 224' ' ' TYR . 23.5 m-85 -82.03 22.0 0.83 Allowed 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.632 0.773 . . . . 0.0 112.95 -174.329 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -46.75 -37.36 8.4 Favored 'General case' 0 N--CA 1.501 2.114 0 C-N-CA 124.72 1.208 . . . . 0.0 112.849 -171.132 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 247' ' ' TRP . . . . . . . . . . . . . 97.7 m95 -77.69 101.83 6.81 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.148 0.579 . . . . 0.0 109.771 175.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -113.98 176.37 5.07 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.357 1.063 . . . . 0.0 110.466 178.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 249' ' ' HIS . . . . . 0.509 ' CD2' ' HB2' ' A' ' 252' ' ' CYS . 0.9 OUTLIER -129.49 144.05 51.09 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.793 1.237 . . . . 0.0 109.166 174.724 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . 0.484 ' HB3' ' O ' ' A' ' 255' ' ' LEU . 65.8 m-85 -62.19 -38.8 90.51 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 124.494 1.118 . . . . 0.0 112.825 -169.219 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -60.72 -36.84 79.83 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 124.252 1.021 . . . . 0.0 111.452 -176.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 252' ' ' CYS . . . . . 0.509 ' HB2' ' CD2' ' A' ' 249' ' ' HIS . 0.5 OUTLIER -64.62 -42.27 95.61 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.346 1.058 . . . . 0.0 110.456 -177.037 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 34.0 m -100.07 5.89 9.78 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 CA-C-N 114.777 -1.101 . . . . 0.0 111.309 -173.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 17.3 m120 66.33 13.17 9.07 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 125.054 1.342 . . . . 0.0 113.288 172.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.484 ' O ' ' HB3' ' A' ' 250' ' ' TYR . 92.3 mt -80.68 125.41 30.0 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 175.318 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -89.33 -23.5 22.23 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 172.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -134.08 150.97 75.73 Favored Pre-proline 0 CA--C 1.55 0.954 0 C-N-CA 124.589 1.156 . . . . 0.0 108.746 179.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 258' ' ' PRO . . . . . 0.429 ' HA ' ' HD3' ' A' ' 259' ' ' PRO . 45.6 Cg_endo -67.28 143.29 63.7 Favored 'Trans proline' 0 C--N 1.375 1.937 0 C-N-CA 122.318 2.012 . . . . 0.0 110.772 172.511 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 259' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 258' ' ' PRO . 40.6 Cg_exo -60.65 163.89 14.68 Favored 'Trans proline' 0 C--N 1.374 1.899 0 C-N-CA 123.215 2.61 . . . . 0.0 113.849 -179.194 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -63.32 -34.66 78.18 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 114.943 -1.026 . . . . 0.0 112.095 -177.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -120.21 -164.44 12.53 Favored Glycine 0 CA--C 1.523 0.579 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.702 175.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 58.9 m -65.76 125.4 25.18 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.446 0.699 . . . . 0.0 110.0 -179.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 263' ' ' TRP . . . . . . . . . . . . . 39.5 t90 -84.5 129.42 34.86 Favored 'General case' 0 C--O 1.242 0.669 0 CA-C-O 121.719 0.771 . . . . 0.0 111.053 -175.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 264' ' ' TYR . . . . . 0.419 ' O ' ' HE3' ' A' ' 269' ' ' LYS . 75.6 m-85 -111.07 126.84 55.24 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.02 1.328 . . . . 0.0 107.587 172.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 265' ' ' CYS . . . . . 0.448 ' SG ' ' HB2' ' A' ' 267' ' ' GLU . 26.4 p -67.98 161.89 63.83 Favored Pre-proline 0 CA--C 1.554 1.121 0 CA-C-O 118.661 -0.685 . . . . 0.0 109.858 175.147 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_exo -46.84 -33.26 13.81 Favored 'Trans proline' 0 C--N 1.39 2.73 0 C-N-CA 123.414 2.743 . . . . 0.0 113.469 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 267' ' ' GLU . . . . . 0.448 ' HB2' ' SG ' ' A' ' 265' ' ' CYS . 26.6 mt-10 -59.9 -58.41 8.68 Favored 'General case' 0 C--O 1.213 -0.837 0 C-N-CA 124.651 1.181 . . . . 0.0 110.054 175.536 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 268' ' ' CYS . . . . . 0.577 ' SG ' ' HA3' ' A' ' 240' ' ' GLY . 99.0 m -63.86 -27.77 69.39 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.603 0.761 . . . . 0.0 113.049 -176.27 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . 0.419 ' HE3' ' O ' ' A' ' 264' ' ' TYR . 94.2 mttt -68.87 -37.32 78.98 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 122.579 0.352 . . . . 0.0 111.059 176.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 74.1 mt -95.66 -72.06 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.814 0 C-N-CA 122.947 0.499 . . . . 0.0 109.841 179.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 . . . . . 0 C--O 1.25 1.123 0 C-N-CA 124.798 1.239 . . . . 0.0 110.315 -179.714 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 8.4 p . . . . . 0 N--CA 1.479 0.983 0 CA-C-O 120.866 0.365 . . . . 0.0 110.336 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 34.4 tp -97.25 119.3 35.52 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.481 0.712 . . . . 0.0 109.254 178.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' TYR . . . . . 0.438 ' HB3' ' HA ' ' A' ' 245' ' ' TYR . 48.0 m-85 -143.87 141.42 30.3 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.377 0.671 . . . . 0.0 110.29 -175.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 45.3 t 170.58 158.47 0.07 Allowed 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 125.367 1.467 . . . . 0.0 109.274 164.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 35.7 t80 -65.62 -37.99 88.14 Favored 'General case' 0 CA--C 1.551 0.991 0 CA-C-N 117.804 0.275 . . . . 0.0 110.985 177.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 4.6 p -80.45 -12.04 59.61 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 122.589 0.356 . . . . 0.0 111.129 176.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 84.2 mm-40 50.01 81.15 0.06 Allowed 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 124.745 1.218 . . . . 0.0 112.077 -173.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' ARG . . . . . 0.464 HH22 ' HB3' ' A' ' 251' ' ' ASP . 46.7 ttp180 -135.09 149.44 50.06 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 176.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 23.6 m -67.18 147.03 12.78 Favored 'Isoleucine or valine' 0 C--O 1.241 0.635 0 C-N-CA 122.63 0.372 . . . . 0.0 111.328 174.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 40.9 m -98.81 81.71 2.68 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 174.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -86.86 99.95 12.2 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.589 0.756 . . . . 0.0 109.768 -176.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 76.97 -0.09 67.67 Favored Glycine 0 N--CA 1.474 1.178 0 CA-C-N 116.232 -0.44 . . . . 0.0 113.823 178.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -135.35 72.71 1.45 Allowed 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.122 0.969 . . . . 0.0 109.571 -178.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 235' ' ' MET . . . . . . . . . . . . . 3.4 mpp? -105.76 108.46 19.99 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.285 -176.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 5.6 p -111.6 124.17 68.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 171.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -99.9 131.04 46.11 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 123.273 0.629 . . . . 0.0 109.732 -179.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 238' ' ' CYS . . . . . . . . . . . . . 18.1 t -81.66 143.25 32.04 Favored 'General case' 0 C--O 1.223 -0.3 0 C-N-CA 123.873 0.869 . . . . 0.0 110.58 179.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -97.39 93.79 6.68 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 166.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -142.56 112.92 0.76 Allowed Glycine 0 CA--C 1.521 0.442 0 CA-C-O 118.34 -1.255 . . . . 0.0 110.445 174.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -67.22 -24.43 44.08 Favored 'Trans proline' 0 C--N 1.366 1.492 0 CA-C-N 120.112 1.956 . . . . 0.0 111.38 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 15.3 p-10 -110.81 70.81 0.73 Allowed 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.408 1.483 . . . . 0.0 108.821 176.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 39.0 t -167.4 107.08 0.58 Allowed 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.308 -169.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? -77.1 -36.15 55.87 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.037 0.535 . . . . 0.0 109.808 171.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . 0.438 ' HA ' ' HB3' ' A' ' 224' ' ' TYR . 12.2 m-85 -79.62 24.77 0.36 Allowed 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 -171.272 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -45.98 -43.5 14.21 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 124.781 1.232 . . . . 0.0 114.122 -170.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 247' ' ' TRP . . . . . . . . . . . . . 70.5 m95 -76.92 129.53 36.3 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-O 121.155 0.502 . . . . 0.0 110.884 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -140.19 174.81 10.14 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.767 1.227 . . . . 0.0 109.193 179.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 249' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -125.1 141.03 52.37 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.062 0.945 . . . . 0.0 109.971 179.346 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 39.3 m-85 -56.16 -35.06 66.76 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 125.622 1.569 . . . . 0.0 112.852 -171.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 251' ' ' ASP . . . . . 0.464 ' HB3' HH22 ' A' ' 229' ' ' ARG . 11.6 t70 -57.97 -51.18 70.7 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 124.746 1.219 . . . . 0.0 111.504 177.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 252' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -62.26 -42.44 99.33 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.832 0.853 . . . . 0.0 110.946 -176.108 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . 0.41 HG23 ' HG ' ' A' ' 255' ' ' LEU . 35.1 m -99.01 5.56 9.66 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.652 -172.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 34.6 m-80 62.95 17.93 10.46 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 125.075 1.35 . . . . 0.0 113.621 171.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.41 ' HG ' HG23 ' A' ' 253' ' ' VAL . 87.2 mt -79.62 126.01 30.35 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 177.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 83.3 mttt -99.18 -25.94 14.36 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.993 0.917 . . . . 0.0 109.399 178.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -119.82 156.41 54.08 Favored Pre-proline 0 CA--C 1.551 0.999 0 C-N-CA 125.013 1.325 . . . . 0.0 109.043 176.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -68.14 143.33 59.02 Favored 'Trans proline' 0 C--N 1.378 2.107 0 C-N-CA 122.409 2.073 . . . . 0.0 111.192 172.075 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 259' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -56.75 156.24 23.85 Favored 'Trans proline' 0 C--N 1.378 2.107 0 C-N-CA 123.163 2.576 . . . . 0.0 113.203 177.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -78.89 -7.53 58.02 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 122.889 0.476 . . . . 0.0 111.967 -179.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 178.93 -133.67 2.15 Favored Glycine 0 C--N 1.346 1.109 0 CA-C-O 119.949 -0.362 . . . . 0.0 112.565 177.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 37.1 p -63.71 106.54 1.0 Allowed 'General case' 0 C--N 1.351 0.651 0 C-N-CA 124.344 1.058 . . . . 0.0 110.356 -178.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 263' ' ' TRP . . . . . . . . . . . . . 54.7 t90 -98.48 109.4 22.16 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.493 0.717 . . . . 0.0 110.535 -174.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 264' ' ' TYR . . . . . 0.406 ' HD2' ' HB3' ' A' ' 268' ' ' CYS . 44.0 m-85 -94.65 106.23 18.2 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.312 0.645 . . . . 0.0 110.036 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 265' ' ' CYS . . . . . 0.425 ' SG ' ' OE2' ' A' ' 267' ' ' GLU . 13.5 p -64.36 157.9 68.83 Favored Pre-proline 0 CA--C 1.565 1.536 0 CA-C-O 118.05 -0.976 . . . . 0.0 109.783 176.453 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -23.67 -63.0 0.05 OUTLIER 'Trans proline' 0 C--N 1.392 2.824 1 C-N-CA 126.26 4.64 . . . . 0.0 117.981 -168.038 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 267' ' ' GLU . . . . . 0.425 ' OE2' ' SG ' ' A' ' 265' ' ' CYS . 0.0 OUTLIER -71.73 -28.11 63.46 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 122.027 -0.421 . . . . 0.0 111.731 -173.116 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 268' ' ' CYS . . . . . 0.406 ' HB3' ' HD2' ' A' ' 264' ' ' TYR . 91.1 m -68.21 -30.33 69.38 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 124.135 0.974 . . . . 0.0 112.315 179.482 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -92.75 -3.9 54.01 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 122.352 0.261 . . . . 0.0 111.595 -178.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 74.8 mt -106.51 -47.43 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 C-N-CA 124.032 0.933 . . . . 0.0 109.899 177.076 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 . . . . . 0 CA--C 1.563 1.448 0 C-N-CA 125.372 1.469 . . . . 0.0 108.997 -176.347 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 48.0 p . . . . . 0 N--CA 1.477 0.898 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 55.5 tp -96.53 94.04 7.14 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.265 0.626 . . . . 0.0 109.328 -179.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' TYR . . . . . 0.708 ' HB3' ' HA ' ' A' ' 245' ' ' TYR . 39.6 m-85 -137.63 126.1 23.48 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.768 0.827 . . . . 0.0 109.417 -178.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' CYS . . . . . 0.402 ' HB2' ' O ' ' A' ' 224' ' ' TYR . 39.0 t 172.47 162.86 0.12 Allowed 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 125.11 1.364 . . . . 0.0 109.294 169.294 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 56.1 t80 -69.01 -35.48 76.72 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 122.736 0.414 . . . . 0.0 111.383 177.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 13.5 p -82.79 -13.22 56.66 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 122.58 0.352 . . . . 0.0 111.434 178.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 83.8 mm-40 54.99 85.58 0.06 Allowed 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.501 1.12 . . . . 0.0 112.02 -172.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 42.0 ttp180 -150.77 150.64 31.26 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 115.064 -0.971 . . . . 0.0 108.439 174.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 32.9 m -76.17 152.98 5.99 Favored 'Isoleucine or valine' 0 C--O 1.242 0.665 0 CA-C-O 121.334 0.587 . . . . 0.0 110.974 178.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . 0.489 ' HB2' ' HG2' ' A' ' 235' ' ' MET . 14.9 m -101.74 101.48 11.98 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.128 0.971 . . . . 0.0 108.445 175.099 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -72.48 81.05 1.06 Allowed 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.776 0.83 . . . . 0.0 109.661 -177.055 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 74.16 -18.39 2.07 Favored Glycine 0 CA--C 1.537 1.437 0 CA-C-N 115.193 -0.912 . . . . 0.0 114.366 -179.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -98.28 66.51 1.77 Allowed 'General case' 0 C--O 1.243 0.743 0 C-N-CA 123.75 0.82 . . . . 0.0 109.62 -176.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 235' ' ' MET . . . . . 0.489 ' HG2' ' HB2' ' A' ' 231' ' ' SER . 60.0 mtm -94.26 120.2 34.15 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 114.804 -1.089 . . . . 0.0 109.822 -178.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 0.526 HG11 HG21 ' A' ' 253' ' ' VAL . 3.3 p -106.1 124.21 61.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 168.567 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -90.71 155.78 18.57 Favored 'General case' 0 C--O 1.242 0.706 0 C-N-CA 123.148 0.579 . . . . 0.0 110.077 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 238' ' ' CYS . . . . . 0.426 ' HB3' ' HA ' ' A' ' 246' ' ' GLU . 35.6 t -127.69 113.97 16.71 Favored 'General case' 0 C--O 1.243 0.735 0 C-N-CA 123.284 0.634 . . . . 0.0 110.069 -178.479 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -73.01 94.46 1.88 Allowed 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 173.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -143.68 133.05 5.2 Favored Glycine 0 C--N 1.346 1.11 0 CA-C-O 117.898 -1.501 . . . . 0.0 110.843 175.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -64.32 -46.04 8.45 Favored 'Trans proline' 0 C--N 1.377 2.051 0 C-N-CA 122.575 2.183 . . . . 0.0 111.352 -178.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 21.4 m120 -101.86 92.2 4.71 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 170.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 9.0 t -159.12 90.63 0.98 Allowed 'General case' 0 C--O 1.24 0.601 0 C-N-CA 122.984 0.514 . . . . 0.0 110.172 179.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 4.9 tppp? -65.87 -42.36 90.45 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-O 121.687 0.755 . . . . 0.0 109.95 173.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . 0.708 ' HA ' ' HB3' ' A' ' 224' ' ' TYR . 23.7 m-85 -84.09 24.6 0.91 Allowed 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 114.435 -1.257 . . . . 0.0 112.224 -177.646 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 246' ' ' GLU . . . . . 0.426 ' HA ' ' HB3' ' A' ' 238' ' ' CYS . 16.2 pt-20 -47.97 -33.75 8.26 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 124.537 1.135 . . . . 0.0 112.203 -179.562 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 247' ' ' TRP . . . . . . . . . . . . . 99.3 m95 -87.37 123.07 31.93 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.339 0.655 . . . . 0.0 110.016 172.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 49.8 m-85 -131.94 175.89 8.83 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.256 1.422 . . . . 0.0 109.23 176.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 249' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -110.94 144.5 39.91 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.093 0.957 . . . . 0.0 109.046 171.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . 0.481 ' HA ' HG22 ' A' ' 253' ' ' VAL . 74.8 m-85 -56.7 -27.06 58.29 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 124.652 1.181 . . . . 0.0 111.854 178.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -53.76 -59.37 4.7 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.861 1.264 . . . . 0.0 111.5 172.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 252' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -65.1 -35.11 80.08 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.789 0.836 . . . . 0.0 111.491 -175.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . 0.526 HG21 HG11 ' A' ' 236' ' ' VAL . 11.9 m -97.2 2.76 10.23 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.715 -172.232 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 64.7 t30 64.75 16.85 10.66 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 124.699 1.2 . . . . 0.0 112.455 168.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 88.6 mt -83.73 116.1 22.52 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 -177.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 46.4 mmtm -76.14 -8.41 56.95 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.719 0.808 . . . . 0.0 111.65 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -156.55 166.37 16.67 Favored Pre-proline 0 CA--C 1.556 1.176 0 C-N-CA 124.884 1.273 . . . . 0.0 108.983 -173.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -52.31 147.45 28.55 Favored 'Trans proline' 0 C--N 1.382 2.337 0 C-N-CA 122.717 2.278 . . . . 0.0 112.298 171.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 259' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -58.69 172.92 1.31 Allowed 'Trans proline' 0 C--N 1.381 2.253 0 C-N-CA 123.137 2.558 . . . . 0.0 113.991 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp -101.1 22.02 12.97 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.743 0.817 . . . . 0.0 111.506 -175.157 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 154.12 -156.29 26.73 Favored Glycine 0 C--N 1.349 1.276 0 N-CA-C 111.242 -0.743 . . . . 0.0 111.242 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 13.6 p -64.32 106.3 1.08 Allowed 'General case' 0 C--N 1.355 0.825 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 170.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 263' ' ' TRP . . . . . . . . . . . . . 80.4 t90 -85.94 126.48 34.13 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.012 -173.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 -106.32 128.24 53.85 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 173.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 23.4 p -75.09 152.4 86.32 Favored Pre-proline 0 N--CA 1.48 1.067 0 CA-C-O 117.832 -1.08 . . . . 0.0 108.443 173.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_exo -31.85 -63.38 0.12 Allowed 'Trans proline' 0 C--N 1.393 2.885 0 C-N-CA 125.238 3.959 . . . . 0.0 116.434 -169.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -57.68 -33.3 68.2 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 124.873 1.269 . . . . 0.0 113.603 -179.29 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 268' ' ' CYS . . . . . . . . . . . . . 89.5 m -70.07 -41.5 74.02 Favored 'General case' 0 N--CA 1.5 2.041 0 C-N-CA 122.807 0.443 . . . . 0.0 111.347 172.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -70.45 -32.92 70.68 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.578 -175.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 76.1 mt -81.35 -51.82 14.82 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 C-N-CA 123.635 0.774 . . . . 0.0 109.53 177.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 . . . . . 0 CA--C 1.554 1.121 0 C-N-CA 124.412 1.085 . . . . 0.0 108.896 -176.367 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 27.3 p . . . . . 0 N--CA 1.473 0.683 0 CA-C-O 120.877 0.37 . . . . 0.0 110.249 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 53.4 tp -83.46 80.04 9.23 Favored 'General case' 0 C--N 1.348 0.521 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 175.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -140.35 122.86 16.12 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 177.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 49.5 t 172.96 161.32 0.12 Allowed 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.652 1.181 . . . . 0.0 109.538 175.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -66.0 -37.96 87.25 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 122.71 0.404 . . . . 0.0 110.583 175.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 5.4 p -81.84 -4.24 56.0 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 111.634 0.235 . . . . 0.0 111.634 174.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 78.4 mm-40 52.37 81.71 0.08 Allowed 'General case' 0 C--N 1.36 1.041 0 C-N-CA 125.205 1.402 . . . . 0.0 112.549 -175.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' ARG . . . . . 0.446 ' HB2' ' CE1' ' A' ' 249' ' ' HIS . 33.1 mmt180 -138.17 155.71 48.44 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.161 0.984 . . . . 0.0 109.343 175.115 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 27.7 m -83.56 -178.59 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.644 177.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 41.8 t -80.6 94.07 6.23 Favored 'General case' 0 CA--C 1.553 1.061 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.196 176.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -101.98 92.21 4.69 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.394 0.678 . . . . 0.0 109.479 179.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 73.88 -7.01 16.52 Favored Glycine 0 C--N 1.35 1.318 0 N-CA-C 114.44 0.536 . . . . 0.0 114.44 175.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -154.6 142.88 20.44 Favored 'General case' 0 C--O 1.242 0.674 0 C-N-CA 124.132 0.973 . . . . 0.0 109.456 -175.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 235' ' ' MET . . . . . . . . . . . . . 25.4 ptt? -158.14 128.43 6.15 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.262 0.625 . . . . 0.0 110.204 175.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 3.3 p -115.11 124.34 71.64 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.767 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 173.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -89.8 156.54 18.44 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.361 0.664 . . . . 0.0 110.332 -179.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 238' ' ' CYS . . . . . 0.62 ' HB3' ' HA ' ' A' ' 246' ' ' GLU . 13.1 t -125.71 149.47 48.48 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.458 0.703 . . . . 0.0 111.543 -173.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -121.01 104.23 9.64 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.221 1.009 . . . . 0.0 109.043 176.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -141.99 162.57 27.11 Favored Glycine 0 C--O 1.244 0.719 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 174.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -61.69 -52.97 2.52 Favored 'Trans proline' 0 C--N 1.371 1.735 0 C-N-CA 122.033 1.822 . . . . 0.0 111.856 174.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 37.8 t30 -116.38 118.23 32.15 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 178.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 18.7 t -167.94 107.51 0.54 Allowed 'General case' 0 N--CA 1.47 0.556 0 O-C-N 123.167 0.292 . . . . 0.0 111.289 -175.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 14.9 ptpt -86.85 -26.99 23.74 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 165.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -83.17 28.95 0.5 Allowed 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.318 1.447 . . . . 0.0 112.683 179.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 246' ' ' GLU . . . . . 0.62 ' HA ' ' HB3' ' A' ' 238' ' ' CYS . 41.3 mt-10 -50.11 -37.3 33.46 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.675 0.79 . . . . 0.0 111.72 176.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 247' ' ' TRP . . . . . . . . . . . . . 84.7 m95 -96.85 134.13 40.57 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.566 -178.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -144.09 176.29 9.41 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.502 1.521 . . . . 0.0 108.939 175.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 249' ' ' HIS . . . . . 0.446 ' CE1' ' HB2' ' A' ' 229' ' ' ARG . 0.2 OUTLIER -119.56 147.44 44.48 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 171.357 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . 0.419 ' HB3' ' O ' ' A' ' 255' ' ' LEU . 20.1 m-85 -62.26 -33.93 75.57 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.026 1.33 . . . . 0.0 112.214 -168.494 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -59.85 -43.91 94.4 Favored 'General case' 0 N--CA 1.476 0.826 0 O-C-N 123.971 0.794 . . . . 0.0 111.31 179.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 252' ' ' CYS . . . . . . . . . . . . . 1.3 m -70.15 -38.34 75.45 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.577 -177.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 35.5 m -99.7 8.78 8.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 122.803 0.441 . . . . 0.0 111.794 -175.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 59.97 22.96 12.06 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 124.894 1.278 . . . . 0.0 113.234 170.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.419 ' O ' ' HB3' ' A' ' 250' ' ' TYR . 93.1 mt -84.3 110.35 18.51 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 174.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -70.25 -33.2 71.34 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 121.44 0.638 . . . . 0.0 109.93 175.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -132.04 159.62 71.32 Favored Pre-proline 0 CA--C 1.555 1.169 0 C-N-CA 124.402 1.081 . . . . 0.0 109.39 -176.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 258' ' ' PRO . . . . . 0.412 ' HA ' ' HD3' ' A' ' 259' ' ' PRO . 26.5 Cg_endo -59.94 148.49 88.57 Favored 'Trans proline' 0 C--N 1.384 2.41 0 C-N-CA 122.813 2.342 . . . . 0.0 112.787 178.617 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 259' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 258' ' ' PRO . 42.0 Cg_exo -58.79 167.83 4.93 Favored 'Trans proline' 0 C--N 1.385 2.5 0 C-N-CA 123.591 2.861 . . . . 0.0 113.727 -178.246 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -100.54 18.01 20.26 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.343 0.657 . . . . 0.0 111.34 -177.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 158.3 -143.9 9.86 Favored Glycine 0 C--N 1.348 1.232 0 N-CA-C 112.169 -0.373 . . . . 0.0 112.169 176.205 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 32.8 p -66.12 107.78 2.04 Favored 'General case' 0 C--N 1.35 0.596 0 C-N-CA 123.679 0.792 . . . . 0.0 110.018 178.162 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 263' ' ' TRP . . . . . . . . . . . . . 55.3 t90 -95.0 122.22 37.43 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.775 0.83 . . . . 0.0 110.676 -170.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -96.88 106.21 18.48 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.15 0.58 . . . . 0.0 109.747 177.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 265' ' ' CYS . . . . . 0.434 ' SG ' ' OE2' ' A' ' 267' ' ' GLU . 13.1 p -70.42 160.17 82.23 Favored Pre-proline 0 CA--C 1.553 1.059 0 CA-C-O 117.861 -1.066 . . . . 0.0 110.109 177.421 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 266' ' ' PRO . . . . . 0.404 ' HD2' ' HB2' ' A' ' 265' ' ' CYS . 6.1 Cg_exo -19.09 -70.11 0.02 OUTLIER 'Trans proline' 0 C--N 1.392 2.866 1 C-N-CA 126.388 4.725 . . . . 0.0 117.536 -174.224 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 267' ' ' GLU . . . . . 0.434 ' OE2' ' SG ' ' A' ' 265' ' ' CYS . 0.0 OUTLIER -68.06 -30.25 69.41 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -173.31 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 268' ' ' CYS . . . . . . . . . . . . . 75.0 m -70.54 -38.3 74.18 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.569 0.748 . . . . 0.0 111.071 175.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -71.95 -41.5 67.71 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.402 -175.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 23.6 pt -86.68 1.08 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.611 -177.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 . . . . . 0 C--O 1.249 1.043 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 174.287 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 25.2 p . . . . . 0 N--CA 1.475 0.819 0 CA-C-O 120.704 0.288 . . . . 0.0 110.479 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 31.5 tp -98.94 111.17 23.64 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.818 0.847 . . . . 0.0 110.353 -178.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' TYR . . . . . 0.422 ' HB3' ' HA ' ' A' ' 245' ' ' TYR . 75.0 m-85 -141.69 129.77 22.07 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 174.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' CYS . . . . . 0.402 ' HB2' ' O ' ' A' ' 224' ' ' TYR . 35.6 t 172.2 153.13 0.07 Allowed 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 125.029 1.332 . . . . 0.0 108.447 169.658 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 80.1 t80 -63.44 -35.11 79.36 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 122.826 0.45 . . . . 0.0 111.786 -178.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 13.7 p -79.18 -16.48 56.52 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 122.531 0.333 . . . . 0.0 111.283 179.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 85.0 mm-40 54.09 80.55 0.11 Allowed 'General case' 0 C--N 1.362 1.151 0 C-N-CA 124.701 1.2 . . . . 0.0 111.543 -171.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' ARG . . . . . 0.462 ' HD3' ' O ' ' A' ' 230' ' ' VAL . 4.5 tmt_? -150.02 148.76 29.42 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 -178.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.462 ' O ' ' HD3' ' A' ' 229' ' ' ARG . 33.4 m -73.33 178.63 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 N-CA-C 112.759 0.652 . . . . 0.0 112.759 -172.009 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 19.6 m -139.22 49.11 1.85 Allowed 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 123.323 0.649 . . . . 0.0 109.54 -176.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 20.0 p90 -65.93 119.37 11.19 Favored 'General case' 0 CA--C 1.551 1.002 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.557 -173.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 77.18 -22.9 2.34 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 124.479 1.037 . . . . 0.0 115.327 178.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 61.7 mm-40 -143.62 99.78 3.48 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.047 0.939 . . . . 0.0 109.861 -178.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 235' ' ' MET . . . . . . . . . . . . . 18.5 ptp -122.91 132.27 54.1 Favored 'General case' 0 C--O 1.242 0.709 0 C-N-CA 124.457 1.103 . . . . 0.0 109.423 172.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 4.0 p -100.69 124.19 54.12 Favored 'Isoleucine or valine' 0 C--O 1.24 0.572 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 171.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -92.17 133.06 36.14 Favored 'General case' 0 C--O 1.242 0.663 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.048 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 238' ' ' CYS . . . . . 0.572 ' SG ' ' HA ' ' A' ' 264' ' ' TYR . 40.9 t -108.26 102.49 11.61 Favored 'General case' 0 C--O 1.243 0.719 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 176.438 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 239' ' ' ASP . . . . . 0.425 ' HB3' HG23 ' A' ' 262' ' ' THR . 30.2 t70 -82.37 94.32 7.36 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . 0.433 ' HA3' ' SG ' ' A' ' 268' ' ' CYS . . . -128.07 141.48 12.64 Favored Glycine 0 CA--C 1.527 0.811 0 CA-C-O 118.186 -1.341 . . . . 0.0 110.489 175.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -52.97 -42.74 62.23 Favored 'Trans proline' 0 C--N 1.379 2.145 0 C-N-CA 123.208 2.605 . . . . 0.0 112.166 -179.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -115.94 112.62 22.14 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.554 1.142 . . . . 0.0 108.02 171.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 243' ' ' CYS . . . . . 0.553 ' SG ' ' HA ' ' A' ' 246' ' ' GLU . 8.0 t -168.75 81.15 0.14 Allowed 'General case' 0 C--N 1.352 0.681 0 CA-C-O 121.496 0.665 . . . . 0.0 110.4 -175.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.5 -29.4 68.82 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 123.778 0.831 . . . . 0.0 112.574 178.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . 0.422 ' HA ' ' HB3' ' A' ' 224' ' ' TYR . 41.9 m-85 -101.75 24.59 9.65 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.86 0.864 . . . . 0.0 111.458 179.58 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 246' ' ' GLU . . . . . 0.553 ' HA ' ' SG ' ' A' ' 243' ' ' CYS . 14.8 pt-20 -47.21 -37.46 10.35 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 125.049 1.34 . . . . 0.0 114.235 -170.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 247' ' ' TRP . . . . . . . . . . . . . 99.0 m95 -80.01 122.17 26.4 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.102 0.561 . . . . 0.0 109.726 176.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -129.21 173.88 10.09 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.039 0.936 . . . . 0.0 109.713 178.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 249' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -124.04 152.52 42.53 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.395 1.078 . . . . 0.0 108.728 173.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -62.87 -27.15 69.15 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.687 1.195 . . . . 0.0 110.818 -173.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -61.2 -47.32 86.66 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.985 1.314 . . . . 0.0 110.947 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 252' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -71.27 -43.38 67.29 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 114.563 -1.199 . . . . 0.0 111.421 -176.106 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . 0.557 HG23 ' HG ' ' A' ' 255' ' ' LEU . 35.6 m -100.02 6.59 9.46 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.806 -172.32 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 12.0 m120 60.75 31.62 20.12 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 124.771 1.229 . . . . 0.0 113.102 171.1 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.557 ' HG ' HG23 ' A' ' 253' ' ' VAL . 70.4 mt -79.22 116.21 19.34 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 176.56 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 50.9 tttp -70.59 -42.62 70.79 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.954 0.902 . . . . 0.0 109.591 174.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -126.7 157.16 72.12 Favored Pre-proline 0 C--O 1.248 0.998 0 CA-C-N 114.49 -1.232 . . . . 0.0 109.788 -176.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -56.93 146.09 81.4 Favored 'Trans proline' 0 C--N 1.378 2.104 0 C-N-CA 122.912 2.408 . . . . 0.0 112.712 171.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 259' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -67.08 148.65 81.66 Favored 'Trans proline' 0 C--N 1.372 1.787 0 C-N-CA 122.255 1.97 . . . . 0.0 111.442 172.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 85.4 mttt -87.86 -32.2 19.13 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.877 0.871 . . . . 0.0 110.299 -179.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -120.03 -171.21 14.56 Favored Glycine 0 C--N 1.345 1.055 0 CA-C-N 115.339 -0.846 . . . . 0.0 112.086 -178.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 262' ' ' THR . . . . . 0.425 HG23 ' HB3' ' A' ' 239' ' ' ASP . 76.9 m -62.95 109.81 1.58 Allowed 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.978 0.911 . . . . 0.0 109.92 179.043 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 263' ' ' TRP . . . . . . . . . . . . . 59.0 t90 -82.2 145.54 30.01 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.018 0.527 . . . . 0.0 110.005 -176.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 264' ' ' TYR . . . . . 0.572 ' HA ' ' SG ' ' A' ' 238' ' ' CYS . 98.6 m-85 -129.78 152.55 49.16 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.898 0.879 . . . . 0.0 110.339 -178.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 15.3 p -114.55 162.16 24.95 Favored Pre-proline 0 N--CA 1.482 1.136 0 CA-C-O 117.701 -1.142 . . . . 0.0 107.959 175.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -30.12 -65.44 0.08 OUTLIER 'Trans proline' 0 C--N 1.391 2.812 0 C-N-CA 125.151 3.901 . . . . 0.0 117.342 -175.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 267' ' ' GLU . . . . . 0.4 ' H ' ' HG3' ' A' ' 267' ' ' GLU . 0.0 OUTLIER -66.2 -12.4 55.83 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 -172.773 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 268' ' ' CYS . . . . . 0.433 ' SG ' ' HA3' ' A' ' 240' ' ' GLY . 74.7 m -88.46 -42.2 12.29 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.669 0.788 . . . . 0.0 112.596 169.422 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . 0.564 ' HG3' HG23 ' A' ' 270' ' ' ILE . 14.7 ptmm? -97.67 -50.4 4.48 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 114.158 1.17 . . . . 0.0 114.158 -162.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 270' ' ' ILE . . . . . 0.564 HG23 ' HG3' ' A' ' 269' ' ' LYS . 19.2 pt -88.9 21.21 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -169.292 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 . . . . . 0 C--O 1.25 1.118 0 C-N-CA 123.805 0.842 . . . . 0.0 109.71 179.051 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 68.9 p . . . . . 0 N--CA 1.482 1.166 0 CA-C-O 121.526 0.679 . . . . 0.0 110.086 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 44.1 tp -135.75 91.42 2.7 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 -177.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -142.13 142.95 32.8 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.012 0.925 . . . . 0.0 109.427 -175.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 45.5 t 171.8 163.84 0.1 Allowed 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 125.469 1.508 . . . . 0.0 108.352 173.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 41.4 t80 -66.78 -31.23 71.73 Favored 'General case' 0 CA--C 1.557 1.221 0 CA-C-N 118.668 0.667 . . . . 0.0 110.302 175.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' CYS . . . . . 0.543 ' SG ' ' HB2' ' A' ' 229' ' ' ARG . 4.6 p -89.49 -3.83 58.2 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 122.919 0.487 . . . . 0.0 111.444 174.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 81.4 mm-40 46.45 81.86 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 125.023 1.329 . . . . 0.0 111.817 -175.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' ARG . . . . . 0.543 ' HB2' ' SG ' ' A' ' 227' ' ' CYS . 1.0 OUTLIER -150.02 158.03 43.75 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 -171.504 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 27.2 m -71.83 150.53 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 O-C-N 123.524 0.515 . . . . 0.0 111.464 178.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . 0.433 ' HB2' ' HG2' ' A' ' 235' ' ' MET . 20.5 m -100.86 77.72 1.88 Allowed 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 175.512 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 82.5 t80 -71.67 101.11 2.46 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.423 0.689 . . . . 0.0 110.642 -174.243 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 80.66 -19.24 7.51 Favored Glycine 0 C--N 1.344 1.014 0 CA-C-N 115.513 -0.767 . . . . 0.0 114.247 175.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . 0.419 ' HB3' ' CD1' ' A' ' 250' ' ' TYR . 59.3 mm-40 -128.03 94.98 4.06 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.127 0.971 . . . . 0.0 109.351 -175.304 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 235' ' ' MET . . . . . 0.433 ' HG2' ' HB2' ' A' ' 231' ' ' SER . 44.7 mtt -118.2 97.76 5.95 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.357 0.663 . . . . 0.0 110.108 -174.537 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 0.421 HG11 HG21 ' A' ' 253' ' ' VAL . 7.4 p -92.56 124.54 45.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 171.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -99.47 141.07 32.74 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 123.884 0.874 . . . . 0.0 109.853 179.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 238' ' ' CYS . . . . . 0.663 ' HB3' ' HA ' ' A' ' 246' ' ' GLU . 5.5 t -105.36 114.48 28.69 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 123.864 0.866 . . . . 0.0 109.785 179.571 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -72.6 95.63 1.86 Allowed 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.096 0.558 . . . . 0.0 109.516 176.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -139.06 116.48 1.25 Allowed Glycine 0 CA--C 1.53 0.988 0 CA-C-O 118.711 -1.049 . . . . 0.0 111.282 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -60.03 -29.08 88.45 Favored 'Trans proline' 0 C--N 1.377 2.055 0 C-N-CA 123.382 2.721 . . . . 0.0 112.621 178.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -120.35 88.71 2.99 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 171.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 42.1 t -172.17 112.15 0.28 Allowed 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.485 0.714 . . . . 0.0 110.456 -172.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 20.8 pttm -89.25 -25.01 21.95 Favored 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 167.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -79.33 27.47 0.26 Allowed 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 124.83 1.252 . . . . 0.0 112.527 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 246' ' ' GLU . . . . . 0.663 ' HA ' ' HB3' ' A' ' 238' ' ' CYS . 41.1 mt-10 -53.35 -46.55 69.57 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.163 0.585 . . . . 0.0 110.601 172.191 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 247' ' ' TRP . . . . . . . . . . . . . 97.8 m95 -72.42 122.18 20.8 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.366 179.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -142.38 171.32 14.21 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 125.206 1.402 . . . . 0.0 109.174 170.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 249' ' ' HIS . . . . . 0.419 ' HB3' ' HA ' ' A' ' 231' ' ' SER . 0.1 OUTLIER -123.12 142.42 50.91 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.249 1.019 . . . . 0.0 108.859 178.804 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . 0.419 ' CD1' ' HB3' ' A' ' 234' ' ' GLU . 8.8 m-85 -58.49 -26.69 63.72 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 124.98 1.312 . . . . 0.0 112.128 -174.087 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -59.46 -56.64 19.45 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.013 0.925 . . . . 0.0 110.833 174.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 252' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -61.39 -49.15 78.07 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.968 0.907 . . . . 0.0 111.595 -178.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . 0.479 HG23 ' HG ' ' A' ' 255' ' ' LEU . 26.8 m -88.64 5.32 4.41 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.909 -174.213 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 44.8 m-80 64.39 16.01 9.89 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 125.006 1.322 . . . . 0.0 113.415 169.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.479 ' HG ' HG23 ' A' ' 253' ' ' VAL . 89.8 mt -74.24 108.02 6.77 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 122.891 0.476 . . . . 0.0 109.868 -176.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 62.1 mttm -72.15 -25.62 61.78 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.973 0.909 . . . . 0.0 110.326 176.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -131.59 159.69 70.71 Favored Pre-proline 0 CA--C 1.552 1.039 0 C-N-CA 124.619 1.167 . . . . 0.0 109.337 -177.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.31 140.64 44.88 Favored 'Trans proline' 0 C--N 1.369 1.625 0 C-N-CA 122.325 2.017 . . . . 0.0 111.78 169.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 259' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -61.66 158.49 36.96 Favored 'Trans proline' 0 C--N 1.38 2.211 0 C-N-CA 122.47 2.113 . . . . 0.0 111.542 169.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 31.6 mmmt -93.37 -2.15 55.08 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 112.724 0.638 . . . . 0.0 112.724 -175.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -164.53 -147.38 5.09 Favored Glycine 0 C--N 1.345 1.05 0 N-CA-C 112.213 -0.355 . . . . 0.0 112.213 -178.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 54.7 p -64.21 107.8 1.4 Allowed 'General case' 0 C--N 1.352 0.699 0 C-N-CA 123.401 0.681 . . . . 0.0 110.552 178.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 263' ' ' TRP . . . . . . . . . . . . . 63.3 t90 -87.45 144.78 26.57 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 176.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 264' ' ' TYR . . . . . 0.438 ' HA ' ' SG ' ' A' ' 238' ' ' CYS . 95.1 m-85 -126.14 129.39 48.97 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.433 0.693 . . . . 0.0 109.654 -178.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 265' ' ' CYS . . . . . 0.421 ' SG ' ' OE1' ' A' ' 267' ' ' GLU . 16.7 p -85.76 156.12 58.58 Favored Pre-proline 0 CA--C 1.555 1.163 0 CA-C-O 118.47 -0.776 . . . . 0.0 109.248 177.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 0.8 OUTLIER -23.7 -64.88 0.04 OUTLIER 'Trans proline' 0 C--N 1.392 2.845 1 C-N-CA 126.314 4.676 . . . . 0.0 118.098 -168.456 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 267' ' ' GLU . . . . . 0.421 ' OE1' ' SG ' ' A' ' 265' ' ' CYS . 0.0 OUTLIER -67.02 -32.18 73.23 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 122.574 0.35 . . . . 0.0 111.565 -171.619 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 268' ' ' CYS . . . . . . . . . . . . . 58.6 m -72.31 -38.59 68.68 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.763 0.825 . . . . 0.0 110.601 176.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 61.5 tttp -71.78 -34.31 69.32 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 115.042 -0.981 . . . . 0.0 111.294 -173.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 25.7 pt -90.0 -9.88 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 123.106 0.563 . . . . 0.0 111.408 -179.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 . . . . . 0 C--O 1.25 1.097 0 C-N-CA 123.739 0.815 . . . . 0.0 110.132 -177.586 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 14.8 p . . . . . 0 N--CA 1.477 0.924 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 51.3 tp -116.64 95.97 5.28 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.227 1.011 . . . . 0.0 108.797 177.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 224' ' ' TYR . . . . . 0.426 ' HB3' ' HA ' ' A' ' 245' ' ' TYR . 47.4 m-85 -137.93 127.57 25.13 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.036 0.934 . . . . 0.0 109.2 178.714 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 225' ' ' CYS . . . . . 0.416 ' HB2' ' O ' ' A' ' 224' ' ' TYR . 14.0 t 174.08 158.08 0.15 Allowed 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.386 1.075 . . . . 0.0 109.953 172.174 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -64.23 -38.89 92.67 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 122.997 0.519 . . . . 0.0 111.412 175.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 9.8 p -77.54 -13.9 59.8 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.086 177.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 81.1 mm-40 52.65 66.82 1.11 Allowed 'General case' 0 C--N 1.368 1.394 0 C-N-CA 124.668 1.187 . . . . 0.0 111.688 -174.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 78.4 ttt180 -130.26 153.58 48.47 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.659 0.784 . . . . 0.0 109.41 -179.437 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 29.3 m -66.21 155.42 7.08 Favored 'Isoleucine or valine' 0 C--O 1.241 0.65 0 C-N-CA 123.38 0.672 . . . . 0.0 111.655 177.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . 0.71 ' HB3' ' HB3' ' A' ' 235' ' ' MET . 46.2 m -105.66 69.18 0.82 Allowed 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.52 178.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 20.2 p90 -70.02 110.32 5.02 Favored 'General case' 0 CA--C 1.549 0.918 0 CA-C-N 114.353 -1.294 . . . . 0.0 111.237 -176.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 76.92 -20.69 2.86 Favored Glycine 0 N--CA 1.478 1.49 0 N-CA-C 115.204 0.842 . . . . 0.0 115.204 171.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . 0.416 ' HB3' ' HD2' ' A' ' 250' ' ' TYR . 49.3 mt-10 -142.75 127.45 18.1 Favored 'General case' 0 C--O 1.243 0.743 0 C-N-CA 124.251 1.02 . . . . 0.0 108.928 -178.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 235' ' ' MET . . . . . 0.71 ' HB3' ' HB3' ' A' ' 231' ' ' SER . 22.4 ptt? -151.91 129.57 11.54 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 123.313 0.645 . . . . 0.0 110.432 175.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 5.4 p -103.31 126.46 57.68 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 C-N-CA 123.866 0.867 . . . . 0.0 108.869 175.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -88.57 164.64 15.29 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.624 0.77 . . . . 0.0 110.281 179.1 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 238' ' ' CYS . . . . . 0.428 ' HB3' ' HA ' ' A' ' 246' ' ' GLU . 15.4 t -136.83 105.54 5.85 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.353 0.661 . . . . 0.0 109.349 179.322 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -79.99 94.96 6.0 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.791 -178.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -141.25 137.19 7.96 Favored Glycine 0 C--N 1.348 1.223 0 CA-C-O 118.678 -1.068 . . . . 0.0 111.456 178.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -60.03 -38.71 76.18 Favored 'Trans proline' 0 C--N 1.376 1.978 0 C-N-CA 123.232 2.622 . . . . 0.0 113.384 179.176 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -109.49 95.88 5.91 Favored 'General case' 0 C--O 1.243 0.739 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 175.109 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 243' ' ' CYS . . . . . 0.456 ' SG ' ' HA ' ' A' ' 246' ' ' GLU . 12.2 t -166.06 101.8 0.65 Allowed 'General case' 0 C--O 1.237 0.429 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.941 -171.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 21.7 pttm -86.16 -37.98 18.18 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 171.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . 0.426 ' HA ' ' HB3' ' A' ' 224' ' ' TYR . 53.9 m-85 -87.66 29.15 0.92 Allowed 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 124.29 1.036 . . . . 0.0 111.874 -179.106 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 246' ' ' GLU . . . . . 0.456 ' HA ' ' SG ' ' A' ' 243' ' ' CYS . 10.4 pt-20 -49.37 -36.57 22.03 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.087 0.955 . . . . 0.0 112.844 179.105 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 247' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -91.09 135.16 33.95 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.381 0.61 . . . . 0.0 111.043 178.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -142.8 174.09 10.96 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 125.665 1.586 . . . . 0.0 108.449 174.105 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 249' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -117.2 141.84 47.78 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.817 0.847 . . . . 0.0 108.832 174.563 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . 0.416 ' HD2' ' HB3' ' A' ' 234' ' ' GLU . 86.3 m-85 -57.2 -26.85 61.33 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 124.658 1.183 . . . . 0.0 112.074 -177.22 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -56.3 -58.4 8.15 Favored 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 123.861 0.864 . . . . 0.0 111.46 174.408 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 252' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -61.37 -41.94 97.91 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 124.203 1.001 . . . . 0.0 112.117 -173.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 35.8 m -92.23 -5.77 10.72 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.733 -175.161 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 10.8 t30 52.41 70.12 0.6 Allowed 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 124.611 1.164 . . . . 0.0 111.243 178.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 96.3 mt -129.92 122.87 29.42 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 178.128 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 64.2 tttp -90.64 -27.48 19.02 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 123.272 0.629 . . . . 0.0 110.166 178.377 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 16.9 mp0 -105.45 147.07 33.99 Favored Pre-proline 0 N--CA 1.477 0.903 0 C-N-CA 124.189 0.996 . . . . 0.0 109.336 178.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -74.63 117.62 5.02 Favored 'Trans proline' 0 C--N 1.373 1.831 0 C-N-CA 122.322 2.015 . . . . 0.0 110.548 170.022 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 259' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_exo -53.6 112.62 1.0 Allowed 'Trans proline' 0 C--N 1.378 2.119 0 C-N-CA 123.1 2.533 . . . . 0.0 113.397 -178.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -68.21 103.14 1.5 Allowed 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.869 0.868 . . . . 0.0 109.855 -179.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 118.3 -167.46 12.96 Favored Glycine 0 N--CA 1.472 1.034 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 -176.321 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 39.4 p -74.13 106.04 5.61 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 177.214 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 263' ' ' TRP . . . . . . . . . . . . . 52.1 t90 -73.79 134.21 43.36 Favored 'General case' 0 C--N 1.349 0.583 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 173.027 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -110.85 113.86 26.77 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 123.029 0.531 . . . . 0.0 109.777 179.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 17.4 p -64.75 160.78 51.17 Favored Pre-proline 0 CA--C 1.55 0.964 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.947 171.278 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -36.63 -38.8 0.37 Allowed 'Trans proline' 0 C--N 1.382 2.317 0 C-N-CA 124.329 3.352 . . . . 0.0 115.991 175.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -54.58 -61.73 2.12 Favored 'General case' 0 N--CA 1.485 1.32 0 CA-C-O 121.652 0.739 . . . . 0.0 110.807 176.098 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 268' ' ' CYS . . . . . . . . . . . . . 35.5 m -80.02 -30.85 39.59 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 114.493 -1.23 . . . . 0.0 111.853 -168.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -75.86 -53.08 8.99 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.7 0.8 . . . . 0.0 111.155 -173.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 270' ' ' ILE . . . . . 0.434 HG22 ' HG3' ' A' ' 271' ' ' GLU . 50.7 mm -72.16 -52.47 24.3 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.978 -176.468 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 271' ' ' GLU . . . . . 0.434 ' HG3' HG22 ' A' ' 270' ' ' ILE . 45.7 mt-10 . . . . . 0 CA--C 1.555 1.164 0 C-N-CA 123.207 0.603 . . . . 0.0 109.553 -178.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 32.6 p . . . . . 0 CA--C 1.544 0.713 0 CA-C-O 121.06 0.457 . . . . 0.0 110.068 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -111.26 90.28 3.29 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 175.222 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 224' ' ' TYR . . . . . 0.524 ' HB3' ' HA ' ' A' ' 245' ' ' TYR . 78.5 m-85 -133.76 130.43 38.03 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 123.855 0.862 . . . . 0.0 108.892 179.535 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 225' ' ' CYS . . . . . 0.43 ' HB2' ' O ' ' A' ' 224' ' ' TYR . 26.5 t 172.29 155.69 0.09 Allowed 'General case' 0 N--CA 1.474 0.761 0 O-C-N 124.794 1.309 . . . . 0.0 109.388 168.387 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 61.5 t80 -64.81 -27.67 69.04 Favored 'General case' 0 CA--C 1.556 1.193 0 C-N-CA 123.201 0.6 . . . . 0.0 111.214 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 13.2 p -90.57 -10.69 42.48 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 122.991 0.517 . . . . 0.0 111.442 177.078 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 83.4 mm-40 52.16 85.46 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 124.607 1.163 . . . . 0.0 111.437 -171.041 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 73.6 ttt180 -140.63 150.71 43.9 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.816 -176.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 34.3 m -69.18 170.38 1.14 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.61 0 C-N-CA 124.29 1.036 . . . . 0.0 112.754 -177.331 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 39.4 t -86.73 116.52 24.88 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 114.662 -1.154 . . . . 0.0 109.762 174.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 232' ' ' PHE . . . . . 0.603 ' HB3' ' HG2' ' A' ' 234' ' ' GLU . 91.8 t80 -75.63 -13.04 60.32 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 123.84 0.856 . . . . 0.0 109.728 166.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 109.78 -18.17 29.56 Favored Glycine 0 C--N 1.349 1.277 0 N-CA-C 111.521 -0.632 . . . . 0.0 111.521 -174.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . 0.603 ' HG2' ' HB3' ' A' ' 232' ' ' PHE . 8.5 pt-20 -77.65 64.55 2.96 Favored 'General case' 0 CA--C 1.555 1.163 0 C-N-CA 124.273 1.029 . . . . 0.0 110.129 174.683 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 235' ' ' MET . . . . . . . . . . . . . 73.2 mtm -91.61 100.96 13.6 Favored 'General case' 0 N--CA 1.475 0.801 0 O-C-N 121.823 -0.548 . . . . 0.0 110.682 -173.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 2.8 p -88.07 124.28 41.09 Favored 'Isoleucine or valine' 0 C--O 1.241 0.652 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 168.124 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -99.32 110.9 23.37 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 123.564 0.746 . . . . 0.0 110.074 -176.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 238' ' ' CYS . . . . . 0.461 ' HB3' ' HA ' ' A' ' 246' ' ' GLU . 42.3 t -71.64 153.75 41.88 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.242 169.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 239' ' ' ASP . . . . . 0.557 ' HB3' ' HB ' ' A' ' 262' ' ' THR . 23.5 t70 -134.23 95.61 3.44 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.606 0.762 . . . . 0.0 109.176 176.317 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . 0.556 ' HA3' ' SG ' ' A' ' 268' ' ' CYS . . . -142.05 140.71 10.26 Favored Glycine 0 CA--C 1.534 1.222 0 CA-C-O 118.442 -1.199 . . . . 0.0 111.917 175.192 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -59.44 -51.69 5.93 Favored 'Trans proline' 0 C--N 1.377 2.03 0 C-N-CA 122.746 2.297 . . . . 0.0 112.145 178.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -89.04 86.49 6.93 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 171.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 10.4 t -174.75 104.6 0.1 Allowed 'General case' 0 C--N 1.351 0.637 0 O-C-N 123.88 0.738 . . . . 0.0 109.688 -176.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -85.75 -31.93 22.13 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-O 121.842 0.83 . . . . 0.0 110.359 173.421 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . 0.524 ' HA ' ' HB3' ' A' ' 224' ' ' TYR . 59.7 m-85 -86.65 26.4 1.11 Allowed 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.053 1.341 . . . . 0.0 112.368 -171.126 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 246' ' ' GLU . . . . . 0.461 ' HA ' ' HB3' ' A' ' 238' ' ' CYS . 5.6 mm-40 -45.96 -42.34 12.85 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 125.105 1.362 . . . . 0.0 112.697 -174.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 247' ' ' TRP . . . . . 0.497 ' HB2' ' HB2' ' A' ' 224' ' ' TYR . 96.0 m95 -70.92 117.93 13.06 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.112 0.565 . . . . 0.0 110.262 175.331 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -131.23 173.49 10.99 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.349 1.06 . . . . 0.0 109.92 175.37 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 249' ' ' HIS . . . . . 0.582 ' HD2' ' HB2' ' A' ' 252' ' ' CYS . 0.2 OUTLIER -121.9 139.57 53.48 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.165 0.986 . . . . 0.0 109.031 175.639 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -54.63 -49.39 70.62 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 124.787 1.235 . . . . 0.0 113.063 -168.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -53.49 -40.83 65.66 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 124.127 0.971 . . . . 0.0 112.107 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 252' ' ' CYS . . . . . 0.582 ' HB2' ' HD2' ' A' ' 249' ' ' HIS . 2.8 t -66.17 -32.11 73.36 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 124.34 1.056 . . . . 0.0 111.582 -175.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 29.8 m -110.48 13.36 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 123.666 0.786 . . . . 0.0 111.362 -174.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 67.4 11.65 8.49 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 124.644 1.177 . . . . 0.0 112.398 173.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 95.0 mt -84.01 157.36 21.86 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-O 121.558 0.695 . . . . 0.0 109.337 174.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 27.0 tptp -145.86 -29.97 0.41 Allowed 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.199 0.999 . . . . 0.0 108.651 174.149 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -93.59 141.44 23.86 Favored Pre-proline 0 C--O 1.245 0.84 0 C-N-CA 124.09 0.956 . . . . 0.0 108.895 177.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -65.09 124.1 12.53 Favored 'Trans proline' 0 C--N 1.373 1.824 0 C-N-CA 122.4 2.066 . . . . 0.0 111.361 177.323 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 259' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -51.01 131.11 33.87 Favored 'Trans proline' 0 C--N 1.38 2.235 0 C-N-CA 123.455 2.77 . . . . 0.0 113.743 178.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.77 -4.79 39.69 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.023 0.929 . . . . 0.0 112.866 -175.002 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -153.25 -170.39 19.41 Favored Glycine 0 N--CA 1.471 0.989 0 N-CA-C 111.149 -0.78 . . . . 0.0 111.149 176.051 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 262' ' ' THR . . . . . 0.557 ' HB ' ' HB3' ' A' ' 239' ' ' ASP . 40.8 p -65.58 106.59 1.48 Allowed 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 175.414 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 263' ' ' TRP . . . . . . . . . . . . . 49.8 t90 -74.38 137.87 43.02 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.201 0.601 . . . . 0.0 111.238 -169.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 41.1 m-85 -114.85 109.27 17.89 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.815 0.846 . . . . 0.0 109.398 -176.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 265' ' ' CYS . . . . . 0.431 ' SG ' ' OE2' ' A' ' 267' ' ' GLU . 16.0 p -72.44 162.5 73.63 Favored Pre-proline 0 CA--C 1.559 1.302 0 C-N-CA 123.563 0.745 . . . . 0.0 110.183 176.505 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_exo -36.93 -51.83 1.37 Allowed 'Trans proline' 0 C--N 1.393 2.869 0 C-N-CA 124.511 3.474 . . . . 0.0 116.45 -178.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 267' ' ' GLU . . . . . 0.431 ' OE2' ' SG ' ' A' ' 265' ' ' CYS . 0.0 OUTLIER -72.11 -18.54 61.9 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -175.28 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 268' ' ' CYS . . . . . 0.556 ' SG ' ' HA3' ' A' ' 240' ' ' GLY . 59.2 m -82.36 -44.74 15.78 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.0 0.52 . . . . 0.0 111.542 171.291 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -82.38 -45.14 15.24 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.259 -166.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 50.9 mm -76.32 -40.18 35.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 123.604 0.761 . . . . 0.0 110.552 -176.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 23.9 mm-40 . . . . . 0 C--O 1.25 1.084 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 177.713 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 30.9 p . . . . . 0 N--CA 1.476 0.855 0 CA-C-O 121.49 0.662 . . . . 0.0 110.048 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -82.89 88.76 6.8 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 178.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 224' ' ' TYR . . . . . 0.477 ' HB2' ' HB2' ' A' ' 247' ' ' TRP . 68.1 m-85 -137.71 138.16 39.07 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 178.628 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 51.3 t 170.93 162.0 0.08 Allowed 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 125.662 1.585 . . . . 0.0 108.649 172.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -62.53 -40.01 95.41 Favored 'General case' 0 CA--C 1.552 1.036 0 CA-C-N 117.992 0.36 . . . . 0.0 110.808 176.406 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 9.2 p -81.49 -19.88 41.34 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 122.608 0.363 . . . . 0.0 111.195 176.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 24.2 mm-40 59.07 99.69 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 124.905 1.282 . . . . 0.0 112.288 -172.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 229' ' ' ARG . . . . . 0.446 ' HD3' ' N ' ' A' ' 230' ' ' VAL . 4.6 tmt_? -163.75 152.91 14.19 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 -173.224 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.446 ' N ' ' HD3' ' A' ' 229' ' ' ARG . 30.7 m -64.52 165.84 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 C-N-CA 123.991 0.916 . . . . 0.0 112.645 -177.461 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 26.0 m -139.26 71.9 1.39 Allowed 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 123.275 0.63 . . . . 0.0 109.988 -177.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 53.2 m-85 -98.67 128.9 45.11 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.667 0.787 . . . . 0.0 110.406 178.173 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 84.25 -14.71 43.49 Favored Glycine 0 CA--C 1.535 1.321 0 O-C-N 123.212 0.32 . . . . 0.0 113.376 178.7 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -153.38 138.54 17.4 Favored 'General case' 0 C--N 1.351 0.645 0 C-N-CA 124.459 1.103 . . . . 0.0 108.83 179.124 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 235' ' ' MET . . . . . . . . . . . . . 21.1 ptp -163.11 133.13 4.37 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.232 0.613 . . . . 0.0 109.791 176.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 0.459 HG13 ' HB2' ' A' ' 248' ' ' PHE . 2.4 p -119.0 122.96 70.63 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 171.395 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -90.61 130.48 36.63 Favored 'General case' 0 C--O 1.239 0.507 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 174.353 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 238' ' ' CYS . . . . . . . . . . . . . 18.9 t -105.89 122.59 46.43 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.88 0.872 . . . . 0.0 111.106 -172.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -71.7 113.47 8.77 Favored 'General case' 0 C--N 1.352 0.715 0 C-N-CA 123.457 0.703 . . . . 0.0 110.082 176.223 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -143.17 144.54 13.91 Favored Glycine 0 CA--C 1.525 0.7 0 CA-C-N 114.388 -1.278 . . . . 0.0 110.551 169.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -57.53 -44.39 42.48 Favored 'Trans proline' 0 C--N 1.37 1.673 0 C-N-CA 122.531 2.154 . . . . 0.0 111.034 165.019 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 36.2 t30 -127.69 115.17 18.32 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 171.131 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 243' ' ' CYS . . . . . 0.543 ' SG ' ' HA ' ' A' ' 246' ' ' GLU . 16.2 t -151.93 97.77 2.37 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 -179.292 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -74.66 -37.94 62.59 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-O 121.279 0.561 . . . . 0.0 110.106 -179.3 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -89.83 25.46 2.06 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.742 1.217 . . . . 0.0 110.743 179.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 246' ' ' GLU . . . . . 0.543 ' HA ' ' SG ' ' A' ' 243' ' ' CYS . 8.9 pt-20 -46.65 -37.66 8.6 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 125.165 1.386 . . . . 0.0 113.744 -173.423 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 247' ' ' TRP . . . . . 0.477 ' HB2' ' HB2' ' A' ' 224' ' ' TYR . 94.0 m95 -88.5 138.54 31.34 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 122.922 0.489 . . . . 0.0 109.887 175.658 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 248' ' ' PHE . . . . . 0.459 ' HB2' HG13 ' A' ' 236' ' ' VAL . 60.1 m-85 -140.36 171.81 13.63 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.387 1.075 . . . . 0.0 109.385 175.394 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 249' ' ' HIS . . . . . 0.473 ' CD2' ' HB2' ' A' ' 252' ' ' CYS . 0.1 OUTLIER -117.7 141.27 48.58 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 173.788 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -58.69 -34.73 71.62 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 124.449 1.099 . . . . 0.0 112.821 -169.237 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -63.43 -38.97 93.21 Favored 'General case' 0 N--CA 1.479 1.02 0 O-C-N 123.854 0.721 . . . . 0.0 111.22 -177.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 252' ' ' CYS . . . . . 0.473 ' HB2' ' CD2' ' A' ' 249' ' ' HIS . 0.2 OUTLIER -66.93 -49.16 66.37 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 124.643 1.177 . . . . 0.0 110.229 -174.747 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 26.9 m -92.0 2.99 7.88 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 CA-C-N 114.222 -1.354 . . . . 0.0 111.358 -174.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 16.2 m120 60.71 24.34 14.18 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 124.802 1.241 . . . . 0.0 112.781 172.393 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.463 HD13 ' HD3' ' A' ' 259' ' ' PRO . 57.2 mt -71.95 94.83 1.5 Allowed 'General case' 0 C--N 1.35 0.59 0 C-N-CA 123.482 0.713 . . . . 0.0 109.458 176.321 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 8.7 mtmp? -77.29 -21.36 53.66 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.372 170.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 12.2 mp0 -111.58 125.85 29.65 Favored Pre-proline 0 C--O 1.244 0.801 0 C-N-CA 124.715 1.206 . . . . 0.0 107.921 178.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -65.71 121.39 8.75 Favored 'Trans proline' 0 C--N 1.372 1.785 0 C-N-CA 122.072 1.848 . . . . 0.0 110.356 172.152 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 259' ' ' PRO . . . . . 0.463 ' HD3' HD13 ' A' ' 255' ' ' LEU . 26.9 Cg_endo -58.28 116.91 3.58 Favored 'Trans proline' 0 C--N 1.378 2.118 0 C-N-CA 122.869 2.379 . . . . 0.0 112.413 -173.06 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 260' ' ' LYS . . . . . 0.558 ' HD3' ' H ' ' A' ' 260' ' ' LYS . 0.0 OUTLIER -56.31 -28.84 60.15 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.764 1.226 . . . . 0.0 113.026 -178.159 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -138.79 -147.49 5.14 Favored Glycine 0 C--N 1.348 1.211 0 CA-C-O 120.139 -0.256 . . . . 0.0 112.634 -178.241 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 46.6 p -72.12 106.1 4.21 Favored 'General case' 0 C--O 1.242 0.709 0 C-N-CA 123.515 0.726 . . . . 0.0 110.339 -178.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 263' ' ' TRP . . . . . . . . . . . . . 78.8 t90 -85.74 118.64 25.37 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.488 1.115 . . . . 0.0 109.543 178.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 264' ' ' TYR . . . . . 0.4 ' HD2' ' HB3' ' A' ' 268' ' ' CYS . 21.1 m-85 -102.31 115.79 31.3 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.231 1.012 . . . . 0.0 109.655 177.35 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 29.1 p -67.32 166.29 22.18 Favored Pre-proline 0 N--CA 1.487 1.417 0 C-N-CA 124.603 1.161 . . . . 0.0 110.634 176.16 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -40.01 -49.66 3.59 Favored 'Trans proline' 0 C--N 1.393 2.87 0 C-N-CA 123.917 3.078 . . . . 0.0 113.801 172.032 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -64.39 -26.8 68.62 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.379 0.672 . . . . 0.0 111.742 -174.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 268' ' ' CYS . . . . . 0.4 ' HB3' ' HD2' ' A' ' 264' ' ' TYR . 61.4 m -85.58 -41.48 15.22 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 123.215 0.606 . . . . 0.0 111.053 175.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 23.1 ttpp -77.37 -33.58 55.23 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.46 0.704 . . . . 0.0 111.634 -167.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 18.9 pt -130.08 50.74 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 124.3 1.04 . . . . 0.0 109.072 178.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 . . . . . 0 CA--C 1.559 1.313 0 CA-C-N 114.476 -1.238 . . . . 0.0 111.452 178.742 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 41.1 p . . . . . 0 N--CA 1.477 0.903 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -152.44 109.94 3.59 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 -176.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 224' ' ' TYR . . . . . 0.587 ' HB2' ' HB2' ' A' ' 247' ' ' TRP . 62.8 m-85 -143.07 130.22 20.79 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 -179.433 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 49.2 t 172.78 158.1 0.11 Allowed 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.318 1.447 . . . . 0.0 108.669 171.001 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -58.22 -46.19 86.33 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 123.102 0.561 . . . . 0.0 110.807 177.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 227' ' ' CYS . . . . . 0.41 ' SG ' ' HB3' ' A' ' 229' ' ' ARG . 14.1 p -75.21 -15.1 60.57 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 122.782 0.433 . . . . 0.0 111.861 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 83.1 mm-40 57.81 90.18 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 124.409 1.084 . . . . 0.0 110.773 -172.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 229' ' ' ARG . . . . . 0.41 ' HB3' ' SG ' ' A' ' 227' ' ' CYS . 75.4 ttt180 -165.31 153.71 11.68 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.098 -171.374 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 35.4 m -73.51 171.85 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.927 0 C-N-CA 123.639 0.776 . . . . 0.0 111.648 175.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 43.4 m -112.5 126.24 55.11 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.943 0.897 . . . . 0.0 109.177 178.173 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 52.9 t80 -91.76 81.6 5.24 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 177.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 75.57 -20.31 2.25 Favored Glycine 0 N--CA 1.474 1.206 0 CA-C-N 115.44 -0.8 . . . . 0.0 114.554 179.046 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 31.9 mm-40 -108.79 99.2 8.58 Favored 'General case' 0 C--O 1.224 -0.25 0 C-N-CA 124.18 0.992 . . . . 0.0 109.781 -176.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 235' ' ' MET . . . . . . . . . . . . . 25.7 ptt? -125.32 129.56 50.2 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.008 0.523 . . . . 0.0 109.706 177.346 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 2.6 p -124.95 125.8 70.21 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 C-N-CA 123.893 0.877 . . . . 0.0 109.346 -178.288 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -86.37 150.07 24.58 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.333 177.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 238' ' ' CYS . . . . . 0.503 ' HB3' ' HA ' ' A' ' 246' ' ' GLU . 7.9 t -110.33 149.71 29.81 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 124.568 1.147 . . . . 0.0 109.184 -178.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -103.31 95.63 6.22 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 172.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -139.55 128.45 3.97 Favored Glycine 0 C--N 1.344 1.001 0 CA-C-O 118.937 -0.924 . . . . 0.0 111.745 177.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -66.19 -36.85 27.12 Favored 'Trans proline' 0 C--N 1.372 1.794 0 C-N-CA 122.647 2.231 . . . . 0.0 111.768 171.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 41.9 t30 -120.73 104.42 9.89 Favored 'General case' 0 C--O 1.242 0.669 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 174.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 46.6 t -173.12 114.34 0.25 Allowed 'General case' 0 N--CA 1.469 0.488 0 O-C-N 123.645 0.591 . . . . 0.0 109.811 -173.478 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 54.5 tptt -83.6 -28.05 28.77 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-O 121.369 0.604 . . . . 0.0 109.399 173.086 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 20.6 m-30 -90.99 28.74 1.5 Allowed 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.18 1.392 . . . . 0.0 111.957 -175.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 246' ' ' GLU . . . . . 0.503 ' HA ' ' HB3' ' A' ' 238' ' ' CYS . 6.4 mm-40 -48.28 -33.84 9.45 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 123.551 0.74 . . . . 0.0 112.829 177.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 247' ' ' TRP . . . . . 0.587 ' HB2' ' HB2' ' A' ' 224' ' ' TYR . 96.4 m95 -94.07 136.57 34.21 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 121.399 0.619 . . . . 0.0 110.68 173.532 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -140.36 176.37 8.83 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 125.845 1.658 . . . . 0.0 108.322 174.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 249' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -126.07 143.94 50.92 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 173.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 36.5 m-85 -58.02 -34.34 69.94 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.78 0.832 . . . . 0.0 112.49 -172.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -62.44 -36.12 81.41 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.043 0.537 . . . . 0.0 111.683 179.734 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 252' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -66.69 -42.56 86.28 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.97 0.908 . . . . 0.0 110.862 -177.303 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . 0.54 HG23 ' HB2' ' A' ' 255' ' ' LEU . 15.4 m -99.18 2.34 10.52 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.325 -176.109 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 4.6 t30 55.68 32.29 19.05 Favored 'General case' 0 N--CA 1.495 1.821 0 C-N-CA 124.513 1.125 . . . . 0.0 110.777 179.051 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.54 ' HB2' HG23 ' A' ' 253' ' ' VAL . 15.7 tp -80.2 108.09 13.52 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 -178.597 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 58.5 tttm -82.77 -21.34 34.67 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.986 0.915 . . . . 0.0 111.34 -174.579 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -135.43 143.3 44.71 Favored Pre-proline 0 CA--C 1.542 0.641 0 C-N-CA 124.631 1.172 . . . . 0.0 109.235 -173.469 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -61.5 153.22 67.98 Favored 'Trans proline' 0 C--N 1.372 1.79 0 C-N-CA 122.648 2.232 . . . . 0.0 112.732 -177.216 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 259' ' ' PRO . . . . . 0.411 ' HB3' ' HB2' ' A' ' 263' ' ' TRP . 43.6 Cg_exo -59.19 127.99 26.05 Favored 'Trans proline' 0 C--N 1.382 2.298 0 C-N-CA 122.794 2.329 . . . . 0.0 112.263 178.503 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -68.64 -37.06 79.38 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.365 0.666 . . . . 0.0 110.258 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -152.49 -126.49 1.2 Allowed Glycine 0 C--N 1.344 1.01 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.88 178.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 24.7 m -65.27 124.44 22.2 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.04 0.936 . . . . 0.0 110.457 177.467 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 263' ' ' TRP . . . . . 0.411 ' HB2' ' HB3' ' A' ' 259' ' ' PRO . 78.1 t90 -125.18 107.24 10.55 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.743 0.817 . . . . 0.0 109.432 -176.094 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -88.72 118.81 28.66 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.645 0.778 . . . . 0.0 109.534 174.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 12.7 p -69.47 156.56 91.43 Favored Pre-proline 0 CA--C 1.56 1.343 0 CA-C-O 117.951 -1.023 . . . . 0.0 109.301 174.376 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -19.6 -70.05 0.02 OUTLIER 'Trans proline' 0 C--N 1.394 2.931 1 C-N-CA 126.263 4.642 . . . . 0.0 117.523 -170.246 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.69 -27.28 65.81 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -172.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 268' ' ' CYS . . . . . . . . . . . . . 82.4 m -69.26 -30.89 69.11 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 123.476 0.71 . . . . 0.0 112.203 177.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -92.57 -46.27 7.7 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.296 0.639 . . . . 0.0 110.569 -177.115 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 85.5 mt -84.14 -48.08 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 123.74 0.816 . . . . 0.0 111.433 -171.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 . . . . . 0 C--O 1.255 1.378 0 CA-C-O 118.732 -0.651 . . . . 0.0 110.718 -171.684 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 9.4 t . . . . . 0 CA--C 1.548 0.889 0 N-CA-C 110.291 -0.262 . . . . 0.0 110.291 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 5.9 tt -155.01 112.98 3.44 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 174.086 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 224' ' ' TYR . . . . . 0.522 ' HB3' ' HA ' ' A' ' 245' ' ' TYR . 67.5 m-85 -141.1 133.58 28.42 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 175.111 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 44.4 t 171.45 157.46 0.08 Allowed 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 124.752 1.221 . . . . 0.0 109.419 170.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -58.27 -44.41 88.41 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.86 0.864 . . . . 0.0 111.587 -179.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 16.2 p -73.33 -13.78 61.17 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 123.12 0.568 . . . . 0.0 111.401 -179.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 84.4 mm-40 55.84 73.69 0.42 Allowed 'General case' 0 C--N 1.366 1.297 0 C-N-CA 124.678 1.191 . . . . 0.0 111.327 -173.088 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 28.2 tpt180 -151.02 151.1 31.56 Favored 'General case' 0 C--O 1.244 0.772 0 CA-C-N 114.808 -1.087 . . . . 0.0 109.129 -178.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 21.0 m -66.93 160.77 3.97 Favored 'Isoleucine or valine' 0 C--O 1.243 0.755 0 C-N-CA 123.285 0.634 . . . . 0.0 111.301 173.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . 0.423 ' HB3' ' O ' ' A' ' 234' ' ' GLU . 45.5 m -87.54 69.33 9.76 Favored 'General case' 0 CA--C 1.549 0.937 0 CA-C-N 115.373 -0.831 . . . . 0.0 109.961 179.566 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -68.97 111.91 5.28 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.223 0.609 . . . . 0.0 111.439 -177.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 79.88 -19.25 6.52 Favored Glycine 0 CA--C 1.538 1.494 0 CA-C-N 115.801 -0.636 . . . . 0.0 114.31 172.249 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . 0.423 ' O ' ' HB3' ' A' ' 231' ' ' SER . 30.0 mt-10 -132.01 148.71 52.52 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 125.235 1.414 . . . . 0.0 107.509 -175.025 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 235' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -154.71 135.21 13.4 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-O 121.593 0.711 . . . . 0.0 111.488 175.359 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 0.528 HG13 ' HB2' ' A' ' 248' ' ' PHE . 1.1 p -145.09 123.08 4.98 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 170.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -96.47 140.26 31.38 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 173.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 238' ' ' CYS . . . . . . . . . . . . . 37.9 t -101.63 114.31 28.24 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 123.393 0.677 . . . . 0.0 109.984 -179.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -69.96 95.39 0.93 Allowed 'General case' 0 CA--C 1.543 0.693 0 O-C-N 123.93 0.769 . . . . 0.0 109.444 178.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -142.52 116.07 1.01 Allowed Glycine 0 C--N 1.342 0.911 0 CA-C-O 118.363 -1.243 . . . . 0.0 112.15 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_exo -58.24 -31.81 94.44 Favored 'Trans proline' 0 C--N 1.379 2.136 0 C-N-CA 122.787 2.325 . . . . 0.0 111.638 173.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -115.39 86.32 2.44 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 171.137 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 7.7 t -161.38 91.03 0.83 Allowed 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.497 0.719 . . . . 0.0 109.704 -178.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.76 -44.93 80.11 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 122.975 0.51 . . . . 0.0 110.026 173.463 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . 0.522 ' HA ' ' HB3' ' A' ' 224' ' ' TYR . 96.5 m-85 -81.14 22.61 0.64 Allowed 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 124.669 1.187 . . . . 0.0 112.715 -176.388 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -52.36 -32.94 40.83 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 125.023 1.329 . . . . 0.0 114.202 -172.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 247' ' ' TRP . . . . . 0.507 ' HB2' ' HB2' ' A' ' 224' ' ' TYR . 39.3 m95 -75.08 130.36 39.15 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-O 121.331 0.586 . . . . 0.0 110.447 176.282 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 248' ' ' PHE . . . . . 0.528 ' HB2' HG13 ' A' ' 236' ' ' VAL . 98.5 m-85 -141.43 171.31 14.23 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.312 1.045 . . . . 0.0 109.746 177.844 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 249' ' ' HIS . . . . . 0.449 ' HD2' ' HB2' ' A' ' 252' ' ' CYS . 0.0 OUTLIER -134.68 145.64 48.72 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 176.745 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . 0.464 ' HB3' ' O ' ' A' ' 255' ' ' LEU . 21.1 m-30 -53.88 -55.98 21.83 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 124.213 1.005 . . . . 0.0 113.303 -166.325 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -60.86 -34.17 74.19 Favored 'General case' 0 N--CA 1.496 1.839 0 C-N-CA 123.311 0.644 . . . . 0.0 111.733 -174.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 252' ' ' CYS . . . . . 0.449 ' HB2' ' HD2' ' A' ' 249' ' ' HIS . 11.3 t -68.45 -32.25 72.14 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 124.162 0.985 . . . . 0.0 111.631 -175.425 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . 0.493 HG23 ' HG ' ' A' ' 255' ' ' LEU . 16.3 m -108.76 6.23 9.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 C-N-CA 124.04 0.936 . . . . 0.0 110.735 175.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 18.4 m120 64.32 24.84 13.37 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 125.574 1.549 . . . . 0.0 113.359 173.425 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.493 ' HG ' HG23 ' A' ' 253' ' ' VAL . 96.5 mt -70.94 121.32 17.92 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 166.331 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 36.4 mtmm -96.55 15.73 20.77 Favored 'General case' 0 N--CA 1.485 1.276 0 CA-C-O 120.805 0.336 . . . . 0.0 110.661 175.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -164.3 163.41 15.07 Favored Pre-proline 0 CA--C 1.554 1.106 0 C-N-CA 124.131 0.972 . . . . 0.0 109.047 -172.432 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -69.41 160.14 50.96 Favored 'Trans proline' 0 C--N 1.374 1.879 0 C-N-CA 122.488 2.125 . . . . 0.0 112.607 175.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 259' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -59.61 156.88 34.7 Favored 'Trans proline' 0 C--N 1.377 2.063 0 C-N-CA 122.95 2.433 . . . . 0.0 112.783 171.361 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -103.73 31.07 4.65 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.703 0.801 . . . . 0.0 109.713 -179.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 136.81 -141.03 11.96 Favored Glycine 0 C--N 1.339 0.749 0 N-CA-C 110.313 -1.115 . . . . 0.0 110.313 -174.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 40.0 p -72.98 114.67 11.39 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 122.948 0.499 . . . . 0.0 109.821 178.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 263' ' ' TRP . . . . . . . . . . . . . 47.1 t90 -90.82 136.81 32.82 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.438 0.695 . . . . 0.0 109.856 -176.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -124.11 115.72 21.59 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.364 0.665 . . . . 0.0 110.688 -177.37 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 265' ' ' CYS . . . . . 0.494 ' SG ' ' HB2' ' A' ' 267' ' ' GLU . 19.1 p -70.75 160.08 83.13 Favored Pre-proline 0 N--CA 1.484 1.231 0 C-N-CA 124.308 1.043 . . . . 0.0 109.658 172.63 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 99.9 Cg_exo -47.29 -27.06 6.32 Favored 'Trans proline' 0 C--N 1.388 2.639 0 C-N-CA 123.825 3.017 . . . . 0.0 115.696 177.198 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 267' ' ' GLU . . . . . 0.494 ' HB2' ' SG ' ' A' ' 265' ' ' CYS . 39.6 mt-10 -59.4 -49.45 77.75 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 123.962 0.905 . . . . 0.0 110.581 174.296 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 268' ' ' CYS . . . . . . . . . . . . . 76.4 m -85.07 -30.86 23.74 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.268 1.027 . . . . 0.0 111.712 -177.263 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 65.2 tttm -85.49 -51.63 6.39 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.867 -168.391 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 45.2 mt -97.8 -52.07 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 C-N-CA 123.1 0.56 . . . . 0.0 110.952 -176.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 . . . . . 0 CA--C 1.554 1.106 0 C-N-CA 123.177 0.591 . . . . 0.0 110.595 -171.721 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 13.2 p . . . . . 0 N--CA 1.476 0.864 0 CA-C-O 120.748 0.308 . . . . 0.0 110.564 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 5.9 tt -99.59 90.53 4.52 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 178.135 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 224' ' ' TYR . . . . . 0.528 ' HB2' ' HB2' ' A' ' 247' ' ' TRP . 71.0 m-85 -135.28 133.21 38.67 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 176.69 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 36.9 t 175.13 166.67 0.3 Allowed 'General case' 0 N--CA 1.474 0.747 0 O-C-N 124.643 1.214 . . . . 0.0 109.562 175.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 32.9 t80 -73.05 -33.46 65.69 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 177.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 9.4 p -82.18 -11.39 58.74 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 122.84 0.456 . . . . 0.0 111.04 173.048 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 82.2 mm-40 56.46 89.38 0.04 OUTLIER 'General case' 0 C--N 1.361 1.08 0 C-N-CA 125.348 1.459 . . . . 0.0 111.249 -174.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 -153.41 149.04 27.37 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.87 -176.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 34.2 m -66.28 148.49 12.05 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.823 0 C-N-CA 123.7 0.8 . . . . 0.0 110.952 174.291 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 35.9 m -107.43 120.66 42.78 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 175.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 31.4 p90 -141.92 125.92 17.25 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.555 0.742 . . . . 0.0 109.822 -174.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 78.09 -14.69 10.32 Favored Glycine 0 C--N 1.354 1.533 0 CA-C-N 116.334 -0.394 . . . . 0.0 113.138 -174.088 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -154.88 101.33 2.27 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.543 1.137 . . . . 0.0 108.165 -176.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 235' ' ' MET . . . . . . . . . . . . . 54.1 mtp -128.25 113.33 15.53 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 -178.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 6.8 p -108.34 125.32 65.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 175.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -99.7 168.54 9.86 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.727 0.811 . . . . 0.0 110.519 179.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 238' ' ' CYS . . . . . . . . . . . . . 26.9 t -144.29 123.25 12.77 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 122.668 0.387 . . . . 0.0 111.51 -177.344 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -79.22 105.38 10.51 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.376 0.67 . . . . 0.0 109.981 174.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -142.16 141.22 10.65 Favored Glycine 0 C--N 1.341 0.813 0 CA-C-O 118.558 -1.134 . . . . 0.0 111.285 175.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -60.09 -52.9 3.58 Favored 'Trans proline' 0 C--N 1.379 2.183 0 C-N-CA 122.758 2.306 . . . . 0.0 110.757 176.356 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -106.55 129.04 54.56 Favored 'General case' 0 C--O 1.242 0.675 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 163.166 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 243' ' ' CYS . . . . . 0.437 ' SG ' ' HA ' ' A' ' 246' ' ' GLU . 26.5 t -173.13 89.42 0.08 Allowed 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 -174.382 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.1 -24.29 30.4 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 122.893 0.477 . . . . 0.0 110.603 179.631 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 53.1 m-85 -101.32 26.88 6.69 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.321 1.049 . . . . 0.0 110.367 177.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 246' ' ' GLU . . . . . 0.437 ' HA ' ' SG ' ' A' ' 243' ' ' CYS . 8.5 pt-20 -48.66 -34.92 12.72 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 124.41 1.084 . . . . 0.0 112.579 176.653 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 247' ' ' TRP . . . . . 0.528 ' HB2' ' HB2' ' A' ' 224' ' ' TYR . 94.5 m95 -96.07 136.4 36.57 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 121.379 0.609 . . . . 0.0 111.133 176.609 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -144.71 173.44 11.83 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 125.196 1.398 . . . . 0.0 108.521 171.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 249' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -113.04 138.23 50.21 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 170.655 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -55.49 -32.86 63.19 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 124.181 0.992 . . . . 0.0 112.157 -173.385 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -56.47 -45.06 81.09 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 125.007 1.323 . . . . 0.0 112.455 178.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 252' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -68.04 -51.29 48.55 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.226 1.011 . . . . 0.0 110.984 -175.472 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 22.3 m -81.7 -9.95 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 CA-C-N 115.223 -0.898 . . . . 0.0 111.963 -178.242 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 17.5 m120 59.84 41.67 17.67 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.857 1.263 . . . . 0.0 110.795 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 34.7 tp -90.9 108.04 19.58 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 178.119 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -70.23 -44.81 67.81 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 122.986 0.515 . . . . 0.0 110.758 -178.205 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -133.53 130.97 21.14 Favored Pre-proline 0 C--O 1.24 0.567 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 -178.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -56.95 141.96 93.57 Favored 'Trans proline' 0 C--N 1.371 1.763 0 C-N-CA 122.257 1.972 . . . . 0.0 110.707 171.608 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 259' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -68.14 -178.94 1.94 Allowed 'Trans proline' 0 C--N 1.37 1.678 0 C-N-CA 123.06 2.507 . . . . 0.0 113.018 -169.02 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 27.7 mmmt -74.75 -3.6 32.55 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 116.068 -0.514 . . . . 0.0 112.383 -174.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -154.43 -143.92 3.79 Favored Glycine 0 C--N 1.338 0.689 0 N-CA-C 111.502 -0.639 . . . . 0.0 111.502 174.028 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 43.5 p -69.68 116.83 10.54 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 123.693 0.797 . . . . 0.0 110.607 -177.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 263' ' ' TRP . . . . . . . . . . . . . 37.9 t90 -66.41 135.69 54.66 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 122.965 0.506 . . . . 0.0 110.266 178.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 264' ' ' TYR . . . . . 0.445 ' HB3' ' HB3' ' A' ' 269' ' ' LYS . 39.6 m-85 -118.44 110.6 17.63 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.433 0.693 . . . . 0.0 109.768 -177.69 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 265' ' ' CYS . . . . . 0.4 ' SG ' ' HB2' ' A' ' 267' ' ' GLU . 14.8 p -67.25 162.77 52.16 Favored Pre-proline 0 CA--C 1.554 1.122 0 C-N-CA 124.128 0.971 . . . . 0.0 109.65 172.1 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -53.57 -24.51 29.31 Favored 'Trans proline' 0 C--N 1.385 2.452 0 C-N-CA 123.374 2.716 . . . . 0.0 114.594 -178.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 267' ' ' GLU . . . . . 0.4 ' HB2' ' SG ' ' A' ' 265' ' ' CYS . 33.7 mt-10 -57.38 -54.79 42.79 Favored 'General case' 0 N--CA 1.483 1.187 0 CA-C-O 121.488 0.661 . . . . 0.0 110.326 173.432 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 268' ' ' CYS . . . . . . . . . . . . . 57.9 m -86.75 -39.28 16.12 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 114.606 -1.179 . . . . 0.0 112.709 -168.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . 0.445 ' HB3' ' HB3' ' A' ' 264' ' ' TYR . 12.5 ptmm? -75.66 -28.87 58.88 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-O 120.654 0.264 . . . . 0.0 111.703 -169.612 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 61.8 mt -92.2 -50.7 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 177.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 . . . . . 0 CA--C 1.554 1.117 0 C-N-CA 123.456 0.703 . . . . 0.0 109.209 179.234 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 33.6 p . . . . . 0 C--O 1.244 0.812 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 57.0 tp -74.96 94.41 2.83 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.15 0.58 . . . . 0.0 109.929 -179.178 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 224' ' ' TYR . . . . . 0.588 ' HB3' ' HA ' ' A' ' 245' ' ' TYR . 77.3 m-85 -135.49 134.33 39.43 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 172.551 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 49.3 t 172.84 161.62 0.12 Allowed 'General case' 0 N--CA 1.474 0.769 0 O-C-N 124.823 1.327 . . . . 0.0 108.284 171.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -67.09 -32.63 73.92 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 122.08 0.152 . . . . 0.0 110.965 177.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 13.1 p -85.52 -17.43 36.4 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 122.706 0.402 . . . . 0.0 111.288 177.711 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 20.4 mm-40 52.92 77.6 0.16 Allowed 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 124.645 1.178 . . . . 0.0 111.907 -172.233 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 4.6 tmt_? -151.32 154.57 36.99 Favored 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 -178.601 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 23.1 m -73.1 156.25 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 CA-C-O 121.394 0.616 . . . . 0.0 112.59 -173.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 17.3 m -95.91 104.48 16.41 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.864 0.866 . . . . 0.0 108.771 172.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -74.14 79.32 1.76 Allowed 'General case' 0 N--CA 1.479 1.009 0 CA-C-O 121.508 0.67 . . . . 0.0 110.24 -179.158 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 74.68 -18.17 2.42 Favored Glycine 0 CA--C 1.539 1.568 0 N-CA-C 115.331 0.893 . . . . 0.0 115.331 177.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . 0.403 ' HB3' ' HD1' ' A' ' 250' ' ' TYR . 20.5 mm-40 -113.28 110.52 20.51 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.829 0.852 . . . . 0.0 109.335 -175.371 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 235' ' ' MET . . . . . . . . . . . . . 55.1 mtm -126.01 102.23 7.16 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.094 0.958 . . . . 0.0 109.679 -172.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 0.4 HG11 HG21 ' A' ' 253' ' ' VAL . 3.9 p -87.98 123.34 40.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 168.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -92.79 155.02 17.93 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 123.083 0.553 . . . . 0.0 109.92 -178.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 238' ' ' CYS . . . . . 0.633 ' HB3' ' HA ' ' A' ' 246' ' ' GLU . 42.1 t -116.23 152.12 34.4 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 115.126 -0.943 . . . . 0.0 108.87 176.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -119.92 99.22 6.49 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 171.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . 0.61 ' HA3' ' SG ' ' A' ' 268' ' ' CYS . . . -139.99 129.52 4.3 Favored Glycine 0 C--N 1.34 0.785 0 CA-C-O 118.124 -1.375 . . . . 0.0 111.004 176.763 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -48.89 -49.56 14.78 Favored 'Trans proline' 0 C--N 1.382 2.325 0 C-N-CA 123.666 2.91 . . . . 0.0 113.752 -177.656 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -111.19 101.87 10.34 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 171.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 43.9 t -172.86 106.62 0.16 Allowed 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 -173.561 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 9.3 ptpp? -86.78 -24.57 25.01 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 173.332 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . 0.588 ' HA ' ' HB3' ' A' ' 224' ' ' TYR . 22.7 m-85 -81.12 23.69 0.56 Allowed 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.403 1.081 . . . . 0.0 112.225 -177.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 246' ' ' GLU . . . . . 0.633 ' HA ' ' HB3' ' A' ' 238' ' ' CYS . 5.9 mm-40 -48.9 -37.51 19.96 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 123.641 0.776 . . . . 0.0 111.35 178.556 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 247' ' ' TRP . . . . . 0.502 ' HB2' ' HB2' ' A' ' 224' ' ' TYR . 98.4 m95 -76.45 115.85 16.58 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.505 174.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -130.18 173.35 10.85 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.652 1.181 . . . . 0.0 109.371 171.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 249' ' ' HIS . . . . . 0.569 ' HD2' ' HB2' ' A' ' 252' ' ' CYS . 0.1 OUTLIER -126.01 142.0 51.71 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.454 1.101 . . . . 0.0 108.508 178.232 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . 0.403 ' HD1' ' HB3' ' A' ' 234' ' ' GLU . 70.3 m-85 -60.58 -34.83 74.77 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 124.489 1.116 . . . . 0.0 113.493 -168.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -67.52 -35.74 79.68 Favored 'General case' 0 N--CA 1.485 1.293 0 CA-C-O 121.537 0.684 . . . . 0.0 110.998 -178.147 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 252' ' ' CYS . . . . . 0.569 ' HB2' ' HD2' ' A' ' 249' ' ' HIS . 9.0 t -71.68 -41.06 69.14 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 125.024 1.33 . . . . 0.0 110.852 -175.454 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . 0.4 HG21 HG11 ' A' ' 236' ' ' VAL . 27.9 m -93.16 -2.02 10.63 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.859 0 CA-C-N 114.481 -1.236 . . . . 0.0 110.957 179.685 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 33.5 m-80 62.69 24.89 14.81 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 124.803 1.241 . . . . 0.0 112.524 175.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 81.0 mt -80.58 119.64 23.49 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 173.161 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 14.3 tppt? -81.06 -25.34 37.17 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.425 0.69 . . . . 0.0 110.51 179.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -136.35 162.56 55.67 Favored Pre-proline 0 CA--C 1.55 0.949 0 C-N-CA 124.319 1.047 . . . . 0.0 109.552 -178.711 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -56.31 136.06 73.43 Favored 'Trans proline' 0 C--N 1.38 2.196 0 C-N-CA 122.435 2.09 . . . . 0.0 111.532 170.329 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 259' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -58.73 156.07 34.39 Favored 'Trans proline' 0 C--N 1.375 1.97 0 C-N-CA 123.289 2.659 . . . . 0.0 113.076 -176.528 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -66.38 -20.72 66.15 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.833 0.853 . . . . 0.0 112.764 -173.313 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -165.57 -141.94 3.28 Favored Glycine 0 C--N 1.347 1.145 0 CA-C-O 119.752 -0.471 . . . . 0.0 112.176 179.232 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 25.4 m -65.32 107.25 1.56 Allowed 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.638 0.775 . . . . 0.0 109.819 178.392 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 263' ' ' TRP . . . . . . . . . . . . . 53.8 t90 -88.58 114.12 24.87 Favored 'General case' 0 C--O 1.242 0.679 0 C-N-CA 123.285 0.634 . . . . 0.0 110.316 -175.613 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -96.64 118.84 33.97 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 123.93 0.892 . . . . 0.0 108.599 171.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 17.9 p -64.04 159.68 53.92 Favored Pre-proline 0 CA--C 1.555 1.164 0 C-N-CA 123.508 0.723 . . . . 0.0 110.122 172.162 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -50.91 -33.87 43.43 Favored 'Trans proline' 0 C--N 1.382 2.315 0 C-N-CA 123.202 2.601 . . . . 0.0 113.714 -178.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -59.18 -43.19 92.18 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-O 121.043 0.449 . . . . 0.0 111.242 177.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 268' ' ' CYS . . . . . 0.61 ' SG ' ' HA3' ' A' ' 240' ' ' GLY . 67.2 m -72.64 -27.92 62.43 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.087 0.955 . . . . 0.0 112.563 -177.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 49.1 mtmt -88.07 -41.56 12.98 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 122.84 0.456 . . . . 0.0 111.337 -175.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 16.8 mt -102.3 15.7 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 C-N-CA 123.283 0.633 . . . . 0.0 110.583 -168.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 . . . . . 0 CA--C 1.565 1.552 0 C-N-CA 122.651 0.38 . . . . 0.0 110.951 175.188 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 23.0 p . . . . . 0 N--CA 1.478 0.95 0 CA-C-O 121.116 0.484 . . . . 0.0 109.81 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 35.8 tp -89.77 79.82 6.65 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 176.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 224' ' ' TYR . . . . . 0.524 ' HB3' ' HA ' ' A' ' 245' ' ' TYR . 74.1 m-85 -138.09 125.95 22.52 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 175.591 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 225' ' ' CYS . . . . . 0.403 ' HB2' ' O ' ' A' ' 224' ' ' TYR . 34.4 t 174.54 161.85 0.2 Allowed 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.959 0.904 . . . . 0.0 109.203 173.586 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -69.24 -34.92 75.56 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 122.347 0.259 . . . . 0.0 110.458 175.306 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 3.9 p -83.47 -14.59 52.13 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.105 175.249 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 22.6 mm-40 53.87 101.09 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 125.601 1.56 . . . . 0.0 112.713 -172.233 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 22.8 tpp180 -162.97 157.97 21.68 Favored 'General case' 0 C--O 1.244 0.801 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 -178.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 19.5 m -71.4 154.21 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 CA-C-O 120.828 0.347 . . . . 0.0 111.173 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 17.1 m -116.86 60.57 0.74 Allowed 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 123.568 0.747 . . . . 0.0 109.422 -179.233 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 79.8 t80 -71.84 108.69 5.26 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.143 0.577 . . . . 0.0 111.769 -172.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 85.18 -18.22 29.03 Favored Glycine 0 N--CA 1.472 1.089 0 CA-C-N 115.6 -0.727 . . . . 0.0 114.156 174.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -131.51 94.57 3.56 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 124.257 1.023 . . . . 0.0 108.62 -177.269 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 235' ' ' MET . . . . . 0.418 ' HB3' ' CE3' ' A' ' 247' ' ' TRP . 63.3 mtm -122.03 100.75 7.14 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.8 0.84 . . . . 0.0 109.062 -179.366 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 4.8 p -87.8 124.83 41.26 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 170.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -88.65 130.53 35.27 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.539 0.736 . . . . 0.0 109.892 -178.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 238' ' ' CYS . . . . . 0.519 ' HB3' ' HA ' ' A' ' 246' ' ' GLU . 36.2 t -99.65 152.29 20.24 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.069 0.947 . . . . 0.0 109.398 175.239 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -127.23 108.23 10.7 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.933 0.893 . . . . 0.0 108.667 172.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -139.97 160.57 26.25 Favored Glycine 0 N--CA 1.473 1.144 0 CA-C-O 119.224 -0.765 . . . . 0.0 111.829 174.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -69.77 -35.31 12.85 Favored 'Trans proline' 0 C--N 1.375 1.973 0 C-N-CA 122.285 1.99 . . . . 0.0 112.156 174.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -128.48 110.19 12.08 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.896 0.879 . . . . 0.0 108.776 176.329 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 29.7 t -177.39 104.76 0.05 Allowed 'General case' 0 C--N 1.347 0.476 0 C-N-CA 123.56 0.744 . . . . 0.0 109.502 -175.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 16.8 tppt? -76.71 -30.6 56.73 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-O 121.548 0.69 . . . . 0.0 110.169 171.496 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . 0.524 ' HA ' ' HB3' ' A' ' 224' ' ' TYR . 15.5 m-85 -87.55 23.76 1.85 Allowed 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.42 1.088 . . . . 0.0 112.537 -168.347 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 246' ' ' GLU . . . . . 0.519 ' HA ' ' HB3' ' A' ' 238' ' ' CYS . 5.9 mm-40 -46.94 -45.07 20.49 Favored 'General case' 0 N--CA 1.499 2.001 0 C-N-CA 124.187 0.995 . . . . 0.0 112.481 -172.145 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 247' ' ' TRP . . . . . 0.418 ' CE3' ' HB3' ' A' ' 235' ' ' MET . 97.1 m95 -77.56 117.11 18.68 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 122.851 0.461 . . . . 0.0 110.056 173.665 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -122.18 159.26 27.61 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.93 0.892 . . . . 0.0 110.515 175.55 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 249' ' ' HIS . . . . . 0.49 ' CD2' ' HB2' ' A' ' 252' ' ' CYS . 0.7 OUTLIER -93.29 129.88 39.22 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 114.792 -1.094 . . . . 0.0 108.386 167.821 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 48.1 m-85 -52.91 -38.24 61.58 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 124.724 1.21 . . . . 0.0 112.272 -175.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -57.13 -34.79 68.75 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 124.79 1.236 . . . . 0.0 112.498 -177.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 252' ' ' CYS . . . . . 0.49 ' HB2' ' CD2' ' A' ' 249' ' ' HIS . 0.5 OUTLIER -65.63 -56.27 13.1 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 124.032 0.933 . . . . 0.0 110.585 -177.488 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . 0.512 HG23 ' HB2' ' A' ' 255' ' ' LEU . 20.7 m -82.85 -1.54 5.78 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.879 0 CA-C-N 114.595 -1.184 . . . . 0.0 111.314 -176.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 9.9 t30 61.13 31.37 19.67 Favored 'General case' 0 C--N 1.365 1.267 0 C-N-CA 124.662 1.185 . . . . 0.0 110.393 179.543 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.529 HD21 ' HG3' ' A' ' 259' ' ' PRO . 16.4 tp -76.45 89.66 3.24 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 177.543 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -71.42 -20.32 62.13 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 115.114 -0.948 . . . . 0.0 111.893 -172.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -139.19 152.95 70.74 Favored Pre-proline 0 CA--C 1.552 1.021 0 C-N-CA 124.509 1.123 . . . . 0.0 109.581 -177.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -59.14 148.51 85.35 Favored 'Trans proline' 0 C--N 1.381 2.274 0 C-N-CA 123.249 2.633 . . . . 0.0 113.663 179.31 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 259' ' ' PRO . . . . . 0.529 ' HG3' HD21 ' A' ' 255' ' ' LEU . 14.3 Cg_exo -68.9 146.31 65.09 Favored 'Trans proline' 0 C--N 1.38 2.205 0 C-N-CA 122.963 2.442 . . . . 0.0 111.987 172.206 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 57.6 mttp -86.31 -28.01 23.97 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.661 0.784 . . . . 0.0 110.876 -178.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -137.1 -150.27 5.74 Favored Glycine 0 C--N 1.345 1.082 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.849 -179.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 25.8 m -71.04 116.87 11.83 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 123.447 0.699 . . . . 0.0 110.511 -177.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 263' ' ' TRP . . . . . . . . . . . . . 27.9 t90 -91.26 114.93 27.59 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.965 0.906 . . . . 0.0 110.207 -175.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -100.64 117.69 35.27 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 170.137 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 265' ' ' CYS . . . . . 0.41 ' SG ' ' OE2' ' A' ' 267' ' ' GLU . 14.4 p -70.92 161.82 75.67 Favored Pre-proline 0 CA--C 1.56 1.328 0 CA-C-O 117.77 -1.11 . . . . 0.0 109.773 176.35 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_exo -27.25 -69.62 0.04 OUTLIER 'Trans proline' 0 C--N 1.397 3.09 1 C-N-CA 125.402 4.068 . . . . 0.0 116.742 -173.673 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 267' ' ' GLU . . . . . 0.41 ' OE2' ' SG ' ' A' ' 265' ' ' CYS . 0.0 OUTLIER -63.81 -26.15 68.5 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -173.794 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 268' ' ' CYS . . . . . . . . . . . . . 97.3 m -72.17 -47.45 50.73 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 123.113 0.565 . . . . 0.0 112.013 176.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 12.2 ptmm? -77.05 -23.66 52.01 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.987 -173.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 86.1 mt -88.39 -43.35 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 123.761 0.824 . . . . 0.0 110.206 178.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 . . . . . 0 C--O 1.257 1.449 0 C-N-CA 123.596 0.759 . . . . 0.0 109.564 -174.874 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 23.2 p . . . . . 0 N--CA 1.477 0.923 0 CA-C-O 120.774 0.321 . . . . 0.0 110.458 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 53.7 tp -94.86 93.81 7.67 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.003 0.921 . . . . 0.0 110.056 -177.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 224' ' ' TYR . . . . . 0.428 ' HB3' ' HA ' ' A' ' 245' ' ' TYR . 66.5 m-85 -135.58 124.09 23.54 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.456 0.702 . . . . 0.0 109.279 172.747 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 36.8 t 172.01 158.69 0.1 Allowed 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 125.208 1.403 . . . . 0.0 109.349 172.033 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 77.5 t80 -66.99 -41.78 86.17 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 117.942 0.337 . . . . 0.0 110.919 177.049 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 6.3 p -72.48 -10.74 60.17 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 122.504 0.321 . . . . 0.0 110.43 176.319 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 82.4 mm-40 53.88 88.8 0.03 OUTLIER 'General case' 0 C--N 1.368 1.388 0 C-N-CA 124.823 1.249 . . . . 0.0 110.78 -173.073 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 2.4 tpm_? -153.32 146.11 24.35 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-N 114.721 -1.127 . . . . 0.0 108.389 -177.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 34.9 m -83.92 149.13 4.56 Favored 'Isoleucine or valine' 0 C--O 1.24 0.587 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 175.306 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 21.4 m -84.73 88.12 7.35 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.324 0.65 . . . . 0.0 110.104 -178.647 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -74.41 88.85 2.1 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.668 0.787 . . . . 0.0 110.625 -176.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 78.44 -19.39 4.81 Favored Glycine 0 CA--C 1.535 1.327 0 CA-C-N 115.112 -0.949 . . . . 0.0 114.614 177.087 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -116.26 94.39 4.62 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.035 0.934 . . . . 0.0 108.773 179.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 235' ' ' MET . . . . . . . . . . . . . 20.4 ptt? -120.03 108.98 14.95 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.957 0.903 . . . . 0.0 110.515 -176.186 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 7.5 p -100.22 125.72 53.91 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 169.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -101.4 138.16 38.78 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.553 0.741 . . . . 0.0 110.795 -172.131 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 238' ' ' CYS . . . . . 0.722 ' HB3' ' HA ' ' A' ' 246' ' ' GLU . 34.9 t -95.93 152.29 18.64 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 123.768 0.827 . . . . 0.0 109.055 173.606 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 239' ' ' ASP . . . . . 0.435 ' HB3' ' HB ' ' A' ' 262' ' ' THR . 31.3 t70 -125.96 104.85 8.51 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 175.442 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -138.43 147.94 19.58 Favored Glycine 0 C--N 1.337 0.607 0 CA-C-O 118.859 -0.967 . . . . 0.0 111.245 177.422 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -66.52 -34.28 34.03 Favored 'Trans proline' 0 C--N 1.372 1.788 0 C-N-CA 122.64 2.226 . . . . 0.0 112.368 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -135.98 94.91 3.12 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 176.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 45.1 t -163.93 110.88 1.11 Allowed 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.972 0.909 . . . . 0.0 109.003 -173.381 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 244' ' ' LYS . . . . . 0.56 ' H ' ' HD3' ' A' ' 244' ' ' LYS . 0.1 OUTLIER -82.92 -31.64 27.66 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.18 0.592 . . . . 0.0 110.876 175.991 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . 0.428 ' HA ' ' HB3' ' A' ' 224' ' ' TYR . 71.5 m-85 -79.54 28.68 0.25 Allowed 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 124.543 1.137 . . . . 0.0 113.208 -178.622 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 246' ' ' GLU . . . . . 0.722 ' HA ' ' HB3' ' A' ' 238' ' ' CYS . 5.7 mm-40 -48.91 -48.35 42.65 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.27 0.628 . . . . 0.0 112.276 178.007 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 247' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -78.69 130.83 36.27 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 121.186 0.517 . . . . 0.0 112.103 -176.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -143.73 172.43 12.84 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.192 1.397 . . . . 0.0 109.953 174.539 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 249' ' ' HIS . . . . . 0.439 ' HD2' ' HB2' ' A' ' 252' ' ' CYS . 0.0 OUTLIER -120.36 140.75 50.85 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.559 1.144 . . . . 0.0 108.499 179.329 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . 0.425 ' HB3' ' O ' ' A' ' 255' ' ' LEU . 49.0 m-85 -54.8 -54.38 42.89 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.855 1.262 . . . . 0.0 113.285 -167.292 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -59.8 -34.41 73.0 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 123.262 0.625 . . . . 0.0 112.174 -175.234 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 252' ' ' CYS . . . . . 0.439 ' HB2' ' HD2' ' A' ' 249' ' ' HIS . 7.3 t -67.0 -43.28 83.34 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.037 0.935 . . . . 0.0 111.195 -177.309 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 9.2 m -93.17 14.76 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.175 0 C-N-CA 123.788 0.835 . . . . 0.0 111.315 177.006 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 6.4 t30 67.48 7.87 5.9 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 125.103 1.361 . . . . 0.0 112.524 172.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.425 ' O ' ' HB3' ' A' ' 250' ' ' TYR . 87.9 mt -74.43 104.15 5.05 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.048 0.539 . . . . 0.0 110.732 -179.004 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 52.3 tttm -63.73 -36.87 85.28 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.237 1.015 . . . . 0.0 110.303 169.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -142.96 149.61 49.98 Favored Pre-proline 0 CA--C 1.549 0.936 0 CA-C-N 114.676 -1.147 . . . . 0.0 109.777 -170.258 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 258' ' ' PRO . . . . . 0.504 ' HA ' ' HD3' ' A' ' 259' ' ' PRO . 33.6 Cg_endo -62.51 138.14 68.74 Favored 'Trans proline' 0 C--N 1.38 2.23 0 C-N-CA 122.864 2.376 . . . . 0.0 113.1 -175.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 259' ' ' PRO . . . . . 0.504 ' HD3' ' HA ' ' A' ' 258' ' ' PRO . 17.3 Cg_exo -69.6 137.81 36.82 Favored 'Trans proline' 0 C--N 1.372 1.779 0 C-N-CA 123.261 2.641 . . . . 0.0 111.917 177.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -73.21 96.99 2.33 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 123.505 0.722 . . . . 0.0 109.931 -175.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 117.65 -168.8 13.05 Favored Glycine 0 N--CA 1.472 1.063 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.83 178.31 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 262' ' ' THR . . . . . 0.435 ' HB ' ' HB3' ' A' ' 239' ' ' ASP . 32.5 p -66.34 107.01 1.86 Allowed 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.08 0.552 . . . . 0.0 109.879 173.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 263' ' ' TRP . . . . . . . . . . . . . 32.0 t90 -70.11 140.2 52.65 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 122.853 0.461 . . . . 0.0 110.139 -179.435 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -113.2 118.66 35.32 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 172.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 20.4 p -57.35 150.59 42.4 Favored Pre-proline 0 N--CA 1.478 0.952 0 CA-C-O 118.543 -0.741 . . . . 0.0 109.489 172.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_exo -45.57 -32.34 8.24 Favored 'Trans proline' 0 C--N 1.386 2.538 0 C-N-CA 123.407 2.738 . . . . 0.0 114.307 -173.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -65.39 -50.04 67.0 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 123.82 0.848 . . . . 0.0 110.822 -179.567 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 268' ' ' CYS . . . . . . . . . . . . . 43.9 m -59.83 -45.88 91.02 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 123.121 0.568 . . . . 0.0 112.306 -179.377 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . 0.595 ' HD3' HG13 ' A' ' 270' ' ' ILE . 0.1 OUTLIER -81.25 -14.53 57.34 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -171.825 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 270' ' ' ILE . . . . . 0.595 HG13 ' HD3' ' A' ' 269' ' ' LYS . 78.5 mt -92.84 -23.11 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 C-N-CA 123.211 0.604 . . . . 0.0 110.057 172.382 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 . . . . . 0 CA--C 1.559 1.322 0 CA-C-O 118.65 -0.69 . . . . 0.0 110.497 178.438 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 15.3 p . . . . . 0 N--CA 1.474 0.759 0 CA-C-O 121.027 0.441 . . . . 0.0 110.37 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 53.3 tp -80.94 82.56 6.88 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 176.35 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 224' ' ' TYR . . . . . 0.532 ' HB2' ' HB2' ' A' ' 247' ' ' TRP . 69.3 m-85 -133.34 125.46 29.24 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 177.259 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 40.8 t 171.3 154.19 0.07 Allowed 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 125.86 1.664 . . . . 0.0 107.734 173.351 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -61.62 -43.26 99.2 Favored 'General case' 0 CA--C 1.549 0.914 0 CA-C-N 117.872 0.305 . . . . 0.0 110.861 177.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . . 6.2 p -68.67 -17.07 64.02 Favored 'General case' 0 N--CA 1.483 1.177 0 O-C-N 123.321 0.388 . . . . 0.0 111.035 177.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 81.3 mm-40 58.81 83.89 0.12 Allowed 'General case' 0 C--N 1.365 1.262 0 C-N-CA 124.581 1.152 . . . . 0.0 110.753 -174.118 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 14.6 tpt180 -150.24 154.52 38.09 Favored 'General case' 0 C--O 1.243 0.727 0 C-N-CA 124.077 0.951 . . . . 0.0 108.532 179.372 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 27.0 m -81.78 177.37 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 CA-C-O 121.488 0.661 . . . . 0.0 110.78 172.711 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 22.2 p -96.64 153.22 17.98 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.897 171.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 40.8 t80 -84.83 1.53 46.54 Favored 'General case' 0 CA--C 1.56 1.334 0 C-N-CA 123.651 0.78 . . . . 0.0 110.002 168.111 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . 135.6 -19.18 3.8 Favored Glycine 0 C--N 1.347 1.147 0 C-N-CA 124.006 0.812 . . . . 0.0 111.387 -179.022 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.41 123.14 35.51 Favored 'General case' 0 CA--C 1.555 1.136 0 C-N-CA 122.901 0.48 . . . . 0.0 110.017 -178.411 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 235' ' ' MET . . . . . . . . . . . . . 7.9 mmt -144.57 119.89 10.23 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.329 0.652 . . . . 0.0 110.391 -177.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 3.7 p -98.57 126.35 51.71 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 C-N-CA 124.423 1.089 . . . . 0.0 109.48 168.057 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -87.25 134.52 33.54 Favored 'General case' 0 C--O 1.242 0.679 0 C-N-CA 123.217 0.607 . . . . 0.0 110.014 177.589 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 238' ' ' CYS . . . . . 0.542 ' HB3' ' HA ' ' A' ' 246' ' ' GLU . 35.5 t -95.52 123.98 39.33 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 123.464 0.705 . . . . 0.0 111.117 -178.405 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -77.9 94.33 4.54 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 123.893 0.877 . . . . 0.0 109.195 177.19 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -142.04 125.03 2.58 Favored Glycine 0 CA--C 1.529 0.945 0 CA-C-O 118.761 -1.022 . . . . 0.0 111.917 -179.34 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -62.77 -33.79 75.13 Favored 'Trans proline' 0 C--N 1.379 2.132 0 C-N-CA 122.61 2.207 . . . . 0.0 111.422 171.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 242' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -118.32 100.02 7.22 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 169.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 243' ' ' CYS . . . . . . . . . . . . . 12.1 t -165.54 109.29 0.83 Allowed 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 178.09 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 22.7 ttmm -82.99 -35.69 25.65 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-O 121.547 0.689 . . . . 0.0 109.25 170.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . 0.463 ' HA ' ' HB3' ' A' ' 224' ' ' TYR . 89.5 m-85 -83.26 24.12 0.83 Allowed 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 124.985 1.314 . . . . 0.0 113.069 -175.045 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 246' ' ' GLU . . . . . 0.542 ' HA ' ' HB3' ' A' ' 238' ' ' CYS . 42.9 mt-10 -47.85 -38.46 16.12 Favored 'General case' 0 N--CA 1.502 2.149 0 C-N-CA 124.33 1.052 . . . . 0.0 113.181 -174.077 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 247' ' ' TRP . . . . . 0.532 ' HB2' ' HB2' ' A' ' 224' ' ' TYR . 85.6 m95 -78.34 127.09 31.71 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.498 -179.343 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -143.93 130.35 19.93 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.052 0.941 . . . . 0.0 109.605 178.551 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 249' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -71.92 129.56 38.87 Favored 'General case' 0 CA--C 1.547 0.854 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 172.646 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . 0.42 ' HB3' ' O ' ' A' ' 255' ' ' LEU . 50.1 m-85 -52.31 -31.68 34.19 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 124.709 1.204 . . . . 0.0 112.321 -178.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -53.54 -48.01 69.48 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 124.116 0.966 . . . . 0.0 111.89 176.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 252' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -61.04 -41.42 96.54 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.86 0.864 . . . . 0.0 111.414 -176.168 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . . . . . . . . . 31.9 m -97.23 0.24 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 CA-C-N 115.395 -0.821 . . . . 0.0 112.038 -175.055 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 20.2 m120 62.78 17.06 9.55 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 124.934 1.294 . . . . 0.0 113.294 175.008 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.42 ' O ' ' HB3' ' A' ' 250' ' ' TYR . 92.6 mt -80.22 109.47 14.72 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 174.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -75.23 -34.98 61.49 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 121.205 0.526 . . . . 0.0 110.041 175.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -116.98 139.0 25.25 Favored Pre-proline 0 CA--C 1.55 0.966 0 C-N-CA 123.482 0.713 . . . . 0.0 109.566 -175.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 258' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -59.72 136.61 71.66 Favored 'Trans proline' 0 C--N 1.378 2.131 0 C-N-CA 123.66 2.907 . . . . 0.0 113.486 179.184 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 259' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -65.59 127.57 18.3 Favored 'Trans proline' 0 C--N 1.372 1.816 0 C-N-CA 122.641 2.227 . . . . 0.0 111.515 172.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 14.8 ptmm? -73.99 -16.08 61.08 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.419 0.688 . . . . 0.0 111.626 -179.101 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . -118.31 176.9 16.31 Favored Glycine 0 C--N 1.345 1.043 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.893 179.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 36.6 p -57.13 123.05 13.89 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 124.131 0.972 . . . . 0.0 111.809 -177.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 263' ' ' TRP . . . . . . . . . . . . . 44.4 t90 -101.87 115.75 31.22 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.262 0.625 . . . . 0.0 109.36 -174.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 264' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -105.63 111.78 24.61 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.951 0.901 . . . . 0.0 109.253 177.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 16.6 p -64.35 149.11 95.29 Favored Pre-proline 0 CA--C 1.559 1.295 0 CA-C-O 118.326 -0.845 . . . . 0.0 109.4 174.223 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 266' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -27.44 -60.32 0.09 OUTLIER 'Trans proline' 0 C--N 1.384 2.411 1 C-N-CA 125.76 4.307 . . . . 0.0 118.026 -160.606 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 267' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.29 -39.89 86.03 Favored 'General case' 0 N--CA 1.485 1.281 0 CA-C-O 119.293 -0.384 . . . . 0.0 111.604 -175.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 268' ' ' CYS . . . . . . . . . . . . . 59.6 m -52.55 -30.94 33.27 Favored 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 -178.507 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 32.7 ttmt -78.35 -24.66 46.39 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.085 0.554 . . . . 0.0 111.516 -177.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 31.7 pt -112.76 2.51 8.49 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.258 0 C-N-CA 123.544 0.737 . . . . 0.0 112.034 179.08 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 271' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 . . . . . 0 C--O 1.256 1.396 0 C-N-CA 123.984 0.914 . . . . 0.0 109.544 -176.125 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 302' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_